[
  {
    "title": "Unknown Title",
    "author": "Yiming Li",
    "date": "2022-12-18T20:53:08",
    "filename": "2212.09870.pdf",
    "processed_text": "metabolomics aging alzheimer ’ disease single omics multi omics yiming li1 yuan luo1 1department preventive medicine northwestern university usa corresponding author yuanluonorthwesternedu abstract aging multifactorial process key factor morbidity mortality alzheimer ’ disease ad age related disorder main cause worldwide disability aging ad characterized metabolic dysfunction metabolomics quantif complete set metabolites studied sample helpful studying metabolic alterations aging ad review w e summarize metabolomic changes regarding aging ad discuss biological functions highlight potential application diagnostic biomarkers therapeutic targets recent advances multiomics approach es understand ing metabolic mechanism aging nd ad also reviewed keywords alzheimer ’ disease aging metabolomics biomarker multi omics 1 introduction aging natural process involving chronological decline different physiological metabolic functions 1 2 metabolic alterations including impaired mitochondrial function deregulated nutrient sensing among hallmarks aging 1 35 since ging major driver morbidity 6 7 mortality 8 9 understanding metabolic pathways associated mechanism useful precision medicine applications 5 alzheimer ’ disease ad age related disorder major cause worldwide disability mortality 10 ad recognized global public health priority insights ad pathogenesis needed treatment prevention ad 10 previous studies shown widespread metabolic pertu rbation defining feature ad 1113 metabolomics high throughput omics technology allows researchers measure complete set etabolites given sample study alterations different metabolism functions 14 powerful tool studying mechanism aging enables researchers systematically study metabolic dysfunction ad patients facilitating biomarker identification drug discovery clinical intervention ad additionally integrating metabolomics omics data phenotypic data may help us better characterize unique health signatures different patients 1518 review begin introduction major analytical platforms metabolomics common approaches metabolomic data analysis next w e discuss applications metabolomics aging ad research highlighting metabolomic links divergences natural aging ad finally w e review recent multi omics studies related aging ad focus metabolomic finding highlight new avenues research explore metabolomics aging ad 2 metabolism metabolomics metabolism refers set life sustaining chemical reactions within organism ’ cells metabolites intermediates products metabolism technological advancements identify quantify characterize small biological molecule 1500 daltons metabolites found within specific biological sample 19 complete set metabolites called metabolome mass spectrometry ms nuclear magnetic resonance nmr spectroscopy two analytical platforms frequently used measure metabolome ms ionize chemical species sample visualizes mass spectrum ion signals sorted according mass tocharge ratio 20 identify metabolites rapidly requires prior sampl e separation using chromatography techniques including gas chromatography 21 liquid chromatography 22 capillary electrophoresis 23 nmr spectroscopy detect nmr signals produced spinning sample inside magnet ic field hence may identi fy metabolites different molecular structures 24 compared ms nmr spectroscopy non destructive require sample separation 25 however less sensitive detecting low molecular weigh molecules 26 comprehensive analysis metabolome parallel application platforms often needed 27 metabolomic data analysis seeks identify metabolites underlying pathways significantly associated certain diseases conditions requires harnessing highdimensional complex datasets – currently human metabolome database contains 248047 metabolite entries 28 single metabolomic dataset may contain hundreds features 29 30 therefore dimensionality reduction methods like principal component analysis pca 31 hierarchical clustering 32 non negative matrix factorizations 3336 tensor factorizations 3739 often used identify clusters functionally related metabolites followed pathway analysis studies interactions among genes metabolites enrichment topological analysis 40 hand high dimensionality nature metabolom ic data directly leveraged achine learning methods like random forests 41 extreme gradient boosting 42 deep learning 4345 characterize metabolic signatures differ ent diseas es application metabolomics may help researchers identify disease biomarkers clinical use better understand etiology pathogenesis different disorders 14 27 3 metabolomic aging alzheimer ’ disease organism ’ lifespan known influenced mitochondrial endocrine function nutrient sensing redox homeostasis 1 3 4 metabolomic allow researchers investigate complex metabol omic variations representing changes different metabolism functions hence powerful tool studying mechanism aging recent applications metabolomics aging research reviewed adav wang 2 major metab olomic biomarkers aging identified previous studies include amino acids leucine 46 47 glycine 48 49 histidine 50 51 lipids related metabolites like triglyceride 52 53 sphingolipid 50 54 phospholipid 51 55 lipoprotein size 52 53 well redox related metabolites suc h n icotinamide adenine dinucleotide nad 56 reactive oxygen nitrogen species rons 57 results indicate amino acid metabolism lipid metabolism redox reactions may play important role aging longevity 1 58 neuron al activity requires large mount energy brain ’ metabolic consumption represent 20 whole body oxygen uptake 59 decline brain metabolism contribute cognitive impairment 60 one earliest symptoms ad 11 systematically study metabolic perturbations ad metabolomic approaches widely applied recent advances field reviewed wilkins trushina 27 previous studies identified variety metabolomic features associated ad instance rons 61 metabolites glycolytic pathway 12 62 64 amino acids like glutamine histidine 6467 well lipids related metabolites like fatty acids 64 66 68 sphingolipid 67 69 71 phospholipid 12 64 72 acylcarnitine 12 73 empirical evidence support impaired mi tochondrial function 13 glucose metabolism dysregulation 74 altered lipid metabolism 27 75 defining ch aracteristics ad patients aging known important risk factor ad aging ad involve perturbed metabolism 76 etabolomic studies researchers could gain deeper understanding connection aging ad 76 77 shown review agi ng ad many shared metabolomic biomarkers example rons amino acids lipids related metabolites recent study xie et al 78 specifically investigated underlying metabolomic mechanism shared aging ad first identified ten metabolic pathways aging analyzing ms metabolomic data 183 patients correlation analysis random forests enrichment analysis 78 next authors performed systematic review ad related metabolomic studies curating 49 different metabolic pathways 78 three pathways purine metabolism arginine proline metabolism well tricarboxylic acid cycle found shared aging ad 78 purine metabolism closely related pentose phosphate pathway turn glycolysis 77 previous studies found excessive glycolysis may accelerate aging onset 79 dysfunctional glycolysis may causative factor ad 80 arginine amino acid essential nitric oxide synthesis whose impairment found contribute aging 81 whereas proline known help reduce oxidativ e stress improve availability 81 sum mary previous studies identified redox reactions glycolysis lipid metabolism potential metabolomic links aging ad cognitive decline time natural process aging 82 however certain abilities vocabulary resilient brain aging 83 impaired ad pat ients therefore part examining metabolomic links aging ad important investigate metabolomic divergence natural age related cognitive decline arcd ad motsinger reif et al 84 fitted stepwise logistic regression models assess ability metabolite markers discriminate 40 ad patients 38 cognitively normal controls 65 years old cross validation metabolites 15 65533 8 9365 found consistent predictors 84 although identities unknown authors pinpointed known metabolomic markers significantly correlated metabolites methionine glutathione kynurenine indole 3propionic acid 84 results suggest glutathione synthesis tryptophan metabolism oxidative stress may involved pathogenesis ad 84 hunsberge r et al 85 analyzed metabolomic data ad contro l including arcd mice pca anova pathway analysis correlation analysis identified difference metabolomic profiles ad arcd mice prominent prefrontal cortex hippocampus right hemisphere 85 found ad mice exhibit altered protein synthesis phenylalanine tyrosine tryptophan biosynthesis amino acid catabolism arginine proline metabolism alanine aspartate glutamate metabolism histidine metabolism pathways p refrontal cortex 85 hand differentially abundant metabol ites hippocampi ad control mice mainly belong protein synthesis aminoacyl trna biosynthesis oxidative stress glutathione metabolism glyoxylate dicarboxylate metabolism pathways 85 summary previous research found metabolomic divergences arcd ad may related protein synthesis amino acid metabolism oxidative stress pathways 4 multi omics approaches advances highthroughput technologies examin ing genome wide multi level omics enabled researchers perform integrative analysis different types omics data genomic epigenomic transcriptomic proteomic metabolomic microbiomic data 86 multi omics analysis could provide holistic view complex traits elucidat ing potential causative factor 15 86 exists increasin g number multi omics studies delineating molecular taxonomy aging ad also worth noting exist different online multi omics resources studying aging ad example aging atlas 87 database hosting aging related genomic epigenomic transcriptomic proteomic metabolomic data adas viewer 88 web server analyzing genomic epigenomic transcriptomic data three independent ad cohorts study molecular changes aging nie et al 89 used multi omics approach estimate biological ages bas human organs systems utilizing genomic metabolomic microbiomic data healthy population cohort 4066 chinese individuals construct bas klemera doudal algorithm 90 used – regressing chronological age ca available biomarkers ba estimated linearly best fitted value ca authors found organs systems age diverse rates ba used prediction mortality organ specific disorders fatty liver disease 89 moreover bas different human organs systems found associated diverse metabolomic pathways 89 example glutathione metabolism pathway specifically associated renal ba fatty acid metabolism pathway significantly associated liver ba 90 ahadi et al 91 performed deep multi omics longitudinal profiling 106 healthy individuals enrichment regression analyses cohort fol lowed quarterly four years 91 visit g enomic transcriptomic metabolomic microbiomic data collected analyzed 91 authors pinpointed 184 molecules microbes significantly correlated age 160 184 8696 found metabolites confirming strong relationship aging metabolism 91 among 160 metabolites 40 lipids 18 xenobiotics hippuric acid 2 aminophenol sulfate quinic aci ds 16 amino acids 91 possibly indicating central role lipid metabolism aging authors next defined four types aging patterns ageotypes based molecular pathways changed time given individual may useful tracking intervening aging process 91 ad known heterogenous different ad patients may distinct subphenotypes progress differently require precise treatment 9294 characterize progression subtypes ad iturria medina et al 29 integrated epigenomic transcriptomic proteomic meta bolomic data 1863 individuals performed patient subtype stratification using multi omics contrastive trajectory inference mcti algorithm mcti framework consisted six steps initial feature selection dimensionality reduction using contrastive principal component analysis 95 dimensionally reduced modalities aggregation using imilarity network fusion algorithm 96 individual molecular disease progression score mdps calculation based network metrics patient subtyping using cross validated expectation maximization algorithm finally subtype significance evaluation permutation testing 29 three ad subtypes identified different set differentially abun dant metabolites 29 first subtype larger number significant metabolic alterations presented changes phosphatidylcholines amino acids methionine histidine ornithine citrulline 29 hand metabolomic changes subtypes 2 3 mainly related glutamate proline threonine valine 29 findings indicate metabolomic changes ad patients may ad subtype dependent preventive treatment interventions ad may benefit taking consideration subtype spec ific patient 29 venugopalan et al 97 focused ad stage prediction building multi modal model using human data alzheimer ’ disease neuroimaging initiative database 98 integrated imaging genetic electronic health records ehrs data including metabolomic measurements using deep learning demonstrated deep multi modality frameworks better predictive performance shallow single modality models 97 results showed asymmetric dimethylarginine adma p hosphatidylcholine pc among top predictors disease stage ad adma inhibits synthase enzyme synthesis 99 abnormal signalling reported brains ad patients 100 therefo adma may act potential target ad interventions 101 pcs class phospholipids ad frequently reported associated abnormal lipid metabolism 68 102 involvement pc ad pathology suggested venugopalan et al 97 supported previous metabo lomic studies 102 103 study role brain metabolism ad pathogenesis varma et al 104 constructed linear mixed models genome scale metabolic network using transcriptomic metabolomic data authors found despite unchanged free cholesterol levels ad brains de novo cholesterol biosynthesis catabolism impacted ad 104 increased nonenzymatic cholesterol catabolism also observed ad patients indicating shift metabolomic pathways 104 horgusluoglu et al 105 followed similar approach identify ad biomarkers construct ed metabolite co expression network using genomic transcriptomic proteomic metabolomic data study found acylcarnitines amines blood brain samples significantly associated worse ad outcomes ad endophenotypes abca1 cpt1a key regulators acylcarnitines amino acids ad 105 results provide new evidence metabolic network failures related ad pathology neurodegeneration 105 5 conclusion perspectives technological advancements metabolomics enabled researchers systematically study metabolic changes aging ad aging process found associated altered mino acid metabolism lipid metabolism red ox reactions whereas ad characterized impaired mitochondrial function well dysregulated glucose metabolism lipid metabolism potential metabolomic links aging ad include redox reactions glycolysis lipid metabolism hand metabolomic divergences natural aging ad may related protein synthesis amino acid metabolism oxidative stress pathways compared purely metabolomic approaches multiomics studies better portray molecular taxonomy aging ad integrating genomic epigenomic transcriptomic proteomic andor microbiomic data metabolomic data researchers successfully constructed metabolic network related aging ad pathology identified key regulators metabolomic biomarkers identified aging ad subtypes potentially useful clinical practice moving forward many promising directions research remain explore spatial transcriptomics provides us spatial persp ective studied tissue addition gene expression data 106 107 recent spatial transcriptomics study identified prominence plaque induc ed gene network involving oxidative stress late ad patients 108 future multi omics studies may benefit integrating metabolomic data spatial transcriptomics data better understand metabolomic aging mechanism ad pathology tissue context although many meta bolomic biomarkers ad identified whether metabolites causal pathogenesis ad often remains unknown mendelian randomization utilized assess causality identified metabol omic features ad 109 110 summary rapidly expanding field metabolomics offers great promise characterizing underlying metabolomic continuum aging ad pertinent precision medicine applications rapidly aging world references 1 c lópez otín blasco l partridge serrano g kroemer hallmarks aging cell vol 153 6 pp 1194 1217 2013 2 adav wang metabolomics signatures agi ng recent advances aging disease vol 12 2 p 646 2021 3 n barzilai huffman r h muzumdar bartke critical role metabolic pathways aging diabetes vol 61 6 pp 1315 1322 2012 4 tomás‐loba b b ernardes de jesus j mato blasco metabolic signature predicts biological age mice aging cell vol 12 1 pp 93 101 2013 5 j panyard b yu p snyder metabolomics human aging advances challenges opportunities science advances vol 8 42 p eadd6155 2022 6 sj kang jung age related morbidity mortality among patients covid 19 infection chemotherapy vol 52 2 p 154 2020 7 hou et al aging‐relate cell type‐specific pathophysiologic immune responses exacerbate disease severity aged covid‐19 patients aging cell vol 21 2 p e13544 2022 8 j dolejs p marešová onset mortality increase age age trajectories mo rtality diseases four nordic countries clinical interventions aging vol 12 p 161 2017 9 k w wachter c e finch n r c c population evolutionary biology age related mortality zeus salmon biodemography longevity national academies press us 1997 10 c lane j hardy j schott alzheimers disease european journal neurology vol 25 1 pp 59 70 2018 11 pagani et al early identification mci c onverting ad fdg pet study european journal nuclear medicine molecular imaging vol 44 12 pp 2042 2052 2017 12 z huo l yu j yang zhu bennett j zhao brain blood metabolome alzheimers dementia find ings targeted metabolomics analysis neurobiology aging vol 86 pp 123 133 2020 13 l demetrius j driver alzheimer ’ metabolic disease biogerontology vol 14 6 pp 641 649 2013 14 g j patti yanes g siuzdak metabolomics apogee omics trilogy nature reviews molecular cell biology vol 13 4 pp 263 269 2012 15 kline et al multimodal machine learning precision health scoping review npj digital medicine vol 5 1 pp 1 14 2022 16 luo et al integrating hypertension phenotype genotype hybrid non negative matrix factorization bioinformatics vol 35 8 pp 1395 1403 2019 doi 101093bioinformaticsbty804 17 zhou et al compre hensive sars cov 2–human protein –protein interactome reveals covid 19 pathobiology potential host therapeutic targets nat biotechnol pp 1 12 2022 18 luo et al multidimensional precision medicine approach identifies autism subtype characterized dyslipidemia nat med vol 26 pp 1375 –1379 20200810 2020 doi 101038s41591 0201007 0 19 wishart et al hmdb human metabolome database nucleic acids research vol 35 suppl1 pp d521 d526 2007 20 j b fenn mann c k meng f wong c whitehouse electrospray ionization mass spectrometry large biomolecules science vol 246 4926 pp 64 71 1989 21 james j martin gas liquid partition chromatography th e separation micro estimation volatile fatty acids formic acid dodecanoic acid biochemical journal vol 50 5 p 679 1952 22 c horváth high performance liquid chromatography advances perspectives 2013 23 g ewing r wallingford olefirowicz capillary electrophoresis analytical chemistry vol 61 4 pp 292a 303a 1989 24 j keeler understanding nmr spectroscopy john wiley sons 2010 25 beckonert et al metabolic profiling metabolomic metabonomic procedures nmr spectroscopy urine plasma serum tissue extracts nature protocols vol 2 11 p 2692 20 07 26 cambiaghi ferrario masseroli analysis metabolomic data tools current strategies future challenges omics data integration briefings bioinformatics vol 18 3 pp 498 510 2017 27 j wilkins e trus hina application metabolomics alzheimer ’ disease frontiers neurology vol 8 p 719 2018 28 wishart et al hmdb 50 human metabolome database 2022 nucleic acids research vol 50 d1 pp d622 d631 2022 29 iturria medina et al unified epigenomic transcriptomic proteomic metabolomic taxonomy alzheimer ’ disease progression heterogeneity science advances vol 8 46 p eabo6764 2022 30 li j karppinen k cheah chan p c sham samartzis integrative analysis metabolomic genomic imaging based phenotypes identify lowdensity lipoprotein potential risk factor lumbar modic changes european spine journal vol 31 3 pp 735 745 2022 31 g nyamundanda l brennan c gormley probabilistic principal component analysis metabolomic data bmc bioinformatics vol 11 1 pp 1 11 2010 32 chanana c thomas f zhang r rajski bugni hcapca automate hierarchical clustering principal component analysis large metabolomic datasets r metabolites vol 10 7 p 297 2020 33 lee h seung algorithms non negative matrix factorization advances neural information processing systems 2001 pp 556 562 34 g chao luo w ding recent advances supervised dimension reduction survey machine learning knowledge extraction vol 1 1 pp 341 358 2019 35 luo c mao scanmap superv ised confounding aware non negative matrix factorization polygenic risk modeling machine learning healthcare conference 2020 pmlr pp 27 45 36 z zeng h vo c mao e clare khan luo cancer classification pathway discovery using non negative matrix factorization journal biomedical informatics vol 96 p 103247 2019 doi httpsdoiorg101016jjbi2019103247 37 g kolda b w bader tensor decompositions applications siam review vol 51 3 pp 455 500 2009 38 luo f wang p szolovits tensor factorization toward precision medicine briefings bioinformatics march 19 2016 2016 doi 101093bibbbw026 39 luo c mao panther pathway augmented nonn egative tensor factorization higher order feature learning proceedings aaai conference artificial intelligence 2021 vol 35 1 40 z pang et al metaboanalyst 50 narrowing gap raw spectra functional insights nucleic acids research vol 49 w1 pp w388 w396 2021 41 p proitsi et al plasma lipidomics analysis finds long chain cholesteryl esters associated alzheimer ’ disease translational psychiatry vol 5 1 pp e494 e494 201 5 42 stamate et al metabolite‐based machine learning approach diagnose alzheimer‐type dementia blood results european medical information framework alzheimer disease biomarker discovery cohort alzheimers dementia transl ational research clinical interventions vol 5 1 pp 933 938 2019 43 f alakwaa k chaudhary l x garmire deep learning accurately predicts estrogen receptor status breast cancer metabolomics data journal proteome research vol 17 1 pp 337 347 2018 44 z zeng et al deep learning cancer type classification driver gene identification bmc bioinformatics vol 22 4 pp 1 13 2021 doi 101186s12859 02104400 4 45 luo shine subhypergraph inductive neural network arxiv preprint arxiv221007309 2022 46 r chaleckis murakami j takada h kondoh yanagida individual variability human blood metabolites identifies age related differences proceedings national academy sciences vol 113 16 pp 4252 4259 2016 47 r calvani et al fecal urinary nmr based metabolomics unveil aging signature mice experimental gerontology vol 49 pp 5 11 2014 48 n g psihogios f gazi elisaf k seferiadis e bairaktari gender‐related age‐related urinalysis healthy subjects nmr‐based metabonom ics nmr biomedicine international journal devoted development application magnetic resonance vivo vol 21 3 pp 195 207 2008 49 h gu et al 1h nmr metabolomics study age profiling children nmr biomedicine international journal devoted development application magnetic resonance vivo vol 22 8 pp 826 833 2009 50 z yu et al human serum metabolic profiles age dependent aging cell vol 11 6 pp 960967 2012 51 cheng et al distinct metabolomic signatures associated longevity humans nature communications vol 6 1 pp 1 10 2015 52 vaarhorst et al lipid metabolism long lived families leiden longevity study age vol 33 2 pp 219 227 2011 53 n barzilai et al unique lipoprotein phenotype genotype associated exceptional longevity jama vol 290 15 pp 2030 2040 2003 54 montoliu et al serum profiling healthy aging identifies phospho sphingolipid species markers human longevity aging albany ny vol 6 1 p 9 2014 55 jové et al human aging metabolome related matter gender journals gerontology series biomedical sciences medical ciences vol 71 5 pp 578 585 2016 56 j covarrubias r perrone grozio e verdin nad metabolism roles cellular processes ageing nature reviews molecular cell biology vol 22 2 pp 119141 2021 57 liguori et al oxidative stress aging diseases clinical interventions aging vol 13 p 757 2018 58 sengupta weljie metabolism sleep aging bridging gap using metabolomics nutrition healthy aging vol 5 3 pp 167 184 2019 59 r g shulman l rothman k l behar f hyder energetic basis brain activity implications neuroimaging trends neurosciences vol 27 8 pp 489 495 2004 60 boveris navarro brain itochondrial dysfunction aging iubmb life vol 60 5 pp 308 314 2008 61 aslan ozben reactive oxygen nitrogen species alzheimers disease current alzheimer research vol 1 2 pp 111 119 2004 62 k ulland et al trem2 maintains microglial metabolic fitness alzheimer ’ disease cell vol 170 4 pp 649 663 e13 2017 63 van gijsel bonnello et al metabolic changes inflammation cultured astrocytes 5xfad mouse model alzheim er ’ disease alleviation pantethine plos one vol 12 4 p e0175369 2017 64 r gonzález domínguez garcía barrera j l gómez ariza metabolite profiling identification altered metabolic pathways alzheimers disease journal pharmaceutical biomedical analysis vol 107 pp 75 81 2015 65 j b toledo et al metabolic network failures alzheimers disease biochemical road map alzheimers dementia vol 13 9 pp 965 984 2017 66 g wang et al plasma metabolite profiles alzheimer ’ disease mild cognitive impairment journal proteome research vol 13 5 pp 2649 2658 2014 67 l sun et al association human blood metabolome risk alzheimers disease annals neurology vol 92 5 pp 756 767 2022 68 dc wang et al serum fatty acid profiles using gc ms multivariate statistical analysis potential biomarkers alzheimers disease neurobiology aging vol 33 6 pp 1057 1066 2012 69 x han et al metabolomics early alzheimers disease identification altered plasma sphingolipidome using shotgun lipidomics plos one vol 6 7 p e21643 2011 70 orešič et al metabolome progression alzheimers disease translational psychiatry vol 1 12 pp e57 e57 2011 71 v r varma et al brain blood metabolite signatures pathology progression alzheimer disease targeted metabolomics study plos medicine vol 15 1 p e10 02482 2018 72 sato nakamura k aoshima oda quantitative wide ranging profiling phospholipids human plasma two dimensional liquid chromatographymass spectrometry analytical chemistry vol 82 23 pp 9858 9864 201 0 73 p baloni et al investigating importance acylcarnitines alzheimer ’ disease alzheimers dementia vol 17 p e056647 2021 74 x yan hu b wang wang x zhang metabolic dysregulation contributes progressio n alzheimer ’ disease frontiers neuroscience vol 14 p 530219 2020 75 j xu et al interpretable deep learning translation gwas multi omics findings identify pathobiology drug repurposing alzheimer ’ disease cell reports vol 41 9 p 111717 2022 76 x xia q jiang j mcdermott j j han aging alzheimer ’ disease comparison associations molecular system level aging cell vol 17 5 p e12802 2018 77 jové portero otín naudí ferrer r pamplona metabolomics human brain aging age related neurodegenerative diseases journal neuropathology experimental neurology vol 73 7 pp 640 657 2014 78 k xie et al high throughput metabolomic discovering potential biomarkers identifying metabolic mechanisms aging alzheimer ’ disease frontiers cell developmental biology vol 9 p 602887 2021 79 k ingram g roth glycolytic inhibition strategy developing calorie restriction mimetics experimental gerontology vol 46 2 3 pp 148 154 2011 80 butterfield b halliwell oxidative stress dysfunctional glucose metabolism alzheimer disease nature reviews neuroscience vol 20 3 pp 148 160 2019 81 ca canfield p c bradshaw amino acids regulation ging aging related diseases translational medicine aging vol 3 pp 70 89 2019 82 c n harada c n love k l triebel normal cognitive aging clinics geriatric medicine vol 29 4 pp 737 752 2013 83 salthouse consequences age related cognitive declines annual review psychology vol 63 p 201 2012 84 motsinger reif et al comparing metabolomic pathologic biomarkers alone combination discriminating alzheimer ’ disease rmal cognitive aging acta neuropathologica communications vol 1 1 pp 1 9 2013 85 h c hunsberger b p greenwood v tolstikov n r narain kiebish c denny divergence metabolome natural aging alzheimer ’ disease scientific reports vol 10 1 pp 1 15 2020 86 hasin seldin lusis multi omics approaches disease genome biology vol 18 1 pp 1 15 2017 87 aging atlas multi omics database aging biology nucl eic acids research vol 49 d1 pp d825 d830 2021 88 han et al adas viewer web based application integrative analysis multi omics data alzheimer ’ disease npj systems biology applications vol 7 1 pp 1 10 2021 89 c nie et al distinct biological ages organs systems identified multi omics study cell reports vol 38 10 p 110459 2022 90 p klemera doubal new approach concept computation biological age mechani sms ageing development vol 127 3 pp 240 248 2006 91 ahadi et al personal aging markers ageotypes revealed deep longitudinal profiling nature medicine vol 26 1 pp 83 90 2020 92 j xu et al data‐driven disco probable alzheimers disease related dementia subphenotypes using electronic health records learning health systems vol 4 4 p e10246 2020 93 ferreira nordberg e westman biological subtypes alzheimer disease systematic review meta analysis neurology vol 94 10 pp 436 448 2020 94 c mao et al ad bert using pre trained contextualized embeddings predict progression mild cognitive impairment alzheimers disease arxiv preprint arxiv221206042 2022 95 abid j zhang v k bagaria j zou exploring patterns enriched dataset contrastive principal component analysis nature communications vol 9 1 pp 1 7 2018 96 b wang et al similarity ne twork fusion aggregating data types genomic scale nature methods vol 11 3 pp 333 337 2014 97 j venugopalan l tong h r hassanzadeh wang multimodal deep learning models early detection alzheimer ’ disease sta ge scientific reports vol 11 1 pp 1 13 2021 98 g mueller et al ways toward early diagnosis alzheimer ’ disease alzheimer ’ disease neuroimaging initiative adni alzheimers dementia vol 1 1 pp 55 66 2005 99 togo katsuse e iseki nitric oxide pathways alzheimers disease neurodegenerative dementias neurological research vol 26 5 pp 563 566 2004 100 j r steinert chernova forsythe nitric oxide signal ing brain function dysfunction dementia neuroscientist vol 16 4 pp 435 452 2010 101 e malden et al circulating asymmetric dimethylarginine cognitive decline 4‐year follow‐up study 1936 aberdeen birth cohort international journal geriatric psychiatry vol 35 10 pp 1181 1188 2020 102 l whiley et al evidence altered phosphatidylcholine metabolism alzheimers disease neurobiology aging vol 35 2 pp 271 278 2014 103 blasko et al plasma phosphatidylcholines vitamin b12folate levels possible prognostic biomarkers progression alzheimers disease experimental gerontology vol 147 p 111264 2021 104 v r varma et al abnormal brain cholesterol homeostasis alzheimer ’ disease —a targeted metabolomic transcriptomic study npj aging mechanisms disease vol 7 1 pp 114 2021 105 e horgusluoglu et al integrative metabolomics‐genomics approach reveals key metabolic pathway regulators alzheimers disease alzheimers dementia vol 18 6 pp 1260 1278 2022 106 z zeng li li luo statistical machine learning methods spatially resolved transcriptomics data analysis genome biol vol 23 1 pp 1 23 2022 107 li et al soar spatial transcriptomics analysis resource model spatial variability cell type interactions biorxiv 2022 108 wt chen et al spatial transcriptomics situ sequencing study alzheimer ’ disease cell vol 182 4 pp 976 991 e19 2020 109 j lord et al mendelian randomi zation identifies blood metabolites previously linked midlife cognition causal candidates alzheimer ’ disease proceedings national academy sciences vol 118 16 p e2009808118 2021 110 sy huang et al investigating causa l relations circulating metabolites alzheimer ’ disease mendelian randomization study journal alzheimers disease preprint pp 1 15 2021",
    "relevance_score": 0.8101,
    "date_score": 0,
    "final_score": 0.6076,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Yiming Li",
    "date": "2022-12-18T20:53:08",
    "filename": "2212.09870.pdf",
    "processed_text": "metabolomics aging alzheimer ’ disease single omics multi omics yiming li1 yuan luo1 1department preventive medicine northwestern university usa corresponding author yuanluonorthwesternedu abstract aging multifactorial process key factor morbidity mortality alzheimer ’ disease ad age related disorder main cause worldwide disability aging ad characterized metabolic dysfunction metabolomics quantif complete set metabolites studied sample helpful studying metabolic alterations aging ad review w e summarize metabolomic changes regarding aging ad discuss biological functions highlight potential application diagnostic biomarkers therapeutic targets recent advances multiomics approach es understand ing metabolic mechanism aging nd ad also reviewed keywords alzheimer ’ disease aging metabolomics biomarker multi omics 1 introduction aging natural process involving chronological decline different physiological metabolic functions 1 2 metabolic alterations including impaired mitochondrial function deregulated nutrient sensing among hallmarks aging 1 35 since ging major driver morbidity 6 7 mortality 8 9 understanding metabolic pathways associated mechanism useful precision medicine applications 5 alzheimer ’ disease ad age related disorder major cause worldwide disability mortality 10 ad recognized global public health priority insights ad pathogenesis needed treatment prevention ad 10 previous studies shown widespread metabolic pertu rbation defining feature ad 1113 metabolomics high throughput omics technology allows researchers measure complete set etabolites given sample study alterations different metabolism functions 14 powerful tool studying mechanism aging enables researchers systematically study metabolic dysfunction ad patients facilitating biomarker identification drug discovery clinical intervention ad additionally integrating metabolomics omics data phenotypic data may help us better characterize unique health signatures different patients 1518 review begin introduction major analytical platforms metabolomics common approaches metabolomic data analysis next w e discuss applications metabolomics aging ad research highlighting metabolomic links divergences natural aging ad finally w e review recent multi omics studies related aging ad focus metabolomic finding highlight new avenues research explore metabolomics aging ad 2 metabolism metabolomics metabolism refers set life sustaining chemical reactions within organism ’ cells metabolites intermediates products metabolism technological advancements identify quantify characterize small biological molecule 1500 daltons metabolites found within specific biological sample 19 complete set metabolites called metabolome mass spectrometry ms nuclear magnetic resonance nmr spectroscopy two analytical platforms frequently used measure metabolome ms ionize chemical species sample visualizes mass spectrum ion signals sorted according mass tocharge ratio 20 identify metabolites rapidly requires prior sampl e separation using chromatography techniques including gas chromatography 21 liquid chromatography 22 capillary electrophoresis 23 nmr spectroscopy detect nmr signals produced spinning sample inside magnet ic field hence may identi fy metabolites different molecular structures 24 compared ms nmr spectroscopy non destructive require sample separation 25 however less sensitive detecting low molecular weigh molecules 26 comprehensive analysis metabolome parallel application platforms often needed 27 metabolomic data analysis seeks identify metabolites underlying pathways significantly associated certain diseases conditions requires harnessing highdimensional complex datasets – currently human metabolome database contains 248047 metabolite entries 28 single metabolomic dataset may contain hundreds features 29 30 therefore dimensionality reduction methods like principal component analysis pca 31 hierarchical clustering 32 non negative matrix factorizations 3336 tensor factorizations 3739 often used identify clusters functionally related metabolites followed pathway analysis studies interactions among genes metabolites enrichment topological analysis 40 hand high dimensionality nature metabolom ic data directly leveraged achine learning methods like random forests 41 extreme gradient boosting 42 deep learning 4345 characterize metabolic signatures differ ent diseas es application metabolomics may help researchers identify disease biomarkers clinical use better understand etiology pathogenesis different disorders 14 27 3 metabolomic aging alzheimer ’ disease organism ’ lifespan known influenced mitochondrial endocrine function nutrient sensing redox homeostasis 1 3 4 metabolomic allow researchers investigate complex metabol omic variations representing changes different metabolism functions hence powerful tool studying mechanism aging recent applications metabolomics aging research reviewed adav wang 2 major metab olomic biomarkers aging identified previous studies include amino acids leucine 46 47 glycine 48 49 histidine 50 51 lipids related metabolites like triglyceride 52 53 sphingolipid 50 54 phospholipid 51 55 lipoprotein size 52 53 well redox related metabolites suc h n icotinamide adenine dinucleotide nad 56 reactive oxygen nitrogen species rons 57 results indicate amino acid metabolism lipid metabolism redox reactions may play important role aging longevity 1 58 neuron al activity requires large mount energy brain ’ metabolic consumption represent 20 whole body oxygen uptake 59 decline brain metabolism contribute cognitive impairment 60 one earliest symptoms ad 11 systematically study metabolic perturbations ad metabolomic approaches widely applied recent advances field reviewed wilkins trushina 27 previous studies identified variety metabolomic features associated ad instance rons 61 metabolites glycolytic pathway 12 62 64 amino acids like glutamine histidine 6467 well lipids related metabolites like fatty acids 64 66 68 sphingolipid 67 69 71 phospholipid 12 64 72 acylcarnitine 12 73 empirical evidence support impaired mi tochondrial function 13 glucose metabolism dysregulation 74 altered lipid metabolism 27 75 defining ch aracteristics ad patients aging known important risk factor ad aging ad involve perturbed metabolism 76 etabolomic studies researchers could gain deeper understanding connection aging ad 76 77 shown review agi ng ad many shared metabolomic biomarkers example rons amino acids lipids related metabolites recent study xie et al 78 specifically investigated underlying metabolomic mechanism shared aging ad first identified ten metabolic pathways aging analyzing ms metabolomic data 183 patients correlation analysis random forests enrichment analysis 78 next authors performed systematic review ad related metabolomic studies curating 49 different metabolic pathways 78 three pathways purine metabolism arginine proline metabolism well tricarboxylic acid cycle found shared aging ad 78 purine metabolism closely related pentose phosphate pathway turn glycolysis 77 previous studies found excessive glycolysis may accelerate aging onset 79 dysfunctional glycolysis may causative factor ad 80 arginine amino acid essential nitric oxide synthesis whose impairment found contribute aging 81 whereas proline known help reduce oxidativ e stress improve availability 81 sum mary previous studies identified redox reactions glycolysis lipid metabolism potential metabolomic links aging ad cognitive decline time natural process aging 82 however certain abilities vocabulary resilient brain aging 83 impaired ad pat ients therefore part examining metabolomic links aging ad important investigate metabolomic divergence natural age related cognitive decline arcd ad motsinger reif et al 84 fitted stepwise logistic regression models assess ability metabolite markers discriminate 40 ad patients 38 cognitively normal controls 65 years old cross validation metabolites 15 65533 8 9365 found consistent predictors 84 although identities unknown authors pinpointed known metabolomic markers significantly correlated metabolites methionine glutathione kynurenine indole 3propionic acid 84 results suggest glutathione synthesis tryptophan metabolism oxidative stress may involved pathogenesis ad 84 hunsberge r et al 85 analyzed metabolomic data ad contro l including arcd mice pca anova pathway analysis correlation analysis identified difference metabolomic profiles ad arcd mice prominent prefrontal cortex hippocampus right hemisphere 85 found ad mice exhibit altered protein synthesis phenylalanine tyrosine tryptophan biosynthesis amino acid catabolism arginine proline metabolism alanine aspartate glutamate metabolism histidine metabolism pathways p refrontal cortex 85 hand differentially abundant metabol ites hippocampi ad control mice mainly belong protein synthesis aminoacyl trna biosynthesis oxidative stress glutathione metabolism glyoxylate dicarboxylate metabolism pathways 85 summary previous research found metabolomic divergences arcd ad may related protein synthesis amino acid metabolism oxidative stress pathways 4 multi omics approaches advances highthroughput technologies examin ing genome wide multi level omics enabled researchers perform integrative analysis different types omics data genomic epigenomic transcriptomic proteomic metabolomic microbiomic data 86 multi omics analysis could provide holistic view complex traits elucidat ing potential causative factor 15 86 exists increasin g number multi omics studies delineating molecular taxonomy aging ad also worth noting exist different online multi omics resources studying aging ad example aging atlas 87 database hosting aging related genomic epigenomic transcriptomic proteomic metabolomic data adas viewer 88 web server analyzing genomic epigenomic transcriptomic data three independent ad cohorts study molecular changes aging nie et al 89 used multi omics approach estimate biological ages bas human organs systems utilizing genomic metabolomic microbiomic data healthy population cohort 4066 chinese individuals construct bas klemera doudal algorithm 90 used – regressing chronological age ca available biomarkers ba estimated linearly best fitted value ca authors found organs systems age diverse rates ba used prediction mortality organ specific disorders fatty liver disease 89 moreover bas different human organs systems found associated diverse metabolomic pathways 89 example glutathione metabolism pathway specifically associated renal ba fatty acid metabolism pathway significantly associated liver ba 90 ahadi et al 91 performed deep multi omics longitudinal profiling 106 healthy individuals enrichment regression analyses cohort fol lowed quarterly four years 91 visit g enomic transcriptomic metabolomic microbiomic data collected analyzed 91 authors pinpointed 184 molecules microbes significantly correlated age 160 184 8696 found metabolites confirming strong relationship aging metabolism 91 among 160 metabolites 40 lipids 18 xenobiotics hippuric acid 2 aminophenol sulfate quinic aci ds 16 amino acids 91 possibly indicating central role lipid metabolism aging authors next defined four types aging patterns ageotypes based molecular pathways changed time given individual may useful tracking intervening aging process 91 ad known heterogenous different ad patients may distinct subphenotypes progress differently require precise treatment 9294 characterize progression subtypes ad iturria medina et al 29 integrated epigenomic transcriptomic proteomic meta bolomic data 1863 individuals performed patient subtype stratification using multi omics contrastive trajectory inference mcti algorithm mcti framework consisted six steps initial feature selection dimensionality reduction using contrastive principal component analysis 95 dimensionally reduced modalities aggregation using imilarity network fusion algorithm 96 individual molecular disease progression score mdps calculation based network metrics patient subtyping using cross validated expectation maximization algorithm finally subtype significance evaluation permutation testing 29 three ad subtypes identified different set differentially abun dant metabolites 29 first subtype larger number significant metabolic alterations presented changes phosphatidylcholines amino acids methionine histidine ornithine citrulline 29 hand metabolomic changes subtypes 2 3 mainly related glutamate proline threonine valine 29 findings indicate metabolomic changes ad patients may ad subtype dependent preventive treatment interventions ad may benefit taking consideration subtype spec ific patient 29 venugopalan et al 97 focused ad stage prediction building multi modal model using human data alzheimer ’ disease neuroimaging initiative database 98 integrated imaging genetic electronic health records ehrs data including metabolomic measurements using deep learning demonstrated deep multi modality frameworks better predictive performance shallow single modality models 97 results showed asymmetric dimethylarginine adma p hosphatidylcholine pc among top predictors disease stage ad adma inhibits synthase enzyme synthesis 99 abnormal signalling reported brains ad patients 100 therefo adma may act potential target ad interventions 101 pcs class phospholipids ad frequently reported associated abnormal lipid metabolism 68 102 involvement pc ad pathology suggested venugopalan et al 97 supported previous metabo lomic studies 102 103 study role brain metabolism ad pathogenesis varma et al 104 constructed linear mixed models genome scale metabolic network using transcriptomic metabolomic data authors found despite unchanged free cholesterol levels ad brains de novo cholesterol biosynthesis catabolism impacted ad 104 increased nonenzymatic cholesterol catabolism also observed ad patients indicating shift metabolomic pathways 104 horgusluoglu et al 105 followed similar approach identify ad biomarkers construct ed metabolite co expression network using genomic transcriptomic proteomic metabolomic data study found acylcarnitines amines blood brain samples significantly associated worse ad outcomes ad endophenotypes abca1 cpt1a key regulators acylcarnitines amino acids ad 105 results provide new evidence metabolic network failures related ad pathology neurodegeneration 105 5 conclusion perspectives technological advancements metabolomics enabled researchers systematically study metabolic changes aging ad aging process found associated altered mino acid metabolism lipid metabolism red ox reactions whereas ad characterized impaired mitochondrial function well dysregulated glucose metabolism lipid metabolism potential metabolomic links aging ad include redox reactions glycolysis lipid metabolism hand metabolomic divergences natural aging ad may related protein synthesis amino acid metabolism oxidative stress pathways compared purely metabolomic approaches multiomics studies better portray molecular taxonomy aging ad integrating genomic epigenomic transcriptomic proteomic andor microbiomic data metabolomic data researchers successfully constructed metabolic network related aging ad pathology identified key regulators metabolomic biomarkers identified aging ad subtypes potentially useful clinical practice moving forward many promising directions research remain explore spatial transcriptomics provides us spatial persp ective studied tissue addition gene expression data 106 107 recent spatial transcriptomics study identified prominence plaque induc ed gene network involving oxidative stress late ad patients 108 future multi omics studies may benefit integrating metabolomic data spatial transcriptomics data better understand metabolomic aging mechanism ad pathology tissue context although many meta bolomic biomarkers ad identified whether metabolites causal pathogenesis ad often remains unknown mendelian randomization utilized assess causality identified metabol omic features ad 109 110 summary rapidly expanding field metabolomics offers great promise characterizing underlying metabolomic continuum aging ad pertinent precision medicine applications rapidly aging world references 1 c lópez otín blasco l partridge serrano g kroemer hallmarks aging cell vol 153 6 pp 1194 1217 2013 2 adav wang metabolomics signatures agi ng recent advances aging disease vol 12 2 p 646 2021 3 n barzilai huffman r h muzumdar bartke critical role metabolic pathways aging diabetes vol 61 6 pp 1315 1322 2012 4 tomás‐loba b b ernardes de jesus j mato blasco metabolic signature predicts biological age mice aging cell vol 12 1 pp 93 101 2013 5 j panyard b yu p snyder metabolomics human aging advances challenges opportunities science advances vol 8 42 p eadd6155 2022 6 sj kang jung age related morbidity mortality among patients covid 19 infection chemotherapy vol 52 2 p 154 2020 7 hou et al aging‐relate cell type‐specific pathophysiologic immune responses exacerbate disease severity aged covid‐19 patients aging cell vol 21 2 p e13544 2022 8 j dolejs p marešová onset mortality increase age age trajectories mo rtality diseases four nordic countries clinical interventions aging vol 12 p 161 2017 9 k w wachter c e finch n r c c population evolutionary biology age related mortality zeus salmon biodemography longevity national academies press us 1997 10 c lane j hardy j schott alzheimers disease european journal neurology vol 25 1 pp 59 70 2018 11 pagani et al early identification mci c onverting ad fdg pet study european journal nuclear medicine molecular imaging vol 44 12 pp 2042 2052 2017 12 z huo l yu j yang zhu bennett j zhao brain blood metabolome alzheimers dementia find ings targeted metabolomics analysis neurobiology aging vol 86 pp 123 133 2020 13 l demetrius j driver alzheimer ’ metabolic disease biogerontology vol 14 6 pp 641 649 2013 14 g j patti yanes g siuzdak metabolomics apogee omics trilogy nature reviews molecular cell biology vol 13 4 pp 263 269 2012 15 kline et al multimodal machine learning precision health scoping review npj digital medicine vol 5 1 pp 1 14 2022 16 luo et al integrating hypertension phenotype genotype hybrid non negative matrix factorization bioinformatics vol 35 8 pp 1395 1403 2019 doi 101093bioinformaticsbty804 17 zhou et al compre hensive sars cov 2–human protein –protein interactome reveals covid 19 pathobiology potential host therapeutic targets nat biotechnol pp 1 12 2022 18 luo et al multidimensional precision medicine approach identifies autism subtype characterized dyslipidemia nat med vol 26 pp 1375 –1379 20200810 2020 doi 101038s41591 0201007 0 19 wishart et al hmdb human metabolome database nucleic acids research vol 35 suppl1 pp d521 d526 2007 20 j b fenn mann c k meng f wong c whitehouse electrospray ionization mass spectrometry large biomolecules science vol 246 4926 pp 64 71 1989 21 james j martin gas liquid partition chromatography th e separation micro estimation volatile fatty acids formic acid dodecanoic acid biochemical journal vol 50 5 p 679 1952 22 c horváth high performance liquid chromatography advances perspectives 2013 23 g ewing r wallingford olefirowicz capillary electrophoresis analytical chemistry vol 61 4 pp 292a 303a 1989 24 j keeler understanding nmr spectroscopy john wiley sons 2010 25 beckonert et al metabolic profiling metabolomic metabonomic procedures nmr spectroscopy urine plasma serum tissue extracts nature protocols vol 2 11 p 2692 20 07 26 cambiaghi ferrario masseroli analysis metabolomic data tools current strategies future challenges omics data integration briefings bioinformatics vol 18 3 pp 498 510 2017 27 j wilkins e trus hina application metabolomics alzheimer ’ disease frontiers neurology vol 8 p 719 2018 28 wishart et al hmdb 50 human metabolome database 2022 nucleic acids research vol 50 d1 pp d622 d631 2022 29 iturria medina et al unified epigenomic transcriptomic proteomic metabolomic taxonomy alzheimer ’ disease progression heterogeneity science advances vol 8 46 p eabo6764 2022 30 li j karppinen k cheah chan p c sham samartzis integrative analysis metabolomic genomic imaging based phenotypes identify lowdensity lipoprotein potential risk factor lumbar modic changes european spine journal vol 31 3 pp 735 745 2022 31 g nyamundanda l brennan c gormley probabilistic principal component analysis metabolomic data bmc bioinformatics vol 11 1 pp 1 11 2010 32 chanana c thomas f zhang r rajski bugni hcapca automate hierarchical clustering principal component analysis large metabolomic datasets r metabolites vol 10 7 p 297 2020 33 lee h seung algorithms non negative matrix factorization advances neural information processing systems 2001 pp 556 562 34 g chao luo w ding recent advances supervised dimension reduction survey machine learning knowledge extraction vol 1 1 pp 341 358 2019 35 luo c mao scanmap superv ised confounding aware non negative matrix factorization polygenic risk modeling machine learning healthcare conference 2020 pmlr pp 27 45 36 z zeng h vo c mao e clare khan luo cancer classification pathway discovery using non negative matrix factorization journal biomedical informatics vol 96 p 103247 2019 doi httpsdoiorg101016jjbi2019103247 37 g kolda b w bader tensor decompositions applications siam review vol 51 3 pp 455 500 2009 38 luo f wang p szolovits tensor factorization toward precision medicine briefings bioinformatics march 19 2016 2016 doi 101093bibbbw026 39 luo c mao panther pathway augmented nonn egative tensor factorization higher order feature learning proceedings aaai conference artificial intelligence 2021 vol 35 1 40 z pang et al metaboanalyst 50 narrowing gap raw spectra functional insights nucleic acids research vol 49 w1 pp w388 w396 2021 41 p proitsi et al plasma lipidomics analysis finds long chain cholesteryl esters associated alzheimer ’ disease translational psychiatry vol 5 1 pp e494 e494 201 5 42 stamate et al metabolite‐based machine learning approach diagnose alzheimer‐type dementia blood results european medical information framework alzheimer disease biomarker discovery cohort alzheimers dementia transl ational research clinical interventions vol 5 1 pp 933 938 2019 43 f alakwaa k chaudhary l x garmire deep learning accurately predicts estrogen receptor status breast cancer metabolomics data journal proteome research vol 17 1 pp 337 347 2018 44 z zeng et al deep learning cancer type classification driver gene identification bmc bioinformatics vol 22 4 pp 1 13 2021 doi 101186s12859 02104400 4 45 luo shine subhypergraph inductive neural network arxiv preprint arxiv221007309 2022 46 r chaleckis murakami j takada h kondoh yanagida individual variability human blood metabolites identifies age related differences proceedings national academy sciences vol 113 16 pp 4252 4259 2016 47 r calvani et al fecal urinary nmr based metabolomics unveil aging signature mice experimental gerontology vol 49 pp 5 11 2014 48 n g psihogios f gazi elisaf k seferiadis e bairaktari gender‐related age‐related urinalysis healthy subjects nmr‐based metabonom ics nmr biomedicine international journal devoted development application magnetic resonance vivo vol 21 3 pp 195 207 2008 49 h gu et al 1h nmr metabolomics study age profiling children nmr biomedicine international journal devoted development application magnetic resonance vivo vol 22 8 pp 826 833 2009 50 z yu et al human serum metabolic profiles age dependent aging cell vol 11 6 pp 960967 2012 51 cheng et al distinct metabolomic signatures associated longevity humans nature communications vol 6 1 pp 1 10 2015 52 vaarhorst et al lipid metabolism long lived families leiden longevity study age vol 33 2 pp 219 227 2011 53 n barzilai et al unique lipoprotein phenotype genotype associated exceptional longevity jama vol 290 15 pp 2030 2040 2003 54 montoliu et al serum profiling healthy aging identifies phospho sphingolipid species markers human longevity aging albany ny vol 6 1 p 9 2014 55 jové et al human aging metabolome related matter gender journals gerontology series biomedical sciences medical ciences vol 71 5 pp 578 585 2016 56 j covarrubias r perrone grozio e verdin nad metabolism roles cellular processes ageing nature reviews molecular cell biology vol 22 2 pp 119141 2021 57 liguori et al oxidative stress aging diseases clinical interventions aging vol 13 p 757 2018 58 sengupta weljie metabolism sleep aging bridging gap using metabolomics nutrition healthy aging vol 5 3 pp 167 184 2019 59 r g shulman l rothman k l behar f hyder energetic basis brain activity implications neuroimaging trends neurosciences vol 27 8 pp 489 495 2004 60 boveris navarro brain itochondrial dysfunction aging iubmb life vol 60 5 pp 308 314 2008 61 aslan ozben reactive oxygen nitrogen species alzheimers disease current alzheimer research vol 1 2 pp 111 119 2004 62 k ulland et al trem2 maintains microglial metabolic fitness alzheimer ’ disease cell vol 170 4 pp 649 663 e13 2017 63 van gijsel bonnello et al metabolic changes inflammation cultured astrocytes 5xfad mouse model alzheim er ’ disease alleviation pantethine plos one vol 12 4 p e0175369 2017 64 r gonzález domínguez garcía barrera j l gómez ariza metabolite profiling identification altered metabolic pathways alzheimers disease journal pharmaceutical biomedical analysis vol 107 pp 75 81 2015 65 j b toledo et al metabolic network failures alzheimers disease biochemical road map alzheimers dementia vol 13 9 pp 965 984 2017 66 g wang et al plasma metabolite profiles alzheimer ’ disease mild cognitive impairment journal proteome research vol 13 5 pp 2649 2658 2014 67 l sun et al association human blood metabolome risk alzheimers disease annals neurology vol 92 5 pp 756 767 2022 68 dc wang et al serum fatty acid profiles using gc ms multivariate statistical analysis potential biomarkers alzheimers disease neurobiology aging vol 33 6 pp 1057 1066 2012 69 x han et al metabolomics early alzheimers disease identification altered plasma sphingolipidome using shotgun lipidomics plos one vol 6 7 p e21643 2011 70 orešič et al metabolome progression alzheimers disease translational psychiatry vol 1 12 pp e57 e57 2011 71 v r varma et al brain blood metabolite signatures pathology progression alzheimer disease targeted metabolomics study plos medicine vol 15 1 p e10 02482 2018 72 sato nakamura k aoshima oda quantitative wide ranging profiling phospholipids human plasma two dimensional liquid chromatographymass spectrometry analytical chemistry vol 82 23 pp 9858 9864 201 0 73 p baloni et al investigating importance acylcarnitines alzheimer ’ disease alzheimers dementia vol 17 p e056647 2021 74 x yan hu b wang wang x zhang metabolic dysregulation contributes progressio n alzheimer ’ disease frontiers neuroscience vol 14 p 530219 2020 75 j xu et al interpretable deep learning translation gwas multi omics findings identify pathobiology drug repurposing alzheimer ’ disease cell reports vol 41 9 p 111717 2022 76 x xia q jiang j mcdermott j j han aging alzheimer ’ disease comparison associations molecular system level aging cell vol 17 5 p e12802 2018 77 jové portero otín naudí ferrer r pamplona metabolomics human brain aging age related neurodegenerative diseases journal neuropathology experimental neurology vol 73 7 pp 640 657 2014 78 k xie et al high throughput metabolomic discovering potential biomarkers identifying metabolic mechanisms aging alzheimer ’ disease frontiers cell developmental biology vol 9 p 602887 2021 79 k ingram g roth glycolytic inhibition strategy developing calorie restriction mimetics experimental gerontology vol 46 2 3 pp 148 154 2011 80 butterfield b halliwell oxidative stress dysfunctional glucose metabolism alzheimer disease nature reviews neuroscience vol 20 3 pp 148 160 2019 81 ca canfield p c bradshaw amino acids regulation ging aging related diseases translational medicine aging vol 3 pp 70 89 2019 82 c n harada c n love k l triebel normal cognitive aging clinics geriatric medicine vol 29 4 pp 737 752 2013 83 salthouse consequences age related cognitive declines annual review psychology vol 63 p 201 2012 84 motsinger reif et al comparing metabolomic pathologic biomarkers alone combination discriminating alzheimer ’ disease rmal cognitive aging acta neuropathologica communications vol 1 1 pp 1 9 2013 85 h c hunsberger b p greenwood v tolstikov n r narain kiebish c denny divergence metabolome natural aging alzheimer ’ disease scientific reports vol 10 1 pp 1 15 2020 86 hasin seldin lusis multi omics approaches disease genome biology vol 18 1 pp 1 15 2017 87 aging atlas multi omics database aging biology nucl eic acids research vol 49 d1 pp d825 d830 2021 88 han et al adas viewer web based application integrative analysis multi omics data alzheimer ’ disease npj systems biology applications vol 7 1 pp 1 10 2021 89 c nie et al distinct biological ages organs systems identified multi omics study cell reports vol 38 10 p 110459 2022 90 p klemera doubal new approach concept computation biological age mechani sms ageing development vol 127 3 pp 240 248 2006 91 ahadi et al personal aging markers ageotypes revealed deep longitudinal profiling nature medicine vol 26 1 pp 83 90 2020 92 j xu et al data‐driven disco probable alzheimers disease related dementia subphenotypes using electronic health records learning health systems vol 4 4 p e10246 2020 93 ferreira nordberg e westman biological subtypes alzheimer disease systematic review meta analysis neurology vol 94 10 pp 436 448 2020 94 c mao et al ad bert using pre trained contextualized embeddings predict progression mild cognitive impairment alzheimers disease arxiv preprint arxiv221206042 2022 95 abid j zhang v k bagaria j zou exploring patterns enriched dataset contrastive principal component analysis nature communications vol 9 1 pp 1 7 2018 96 b wang et al similarity ne twork fusion aggregating data types genomic scale nature methods vol 11 3 pp 333 337 2014 97 j venugopalan l tong h r hassanzadeh wang multimodal deep learning models early detection alzheimer ’ disease sta ge scientific reports vol 11 1 pp 1 13 2021 98 g mueller et al ways toward early diagnosis alzheimer ’ disease alzheimer ’ disease neuroimaging initiative adni alzheimers dementia vol 1 1 pp 55 66 2005 99 togo katsuse e iseki nitric oxide pathways alzheimers disease neurodegenerative dementias neurological research vol 26 5 pp 563 566 2004 100 j r steinert chernova forsythe nitric oxide signal ing brain function dysfunction dementia neuroscientist vol 16 4 pp 435 452 2010 101 e malden et al circulating asymmetric dimethylarginine cognitive decline 4‐year follow‐up study 1936 aberdeen birth cohort international journal geriatric psychiatry vol 35 10 pp 1181 1188 2020 102 l whiley et al evidence altered phosphatidylcholine metabolism alzheimers disease neurobiology aging vol 35 2 pp 271 278 2014 103 blasko et al plasma phosphatidylcholines vitamin b12folate levels possible prognostic biomarkers progression alzheimers disease experimental gerontology vol 147 p 111264 2021 104 v r varma et al abnormal brain cholesterol homeostasis alzheimer ’ disease —a targeted metabolomic transcriptomic study npj aging mechanisms disease vol 7 1 pp 114 2021 105 e horgusluoglu et al integrative metabolomics‐genomics approach reveals key metabolic pathway regulators alzheimers disease alzheimers dementia vol 18 6 pp 1260 1278 2022 106 z zeng li li luo statistical machine learning methods spatially resolved transcriptomics data analysis genome biol vol 23 1 pp 1 23 2022 107 li et al soar spatial transcriptomics analysis resource model spatial variability cell type interactions biorxiv 2022 108 wt chen et al spatial transcriptomics situ sequencing study alzheimer ’ disease cell vol 182 4 pp 976 991 e19 2020 109 j lord et al mendelian randomi zation identifies blood metabolites previously linked midlife cognition causal candidates alzheimer ’ disease proceedings national academy sciences vol 118 16 p e2009808118 2021 110 sy huang et al investigating causa l relations circulating metabolites alzheimer ’ disease mendelian randomization study journal alzheimers disease preprint pp 1 15 2021",
    "relevance_score": 0.8101,
    "date_score": 0.0,
    "final_score": 0.4051,
    "date_numeric": 0
  },
  {
    "title": "Manuscript V 2.5 Arxiv version",
    "author": "Eric Mayor",
    "date": "2023-05-03T15:49:58",
    "filename": "2305.11425.pdf",
    "processed_text": "neurotrophic effects intermittent fasting calorie restriction exercise review annotated bibliography eric mayor university basel switzerland corresponding author eric mayor university basel missiosstrasse 62a 4055 basel switzerland ericmarcelmayorunibasch citation mayor e 2023 neurotrophic effects intermittent fasting calorie restr iction exercise review anno tated bibliography frontiers aging 4 11 61814 final version available httpswwwfro ntiersinorgarticles10 3389fragi2023 1161814abstract abstract last decades important progress achieved understanding neurotrophic effects intermittent fasting caloric restriction cr exercise improved neuroprotection synaptic plasticity adult neurogenesis nspan essential examples neurotrophic effects importance respect metabolic switch glucose ketone bodies cellular fuel highlighted recently calorie restriction mimetics crms resveratrol polyphenols particular investigated thoroughly relation nspan narrative review sections manuscript recent findings essential functions synthesized important molecules involved presented researched signaling pathways pi3k akt mtor ampk gsk3β ulk mapk pgc1α nfκb sirtuins notch sonic hedgehog wnt processes eg antiinflammation autophagy apoptosis support thwart neuroprotection synaptic plasticity neurogenesis briefly presented provides accessible entry point literature annotated bibliography section contribution brief summaries provided 30 literature reviews relating neurotrophic effects interest relation cr crms exercise selected reviews address essential functions perspective healthier aging sometimes discussing epigenetic factors reduction risk neurodegenerative diseases alzheimer ’ disease huntington ’ disease parkinson ’ disease depression improvement cognitive function keywords neuroprotection neurogenesis synaptic plasticity neurotrophic effects intermittent fasting calorie restriction caloric restriction mimetics exercise signaling pathways betahydroxybutyrate brainderived neurotrophic factor alzheimer ’ disease depression neurotrophic effects intermittent fasting calorie restriction exercise narrative review annotated bibliography exercise intermittent fasting calorie restriction eic common beneficial effects energy metabolism signaling pathways three induce metabolic switching glucose ketone bodies gtok cellular fuel source glucose scarce mattson et al 2018 lowering available cellular energy cellular sensing limited availability nutrients1 ensues induce activation inhibition several signaling pathways relevant neuroprotection synaptic plasticity neurogenesis nspan eg garcíarodríguez giménezcassina 2021 mattson 2019 van praag et al 2014 shortterm implications cognitive performance eg diano et al 2006 benefits eic achieved part influence hunger hormone ghrelin glucose homeostasis activity insulin receptor bayliss et al 2016 chabot et al 2014 upstream effector signaling pathways relevant nspan sadria layton 2021 hormone ghrelin also plays role signaling pathways regulating nspan bayliss et al 2016 buntwal et al 2019 davies 2022 diano et al 2006 gahette et al 2011 exerkines also regulate activity pathways among others eg chow et al 2022 reddy et al 2022 vints et al 2022 calorie restriction mimetics crms polyphenols sirtuin activators well precursors nicotinamide adenine dinucleotide particular rely upon glucose depletion produce similar effects including enhanced energy metabolism decreased oxidative stress inflammation enhanced nspan cognition testa et al 2014 efficacy crms regards overall physiological parameters questioned handschin 2016 general consensus literature points potential crms prevention treatment neurodegenerative disorders eg bonkowski sinclair 2016 crms considered promising area eg almendarizpalacios et al 2020 bonkowski sinclair 2016 carosi sargeant 2019 heberden 2016 hofer et al 2021 martel et al 2021 sharman et al 2019 xue et al 2021 state current knowledge insufficient recommend crms treatment individuals presenting neurodegenerative disorders instance heger 2017 mentions 17 45 trials time show efficacy curcumin relation diverse clinical targets hofer et al 2021 provide summary human clinical trials interested various crms relating diversity outcomes martel et al 2021 focus human clinical trials interested crms extension human healthy lifespan including neuroprotection neurogenesis discussing advantages disadvantages treatment always provided sufficient clinical trials conducted early progression disease eg carosi sargeant 2019 sharman et al 2019 eic crms beneficial attenuation epigenetic changes induced aging important contributors neurodegeneration among risks almendarizpalacios et al 2020 madeo et al 2019 maharajan et al 2020 mattson et al 2018 xue et al 2021 aims article threefold discuss relevance eic crms nspan relying upon recent publications b briefly present biochemical processes involved metabolism oxidative stress nspan c present selective annotated bibliography existing literature reviews summaries appendix focus ways eic crms improve nspan cognitive function brain resilience eg van praag et al 2014 1 eg increased adenosine monophosphate amp adenosine triphosphate atp ratios sensed 5 adenosine monophosphateactivated protein kinase ampk hardie 2018 relevance exercise calorie restriction cr intermittent fasting crms neurogenesis neuroprotection neurotrophic effects body transition using glucose energy using ketone bodies garcíarodríguez giménezcassina 2021 details see section b liver glycogen store contain equivalent 700 calories depleted energy intake doesnt occur period 10 12 hours least periods high energy expenditure eg running one hour following four hours period last meal mattson et al 2018 glycogen also stored skeletal muscles richter hargreaves 2013 eic result depletion glycogen store thus activate gtok metabolic switch ktog metabolic switch occurs glycogen store repleted energy intake repeated switching glucose ketone bodies main sources cellular fuel advantages organism level terms cellular regeneration protection including brain terms neurogenesis neuroprotection matteson et al 2017 crms resveratrol rapamycin potential prevention treatment neurodegenerative diseases albani et al 2010 baur sinclair 2006 dos santos et al 2022 rege et al 2014 “ compounds also show impressive effects rodent models ageassociated diseases ” kaeberlin 2010 p 96 could modulate cell signaling close fasting state eg resveratrol chatam et al 2022 rapamycin blagosklonny 2019 sustainable alternation exercise cr use crms might lead benefits similar continued reliance upon single modality nspan intervention contribution potential benefits eic crms dwelved upon including metabolic signaling processes trough advantages achieved neurodegenerative diseases depression large majority papers mentioned review mention devastating consequences aging one motors research neurotrophic effects eic crms including nspan variety essential restorative functions decreased age leads brain aging eg zia et al 2021 addition aging increases damage dna tissues including neurons stem cells niches brunet et al 2022 maharajan et al 2020 bibliometric analysis literature cognitive aging provided othman et al 2022 consequences aging due epigenic changes signaling pathways eg iside et al 2020 wang et al 2022a instance agingrelated impaired ampk signaling see related atherosclerosis cardiovascular diseases increased risks insulin resistance diabetes obesity chronic inflammation nonalcoholic fatty liver diseases polycystic ovary syndrome cancer neurodegenerative diseases yadav et al 2017 neurodegenerative diseases share ethiological processes oxidative stress posttranslational modifications metabolic changes cell death mechanisms disturbed immune response balusu et al 2023 fan et al 2017 factors epigenetic causes environmental behavioral causes fan et al 2017 frequent neurodegenerative diseases alzheimer ’ disease parkinson ’ disease mcgregor nelson 2019 alzheimer ’ disease characterized aggregation amyloid beta peptide accumulation misfolded tau proteins result epigenetic dysregulations cell signaling including mitochondrial metabolic disfunctions aman et al 2021 amorim et al 2022 balusu et al 2023 bloom 2014 guo et al 2022 examples dysregulated processes linked neurodegenerative impairments alzheimer ’ disease endocytosis proteastasis phagocytosis microglia inflammation metal ion homeostasis astrocytes well myelin loss lipid deposits oligodendrocytes balusu et al 2023 parkinsons ’ disease characterized presence lewy bodies different areas brain neurodegenerative cell loss dopaminergic neurons particular balusu et al 2023 mcgregor nelson 2019 examples dysregulated processes associated neurodegeneration parkinsons ’ disease proteostasis potassium ion transport phagocytosis microglia heatshock response metal ion homeostasis astrocytes well proteostasis zinc homeostasis oligodendrocytes balusu et al 2023 major depression important factor associated disability among causes craske et al 2017 search biomarkers major depression challenging due heterogeneity description disorder eg increased appetitesleep decreased appetitesleep decreased emotionality increased nervousness feeling slow feeling restless dysregulated cell signaling protein pathways relation inflammation metabolism candidate biomarkers major depression van haeringen et al 2022 progress stemming focus brain circuits disappointing research prevention treatment neurodegenerative disorders depression authors point relevance examining etiology treatment neurodegenerative diseases molecular cellular level balusu et al 2023 eic crms potential maintain healthy cell signaling restore dysregulated cell signaling eg bayliss et al 2016 erbaba et al 2021 heberden 2016 igwe et al 2021 kallies et al 2019 magliulo et al 2022 ntsapi loos 2016 overall et al 2016 radak et al 2020 ravula et al 2021 spasić et al 2009 szwed et al 2021 van praag et al 2008 van praag et al 2014 vints et al 2022 walsh et al 2020 eic crm discussed next exercise american college sports medicine acsm 2013 defines physical exercise planned voluntary physical activity performed aim maintaining improving fitness body several types exercise distinctions include aerobic vs anaerobic exercise strength vs endurance training acsm 2013 aerobic exercise body relies aerobic metabolism oxygen provided pulmonary respiration generate adenosine triphosphate atp necessary activity whereas anaerobic exercise anaerobic glycolysis relied upon atp production strength training aims increase force muscle endurance training aims increase potential duration exertion acsm 2013 exercise reduce oxidative stress chronic inflammation eg beavers et al 2010 gomezcabrera et al 2008 exercise also source reactive oxygen species ros thereby increase oxidative stress bloomer et al 2005 et al 2016 antioxidative benefits exercise therefore depend upon duration type intensity fisherwellman bloomer 2009 gomezcabrera et al 2008 importance redox balance relation exercise discussed sutkowy et al 2021 exercise still provide benefits even oxidative benefits include activation 5 ’ adenosine monophosphateactivated protein kinase ampk see richter hargreaves 2013 richter ruderman 2009 sirtuins sirts radak et al 2020 addition indirect increase concentration brain derived neurotrophic factor bdnf also potential consequence exercise leckie et al 2014 “ bdnf mediates beneficial effects energetic challenges vigorous exercise fasting cognition mood cardiovascular function peripheral metabolism ” marosi mattson 2014 p89 benefits balanced inflammation stemming oxidative stress recent years important role exerkines – defined “ humoral factors secreted circulation tissues response exercise ” magliulo et al 2022 p 105 – highlighted explanation benefic effects exercise eg chow et al 2022 magliulo et al 2022 reddy et al 2022 vints et al 2022 vints et al 2022 discuss implications exercises exerkines regards synaptic plasticity recent metaanalysis pillon et al 2020 focused studies relying upon transcriptomic profiling identify genes expression modified exercise skeletal muscles mechanisms play exerciseinduced tissue regeneration including central nervous system neurogenesis well neuron myelin axon regeneration instance described chen et al 2022a cortes de miguel 2022 highlight sex differences cns responses exercise intermittent fasting overconsumption food issue modern societies constant availability discussing detrimental effects overconsumption cognitive functioning damaging implications regarding neurodegenerative diseases mattson 2019 specifies “ underlying molecular mechanisms involve epigenetic modifications … alter expression genes involved neuroplasticity ” p 204 lead “ synaptic dysfunction impaired neurogenesis neuronal degeneration ” p 205 nutritional practices reestablish “ adaptive cellular signalling ” cr mitigate negative effects food overconsumption cognition enhancing nspan mattson 2019 “ intermittent fasting regimen repeating cycles ad libitum eating fasting ” erbaba et al 2021 p 2 four main forms frequently studied addition religious forms fasting alternate day fasting important lowering energy intake every two days whole day fasting one two days food abstinence week time restricted feeding energy intake limited time window 8 12 hours generally periodic fasting 5 days ad libitum diet followed two days fasting eg bhoumik et al 2023 li et al 2023 seidler barrow 2022 tinsley la bounty 2015 similar benefits cr eg improved neurogenesis baik et al 2020 discussed next observed fasting mimicking diets baik et al 2020 seidler barrow 2022 zhao et al 2022 consist limiting intake calories proteins cycles days week see seidler barrow 2022 chen et al 2022a provide bibliometric analysis intermittent fasting li et al 2023 provide balanced view intermittent fasting including potential disadvantages summaries processes relating circadian rhythms caloric restriction cr entails limitation energy intake food – “ rough guideline would 1800–2200 kcalday men 1600–2000 calories women ” mattson 2010 p 8 – prolonged period time mattson 2010 availability nutrients ratio adenosine monophosphate atp yadav et al 2017 regulates several signaling pathways relevance nspan various mechanisms cr delay cognitive effects aging gillespie et al 2016 instance cr leads reduction oxidative stress almendarizpalacios et al 2020 yu et al 2020a proliferation new neurons maharajan et al 2020 mattson arumugam 2018 better regulation autophagy neurons ie recycling material deficient damaged cells increased energy scarce appendix see summary ntsapi loos 2016 examples include increase antiinflammatory hormones decrease chronic inflammation modulation cell survival eg apoptosis testa et al 2014 signaling pathways involved processes others described next section caloric restriction mimetics crms share benefits eic testa et al 2014 xue et al 2021 instance bonkowski sinclair 2016 see appendix discuss increasing use nicotinamide adenine dinucleotide precursors activators sirts clinical trials context neurodegenerative disease prevention treatment promotion longevity several reviews summarized appendix discuss role polyphenols modulation synaptic plasticity increased neuronal proliferation reduction oxidative stress neurotoxicity particular eg moosavi et al 2016 rendeiro et al 2015 zhang et al 2021 noted miller et al 2011 found resveratrol simvastatin provide longevity benefits rodents whereas rapamycin three crms thus impacted longevity differently miller et al 2011 see madeo et al 2019 sharman et al 2019 note low success rate phytocomponents among nicotinamide adenine dinucleide boosters sirtuins upstream effectors terms symptom reduction human trials alzheimer ’ patients importantly safety nicotinamide mononucleotide nicontinamide adenine dinucleotide precursor needs investigated nadeeshani et al 2022 neurogenesis adult neurogenesis refers formation new neurons adult central nervous system overall et al 2016 description different stages neurogenesis starting stem cell leading mature neuron provided overall et al 2016 new neurons hyperexcitable less receptive inhibitory neurotransmitters eg gammaaminobutyric acid – gaba confers influence older neurons neural circuit fares et al 2019 adult neurogenesis documented different mammals lucassen et al 2020 studies matter overwhelmingly conclude neurogenesis occurs adult human hippocampus see lucassen et al 2020 kempermann et al 2018 hippocampus fulfills important functions respect spatial episodic memory involved emotional processes anacker hen 2017 neurogenesis region – accounting 700 new neurons every day 2 total spalding et al 2013 – might required flexible representations behavior ie dealing new situations adaptively tuncdemir et al 2019 reduced hippocampal neurogenesis associated diminished ability form new memories forgetting old memories frankland et al 2013 whereas increasing hippocampal neurogenesis allows flexibility strategy choice compensate preceding deficiencies aging brain bergugovega et al 2020 adult neurogenesis induced enhanced eic crms slows cognitive decline also enhance cognition eg chow et al 2022 mattson arumugam 2018 overall et al 2016 describe different mechanisms neurogenesis promoted physical activity maharajan et al 2020 negredo et al 2020 discuss potential cr maintaining health stem cells stem cell niche regeneration fares et al 2019 provide historical perspective study neurogenesis neuroprotection eic crms promote neuroprotection thereby delay cognitive aging eg burtcsher et al 2022 mattson arumugam 2018 reddy et al 2022 achieved several mechanisms two addressed paragraph others briefly mentioned pages follow first mechanisms protection neuron microenvironment neurons oxidative stress eg protection membrane dna integrity li et al 2022 lüscher et al 2021 second related mechanism regulation cell survival eg ying 2006 ideal conditions survival healthy cells promoted survival senescent otherwise deficient cells impeded different mechanisms eg autophagy apoptosis eg bortner cidlowsky 2020 laberge et al 2013 neuroprotective effects thereby achieved brain bhaduri et al 2023 cellular level different molecules signaling pathways play role determining fate cells including neurons eg bathina das 2015 fayad et al 2005 huang reichardt 2001 jaworski et al 2019 krieglstein et al 2002 li et al 2022 lüscher et al 2021 nordvall et al 2022 rai et al 2019 ying 2006 yamamoto et al 2007 zhao et al 2019 eic crms regulate processes eg mattson arumugam 2018 synaptic plasticity synaptic plasticity also important neurotrophic effect eic crms eg reddy et al 2022 rendeiro et al 2015 seidler barrow 2022 ability brain reorganize following internal external events key learning adaptive conduct one mechanism synaptic plasticity bliss et al 2018 magee grienberger 2020 mcallister et al 1999 neurotrophins particular bdnf see current section play important role synaptic plasticity well synaptic transmission gómezpalacioschjetnan escobar 2013 mcallister et al 1999 magee grienberger 2020 discuss several forms synaptic plasticity including form commonly studied hebbian plasticity strength synapse depends often presynaptic neuron fires toward postsynaptic neuron abraham 2008 discusses metaplasticity refer tuning synapses neuron networks plasticity “ metaplasticity entails change physiological biochemical state neurons synapses alters ability generate synaptic plasticity ” abraham 2008 p 387 alternations phases high stimulation phases low stimulation paradigmatic promotion metaplasticity physical exercise induce high stimulation b energy metabolism oxidative stress neuroprotection synaptic plasticity adult neurogenesis biochemical processes section several processes responsible effects eic crms nspan discussed neurotrophic protective effects signaling pathways elicited eic crms presented comprehensiveness energy metabolism liver glycogen storage provides body continued access ‘ fuel ’ long supply lasts release glucose bloodstream mcbride hardie 2009 glucose transporters proteins mediate entry glucose across cell membranes blood brain barrier bbb eg simpson et al 1999 thorens mueckler 2010 cellular respiration results production atp cell mitochondria korla mitra 2014 process also releases h2o co2 cellular respiration starts glycolysis transformation glucose pyruvate acetylcoenzymea acetylcoa availability nicotinamide adenine dinucleotide important requirement continues krebs cycle ends oxidative phosphorylation – involving electron transport chain etc chemiosmosis zhao et al 2019 energy necessary cell notably hydrolysis binding h2o atp atp converted adenosine diphosphate adp one phosphate consumed energy yadav et al 2017 occur adp leading adenosine monophosphate amp one phosphate ratios adpatp ampatp thus indicators energy requirements cell yadav et al 2017 hydrolysis triglycerides occurs adpatp ampatp ratios high results synthesis fatty acids converted ketone bodies oxidation fuel cells gtok metabolic switching martínezreyes chandel 2020 mattson et al 2018 newman verdin 2017 energy expenditure eg exercise increases ros organism et al 2016 major contributor ros slippage electrons etc mitochondria mazat devin ransac 2020 shofield schafer 2021 zhao et al 2019 proton slippage partially downregulated uncoupling proteins ucps demine et al 2019 haas barnstable 2021 holmström finkel 2014 discuss sources ros processes ros generation role antioxidants ros inhibitors reviewed brieger et al 2012 oxidative stress ensues elevated production ros coupled insufficient availability antioxidants ros imbalance aon et al 2010 shofield schafer 2021 “ signaling molecules ros play important role cell proliferation hypoxia adaptation cell fate determination excessive ros cause irreversible cell damage even cell death ” zhao et al 2019 p 3 oxidative stress generally also lead negative consequences murphy 2009 di meo et al 2016 shofield schafer 2021 zeliger 2013 discusses diseases linked oxidative stress comorbidity prevention well oxidative stress index questionnaire permits assess potential future onset noncommunitive chronic diseases list environmental sources ros moderate ros ideal endocrine immune cognitive functions brieger et al 2012 thus low high ros related metabolic disfunctions diseases brieger et al 2012 importantly elevated ros associated range neurodegenerative diseases singh et al 2019 dunn et al 2015 present antimicrobial function ros holmström finkel 2014 discuss redox signaling chun et al 2010 discuss antioxidant intake americans several sources high ampatp ratio high ros sensed 5 ’ adenosine monophosphateactivated protein kinase ampk trigger signaling eg hinchy et al 2018 rabinovitch et al 2017 different protective mechanisms thereby indirectly activated increased ros involve sirts peroxisome proliferatoractivated receptorγ coactivator pgc1α mammalian target rapamycin mtor unc51 like autophagy activating kinase 1 ulk1 transcription factors forkhead box foxo p53 promyelocytic leukemia pml sensor ros ros sensed activates p53 niwakawakita et al 2017 p53 inhibitor cell growth propagation involved tumor suppression aubrey et al 2018 budanov karin 2009 involved neuroprotection regulating neuronal apoptosis culmsee mattson 2005 maornof et al 2021 note p53 linked neurodegeneration nucleotides metabolites neurotrophic factors nicotinamide adenine dinucleotide nad involved dna repair mitophagy process recycling nonessential damaged mitochondria schofield schafer 2021 required sirt1 activation chen et al 2020 fang bohr 2017 nad participates glycolysis reduced nadh process navas carnero 2020 ying 2006 mentioned high level ros important threat mitochondrial cellular integrity increased nad upregulate immunity inflammation dna repair activation nad dependent enzymes sirts poly adpribose polymerases parps navas carnero 2020 xie et al 2020 ying 2006 although reported nad acts proinflammatory cytokine eg navas carnero 2020 xie et al 2020 also shown nad precursors regulate chronic inflammation reduce ros thereby inflammation covarrubias et al 2021 xie et al 2020 nad also modulates effect different enzymes facilitates energy metabolism helps synchronization circadian clock xie et al 2020 nad nadh also play important roles cell survival death ying 2006 including role adpribosylation li et al 2022 lüscher et al 2021 aging related nad deficiency deficiency related accelerated aging eg increased mitochondrial disfunctions xie et al 2020 constitutes vicious circle – thwarted instance supplementation nad precursors bonkowski sinclair 2016 upregulation ampk signaling exercise richter hargreaves 2013 calorie restriction mattson arumugam 2018 consequences include disturbed circadian rhythms increased inflammation poor immunity hampered dna repair increased risk cancer aggravated high levels ros navas carnero 2020 xie et al 2020 three pathways play synthesis nad de novo preisshandler salvage pathways lautrup et al 2019 xie et al 2020 ying 2006 synthesis nad de novo pathway neuroprotective neurotoxic effects lautrup et al 2019 “ starts catabolism amino acid tryptophan converted via two steps intermediate kynurenine generate nad kynurenic acid xanthurenic acid ” lautrup et al 2019 p 630 nad synthesized nicotinic acid na preisshandler pathway nicotinamide riboside nr reuse nicotinamide nam salvage pathway lautrup et al 2019 xie et al 2020 ying 2006 preisshandler salvage pathways rely upon intermediary synthesis nicotinic acid mononucleotide namn lautrup et al 2019 xie et al 2020 ying 2006 worth noting “ atp may consumed replete nad nad selectively depleted enzymes parp1 vice versa nad may also consumed regenerate atp pathological conditions atp selectively depleted ” ying 2006 therapeutic potential nicotinamide riboside supplementation examined mehmel et al 2020 ketone bodies fatty acids synthesized hydrolysis triglycerides glucose lacking instance following eic converted three ketone bodies βhydroxybutyrate bhb acetone ace acetoacetic acid also referred acetoacetate acac newman verdin 2017 ketone bodies distributed cells organs including brain release blood circulation ketone bodies used alternate fuel sources glucose cell catabolized acetylcoa newman verdin 2017 acetylcoa converted atp result krebs cycle details see martínezreyes chandel 2020 ketone bodies also regulatory roles response oxidative stress cell excitability regulation protein expression signaling generally brain see garcíarodríguez giménezcassina 2021 koppel swerdlow 2018 evidence increases ketone bodies bhb particular result neuroprotection eg kolb et al 2021 bhb transported across bbb monocarboxylic acid transporters mct amount mct regulates bhb brain responsible variety actions newman verdin 2017 briefly mentioned important role bhb upregulation activation nfκb hippocampal expression bdnf case either scarce sufficient glucose supply hu et al 2018 mattson arumugam 2018 words bhb increases bdnf even absence gtok metabolic switching bhb affects sympathetic tone inhibition free fatty acid receptor 3 newman verdin 2017 upregulates gene expression suppresses oxidative stress inhibiting class histone deacetylases hdac newman verdin 2017 shimazu et al 2013 appears bhb capable stimulating pgc1α mitochondrial biogenesis mitophagy foxo1 metabolic regulation reduced sympathetic tone apoptosis santo paik 2018 without ampk modulation phosphoinositide 3kinase – protein kinase b pi3kakt pathway kim et al 2019 activation macrophages bhb nicotinic acid na activate hydroxycarboxylic acid receptor 2 hcar2 induce neuroprotection reduction neuroinflammation also regulates lipid metabolism newman verdin 2017 rahman et al 2014 bhb also involved synaptic plasticity mattson arumugam 2018 gabaergic regulation newman verdin 2017 plays major role cognition health general cavaleri bashar 2018 brain derived neurotrophic factor bdnf bdnf member neurotrophins family main protagonist nspan increased exercise bathina das 2015 kallies et al 2019 zhao et al 2008 neurotrophins family proteins regulate neural function growth survival neuroplasticity various signaling pathways huang reichardt 2001 bathina das 2015 four neurotrophins nerve growth factor ngf neurotrophin3 nt3 neurotrophin4 nt4 bdnf role played bdnf regulating neurophysiological processes modulating synaptic interactions neuroplasticity neuroprotection extensively studied kowiański et al 2018 functions mediated several downstream effectors including trk family tyrosine kinase family receptors foltran diaz 2017 activation tyrosine receptor kinase b trkb kinase promotes signaling along two pathways pi3kakt rafmekerk foltran diaz 2017 examples specific roles bdnf provided research found bdnf increases axonal arborization tyrosine receptor kinase b trkb signaling process regulated phosphitylation mitogenactivated protein kinases mapk cheng et al 2011 jeanneteau et al 2010 trkb involved neural plasticity johnstone mobley 2020 bdnf also increases activation neuronal stathmins cardinaux et al 1997 stathmins induce plasticity generation new neurons development chauvin sobel 2015 notable bdnf also upregulates mtorc1 detrimental action inhibited ampk effect sirt signaling upregulation nad metabolism ishizuka et al 2013 sadria layton 2021 reduced levels bdnf associated neurodegenerative diseases reviews see bathina das 2015 autry monteggia 2012 – mention relation neurotransmitter serotonin body brain bdnf also involved energy homeostasis regulation parasympathetic tone marosi mattson 2014 interventions targeting neurotrophins including bdnf discussed nordvall et al 2022 agonists trkb bdnf explored interventions eg steroid derivatives “ gambogic amide asiaticoside sarcodonin ” p 3 well 78dihydroxy flavone polyphenol see emili et al 2022 several show robust effectiveness questions validity nordvall et al 2022 protein lipid kinases involved nspan kinases enzymes add phosphor group target activated phosphorylation taylor kornev 2011 subsection several protein lipid kinases involved nspan briefly presented main actions effectors summarized table 1 phosphoinositide 3 pi3k cr involved improvement mitochondrial function regulation pi3k effectors lu et al 2019 zhao et al 2022 pi3k dysregulation implicated neurodegenerative diseases ad kumar bansal 2022 associated increased chronic microglia activation following dysregulation chu et al 2021 “ considerable evidence suggests chronically activated microglia continually secrete neurotoxic molecules sustain neuroinflammation ” p 3 pi3k involved regulation autophagy cellular growth survival synaptogenesis notably direct indirect influence akt mtor pi3kaktmtor pathway ersahin et al 2015 erk carracedo pandolfi 2008 chen et al 2013 cuesto et al 2011 rai et al 2019 sadria layton 2021 key activators pi3k include insulininsulin growth factor 1 igf1 tyrosine receptor kinase b trkb bhb foltran diaz 2017 kim et al 2019 sadria layton 2021 pi3k upstream regulator ras bathina das 2015 regulates raf entry point rafmekerk pathway peyssonnaux eychène 2001 pi3k upregulated insulin receptor activation igf1 trkb activity particular foltran diaz 2017 sadria layton 2021 fakhri et al 2021 examine use natural molecules reduce activity pi3kaktmtor signaling pathway history research pi3k provided vanhaesebroeck et al 2012 bibliometric analysis literature pi3k ho hartley 2020 protein kinase b akt akt dysregulation implicated neurodegenerative diseases ad kumar bansal 2022 akt involved neuroprotection several ways downregulation functions proteins responsible apoptosis programmed death deficient cells survival proliferation cells – including autophagy notably neurons regulation neuronal toxicity chen et al 2013 fayad et al 2005 rai et al 2019 examples include downregulation ampk – decrease ampatp ratio upregulation mtor hahnwindgassen et al 2005 fayad et al 2005 mention pathways may also regulate pathways modulated akt akt also phosphorylates foxo tuberous sclerosis complex tsc1 tsc2 important regulators mtor huang et al 2008 sadria layton 2021 regulates antiapoptotic prosurvival extracellular signalregulated kinases erk rai et al 2019 vadlakonda et al 2013 discuss interplay ‘ interactions feedback loops ’ akt mtor mediating role ampk foxo particular insulininsulin growth factor 1 igf1 pathway activates phosphoinositidedependent kinase1 activates akt sadria layton 2021 akt activation also promoted pi3k mtorc2 huang et al 2008 sadria layton 2021 esrahin et al 2015 vadlakonda et al 2013 mammalian target rapamycin mtor mtor related two complexes mtorc1 mtorc2 tsc1tsc2 complex downregulates mtorc1 upregulate mtorc2 huang et al 2008 neurodegenerative diseases potential consequence chronic activation mtorc1 sardia layton 2021 mtor inhibited cr due effect ampk zhao et al 2022 exercise potential increase mtor activation due activation akt “ far increasing mtorc1 activity running high amounts metabolic stress induced endurance exercise decrease mtorc1 activity decrease mtorc1 activity following running may result activation 5′adenosine monophosphate activated protein kinase ampk ” watson baar 2014 p 134 mtor downstream upstream effector akt mtor involved sensing “ nutrient levels presence growth factors cellular energy status mediates several catabolic anabolic processes maintain metabolism cell growth ” ersahin et al 2015 p 1947 specifically mtor participates autophagy recycling cell materials potentially cell death synthesis proteins nucleotides well glucose mitochondrial lipids metabolism chen et al 2013 liu sabatini 2020 szwed et al 2021 mtorc1 activated chronically potentially case severe prolongued acute activation risk cancer increased sadria layton 2021 mtorc1 directly inhibited rapamycin szwed et al 2021 less active amino acids low szwed et al 2021 particular activation results binding arginine cytosolic arginine sensor mtorc1 subunit 1 castor1 budanov karin 2009 chantranupong et al 2016 szwed et al 2021 leucine sesn 2 budanov karin 2009 chen et al 2022b szwed et al 2021 phosphorylation ulk1 ampk downregulates mtorc1 phosphatidylinositol 3kinaseakt pathway upregulates mtorc1 szwed et al 2021 sadria layton 2021 unlike mtorc1 mtorc2 inhibited rapamycin directly szwed et al 2021 pi3k activates mtorc2 sadria layton 2021 mtorc2 promotes akt activation different means huang et al 2008 sadria layton 2021 esrahin et al 2015 caron et al 2010 provide summary upstream downstream effectors mtor bibliometric analysis literature mtor provided li et al 2022 5 ’ adenosine monophosphateactivated protein kinase ampk ampk considered target antiaging approaches aiming neuroprotection including prevention alleviation neurodegenerative diseases eg bayliss et al 2016 primary functions ampk sensing cellular energy eg high ampatp ratio low atp metabolic regulation ensues well regulation mitochondrial ros rabinovitch et al 2017 zhao et al 2019 important functions include subsequent increase decrease oxidized form nicotinamide adenine dinucleotide nad sirtuin1 sirt1 cantó et al 2009 b upregulation pathways consume produce atp cantó et al 2009 c mitochondrial biogenesis cantó et al 2009 neuron cell fate spasić et al 2009 role ampk cellular metabolism eg fatty acid synthesis protein synthesis glycolysis glucose transport endothelial nitride oxide synthase discussed yadav et al 2017 importantly result restoring energy balance cell ampk upregulates pgc1α phosphorizes ulk1 tuberous sclerosis complex tsc 2 thereby suppresses mtor signaling rabinovitch et al 2017 sadria layton 2021 action requires activation protein kinase b akt alessi et al 2006 sirt directly yadav et al 2017 indirectly increasing nad tang et al 2016 ampk serves several functions including among others regulation autophagy karabiyik et al 2021 penugurti et al 2022 addition regulation related energy sensing ampk activity inhibited ulk1 sadria layton 2021 activated cellular stress leptinadiponectin fasting exercise chen et al 2022a hinchy et al 2018 richter hargreaves 2013 richter hargreaves 2013 yadav et al 2017 p53 activates ampk sestrin sesn 1 sesn 2 budanov karin 2009 sesns stress sensing proteins participate cellular homeostasis regulation ampk mtor play essential role disease prevention chen et al 2022b p53 activated well tumour suppressor serine–threonine kinase liver kinase b1 lkb1 alessi et al 2006 shackelford shaw 2009 also required ampk downregulation mtor signaling shaw et al 2004 bibliometric analysis literature ampk provided lyu et al 2022 gylcogen synthase kinase3β gsk3β neurotrophic actions gsk3β mainy related role regulation synaptic plasticity synaptogenesis neuronal proliferation migration cuesto et al 2015 jaworski et al 2019 gsk3β also involved cell survival proliferation metabolism neuronal function jaworski et al 2019 gsk3β plays important role regulation circadian rhythms activation inactivation nuclear factor erythroid 2related factor 2 nrf2 also activated oxidative stress shilovsky et al 2021 nrf2 upregulates stress adaptation inhibition inflammatory processes ros reduction shilovsky et al 2021 dysregulation gsk3β implications neurodegenerative diseases major depression jaworksi et al 2019 gsk3β downregulated phosphorylation eg akt activated dephosphorization eg serinethreonine protein phosphatase 1 jaworski et al 2019 igf1 upregulates pi3k akt downregulates gsk3β duarte et al 2008 mutations along several pathways pi3k hedgehog notch wnt related alterations gsk3β activity mccubrey et al 2016 gsk3β phosphorylates βcatenin hermida et al 2017 essential canonical actions wnt arredondo et al 2020 unc51 like autophagy activating kinase ulk ulk complex composed ulk1 ulk2 ulk1 involved autophagy recycling cell materials conditions cellular stress affect functioning cells survival death nie et al 2016 ulk complex also involved mitophagy quality control process mitochondria functions “ degradation damaged superfluous mitochondria prevention detrimental effects ros mitochondrial disfunction reinstation cellular homeostasis response stress ” chen et al 2020 p 1 disfunctions autophagy mitophagy importantly linked neurodegenerative disorders eg chen et al 2020 ulk upregulated ampk inhibited mtor sadria layton 2021 yu et al 2021 mitogenactivated protein kinases mapk signal cascades mapk signal cascades play essential role expression genes immunity cell differentiation proliferation also involved regulating neuronal inflammation axon arborization ersahin et al 2015 peyssonnaux eychène 2001 wancket et al 2012 among important signal cascade rafmekerk pathway peyssonnaux eychène 2001 rafmekerk also involved cellular apoptosis thereby regulates cell survival peyssonnaux eychène 2001 signaling pathway complementary pi3kaktmtor pathway ersahin et al 2015 however “ mapks implicated pathogenesis many conditions ” wancket et al 2012 p 244 mapk phosphatases mkps downregulate mapks mapks increase activity mkps wancket et al 2012 feedback loop allows beneficial functions mapks achieved keeping activity control ras raf indirectly upregulated pi3k leading activation mapks eg erk peyssonnaux eychène 2001 “ one hand hypoglycemia eg achieved eic decreases anabolic hormones eg insulin gh igf1 well sex thyroid hormones increases expression catabolic cortisol subsequently inhibits mapk pathway ie rasrafmekerk pi3kaktmtor pathway hand inhibition erk avoids mtor activation subsequently induces autophagy activity contributes suppression inflammation downregulation ifn ie interferons proinflammatory cytokine responses ” kökten et al 2021 p 1561 signaling proteins involved nspan signaling proteins play important role nspan presented main actions summarized table 1 peroxisome proliferatoractivated receptorγ coactivator pgc1α exercise calorie restriction intermittent fasting well exposure cold temperature upregulates pgc1α anderson prolla 2009 chen et al 2022a vernier giguère 2021 pgc1α plays major role reducing oxidative stress inflammation regulating mitochondrial biogenesis mitophagy riuspérez et al 2020 tang et al 2016 also involved fatty acid oxidation glucogenesis energy metabolism regulation krebs cycle atp production riuspérez et al 2020 “ dysregulation pgc1α alters redox homeostasis cells exacerbates inflammatory response commonly accompanied metabolic disturbances ” riuspérez et al 2020 p 1 dysregulation pgc1α accrues aging antiaging intervention documented target pgc1α limit impact mitochondrial decline including nervous system anderson prolla 2009 vernier giguère 2021 pgc1α mainly regulated ampk positively akt negatively glycogen synthase kinase 3β gsk3β negatively chen et al 2022a riuspérez et al 2020 well indirectly sirt cantó et al 2013 bhb upregulate pgc1α kim et al 2019 nuclear factor κb nfκb moderate exercise might inhibit nfκb resistance exercise activates liu et al 2018 vella et al 2012 nfκb important regulator cell cycle thereby affecting cell fate immunity inflammation liu et al 2017 mattson arumugam 2018 functions nfκb relevant neurodegeneration yu et al 2020b particular nfκb chronic activation implicated pejoration symptoms alzheimer ’ disease neuroinflammation – risk factor neurodegenerative diseases depression capece et al 2022 dolatschahi et al 2021 nfκb involved contradictory functions cell survival neurodegeneration minchevatasheva et al 2013 “ stimulus produces opposite responses activating nfκb different cell types ” p 187 upstream effectors nfκb lactate succinate bhb unsaturated fatty acids complete list provided capece et al 2022 nfκb also indirectly activated ros liu et al 2017 sirtuins sirt sirts class histone deacetylases carafa et al 2016 “ seven members family enzymes considered potential targets treatment human pathologies including neurodegenerative diseases cardiovascular diseases cancer ” carafa et al 2016 p 1 availability nad required activation 7 sirts cantó et al 2009 tang et al 2016 elkhwanky hakkola 2018 fagerli et al 2022 requirement fulfills energy sensing functions thereby sirts optimally respond cellular energy requirements elkhwanky hakkola 2018 sirt1 sirt6 sirt7 present cell nucleus whereas sirt2 present cytosol sirt3 sirt4 sirt5 present mitochondria elkhwanky hakkola 2018 fargeli et al 2022 morris 2013 focus aging yamamoto et al 2007 addresses detail functions sirts notably gluconeogenesis lipid metabolism mitochondrial respiration cellular proliferation differentiation cell cycle control gene expression apoptosis inflammation insulin secretion neuroprotection axonal protection dna repair elkhwanky hakkola 2018 discuss important role extranuclear sirts sirt1 activity particular associated increased longevity details see tang et al 2016 focus research sirts follows activity sirts discussed general terms signaling sirts especially complex would require much space see cantó et al 2009 2013 tang et al 2016 elkhwanky hakkola 2018 fagerli et al 2022 specific mentions sirt signaling found sections increased activity sirts eg ampk indirectly exercise cr crms eg chen et al 2022a related energy homeostasis eg regulation krebs cycle oxidative phosphorylation triggering glucose uptake fatty acid oxidation ketogenesis mitochondrial homeostasis integrity notably reduction ros dna repair activation parps see nspan regulation synaptic plasticity mitochondrial biogenesis neurons importantly reduction ros elkhwanky hakkola 2018 fagerli et al 2022 functions sirts indirectly involved rely upon adpribosylation signaling see parps play major role hottiger 2015 higher risk neurodegenerative diseases ensues decreased activity sirts mitochondrial cardiovascular diseases neurodegenerative diseases elkhwanky hakkola 2018 et al 2022 jiao gong 2020 importantly sirts activate lkb1 turn activate ampk downregulate mtor sadria layton 2021 shaw et al 2004 woods et al 2003 regulate pgc1α cantó et al 2013 modulation sirts instance using resveratrol among sirt activators promising prevention treatment target neurodegenerative disorders cancer cao et al 2018 carafa et al 2016 leite et al 2021 discuss relevance targeting sirts pharmacologically prevention treatment neurodegenerative disorders particular fang et al 2019 discuss role sirts regulation stem cells sonic hedgehog shh recurrent finding signaling pathways essential brain development also active neurogenesis synaptic plasticity yao et al 2016 demonstrably case hedgehog dependent pathways particular dependent upon shh yao et al 2016 particular shh active brain development also maintenance proliferation neural stem cells adult brain carballo et al 2018 schwarz el al 2012 action shh neurogenesis appears regulated primary cilia hippocampal neurons breunig et al 2008 shh also participates axon regeneration see bibliometric analysis chou et al 2022 interplay notch shh pathways notch signalling potentiates cell proliferative effect shh recurrent finding recent years yao et al 2016 crosstalk shh wnt also documented carballo et al 2018 dysfunctions shh signalling present neurodegenerative diseases metabolic disorders depression garg et al 2022 tayyab et al 2017 yao et al 2016 notch increased notch signalling observed following intermittent fasting exercise baik et al 2020 brandt et al 2010 development notchdependant pathways ensure neural stem cells maintenance developing brain ehm et al 2010 notch signaling pathway also plays important role regulation plasticity neural stem cells neural progenitor cells several niches adult brain bagherimohammni 2022 brandt et al 2010 ehm et al 2010 disfunctions notch signaling present ad neurodegenerative diseases ables et al 2011 notch master regulator neuronal life cycle synaptic plasticity ables et al 2011 “ notch signaling deeply participates development homeostasis multiple tissues organs ” zhou et al 2022 p 1 transcriptional activation known way notch activity enhanced protein activation also possible ‘ noncanonical ’ signalling ables et al 2011 precursors notch receptors generated transcription translation endoplasmic reticulum undergo maturation golgi apparatus zhou et al 2022 inhibition gsk3 pi3kakt increases activity notch notch signalling enhance activity hedgehog pathway including ssh ligand jacobs huang 2020 hedgehog pathway also regulates notch signaling jacobs huang 2020 notch activity carcinogenic anticarinogenic zhou et al 2022 wnt wnt pathways also important neurotrophic activity including adult neurogenesis arredondo et al 2020 alkailani et al 2022 “ wnt signaling pathway plays multiple roles adult hippocampal neurogenesis including regulation proliferation fatecommitment maturation adultborn neurons ” arredondo et al 2022 p 636 wntbcatenin pathway potentiated ampk gsk3β phosphorilate βcatenin hermida et al 2017 zhao et al 2010 wnt also plays major role differentiation neuronal precursor cells arredondo et al 2020 general blockade wnt almost completely impedes neurogenesis arredondo et al 2020 neural cell proliferation differentiation results autophagy regulated wnt lorzadeh et al 2021 wnt also participates presynaptic differentiation eg remodeling axon synapse button presynaptic post synaptic assembly cns particularly hippocampus well regulation distribution synapses salinas et al 2013 wnt also participates axon regeneration chou et al 2022 mentioned deficient wnt signaling linked brain tumor genesis alkailani et al 2022 others found increased wnt signaling due high glucose might responsible link diabetes cancer garcíagiménez et al 2014 wnt reported activate mtor gsk3 inhibition promotes cell growth inoki et al2006 association wnt signaling carcinogenesis thus remains clarified wnt activity inhibited notch mtor acar et al 2021 zeng et al 2018 bibliometric analysis wnt provided xu et al 2021 poly adpribose polymerases parps parps participate antiaging functions promotion chromosome integrity metabolic cell cycle regulation inflammation protein expression rna transcription processing bai 2015 cantó et al 2013 epigenetic alterations parp activities linked neurodegenerative diseases agingrelated diseases due genomic instability amorim et al 2022 mao zhang 2022 eic modulator activity parps ’ souza et al 2017 hofer et al 2022 adpribosylation reversible posttranslational modification proteins function substrate altered li et al 2022 lüscher et al 2021 adpribosylation plays important role neurodevelopment signal transduction maintenance dna integrity rna expression well neuron cell fate conditions cellular stress li et al 2022 lüscher et al 2021 li et al 2022 detail process adpribosylation functioning regulating physiological pathological processes including roles different molecules writers eg nad parps readers eg parps histones erasers eg macrodomaincontaining proteins adpribosylation parps play major role adpribosylation cantó et al 2013 lüscher et al 2021 17 parps detailed see bai 2015 except mention adpribosylation signaling mainly regulated parp1 lesser extent parps cantó et al 2013 lüscher et al 2021 parps activated following dna damage xie et al 2020 indeed important function parps dna repair particularly cellular stress cantó et al 2013 also involved regulation gene expression immune cell maturation influence energy metabolism response inflammation bai 2015 cantó et al 2013 chronic activity parps induce nad depletion result shutdown mitochondrial function glycolytic slowdown reduction nad availability processes activation sirts elevated parp activation ros increase lead several diseases affecting major organs bai 2015 cantó et al 2013 including increased tumor growth therefore parp inhibitors actively researched li et al 2022 table 1 several signaling proteins involved nspan effector type main actions pi3k lipid kinases cell proliferation autophagy synaptogenesis akt protein kinases cell proliferation apoptosis insulin signaling protein synthesis mtor protein kinases cell proliferation protein synthesis autophagy immune function ampk protein kinases cellular metabolism nutrient sensing gsk3β protein kinases glycogen metabolism cell cycle regulation cell division gene transcription insulin signaling ulk protein kinases autophagy mitophagy mapk protein kinases cell proliferation differentiation immune responses inflammation axon arborization pgc1alpha transcription coactivators regulation oxidative stress inflammation mitochondrial biogenesis mitophagy nfκb transcription factor metabolism immunity inflammation protein synthesis cell survival response tumor microenvironment sirtuins protein deacetylases gluconeogenesis lipid metabolism mitochondrial respiration cell cycle control gene expression apoptosis inflammation insulin secretion neuroprotection axonal protection dna repair notch transmembrane proteins cell fate development differentiation regulation plasticity neural stem cells sonic hedgehog morphogens cell proliferation differentiation brain development neural stem cell maintenance proliferation wnt endoplasmic reticulum proteins cell proliferation differentiation survival differentiation neuronal precursor cells presynaptic postsynaptic assembly parps nuclear enzymes transcriptional regulation dna repair cell survival death note table created help gpt35 content thoroughly verified c presentation annotated bibliography subsection focusing exercise following literature reviews summarized radak et al 2007 focused role exercise regulating ros brain discussed implications regards neuroprotection powers et al 2020 described exercise producer ros cause oxidative stress – mentioning hormesis hypothesis experience mild stress prepares neurons tissues important stressors walsh et al 2020 focused link exercise bdnf well cognition reddy et al 2022 discussed cellular processes involved exerciseinduced neuroregulation chow et al 2022 focused exerkines ’ health implications including cognitive decline mattson arumugam 2018 discussed epigenetic changes leading mitochondrial disfunctions eg decreased nadnadh ratio leading decreased sirt signaling alleviating role exercise lucassen et al 2010 focused neuroprotective role exercise sleep well deteriorating effects stress inflammation section following literature reviews summarized mattson et al 2018 focused importance intermittent metabolic switching involved cr nspan neurodegenerative danger lifestyles without opportunities intermittent metabolic switching seidler barrow 2022 examined role bdnf relation cognitive function cherif et al 2016 examined cr ramadan fasting relation cognitive function – mentioning upregulation wang et al 2020 focused influence inflammatory markers – related nspan section cr literature reviews follow summarized almendarizpalacios et al 2020 – updated review focused signaling pathways involved reduced cellular aging stemming cr relevant aspects summarized subsection crms relevant aspects summarized next subsection ntsapi loos 2016 focused regulation autophagy means different cycle durations cr distinguishing macroautophagy starting 30 minutes glucose depletion microautophagy cma starting 10 hours glucose depletion – cma targeted forms autophagy de mello et al 2019 focused triumvirate insulin autophagy neurodegeneration – examining signaling pathways involved maharajan et al 2020 discusses regulation stem cells aging stem cell niches means cr – focus signaling pathways zhang et al 2021 focused optimization brain extracellular microenvironment cr role towards neuroprotection yu et al 2020b examined restauration maintenance cognitive function cr section crms literature reviews follow summarized almendarizpalacios et al 2020 – summary continues bonkowski sinclair 2016 explained use nad precursors sirts activators relation disease prevention – including neurodegeneration longevity focus signaling pathways isde et al 2020 focused activation sirt1 particular phytochemicals crms included hofer et al 2021 examined clinical trials focusing crms discusses list crms available nutrition moosavi et al 2016 focused neurotrophic actions polyphenols discussing nspan oluwole et al 2022 detailed role different polyphenol subclasses tannins phenolic acid lignans flavonoids stilbenes health including main outcomes interest rendeiro et al 2015 examined effect direct indirect flavonoids alleviating neurodegeneration particular zhan et al 2021 focused preclinical uses resveratrol addressing neuroprotection antiinflammatory effect moradi et al 2022 focused mechanisms neuronal regeneration following polyphenol intake addressing ros scavenging reduced betaamyloid accumulation regulation apoptosis gene expression grewal et al 2021 detailed mechanisms neuroprotection afforded quercetin implications regarding neurodegenerative diseases ravula et al 2021 provided updated literature review prospects treatment neurodegenerative disorders offered fisetin subsection nutrients inducing neurotrophic effects summaries following reviews provided hebergen 2016 examined role n3 polyunsaturated fatty acids polyphenols promotion adult neurogenesis carneiro et al 2021 provided updated systematic literature review neuroprotective effects coffee focusing several compounds chen et al 2010 addressed protective role caffeine bbb specifically cui et al 2017 focused role vitamin brain development neuroprotection immunity distinguishing genomic nongenomic actions discussion first pages contribution section firstly literature promotion nspan eic crms briefly presented question gtok metabolic switch addressed ktog metabolic switching mentioned made clear repetition cycles affords health benefits “ repeating cycles metabolic challenge induces ketosis fasting andor exercise followed recovery period eating resting sleeping may optimize brain function resilience throughout lifespan ” mattson et al 2018 p 81 thus section b glucose metabolism expenditure well oxidative stress discussed latter result cellular respiration electron slippage etc leading increase ros introduction continued review main nucleotides atp adp amp metabolites nad nadh bhb neurotrophic factors primarily bdnf well protein kinases signaling proteins involved pi3k akt mtor ampk gsk3β ulk mapk pgc1α nfκb sirtuinsas well notch shh wnt selected signaling pathways focus neurogenesis neuroprotection important functions involved discussed eg regulation energy metabolism oxidative stress inflammation immune function apoptosis autophagy gene expression protein synthesis well tumor suppression since beyond primary role functions support main outcomes interest beckervordersandforth 2017 discuss role mitochondrial metabolism adult neurogenesis guo et al 2022 review literature aging general terms related diseases interventions carrasco et al 2022 mittelbrunn kroemer 2021 examine role cells neurodegenerative diseases among others health consequences related inflammaging section c selective list reviews interest included summary provided appendix selection reviews organized five subsections covering relation neuroprotection andor neurogenesis exercise cr crms well nutrients inducing neurotrophic effects aim subsection provided overall general overview benefits topic eg cr relation neuroprotection neurogenesis summarized literature review adding specific aspects goal implications healthy individuals policy pharmacological cognitive enhancement pce yet mentioned per se contribution improving maintaining nspan requires months years pce usually focuses hope rapid gains particularly relied upon students pressured professionals franke lieb 2013 mayor et al 2020 users pce rely upon pharmacological solutions eg methylphenidate adderall modafinil generally deviating inteded use medications rely upon illicit drugs attitude public towards pce generally rather negative mayor et al 2019 due conception pce focusing short term performance school workplace considered artificial therefore unfair undeserved faber et al 2016 adoption nspan focus individual health collective welfare rather achievement might acceptable public ’ connor joffe 2015 instance indicated individuals tolerant ce aim compensate cognitive deficiency maintenance healthy brain function might even true periods collective challenges covid19 pandemic massell et al 2022 mayor et al 2022a 2022b importance greater good might paramount regulation pce important consideration government policy aims tackle task balancing benefits risks negligible case pce usually conceived ie focus neurotransmitters short term functioning brain regions outram racine 2011 advocating favor nspan eic crms might good strategy benefits eg reduced health burden individual collectivity far surpass pce – allowing maintained improved cognitive functioning long run risks inappreciable performed within reason instance exercise source ros bloomer et al 2005 therefore performed excess calorie restriction lead malnutrition studies literature presented main text reviews summarized annotated bibliography exhibited implications eic potential crms towards enhancement nspan including context neurodegenerative diseases notwithstanding focus basic research rodents believed discovered mechanisms present humans well relate functioning eukaryotic cell largely conserved mammals mattson et al 2018 whether adult neurogenesis exists human remains definitely established denothlippuner jessberger 2021 majority cases studies compare effect regulation different signaling pathways nspan often effect exercise calorie restriction intermittent fasting calorie restriction mimetics compared either thus remains unclear intervention appropriate achieve improved nspan best case matter judgement researcher signaling pathway might operate opposite directions relation nspan instance activation nfκb linked neuroprotective neurodegenerative actions capece et al 2022 minchevatasheva et al 2013 might related decreased risk depression upregulation bdnf nfκb also related increased neuroinflammation risk factor depression roy et al 2023 also unclear whether heightened activation wnt beneficial overall involved carcinogenesis carcinoprevention garcíagiménez et al 2014 inoki et al 2006 another example sirt6 elevated chronically exercised individuals performs protective pejorative actions relation cancer song et al 2022 yang et al 2020 recommendations regards nspan consider effect important protective pejorative regards different pathways regulated eic crm establishing minimal optimal thresholds across modalities studies investigate doseresponse robust effect sizes areas compare across modalities eiccrm signaling pathways prerequisite setting thresholds recommendations regards eic crm elements infrequently reported literature reviews see lucassen et al 2010 absent large majority studies field examples exceptions walsch et al 2020 mention 30 minutes exercise necessary significant changes bdnf occur whereas study related field moore et al 2020 note blood glucose affected single short bouts exercise doseresponse manner benefits starting one minute follows target duration exercise depends parameter one wishes increase information aspects reliability estimates frequently lacking literature li et al 2023 research could also compare relation doseresponse effect sizes studies focusing eic crms ketogenic diets show promise prevention ad eg neth et al 2020 comparison effect eic crms different signaling pathways modalities eiccrm ideally performed within study minimize risk differences effects due methodological differences studies review sharman et al 2019 human trials focusing phytocomponents treatment alzheimer ’ patients successful also noted sample size sufficient detect small moderate improvement adequate power instance sample size 128 least twotailed test difference symptoms two balanced independent groups cohen 05 medium effect size statistical power 08 calculated gpower 3 p value 005 minimal required sample size achieve relevant power studies fail detect desired effect size use metaanalyses well implanted field examples pillon et al 2020 wang et al 2020 mentioned increased reliance upon metaanalyses could provide precious information aspects use precluded heterogeneity existing studies lack reporting effect sizes melsen et al 2014 important element determination minimum optimal thresholds adoption eic crm modalities humans eg kelly et al 2020 rendeiro et al 2015 yu et al 2020a possible find reliable reproducible means targeting ideal quantities individual needs hallmark precision medicine wang et al 2023 importantly needs members specific groups considered future research clarify whether eic crm play important role targeted metabolic reprogramming already successfully used treatment cancer might beneficial regards nspan elsahli wang 2020 mela et al 2020 pateras et al 2023 wang et al 2022b also entails ideally setting objectives realistic expected improvements prior running research programs studies relying upon massspectrometry nuclear magnetic resonance potential highlight value eic crms terms nspan might help identifying additional signaling metabolites effectors affected eic crms could investigated detail second step massspectrometry nuclear magnetic resonance uncommonly used related research questions baker rutter 2023 kelly et al 2020 kristal et al 2017 luan et al 2017 timing important signal transduction also within cell processes unfold time uninterrupted successions events koseska bastiaens 2017 overwhelming majority studies examine effect eic crms single timepoint blurring complexity orchestration events live cell imaging potential determining distinctions signaling dynamics crosstalk different pathways valls esposito 2022 starved cells high availability nutrients conclusion review annotated bibliography synthesized recent efforts understanding mechanisms eic crms afford enhanced nspan mentioned benefits different approaches terms enhancement nspan well explanations pathways mechanisms goal achieved highlighted potential eic crms healthier aging acknowledgements table 1 prepared help gpt35 thoroughly checked addition gpt35 gpt4 used support ideation revised version manuscript discussion except elements table 1 content written generative pretrained transformers included submission references ables j l breunig j j eisch j rakic p 2011 ch development notch signalling adult brain nature reviews neuroscience 12 269283 httpsdoiorg101038nrn3024 abraham w c 2008 metaplasticity tuning synapses networks plasticity nature reviews 9 387399 httpsdoiorg101038nrn2356 acar hidalgosastre leverentz k mills c g woodcock baron collu g brennan k 2021 inhibition wnt signalling notch via two distinct mechanisms scientific reports 11 112 httpsdoiorg101038s41598021886185 american college sports medicine 2013 acsms guidelines exercise testing prescription new yort lippincott williams wilkins albani polito l signorini forloni g 2010 neuroprotective properties resveratrol different neurodegenerative disorders biofactors 36 370376 httpsdoiorg101002biof118 alessi r sakamoto k bayascas j r 2006 lkb1dependent signaling pathways annual review biochemistry 75 137163 httpsdoiorg101146 annurevbiochem75103004142702 alkailani aittaleb tissir f 2022 wnt signaling intersection neurogenesis brain tumorigenesis frontiers molecular neuroscience 15 1017568 httpsdoiorg103389fnmol20221017568 almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 httpsdoiorg103390ijms21239220 aman schmauckmedina hansen morimoto r simon k bjedov fang e f 2021 autophagy healthy aging disease nature aging 1 634650 httpsdoiorg101038s43587021000984 amorim j coppotelli g rolo p palmeira c ross j sinclair 2022 mitochondrial metabolic dysfunction ageing agerelated diseases nature reviews endocrinology 18 243258 httpsdoiorg101038 s41574021006267 anacker c hen r 2017 adult hippocampal neurogenesis cognitive flexibility — linking memory mood nature reviews neuroscience 18 335–346 httpsdoiorg101038nrn201745 anderson r prolla 2009 pgc1α aging antiaging interventions biochimica et biophysica acta bbageneral subjects 1790 10591066 httpsdoiorg101016jbbagen200904005 aon cortassa orourke b 2010 redoxoptimized ros balance unifying hypothesis biochimica et biophysica acta bbabioenergetics 1797 865877 httpsdoiorg101016jbbabio201002016 arredondo sb valenzuelabezanilla mardones md varelanallar l 2020 role wnt signaling adult hippocampal neurogenesis health disease frontiers cell developmental biology 8860 httpsdoiorg103389fcell202000860 arredondo b valenzuelabezanilla santibanez h varelanallar l 2022 wnt signaling adult hippocampal neurogenic niche stem cells 40 630640 httpsdoiorg101093stmclssxac027 aubrey b j kelly g l janic herold j strasser a2018 p53 induce apoptosis relate p53mediated tumour suppression cell death differentiation 25 104113 httpsdoiorg101038cdd2017169 autry e monteggia l 2012 brainderived neurotrophic factor neuropsychiatric disorders pharmacological reviews 64 238–258 httpsdoiorg101124pr111005108 bagherimohammadi 2022 adult neurogenesis molecular signalling pathways brain role stem cells adult hippocampal neurogenesis international journal neuroscience 132 11651177 httpsdoiorg1010800020745420201865953 bai p 2015 biology polyadpribose polymerases factotums cell maintenance molecular cell 58 947–958 httpsdoiorg101016jmolcel201501034 baik rajeev v fann jo arumugam v 2020 intermittent fasting increases adult hippocampal neurogenesis brain behavior 10 e01444 httpsdoiorg101002brb31444 baker sa rutter j 2023 metabolites signalling molecules nature reviews molecular cell biology advance online publication httpsdoiorg101038s4158002200572w balusu praschberger r lauwers e de strooper b verstreken p 2023 neurodegeneration cell per cell neuron 111 767786 httpsdoiorg101016jneuron202301016 bathina das u n 2015 brainderived neurotrophic factor clinical implications archives medical science 6 1164–1178 httpsdoiorg105114aoms201556342 baur j sinclair 2006 therapeutic potential resveratrol vivo evidence nature reviews drug discovery 5 493506 httpsdoiorg101038nrd2060 bayliss j lemus b stark r santos v v thompson rees j andrews z b 2016 ghrelinampk signaling mediates neuroprotective effects calorie restriction parkinsons disease journal neuroscience 36 30493063 httpsdoiorg101523jneurosci4373152016 beavers k brinkley e nicklas b j 2010 effect exercise training chronic inflammation clinica chimica acta 411 785–793 httpsdoiorg101016jcca201002069 beckervordersandforth r 2017 mitochondrial metabolismmediated regulation adult neurogenesis brain plasticity 3 7387 httpsdoiorg103233bpl170044 berdugovega g ariasgil g lópezfernández artegiani b wasielewska j lee cc lippert kempermann g takagaki k calegari f 2020 increasing neurogenesis refines hippocampal activity rejuvenating navigational learning strategies contextual memory throughout life nature communications 11 135 httpsdoiorg101038s4146701914026z bhaduri trisal singh ak 2023 autophagy promising therapeutic target ageassociated neurodegenerative disorders rizvi si eds emerging antiaging strategies pp 135154 singapore springer httpsdoiorg10100797898119744343 bhoumik yadawa ak srivastava p rizvi si 2023 intermittent fasting antiaging strategy rizvi si eds emerging antiaging strategies pp 191206 singapore springer httpsdoiorg101007978981197443410 blagosklonny v 2019 fasting rapamycin diabetes versus benevolent glucose intolerance cell death disease 10 607 httpsdoiorg101038s4141901918228 bliss v p collingridge g l morris r g reymann k g 2018 longterm potentiation hippocampus discovery mechanisms function neuroforum 24 a103–a120 httpsdoiorg101515nf2017a059 bloom g 2014 amyloidβ tau trigger bullet alzheimer disease pathogenesis jama neurology 71 505508 httpsdoiorg101001jamaneurol20135847 bloomer r j goldfarb h wideman l mckenzie j consitt l 2005 effects acute aerobic anaerobic exercise blood markers oxidative stress journal strength conditioning research 19 276285 doi httpsdoiorg1015190012427820050500000007 bonkowski sinclair 2016 slowing ageing design rise nad sirtuinactivating compounds nature reviews molecular cell biology 17 679–690 httpsdoiorg101038nrm201693 bortner c cidlowski j 2020 ions movement water apoptotic volume decrease frontiers cell developmental biology 8 611211 httpsdoiorg103389fcell202061121 brandt maass kempermann g storch 2010 physical exercise increases notch activity proliferation cell cycle exit type3 progenitor cells adult hippocampal neurogenesis european journal neuroscience 32 12561264 httpsdoiorg101111j14609568201007410x breunig j j sarkisian r arellano j morozov ayoub e sojitra town 2008 primary cilia regulate hippocampal neurogenesis mediating sonic hedgehog signaling proceedings national academy sciences 105 1312713132 httpsdoiorg101073pnas0804558105 brieger k schiavone miller jr krause k 2012 reactive oxygen species health disease swiss medical weekly 142 w13659 httpsdoiorg104414smw201213659 brunet goodell rando 2022 ageing rejuvenation tissue stem cells niches nature reviews molecular cell biology httpsdoiorg101038s4158002200510w budanov v karin 2008 p53 target genes sestrin1 sestrin2 connect genotoxic stress mtor signaling cell 134 451–460 httpsdoiorg101016jcell200806028 buntwal l sassi morgan h andrews z b davies j 2019 ghrelinmediated hippocampal neurogenesis implications health disease trends endocrinology metabolism 30 844–859 httpsdoiorg101016jtem201907001 burtscher j romani bernardo g popa ziviani e hummel f c millet g p 2022 boosting mitochondrial health counteract neurodegeneration progress neurobiology 215 102289 httpsdoiorg101016jpneurobio2022102289 chatam chapnik n froy 2022 resveratrol induces fasting state alters circadian metabolism hepatocytes plant foods human nutrition 77 128–134 httpsdoiorg101007s11130022009547 cao w dou li 2018 resveratrol boosts cognitive function targeting sirt1 neurochemical research 43 17051713 httpsdoiorg101007s1106401825868 cantó c gerharthines z feige j n lagouge noriega l milne j c elliott p j puigserver p auwerx j 2009 ampk regulates energy expenditure modulating nad metabolism sirt1 activity nature 458 1056–1060 httpsdoiorg101038nature07813 cantó c sauve bai p 2013 crosstalk polyadpribose polymerase sirtuin enzymes molecular aspects medicine 34 1168–1201 httpsdoiorg101016jmam201301004 capece verzella flati arboretto p cornice j franzoso g 2022 nfκb blending metabolism immunity inflammation trends immunology 43 757775 httpsdoiorg101016jit202207004 carafa v rotili forgione cuomo f serretiello e hailu g altucci l 2016 sirtuin functions modulation chemistry clinic clinical epigenetics 8 121 httpsdoiorg101186s1314801602243 carballo g b honorato j r de lopes g p de sampaio e spohr c l 2018 highlight sonic hedgehog pathway cell communication signaling 16 115 httpsdoiorg101186s1296401802207 cardinaux j r magistretti p j martin j l 1997 brainderived neurotrophic factor stimulates phosphorylation stathmin cortical neurons molecular brain research 51 220228 httpsdoiorg101016s0169328x97002416 carneiro oliveira b p alves r c 2021 neuroprotective properties coffee update trends food science technology 113 167179 httpsdoiorg101016jtifs202104052 caron e ghosh matsuoka ashtonbeaucage therrien lemieux perreault c roux p p kitano h 2010 comprehensive map mtor signaling network molecular systems biology 6 453 httpsdoiorg101038msb2010108 carosi j sargeant j 2019 rapamycin alzheimer disease doubleedged sword autophagy 15 14601462 httpsdoiorg1010801554862720191615823 carracedo pandolfi p 2008 pten–pi3k pathway feedbacks crosstalks oncogene 27 5527–5541 httpsdoiorg101038onc2008247 carrasco e gómez de las heras gabandérodríguez e desdínmicó g aranda j f mittelbrunn 2022 role cells agerelated diseases nature reviews immunology 22 97111 httpsdoiorg101038s41577021005574 cavaleri f bashar e 2018 potential synergies β hydroxybutyrate butyrate modulation metabolism inflammation cognition general health journal nutrition metabolism 2018 1–13 httpsdoiorg10115520187195760 chabot f caron laplante stpierre h 2014 interrelationships ghrelin insulin glucose homeostasis physiological relevance world journal diabetes 5 328341 httpsdoiorg104239wjdv5i3328 chantranupong l scaria saxton r gygi p shen k wyant g wang harper j w gygi p sabatini 2016 castor proteins arginine sensors mtorc1 pathway cell 165 153–164 httpsdoiorg101016jcell201602035 chauvin sobel 2015 neuronal stathmins family phosphoproteins cooperating neuronal development plasticity regeneration progress neurobiology 126 1–18 httpsdoiorg101016jpneurobio201409002 chen x ghribi geiger j 2010 caffeine protects disruptions bloodbrain barrier animal models alzheimer ’ parkinson ’ diseases journal alzheimer ’ disease 20 s127–s141 httpsdoiorg103233jad20101376 chen xiong lj tong mao 2013 neuroprotective effect brainderived neurotrophic factor mediated autophagy pi3kaktmtor pathway molecular medicine reports 8 1011–1016 httpsdoiorg103892mmr20131628 chen g kroemer g kepp 2020 mitophagy emerging role aging ageassociated diseases frontiers cell developmental biology 8 200 httpsdoiorg103389fcell202000200 chen j zhou r feng cheng l 2022a molecular mechanisms exercise contributing tissue regeneration signal transduction targeted therapy 7 383 httpsdoiorg101038s41392022012332 chen huang yu z et al 2022b functions roles sestrins regulating human diseases cellular molecular biology letters 27 2 httpsdoiorg101186s11658021003028 cheng pl song ah wong yh wang zhang x poo mm 2011 selfamplifying autocrine actions bdnf axon development proceedings national academy sciences 108 18430–18435 httpsdoiorg101073pnas1115907108 cherif roelands b meeusen r chamari k 2016 effects intermittent fasting caloric restriction ramadan intermittent fasting cognitive performance rest exercise adults sports medicine 46 3547 doi 101007s4027901504086 chou nawabi h li j 2022 research hotspots trends axon regeneration 2000–2021 bibliometric study systematic review inflammation regeneration 42 115 httpsdoiorg101186s41232022002444 chow l gerszten r e taylor j pedersen b k van praag h trappe febbraio galis z gao haus j lanza r lavie c j lee ch lucia moro c pandey robbins j stanford k thackray e … snyder p 2022 exerkines health resilience disease nature reviews endocrinology 18 273–289 httpsdoiorg101038s41574022006412 chu e mychasiuk r hibbs l semple b 2021 dysregulated phosphoinositide 3kinase signaling microglia shaping chronic neuroinflammation journal neuroinflammation 18 117 httpsdoiorg101186s12974021023256 chun k floegel chung sj chung c e song w koo 2010 estimation antioxidant intakes diet supplements us adults journal nutrition 140 317–324 httpsdoiorg103945jn109114413 cortes c j de miguel z 2022 precision exercise medicine sex specific differences immune cns responses physical activity brain plasticity 8 6577 httpsdoiorg103233bpl220139 craske mg stein b eley c milad r holmes rapee r wittchen h u 2017 anxiety disorders nature reviews disease primers 3 17024 httpsdoiorg101038nrdp201724 cuesto g enriquezbarreto l carames c cantarero gasull x sandi c ferrus acebes morales 2011 phosphoinositide3kinase activation controls synaptogenesis spinogenesis hippocampal neurons journal neuroscience 31 2721–2733 httpsdoiorg101523jneurosci4477102011 cuesto g jordánálvarez enriquezbarreto l ferrús morales acebes á 2015 gsk3β inhibition promotes synaptogenesis drosophila mammalian neurons plos one 10 e0118475 httpsdoiorg101371journalpone0118475 cui x gooch h petty mcgrath j j eyles 2017 vitamin brain genomic nongenomic actions molecular cellular endocrinology 453 131143 httpsdoiorg101016jmce201705035 culmsee c mattson p 2005 p53 neuronal apoptosis biochemical biophysical research communications 331 761–777 httpsdoiorg101016jbbrc200503149 davies j 2022 ghrelin mediated hippocampal neurogenesis vitamins hormones 118 337–367 httpsdoiorg101016bsvh202112003 de mello n p orellana mazucanti c h de morais lima g scavone c kawamoto e 2019 insulin autophagy neurodegeneration frontiers neuroscience 13 491 httpsdoiorg103389fnins201900491 dos santos mg schimith le andrémiral c et al 2022 neuroprotective effects resveratrol vivo vitro experimental models parkinson ’ disease systematic review neurotoxicity research 40 319–345 httpsdoiorg101007s1264002100450x ’ souza r f markworth j f aasen k zeng n cameronsmith mitchell c j 2017 acute resistance exercise modulates microrna expression profiles combined tissue circulatory targeted analyses plos one 12 e0181594 httpsdoiorg101371journalpone0181594 demine renard arnould 2019 mitochondrial uncoupling key controller biological processes physiology diseases cells 8 795 httpsdoiorg103390cells8080795 denothlippuner jessberger 2021 formation integration new neurons adult hippocampus nature reviews neuroscience 22 223236 httpsdoiorg101038s4158302100433z diano farr benoit c mcnay e c da silva horvath b horvath l 2006 ghrelin controls hippocampal spine synapse density memory performance nature neuroscience 9 381388 httpsdoiorg101038nn1656 di meo reed venditti p victor v 2016 role ros rns sources physiological pathological conditions oxidative medicine cellular longevity 2016 1–44 httpsdoiorg10115520161245049 dolatshahi ranjbar hameghavandi h sabahi rostamkhani 2021 nuclear factorkappa b nfκb pathophysiology parkinson disease diverse patterns mechanisms contributing neurodegeneration european journal neuroscience 54 41014123 httpsdoiorg101111ejn15242 duarte santos p oliveira c r santos rego c 2008 insulin neuroprotection oxidative stress mediated akt gsk3β signaling pathways changes protein expression biochimica et biophysica acta bba molecular cell research 1783 994–1002 httpsdoiorg101016jbbamcr200802016 ehm göritz c covic schäffner schwarz j karaca e lie c 2010 rbpjκdependent signaling essential longterm maintenance neural stem cells adult hippocampus journal neuroscience 30 1379413807 httpsdoiorg101523jneurosci1567102010 elkhwanky ms hakkola j 2018 extranuclear sirtuins metabolic stress antioxidants redox signaling 28 662–676 httpsdoiorg101089ars20177270 elsahli wang l 2020 cancer stem cellassociated pathways metabolic reprogramming breast cancer international journal molecular sciences 21 9125 httpsdoiorg103390ijms21239125 emili guidi uguagliati b giacomini bartesaghi r stagni f 2022 treatment flavonoid 78dihydroxyflavone promising strategy constellation body brain disorders critical reviews food science nutrition 62 13–50 httpsdoiorg1010801040839820201810625 erbaba b arslanergul adams 2021 effects caloric restriction antagonistic integrative hallmarks aging ageing research reviews 66 101228 httpsdoiorg101016jarr2020101228 ersahin tuncbag n cetinatalay r 2015 pi3kaktmtor interactive pathway molecular biosystems 11 1946–1954 httpsdoiorg101039c5mb00101c faber n savulescu j douglas 2016 cognitive enhancement deemed unacceptable role fairness deservingness hollow achievements frontiers psychology 7 232 httpsdoiorg103389fpsyg201600232 fan j dawson dawson v l 2017 cell death mechanisms neurodegeneration p beart robinson rattray n j maragakis eds neurodegenerative diseases pathology mechanisms potential therapeutic targets pp 403425 httpsdoiorg101007978331957193516 fang e f bohr v 2017 nad convergence dna repair mitophagy autophagy 13 442–443 httpsdoiorg1010801554862720161257467 fang tang li x 2019 sirtuins metabolic epigenetic regulation stem cells trends endocrinology metabolism 30 177–188 httpsdoiorg101016jtem201812002 fares j bou diab z nabha fares 2019 neurogenesis adult hippocampus history regulation prospective roles international journal neuroscience 129 598–611 httpsdoiorg1010800020745420181545771 fagerli e escobar ferrier f j jackson c w perezlao e j perezpinzon 2022 sirtuins cognition implications learning memory neurological disorders frontiers physiology 13 908689 https103389fphys2022908689 fayard e tintignac l baudry hemmings b 2005 protein kinase bakt glance journal cell science 118 5675–5678 httpsdoiorg101242jcs02724 fisherwellman k bloomer r j 2009 acute exercise oxidative stress 30 year history dynamic medicine 8 1 httpsdoiorg1011861476591881 foltran r b diaz l 2016 bdnf isoforms round trip ticket neurogenesis serotonin journal neurochemistry 138 204–221 httpsdoiorg101111jnc13658 franke g lieb k 2013 pharmacological neuroenhancement substances epidemiology e hildt g franke cognitive enhancement pp 1727 dordrecht springer frankland p w köhler josselyn 2013 hippocampal neurogenesis forgetting trends neurosciences 36 497–503 httpsdoiorg101016jtins201305002 gahete córdobachacón j kineman r luque r castaño j p 2011 role ghrelin system neuroprotection cognitive functions implications alzheimers disease peptides 32 22252228 httpsdoiorg101016jpeptides201109019 garcíajiménez c garcíamartínez j chocarrocalvo de la vieja 2014 new link diabetes cancer enhanced wntβcatenin signaling high glucose journal molecular endocrinology 52 r51r66 httpsdoiorg101530jme130152 garcíarodríguez giménezcassina 2021 ketone bodies brain beyond fuel metabolism excitability gene expression cell signaling frontiers molecular neuroscience 14 732120 httpsdoiorg103389fnmol2021732120 garg c kaur singh g sharma v k singh k 2022 therapeutic implications sonic hedgehog pathway metabolic disorders novel target effective treatment pharmacological research 179 106194 httpsdoiorg101016jphrs2022106194 gillespie z e pickering j eskiw c h 2016 better living chemistry caloric restriction cr cr mimetics alter genome function promote increased health lifespan frontiers genetics 7 142 httpsdoiorg103389fgene201600142 gomezcabrera c domenech e viña j 2008 moderate exercise antioxidant upregulation antioxidant genes training free radical biology medicine 44 126131 httpsdoiorg101016jfreeradbiomed200702001 gómezpalacioschjetnan escobar l 2013 neurotrophins synaptic plasticity c belzung p wigmore eds neurogenesis neural plasticity pp 117136 berlin springer grewal k singh g sharma sharma v singh rahman md h najda walasekjanusz kamel albadrani g akhtar f saleem abdeldaim 2021 mechanistic insights perspectives involved neuroprotective action quercetin biomedicine pharmacotherapy 140 111729 httpsdoiorg101016jbiopha2021111729 guo j huang x dou l yan shen tang w li j 2022 aging agingrelated diseases molecular mechanisms interventions treatments signal transduction targeted therapy 391 httpsdoiorg101038s41392022012510 van haeringen milaneschi lamers f penninx b w jansen r 2022 dissection depression heterogeneity using proteomic clusters psychological medicine 19 httpsdoiorg101017s0033291721004888 haas r cucchi smith j pucino v macdougall c e mauro c 2016 intermediates metabolism bystanders signalling molecules trends biochemical sciences 41 460–471 httpsdoiorg101016jtibs201602003 hahnwindgassen nogueira v chen cc skeen j e sonenberg n hay n 2005 akt activates mammalian target rapamycin regulating cellular atp level ampk activity journal biological chemistry 280 32081–32089 httpsdoiorg101074jbcm502876200 handschin c 2016 caloric restriction exercise “ mimetics ’ ’ ready prime time pharmacological research 103 158–166 httpsdoiorg101016jphrs201511009 hardie g 2018 keeping home fires burning ampactivated protein kinase journal royal society interface 15 20170774 httpsdoiorg101098rsif20170774 hass barnstable c j 2021 uncoupling proteins mitochondrial defense oxidative stress progress retinal eye research 83 100941 httpsdoiorg101016jpreteyeres2021100941 f li j liu z chuang cc yang w zuo l 2016 redox mechanism reactive oxygen species exercise frontiers physiology 7 httpsdoiorg103389fphys201600486 l wang j yang li j tu h 2022 mitochondrial sirtuins parkinson ’ disease neurochemical research 47 1491–1502 httpsdoiorg101007s1106402203560w heberden c 2016 modulating adult neurogenesis dietary interventions nutrition research reviews 29 163–171 httpsdoiorg101017s0954422416000081 heger 2017 dont discount curcumin trial data nature 543 40 httpsdoiorg101038543040c hermida kumar j leslie n r 2017 gsk3 interactions pi3kaktmtor signalling network advances biological regulation 65 515 httpdoiorg101016jjbior201706003 hinchy e c gruszczyk v willows r navaratnam n hall r bates g bright p krieg carling murphy p 2018 mitochondriaderived ros activate ampactivated protein kinase ampk indirectly journal biological chemistry 293 17208–17217 httpsdoiorg101074jbcra118002579 hofer j davinelli bergmann scapagnini g madeo f 2021 caloric restriction mimetics nutrition clinical trials frontiers nutrition 8 717343 httpsdoiorg103389fnut2021717343 hofer j carmonagutierrez mueller madeo f 2022 ups downs caloric restriction fasting molecular effects clinical application embo molecular medicine 14 e14418 httpsdoiorg1015252emmm202114418 holmström k finkel 2014 cellular mechanisms physiological consequences redoxdependent signalling nature reviews molecular cell biology 15 411–421 httpsdoiorg101038nrm3801 hottiger 2015 snapshot adpribosylation signaling molecular cell 58 11341134e1 httpsdoiorg101016jmolcel201506001 hu e du h zhu x wang l shang wu x lu h lu x 2018 betahydroxybutyrate promotes expression bdnf hippocampal neurons adequate glucose supply neuroscience 386 315–325 httpsdoiorg101016jneuroscience201806036 huang j dibble c c matsuzaki manning b 2008 tsc1tsc2 complex required proper activation mtor complex 2 molecular cellular biology 28 4104–4115 httpsdoiorg101128mcb0028908 igwe sone matveychuk baker g b dursun 2021 review effects calorie restriction fasting potential relevance depression progress neuropsychopharmacology biological psychiatry 111 110206 httpsdoiorg101016jpnpbp2020110206 inoki k ouyang h zhu lindvall c wang zhang x yang q bennet c harada stankunas k wang c xi h macdougald williams b guan kl 2006 tsc2 integrates wnt energy signals via coordinated phosphorylation ampk gsk3 regulate cell growth cell 126 955968 httpsdoiorg101016jcell200606055 ishizuka kakiya n witters l oshiro n shirao nawa h takei n 2013 ampactivated protein kinase counteracts brainderived neurotrophic factorinduced mammalian target rapamycin complex 1 signaling neurons journal neurochemistry 127 6677 httpsdoiorg101111jnc12362 iside c scafuro nebbioso altucci l 2020 sirt1 activation natural phytochemicals overview frontiers pharmacology 11 1225 jacobs c huang p 2021 complex crosstalk notch hedgehog signalling development central nervous system cellular molecular life sciences 78 635644 httpsdoiorg101007s00018020036273 jaworski banachkasper e gralec k 2019 gsk3 β intersection neuronal plasticity neurodegeneration neural plasticity 1–14 httpsdoiorg10115520194209475 jeanneteau f deinhardt k miyoshi g bennett chao v 2010 map kinase phosphatase mkp1 regulates bdnfinduced axon branching nature neuroscience 13 1373–1379 httpsdoiorg101038nn2655 jiao f gong z 2020 beneficial roles sirt1 neuroinflammationrelated diseases oxidative medicine cellular longevity 2020 1–19 httpsdoiorg10115520206782872 johnstone mobley w 2020 local trkb signaling themes development neural plasticity cell tissue research 382 101–111 httpsdoiorg101007s00441020032787 kaeberlein 2010 resveratrol rapamycin antiaging drugs bioessays 32 9699 httpsdoiorg101002bies200900171 kallies g rapp fydrich fehm l tschorn terán c heissel 2019 serum brainderived neurotrophic factor bdnf rest acute aerobic exercise major depressive disorder psychoneuroendocrinology 102 212215 httpsdoiorg101016jpsyneuen201812015 karabiyik c vicinanza son rubinsztein c 2021 glucose starvation induces autophagy via ulk1mediated activation pikfyve ampkdependent manner developmental cell 56 19611975 httpsdoiorg101016jdevcel202105010 kelly r kelly p kelly p 2020 metabolomics physical activity exercise health review current evidence biochimica et biophysica acta bbamolecular basis disease 1866 165936 httpsdoiorg101016jbbadis2020165936 kempermann g gage f h aigner l song h curtis thuret kuhn h g jessberger frankland p w cameron h gould e hen r abrous n toni n schinder f zhao x lucassen p j frisén j 2018 human adult neurogenesis evidence remaining questions cell stem cell 23 25–30 httpsdoiorg101016jstem201804004 kim h park h ha bang e j lee lee k lee j yu b p chung h 2019 antiinflammatory action βhydroxybutyrate via modulation pgc1α foxo1 mimicking calorie restriction aging 11 1283–1304 httpsdoiorg1018632aging101838 kökten hansmannel f ndiaye n c heba c quilliot dreumont n arnone peyrinbiroulet l 2021 calorie restriction new treatment inflammatory diseases advances nutrition 12 15581570 httpsdoiorg101093advancesnmaa179 kolb h kempf k röhling lenzenschulte schloot n c martin 2021 ketone bodies enemy friend guardian angel bmc medicine 19 115 httpsdoiorg101186s12916021021850 koppel j swerdlow r h 2018 neuroketotherapeutics modern review centuryold therapy neurochemistry international 117 114–125 httpsdoiorg101016jneuint201705019 korla k mitra c k 2014 modelling krebs cycle oxidative phosphorylation journal biomolecular structure dynamics 32 242–256 httpsdoiorg101080073911022012762723 koseska bastiaens p 2017 cell signaling cognitive process embo journal 36 568582 httpsdoiorg1015252embj201695383 kowiański p lietzau g czuba e waśkow steliga moryś j 2018 bdnf key factor multipotent impact brain signaling synaptic plasticity cellular molecular neurobiology 38 579–593 httpsdoiorg101007s1057101705104 krieglstein k strelau j schober sullivan unsicker k 2002 tgf β regulation neuron survival death journal physiology 96 2530 httpsdoiorg101016s0928425701000778 kristal b shurubor kaddurahdaouk r matson w r 2007 metabolomics study aging caloric restriction tollefsbol eds biological aging methods protocols pp 393409 totowa humana press kumar bansal n 2022 implications phosphoinositide 3kinaseakt pi3kakt pathway pathogenesis alzheimer ’ disease molecular neurobiology 59 354385 httpsdoiorg101007s12035021026117 laberge rm adler demaria mechtouf n teachenor r cardin g b desprez py campisi j rodier f 2013 mitochondrial dna damage induces apoptosis senescent cells cell death disease 4 e727–e727 httpsdoiorg101038cddis2013199 lautrup sinclair mattson p fang e f 2019 nad brain aging neurodegenerative disorders cell metabolism 30 630–655 httpsdoiorg101016jcmet201909001 leckie r l oberlin l e voss w prakash r szaboreed chaddockheyman l erickson k 2014 bdnf mediates improvements executive function following 1year exercise intervention frontiers human neuroscience 8 985 httpsdoiorg103389fnhum201400985 leite j ghirotto b targhetta v p lima j câmara n 2022 sirtuins pharmacological targets neurodegenerative neuropsychiatric disorders british journal pharmacology 179 1496–1511 httpsdoiorg101111bph15570 li p lei qi j liu w yao k 2022 functional roles adpribosylation writers readers erasers frontiers cell developmental biology 10 941356 httpsdoiorg103389fcell2022941356 li z huang l luo yu b tian g 2023 effects possible mechanisms intermittent fasting health disease narrative review nutrition reviews nuad026 httpsdoiorg101093nutritnuad026 liu g sabatini 2020 mtor nexus nutrition growth ageing disease nature reviews molecular cell biology 21 183–203 httpsdoiorg101038s415800190199y liu zhang l joo sun sc 2017 nfκb signaling inflammation signal transduction targeted therapy 2 17023 httpsdoiorg101038sigtrans201723 lorzadeh kohan l ghavami azarpira n 2021 autophagy wnt signaling pathway focus wntβcatenin signaling biochimica et biophysica acta bbamolecular cell research 1868 118926 httpsdoiorg101016jbbamcr2020118926 lu tao f zhou tang k f 2019 signaling pathways mediate anticancer effects caloric restriction pharmacological research 141 512520 httpsdoiorg101016jphrs201901021 luan h wang x cai z 2019 mass spectrometrybased metabolomics targeting crosstalk gut microbiota brain neurodegenerative disorders mass spectrometry reviews 38 2233 httpsdoiorg101002mas21553 lucassen p j meerlo p naylor van dam dayer g fuchs e oomen c czéh b 2010 regulation adult neurogenesis stress sleep disruption exercise inflammation implications depression antidepressant action european neuropsychopharmacology 20 1–17 httpsdoiorg101016jeuroneuro200908003 lucassen p j fitzsimons c p salta e maleticsavatic 2020 adult neurogenesis human classic optimized future approaches behavioural brain research 381 112458 httpsdoiorg101016jbbr2019112458 lüscher b ahel altmeyer ashworth bai p chang p cohen corda dantzer f daugherty dawson dawson v l deindl fehr r feijs k l h filippov v gagné j grimaldi g guettler … ziegler 2022 adpribosyltransferases update function nomenclature febs journal 289 7399–7410 httpsdoiorg101111febs16142 mcallister k katz l c lo c 1999 neurotrophins synaptic plasticity annual review neuroscience 22 295318 httpsdoiorg101146annurevneuro221295 mccubrey j rakus gizak steelman l abrams l lertpiriyapong k martelli 2016 effects mutations wntβcatenin hedgehog notch pi3k pathways gsk3 activity—diverse effects cell growth metabolism cancer biochimica et biophysica acta bbamolecular cell research 1863 29422976 httpsdoiorg101016jbbamcr201609004 mcgregor nelson b 2019 circuit mechanisms parkinson ’ disease neuron 101 10421056 httpsdoiorg101016jneuron201903004 madeo f carmonagutierrez hofer j kroemer g 2019 caloric restriction mimetics ageassociated disease targets mechanisms therapeutic potential cell metabolism 29 592610 httpsdoiorg101016jcmet201901018 magee j c grienberger c 2020 synaptic plasticity forms functions annual review neuroscience 43 95–117 httpsdoiorg101146annurevneuro090919022842 magliulo l bondi pini n marramiero l di filippo e 2022 wonder exerkines—novel insights critical stateoftheart review molecular cellular biochemistry 477 105–113 httpsdoiorg101007s11010021042645 maharajan n vijayakumar k jang c h cho gw 2020 caloric restriction maintains stem cells niche regulates stem cell aging journal molecular medicine 98 25–37 httpsdoiorg101007s00109019018461 mao k zhang g 2022 role parp1 neurodegenerative diseases aging febs journal 289 20132024 httpsdoiorg101111febs15716 martel j chang h wu c peng h h hwang l ko f ojcius 2021 recent advances field caloric restriction mimetics antiaging molecules ageing research reviews 66 101240 httpsdoiorg101016jarr2020101240 martínezreyes chandel n 2020 mitochondrial tca cycle metabolites control physiology disease nature communications 11 102 httpsdoiorg101038s41467019136683 massell j lieb r meyer mayor e 2022 fluctuations psychological states twitter covid19 plos one 17 e0278018 httpsdoiorg101371journalpone0278018 marosi k mattson p 2014 bdnf mediates adaptive brain body responses energetic challenges trends endocrinology metabolism 25 8998 httpsdoiorg101016jtem201310006 mattson p 2019 evolutionary perspective food overconsumption impairs cognition trends cognitive sciences 23 200212 httpsdoiorg101016jtics201901003 mattson p moehl k ghena n schmaedick cheng 2018 intermittent metabolic switching neuroplasticity brain health nature reviews neuroscience 19 8194 httpsdoiorg101038nrn2017156 mattson p arumugam v 2018 hallmarks brain aging adaptive pathological modification metabolic states cell metabolism 27 1176–1199 httpsdoiorg101016jcmet201805011 mayor e daehne bianchi r 2019 perceived substance characteristics affect ethical judgement towards cognitive enhancement plos one 14 e0213619 httpsdoiorg101371journalpone0213619 mayor e daehne bianchi r 2020 dark triad personality attitudes toward cognitive enhancement bmc psychology 8 112 httpsdoiorg101186s40359020004862 mayor e bietti l canalesrodríguez e j 2022 text signal tutorial case studies focusing social media twitter behavior research methods advance online publication httpsdoiorg103758s13428022019171 mayor e miché lieb r 2022 associations emotions expressed internet news subsequent emotional content twitter heliyon 8 e12133 httpsdoiorg101016jheliyon2022e12133 mazat jp devin ransac 2020 modelling mitochondrial ros production respiratory chain cellular molecular life sciences 77 455–465 httpsdoiorg101007s00018019033811 mehmel jovanović n spitz u 2020 nicotinamide riboside — current state research therapeutic uses nutrients 12 1616 httpsdoiorg103390nu12061616 mela v mota b c milner mcginley mills k h kelly á lynch 2020 exerciseinduced reprogramming agerelated metabolic changes microglia accompanied reduction senescent cells brain behavior immunity 87 413428 httpsdoiorg101016jbbi202001012 melsen w g bootsma c j rovers bonten j 2014 effects clinical statistical heterogeneity predictive values results metaanalyses clinical microbiology infection 20 123129 https1011111469069112494 miller r harrison e astle c baur j boyd r de cabo r strong r 2011 rapamycin resveratrol simvastatin extends life span genetically heterogeneous mice journals gerontology series 66 191201 httpsdoiorg101093geronaglq178 minchevatasheva soler r 2013 nfκb signaling pathways role nervous system physiology pathology neuroscientist 19 175194 httpsdoiorg1011771073858412444007 mittelbrunn kroemer g 2021 hallmarks cell aging nature immunology 22 687698 httpsdoiorg101038s4159002100927z moosavi f hosseini r saso l firuzi 2016 modulation neurotrophic signaling pathways polyphenols drug design development therapy 10 2342 doi 102147dddts96936 moore j salmons h vinoskey c kressler j 2020 single oneminute comfortable paced stairclimbing bout reduces postprandial glucose following mixed meal nutrition metabolism cardiovascular diseases 30 19671972 httpsdoiorg101016jnumecd202006020 moradi z jalili f farhadian n joshi wang zou l cao h farzaei h xiao j 2022 polyphenols neurodegenerative diseases focus neuronal regeneration critical reviews food science nutrition 62 3421–3436 httpsdoiorg1010801040839820201865870 morris b j 2013 seven sirtuins seven deadly diseases aging free radical biology medicine 56 133–171 httpsdoiorg101016jfreeradbiomed201210525 murphy p 2009 mitochondria produce reactive oxygen species biochemical journal 417 1–13 httpsdoiorg101042bj20081386 nadeeshani h li j ying zhang b lu j 2022 nicotinamide mononucleotide nmn antiaging health product–promises safety concerns journal advanced research 37 267278 httpsdoiorg101016jjare202108003 negredo p n yeo r w brunet 2020 aging rejuvenation neural stem cells niches cell stem cell 202–223 httpsdoiorg101016jstem202007002 navas l e carnero 2021 nad metabolism stemness immune response cancer signal transduction targeted therapy 6 2 httpsdoiorg101038s4139202000354w neth b j mintz whitlow c jung sai k register c craft 2020 modified ketogenic diet associated improved cerebrospinal fluid biomarker profile cerebral perfusion cerebral ketone body uptake older adults risk alzheimer ’ disease pilot study neurobiology aging 86 5463 httpsdoiorg101016jneurobiolaging201909015 newman j c verdin e 2017 βhydroxybutyrate signaling metabolite annual review nutrition 37 51–76 httpsdoiorg101146annurevnutr071816064916 nie yang h zhang l lu f tao k wang r yang r huang l mao z yang q 2016 regulation er stressinduced autophagy gsk3βtip60ulk1 pathway cell death disease 7 e2563–e2563 httpsdoiorg101038cddis2016423 niwakawakita ferhi soilihi h le bras lallemandbreitenbach v de thé h 2017 pml ros sensor activating p53 upon oxidative stress journal experimental medicine 214 3197–3206 httpsdoiorg101084jem20160301 nordvall g forsell p sandin j 2022 neurotrophintargeted therapeutics gateway cognition drug discovery today 27 103318 httpsdoiorg101016jdrudis202207003 ntsapi c loos b 2016 caloric restriction precisioncontrol autophagy strategy delaying neurodegenerative disease progression experimental gerontology 83 97–111 httpsdoiorg101016jexger201607014 ’ connor c joffe h 2015 public engages brain optimization mediamind relationship science technology human values 40 712743 httpsdoiorg1011770162243915576374 othman z halim azman k f ahmad h zakaria r sirajudeen k n ahmi 2022 profiling research landscape cognitive aging bibliometric analysis network visualization frontiers aging neuroscience 14 httpsdoiorg103389fnagi2022876159 outram racine e 2011 examining reports policies cognitive enhancement approaches rationale recommendations accountability research 18 323341 httpsdoiorg101080089896212011606734 oluwole fernando w b lumanlan j ademuyiwa jayasena v 2022 role phenolic acid tannins stilbenes lignans flavonoids human health – review international journal food science technology 57 6326–6335 httpsdoiorg101111ijfs15936 overall r w walker l fischer j brandt kempermann g 2016 different mechanisms must considered explain increase hippocampal neural precursor cell proliferation physical activity frontiers neuroscience 10 362 httpsdoiorg103389fnins201600362 pateras williams c gianniou margetis avgeris rousakis p frisan 2023 short term starvation potentiates efficacy chemotherapy triple negative breast cancer via metabolic reprogramming journal translational medicine 21 169 httpsdoiorg101186s12967023039359 peyssonnaux c eychène 2001 rafmekerk pathway new concepts activation biology cell 93 53–62 httpsdoiorg101016s024849000101125x pillon n j gabriel b dollet l smith j sardón puig l botella j zierath j r 2020 transcriptomic profiling skeletal muscle adaptations exercise inactivity nature communications 11 470 httpsdoiorg101038s4146701913869w powers k deminice r ozdemir yoshihara bomkamp p hyatt h 2020 exerciseinduced oxidative stress friend foe journal sport health science 9 415–425 httpsdoiorg101016jjshs202004001 rabinovitch r c samborska b faubert b e h gravel sp andrzejewski raissi c pause stpierre j jones r g 2017 ampk maintains cellular metabolic homeostasis regulation mitochondrial reactive oxygen species cell reports 21 1–9 httpsdoiorg101016jcelrep201709026 radak z kumagai taylor w naito h goto 2007 effects exercise brain function role free radicals applied physiology nutrition metabolism 32 942–946 httpsdoiorg101139h07081 radak z suzuki k posa petrovszky z koltai e boldogh 2020 systemic role sirt1 exercise mediated adaptation redox biology 35 101467 httpsdoiorg101016jredox2020101467 rahman muhammad khan chen h ridder müllerfielitz h pokorná b vollbrandt stölting nadrowitz r okun j g offermanns schwaninger 2014 βhydroxybutyrate receptor hca2 activates neuroprotective subset macrophages nature communications 5 3944 httpsdoiorg101038ncomms4944 rai n dilnashin h birla h singh zahra w rathore singh b k singh p 2019 role pi3kakt erk neurodegenerative disorders neurotoxicity research 35 775–795 httpsdoiorg101007s126400190003y ravula r teegala b kalakotla pasangulapati j p perumal v boyina h k 2021 fisetin potential flavonoid multifarious targets treating neurological disorders updated review european journal pharmacology 910 174492 httpsdoiorg101016jejphar2021174492 reddy yadav dey c 2023 cellular molecular regulation exercise — neuronal perspective cellular molecular neurobiology 43 1551–1571 httpsdoiorg101007s1057102201272x rege geetha griffin g broderick l babu j r 2014 neuroprotective effects resveratrol alzheimer disease pathology frontiers aging neuroscience 6 218 httpsdoiorg103389fnagi201400218 rendeiro c rhodes j spencer j p 2015 mechanisms action flavonoids brain direct versus indirect effects neurochemistry international 89 126139 httpsdoiorg101016jneuint201508002 richter e ruderman n b 2009 ampk biochemistry exercise implications human health disease biochemical journal 418 261–275 httpsdoiorg101042bj20082055 richter e hargreaves 2013 exercise glut4 skeletal muscle glucose uptake physiological reviews 93 9931017 httpsdoiorg101152physrev000382012 riuspérez torrescuevas millán ortega á l pérez 2020 pgc1α inflammation oxidative stress integrative view metabolism oxidative medicine cellular longevity 2020 1–20 httpsdoiorg10115520201452696 roy ansari choudhary k singh 2023 nlrp3 inflammasome depression review international immunopharmacology 117 109916 httpsdoiorg101016jintimp2023109916 sadria layton 2021 interactions among mtorc ampk sirt computational model cell energy balance metabolism cell communication signaling 19 117 httpsdoiorg101186s12964021007061 salinas p c 2013 wnt signaling j lr rubenstein p rakic eds cellular migration formation neuronal connections pp 623–638 elsevier httpsdoiorg101016b978012397266800106x santo e e paik j 2018 foxo neural cells diseases nervous system current topics developmental biology 127 105–118 elsevier httpsdoiorg101016bsctdb201710002 schofield j h schafer z 2021 mitochondrial reactive oxygen species mitophagy complex nuanced relationship antioxidants redox signaling 34 517–530 httpsdoiorg101089ars20208058 schwarz j ebert b lie c 2012 stem cell maintenance adult mammalian hippocampus matter signal integration developmental neurobiology 72 10061015 httpsdoiorg101002dneu22026 seidler k barrow 2022 intermittent fasting cognitive performance – targeting bdnf potential strategy optimise brain health frontiers neuroendocrinology 65 100971 httpsdoiorg101016jyfrne2021100971 shackelford b shaw r j 2009 lkb1–ampk pathway metabolism growth control tumour suppression nature reviews cancer 9 563–575 httpsdoiorg101038nrc2676 sharman mj verdile g kirubakaran parenti c singh watt g karl chang li c g münch g 2019 targeting inflammatory pathways alzheimer ’ disease focus natural products phytomedicines cns drugs 33 457–480 httpsdoiorg101007s40263019006191 shaw r j 2009 lkb1 ampactivated protein kinase control mtor signalling growth acta physiologica 196 65–80 httpsdoiorg101111j17481716200901972x shilovsky g putyatina morgunova g v seliverstov v ashapkin v v sorokina e v markov v skulachev v p 2021 crosstalk biorhythms gatekeepers longevity dual role glycogen synthase kinase3 biochemistry moscow 86 433–448 httpsdoiorg101134s0006297921040052 shimazu hirschey newman j w shirakawa k le moan n verdin e 2013 suppression oxidative stress βhydroxybutyrate endogenous histone deacetylase inhibitor science 339 211214 httpsdoiorg101126science1227166 simpson appel n hokari oki j holman g maher f smith q r 1999 bloodbrain barrier glucose transporter effects hypoand hyperglycemia revisited journal neurochemistry 72 238247 httpsdoiorg101046j1471415919990720238x singh kukreti r saso l kukreti 2019 oxidative stress key modulator neurodegenerative diseases molecules 24 1583 httpsdoiorg103390molecules24081583 song han c moon j lee j h bae e j park b h 2022 sirt6 reprograms myofibers oxidative type crebdependent sox6 suppression nature communications 13 1808 httpsdoiorg101038s41467022294725 spalding k l bergmann alkass k bernard salehpour huttner h b boström e westerlund vial c buchholz b possnert g mash c druid h frisén j 2013 dynamics hippocampal neurogenesis adult humans cell 153 1219–1227 httpsdoiorg101016jcell201305002 spasić r callaerts p norga k k 2009 ampactivated protein kinase ampk molecular crossroad metabolic control survival neurons neuroscientist 15 309–316 httpsdoiorg1011771073858408327805 sutkowy p woźniak milakierzenkowska c szewczykgolec k wesołowski r pawłowska nuszkiewicz j 2021 physical activity vs redox balance brain brain health aging diseases antioxidants 11 95 httpsdoiorg103390antiox11010095 szwed kim e jacinto e 2021 regulation metabolic functions mtorc1 mtorc2 physiological reviews 101 1371–1426 httpsdoiorg101152physrev000262020 tang b l 2016 sirt1 mitochondria molecules cells 39 8795 httpsdoiorg1014348molcells20162318 taylor kornev p 2011 protein kinases evolution dynamic regulatory proteins trends biochemical sciences 36 6577 httpsdoiorg101016jtibs201009006 tayyab shahi h farheen mariyath p khanam n castresana j hossain 2018 sonic hedgehog wnt brainderived neurotrophic factor cell signaling pathway crosstalk potential therapy depression journal neuroscience research 96 5362 httpsdoiorg101002jnr24104 testa g biasi f poli g chiarpotto e 2014 calorie restriction dietary restriction mimetics strategy improving healthy aging longevity current pharmaceutical design 20 29502977 httpswwwdoiorg10217413816128113196660699 thorens b mueckler 2010 glucose transporters 21st century american journal physiologyendocrinology metabolism 298 e141e145 httpsdoiorg101152ajpendo007122009 tinsley g la bounty p 2015 effects intermittent fasting body composition clinical health markers humans nutrition reviews 73 661–674 httpsdoiorg101093nutritnuv041 tuncdemir n lacefield c hen r 2019 contributions adult neurogenesis dentate gyrus network activity computations behavioural brain research 374 112112 httpsdoiorg101016jbbr2019112112 vadlakonda l dash pasupuleti anil kumar k reddanna p 2013 paradox aktmtor interactions frontiers oncology 3 httpsdoiorg103389fonc201300165 valls p esposito 2022 signalling dynamics cell decisions homeostatic control health disease current opinion cell biology 75 102066 httpsdoiorg101016jceb202201011 van praag h 2008 neurogenesis exercise past future directions neuromolecular medicine 10 128–140 httpsdoiorg101007s120170088028z van praag h fleshner schwartz w mattson p 2014 exercise energy intake glucose homeostasis brain journal neuroscience 34 1513915149 httpsdoiorg101523jneurosci2814142014 vanhaesebroeck b stephens l hawkins p 2012 pi3k signalling path discovery understanding nature reviews molecular cell biology 13 195–203 httpsdoiorg101038nrm3290 vella l caldow k larsen e tassoni della gatta p gran p cameronsmith 2012 resistance exercise increases nfκb activity human skeletal muscle american journal physiologyregulatory integrative comparative physiology 302 r667r673 httpsdoiorg101152ajpregu003362011 vernier giguère v 2021 aging senescence mitochondria pgc1err axis endocrinology 1 661 httpsdoiorg101530jme200196 vints w j levin fujiyama h verbunt j masiulis n 2022 exerkines longterm synaptic potentiation mechanisms exerciseinduced neuroplasticity frontiers neuroendocrinology 66 100993 httpsdoiorg101016jyfrne2022100993 walsh e smith l northey j rattray b cherbuin n 2020 towards understanding physical activitybdnfcognition triumvirate review associations dosage ageing research reviews 60 101044 httpsdoiorg101016jarr2020101044 wancket l frazier w j liu 2012 mitogenactivated protein kinase phosphatase mkp1 immunology physiology disease life sciences 90 237–248 httpsdoiorg101016jlfs201111017 wang x yang q liao q li zhang p santos h abshirini 2020 effects intermittent fasting diets plasma concentrations inflammatory biomarkers systematic review metaanalysis randomized controlled trials nutrition 79 110974 doi 101016jnut2020110974 wang k liu h hu q wang l liu j zheng z zhang w ren j zhu f liu gh 2022a epigenetic regulation aging implications interventions aging diseases signal transduction targeted therapy 7 374 httpsdoiorg101038s41392022012118 wang q lu zhu x gu x zhang xia c yang l xu x zhou 2022b role microglia immunometabolism neurodegeneration focus molecular determinants metabolic intermediates metabolic reprogramming biomedicine pharmacotherapy 153 113412 httpsdoiorg101016jbiopha2022113412 wang li z mo f chenmayfield j saini lamere hu q 2023 chemically engineering cells precision medicine chemical society reviews 52 10681102 httpsdoiorg101039d2cs00142j watson k baar k 2014 mtor health benefits exercise seminars cell developmental biology 36 130–139 httpsdoiorg101016jsemcdb201408013 woods johnstone r dickerson k leiper f c fryer l g neumann schlattner u wallimann carlson carling 2003 lkb1 upstream kinase ampactivated protein kinase cascade current biology 13 2004–2008 httpsdoiorg101016jcub200310031 xie n zhang l gao w huang c huber p e zhou x zou b 2020 nad metabolism pathophysiologic mechanisms therapeutic potential signal transduction targeted therapy 5 227 httpsdoiorg101038s41392020003117 xu j q tang n zhang l f tan c su george huang l 2021 bibliometric analysis wnt signaling pathway top100 cited articles emerging trends annals translational medicine 9 1065 httpsdoiorg1021037atm21174 xue f li x qin l liu x li c adhikari b 2021 antiaging properties phytoconstituents phytonanoemulsions application managing agingrelated diseases advanced drug delivery reviews 176 113886 httpsdoiorg101016jaddr2021113886 yadav tripathi b singh p kesharwani r k keservani r k 2017 roles amp adp atp ampk healthy energy boosting prolonged life span bagchi ed sustained energy enhanced human functions activity pp 31–51 elsevier httpsdoiorg101016b9780128054130000028 yamamoto h schoonjans k auwerx j 2007 sirtuin functions health disease molecular endocrinology 21 1745–1755 httpsdoiorg101210me20070079 yang j li zhang fang x chen n zhou x wang x 2020 sirt6 promotes tumorigenesis drug resistance diffuse large bcell lymphoma mediating pi3kakt signaling journal experimental clinical cancer research 39 116 httpsdoiorg101186s1304602001623w yao p j petralia r mattson p 2016 sonic hedgehog signaling hippocampal neuroplasticity trends neurosciences 39 840850 httpsdoiorg101016jtins201610001 yu q zou l kong z yang l 2020a cognitive impact calorie restriction narrative review journal american medical directors association 21 1394–1401 httpsdoiorg101016jjamda202005047 yu h lin l zhang z zhang h hu h 2020b targeting nfκb pathway therapy diseases mechanism clinical study signal transduction targeted therapy 5 123 httpsdoiorg101038s41392020003126 yu zhang h wang b zhang zheng x shao b jin k 2021 key signaling pathways aging potential interventions healthy aging cells 10 660 httpsdoiorg103390cells10030660 zeng h lu b zamponi r yang z wetzel k loureiro j cong f 2018 mtorc1 signaling suppresses wntβcatenin signaling dvldependent regulation wnt receptor fzd level proceedings national academy sciences 115 e10362e10369 httpsdoiorg101073pnas1808575115 zhang l xu h ding n li x chen x chen z 2021a beneficial effects brain microenvironment caloric restriction alleviating neurodegenerative diseases brain aging frontiers physiolology 12 715443 doi 103389fphys2021715443 zhang lx li cx kakar u khan wu pf amir r dai df naveed li qy saeed shen jq rajput li jh 2021b resveratrol rv pharmacological review call research biomedicine pharmacotherapy 143 112164 httpsdoiorg101016jbiopha2021112164 zhao c deng w gage f h 2008 mechanisms functional implications adult neurogenesis cell 132 645–660 httpsdoiorg101016jcell200801033 zhao j yue w zhu j sreejayan n du 2010 ampactivated protein kinase ampk crosstalks canonical wnt signaling via phosphorylation βcatenin ser 552 biochemical biophysical research communications 395 146151 httpsdoiorg101016jbbrc201003161 zhao r jiang zhang l yu z 2019 mitochondrial electron transport chain ros generation uncoupling review international journal molecular medicine 44 315 httpsdoiorg103892ijmm20194188 zhao jia chen w liu z 2022 neuroprotective effects intermittent fasting brain aging neurodegenerative diseases via regulating mitochondrial function free radical biology medicine 182 206218 httpsdoiorg101016jfreeradbiomed202202021 zhou b lin w long yang zhang h wu k chu q 2022 notch signaling pathway architecture disease therapeutics signal transduction targeted therapy 7 95 httpsdoiorg101038s4139202200934y zia pourbaghershahri farkhondeh samarghandian 2021 molecular cellular pathways contributing brain aging behavioral brain functions 17 130 httpsdoiorg101186s12993021001799 appendix annotated bibliography exercise radak z kumagai taylor w naito h goto 2007 effects exercise brain function role free radicals applied physiology nutrition metabolism 32 942–946 httpsdoiorg101139h07081 role exercise management ros discussed radak et al 2007 focus implications cns showed oxidative damage ros ultimately linked neurodegenerative diseases protective role exercise focus neurotrophins trophic factors discussed among neurotrophins details provided bdnf upregulation related exercise signaling pathways activate bdnf protective role regards ros notably creb mentioned downstream effector bdnf linked increase bdnf dependent upon level ros hence feedback loop potentiated exercise powers k deminice r ozdemir yoshihara bomkamp p hyatt h 2020 exerciseinduced oxidative stress friend foe journal sport health science 95 415–425 httpsdoiorg101016jjshs202004001 powers et al 2020 focus exercise producer ros cause oxidative stress skeletal muscle primarily concept oxidative stress defined imbalance prooxidantantioxidant ratio leads cellular damage short explanation free radicals provided several molecule compose ros reactive nitrogen species nos labels briefly discussed enzymatic nonenzymatic antioxidants presented central cellular control ros history research exerciseinduced oxidative stress production ros produced skeletal muscles exercise presented well impact ros muscle performance mention made hormesis theory exercise presented mild stressor prepares body future challenges walsh e smith l northey j rattray b cherbuin n 2020 towards understanding physical activitybdnfcognition triumvirate review associations dosage ageing research reviews 60 101044 walsh et al 2020 focus exercisecirculating bdnfcognition doseresponse associations physical activity important factors increasing bdnf neurotrophic functions mentioned bdnf measurement concentration discussed across life span 2030 nanograms per liter decrease 05 – 5 per year modulators bdnf notably physical activity presented brain aging discussed mention mechanisms first next presentation aging result presented mechanisms cognitive decline consequence latter discussion continues involvement bdnf aging processes focusing brain changes cognitive performance association bdnf exercise mentions values interest mentioned notably 30 minutes exercise necessary increase serum bdnf exercise intensity might marginally related magnitude increase bdnf chronic effects interventions targeting basal bdnf metaanalyses notably show small effects exercise serum bdnf next presented elements inconclusive link serum bdnf concentration cerebral blood flow cellular signaling important confound assessment effect physical activity bdnf lack research acute bdnf response cognition finally mode physical activity exercise intensity duration well work rest periods prior training bdnf response exercise context aging discussed reddy yadav dey c 2023 cellular molecular regulation exercise—a neuronal perspective cellular molecular neurobiology 43 1551–1571 httpsdoiorg101007s1057102201272x reddy et al 2023 provide literature review processes involved exerciseinduces neuronal regulation research physiological response exercise synthesized focus proteins metabolites exerkines irisin cathepsin b interleukin6 il6 adiponectin osteocacin leptin fibroblast growth factor21 fgf21 growth factors signaling proteins regulated exercise notably irisin involved neuroprotection cognitive improvements amelioration alzheimers disease cathepsin b involved cognitive improvements il6 regulates brain metabolism notably reduces brain inflammation adiponectin involved dendritic arborization spinogenesis neurogenesis notably isteocalcin regulates cognition neuroplasticity memory learning fgf21 reduces neuroinflammation improves synaptic plasticity leptin involved neurogenesis axonal growth improved spatial memory notably signaling proteins mentioned orexin musclin secreted protein acidic rich cysteine sparc meteorinlike protein metrnl bdnf ampk sirt1 pgc1α igf1 mentioned bdnf ampk sirt1 pgc1α igf1 main text orexin sparc related neurodegenerative diseases increased musclin detrimental metabolism musclin secretion downregulated exercise metrnl involved different functions finally exercise mimetics mentioned chow l gerszten r e taylor j pedersen b k van praag h trappe febbraio galis z gao haus j lanza r lavie c j lee ch lucia moro c pandey robbins j stanford k thackray e … snyder p 2022 exerkines health resilience disease nature reviews endocrinology 185 273–289 httpsdoiorg101038s41574022006412 chow et al 2022 health implications exerkines – substances increased exercise involved signaling – presented mention made health benefits exercise linked release exerkines although primarily studied skeletal muscle exerkines released variety organs might promote health notably diminishing obesity reducing risks cardiaovascular disease cancer protecting cognitive decline list exerkines provided eg adiponectin bdnf fgf21 il6 lactate musclin nitric oxide mention location origin made eg muscle brain brown adipose tissue common measures exerkines advantages disadvantages discussed exerkines play different roles cardiometabolic system improvement angiogenesis angiopoietin optimization glucose lipids adiponectin adipose tissue skeletal muscle bones liver gut nervous immune endocrine systems musclebrain crosstalk also discussed review mention role myokines exerkines released skeletal muscle hippocampal neurogenesis particular distinction acute chronic exercise important matter kynurenine liversecreted exerkine protect brain stress mattson p arumugam v 2018 hallmarks brain aging adaptive pathological modification metabolic states cell metabolism 27 1176–1199 httpsdoiorg101016jcmet201805011 mattson arumugam 2018 focus exercise relation healthy brain aging cognitive decline presented context aging accelerates 50 years age increases odds neurodegenerative disorders physiological age brain modulated environmental factors cr crms notably early midlife environmental factors affect risk future neurodegenerative diseases traumatic brain injury history intermittent metabolic switching eg cr beneficial chronic positive energy balance detrimental presented followed mitochondrial dysfunction notably axons dendrites brain aging process mitochondrial dysfunction result notably decreased nadnadh ratio affects signaling eg sirt different issues caused mitochondrial dysfunction eg deficient etc increased ros lead neurodegenerative disorders focus cr alleviative process processes oxidative imbalance lead impaired brain health well impaired degradation damaged proteins discussed next discussion continues dysregulated calcium ion homeostasis neurons modulator neuron function neuronal networks deficient cellular stress response well relevant processes signaling pathways involved dysfunctional neuronal activity next topic addressed review followed impaired dna repair aging agerelated heightened inflammation impaired neurogenesis well limited role telomere attrition neurons cell senescence discussion dysregulation energy metabolism focus irs1 bhb omega3 fatty acids presented next neurodegenerative disorders related aging examples alzheimer disease parkinson ’ notably discussed intermittent metabolic challenges pharmacological interventions mentioned means delaying brain aging improve cognitive function neuroprotection review focuses processes involved starting depletion liver glycogen store lipolysis pathways play examples pharmacological strategies provided instance ketone esters improve cognition nicotinamide riboside extend lifespan diminish neurodegeneration well mechanisms action lucassen p j meerlo p naylor van dam dayer g fuchs e oomen c czéh b 2010 regulation adult neurogenesis stress sleep disruption exercise inflammation implications depression antidepressant action european neuropsychopharmacology 20 1–17 httpsdoiorg101016jeuroneuro200908003 lucassen et al 2010 focus implications exercise sleep antidepressants well deteriorating effects stress inflammation regards neurogenesis importance stress alarm system mobilization organism deleterious consequences chronic uncontrollable stress severe acute stress presented manifestations stress lead diverse pathologies notably major depressive disorder authors mention hippocampal alterations stress affects functions hippocampus structure eg volume loss aberrations synaptic organization adult neurogenesis discussed including areas established occur humans – points controversy different steps process exercise plays important role improved neurogenesis discussed including regulation adult hippocampal neurogenesis exercise affected stress mentioning suppressive effect latter mechanisms detrimental effect stress relation neurogenesis detailed mention concentration neurotransmitters neurotrophic factors different aspects relative perinatal stress presented well sleep disruption stressor ramifications impaired neurogenesis sleep disruption one single night seems unrelated process hormones neurotransmitters affected sleep disruption presented inflammation cell stressor discussed well importance hypothalamic–pituitary–adrenocortical axis dysregulation consequences regarding adult neurogenesis stress also affects prefrontal cortex pfc cytogenesis area particular dysregulation activity pfc result impaired cytogenesis neurogenic theory described theory links increased risks depression impaired neurogenesis following stress exposure conclusion addresses reduced long lasting reduced neurogenesis cause depression protective role voluntary exercise antidepressants intermittent fasting mattson p moehl k ghena n schmaedick cheng 2018 intermittent metabolic switching neuroplasticity brain health nature reviews neuroscience 19 81–94 httpsdoiorg101038nrn2017156 evolutionary account contribution repeated metabolic switching improved neuroplasticity provided mattson et al 2018 form comprehensive review presented frequent repeated metabolic switching paradigm different forms mentioned alternate day feeding daily timerestricted feeding together exercise intermittent metabolic switching involves glucosetoketone leading cellular stress resistance switch ketonetoglucose leading cell growth plasticity organisms evolved perform well conditions scarce resources metabolic switching one way achieve result production ketone bodies due lipolysis used cellular fuel glucose scarce neuronal dynamics induced repeated metabolic switching discussed mention cognitive benefits exercise neuroprotection well synaptic plasticity followed signaling pathways elicited metabolic switching focusing one hand neurotransmitters neurotrophic factors hand management cellular stress mitochondrial biogenesis following role hunger hormone ghrelin introduced well neurotrophic factors insulinlike growth factor igf1 fibroblast growth factor 2 fgf2 well bhb finally repeated metabolic switching presented brain health intervention seidler k barrow 2022 intermittent fasting cognitive performance – targeting bdnf potential strategy optimise brain health frontiers neuroendocrinology 65 100971 httpsdoiorg101016jyfrne2021100971 link cognition focus seidler barrow 2022 introduction high caloric diets participates development neurodegenerative diseases discussed role bdnf central molecule healthy aging adaptation presented next review links cr bdnf signaling mention relevance relation neurogenesis synaptic plasticity long term potentiation memory learning notably central role diminished synaptic plasticity neurogenesis neurodegeneration described systematic review part research animals presented followed humans findings systematic review demonstrate nutritional challenges fulfill adaptative functions involve bdnftrkb signaling pathway short vs long term benefits cognition take place depending duration bdnf stimulation cherif roelands b meeusen r chamari k 2016 effects intermittent fasting caloric restriction ramadan intermittent fasting cognitive performance rest exercise adults sports medicine 46 3547 httpsdoiorg101007s4027901504086 influence ramadan fasting cr adult cognitive performance exercise rest focus cherif et al 2016 health benefits exercise affects brain importance balanced energy intake distinction calories restriction mentioned followed brief review literature fasting cognitive function well importance nutrition athletic performance next cr presented mention caloric deficit values benefits associated cr eg increased lifespan accompanying experimental evidence mechanisms benefits cr cognitive function presented distinguished religious fasting alternate day fasting cognitive benefits beneficial changes neurochemistry neuronal networks stem including bdnf concentration discussed mention made increase parasympathetic activity exercise promotes benefits metabolic switching next discussion ramadan fasting defines scope describe effects positive negative cognition areas eg sleep general overview effects diets interest cognitive function proposed starting importance relationship immunity cognitive function focusing cytokines related interferences inflammation expression bdnf bdnf signaling effects diets glucose lipid metabolism related cognition poorer hypoglycemia importance lactate byproduct glycolysis long term memory metabolic changes associated diets relation neuroprotection discussed followed detrimental effects dehydration cognition start 1 loss body weight review evidence relating combination exercise diets healthy brain wang x yang q liao q li zhang p santos h abshirini 2020 effects intermittent fasting diets plasma concentrations inflammatory biomarkers systematic review metaanalysis randomized controlled trials nutrition 79 110974 doi 101016jnut2020110974 metaanalysis focusing inflammatory biomarkers proposed wang et al 2020 introduced mention importance balanced energy intake longevity risks associated consumption calories related metabolic disorders aging processes attenuated energyrestricted diets variations discussed next energy restricted diets presented relation activation ampk central process benefits diets metaanalysis k 18 15 articles examines effects diets concentration creactive protein crp tumor necrosis factor α tnf α interleukin6 il6 findings show diets compared ad libitum feeding affected crp energy restricted diets tnf α il6 evidence publication bias reported calorie restriction cr almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 doi103390ijms21239220 updated review literature see gillespie et al 2016 original review healthy lifespan improvement relation cr crms performed almendarizpalacios et al 2020 starts mention impact aging pathologies including neurodegenerative disorders role excessive calorie consumption next role cr limitation effects aging organism reduced cellular aging discussed aging related increased senescence cells leading “ key alterations … include increased genomic instability telomere shortening changes epigenome loss protein homeostasis proteostasis deregulated nutrient sensing mitochondrial dysfunction stem cell exhaustion altered intracellular signaling ” p 2 mention made importance ros mitochondrial dysfunction leading cellular senescence role cr minimizing consequences aging presented mention hormesis theory preparative role mild cellular stress leading protection explanation effectiveness cr follows downstream effects cr including cellular nutrient sensing related pathways eg ampk upregulation increased ampatp ratio mtor downregulation case calorie restriction discussed important factor healthy lifespan optimization following role amino acid restriction healthier lifespan presented relation mtor amino acid sensors notably sestrin2 cytosolic arginine sensor mtorc1 castor inhibit mtor1 case arginine leucine depletion effects cr amino acid restriction compared similarities differences terms involved signaling pathways authors discuss crms see ntsapi c loos b 2016 caloric restriction precisioncontrol autophagy strategy delaying neurodegenerative disease progression experimental gerontology 83 97–111 httpsdoiorg101016jexger201607014 ntsapi loos 2016 focus autophagy cr first estimates people aged 60 2050 22 worldwide related challenges mentioned notably relation chronic disease including neurodegenerative diseases linked accumulation proteins autophagy presented protective means respect reducing ros autophagy enhanced cr general health benefits increased longevity mentioned autophagy presented response nutrient deprivation implications neuronal homeostasis cell survival three types autophagy exist mammals “ macroautophagy chaperonemediated autophagy cma microautophagy ” p 98 defined characterized signaling pathways diminishing autophagy types aging related different processes counteracted cr instance macroautophagy increased already 30 minutes nutrient depletion whereas cma requires 10 hours caloric intake abstinence depletion cma preferable macroautophagy less selective proteins degradation could counterproductive neuroprotective role autophagy presented distinction macroautophagy cma terms outcomes made studies relation neurodegenerative diseases interested macroautophagy association macroautophagy cma different neurodegenerative diseases discussed well detrimental role specific aggregative proteins importance mitochondrial dysfunction increases age insufficient clearance proteins review ends description implication targeted autophagy increased healthy lifespan presenting igf1 central aspect effectiveness calorie restriction process de mello n p orellana mazucanti c h de morais lima g scavone c kawamoto e 2019 insulin autophagy neurodegeneration frontiers neuroscience 13 491 httpsdoiorg103389fnins201900491 de mello et al 2019 focus insulin autophagy relation neurodegeneration metabolic disorders among important cause reduced life expectancy comorbidity including neurodegenerative diseases discussed first linked imbalanced insulin signaling plays important role neurodegeneration different processes autophagy apoptosis rely upon different signaling pathways eg pi3k ampk akt mtor alleviate pejorate examined next “ review summarizes origin role insulin cns discusses relationship insulin autophagy neurodegenerative diseases ” p 2 insulin resistance presented factor neurodegeneration effects insulin including neurons presented brain insulin linked igf1 insulin signaling autophagy neurodegeneration different signaling pathways several neurodegenerative diseases cr exercise finally discussed important means regulation autophagy maharajan n vijayakumar k jang c h cho gw 2020 caloric restriction maintains stem cells niche regulates stem cell aging journal molecular medicine 98 25–37 httpsdoiorg101007s00109019018461 maharajan et al 2020 focus optimization stem cells function cr first mention made importance stem cells aging process homeostasis general review continues mention presence stem cells niches communicate environment next calorie restriction crms beneficial terms health longevity stem cell aging defined decrease functions list different associated impairments discussed relation intrinsic extrinsic influences components niche defined “ cells physically attached stem cells stromal cells mesenchymal cells adhesion molecules membrane membrane bound ligands receptors niche cells ” p 28 well “ secretory soluble factors chemokines hormones gf hedgehog tnf nuclear factorkappa b nfkb wnt3 egf notch produced stem cells stem cell progenitor cells niche cells ” p 29 niche affects stem cell instance alteration components niche detrimental stem cell discussed examples different organs notably brain regulation niche noncellular components presented extracellular matrix importance integrins notably promote stem cells adhesion extracellular matrix deteriorated signaling involved neurodegeneration following aging affected energy metabolism cr activation inhibition different pathways eg ampk sirt mtor presented mention normal caloric intake relation lower selfrenewal stem cells anomalous functioning higher differentiation stem cells opposite effects cr differentiated impact presence absence abundant nutrients pathways involved discussed cr crms finally presented means increase healthy lifespan notably improved stem cell niche stem cell proliferation zhang l xu h ding n li x chen x chen z 2021 beneficial effects brain microenvironment caloric restriction alleviating neurodegenerative diseases brain aging frontiers physiolology 12 715443 httpsdoiorg103389fphys2021715443 zhang et al 2021 examine optimization brain extracellular microenvironment cr focus minimizing brain aging symptoms neurodegenerative diseases first mention made consequences aging cellular level eg cellular senescence disrupted gene expression brain eg neuronal damage importance extracellular matrix cerebrospinal fluid health neurons broader consequences organism eg neurodegeneration presented followed review signaling pathways linked cerebral inflammation role cytokines inflammation microglial cells sensing cytokine secretion notably process detrimental effect metabolic waste extracellular microenvironment reduction antioxidants accompanies aging presented well clearing waste cellular autophagy transport waste outside brain bbb next untimely removal metabolic waste aging due disruption permeability bbb discussed subsequent topics addressed modulation gene expression impacted aging alterations chromosome structures cellular microenvironment enhanced cr relation diminished risks neurodegenerative diseases implications cr respect cellular microenvironment molecular level eg inhibition mtor activation sirt upregulation creb leading increase bdnf examined presentation increase neurotrophic factor concentration consequence cr role cr improving microenvironment cellular level distinguishing mitochondrial biogenesis autophagy gut microbiota implications cr tissue level provided mention reduction tissue inflammation cr influence cr permeability bbb synaptic plasticity neurogenesis neuron immunity addressed cr interventions focus next section reduction aging induced cr due neurogenesis implications specific diseases parkinson ’ huntington discussed yu q zou l kong z yang l 2020b cognitive impact calorie restriction narrative review journal american medical directors association 21 1394–1401 httpsdoiorg101016jjamda202005047 yu colleagues 2020b discuss restauration maintenance cognitive function cr six dimensions cognitive abilities decline aging social economic costs decline well pharmacological treatment presented cr discussed alternative method dealing cognitive decline next amelioration variety agingrelated health conditions cr detailed potential mechanisms relating time cr cognitive function presented oxidative stress areas related cognition risk ros damage inflammation secretion inflammatory molecules senescent cells proinflammatory environment neurogenesis synaptic plasticity neurotrophic factors bdnf signaling neuroprotection preservation gray white matter conclusion call made studies investigate several aspects cr order optimize benefits relation duration cr amount cr combination cr interventions calorie restriction mimetics crms almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 doi103390ijms21239220 summary almendarizpalacios et al 2020 continued relation crms crms portrayed means promote healthy lifespan rapamycin immunosuppressant antitumor medication related decreased mtor1 signaling mention made benefits terms lifespan extension reduced risk cancer well augmentation autophagy neuroprotection among benefits rapamycin analogs discussed resveratrol exerts effects ampk sirt activation detrimental effects high concentration metformin type 2 diabetes medication also discussed along pathways regulates bonkowski sinclair 2016 slowing ageing design rise nad sirtuinactivating compounds nature reviews molecular cell biology 17 679–690 httpsdoiorg101038nrm201693 bonkowski sinclair 2016 focus nad precursors sirt activators first importance disease prevention – including neurodegeneration implications longevity extension presented several signaling pathways conserved simple complex organisms examined next explain part effectiveness calorie restriction healthy aging including ampk sirts mtor regulation natural molecules capable activating mentioned pathways discussed review focuses sirts activators stacs including nad precursors animal models primate human studies discussed presentation mechanisms stacs following specifics nad precursors discussed nad required activity sirts “ nadboosting molecules constitute newer class stacs gaining attention way restore nad levels elderly individuals potentially activate seven sirtuins single compound “ bonkowski sinclair 2016 p 17 iside c scafuro nebbioso altucci l 2020 sirt1 activation natural phytochemicals overview frontiers pharmacology 11 1225 iside et al 2020 focus activation sirt1 phytochemicals epigenic modifications associated aging presented role sirts reducing consequences improving range parameters relate better health including neuroprotection review continues importance diet health including protective nature phytochemicals like “ polyphenolic substances resveratrol quercetin curcumin fisetin natural nonpolyphenolic substances berberine ” p 2 molecules related expression activity sirts studies exemplify activation sirts resveratrol quercetin berberine curcumin fisetin reviewed focusing signaling pathways involved conclusion focuses activation sirts natural crms might explain role molecules preserving improving health bioavailability mentioned phytochemicals hofer j davinelli bergmann scapagnini g madeo f 2021 caloric restriction mimetics nutrition clinical trials frontiers nutrition 8 717343 httpsdoiorg103389fnut2021717343 hofer colleagues 2021 focus availability crms nutrition although nutrition essential health relative lack agreement regarding definition healthy diet cr presented point consensus debate crms defined “ pharmacologically active substances mimic cr ’ myriads effects core crm definition others argue potential crmimicking compounds principle increase life andor healthspan ameliorate ageassociated diseases model organisms thus often simultaneous use term ‘ antiaging substances ’ ” p 2 table sources nutritional crms provided several classes glycolysis inhibitors hydroxycitric acid nad precursors polyamines polyphenols salicylic acid example studies classes crms examined conclusion elaborates need studies examining points uncertainty confirming beneficial effects crms humans moosavi f hosseini r saso l firuzi 2016 modulation neurotrophic signaling pathways polyphenols drug design development therapy 10 2342 doi 102147dddts96936 moosavi et al 2016 focus neurotrophic actions polyphenols first sources health protective role polyphenols relation different diseases including neurodegenerative ones presented distinguishing different neurotrophic functions polyphenols eg neuroprotection neuronal proliferation antioxidant effect details provided signaling pathways eg trk mtor erk pi3k creb nrf2 targeted different polyphenols eg curcumin quercetin egcg carnosic acid neurotrophic factors affected bdnf nerve growth factor – ngf glial cell linederived neurotrophic factor functions achieved eg antidepressantlike effects cognition enhancement attenuation neuronal degeneration oluwole fernando w b lumanlan j ademuyiwa jayasena v 2022 role phenolic acid tannins stilbenes lignans flavonoids human health – review international journal food science technology 5710 6326–6335 httpsdoiorg101111ijfs15936 oluwole et al 2022 focuses role different polyphenol subclasses tannins phenolic acid lignans flavonoids stilbenes classification large variety polyphenols flavonoid vs nonflavonoid depends quantity phenols molecule contains functions uses mentioned subclasses summarized phenolic acids defined biological functions mentioned antioxidant eg ros scavenging gastroprotective antidiabetic cardioprotective chemopreventive eg lipid protein metabolism antimicrobial antiinflammatory role prevention neurodegeneration neuronal injury detailed next tannins presented antimicrobial antiviral antimutagenic properties well role diabetes stilbenes discussed mention chemopreventive properties eg antioxidant antiinflammatory role obesity diabetes well prevention neurodegeneration discussion continues lignans chemopreventive eg hormone regulation inhibition cell growth cardioprotective antimicrobial properties finally flavonoids defined biological functions eg antioxidant regulation hydroperoxides mention properties inhibition lipid peroxidation chemoprevention eg protective role cancer antimicrobial antiviral protection cardioprotection hepatoprotection antiinflammation antineurodegeneration rendeiro c rhodes j spencer j p 2015 mechanisms action flavonoids brain direct versus indirect effects neurochemistry international 89 126139 httpsdoiorg101016jneuint201508002 rendeiro et al 2015 examine mechanisms action flavonoid polyphenols context prevention neurodegenerative diseases elevation serum nitric oxide one benefits flavonoids bioavailability flavonoids metabolites brain mentioned relation ability cross bbb several flavonoid metabolites detected brain supports requirement neuroprotection human cognition influenced flavonoids reported benefits several groups flavonoids mentioned mechanisms action flavonoids ie modulation synaptic plasticity pathways action discussed including indirect mechanisms relate improvement neurovascular system cerebrovascular functioning eg blood oxygenation levels increased brain vascularization increased nitric oxide bioavailability notably correlational nature reported association discussed need research improves mechanistical assumptions relying upon strong empirical evidence already available neither long term effects flavonoids yet thoroughly investigated humans recommended daily dose also discussed zhang lx li cx kakar u khan wu pf amir r dai df naveed li qy saeed shen jq rajput li jh 2021 resveratrol rv pharmacological review call research biomedicine pharmacotherapy 143 112164 httpsdoiorg101016jbiopha2021112164 zhang et al 2021 focus pharmacological actions resveratrol stilbenoid polyphenol first brief presentation resveratrol proposed list functions eg cardioprotection reduction neurotoxicity brief mention signaling pathways involved eg reduction oxidative stress improvement mitochondrial health next chemical structure resveratrol presented mention important nutritional sources eg tomatoes peanuts red grapes different berries pomegranates cranberries dark chocolate intake recommendations presentation continues pharmacokinetics resveratrol including metabolization liver plasma concentration distribution different organs mechanisms action explained focusing detail signaling pathways supports regulation finally health perspective resveratrol proposed form synthesis focusing antioxidant antiinflammatory actions well role protection neurodegenerative diseases among others moradi z jalili f farhadian n joshi wang zou l cao h farzaei h xiao j 2022 polyphenols neurodegenerative diseases focus neuronal regeneration critical reviews food science nutrition 6213 3421–3436 httpsdoiorg1010801040839820201865870 moradi et al 2022 focus neuronal regeneration following polyphenol intake following mention scarcity organ donation importance regenerative medicine review continues explanations nervous system diseases ad pd hd als therapy notably focusing cytokines growth factors neurotrophic factors stem cells next therapeutic effects polyphenols neurodegenerative disorders examined distinguishing flavonoids isoflavones phenolic acids tannins classes polyphenols benefits investigated mechanisms action detailed ros scavenging reduced betaamyloid accumulation regulation apoptosis gene expression example studies regenerative effect polyphenols proposed focusing single multiple molecules role stem cells neuronal regeneration examined “ stem cell therapy one important branches regeneration medicine enhanced researcher ’ hope treat improve condition patient varying debilitating diseases ” p 4 examples studies provided neuronal regeneration chemical stimulation emerging role gene therapy presented neuronal perspective addresses role polyphenols regeneration antioxidative properties polyphenols potential improvements neurogenesis neuronal connectivity nerve damage neuron survival notably stemming variety polyphenols presented next finally challenges future perspectives field discussed potential mentioned treatments alleviating consequences aging highlighted grewal k singh g sharma sharma v singh rahman md h najda walasekjanusz kamel albadrani g akhtar f saleem abdeldaim 2021 mechanistic insights perspectives involved neuroprotective action quercetin biomedicine pharmacotherapy 140 111729 httpsdoiorg101016jbiopha2021111729 grewal et al 2021 delineate mechanisms neuroprotection quercetin flavonoid polyphenol neuroprotective effect polyphenols notably reduced oxidative damage reduction risks several neurodegenerative diseases examined nutritional sources quercetin eg red onion garlic apple pomegranate chemical formula pharmacological action presented neuroprotective effect quercetin enhanced nanoemulsion pathogenesis neurodegenerative diseases discussed notably involves mitochondrial dysfunction oxidative stress elevated apoptosis inflammation review elaborates different neurodegenerative diseases quercetin shown reduce risks symptoms proposed mechanisms action eg alzheimer ’ disease improvement neuroinflammation oxidative stress amyloid plaques cholinesterases notably parkinson disease improvement neuroinflammation oxidative stress apoptosis autophagy notably huntington disease improvement neuroinflammation oxidative stress cognitive deficits neuronal dysfunction notably finally signaling pathways influenced quercetin detailed among others paraoxonase 2 pon2 nuclear factor erythroid 2related factor 2 nrf2 adenylateuridylaterich elements ravula r teegala b kalakotla pasangulapati j p perumal v boyina h k 2021 fisetin potential flavonoid multifarious targets treating neurological disorders updated review european journal pharmacology 910 174492 httpsdoiorg101016jejphar2021174492 ravula et al 2021 provide updated review neuroprotective neurogenerative impact flavonoid polyphenol fisetin neurological diseases leading cause disability mortality difficulty therapy diseases discussed complementary role flavonoids treatment neurodegenerative disorders presented mention “ potential flavonoids antioxidants antiviral antiinflammatory anticarcinogenic antibacterial neurotrophic neuroprotective immunestimulants ” p 2 functions fisetin particular prevention neurodegeneration mentioned reduced neuroinflammation improved immune response optimization signaling pathways disrupted aging neurodegenerative disorders research showing fisetin effective improving cognition presented followed mechanisms affected fisetin discussed main text review ‘ modulation cdk5p35 ’ associated neuroinflammation synaptic damage notably neuronal death ‘ regulation eicosanoids ’ proinflammatory lipid componds ‘ saving atpase ’ important homeostasis impaired oxidative stress ‘ fisetintfeb—mtorc1nrf2 linkage ’ role autophagy notably ‘ modulation kelchlike echassociated protein 1 keap 1 nuclear factor erythroid 2related factor 2 nrf2 antioxidant response elements pathway ’ control xenobiotic damage oxidative stress maintenance enegery metabolism redox balance cells ‘ regulation advanced glycation end products ages ’ inhibit protein functions impair antioxidant enzymes aggregate proteins notably well ‘ modulation creb ’ involved learning memory ‘ nad degradation ’ see ‘ restauration synaptic proteins ’ ‘ elevation acetyl coa ’ involved glycolysis fatty acid synthesis oxidation abnormalities acetylcoa lead dementia precursor neurotransmitter acetylcholine ‘ modulation nfkb ’ proinflammatory regulates cytokine expression involved neurodegeneration research fisetin relation neurodegeneration summarized table 1 figure 7 indicates fisetin decreases inhibits among others lipid peroxides il6 tnfalpha nfkb nitric oxide superoxides serum homocysteine increases activates among others bdnf acetylcholine butyrylcholine serotonine noradrenaline nrf2 trkb mekerk nutrients inducing neurotrophic effects several molecules considered crms neurotrophic effects molecules briefly introduced continuation annotated bibliography heberden c 2016 modulating adult neurogenesis dietary interventions nutrition research reviews 29 163–171 modulation adult neurogenesis polyphenols n3 polyunsaturated fatty acids examined heberden et al 2016 potential human brain regenerate might less rodents limited specific areas neural stem cells presented subgranular zone dentate gyrus subventricular zone lateral ventricle median eminence hypothalamus regulators effectors neurogenesis neurotrophins growth factors examined mention concentrated nature neural stem cells niches role leptin promoter neural stem cell proliferation well peptide hormones highlighted detrimental effect aging neurogenesis examined following dietary influences process unfavorable effects overnutrition addressed notably terms proliferation survival new neurons potential dietary intervention polyphenols see also n3 polyunsaturated fatty acids addressed beneficial terms neural stem cell proliferation differentiation neurogenesis arborization new neurons targets signaling pathways involved detailed ampk bdnfcreb nfkb sirt1 gut microbiota presented potential effector nutrition induced adult neurogenesis instance action metabolism inflammation carneiro oliveira b p alves r c 2021 neuroprotective properties coffee update trends food science technology 113 167179 httpsdoiorg101016jtifs202104052 carneiro et al 2021 provide updated systematic literature review neuroprotective effects coffee stimulant properties cns presented factor contributing large worldwide consumption coffee health benefits coffee also mentioned aims review synthesize literature relating coffee consumption reduction risk neurodegenerative disorders mechanisms involved 1000 components coffee important presented studied caffeine antagonist inhibitory neurotransmitter adenosine notably explains stimulant properties coffee another important compound trigonelline related neuroprotection neurotransmitter serotonin also compound coffee coffee also contains polysaccharides impact gut microbiome enhances cognitive function antioxidants cafestol kahweol nicotinic acid b3 component roasted coffee components enumerated health benefits mentioned eg antioxidant antiinflammatory anticarcinogenic next role coffee prevention several neurodegenerative diseases examined instance reduction excitotoxicity oxidation inflammation caffeine prevention memory impairments trigonelline phenolic components components coffee neuroprotective properties also mentioned research protective role coffee risk different neurodegenerative diseases detailed positive global health impact coffee notably relation neurodegenerative disorders discussed chen x ghribi geiger j 2010 caffeine protects disruptions bloodbrain barrier animal models alzheimer ’ parkinson ’ diseases journal alzheimer ’ disease 20s1 s127–s141 httpsdoiorg103233jad20101376 chen et al 2010 focus protective role caffeine regards integrity bbb one neuroprotective effects caffeine function bbb isolate brain toxins notably structure bbb first described disruption bbb mentioned one causes onset ad notably result high cholesterol levels potentially pd bbb disruption occurring loss dopaminergic neurons characteristic pd three mechanisms caffeine believed protect bbb examined notably “ blocking cell surface adenosine receptors inhibition camp phosphodiesterase pde activity affecting release calcium intracellular stores ” p s131 next integrity bbb chronic caffeine consumption might explain part neuroprotective effect caffeine examples relating instance better memory cognition reduced loss dopaminergic neurons indicators effect provided protective actions caffeine bbb mentioned primary comparison neuroprotective actions caffeine cui x gooch h petty mcgrath j j eyles 2017 vitamin brain genomic nongenomic actions molecular cellular endocrinology 453 131143 httpsdoiorg101016jmce201705035 cui et al 2017 examine role vitamin brain development neuroprotection immunity vitamin presented developmental neurosteroid positively involved brain development neuroprotection signaling functions vitamin vitamin receptor vdr detailed brain morphology physiology importantly linked vitamin goals review presented examination actions vitamin “ brain cell differentiation neurotransmitter release calcium signaling via genomic nongenomic functions ” p 132 vdr distributed brain rodent models discussed first “ pattern vdr distribution indicates vitamin may involved proliferation andor differentiation neuronal stem cells ” p 132 human brain “ vdr protein also identified human brain distribution pattern vdr found strikingly similar reported rodents p 133 genomic actions vitamin addressed particular involvement apoptosis cell proliferation neural growth role vitamin regulation development dopaminergic neurons cells differentiation adult neural stem cells myelination also examined effect vitamin neuronal survival programmed glioma cell death neurotransmitter release addressed followed neuroprotective effects vitamin aged brain relation neurotrophic factors bdnf notably next mention made vitamin compensate neuroinflammation aging brain well immune response also “ vitamin could potentially increase local estrogen synthesis glial cells important maintain neuronal function ” p 137 nongenomic functions vitamin underexplored area examined includes role vitamin regulation calcium kinase activated pathway signaling recently discovered developing cortex modulatory effects vitamin neuroprotective properties therapeutic potential vitamin negative consequences deficiencies vitamin finally discussed",
    "relevance_score": 0.81,
    "date_score": 0,
    "final_score": 0.6075,
    "date_numeric": 0
  },
  {
    "title": "Manuscript V 2.5 Arxiv version",
    "author": "Eric Mayor",
    "date": "2023-05-03T15:49:58",
    "filename": "2305.11425.pdf",
    "processed_text": "neurotrophic effects intermittent fasting calorie restriction exercise review annotated bibliography eric mayor university basel switzerland corresponding author eric mayor university basel missiosstrasse 62a 4055 basel switzerland ericmarcelmayorunibasch citation mayor e 2023 neurotrophic effects intermittent fasting calorie restr iction exercise review anno tated bibliography frontiers aging 4 11 61814 final version available httpswwwfro ntiersinorgarticles10 3389fragi2023 1161814abstract abstract last decades important progress achieved understanding neurotrophic effects intermittent fasting caloric restriction cr exercise improved neuroprotection synaptic plasticity adult neurogenesis nspan essential examples neurotrophic effects importance respect metabolic switch glucose ketone bodies cellular fuel highlighted recently calorie restriction mimetics crms resveratrol polyphenols particular investigated thoroughly relation nspan narrative review sections manuscript recent findings essential functions synthesized important molecules involved presented researched signaling pathways pi3k akt mtor ampk gsk3β ulk mapk pgc1α nfκb sirtuins notch sonic hedgehog wnt processes eg antiinflammation autophagy apoptosis support thwart neuroprotection synaptic plasticity neurogenesis briefly presented provides accessible entry point literature annotated bibliography section contribution brief summaries provided 30 literature reviews relating neurotrophic effects interest relation cr crms exercise selected reviews address essential functions perspective healthier aging sometimes discussing epigenetic factors reduction risk neurodegenerative diseases alzheimer ’ disease huntington ’ disease parkinson ’ disease depression improvement cognitive function keywords neuroprotection neurogenesis synaptic plasticity neurotrophic effects intermittent fasting calorie restriction caloric restriction mimetics exercise signaling pathways betahydroxybutyrate brainderived neurotrophic factor alzheimer ’ disease depression neurotrophic effects intermittent fasting calorie restriction exercise narrative review annotated bibliography exercise intermittent fasting calorie restriction eic common beneficial effects energy metabolism signaling pathways three induce metabolic switching glucose ketone bodies gtok cellular fuel source glucose scarce mattson et al 2018 lowering available cellular energy cellular sensing limited availability nutrients1 ensues induce activation inhibition several signaling pathways relevant neuroprotection synaptic plasticity neurogenesis nspan eg garcíarodríguez giménezcassina 2021 mattson 2019 van praag et al 2014 shortterm implications cognitive performance eg diano et al 2006 benefits eic achieved part influence hunger hormone ghrelin glucose homeostasis activity insulin receptor bayliss et al 2016 chabot et al 2014 upstream effector signaling pathways relevant nspan sadria layton 2021 hormone ghrelin also plays role signaling pathways regulating nspan bayliss et al 2016 buntwal et al 2019 davies 2022 diano et al 2006 gahette et al 2011 exerkines also regulate activity pathways among others eg chow et al 2022 reddy et al 2022 vints et al 2022 calorie restriction mimetics crms polyphenols sirtuin activators well precursors nicotinamide adenine dinucleotide particular rely upon glucose depletion produce similar effects including enhanced energy metabolism decreased oxidative stress inflammation enhanced nspan cognition testa et al 2014 efficacy crms regards overall physiological parameters questioned handschin 2016 general consensus literature points potential crms prevention treatment neurodegenerative disorders eg bonkowski sinclair 2016 crms considered promising area eg almendarizpalacios et al 2020 bonkowski sinclair 2016 carosi sargeant 2019 heberden 2016 hofer et al 2021 martel et al 2021 sharman et al 2019 xue et al 2021 state current knowledge insufficient recommend crms treatment individuals presenting neurodegenerative disorders instance heger 2017 mentions 17 45 trials time show efficacy curcumin relation diverse clinical targets hofer et al 2021 provide summary human clinical trials interested various crms relating diversity outcomes martel et al 2021 focus human clinical trials interested crms extension human healthy lifespan including neuroprotection neurogenesis discussing advantages disadvantages treatment always provided sufficient clinical trials conducted early progression disease eg carosi sargeant 2019 sharman et al 2019 eic crms beneficial attenuation epigenetic changes induced aging important contributors neurodegeneration among risks almendarizpalacios et al 2020 madeo et al 2019 maharajan et al 2020 mattson et al 2018 xue et al 2021 aims article threefold discuss relevance eic crms nspan relying upon recent publications b briefly present biochemical processes involved metabolism oxidative stress nspan c present selective annotated bibliography existing literature reviews summaries appendix focus ways eic crms improve nspan cognitive function brain resilience eg van praag et al 2014 1 eg increased adenosine monophosphate amp adenosine triphosphate atp ratios sensed 5 adenosine monophosphateactivated protein kinase ampk hardie 2018 relevance exercise calorie restriction cr intermittent fasting crms neurogenesis neuroprotection neurotrophic effects body transition using glucose energy using ketone bodies garcíarodríguez giménezcassina 2021 details see section b liver glycogen store contain equivalent 700 calories depleted energy intake doesnt occur period 10 12 hours least periods high energy expenditure eg running one hour following four hours period last meal mattson et al 2018 glycogen also stored skeletal muscles richter hargreaves 2013 eic result depletion glycogen store thus activate gtok metabolic switch ktog metabolic switch occurs glycogen store repleted energy intake repeated switching glucose ketone bodies main sources cellular fuel advantages organism level terms cellular regeneration protection including brain terms neurogenesis neuroprotection matteson et al 2017 crms resveratrol rapamycin potential prevention treatment neurodegenerative diseases albani et al 2010 baur sinclair 2006 dos santos et al 2022 rege et al 2014 “ compounds also show impressive effects rodent models ageassociated diseases ” kaeberlin 2010 p 96 could modulate cell signaling close fasting state eg resveratrol chatam et al 2022 rapamycin blagosklonny 2019 sustainable alternation exercise cr use crms might lead benefits similar continued reliance upon single modality nspan intervention contribution potential benefits eic crms dwelved upon including metabolic signaling processes trough advantages achieved neurodegenerative diseases depression large majority papers mentioned review mention devastating consequences aging one motors research neurotrophic effects eic crms including nspan variety essential restorative functions decreased age leads brain aging eg zia et al 2021 addition aging increases damage dna tissues including neurons stem cells niches brunet et al 2022 maharajan et al 2020 bibliometric analysis literature cognitive aging provided othman et al 2022 consequences aging due epigenic changes signaling pathways eg iside et al 2020 wang et al 2022a instance agingrelated impaired ampk signaling see related atherosclerosis cardiovascular diseases increased risks insulin resistance diabetes obesity chronic inflammation nonalcoholic fatty liver diseases polycystic ovary syndrome cancer neurodegenerative diseases yadav et al 2017 neurodegenerative diseases share ethiological processes oxidative stress posttranslational modifications metabolic changes cell death mechanisms disturbed immune response balusu et al 2023 fan et al 2017 factors epigenetic causes environmental behavioral causes fan et al 2017 frequent neurodegenerative diseases alzheimer ’ disease parkinson ’ disease mcgregor nelson 2019 alzheimer ’ disease characterized aggregation amyloid beta peptide accumulation misfolded tau proteins result epigenetic dysregulations cell signaling including mitochondrial metabolic disfunctions aman et al 2021 amorim et al 2022 balusu et al 2023 bloom 2014 guo et al 2022 examples dysregulated processes linked neurodegenerative impairments alzheimer ’ disease endocytosis proteastasis phagocytosis microglia inflammation metal ion homeostasis astrocytes well myelin loss lipid deposits oligodendrocytes balusu et al 2023 parkinsons ’ disease characterized presence lewy bodies different areas brain neurodegenerative cell loss dopaminergic neurons particular balusu et al 2023 mcgregor nelson 2019 examples dysregulated processes associated neurodegeneration parkinsons ’ disease proteostasis potassium ion transport phagocytosis microglia heatshock response metal ion homeostasis astrocytes well proteostasis zinc homeostasis oligodendrocytes balusu et al 2023 major depression important factor associated disability among causes craske et al 2017 search biomarkers major depression challenging due heterogeneity description disorder eg increased appetitesleep decreased appetitesleep decreased emotionality increased nervousness feeling slow feeling restless dysregulated cell signaling protein pathways relation inflammation metabolism candidate biomarkers major depression van haeringen et al 2022 progress stemming focus brain circuits disappointing research prevention treatment neurodegenerative disorders depression authors point relevance examining etiology treatment neurodegenerative diseases molecular cellular level balusu et al 2023 eic crms potential maintain healthy cell signaling restore dysregulated cell signaling eg bayliss et al 2016 erbaba et al 2021 heberden 2016 igwe et al 2021 kallies et al 2019 magliulo et al 2022 ntsapi loos 2016 overall et al 2016 radak et al 2020 ravula et al 2021 spasić et al 2009 szwed et al 2021 van praag et al 2008 van praag et al 2014 vints et al 2022 walsh et al 2020 eic crm discussed next exercise american college sports medicine acsm 2013 defines physical exercise planned voluntary physical activity performed aim maintaining improving fitness body several types exercise distinctions include aerobic vs anaerobic exercise strength vs endurance training acsm 2013 aerobic exercise body relies aerobic metabolism oxygen provided pulmonary respiration generate adenosine triphosphate atp necessary activity whereas anaerobic exercise anaerobic glycolysis relied upon atp production strength training aims increase force muscle endurance training aims increase potential duration exertion acsm 2013 exercise reduce oxidative stress chronic inflammation eg beavers et al 2010 gomezcabrera et al 2008 exercise also source reactive oxygen species ros thereby increase oxidative stress bloomer et al 2005 et al 2016 antioxidative benefits exercise therefore depend upon duration type intensity fisherwellman bloomer 2009 gomezcabrera et al 2008 importance redox balance relation exercise discussed sutkowy et al 2021 exercise still provide benefits even oxidative benefits include activation 5 ’ adenosine monophosphateactivated protein kinase ampk see richter hargreaves 2013 richter ruderman 2009 sirtuins sirts radak et al 2020 addition indirect increase concentration brain derived neurotrophic factor bdnf also potential consequence exercise leckie et al 2014 “ bdnf mediates beneficial effects energetic challenges vigorous exercise fasting cognition mood cardiovascular function peripheral metabolism ” marosi mattson 2014 p89 benefits balanced inflammation stemming oxidative stress recent years important role exerkines – defined “ humoral factors secreted circulation tissues response exercise ” magliulo et al 2022 p 105 – highlighted explanation benefic effects exercise eg chow et al 2022 magliulo et al 2022 reddy et al 2022 vints et al 2022 vints et al 2022 discuss implications exercises exerkines regards synaptic plasticity recent metaanalysis pillon et al 2020 focused studies relying upon transcriptomic profiling identify genes expression modified exercise skeletal muscles mechanisms play exerciseinduced tissue regeneration including central nervous system neurogenesis well neuron myelin axon regeneration instance described chen et al 2022a cortes de miguel 2022 highlight sex differences cns responses exercise intermittent fasting overconsumption food issue modern societies constant availability discussing detrimental effects overconsumption cognitive functioning damaging implications regarding neurodegenerative diseases mattson 2019 specifies “ underlying molecular mechanisms involve epigenetic modifications … alter expression genes involved neuroplasticity ” p 204 lead “ synaptic dysfunction impaired neurogenesis neuronal degeneration ” p 205 nutritional practices reestablish “ adaptive cellular signalling ” cr mitigate negative effects food overconsumption cognition enhancing nspan mattson 2019 “ intermittent fasting regimen repeating cycles ad libitum eating fasting ” erbaba et al 2021 p 2 four main forms frequently studied addition religious forms fasting alternate day fasting important lowering energy intake every two days whole day fasting one two days food abstinence week time restricted feeding energy intake limited time window 8 12 hours generally periodic fasting 5 days ad libitum diet followed two days fasting eg bhoumik et al 2023 li et al 2023 seidler barrow 2022 tinsley la bounty 2015 similar benefits cr eg improved neurogenesis baik et al 2020 discussed next observed fasting mimicking diets baik et al 2020 seidler barrow 2022 zhao et al 2022 consist limiting intake calories proteins cycles days week see seidler barrow 2022 chen et al 2022a provide bibliometric analysis intermittent fasting li et al 2023 provide balanced view intermittent fasting including potential disadvantages summaries processes relating circadian rhythms caloric restriction cr entails limitation energy intake food – “ rough guideline would 1800–2200 kcalday men 1600–2000 calories women ” mattson 2010 p 8 – prolonged period time mattson 2010 availability nutrients ratio adenosine monophosphate atp yadav et al 2017 regulates several signaling pathways relevance nspan various mechanisms cr delay cognitive effects aging gillespie et al 2016 instance cr leads reduction oxidative stress almendarizpalacios et al 2020 yu et al 2020a proliferation new neurons maharajan et al 2020 mattson arumugam 2018 better regulation autophagy neurons ie recycling material deficient damaged cells increased energy scarce appendix see summary ntsapi loos 2016 examples include increase antiinflammatory hormones decrease chronic inflammation modulation cell survival eg apoptosis testa et al 2014 signaling pathways involved processes others described next section caloric restriction mimetics crms share benefits eic testa et al 2014 xue et al 2021 instance bonkowski sinclair 2016 see appendix discuss increasing use nicotinamide adenine dinucleotide precursors activators sirts clinical trials context neurodegenerative disease prevention treatment promotion longevity several reviews summarized appendix discuss role polyphenols modulation synaptic plasticity increased neuronal proliferation reduction oxidative stress neurotoxicity particular eg moosavi et al 2016 rendeiro et al 2015 zhang et al 2021 noted miller et al 2011 found resveratrol simvastatin provide longevity benefits rodents whereas rapamycin three crms thus impacted longevity differently miller et al 2011 see madeo et al 2019 sharman et al 2019 note low success rate phytocomponents among nicotinamide adenine dinucleide boosters sirtuins upstream effectors terms symptom reduction human trials alzheimer ’ patients importantly safety nicotinamide mononucleotide nicontinamide adenine dinucleotide precursor needs investigated nadeeshani et al 2022 neurogenesis adult neurogenesis refers formation new neurons adult central nervous system overall et al 2016 description different stages neurogenesis starting stem cell leading mature neuron provided overall et al 2016 new neurons hyperexcitable less receptive inhibitory neurotransmitters eg gammaaminobutyric acid – gaba confers influence older neurons neural circuit fares et al 2019 adult neurogenesis documented different mammals lucassen et al 2020 studies matter overwhelmingly conclude neurogenesis occurs adult human hippocampus see lucassen et al 2020 kempermann et al 2018 hippocampus fulfills important functions respect spatial episodic memory involved emotional processes anacker hen 2017 neurogenesis region – accounting 700 new neurons every day 2 total spalding et al 2013 – might required flexible representations behavior ie dealing new situations adaptively tuncdemir et al 2019 reduced hippocampal neurogenesis associated diminished ability form new memories forgetting old memories frankland et al 2013 whereas increasing hippocampal neurogenesis allows flexibility strategy choice compensate preceding deficiencies aging brain bergugovega et al 2020 adult neurogenesis induced enhanced eic crms slows cognitive decline also enhance cognition eg chow et al 2022 mattson arumugam 2018 overall et al 2016 describe different mechanisms neurogenesis promoted physical activity maharajan et al 2020 negredo et al 2020 discuss potential cr maintaining health stem cells stem cell niche regeneration fares et al 2019 provide historical perspective study neurogenesis neuroprotection eic crms promote neuroprotection thereby delay cognitive aging eg burtcsher et al 2022 mattson arumugam 2018 reddy et al 2022 achieved several mechanisms two addressed paragraph others briefly mentioned pages follow first mechanisms protection neuron microenvironment neurons oxidative stress eg protection membrane dna integrity li et al 2022 lüscher et al 2021 second related mechanism regulation cell survival eg ying 2006 ideal conditions survival healthy cells promoted survival senescent otherwise deficient cells impeded different mechanisms eg autophagy apoptosis eg bortner cidlowsky 2020 laberge et al 2013 neuroprotective effects thereby achieved brain bhaduri et al 2023 cellular level different molecules signaling pathways play role determining fate cells including neurons eg bathina das 2015 fayad et al 2005 huang reichardt 2001 jaworski et al 2019 krieglstein et al 2002 li et al 2022 lüscher et al 2021 nordvall et al 2022 rai et al 2019 ying 2006 yamamoto et al 2007 zhao et al 2019 eic crms regulate processes eg mattson arumugam 2018 synaptic plasticity synaptic plasticity also important neurotrophic effect eic crms eg reddy et al 2022 rendeiro et al 2015 seidler barrow 2022 ability brain reorganize following internal external events key learning adaptive conduct one mechanism synaptic plasticity bliss et al 2018 magee grienberger 2020 mcallister et al 1999 neurotrophins particular bdnf see current section play important role synaptic plasticity well synaptic transmission gómezpalacioschjetnan escobar 2013 mcallister et al 1999 magee grienberger 2020 discuss several forms synaptic plasticity including form commonly studied hebbian plasticity strength synapse depends often presynaptic neuron fires toward postsynaptic neuron abraham 2008 discusses metaplasticity refer tuning synapses neuron networks plasticity “ metaplasticity entails change physiological biochemical state neurons synapses alters ability generate synaptic plasticity ” abraham 2008 p 387 alternations phases high stimulation phases low stimulation paradigmatic promotion metaplasticity physical exercise induce high stimulation b energy metabolism oxidative stress neuroprotection synaptic plasticity adult neurogenesis biochemical processes section several processes responsible effects eic crms nspan discussed neurotrophic protective effects signaling pathways elicited eic crms presented comprehensiveness energy metabolism liver glycogen storage provides body continued access ‘ fuel ’ long supply lasts release glucose bloodstream mcbride hardie 2009 glucose transporters proteins mediate entry glucose across cell membranes blood brain barrier bbb eg simpson et al 1999 thorens mueckler 2010 cellular respiration results production atp cell mitochondria korla mitra 2014 process also releases h2o co2 cellular respiration starts glycolysis transformation glucose pyruvate acetylcoenzymea acetylcoa availability nicotinamide adenine dinucleotide important requirement continues krebs cycle ends oxidative phosphorylation – involving electron transport chain etc chemiosmosis zhao et al 2019 energy necessary cell notably hydrolysis binding h2o atp atp converted adenosine diphosphate adp one phosphate consumed energy yadav et al 2017 occur adp leading adenosine monophosphate amp one phosphate ratios adpatp ampatp thus indicators energy requirements cell yadav et al 2017 hydrolysis triglycerides occurs adpatp ampatp ratios high results synthesis fatty acids converted ketone bodies oxidation fuel cells gtok metabolic switching martínezreyes chandel 2020 mattson et al 2018 newman verdin 2017 energy expenditure eg exercise increases ros organism et al 2016 major contributor ros slippage electrons etc mitochondria mazat devin ransac 2020 shofield schafer 2021 zhao et al 2019 proton slippage partially downregulated uncoupling proteins ucps demine et al 2019 haas barnstable 2021 holmström finkel 2014 discuss sources ros processes ros generation role antioxidants ros inhibitors reviewed brieger et al 2012 oxidative stress ensues elevated production ros coupled insufficient availability antioxidants ros imbalance aon et al 2010 shofield schafer 2021 “ signaling molecules ros play important role cell proliferation hypoxia adaptation cell fate determination excessive ros cause irreversible cell damage even cell death ” zhao et al 2019 p 3 oxidative stress generally also lead negative consequences murphy 2009 di meo et al 2016 shofield schafer 2021 zeliger 2013 discusses diseases linked oxidative stress comorbidity prevention well oxidative stress index questionnaire permits assess potential future onset noncommunitive chronic diseases list environmental sources ros moderate ros ideal endocrine immune cognitive functions brieger et al 2012 thus low high ros related metabolic disfunctions diseases brieger et al 2012 importantly elevated ros associated range neurodegenerative diseases singh et al 2019 dunn et al 2015 present antimicrobial function ros holmström finkel 2014 discuss redox signaling chun et al 2010 discuss antioxidant intake americans several sources high ampatp ratio high ros sensed 5 ’ adenosine monophosphateactivated protein kinase ampk trigger signaling eg hinchy et al 2018 rabinovitch et al 2017 different protective mechanisms thereby indirectly activated increased ros involve sirts peroxisome proliferatoractivated receptorγ coactivator pgc1α mammalian target rapamycin mtor unc51 like autophagy activating kinase 1 ulk1 transcription factors forkhead box foxo p53 promyelocytic leukemia pml sensor ros ros sensed activates p53 niwakawakita et al 2017 p53 inhibitor cell growth propagation involved tumor suppression aubrey et al 2018 budanov karin 2009 involved neuroprotection regulating neuronal apoptosis culmsee mattson 2005 maornof et al 2021 note p53 linked neurodegeneration nucleotides metabolites neurotrophic factors nicotinamide adenine dinucleotide nad involved dna repair mitophagy process recycling nonessential damaged mitochondria schofield schafer 2021 required sirt1 activation chen et al 2020 fang bohr 2017 nad participates glycolysis reduced nadh process navas carnero 2020 ying 2006 mentioned high level ros important threat mitochondrial cellular integrity increased nad upregulate immunity inflammation dna repair activation nad dependent enzymes sirts poly adpribose polymerases parps navas carnero 2020 xie et al 2020 ying 2006 although reported nad acts proinflammatory cytokine eg navas carnero 2020 xie et al 2020 also shown nad precursors regulate chronic inflammation reduce ros thereby inflammation covarrubias et al 2021 xie et al 2020 nad also modulates effect different enzymes facilitates energy metabolism helps synchronization circadian clock xie et al 2020 nad nadh also play important roles cell survival death ying 2006 including role adpribosylation li et al 2022 lüscher et al 2021 aging related nad deficiency deficiency related accelerated aging eg increased mitochondrial disfunctions xie et al 2020 constitutes vicious circle – thwarted instance supplementation nad precursors bonkowski sinclair 2016 upregulation ampk signaling exercise richter hargreaves 2013 calorie restriction mattson arumugam 2018 consequences include disturbed circadian rhythms increased inflammation poor immunity hampered dna repair increased risk cancer aggravated high levels ros navas carnero 2020 xie et al 2020 three pathways play synthesis nad de novo preisshandler salvage pathways lautrup et al 2019 xie et al 2020 ying 2006 synthesis nad de novo pathway neuroprotective neurotoxic effects lautrup et al 2019 “ starts catabolism amino acid tryptophan converted via two steps intermediate kynurenine generate nad kynurenic acid xanthurenic acid ” lautrup et al 2019 p 630 nad synthesized nicotinic acid na preisshandler pathway nicotinamide riboside nr reuse nicotinamide nam salvage pathway lautrup et al 2019 xie et al 2020 ying 2006 preisshandler salvage pathways rely upon intermediary synthesis nicotinic acid mononucleotide namn lautrup et al 2019 xie et al 2020 ying 2006 worth noting “ atp may consumed replete nad nad selectively depleted enzymes parp1 vice versa nad may also consumed regenerate atp pathological conditions atp selectively depleted ” ying 2006 therapeutic potential nicotinamide riboside supplementation examined mehmel et al 2020 ketone bodies fatty acids synthesized hydrolysis triglycerides glucose lacking instance following eic converted three ketone bodies βhydroxybutyrate bhb acetone ace acetoacetic acid also referred acetoacetate acac newman verdin 2017 ketone bodies distributed cells organs including brain release blood circulation ketone bodies used alternate fuel sources glucose cell catabolized acetylcoa newman verdin 2017 acetylcoa converted atp result krebs cycle details see martínezreyes chandel 2020 ketone bodies also regulatory roles response oxidative stress cell excitability regulation protein expression signaling generally brain see garcíarodríguez giménezcassina 2021 koppel swerdlow 2018 evidence increases ketone bodies bhb particular result neuroprotection eg kolb et al 2021 bhb transported across bbb monocarboxylic acid transporters mct amount mct regulates bhb brain responsible variety actions newman verdin 2017 briefly mentioned important role bhb upregulation activation nfκb hippocampal expression bdnf case either scarce sufficient glucose supply hu et al 2018 mattson arumugam 2018 words bhb increases bdnf even absence gtok metabolic switching bhb affects sympathetic tone inhibition free fatty acid receptor 3 newman verdin 2017 upregulates gene expression suppresses oxidative stress inhibiting class histone deacetylases hdac newman verdin 2017 shimazu et al 2013 appears bhb capable stimulating pgc1α mitochondrial biogenesis mitophagy foxo1 metabolic regulation reduced sympathetic tone apoptosis santo paik 2018 without ampk modulation phosphoinositide 3kinase – protein kinase b pi3kakt pathway kim et al 2019 activation macrophages bhb nicotinic acid na activate hydroxycarboxylic acid receptor 2 hcar2 induce neuroprotection reduction neuroinflammation also regulates lipid metabolism newman verdin 2017 rahman et al 2014 bhb also involved synaptic plasticity mattson arumugam 2018 gabaergic regulation newman verdin 2017 plays major role cognition health general cavaleri bashar 2018 brain derived neurotrophic factor bdnf bdnf member neurotrophins family main protagonist nspan increased exercise bathina das 2015 kallies et al 2019 zhao et al 2008 neurotrophins family proteins regulate neural function growth survival neuroplasticity various signaling pathways huang reichardt 2001 bathina das 2015 four neurotrophins nerve growth factor ngf neurotrophin3 nt3 neurotrophin4 nt4 bdnf role played bdnf regulating neurophysiological processes modulating synaptic interactions neuroplasticity neuroprotection extensively studied kowiański et al 2018 functions mediated several downstream effectors including trk family tyrosine kinase family receptors foltran diaz 2017 activation tyrosine receptor kinase b trkb kinase promotes signaling along two pathways pi3kakt rafmekerk foltran diaz 2017 examples specific roles bdnf provided research found bdnf increases axonal arborization tyrosine receptor kinase b trkb signaling process regulated phosphitylation mitogenactivated protein kinases mapk cheng et al 2011 jeanneteau et al 2010 trkb involved neural plasticity johnstone mobley 2020 bdnf also increases activation neuronal stathmins cardinaux et al 1997 stathmins induce plasticity generation new neurons development chauvin sobel 2015 notable bdnf also upregulates mtorc1 detrimental action inhibited ampk effect sirt signaling upregulation nad metabolism ishizuka et al 2013 sadria layton 2021 reduced levels bdnf associated neurodegenerative diseases reviews see bathina das 2015 autry monteggia 2012 – mention relation neurotransmitter serotonin body brain bdnf also involved energy homeostasis regulation parasympathetic tone marosi mattson 2014 interventions targeting neurotrophins including bdnf discussed nordvall et al 2022 agonists trkb bdnf explored interventions eg steroid derivatives “ gambogic amide asiaticoside sarcodonin ” p 3 well 78dihydroxy flavone polyphenol see emili et al 2022 several show robust effectiveness questions validity nordvall et al 2022 protein lipid kinases involved nspan kinases enzymes add phosphor group target activated phosphorylation taylor kornev 2011 subsection several protein lipid kinases involved nspan briefly presented main actions effectors summarized table 1 phosphoinositide 3 pi3k cr involved improvement mitochondrial function regulation pi3k effectors lu et al 2019 zhao et al 2022 pi3k dysregulation implicated neurodegenerative diseases ad kumar bansal 2022 associated increased chronic microglia activation following dysregulation chu et al 2021 “ considerable evidence suggests chronically activated microglia continually secrete neurotoxic molecules sustain neuroinflammation ” p 3 pi3k involved regulation autophagy cellular growth survival synaptogenesis notably direct indirect influence akt mtor pi3kaktmtor pathway ersahin et al 2015 erk carracedo pandolfi 2008 chen et al 2013 cuesto et al 2011 rai et al 2019 sadria layton 2021 key activators pi3k include insulininsulin growth factor 1 igf1 tyrosine receptor kinase b trkb bhb foltran diaz 2017 kim et al 2019 sadria layton 2021 pi3k upstream regulator ras bathina das 2015 regulates raf entry point rafmekerk pathway peyssonnaux eychène 2001 pi3k upregulated insulin receptor activation igf1 trkb activity particular foltran diaz 2017 sadria layton 2021 fakhri et al 2021 examine use natural molecules reduce activity pi3kaktmtor signaling pathway history research pi3k provided vanhaesebroeck et al 2012 bibliometric analysis literature pi3k ho hartley 2020 protein kinase b akt akt dysregulation implicated neurodegenerative diseases ad kumar bansal 2022 akt involved neuroprotection several ways downregulation functions proteins responsible apoptosis programmed death deficient cells survival proliferation cells – including autophagy notably neurons regulation neuronal toxicity chen et al 2013 fayad et al 2005 rai et al 2019 examples include downregulation ampk – decrease ampatp ratio upregulation mtor hahnwindgassen et al 2005 fayad et al 2005 mention pathways may also regulate pathways modulated akt akt also phosphorylates foxo tuberous sclerosis complex tsc1 tsc2 important regulators mtor huang et al 2008 sadria layton 2021 regulates antiapoptotic prosurvival extracellular signalregulated kinases erk rai et al 2019 vadlakonda et al 2013 discuss interplay ‘ interactions feedback loops ’ akt mtor mediating role ampk foxo particular insulininsulin growth factor 1 igf1 pathway activates phosphoinositidedependent kinase1 activates akt sadria layton 2021 akt activation also promoted pi3k mtorc2 huang et al 2008 sadria layton 2021 esrahin et al 2015 vadlakonda et al 2013 mammalian target rapamycin mtor mtor related two complexes mtorc1 mtorc2 tsc1tsc2 complex downregulates mtorc1 upregulate mtorc2 huang et al 2008 neurodegenerative diseases potential consequence chronic activation mtorc1 sardia layton 2021 mtor inhibited cr due effect ampk zhao et al 2022 exercise potential increase mtor activation due activation akt “ far increasing mtorc1 activity running high amounts metabolic stress induced endurance exercise decrease mtorc1 activity decrease mtorc1 activity following running may result activation 5′adenosine monophosphate activated protein kinase ampk ” watson baar 2014 p 134 mtor downstream upstream effector akt mtor involved sensing “ nutrient levels presence growth factors cellular energy status mediates several catabolic anabolic processes maintain metabolism cell growth ” ersahin et al 2015 p 1947 specifically mtor participates autophagy recycling cell materials potentially cell death synthesis proteins nucleotides well glucose mitochondrial lipids metabolism chen et al 2013 liu sabatini 2020 szwed et al 2021 mtorc1 activated chronically potentially case severe prolongued acute activation risk cancer increased sadria layton 2021 mtorc1 directly inhibited rapamycin szwed et al 2021 less active amino acids low szwed et al 2021 particular activation results binding arginine cytosolic arginine sensor mtorc1 subunit 1 castor1 budanov karin 2009 chantranupong et al 2016 szwed et al 2021 leucine sesn 2 budanov karin 2009 chen et al 2022b szwed et al 2021 phosphorylation ulk1 ampk downregulates mtorc1 phosphatidylinositol 3kinaseakt pathway upregulates mtorc1 szwed et al 2021 sadria layton 2021 unlike mtorc1 mtorc2 inhibited rapamycin directly szwed et al 2021 pi3k activates mtorc2 sadria layton 2021 mtorc2 promotes akt activation different means huang et al 2008 sadria layton 2021 esrahin et al 2015 caron et al 2010 provide summary upstream downstream effectors mtor bibliometric analysis literature mtor provided li et al 2022 5 ’ adenosine monophosphateactivated protein kinase ampk ampk considered target antiaging approaches aiming neuroprotection including prevention alleviation neurodegenerative diseases eg bayliss et al 2016 primary functions ampk sensing cellular energy eg high ampatp ratio low atp metabolic regulation ensues well regulation mitochondrial ros rabinovitch et al 2017 zhao et al 2019 important functions include subsequent increase decrease oxidized form nicotinamide adenine dinucleotide nad sirtuin1 sirt1 cantó et al 2009 b upregulation pathways consume produce atp cantó et al 2009 c mitochondrial biogenesis cantó et al 2009 neuron cell fate spasić et al 2009 role ampk cellular metabolism eg fatty acid synthesis protein synthesis glycolysis glucose transport endothelial nitride oxide synthase discussed yadav et al 2017 importantly result restoring energy balance cell ampk upregulates pgc1α phosphorizes ulk1 tuberous sclerosis complex tsc 2 thereby suppresses mtor signaling rabinovitch et al 2017 sadria layton 2021 action requires activation protein kinase b akt alessi et al 2006 sirt directly yadav et al 2017 indirectly increasing nad tang et al 2016 ampk serves several functions including among others regulation autophagy karabiyik et al 2021 penugurti et al 2022 addition regulation related energy sensing ampk activity inhibited ulk1 sadria layton 2021 activated cellular stress leptinadiponectin fasting exercise chen et al 2022a hinchy et al 2018 richter hargreaves 2013 richter hargreaves 2013 yadav et al 2017 p53 activates ampk sestrin sesn 1 sesn 2 budanov karin 2009 sesns stress sensing proteins participate cellular homeostasis regulation ampk mtor play essential role disease prevention chen et al 2022b p53 activated well tumour suppressor serine–threonine kinase liver kinase b1 lkb1 alessi et al 2006 shackelford shaw 2009 also required ampk downregulation mtor signaling shaw et al 2004 bibliometric analysis literature ampk provided lyu et al 2022 gylcogen synthase kinase3β gsk3β neurotrophic actions gsk3β mainy related role regulation synaptic plasticity synaptogenesis neuronal proliferation migration cuesto et al 2015 jaworski et al 2019 gsk3β also involved cell survival proliferation metabolism neuronal function jaworski et al 2019 gsk3β plays important role regulation circadian rhythms activation inactivation nuclear factor erythroid 2related factor 2 nrf2 also activated oxidative stress shilovsky et al 2021 nrf2 upregulates stress adaptation inhibition inflammatory processes ros reduction shilovsky et al 2021 dysregulation gsk3β implications neurodegenerative diseases major depression jaworksi et al 2019 gsk3β downregulated phosphorylation eg akt activated dephosphorization eg serinethreonine protein phosphatase 1 jaworski et al 2019 igf1 upregulates pi3k akt downregulates gsk3β duarte et al 2008 mutations along several pathways pi3k hedgehog notch wnt related alterations gsk3β activity mccubrey et al 2016 gsk3β phosphorylates βcatenin hermida et al 2017 essential canonical actions wnt arredondo et al 2020 unc51 like autophagy activating kinase ulk ulk complex composed ulk1 ulk2 ulk1 involved autophagy recycling cell materials conditions cellular stress affect functioning cells survival death nie et al 2016 ulk complex also involved mitophagy quality control process mitochondria functions “ degradation damaged superfluous mitochondria prevention detrimental effects ros mitochondrial disfunction reinstation cellular homeostasis response stress ” chen et al 2020 p 1 disfunctions autophagy mitophagy importantly linked neurodegenerative disorders eg chen et al 2020 ulk upregulated ampk inhibited mtor sadria layton 2021 yu et al 2021 mitogenactivated protein kinases mapk signal cascades mapk signal cascades play essential role expression genes immunity cell differentiation proliferation also involved regulating neuronal inflammation axon arborization ersahin et al 2015 peyssonnaux eychène 2001 wancket et al 2012 among important signal cascade rafmekerk pathway peyssonnaux eychène 2001 rafmekerk also involved cellular apoptosis thereby regulates cell survival peyssonnaux eychène 2001 signaling pathway complementary pi3kaktmtor pathway ersahin et al 2015 however “ mapks implicated pathogenesis many conditions ” wancket et al 2012 p 244 mapk phosphatases mkps downregulate mapks mapks increase activity mkps wancket et al 2012 feedback loop allows beneficial functions mapks achieved keeping activity control ras raf indirectly upregulated pi3k leading activation mapks eg erk peyssonnaux eychène 2001 “ one hand hypoglycemia eg achieved eic decreases anabolic hormones eg insulin gh igf1 well sex thyroid hormones increases expression catabolic cortisol subsequently inhibits mapk pathway ie rasrafmekerk pi3kaktmtor pathway hand inhibition erk avoids mtor activation subsequently induces autophagy activity contributes suppression inflammation downregulation ifn ie interferons proinflammatory cytokine responses ” kökten et al 2021 p 1561 signaling proteins involved nspan signaling proteins play important role nspan presented main actions summarized table 1 peroxisome proliferatoractivated receptorγ coactivator pgc1α exercise calorie restriction intermittent fasting well exposure cold temperature upregulates pgc1α anderson prolla 2009 chen et al 2022a vernier giguère 2021 pgc1α plays major role reducing oxidative stress inflammation regulating mitochondrial biogenesis mitophagy riuspérez et al 2020 tang et al 2016 also involved fatty acid oxidation glucogenesis energy metabolism regulation krebs cycle atp production riuspérez et al 2020 “ dysregulation pgc1α alters redox homeostasis cells exacerbates inflammatory response commonly accompanied metabolic disturbances ” riuspérez et al 2020 p 1 dysregulation pgc1α accrues aging antiaging intervention documented target pgc1α limit impact mitochondrial decline including nervous system anderson prolla 2009 vernier giguère 2021 pgc1α mainly regulated ampk positively akt negatively glycogen synthase kinase 3β gsk3β negatively chen et al 2022a riuspérez et al 2020 well indirectly sirt cantó et al 2013 bhb upregulate pgc1α kim et al 2019 nuclear factor κb nfκb moderate exercise might inhibit nfκb resistance exercise activates liu et al 2018 vella et al 2012 nfκb important regulator cell cycle thereby affecting cell fate immunity inflammation liu et al 2017 mattson arumugam 2018 functions nfκb relevant neurodegeneration yu et al 2020b particular nfκb chronic activation implicated pejoration symptoms alzheimer ’ disease neuroinflammation – risk factor neurodegenerative diseases depression capece et al 2022 dolatschahi et al 2021 nfκb involved contradictory functions cell survival neurodegeneration minchevatasheva et al 2013 “ stimulus produces opposite responses activating nfκb different cell types ” p 187 upstream effectors nfκb lactate succinate bhb unsaturated fatty acids complete list provided capece et al 2022 nfκb also indirectly activated ros liu et al 2017 sirtuins sirt sirts class histone deacetylases carafa et al 2016 “ seven members family enzymes considered potential targets treatment human pathologies including neurodegenerative diseases cardiovascular diseases cancer ” carafa et al 2016 p 1 availability nad required activation 7 sirts cantó et al 2009 tang et al 2016 elkhwanky hakkola 2018 fagerli et al 2022 requirement fulfills energy sensing functions thereby sirts optimally respond cellular energy requirements elkhwanky hakkola 2018 sirt1 sirt6 sirt7 present cell nucleus whereas sirt2 present cytosol sirt3 sirt4 sirt5 present mitochondria elkhwanky hakkola 2018 fargeli et al 2022 morris 2013 focus aging yamamoto et al 2007 addresses detail functions sirts notably gluconeogenesis lipid metabolism mitochondrial respiration cellular proliferation differentiation cell cycle control gene expression apoptosis inflammation insulin secretion neuroprotection axonal protection dna repair elkhwanky hakkola 2018 discuss important role extranuclear sirts sirt1 activity particular associated increased longevity details see tang et al 2016 focus research sirts follows activity sirts discussed general terms signaling sirts especially complex would require much space see cantó et al 2009 2013 tang et al 2016 elkhwanky hakkola 2018 fagerli et al 2022 specific mentions sirt signaling found sections increased activity sirts eg ampk indirectly exercise cr crms eg chen et al 2022a related energy homeostasis eg regulation krebs cycle oxidative phosphorylation triggering glucose uptake fatty acid oxidation ketogenesis mitochondrial homeostasis integrity notably reduction ros dna repair activation parps see nspan regulation synaptic plasticity mitochondrial biogenesis neurons importantly reduction ros elkhwanky hakkola 2018 fagerli et al 2022 functions sirts indirectly involved rely upon adpribosylation signaling see parps play major role hottiger 2015 higher risk neurodegenerative diseases ensues decreased activity sirts mitochondrial cardiovascular diseases neurodegenerative diseases elkhwanky hakkola 2018 et al 2022 jiao gong 2020 importantly sirts activate lkb1 turn activate ampk downregulate mtor sadria layton 2021 shaw et al 2004 woods et al 2003 regulate pgc1α cantó et al 2013 modulation sirts instance using resveratrol among sirt activators promising prevention treatment target neurodegenerative disorders cancer cao et al 2018 carafa et al 2016 leite et al 2021 discuss relevance targeting sirts pharmacologically prevention treatment neurodegenerative disorders particular fang et al 2019 discuss role sirts regulation stem cells sonic hedgehog shh recurrent finding signaling pathways essential brain development also active neurogenesis synaptic plasticity yao et al 2016 demonstrably case hedgehog dependent pathways particular dependent upon shh yao et al 2016 particular shh active brain development also maintenance proliferation neural stem cells adult brain carballo et al 2018 schwarz el al 2012 action shh neurogenesis appears regulated primary cilia hippocampal neurons breunig et al 2008 shh also participates axon regeneration see bibliometric analysis chou et al 2022 interplay notch shh pathways notch signalling potentiates cell proliferative effect shh recurrent finding recent years yao et al 2016 crosstalk shh wnt also documented carballo et al 2018 dysfunctions shh signalling present neurodegenerative diseases metabolic disorders depression garg et al 2022 tayyab et al 2017 yao et al 2016 notch increased notch signalling observed following intermittent fasting exercise baik et al 2020 brandt et al 2010 development notchdependant pathways ensure neural stem cells maintenance developing brain ehm et al 2010 notch signaling pathway also plays important role regulation plasticity neural stem cells neural progenitor cells several niches adult brain bagherimohammni 2022 brandt et al 2010 ehm et al 2010 disfunctions notch signaling present ad neurodegenerative diseases ables et al 2011 notch master regulator neuronal life cycle synaptic plasticity ables et al 2011 “ notch signaling deeply participates development homeostasis multiple tissues organs ” zhou et al 2022 p 1 transcriptional activation known way notch activity enhanced protein activation also possible ‘ noncanonical ’ signalling ables et al 2011 precursors notch receptors generated transcription translation endoplasmic reticulum undergo maturation golgi apparatus zhou et al 2022 inhibition gsk3 pi3kakt increases activity notch notch signalling enhance activity hedgehog pathway including ssh ligand jacobs huang 2020 hedgehog pathway also regulates notch signaling jacobs huang 2020 notch activity carcinogenic anticarinogenic zhou et al 2022 wnt wnt pathways also important neurotrophic activity including adult neurogenesis arredondo et al 2020 alkailani et al 2022 “ wnt signaling pathway plays multiple roles adult hippocampal neurogenesis including regulation proliferation fatecommitment maturation adultborn neurons ” arredondo et al 2022 p 636 wntbcatenin pathway potentiated ampk gsk3β phosphorilate βcatenin hermida et al 2017 zhao et al 2010 wnt also plays major role differentiation neuronal precursor cells arredondo et al 2020 general blockade wnt almost completely impedes neurogenesis arredondo et al 2020 neural cell proliferation differentiation results autophagy regulated wnt lorzadeh et al 2021 wnt also participates presynaptic differentiation eg remodeling axon synapse button presynaptic post synaptic assembly cns particularly hippocampus well regulation distribution synapses salinas et al 2013 wnt also participates axon regeneration chou et al 2022 mentioned deficient wnt signaling linked brain tumor genesis alkailani et al 2022 others found increased wnt signaling due high glucose might responsible link diabetes cancer garcíagiménez et al 2014 wnt reported activate mtor gsk3 inhibition promotes cell growth inoki et al2006 association wnt signaling carcinogenesis thus remains clarified wnt activity inhibited notch mtor acar et al 2021 zeng et al 2018 bibliometric analysis wnt provided xu et al 2021 poly adpribose polymerases parps parps participate antiaging functions promotion chromosome integrity metabolic cell cycle regulation inflammation protein expression rna transcription processing bai 2015 cantó et al 2013 epigenetic alterations parp activities linked neurodegenerative diseases agingrelated diseases due genomic instability amorim et al 2022 mao zhang 2022 eic modulator activity parps ’ souza et al 2017 hofer et al 2022 adpribosylation reversible posttranslational modification proteins function substrate altered li et al 2022 lüscher et al 2021 adpribosylation plays important role neurodevelopment signal transduction maintenance dna integrity rna expression well neuron cell fate conditions cellular stress li et al 2022 lüscher et al 2021 li et al 2022 detail process adpribosylation functioning regulating physiological pathological processes including roles different molecules writers eg nad parps readers eg parps histones erasers eg macrodomaincontaining proteins adpribosylation parps play major role adpribosylation cantó et al 2013 lüscher et al 2021 17 parps detailed see bai 2015 except mention adpribosylation signaling mainly regulated parp1 lesser extent parps cantó et al 2013 lüscher et al 2021 parps activated following dna damage xie et al 2020 indeed important function parps dna repair particularly cellular stress cantó et al 2013 also involved regulation gene expression immune cell maturation influence energy metabolism response inflammation bai 2015 cantó et al 2013 chronic activity parps induce nad depletion result shutdown mitochondrial function glycolytic slowdown reduction nad availability processes activation sirts elevated parp activation ros increase lead several diseases affecting major organs bai 2015 cantó et al 2013 including increased tumor growth therefore parp inhibitors actively researched li et al 2022 table 1 several signaling proteins involved nspan effector type main actions pi3k lipid kinases cell proliferation autophagy synaptogenesis akt protein kinases cell proliferation apoptosis insulin signaling protein synthesis mtor protein kinases cell proliferation protein synthesis autophagy immune function ampk protein kinases cellular metabolism nutrient sensing gsk3β protein kinases glycogen metabolism cell cycle regulation cell division gene transcription insulin signaling ulk protein kinases autophagy mitophagy mapk protein kinases cell proliferation differentiation immune responses inflammation axon arborization pgc1alpha transcription coactivators regulation oxidative stress inflammation mitochondrial biogenesis mitophagy nfκb transcription factor metabolism immunity inflammation protein synthesis cell survival response tumor microenvironment sirtuins protein deacetylases gluconeogenesis lipid metabolism mitochondrial respiration cell cycle control gene expression apoptosis inflammation insulin secretion neuroprotection axonal protection dna repair notch transmembrane proteins cell fate development differentiation regulation plasticity neural stem cells sonic hedgehog morphogens cell proliferation differentiation brain development neural stem cell maintenance proliferation wnt endoplasmic reticulum proteins cell proliferation differentiation survival differentiation neuronal precursor cells presynaptic postsynaptic assembly parps nuclear enzymes transcriptional regulation dna repair cell survival death note table created help gpt35 content thoroughly verified c presentation annotated bibliography subsection focusing exercise following literature reviews summarized radak et al 2007 focused role exercise regulating ros brain discussed implications regards neuroprotection powers et al 2020 described exercise producer ros cause oxidative stress – mentioning hormesis hypothesis experience mild stress prepares neurons tissues important stressors walsh et al 2020 focused link exercise bdnf well cognition reddy et al 2022 discussed cellular processes involved exerciseinduced neuroregulation chow et al 2022 focused exerkines ’ health implications including cognitive decline mattson arumugam 2018 discussed epigenetic changes leading mitochondrial disfunctions eg decreased nadnadh ratio leading decreased sirt signaling alleviating role exercise lucassen et al 2010 focused neuroprotective role exercise sleep well deteriorating effects stress inflammation section following literature reviews summarized mattson et al 2018 focused importance intermittent metabolic switching involved cr nspan neurodegenerative danger lifestyles without opportunities intermittent metabolic switching seidler barrow 2022 examined role bdnf relation cognitive function cherif et al 2016 examined cr ramadan fasting relation cognitive function – mentioning upregulation wang et al 2020 focused influence inflammatory markers – related nspan section cr literature reviews follow summarized almendarizpalacios et al 2020 – updated review focused signaling pathways involved reduced cellular aging stemming cr relevant aspects summarized subsection crms relevant aspects summarized next subsection ntsapi loos 2016 focused regulation autophagy means different cycle durations cr distinguishing macroautophagy starting 30 minutes glucose depletion microautophagy cma starting 10 hours glucose depletion – cma targeted forms autophagy de mello et al 2019 focused triumvirate insulin autophagy neurodegeneration – examining signaling pathways involved maharajan et al 2020 discusses regulation stem cells aging stem cell niches means cr – focus signaling pathways zhang et al 2021 focused optimization brain extracellular microenvironment cr role towards neuroprotection yu et al 2020b examined restauration maintenance cognitive function cr section crms literature reviews follow summarized almendarizpalacios et al 2020 – summary continues bonkowski sinclair 2016 explained use nad precursors sirts activators relation disease prevention – including neurodegeneration longevity focus signaling pathways isde et al 2020 focused activation sirt1 particular phytochemicals crms included hofer et al 2021 examined clinical trials focusing crms discusses list crms available nutrition moosavi et al 2016 focused neurotrophic actions polyphenols discussing nspan oluwole et al 2022 detailed role different polyphenol subclasses tannins phenolic acid lignans flavonoids stilbenes health including main outcomes interest rendeiro et al 2015 examined effect direct indirect flavonoids alleviating neurodegeneration particular zhan et al 2021 focused preclinical uses resveratrol addressing neuroprotection antiinflammatory effect moradi et al 2022 focused mechanisms neuronal regeneration following polyphenol intake addressing ros scavenging reduced betaamyloid accumulation regulation apoptosis gene expression grewal et al 2021 detailed mechanisms neuroprotection afforded quercetin implications regarding neurodegenerative diseases ravula et al 2021 provided updated literature review prospects treatment neurodegenerative disorders offered fisetin subsection nutrients inducing neurotrophic effects summaries following reviews provided hebergen 2016 examined role n3 polyunsaturated fatty acids polyphenols promotion adult neurogenesis carneiro et al 2021 provided updated systematic literature review neuroprotective effects coffee focusing several compounds chen et al 2010 addressed protective role caffeine bbb specifically cui et al 2017 focused role vitamin brain development neuroprotection immunity distinguishing genomic nongenomic actions discussion first pages contribution section firstly literature promotion nspan eic crms briefly presented question gtok metabolic switch addressed ktog metabolic switching mentioned made clear repetition cycles affords health benefits “ repeating cycles metabolic challenge induces ketosis fasting andor exercise followed recovery period eating resting sleeping may optimize brain function resilience throughout lifespan ” mattson et al 2018 p 81 thus section b glucose metabolism expenditure well oxidative stress discussed latter result cellular respiration electron slippage etc leading increase ros introduction continued review main nucleotides atp adp amp metabolites nad nadh bhb neurotrophic factors primarily bdnf well protein kinases signaling proteins involved pi3k akt mtor ampk gsk3β ulk mapk pgc1α nfκb sirtuinsas well notch shh wnt selected signaling pathways focus neurogenesis neuroprotection important functions involved discussed eg regulation energy metabolism oxidative stress inflammation immune function apoptosis autophagy gene expression protein synthesis well tumor suppression since beyond primary role functions support main outcomes interest beckervordersandforth 2017 discuss role mitochondrial metabolism adult neurogenesis guo et al 2022 review literature aging general terms related diseases interventions carrasco et al 2022 mittelbrunn kroemer 2021 examine role cells neurodegenerative diseases among others health consequences related inflammaging section c selective list reviews interest included summary provided appendix selection reviews organized five subsections covering relation neuroprotection andor neurogenesis exercise cr crms well nutrients inducing neurotrophic effects aim subsection provided overall general overview benefits topic eg cr relation neuroprotection neurogenesis summarized literature review adding specific aspects goal implications healthy individuals policy pharmacological cognitive enhancement pce yet mentioned per se contribution improving maintaining nspan requires months years pce usually focuses hope rapid gains particularly relied upon students pressured professionals franke lieb 2013 mayor et al 2020 users pce rely upon pharmacological solutions eg methylphenidate adderall modafinil generally deviating inteded use medications rely upon illicit drugs attitude public towards pce generally rather negative mayor et al 2019 due conception pce focusing short term performance school workplace considered artificial therefore unfair undeserved faber et al 2016 adoption nspan focus individual health collective welfare rather achievement might acceptable public ’ connor joffe 2015 instance indicated individuals tolerant ce aim compensate cognitive deficiency maintenance healthy brain function might even true periods collective challenges covid19 pandemic massell et al 2022 mayor et al 2022a 2022b importance greater good might paramount regulation pce important consideration government policy aims tackle task balancing benefits risks negligible case pce usually conceived ie focus neurotransmitters short term functioning brain regions outram racine 2011 advocating favor nspan eic crms might good strategy benefits eg reduced health burden individual collectivity far surpass pce – allowing maintained improved cognitive functioning long run risks inappreciable performed within reason instance exercise source ros bloomer et al 2005 therefore performed excess calorie restriction lead malnutrition studies literature presented main text reviews summarized annotated bibliography exhibited implications eic potential crms towards enhancement nspan including context neurodegenerative diseases notwithstanding focus basic research rodents believed discovered mechanisms present humans well relate functioning eukaryotic cell largely conserved mammals mattson et al 2018 whether adult neurogenesis exists human remains definitely established denothlippuner jessberger 2021 majority cases studies compare effect regulation different signaling pathways nspan often effect exercise calorie restriction intermittent fasting calorie restriction mimetics compared either thus remains unclear intervention appropriate achieve improved nspan best case matter judgement researcher signaling pathway might operate opposite directions relation nspan instance activation nfκb linked neuroprotective neurodegenerative actions capece et al 2022 minchevatasheva et al 2013 might related decreased risk depression upregulation bdnf nfκb also related increased neuroinflammation risk factor depression roy et al 2023 also unclear whether heightened activation wnt beneficial overall involved carcinogenesis carcinoprevention garcíagiménez et al 2014 inoki et al 2006 another example sirt6 elevated chronically exercised individuals performs protective pejorative actions relation cancer song et al 2022 yang et al 2020 recommendations regards nspan consider effect important protective pejorative regards different pathways regulated eic crm establishing minimal optimal thresholds across modalities studies investigate doseresponse robust effect sizes areas compare across modalities eiccrm signaling pathways prerequisite setting thresholds recommendations regards eic crm elements infrequently reported literature reviews see lucassen et al 2010 absent large majority studies field examples exceptions walsch et al 2020 mention 30 minutes exercise necessary significant changes bdnf occur whereas study related field moore et al 2020 note blood glucose affected single short bouts exercise doseresponse manner benefits starting one minute follows target duration exercise depends parameter one wishes increase information aspects reliability estimates frequently lacking literature li et al 2023 research could also compare relation doseresponse effect sizes studies focusing eic crms ketogenic diets show promise prevention ad eg neth et al 2020 comparison effect eic crms different signaling pathways modalities eiccrm ideally performed within study minimize risk differences effects due methodological differences studies review sharman et al 2019 human trials focusing phytocomponents treatment alzheimer ’ patients successful also noted sample size sufficient detect small moderate improvement adequate power instance sample size 128 least twotailed test difference symptoms two balanced independent groups cohen 05 medium effect size statistical power 08 calculated gpower 3 p value 005 minimal required sample size achieve relevant power studies fail detect desired effect size use metaanalyses well implanted field examples pillon et al 2020 wang et al 2020 mentioned increased reliance upon metaanalyses could provide precious information aspects use precluded heterogeneity existing studies lack reporting effect sizes melsen et al 2014 important element determination minimum optimal thresholds adoption eic crm modalities humans eg kelly et al 2020 rendeiro et al 2015 yu et al 2020a possible find reliable reproducible means targeting ideal quantities individual needs hallmark precision medicine wang et al 2023 importantly needs members specific groups considered future research clarify whether eic crm play important role targeted metabolic reprogramming already successfully used treatment cancer might beneficial regards nspan elsahli wang 2020 mela et al 2020 pateras et al 2023 wang et al 2022b also entails ideally setting objectives realistic expected improvements prior running research programs studies relying upon massspectrometry nuclear magnetic resonance potential highlight value eic crms terms nspan might help identifying additional signaling metabolites effectors affected eic crms could investigated detail second step massspectrometry nuclear magnetic resonance uncommonly used related research questions baker rutter 2023 kelly et al 2020 kristal et al 2017 luan et al 2017 timing important signal transduction also within cell processes unfold time uninterrupted successions events koseska bastiaens 2017 overwhelming majority studies examine effect eic crms single timepoint blurring complexity orchestration events live cell imaging potential determining distinctions signaling dynamics crosstalk different pathways valls esposito 2022 starved cells high availability nutrients conclusion review annotated bibliography synthesized recent efforts understanding mechanisms eic crms afford enhanced nspan mentioned benefits different approaches terms enhancement nspan well explanations pathways mechanisms goal achieved highlighted potential eic crms healthier aging acknowledgements table 1 prepared help gpt35 thoroughly checked addition gpt35 gpt4 used support ideation revised version manuscript discussion except elements table 1 content written generative pretrained transformers included submission references ables j l breunig j j eisch j rakic p 2011 ch development notch signalling adult brain nature reviews neuroscience 12 269283 httpsdoiorg101038nrn3024 abraham w c 2008 metaplasticity tuning synapses networks plasticity nature reviews 9 387399 httpsdoiorg101038nrn2356 acar hidalgosastre leverentz k mills c g woodcock baron collu g brennan k 2021 inhibition wnt signalling notch via two distinct mechanisms scientific reports 11 112 httpsdoiorg101038s41598021886185 american college sports medicine 2013 acsms guidelines exercise testing prescription new yort lippincott williams wilkins albani polito l signorini forloni g 2010 neuroprotective properties resveratrol different neurodegenerative disorders biofactors 36 370376 httpsdoiorg101002biof118 alessi r sakamoto k bayascas j r 2006 lkb1dependent signaling pathways annual review biochemistry 75 137163 httpsdoiorg101146 annurevbiochem75103004142702 alkailani aittaleb tissir f 2022 wnt signaling intersection neurogenesis brain tumorigenesis frontiers molecular neuroscience 15 1017568 httpsdoiorg103389fnmol20221017568 almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 httpsdoiorg103390ijms21239220 aman schmauckmedina hansen morimoto r simon k bjedov fang e f 2021 autophagy healthy aging disease nature aging 1 634650 httpsdoiorg101038s43587021000984 amorim j coppotelli g rolo p palmeira c ross j sinclair 2022 mitochondrial metabolic dysfunction ageing agerelated diseases nature reviews endocrinology 18 243258 httpsdoiorg101038 s41574021006267 anacker c hen r 2017 adult hippocampal neurogenesis cognitive flexibility — linking memory mood nature reviews neuroscience 18 335–346 httpsdoiorg101038nrn201745 anderson r prolla 2009 pgc1α aging antiaging interventions biochimica et biophysica acta bbageneral subjects 1790 10591066 httpsdoiorg101016jbbagen200904005 aon cortassa orourke b 2010 redoxoptimized ros balance unifying hypothesis biochimica et biophysica acta bbabioenergetics 1797 865877 httpsdoiorg101016jbbabio201002016 arredondo sb valenzuelabezanilla mardones md varelanallar l 2020 role wnt signaling adult hippocampal neurogenesis health disease frontiers cell developmental biology 8860 httpsdoiorg103389fcell202000860 arredondo b valenzuelabezanilla santibanez h varelanallar l 2022 wnt signaling adult hippocampal neurogenic niche stem cells 40 630640 httpsdoiorg101093stmclssxac027 aubrey b j kelly g l janic herold j strasser a2018 p53 induce apoptosis relate p53mediated tumour suppression cell death differentiation 25 104113 httpsdoiorg101038cdd2017169 autry e monteggia l 2012 brainderived neurotrophic factor neuropsychiatric disorders pharmacological reviews 64 238–258 httpsdoiorg101124pr111005108 bagherimohammadi 2022 adult neurogenesis molecular signalling pathways brain role stem cells adult hippocampal neurogenesis international journal neuroscience 132 11651177 httpsdoiorg1010800020745420201865953 bai p 2015 biology polyadpribose polymerases factotums cell maintenance molecular cell 58 947–958 httpsdoiorg101016jmolcel201501034 baik rajeev v fann jo arumugam v 2020 intermittent fasting increases adult hippocampal neurogenesis brain behavior 10 e01444 httpsdoiorg101002brb31444 baker sa rutter j 2023 metabolites signalling molecules nature reviews molecular cell biology advance online publication httpsdoiorg101038s4158002200572w balusu praschberger r lauwers e de strooper b verstreken p 2023 neurodegeneration cell per cell neuron 111 767786 httpsdoiorg101016jneuron202301016 bathina das u n 2015 brainderived neurotrophic factor clinical implications archives medical science 6 1164–1178 httpsdoiorg105114aoms201556342 baur j sinclair 2006 therapeutic potential resveratrol vivo evidence nature reviews drug discovery 5 493506 httpsdoiorg101038nrd2060 bayliss j lemus b stark r santos v v thompson rees j andrews z b 2016 ghrelinampk signaling mediates neuroprotective effects calorie restriction parkinsons disease journal neuroscience 36 30493063 httpsdoiorg101523jneurosci4373152016 beavers k brinkley e nicklas b j 2010 effect exercise training chronic inflammation clinica chimica acta 411 785–793 httpsdoiorg101016jcca201002069 beckervordersandforth r 2017 mitochondrial metabolismmediated regulation adult neurogenesis brain plasticity 3 7387 httpsdoiorg103233bpl170044 berdugovega g ariasgil g lópezfernández artegiani b wasielewska j lee cc lippert kempermann g takagaki k calegari f 2020 increasing neurogenesis refines hippocampal activity rejuvenating navigational learning strategies contextual memory throughout life nature communications 11 135 httpsdoiorg101038s4146701914026z bhaduri trisal singh ak 2023 autophagy promising therapeutic target ageassociated neurodegenerative disorders rizvi si eds emerging antiaging strategies pp 135154 singapore springer httpsdoiorg10100797898119744343 bhoumik yadawa ak srivastava p rizvi si 2023 intermittent fasting antiaging strategy rizvi si eds emerging antiaging strategies pp 191206 singapore springer httpsdoiorg101007978981197443410 blagosklonny v 2019 fasting rapamycin diabetes versus benevolent glucose intolerance cell death disease 10 607 httpsdoiorg101038s4141901918228 bliss v p collingridge g l morris r g reymann k g 2018 longterm potentiation hippocampus discovery mechanisms function neuroforum 24 a103–a120 httpsdoiorg101515nf2017a059 bloom g 2014 amyloidβ tau trigger bullet alzheimer disease pathogenesis jama neurology 71 505508 httpsdoiorg101001jamaneurol20135847 bloomer r j goldfarb h wideman l mckenzie j consitt l 2005 effects acute aerobic anaerobic exercise blood markers oxidative stress journal strength conditioning research 19 276285 doi httpsdoiorg1015190012427820050500000007 bonkowski sinclair 2016 slowing ageing design rise nad sirtuinactivating compounds nature reviews molecular cell biology 17 679–690 httpsdoiorg101038nrm201693 bortner c cidlowski j 2020 ions movement water apoptotic volume decrease frontiers cell developmental biology 8 611211 httpsdoiorg103389fcell202061121 brandt maass kempermann g storch 2010 physical exercise increases notch activity proliferation cell cycle exit type3 progenitor cells adult hippocampal neurogenesis european journal neuroscience 32 12561264 httpsdoiorg101111j14609568201007410x breunig j j sarkisian r arellano j morozov ayoub e sojitra town 2008 primary cilia regulate hippocampal neurogenesis mediating sonic hedgehog signaling proceedings national academy sciences 105 1312713132 httpsdoiorg101073pnas0804558105 brieger k schiavone miller jr krause k 2012 reactive oxygen species health disease swiss medical weekly 142 w13659 httpsdoiorg104414smw201213659 brunet goodell rando 2022 ageing rejuvenation tissue stem cells niches nature reviews molecular cell biology httpsdoiorg101038s4158002200510w budanov v karin 2008 p53 target genes sestrin1 sestrin2 connect genotoxic stress mtor signaling cell 134 451–460 httpsdoiorg101016jcell200806028 buntwal l sassi morgan h andrews z b davies j 2019 ghrelinmediated hippocampal neurogenesis implications health disease trends endocrinology metabolism 30 844–859 httpsdoiorg101016jtem201907001 burtscher j romani bernardo g popa ziviani e hummel f c millet g p 2022 boosting mitochondrial health counteract neurodegeneration progress neurobiology 215 102289 httpsdoiorg101016jpneurobio2022102289 chatam chapnik n froy 2022 resveratrol induces fasting state alters circadian metabolism hepatocytes plant foods human nutrition 77 128–134 httpsdoiorg101007s11130022009547 cao w dou li 2018 resveratrol boosts cognitive function targeting sirt1 neurochemical research 43 17051713 httpsdoiorg101007s1106401825868 cantó c gerharthines z feige j n lagouge noriega l milne j c elliott p j puigserver p auwerx j 2009 ampk regulates energy expenditure modulating nad metabolism sirt1 activity nature 458 1056–1060 httpsdoiorg101038nature07813 cantó c sauve bai p 2013 crosstalk polyadpribose polymerase sirtuin enzymes molecular aspects medicine 34 1168–1201 httpsdoiorg101016jmam201301004 capece verzella flati arboretto p cornice j franzoso g 2022 nfκb blending metabolism immunity inflammation trends immunology 43 757775 httpsdoiorg101016jit202207004 carafa v rotili forgione cuomo f serretiello e hailu g altucci l 2016 sirtuin functions modulation chemistry clinic clinical epigenetics 8 121 httpsdoiorg101186s1314801602243 carballo g b honorato j r de lopes g p de sampaio e spohr c l 2018 highlight sonic hedgehog pathway cell communication signaling 16 115 httpsdoiorg101186s1296401802207 cardinaux j r magistretti p j martin j l 1997 brainderived neurotrophic factor stimulates phosphorylation stathmin cortical neurons molecular brain research 51 220228 httpsdoiorg101016s0169328x97002416 carneiro oliveira b p alves r c 2021 neuroprotective properties coffee update trends food science technology 113 167179 httpsdoiorg101016jtifs202104052 caron e ghosh matsuoka ashtonbeaucage therrien lemieux perreault c roux p p kitano h 2010 comprehensive map mtor signaling network molecular systems biology 6 453 httpsdoiorg101038msb2010108 carosi j sargeant j 2019 rapamycin alzheimer disease doubleedged sword autophagy 15 14601462 httpsdoiorg1010801554862720191615823 carracedo pandolfi p 2008 pten–pi3k pathway feedbacks crosstalks oncogene 27 5527–5541 httpsdoiorg101038onc2008247 carrasco e gómez de las heras gabandérodríguez e desdínmicó g aranda j f mittelbrunn 2022 role cells agerelated diseases nature reviews immunology 22 97111 httpsdoiorg101038s41577021005574 cavaleri f bashar e 2018 potential synergies β hydroxybutyrate butyrate modulation metabolism inflammation cognition general health journal nutrition metabolism 2018 1–13 httpsdoiorg10115520187195760 chabot f caron laplante stpierre h 2014 interrelationships ghrelin insulin glucose homeostasis physiological relevance world journal diabetes 5 328341 httpsdoiorg104239wjdv5i3328 chantranupong l scaria saxton r gygi p shen k wyant g wang harper j w gygi p sabatini 2016 castor proteins arginine sensors mtorc1 pathway cell 165 153–164 httpsdoiorg101016jcell201602035 chauvin sobel 2015 neuronal stathmins family phosphoproteins cooperating neuronal development plasticity regeneration progress neurobiology 126 1–18 httpsdoiorg101016jpneurobio201409002 chen x ghribi geiger j 2010 caffeine protects disruptions bloodbrain barrier animal models alzheimer ’ parkinson ’ diseases journal alzheimer ’ disease 20 s127–s141 httpsdoiorg103233jad20101376 chen xiong lj tong mao 2013 neuroprotective effect brainderived neurotrophic factor mediated autophagy pi3kaktmtor pathway molecular medicine reports 8 1011–1016 httpsdoiorg103892mmr20131628 chen g kroemer g kepp 2020 mitophagy emerging role aging ageassociated diseases frontiers cell developmental biology 8 200 httpsdoiorg103389fcell202000200 chen j zhou r feng cheng l 2022a molecular mechanisms exercise contributing tissue regeneration signal transduction targeted therapy 7 383 httpsdoiorg101038s41392022012332 chen huang yu z et al 2022b functions roles sestrins regulating human diseases cellular molecular biology letters 27 2 httpsdoiorg101186s11658021003028 cheng pl song ah wong yh wang zhang x poo mm 2011 selfamplifying autocrine actions bdnf axon development proceedings national academy sciences 108 18430–18435 httpsdoiorg101073pnas1115907108 cherif roelands b meeusen r chamari k 2016 effects intermittent fasting caloric restriction ramadan intermittent fasting cognitive performance rest exercise adults sports medicine 46 3547 doi 101007s4027901504086 chou nawabi h li j 2022 research hotspots trends axon regeneration 2000–2021 bibliometric study systematic review inflammation regeneration 42 115 httpsdoiorg101186s41232022002444 chow l gerszten r e taylor j pedersen b k van praag h trappe febbraio galis z gao haus j lanza r lavie c j lee ch lucia moro c pandey robbins j stanford k thackray e … snyder p 2022 exerkines health resilience disease nature reviews endocrinology 18 273–289 httpsdoiorg101038s41574022006412 chu e mychasiuk r hibbs l semple b 2021 dysregulated phosphoinositide 3kinase signaling microglia shaping chronic neuroinflammation journal neuroinflammation 18 117 httpsdoiorg101186s12974021023256 chun k floegel chung sj chung c e song w koo 2010 estimation antioxidant intakes diet supplements us adults journal nutrition 140 317–324 httpsdoiorg103945jn109114413 cortes c j de miguel z 2022 precision exercise medicine sex specific differences immune cns responses physical activity brain plasticity 8 6577 httpsdoiorg103233bpl220139 craske mg stein b eley c milad r holmes rapee r wittchen h u 2017 anxiety disorders nature reviews disease primers 3 17024 httpsdoiorg101038nrdp201724 cuesto g enriquezbarreto l carames c cantarero gasull x sandi c ferrus acebes morales 2011 phosphoinositide3kinase activation controls synaptogenesis spinogenesis hippocampal neurons journal neuroscience 31 2721–2733 httpsdoiorg101523jneurosci4477102011 cuesto g jordánálvarez enriquezbarreto l ferrús morales acebes á 2015 gsk3β inhibition promotes synaptogenesis drosophila mammalian neurons plos one 10 e0118475 httpsdoiorg101371journalpone0118475 cui x gooch h petty mcgrath j j eyles 2017 vitamin brain genomic nongenomic actions molecular cellular endocrinology 453 131143 httpsdoiorg101016jmce201705035 culmsee c mattson p 2005 p53 neuronal apoptosis biochemical biophysical research communications 331 761–777 httpsdoiorg101016jbbrc200503149 davies j 2022 ghrelin mediated hippocampal neurogenesis vitamins hormones 118 337–367 httpsdoiorg101016bsvh202112003 de mello n p orellana mazucanti c h de morais lima g scavone c kawamoto e 2019 insulin autophagy neurodegeneration frontiers neuroscience 13 491 httpsdoiorg103389fnins201900491 dos santos mg schimith le andrémiral c et al 2022 neuroprotective effects resveratrol vivo vitro experimental models parkinson ’ disease systematic review neurotoxicity research 40 319–345 httpsdoiorg101007s1264002100450x ’ souza r f markworth j f aasen k zeng n cameronsmith mitchell c j 2017 acute resistance exercise modulates microrna expression profiles combined tissue circulatory targeted analyses plos one 12 e0181594 httpsdoiorg101371journalpone0181594 demine renard arnould 2019 mitochondrial uncoupling key controller biological processes physiology diseases cells 8 795 httpsdoiorg103390cells8080795 denothlippuner jessberger 2021 formation integration new neurons adult hippocampus nature reviews neuroscience 22 223236 httpsdoiorg101038s4158302100433z diano farr benoit c mcnay e c da silva horvath b horvath l 2006 ghrelin controls hippocampal spine synapse density memory performance nature neuroscience 9 381388 httpsdoiorg101038nn1656 di meo reed venditti p victor v 2016 role ros rns sources physiological pathological conditions oxidative medicine cellular longevity 2016 1–44 httpsdoiorg10115520161245049 dolatshahi ranjbar hameghavandi h sabahi rostamkhani 2021 nuclear factorkappa b nfκb pathophysiology parkinson disease diverse patterns mechanisms contributing neurodegeneration european journal neuroscience 54 41014123 httpsdoiorg101111ejn15242 duarte santos p oliveira c r santos rego c 2008 insulin neuroprotection oxidative stress mediated akt gsk3β signaling pathways changes protein expression biochimica et biophysica acta bba molecular cell research 1783 994–1002 httpsdoiorg101016jbbamcr200802016 ehm göritz c covic schäffner schwarz j karaca e lie c 2010 rbpjκdependent signaling essential longterm maintenance neural stem cells adult hippocampus journal neuroscience 30 1379413807 httpsdoiorg101523jneurosci1567102010 elkhwanky ms hakkola j 2018 extranuclear sirtuins metabolic stress antioxidants redox signaling 28 662–676 httpsdoiorg101089ars20177270 elsahli wang l 2020 cancer stem cellassociated pathways metabolic reprogramming breast cancer international journal molecular sciences 21 9125 httpsdoiorg103390ijms21239125 emili guidi uguagliati b giacomini bartesaghi r stagni f 2022 treatment flavonoid 78dihydroxyflavone promising strategy constellation body brain disorders critical reviews food science nutrition 62 13–50 httpsdoiorg1010801040839820201810625 erbaba b arslanergul adams 2021 effects caloric restriction antagonistic integrative hallmarks aging ageing research reviews 66 101228 httpsdoiorg101016jarr2020101228 ersahin tuncbag n cetinatalay r 2015 pi3kaktmtor interactive pathway molecular biosystems 11 1946–1954 httpsdoiorg101039c5mb00101c faber n savulescu j douglas 2016 cognitive enhancement deemed unacceptable role fairness deservingness hollow achievements frontiers psychology 7 232 httpsdoiorg103389fpsyg201600232 fan j dawson dawson v l 2017 cell death mechanisms neurodegeneration p beart robinson rattray n j maragakis eds neurodegenerative diseases pathology mechanisms potential therapeutic targets pp 403425 httpsdoiorg101007978331957193516 fang e f bohr v 2017 nad convergence dna repair mitophagy autophagy 13 442–443 httpsdoiorg1010801554862720161257467 fang tang li x 2019 sirtuins metabolic epigenetic regulation stem cells trends endocrinology metabolism 30 177–188 httpsdoiorg101016jtem201812002 fares j bou diab z nabha fares 2019 neurogenesis adult hippocampus history regulation prospective roles international journal neuroscience 129 598–611 httpsdoiorg1010800020745420181545771 fagerli e escobar ferrier f j jackson c w perezlao e j perezpinzon 2022 sirtuins cognition implications learning memory neurological disorders frontiers physiology 13 908689 https103389fphys2022908689 fayard e tintignac l baudry hemmings b 2005 protein kinase bakt glance journal cell science 118 5675–5678 httpsdoiorg101242jcs02724 fisherwellman k bloomer r j 2009 acute exercise oxidative stress 30 year history dynamic medicine 8 1 httpsdoiorg1011861476591881 foltran r b diaz l 2016 bdnf isoforms round trip ticket neurogenesis serotonin journal neurochemistry 138 204–221 httpsdoiorg101111jnc13658 franke g lieb k 2013 pharmacological neuroenhancement substances epidemiology e hildt g franke cognitive enhancement pp 1727 dordrecht springer frankland p w köhler josselyn 2013 hippocampal neurogenesis forgetting trends neurosciences 36 497–503 httpsdoiorg101016jtins201305002 gahete córdobachacón j kineman r luque r castaño j p 2011 role ghrelin system neuroprotection cognitive functions implications alzheimers disease peptides 32 22252228 httpsdoiorg101016jpeptides201109019 garcíajiménez c garcíamartínez j chocarrocalvo de la vieja 2014 new link diabetes cancer enhanced wntβcatenin signaling high glucose journal molecular endocrinology 52 r51r66 httpsdoiorg101530jme130152 garcíarodríguez giménezcassina 2021 ketone bodies brain beyond fuel metabolism excitability gene expression cell signaling frontiers molecular neuroscience 14 732120 httpsdoiorg103389fnmol2021732120 garg c kaur singh g sharma v k singh k 2022 therapeutic implications sonic hedgehog pathway metabolic disorders novel target effective treatment pharmacological research 179 106194 httpsdoiorg101016jphrs2022106194 gillespie z e pickering j eskiw c h 2016 better living chemistry caloric restriction cr cr mimetics alter genome function promote increased health lifespan frontiers genetics 7 142 httpsdoiorg103389fgene201600142 gomezcabrera c domenech e viña j 2008 moderate exercise antioxidant upregulation antioxidant genes training free radical biology medicine 44 126131 httpsdoiorg101016jfreeradbiomed200702001 gómezpalacioschjetnan escobar l 2013 neurotrophins synaptic plasticity c belzung p wigmore eds neurogenesis neural plasticity pp 117136 berlin springer grewal k singh g sharma sharma v singh rahman md h najda walasekjanusz kamel albadrani g akhtar f saleem abdeldaim 2021 mechanistic insights perspectives involved neuroprotective action quercetin biomedicine pharmacotherapy 140 111729 httpsdoiorg101016jbiopha2021111729 guo j huang x dou l yan shen tang w li j 2022 aging agingrelated diseases molecular mechanisms interventions treatments signal transduction targeted therapy 391 httpsdoiorg101038s41392022012510 van haeringen milaneschi lamers f penninx b w jansen r 2022 dissection depression heterogeneity using proteomic clusters psychological medicine 19 httpsdoiorg101017s0033291721004888 haas r cucchi smith j pucino v macdougall c e mauro c 2016 intermediates metabolism bystanders signalling molecules trends biochemical sciences 41 460–471 httpsdoiorg101016jtibs201602003 hahnwindgassen nogueira v chen cc skeen j e sonenberg n hay n 2005 akt activates mammalian target rapamycin regulating cellular atp level ampk activity journal biological chemistry 280 32081–32089 httpsdoiorg101074jbcm502876200 handschin c 2016 caloric restriction exercise “ mimetics ’ ’ ready prime time pharmacological research 103 158–166 httpsdoiorg101016jphrs201511009 hardie g 2018 keeping home fires burning ampactivated protein kinase journal royal society interface 15 20170774 httpsdoiorg101098rsif20170774 hass barnstable c j 2021 uncoupling proteins mitochondrial defense oxidative stress progress retinal eye research 83 100941 httpsdoiorg101016jpreteyeres2021100941 f li j liu z chuang cc yang w zuo l 2016 redox mechanism reactive oxygen species exercise frontiers physiology 7 httpsdoiorg103389fphys201600486 l wang j yang li j tu h 2022 mitochondrial sirtuins parkinson ’ disease neurochemical research 47 1491–1502 httpsdoiorg101007s1106402203560w heberden c 2016 modulating adult neurogenesis dietary interventions nutrition research reviews 29 163–171 httpsdoiorg101017s0954422416000081 heger 2017 dont discount curcumin trial data nature 543 40 httpsdoiorg101038543040c hermida kumar j leslie n r 2017 gsk3 interactions pi3kaktmtor signalling network advances biological regulation 65 515 httpdoiorg101016jjbior201706003 hinchy e c gruszczyk v willows r navaratnam n hall r bates g bright p krieg carling murphy p 2018 mitochondriaderived ros activate ampactivated protein kinase ampk indirectly journal biological chemistry 293 17208–17217 httpsdoiorg101074jbcra118002579 hofer j davinelli bergmann scapagnini g madeo f 2021 caloric restriction mimetics nutrition clinical trials frontiers nutrition 8 717343 httpsdoiorg103389fnut2021717343 hofer j carmonagutierrez mueller madeo f 2022 ups downs caloric restriction fasting molecular effects clinical application embo molecular medicine 14 e14418 httpsdoiorg1015252emmm202114418 holmström k finkel 2014 cellular mechanisms physiological consequences redoxdependent signalling nature reviews molecular cell biology 15 411–421 httpsdoiorg101038nrm3801 hottiger 2015 snapshot adpribosylation signaling molecular cell 58 11341134e1 httpsdoiorg101016jmolcel201506001 hu e du h zhu x wang l shang wu x lu h lu x 2018 betahydroxybutyrate promotes expression bdnf hippocampal neurons adequate glucose supply neuroscience 386 315–325 httpsdoiorg101016jneuroscience201806036 huang j dibble c c matsuzaki manning b 2008 tsc1tsc2 complex required proper activation mtor complex 2 molecular cellular biology 28 4104–4115 httpsdoiorg101128mcb0028908 igwe sone matveychuk baker g b dursun 2021 review effects calorie restriction fasting potential relevance depression progress neuropsychopharmacology biological psychiatry 111 110206 httpsdoiorg101016jpnpbp2020110206 inoki k ouyang h zhu lindvall c wang zhang x yang q bennet c harada stankunas k wang c xi h macdougald williams b guan kl 2006 tsc2 integrates wnt energy signals via coordinated phosphorylation ampk gsk3 regulate cell growth cell 126 955968 httpsdoiorg101016jcell200606055 ishizuka kakiya n witters l oshiro n shirao nawa h takei n 2013 ampactivated protein kinase counteracts brainderived neurotrophic factorinduced mammalian target rapamycin complex 1 signaling neurons journal neurochemistry 127 6677 httpsdoiorg101111jnc12362 iside c scafuro nebbioso altucci l 2020 sirt1 activation natural phytochemicals overview frontiers pharmacology 11 1225 jacobs c huang p 2021 complex crosstalk notch hedgehog signalling development central nervous system cellular molecular life sciences 78 635644 httpsdoiorg101007s00018020036273 jaworski banachkasper e gralec k 2019 gsk3 β intersection neuronal plasticity neurodegeneration neural plasticity 1–14 httpsdoiorg10115520194209475 jeanneteau f deinhardt k miyoshi g bennett chao v 2010 map kinase phosphatase mkp1 regulates bdnfinduced axon branching nature neuroscience 13 1373–1379 httpsdoiorg101038nn2655 jiao f gong z 2020 beneficial roles sirt1 neuroinflammationrelated diseases oxidative medicine cellular longevity 2020 1–19 httpsdoiorg10115520206782872 johnstone mobley w 2020 local trkb signaling themes development neural plasticity cell tissue research 382 101–111 httpsdoiorg101007s00441020032787 kaeberlein 2010 resveratrol rapamycin antiaging drugs bioessays 32 9699 httpsdoiorg101002bies200900171 kallies g rapp fydrich fehm l tschorn terán c heissel 2019 serum brainderived neurotrophic factor bdnf rest acute aerobic exercise major depressive disorder psychoneuroendocrinology 102 212215 httpsdoiorg101016jpsyneuen201812015 karabiyik c vicinanza son rubinsztein c 2021 glucose starvation induces autophagy via ulk1mediated activation pikfyve ampkdependent manner developmental cell 56 19611975 httpsdoiorg101016jdevcel202105010 kelly r kelly p kelly p 2020 metabolomics physical activity exercise health review current evidence biochimica et biophysica acta bbamolecular basis disease 1866 165936 httpsdoiorg101016jbbadis2020165936 kempermann g gage f h aigner l song h curtis thuret kuhn h g jessberger frankland p w cameron h gould e hen r abrous n toni n schinder f zhao x lucassen p j frisén j 2018 human adult neurogenesis evidence remaining questions cell stem cell 23 25–30 httpsdoiorg101016jstem201804004 kim h park h ha bang e j lee lee k lee j yu b p chung h 2019 antiinflammatory action βhydroxybutyrate via modulation pgc1α foxo1 mimicking calorie restriction aging 11 1283–1304 httpsdoiorg1018632aging101838 kökten hansmannel f ndiaye n c heba c quilliot dreumont n arnone peyrinbiroulet l 2021 calorie restriction new treatment inflammatory diseases advances nutrition 12 15581570 httpsdoiorg101093advancesnmaa179 kolb h kempf k röhling lenzenschulte schloot n c martin 2021 ketone bodies enemy friend guardian angel bmc medicine 19 115 httpsdoiorg101186s12916021021850 koppel j swerdlow r h 2018 neuroketotherapeutics modern review centuryold therapy neurochemistry international 117 114–125 httpsdoiorg101016jneuint201705019 korla k mitra c k 2014 modelling krebs cycle oxidative phosphorylation journal biomolecular structure dynamics 32 242–256 httpsdoiorg101080073911022012762723 koseska bastiaens p 2017 cell signaling cognitive process embo journal 36 568582 httpsdoiorg1015252embj201695383 kowiański p lietzau g czuba e waśkow steliga moryś j 2018 bdnf key factor multipotent impact brain signaling synaptic plasticity cellular molecular neurobiology 38 579–593 httpsdoiorg101007s1057101705104 krieglstein k strelau j schober sullivan unsicker k 2002 tgf β regulation neuron survival death journal physiology 96 2530 httpsdoiorg101016s0928425701000778 kristal b shurubor kaddurahdaouk r matson w r 2007 metabolomics study aging caloric restriction tollefsbol eds biological aging methods protocols pp 393409 totowa humana press kumar bansal n 2022 implications phosphoinositide 3kinaseakt pi3kakt pathway pathogenesis alzheimer ’ disease molecular neurobiology 59 354385 httpsdoiorg101007s12035021026117 laberge rm adler demaria mechtouf n teachenor r cardin g b desprez py campisi j rodier f 2013 mitochondrial dna damage induces apoptosis senescent cells cell death disease 4 e727–e727 httpsdoiorg101038cddis2013199 lautrup sinclair mattson p fang e f 2019 nad brain aging neurodegenerative disorders cell metabolism 30 630–655 httpsdoiorg101016jcmet201909001 leckie r l oberlin l e voss w prakash r szaboreed chaddockheyman l erickson k 2014 bdnf mediates improvements executive function following 1year exercise intervention frontiers human neuroscience 8 985 httpsdoiorg103389fnhum201400985 leite j ghirotto b targhetta v p lima j câmara n 2022 sirtuins pharmacological targets neurodegenerative neuropsychiatric disorders british journal pharmacology 179 1496–1511 httpsdoiorg101111bph15570 li p lei qi j liu w yao k 2022 functional roles adpribosylation writers readers erasers frontiers cell developmental biology 10 941356 httpsdoiorg103389fcell2022941356 li z huang l luo yu b tian g 2023 effects possible mechanisms intermittent fasting health disease narrative review nutrition reviews nuad026 httpsdoiorg101093nutritnuad026 liu g sabatini 2020 mtor nexus nutrition growth ageing disease nature reviews molecular cell biology 21 183–203 httpsdoiorg101038s415800190199y liu zhang l joo sun sc 2017 nfκb signaling inflammation signal transduction targeted therapy 2 17023 httpsdoiorg101038sigtrans201723 lorzadeh kohan l ghavami azarpira n 2021 autophagy wnt signaling pathway focus wntβcatenin signaling biochimica et biophysica acta bbamolecular cell research 1868 118926 httpsdoiorg101016jbbamcr2020118926 lu tao f zhou tang k f 2019 signaling pathways mediate anticancer effects caloric restriction pharmacological research 141 512520 httpsdoiorg101016jphrs201901021 luan h wang x cai z 2019 mass spectrometrybased metabolomics targeting crosstalk gut microbiota brain neurodegenerative disorders mass spectrometry reviews 38 2233 httpsdoiorg101002mas21553 lucassen p j meerlo p naylor van dam dayer g fuchs e oomen c czéh b 2010 regulation adult neurogenesis stress sleep disruption exercise inflammation implications depression antidepressant action european neuropsychopharmacology 20 1–17 httpsdoiorg101016jeuroneuro200908003 lucassen p j fitzsimons c p salta e maleticsavatic 2020 adult neurogenesis human classic optimized future approaches behavioural brain research 381 112458 httpsdoiorg101016jbbr2019112458 lüscher b ahel altmeyer ashworth bai p chang p cohen corda dantzer f daugherty dawson dawson v l deindl fehr r feijs k l h filippov v gagné j grimaldi g guettler … ziegler 2022 adpribosyltransferases update function nomenclature febs journal 289 7399–7410 httpsdoiorg101111febs16142 mcallister k katz l c lo c 1999 neurotrophins synaptic plasticity annual review neuroscience 22 295318 httpsdoiorg101146annurevneuro221295 mccubrey j rakus gizak steelman l abrams l lertpiriyapong k martelli 2016 effects mutations wntβcatenin hedgehog notch pi3k pathways gsk3 activity—diverse effects cell growth metabolism cancer biochimica et biophysica acta bbamolecular cell research 1863 29422976 httpsdoiorg101016jbbamcr201609004 mcgregor nelson b 2019 circuit mechanisms parkinson ’ disease neuron 101 10421056 httpsdoiorg101016jneuron201903004 madeo f carmonagutierrez hofer j kroemer g 2019 caloric restriction mimetics ageassociated disease targets mechanisms therapeutic potential cell metabolism 29 592610 httpsdoiorg101016jcmet201901018 magee j c grienberger c 2020 synaptic plasticity forms functions annual review neuroscience 43 95–117 httpsdoiorg101146annurevneuro090919022842 magliulo l bondi pini n marramiero l di filippo e 2022 wonder exerkines—novel insights critical stateoftheart review molecular cellular biochemistry 477 105–113 httpsdoiorg101007s11010021042645 maharajan n vijayakumar k jang c h cho gw 2020 caloric restriction maintains stem cells niche regulates stem cell aging journal molecular medicine 98 25–37 httpsdoiorg101007s00109019018461 mao k zhang g 2022 role parp1 neurodegenerative diseases aging febs journal 289 20132024 httpsdoiorg101111febs15716 martel j chang h wu c peng h h hwang l ko f ojcius 2021 recent advances field caloric restriction mimetics antiaging molecules ageing research reviews 66 101240 httpsdoiorg101016jarr2020101240 martínezreyes chandel n 2020 mitochondrial tca cycle metabolites control physiology disease nature communications 11 102 httpsdoiorg101038s41467019136683 massell j lieb r meyer mayor e 2022 fluctuations psychological states twitter covid19 plos one 17 e0278018 httpsdoiorg101371journalpone0278018 marosi k mattson p 2014 bdnf mediates adaptive brain body responses energetic challenges trends endocrinology metabolism 25 8998 httpsdoiorg101016jtem201310006 mattson p 2019 evolutionary perspective food overconsumption impairs cognition trends cognitive sciences 23 200212 httpsdoiorg101016jtics201901003 mattson p moehl k ghena n schmaedick cheng 2018 intermittent metabolic switching neuroplasticity brain health nature reviews neuroscience 19 8194 httpsdoiorg101038nrn2017156 mattson p arumugam v 2018 hallmarks brain aging adaptive pathological modification metabolic states cell metabolism 27 1176–1199 httpsdoiorg101016jcmet201805011 mayor e daehne bianchi r 2019 perceived substance characteristics affect ethical judgement towards cognitive enhancement plos one 14 e0213619 httpsdoiorg101371journalpone0213619 mayor e daehne bianchi r 2020 dark triad personality attitudes toward cognitive enhancement bmc psychology 8 112 httpsdoiorg101186s40359020004862 mayor e bietti l canalesrodríguez e j 2022 text signal tutorial case studies focusing social media twitter behavior research methods advance online publication httpsdoiorg103758s13428022019171 mayor e miché lieb r 2022 associations emotions expressed internet news subsequent emotional content twitter heliyon 8 e12133 httpsdoiorg101016jheliyon2022e12133 mazat jp devin ransac 2020 modelling mitochondrial ros production respiratory chain cellular molecular life sciences 77 455–465 httpsdoiorg101007s00018019033811 mehmel jovanović n spitz u 2020 nicotinamide riboside — current state research therapeutic uses nutrients 12 1616 httpsdoiorg103390nu12061616 mela v mota b c milner mcginley mills k h kelly á lynch 2020 exerciseinduced reprogramming agerelated metabolic changes microglia accompanied reduction senescent cells brain behavior immunity 87 413428 httpsdoiorg101016jbbi202001012 melsen w g bootsma c j rovers bonten j 2014 effects clinical statistical heterogeneity predictive values results metaanalyses clinical microbiology infection 20 123129 https1011111469069112494 miller r harrison e astle c baur j boyd r de cabo r strong r 2011 rapamycin resveratrol simvastatin extends life span genetically heterogeneous mice journals gerontology series 66 191201 httpsdoiorg101093geronaglq178 minchevatasheva soler r 2013 nfκb signaling pathways role nervous system physiology pathology neuroscientist 19 175194 httpsdoiorg1011771073858412444007 mittelbrunn kroemer g 2021 hallmarks cell aging nature immunology 22 687698 httpsdoiorg101038s4159002100927z moosavi f hosseini r saso l firuzi 2016 modulation neurotrophic signaling pathways polyphenols drug design development therapy 10 2342 doi 102147dddts96936 moore j salmons h vinoskey c kressler j 2020 single oneminute comfortable paced stairclimbing bout reduces postprandial glucose following mixed meal nutrition metabolism cardiovascular diseases 30 19671972 httpsdoiorg101016jnumecd202006020 moradi z jalili f farhadian n joshi wang zou l cao h farzaei h xiao j 2022 polyphenols neurodegenerative diseases focus neuronal regeneration critical reviews food science nutrition 62 3421–3436 httpsdoiorg1010801040839820201865870 morris b j 2013 seven sirtuins seven deadly diseases aging free radical biology medicine 56 133–171 httpsdoiorg101016jfreeradbiomed201210525 murphy p 2009 mitochondria produce reactive oxygen species biochemical journal 417 1–13 httpsdoiorg101042bj20081386 nadeeshani h li j ying zhang b lu j 2022 nicotinamide mononucleotide nmn antiaging health product–promises safety concerns journal advanced research 37 267278 httpsdoiorg101016jjare202108003 negredo p n yeo r w brunet 2020 aging rejuvenation neural stem cells niches cell stem cell 202–223 httpsdoiorg101016jstem202007002 navas l e carnero 2021 nad metabolism stemness immune response cancer signal transduction targeted therapy 6 2 httpsdoiorg101038s4139202000354w neth b j mintz whitlow c jung sai k register c craft 2020 modified ketogenic diet associated improved cerebrospinal fluid biomarker profile cerebral perfusion cerebral ketone body uptake older adults risk alzheimer ’ disease pilot study neurobiology aging 86 5463 httpsdoiorg101016jneurobiolaging201909015 newman j c verdin e 2017 βhydroxybutyrate signaling metabolite annual review nutrition 37 51–76 httpsdoiorg101146annurevnutr071816064916 nie yang h zhang l lu f tao k wang r yang r huang l mao z yang q 2016 regulation er stressinduced autophagy gsk3βtip60ulk1 pathway cell death disease 7 e2563–e2563 httpsdoiorg101038cddis2016423 niwakawakita ferhi soilihi h le bras lallemandbreitenbach v de thé h 2017 pml ros sensor activating p53 upon oxidative stress journal experimental medicine 214 3197–3206 httpsdoiorg101084jem20160301 nordvall g forsell p sandin j 2022 neurotrophintargeted therapeutics gateway cognition drug discovery today 27 103318 httpsdoiorg101016jdrudis202207003 ntsapi c loos b 2016 caloric restriction precisioncontrol autophagy strategy delaying neurodegenerative disease progression experimental gerontology 83 97–111 httpsdoiorg101016jexger201607014 ’ connor c joffe h 2015 public engages brain optimization mediamind relationship science technology human values 40 712743 httpsdoiorg1011770162243915576374 othman z halim azman k f ahmad h zakaria r sirajudeen k n ahmi 2022 profiling research landscape cognitive aging bibliometric analysis network visualization frontiers aging neuroscience 14 httpsdoiorg103389fnagi2022876159 outram racine e 2011 examining reports policies cognitive enhancement approaches rationale recommendations accountability research 18 323341 httpsdoiorg101080089896212011606734 oluwole fernando w b lumanlan j ademuyiwa jayasena v 2022 role phenolic acid tannins stilbenes lignans flavonoids human health – review international journal food science technology 57 6326–6335 httpsdoiorg101111ijfs15936 overall r w walker l fischer j brandt kempermann g 2016 different mechanisms must considered explain increase hippocampal neural precursor cell proliferation physical activity frontiers neuroscience 10 362 httpsdoiorg103389fnins201600362 pateras williams c gianniou margetis avgeris rousakis p frisan 2023 short term starvation potentiates efficacy chemotherapy triple negative breast cancer via metabolic reprogramming journal translational medicine 21 169 httpsdoiorg101186s12967023039359 peyssonnaux c eychène 2001 rafmekerk pathway new concepts activation biology cell 93 53–62 httpsdoiorg101016s024849000101125x pillon n j gabriel b dollet l smith j sardón puig l botella j zierath j r 2020 transcriptomic profiling skeletal muscle adaptations exercise inactivity nature communications 11 470 httpsdoiorg101038s4146701913869w powers k deminice r ozdemir yoshihara bomkamp p hyatt h 2020 exerciseinduced oxidative stress friend foe journal sport health science 9 415–425 httpsdoiorg101016jjshs202004001 rabinovitch r c samborska b faubert b e h gravel sp andrzejewski raissi c pause stpierre j jones r g 2017 ampk maintains cellular metabolic homeostasis regulation mitochondrial reactive oxygen species cell reports 21 1–9 httpsdoiorg101016jcelrep201709026 radak z kumagai taylor w naito h goto 2007 effects exercise brain function role free radicals applied physiology nutrition metabolism 32 942–946 httpsdoiorg101139h07081 radak z suzuki k posa petrovszky z koltai e boldogh 2020 systemic role sirt1 exercise mediated adaptation redox biology 35 101467 httpsdoiorg101016jredox2020101467 rahman muhammad khan chen h ridder müllerfielitz h pokorná b vollbrandt stölting nadrowitz r okun j g offermanns schwaninger 2014 βhydroxybutyrate receptor hca2 activates neuroprotective subset macrophages nature communications 5 3944 httpsdoiorg101038ncomms4944 rai n dilnashin h birla h singh zahra w rathore singh b k singh p 2019 role pi3kakt erk neurodegenerative disorders neurotoxicity research 35 775–795 httpsdoiorg101007s126400190003y ravula r teegala b kalakotla pasangulapati j p perumal v boyina h k 2021 fisetin potential flavonoid multifarious targets treating neurological disorders updated review european journal pharmacology 910 174492 httpsdoiorg101016jejphar2021174492 reddy yadav dey c 2023 cellular molecular regulation exercise — neuronal perspective cellular molecular neurobiology 43 1551–1571 httpsdoiorg101007s1057102201272x rege geetha griffin g broderick l babu j r 2014 neuroprotective effects resveratrol alzheimer disease pathology frontiers aging neuroscience 6 218 httpsdoiorg103389fnagi201400218 rendeiro c rhodes j spencer j p 2015 mechanisms action flavonoids brain direct versus indirect effects neurochemistry international 89 126139 httpsdoiorg101016jneuint201508002 richter e ruderman n b 2009 ampk biochemistry exercise implications human health disease biochemical journal 418 261–275 httpsdoiorg101042bj20082055 richter e hargreaves 2013 exercise glut4 skeletal muscle glucose uptake physiological reviews 93 9931017 httpsdoiorg101152physrev000382012 riuspérez torrescuevas millán ortega á l pérez 2020 pgc1α inflammation oxidative stress integrative view metabolism oxidative medicine cellular longevity 2020 1–20 httpsdoiorg10115520201452696 roy ansari choudhary k singh 2023 nlrp3 inflammasome depression review international immunopharmacology 117 109916 httpsdoiorg101016jintimp2023109916 sadria layton 2021 interactions among mtorc ampk sirt computational model cell energy balance metabolism cell communication signaling 19 117 httpsdoiorg101186s12964021007061 salinas p c 2013 wnt signaling j lr rubenstein p rakic eds cellular migration formation neuronal connections pp 623–638 elsevier httpsdoiorg101016b978012397266800106x santo e e paik j 2018 foxo neural cells diseases nervous system current topics developmental biology 127 105–118 elsevier httpsdoiorg101016bsctdb201710002 schofield j h schafer z 2021 mitochondrial reactive oxygen species mitophagy complex nuanced relationship antioxidants redox signaling 34 517–530 httpsdoiorg101089ars20208058 schwarz j ebert b lie c 2012 stem cell maintenance adult mammalian hippocampus matter signal integration developmental neurobiology 72 10061015 httpsdoiorg101002dneu22026 seidler k barrow 2022 intermittent fasting cognitive performance – targeting bdnf potential strategy optimise brain health frontiers neuroendocrinology 65 100971 httpsdoiorg101016jyfrne2021100971 shackelford b shaw r j 2009 lkb1–ampk pathway metabolism growth control tumour suppression nature reviews cancer 9 563–575 httpsdoiorg101038nrc2676 sharman mj verdile g kirubakaran parenti c singh watt g karl chang li c g münch g 2019 targeting inflammatory pathways alzheimer ’ disease focus natural products phytomedicines cns drugs 33 457–480 httpsdoiorg101007s40263019006191 shaw r j 2009 lkb1 ampactivated protein kinase control mtor signalling growth acta physiologica 196 65–80 httpsdoiorg101111j17481716200901972x shilovsky g putyatina morgunova g v seliverstov v ashapkin v v sorokina e v markov v skulachev v p 2021 crosstalk biorhythms gatekeepers longevity dual role glycogen synthase kinase3 biochemistry moscow 86 433–448 httpsdoiorg101134s0006297921040052 shimazu hirschey newman j w shirakawa k le moan n verdin e 2013 suppression oxidative stress βhydroxybutyrate endogenous histone deacetylase inhibitor science 339 211214 httpsdoiorg101126science1227166 simpson appel n hokari oki j holman g maher f smith q r 1999 bloodbrain barrier glucose transporter effects hypoand hyperglycemia revisited journal neurochemistry 72 238247 httpsdoiorg101046j1471415919990720238x singh kukreti r saso l kukreti 2019 oxidative stress key modulator neurodegenerative diseases molecules 24 1583 httpsdoiorg103390molecules24081583 song han c moon j lee j h bae e j park b h 2022 sirt6 reprograms myofibers oxidative type crebdependent sox6 suppression nature communications 13 1808 httpsdoiorg101038s41467022294725 spalding k l bergmann alkass k bernard salehpour huttner h b boström e westerlund vial c buchholz b possnert g mash c druid h frisén j 2013 dynamics hippocampal neurogenesis adult humans cell 153 1219–1227 httpsdoiorg101016jcell201305002 spasić r callaerts p norga k k 2009 ampactivated protein kinase ampk molecular crossroad metabolic control survival neurons neuroscientist 15 309–316 httpsdoiorg1011771073858408327805 sutkowy p woźniak milakierzenkowska c szewczykgolec k wesołowski r pawłowska nuszkiewicz j 2021 physical activity vs redox balance brain brain health aging diseases antioxidants 11 95 httpsdoiorg103390antiox11010095 szwed kim e jacinto e 2021 regulation metabolic functions mtorc1 mtorc2 physiological reviews 101 1371–1426 httpsdoiorg101152physrev000262020 tang b l 2016 sirt1 mitochondria molecules cells 39 8795 httpsdoiorg1014348molcells20162318 taylor kornev p 2011 protein kinases evolution dynamic regulatory proteins trends biochemical sciences 36 6577 httpsdoiorg101016jtibs201009006 tayyab shahi h farheen mariyath p khanam n castresana j hossain 2018 sonic hedgehog wnt brainderived neurotrophic factor cell signaling pathway crosstalk potential therapy depression journal neuroscience research 96 5362 httpsdoiorg101002jnr24104 testa g biasi f poli g chiarpotto e 2014 calorie restriction dietary restriction mimetics strategy improving healthy aging longevity current pharmaceutical design 20 29502977 httpswwwdoiorg10217413816128113196660699 thorens b mueckler 2010 glucose transporters 21st century american journal physiologyendocrinology metabolism 298 e141e145 httpsdoiorg101152ajpendo007122009 tinsley g la bounty p 2015 effects intermittent fasting body composition clinical health markers humans nutrition reviews 73 661–674 httpsdoiorg101093nutritnuv041 tuncdemir n lacefield c hen r 2019 contributions adult neurogenesis dentate gyrus network activity computations behavioural brain research 374 112112 httpsdoiorg101016jbbr2019112112 vadlakonda l dash pasupuleti anil kumar k reddanna p 2013 paradox aktmtor interactions frontiers oncology 3 httpsdoiorg103389fonc201300165 valls p esposito 2022 signalling dynamics cell decisions homeostatic control health disease current opinion cell biology 75 102066 httpsdoiorg101016jceb202201011 van praag h 2008 neurogenesis exercise past future directions neuromolecular medicine 10 128–140 httpsdoiorg101007s120170088028z van praag h fleshner schwartz w mattson p 2014 exercise energy intake glucose homeostasis brain journal neuroscience 34 1513915149 httpsdoiorg101523jneurosci2814142014 vanhaesebroeck b stephens l hawkins p 2012 pi3k signalling path discovery understanding nature reviews molecular cell biology 13 195–203 httpsdoiorg101038nrm3290 vella l caldow k larsen e tassoni della gatta p gran p cameronsmith 2012 resistance exercise increases nfκb activity human skeletal muscle american journal physiologyregulatory integrative comparative physiology 302 r667r673 httpsdoiorg101152ajpregu003362011 vernier giguère v 2021 aging senescence mitochondria pgc1err axis endocrinology 1 661 httpsdoiorg101530jme200196 vints w j levin fujiyama h verbunt j masiulis n 2022 exerkines longterm synaptic potentiation mechanisms exerciseinduced neuroplasticity frontiers neuroendocrinology 66 100993 httpsdoiorg101016jyfrne2022100993 walsh e smith l northey j rattray b cherbuin n 2020 towards understanding physical activitybdnfcognition triumvirate review associations dosage ageing research reviews 60 101044 httpsdoiorg101016jarr2020101044 wancket l frazier w j liu 2012 mitogenactivated protein kinase phosphatase mkp1 immunology physiology disease life sciences 90 237–248 httpsdoiorg101016jlfs201111017 wang x yang q liao q li zhang p santos h abshirini 2020 effects intermittent fasting diets plasma concentrations inflammatory biomarkers systematic review metaanalysis randomized controlled trials nutrition 79 110974 doi 101016jnut2020110974 wang k liu h hu q wang l liu j zheng z zhang w ren j zhu f liu gh 2022a epigenetic regulation aging implications interventions aging diseases signal transduction targeted therapy 7 374 httpsdoiorg101038s41392022012118 wang q lu zhu x gu x zhang xia c yang l xu x zhou 2022b role microglia immunometabolism neurodegeneration focus molecular determinants metabolic intermediates metabolic reprogramming biomedicine pharmacotherapy 153 113412 httpsdoiorg101016jbiopha2022113412 wang li z mo f chenmayfield j saini lamere hu q 2023 chemically engineering cells precision medicine chemical society reviews 52 10681102 httpsdoiorg101039d2cs00142j watson k baar k 2014 mtor health benefits exercise seminars cell developmental biology 36 130–139 httpsdoiorg101016jsemcdb201408013 woods johnstone r dickerson k leiper f c fryer l g neumann schlattner u wallimann carlson carling 2003 lkb1 upstream kinase ampactivated protein kinase cascade current biology 13 2004–2008 httpsdoiorg101016jcub200310031 xie n zhang l gao w huang c huber p e zhou x zou b 2020 nad metabolism pathophysiologic mechanisms therapeutic potential signal transduction targeted therapy 5 227 httpsdoiorg101038s41392020003117 xu j q tang n zhang l f tan c su george huang l 2021 bibliometric analysis wnt signaling pathway top100 cited articles emerging trends annals translational medicine 9 1065 httpsdoiorg1021037atm21174 xue f li x qin l liu x li c adhikari b 2021 antiaging properties phytoconstituents phytonanoemulsions application managing agingrelated diseases advanced drug delivery reviews 176 113886 httpsdoiorg101016jaddr2021113886 yadav tripathi b singh p kesharwani r k keservani r k 2017 roles amp adp atp ampk healthy energy boosting prolonged life span bagchi ed sustained energy enhanced human functions activity pp 31–51 elsevier httpsdoiorg101016b9780128054130000028 yamamoto h schoonjans k auwerx j 2007 sirtuin functions health disease molecular endocrinology 21 1745–1755 httpsdoiorg101210me20070079 yang j li zhang fang x chen n zhou x wang x 2020 sirt6 promotes tumorigenesis drug resistance diffuse large bcell lymphoma mediating pi3kakt signaling journal experimental clinical cancer research 39 116 httpsdoiorg101186s1304602001623w yao p j petralia r mattson p 2016 sonic hedgehog signaling hippocampal neuroplasticity trends neurosciences 39 840850 httpsdoiorg101016jtins201610001 yu q zou l kong z yang l 2020a cognitive impact calorie restriction narrative review journal american medical directors association 21 1394–1401 httpsdoiorg101016jjamda202005047 yu h lin l zhang z zhang h hu h 2020b targeting nfκb pathway therapy diseases mechanism clinical study signal transduction targeted therapy 5 123 httpsdoiorg101038s41392020003126 yu zhang h wang b zhang zheng x shao b jin k 2021 key signaling pathways aging potential interventions healthy aging cells 10 660 httpsdoiorg103390cells10030660 zeng h lu b zamponi r yang z wetzel k loureiro j cong f 2018 mtorc1 signaling suppresses wntβcatenin signaling dvldependent regulation wnt receptor fzd level proceedings national academy sciences 115 e10362e10369 httpsdoiorg101073pnas1808575115 zhang l xu h ding n li x chen x chen z 2021a beneficial effects brain microenvironment caloric restriction alleviating neurodegenerative diseases brain aging frontiers physiolology 12 715443 doi 103389fphys2021715443 zhang lx li cx kakar u khan wu pf amir r dai df naveed li qy saeed shen jq rajput li jh 2021b resveratrol rv pharmacological review call research biomedicine pharmacotherapy 143 112164 httpsdoiorg101016jbiopha2021112164 zhao c deng w gage f h 2008 mechanisms functional implications adult neurogenesis cell 132 645–660 httpsdoiorg101016jcell200801033 zhao j yue w zhu j sreejayan n du 2010 ampactivated protein kinase ampk crosstalks canonical wnt signaling via phosphorylation βcatenin ser 552 biochemical biophysical research communications 395 146151 httpsdoiorg101016jbbrc201003161 zhao r jiang zhang l yu z 2019 mitochondrial electron transport chain ros generation uncoupling review international journal molecular medicine 44 315 httpsdoiorg103892ijmm20194188 zhao jia chen w liu z 2022 neuroprotective effects intermittent fasting brain aging neurodegenerative diseases via regulating mitochondrial function free radical biology medicine 182 206218 httpsdoiorg101016jfreeradbiomed202202021 zhou b lin w long yang zhang h wu k chu q 2022 notch signaling pathway architecture disease therapeutics signal transduction targeted therapy 7 95 httpsdoiorg101038s4139202200934y zia pourbaghershahri farkhondeh samarghandian 2021 molecular cellular pathways contributing brain aging behavioral brain functions 17 130 httpsdoiorg101186s12993021001799 appendix annotated bibliography exercise radak z kumagai taylor w naito h goto 2007 effects exercise brain function role free radicals applied physiology nutrition metabolism 32 942–946 httpsdoiorg101139h07081 role exercise management ros discussed radak et al 2007 focus implications cns showed oxidative damage ros ultimately linked neurodegenerative diseases protective role exercise focus neurotrophins trophic factors discussed among neurotrophins details provided bdnf upregulation related exercise signaling pathways activate bdnf protective role regards ros notably creb mentioned downstream effector bdnf linked increase bdnf dependent upon level ros hence feedback loop potentiated exercise powers k deminice r ozdemir yoshihara bomkamp p hyatt h 2020 exerciseinduced oxidative stress friend foe journal sport health science 95 415–425 httpsdoiorg101016jjshs202004001 powers et al 2020 focus exercise producer ros cause oxidative stress skeletal muscle primarily concept oxidative stress defined imbalance prooxidantantioxidant ratio leads cellular damage short explanation free radicals provided several molecule compose ros reactive nitrogen species nos labels briefly discussed enzymatic nonenzymatic antioxidants presented central cellular control ros history research exerciseinduced oxidative stress production ros produced skeletal muscles exercise presented well impact ros muscle performance mention made hormesis theory exercise presented mild stressor prepares body future challenges walsh e smith l northey j rattray b cherbuin n 2020 towards understanding physical activitybdnfcognition triumvirate review associations dosage ageing research reviews 60 101044 walsh et al 2020 focus exercisecirculating bdnfcognition doseresponse associations physical activity important factors increasing bdnf neurotrophic functions mentioned bdnf measurement concentration discussed across life span 2030 nanograms per liter decrease 05 – 5 per year modulators bdnf notably physical activity presented brain aging discussed mention mechanisms first next presentation aging result presented mechanisms cognitive decline consequence latter discussion continues involvement bdnf aging processes focusing brain changes cognitive performance association bdnf exercise mentions values interest mentioned notably 30 minutes exercise necessary increase serum bdnf exercise intensity might marginally related magnitude increase bdnf chronic effects interventions targeting basal bdnf metaanalyses notably show small effects exercise serum bdnf next presented elements inconclusive link serum bdnf concentration cerebral blood flow cellular signaling important confound assessment effect physical activity bdnf lack research acute bdnf response cognition finally mode physical activity exercise intensity duration well work rest periods prior training bdnf response exercise context aging discussed reddy yadav dey c 2023 cellular molecular regulation exercise—a neuronal perspective cellular molecular neurobiology 43 1551–1571 httpsdoiorg101007s1057102201272x reddy et al 2023 provide literature review processes involved exerciseinduces neuronal regulation research physiological response exercise synthesized focus proteins metabolites exerkines irisin cathepsin b interleukin6 il6 adiponectin osteocacin leptin fibroblast growth factor21 fgf21 growth factors signaling proteins regulated exercise notably irisin involved neuroprotection cognitive improvements amelioration alzheimers disease cathepsin b involved cognitive improvements il6 regulates brain metabolism notably reduces brain inflammation adiponectin involved dendritic arborization spinogenesis neurogenesis notably isteocalcin regulates cognition neuroplasticity memory learning fgf21 reduces neuroinflammation improves synaptic plasticity leptin involved neurogenesis axonal growth improved spatial memory notably signaling proteins mentioned orexin musclin secreted protein acidic rich cysteine sparc meteorinlike protein metrnl bdnf ampk sirt1 pgc1α igf1 mentioned bdnf ampk sirt1 pgc1α igf1 main text orexin sparc related neurodegenerative diseases increased musclin detrimental metabolism musclin secretion downregulated exercise metrnl involved different functions finally exercise mimetics mentioned chow l gerszten r e taylor j pedersen b k van praag h trappe febbraio galis z gao haus j lanza r lavie c j lee ch lucia moro c pandey robbins j stanford k thackray e … snyder p 2022 exerkines health resilience disease nature reviews endocrinology 185 273–289 httpsdoiorg101038s41574022006412 chow et al 2022 health implications exerkines – substances increased exercise involved signaling – presented mention made health benefits exercise linked release exerkines although primarily studied skeletal muscle exerkines released variety organs might promote health notably diminishing obesity reducing risks cardiaovascular disease cancer protecting cognitive decline list exerkines provided eg adiponectin bdnf fgf21 il6 lactate musclin nitric oxide mention location origin made eg muscle brain brown adipose tissue common measures exerkines advantages disadvantages discussed exerkines play different roles cardiometabolic system improvement angiogenesis angiopoietin optimization glucose lipids adiponectin adipose tissue skeletal muscle bones liver gut nervous immune endocrine systems musclebrain crosstalk also discussed review mention role myokines exerkines released skeletal muscle hippocampal neurogenesis particular distinction acute chronic exercise important matter kynurenine liversecreted exerkine protect brain stress mattson p arumugam v 2018 hallmarks brain aging adaptive pathological modification metabolic states cell metabolism 27 1176–1199 httpsdoiorg101016jcmet201805011 mattson arumugam 2018 focus exercise relation healthy brain aging cognitive decline presented context aging accelerates 50 years age increases odds neurodegenerative disorders physiological age brain modulated environmental factors cr crms notably early midlife environmental factors affect risk future neurodegenerative diseases traumatic brain injury history intermittent metabolic switching eg cr beneficial chronic positive energy balance detrimental presented followed mitochondrial dysfunction notably axons dendrites brain aging process mitochondrial dysfunction result notably decreased nadnadh ratio affects signaling eg sirt different issues caused mitochondrial dysfunction eg deficient etc increased ros lead neurodegenerative disorders focus cr alleviative process processes oxidative imbalance lead impaired brain health well impaired degradation damaged proteins discussed next discussion continues dysregulated calcium ion homeostasis neurons modulator neuron function neuronal networks deficient cellular stress response well relevant processes signaling pathways involved dysfunctional neuronal activity next topic addressed review followed impaired dna repair aging agerelated heightened inflammation impaired neurogenesis well limited role telomere attrition neurons cell senescence discussion dysregulation energy metabolism focus irs1 bhb omega3 fatty acids presented next neurodegenerative disorders related aging examples alzheimer disease parkinson ’ notably discussed intermittent metabolic challenges pharmacological interventions mentioned means delaying brain aging improve cognitive function neuroprotection review focuses processes involved starting depletion liver glycogen store lipolysis pathways play examples pharmacological strategies provided instance ketone esters improve cognition nicotinamide riboside extend lifespan diminish neurodegeneration well mechanisms action lucassen p j meerlo p naylor van dam dayer g fuchs e oomen c czéh b 2010 regulation adult neurogenesis stress sleep disruption exercise inflammation implications depression antidepressant action european neuropsychopharmacology 20 1–17 httpsdoiorg101016jeuroneuro200908003 lucassen et al 2010 focus implications exercise sleep antidepressants well deteriorating effects stress inflammation regards neurogenesis importance stress alarm system mobilization organism deleterious consequences chronic uncontrollable stress severe acute stress presented manifestations stress lead diverse pathologies notably major depressive disorder authors mention hippocampal alterations stress affects functions hippocampus structure eg volume loss aberrations synaptic organization adult neurogenesis discussed including areas established occur humans – points controversy different steps process exercise plays important role improved neurogenesis discussed including regulation adult hippocampal neurogenesis exercise affected stress mentioning suppressive effect latter mechanisms detrimental effect stress relation neurogenesis detailed mention concentration neurotransmitters neurotrophic factors different aspects relative perinatal stress presented well sleep disruption stressor ramifications impaired neurogenesis sleep disruption one single night seems unrelated process hormones neurotransmitters affected sleep disruption presented inflammation cell stressor discussed well importance hypothalamic–pituitary–adrenocortical axis dysregulation consequences regarding adult neurogenesis stress also affects prefrontal cortex pfc cytogenesis area particular dysregulation activity pfc result impaired cytogenesis neurogenic theory described theory links increased risks depression impaired neurogenesis following stress exposure conclusion addresses reduced long lasting reduced neurogenesis cause depression protective role voluntary exercise antidepressants intermittent fasting mattson p moehl k ghena n schmaedick cheng 2018 intermittent metabolic switching neuroplasticity brain health nature reviews neuroscience 19 81–94 httpsdoiorg101038nrn2017156 evolutionary account contribution repeated metabolic switching improved neuroplasticity provided mattson et al 2018 form comprehensive review presented frequent repeated metabolic switching paradigm different forms mentioned alternate day feeding daily timerestricted feeding together exercise intermittent metabolic switching involves glucosetoketone leading cellular stress resistance switch ketonetoglucose leading cell growth plasticity organisms evolved perform well conditions scarce resources metabolic switching one way achieve result production ketone bodies due lipolysis used cellular fuel glucose scarce neuronal dynamics induced repeated metabolic switching discussed mention cognitive benefits exercise neuroprotection well synaptic plasticity followed signaling pathways elicited metabolic switching focusing one hand neurotransmitters neurotrophic factors hand management cellular stress mitochondrial biogenesis following role hunger hormone ghrelin introduced well neurotrophic factors insulinlike growth factor igf1 fibroblast growth factor 2 fgf2 well bhb finally repeated metabolic switching presented brain health intervention seidler k barrow 2022 intermittent fasting cognitive performance – targeting bdnf potential strategy optimise brain health frontiers neuroendocrinology 65 100971 httpsdoiorg101016jyfrne2021100971 link cognition focus seidler barrow 2022 introduction high caloric diets participates development neurodegenerative diseases discussed role bdnf central molecule healthy aging adaptation presented next review links cr bdnf signaling mention relevance relation neurogenesis synaptic plasticity long term potentiation memory learning notably central role diminished synaptic plasticity neurogenesis neurodegeneration described systematic review part research animals presented followed humans findings systematic review demonstrate nutritional challenges fulfill adaptative functions involve bdnftrkb signaling pathway short vs long term benefits cognition take place depending duration bdnf stimulation cherif roelands b meeusen r chamari k 2016 effects intermittent fasting caloric restriction ramadan intermittent fasting cognitive performance rest exercise adults sports medicine 46 3547 httpsdoiorg101007s4027901504086 influence ramadan fasting cr adult cognitive performance exercise rest focus cherif et al 2016 health benefits exercise affects brain importance balanced energy intake distinction calories restriction mentioned followed brief review literature fasting cognitive function well importance nutrition athletic performance next cr presented mention caloric deficit values benefits associated cr eg increased lifespan accompanying experimental evidence mechanisms benefits cr cognitive function presented distinguished religious fasting alternate day fasting cognitive benefits beneficial changes neurochemistry neuronal networks stem including bdnf concentration discussed mention made increase parasympathetic activity exercise promotes benefits metabolic switching next discussion ramadan fasting defines scope describe effects positive negative cognition areas eg sleep general overview effects diets interest cognitive function proposed starting importance relationship immunity cognitive function focusing cytokines related interferences inflammation expression bdnf bdnf signaling effects diets glucose lipid metabolism related cognition poorer hypoglycemia importance lactate byproduct glycolysis long term memory metabolic changes associated diets relation neuroprotection discussed followed detrimental effects dehydration cognition start 1 loss body weight review evidence relating combination exercise diets healthy brain wang x yang q liao q li zhang p santos h abshirini 2020 effects intermittent fasting diets plasma concentrations inflammatory biomarkers systematic review metaanalysis randomized controlled trials nutrition 79 110974 doi 101016jnut2020110974 metaanalysis focusing inflammatory biomarkers proposed wang et al 2020 introduced mention importance balanced energy intake longevity risks associated consumption calories related metabolic disorders aging processes attenuated energyrestricted diets variations discussed next energy restricted diets presented relation activation ampk central process benefits diets metaanalysis k 18 15 articles examines effects diets concentration creactive protein crp tumor necrosis factor α tnf α interleukin6 il6 findings show diets compared ad libitum feeding affected crp energy restricted diets tnf α il6 evidence publication bias reported calorie restriction cr almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 doi103390ijms21239220 updated review literature see gillespie et al 2016 original review healthy lifespan improvement relation cr crms performed almendarizpalacios et al 2020 starts mention impact aging pathologies including neurodegenerative disorders role excessive calorie consumption next role cr limitation effects aging organism reduced cellular aging discussed aging related increased senescence cells leading “ key alterations … include increased genomic instability telomere shortening changes epigenome loss protein homeostasis proteostasis deregulated nutrient sensing mitochondrial dysfunction stem cell exhaustion altered intracellular signaling ” p 2 mention made importance ros mitochondrial dysfunction leading cellular senescence role cr minimizing consequences aging presented mention hormesis theory preparative role mild cellular stress leading protection explanation effectiveness cr follows downstream effects cr including cellular nutrient sensing related pathways eg ampk upregulation increased ampatp ratio mtor downregulation case calorie restriction discussed important factor healthy lifespan optimization following role amino acid restriction healthier lifespan presented relation mtor amino acid sensors notably sestrin2 cytosolic arginine sensor mtorc1 castor inhibit mtor1 case arginine leucine depletion effects cr amino acid restriction compared similarities differences terms involved signaling pathways authors discuss crms see ntsapi c loos b 2016 caloric restriction precisioncontrol autophagy strategy delaying neurodegenerative disease progression experimental gerontology 83 97–111 httpsdoiorg101016jexger201607014 ntsapi loos 2016 focus autophagy cr first estimates people aged 60 2050 22 worldwide related challenges mentioned notably relation chronic disease including neurodegenerative diseases linked accumulation proteins autophagy presented protective means respect reducing ros autophagy enhanced cr general health benefits increased longevity mentioned autophagy presented response nutrient deprivation implications neuronal homeostasis cell survival three types autophagy exist mammals “ macroautophagy chaperonemediated autophagy cma microautophagy ” p 98 defined characterized signaling pathways diminishing autophagy types aging related different processes counteracted cr instance macroautophagy increased already 30 minutes nutrient depletion whereas cma requires 10 hours caloric intake abstinence depletion cma preferable macroautophagy less selective proteins degradation could counterproductive neuroprotective role autophagy presented distinction macroautophagy cma terms outcomes made studies relation neurodegenerative diseases interested macroautophagy association macroautophagy cma different neurodegenerative diseases discussed well detrimental role specific aggregative proteins importance mitochondrial dysfunction increases age insufficient clearance proteins review ends description implication targeted autophagy increased healthy lifespan presenting igf1 central aspect effectiveness calorie restriction process de mello n p orellana mazucanti c h de morais lima g scavone c kawamoto e 2019 insulin autophagy neurodegeneration frontiers neuroscience 13 491 httpsdoiorg103389fnins201900491 de mello et al 2019 focus insulin autophagy relation neurodegeneration metabolic disorders among important cause reduced life expectancy comorbidity including neurodegenerative diseases discussed first linked imbalanced insulin signaling plays important role neurodegeneration different processes autophagy apoptosis rely upon different signaling pathways eg pi3k ampk akt mtor alleviate pejorate examined next “ review summarizes origin role insulin cns discusses relationship insulin autophagy neurodegenerative diseases ” p 2 insulin resistance presented factor neurodegeneration effects insulin including neurons presented brain insulin linked igf1 insulin signaling autophagy neurodegeneration different signaling pathways several neurodegenerative diseases cr exercise finally discussed important means regulation autophagy maharajan n vijayakumar k jang c h cho gw 2020 caloric restriction maintains stem cells niche regulates stem cell aging journal molecular medicine 98 25–37 httpsdoiorg101007s00109019018461 maharajan et al 2020 focus optimization stem cells function cr first mention made importance stem cells aging process homeostasis general review continues mention presence stem cells niches communicate environment next calorie restriction crms beneficial terms health longevity stem cell aging defined decrease functions list different associated impairments discussed relation intrinsic extrinsic influences components niche defined “ cells physically attached stem cells stromal cells mesenchymal cells adhesion molecules membrane membrane bound ligands receptors niche cells ” p 28 well “ secretory soluble factors chemokines hormones gf hedgehog tnf nuclear factorkappa b nfkb wnt3 egf notch produced stem cells stem cell progenitor cells niche cells ” p 29 niche affects stem cell instance alteration components niche detrimental stem cell discussed examples different organs notably brain regulation niche noncellular components presented extracellular matrix importance integrins notably promote stem cells adhesion extracellular matrix deteriorated signaling involved neurodegeneration following aging affected energy metabolism cr activation inhibition different pathways eg ampk sirt mtor presented mention normal caloric intake relation lower selfrenewal stem cells anomalous functioning higher differentiation stem cells opposite effects cr differentiated impact presence absence abundant nutrients pathways involved discussed cr crms finally presented means increase healthy lifespan notably improved stem cell niche stem cell proliferation zhang l xu h ding n li x chen x chen z 2021 beneficial effects brain microenvironment caloric restriction alleviating neurodegenerative diseases brain aging frontiers physiolology 12 715443 httpsdoiorg103389fphys2021715443 zhang et al 2021 examine optimization brain extracellular microenvironment cr focus minimizing brain aging symptoms neurodegenerative diseases first mention made consequences aging cellular level eg cellular senescence disrupted gene expression brain eg neuronal damage importance extracellular matrix cerebrospinal fluid health neurons broader consequences organism eg neurodegeneration presented followed review signaling pathways linked cerebral inflammation role cytokines inflammation microglial cells sensing cytokine secretion notably process detrimental effect metabolic waste extracellular microenvironment reduction antioxidants accompanies aging presented well clearing waste cellular autophagy transport waste outside brain bbb next untimely removal metabolic waste aging due disruption permeability bbb discussed subsequent topics addressed modulation gene expression impacted aging alterations chromosome structures cellular microenvironment enhanced cr relation diminished risks neurodegenerative diseases implications cr respect cellular microenvironment molecular level eg inhibition mtor activation sirt upregulation creb leading increase bdnf examined presentation increase neurotrophic factor concentration consequence cr role cr improving microenvironment cellular level distinguishing mitochondrial biogenesis autophagy gut microbiota implications cr tissue level provided mention reduction tissue inflammation cr influence cr permeability bbb synaptic plasticity neurogenesis neuron immunity addressed cr interventions focus next section reduction aging induced cr due neurogenesis implications specific diseases parkinson ’ huntington discussed yu q zou l kong z yang l 2020b cognitive impact calorie restriction narrative review journal american medical directors association 21 1394–1401 httpsdoiorg101016jjamda202005047 yu colleagues 2020b discuss restauration maintenance cognitive function cr six dimensions cognitive abilities decline aging social economic costs decline well pharmacological treatment presented cr discussed alternative method dealing cognitive decline next amelioration variety agingrelated health conditions cr detailed potential mechanisms relating time cr cognitive function presented oxidative stress areas related cognition risk ros damage inflammation secretion inflammatory molecules senescent cells proinflammatory environment neurogenesis synaptic plasticity neurotrophic factors bdnf signaling neuroprotection preservation gray white matter conclusion call made studies investigate several aspects cr order optimize benefits relation duration cr amount cr combination cr interventions calorie restriction mimetics crms almendarizpalacios c mousseau eskiw c h gillespie z e 2020 still living better chemistry update caloric restriction caloric restriction mimetics tools promote health lifespan international journal molecular sciences 21 9220 doi103390ijms21239220 summary almendarizpalacios et al 2020 continued relation crms crms portrayed means promote healthy lifespan rapamycin immunosuppressant antitumor medication related decreased mtor1 signaling mention made benefits terms lifespan extension reduced risk cancer well augmentation autophagy neuroprotection among benefits rapamycin analogs discussed resveratrol exerts effects ampk sirt activation detrimental effects high concentration metformin type 2 diabetes medication also discussed along pathways regulates bonkowski sinclair 2016 slowing ageing design rise nad sirtuinactivating compounds nature reviews molecular cell biology 17 679–690 httpsdoiorg101038nrm201693 bonkowski sinclair 2016 focus nad precursors sirt activators first importance disease prevention – including neurodegeneration implications longevity extension presented several signaling pathways conserved simple complex organisms examined next explain part effectiveness calorie restriction healthy aging including ampk sirts mtor regulation natural molecules capable activating mentioned pathways discussed review focuses sirts activators stacs including nad precursors animal models primate human studies discussed presentation mechanisms stacs following specifics nad precursors discussed nad required activity sirts “ nadboosting molecules constitute newer class stacs gaining attention way restore nad levels elderly individuals potentially activate seven sirtuins single compound “ bonkowski sinclair 2016 p 17 iside c scafuro nebbioso altucci l 2020 sirt1 activation natural phytochemicals overview frontiers pharmacology 11 1225 iside et al 2020 focus activation sirt1 phytochemicals epigenic modifications associated aging presented role sirts reducing consequences improving range parameters relate better health including neuroprotection review continues importance diet health including protective nature phytochemicals like “ polyphenolic substances resveratrol quercetin curcumin fisetin natural nonpolyphenolic substances berberine ” p 2 molecules related expression activity sirts studies exemplify activation sirts resveratrol quercetin berberine curcumin fisetin reviewed focusing signaling pathways involved conclusion focuses activation sirts natural crms might explain role molecules preserving improving health bioavailability mentioned phytochemicals hofer j davinelli bergmann scapagnini g madeo f 2021 caloric restriction mimetics nutrition clinical trials frontiers nutrition 8 717343 httpsdoiorg103389fnut2021717343 hofer colleagues 2021 focus availability crms nutrition although nutrition essential health relative lack agreement regarding definition healthy diet cr presented point consensus debate crms defined “ pharmacologically active substances mimic cr ’ myriads effects core crm definition others argue potential crmimicking compounds principle increase life andor healthspan ameliorate ageassociated diseases model organisms thus often simultaneous use term ‘ antiaging substances ’ ” p 2 table sources nutritional crms provided several classes glycolysis inhibitors hydroxycitric acid nad precursors polyamines polyphenols salicylic acid example studies classes crms examined conclusion elaborates need studies examining points uncertainty confirming beneficial effects crms humans moosavi f hosseini r saso l firuzi 2016 modulation neurotrophic signaling pathways polyphenols drug design development therapy 10 2342 doi 102147dddts96936 moosavi et al 2016 focus neurotrophic actions polyphenols first sources health protective role polyphenols relation different diseases including neurodegenerative ones presented distinguishing different neurotrophic functions polyphenols eg neuroprotection neuronal proliferation antioxidant effect details provided signaling pathways eg trk mtor erk pi3k creb nrf2 targeted different polyphenols eg curcumin quercetin egcg carnosic acid neurotrophic factors affected bdnf nerve growth factor – ngf glial cell linederived neurotrophic factor functions achieved eg antidepressantlike effects cognition enhancement attenuation neuronal degeneration oluwole fernando w b lumanlan j ademuyiwa jayasena v 2022 role phenolic acid tannins stilbenes lignans flavonoids human health – review international journal food science technology 5710 6326–6335 httpsdoiorg101111ijfs15936 oluwole et al 2022 focuses role different polyphenol subclasses tannins phenolic acid lignans flavonoids stilbenes classification large variety polyphenols flavonoid vs nonflavonoid depends quantity phenols molecule contains functions uses mentioned subclasses summarized phenolic acids defined biological functions mentioned antioxidant eg ros scavenging gastroprotective antidiabetic cardioprotective chemopreventive eg lipid protein metabolism antimicrobial antiinflammatory role prevention neurodegeneration neuronal injury detailed next tannins presented antimicrobial antiviral antimutagenic properties well role diabetes stilbenes discussed mention chemopreventive properties eg antioxidant antiinflammatory role obesity diabetes well prevention neurodegeneration discussion continues lignans chemopreventive eg hormone regulation inhibition cell growth cardioprotective antimicrobial properties finally flavonoids defined biological functions eg antioxidant regulation hydroperoxides mention properties inhibition lipid peroxidation chemoprevention eg protective role cancer antimicrobial antiviral protection cardioprotection hepatoprotection antiinflammation antineurodegeneration rendeiro c rhodes j spencer j p 2015 mechanisms action flavonoids brain direct versus indirect effects neurochemistry international 89 126139 httpsdoiorg101016jneuint201508002 rendeiro et al 2015 examine mechanisms action flavonoid polyphenols context prevention neurodegenerative diseases elevation serum nitric oxide one benefits flavonoids bioavailability flavonoids metabolites brain mentioned relation ability cross bbb several flavonoid metabolites detected brain supports requirement neuroprotection human cognition influenced flavonoids reported benefits several groups flavonoids mentioned mechanisms action flavonoids ie modulation synaptic plasticity pathways action discussed including indirect mechanisms relate improvement neurovascular system cerebrovascular functioning eg blood oxygenation levels increased brain vascularization increased nitric oxide bioavailability notably correlational nature reported association discussed need research improves mechanistical assumptions relying upon strong empirical evidence already available neither long term effects flavonoids yet thoroughly investigated humans recommended daily dose also discussed zhang lx li cx kakar u khan wu pf amir r dai df naveed li qy saeed shen jq rajput li jh 2021 resveratrol rv pharmacological review call research biomedicine pharmacotherapy 143 112164 httpsdoiorg101016jbiopha2021112164 zhang et al 2021 focus pharmacological actions resveratrol stilbenoid polyphenol first brief presentation resveratrol proposed list functions eg cardioprotection reduction neurotoxicity brief mention signaling pathways involved eg reduction oxidative stress improvement mitochondrial health next chemical structure resveratrol presented mention important nutritional sources eg tomatoes peanuts red grapes different berries pomegranates cranberries dark chocolate intake recommendations presentation continues pharmacokinetics resveratrol including metabolization liver plasma concentration distribution different organs mechanisms action explained focusing detail signaling pathways supports regulation finally health perspective resveratrol proposed form synthesis focusing antioxidant antiinflammatory actions well role protection neurodegenerative diseases among others moradi z jalili f farhadian n joshi wang zou l cao h farzaei h xiao j 2022 polyphenols neurodegenerative diseases focus neuronal regeneration critical reviews food science nutrition 6213 3421–3436 httpsdoiorg1010801040839820201865870 moradi et al 2022 focus neuronal regeneration following polyphenol intake following mention scarcity organ donation importance regenerative medicine review continues explanations nervous system diseases ad pd hd als therapy notably focusing cytokines growth factors neurotrophic factors stem cells next therapeutic effects polyphenols neurodegenerative disorders examined distinguishing flavonoids isoflavones phenolic acids tannins classes polyphenols benefits investigated mechanisms action detailed ros scavenging reduced betaamyloid accumulation regulation apoptosis gene expression example studies regenerative effect polyphenols proposed focusing single multiple molecules role stem cells neuronal regeneration examined “ stem cell therapy one important branches regeneration medicine enhanced researcher ’ hope treat improve condition patient varying debilitating diseases ” p 4 examples studies provided neuronal regeneration chemical stimulation emerging role gene therapy presented neuronal perspective addresses role polyphenols regeneration antioxidative properties polyphenols potential improvements neurogenesis neuronal connectivity nerve damage neuron survival notably stemming variety polyphenols presented next finally challenges future perspectives field discussed potential mentioned treatments alleviating consequences aging highlighted grewal k singh g sharma sharma v singh rahman md h najda walasekjanusz kamel albadrani g akhtar f saleem abdeldaim 2021 mechanistic insights perspectives involved neuroprotective action quercetin biomedicine pharmacotherapy 140 111729 httpsdoiorg101016jbiopha2021111729 grewal et al 2021 delineate mechanisms neuroprotection quercetin flavonoid polyphenol neuroprotective effect polyphenols notably reduced oxidative damage reduction risks several neurodegenerative diseases examined nutritional sources quercetin eg red onion garlic apple pomegranate chemical formula pharmacological action presented neuroprotective effect quercetin enhanced nanoemulsion pathogenesis neurodegenerative diseases discussed notably involves mitochondrial dysfunction oxidative stress elevated apoptosis inflammation review elaborates different neurodegenerative diseases quercetin shown reduce risks symptoms proposed mechanisms action eg alzheimer ’ disease improvement neuroinflammation oxidative stress amyloid plaques cholinesterases notably parkinson disease improvement neuroinflammation oxidative stress apoptosis autophagy notably huntington disease improvement neuroinflammation oxidative stress cognitive deficits neuronal dysfunction notably finally signaling pathways influenced quercetin detailed among others paraoxonase 2 pon2 nuclear factor erythroid 2related factor 2 nrf2 adenylateuridylaterich elements ravula r teegala b kalakotla pasangulapati j p perumal v boyina h k 2021 fisetin potential flavonoid multifarious targets treating neurological disorders updated review european journal pharmacology 910 174492 httpsdoiorg101016jejphar2021174492 ravula et al 2021 provide updated review neuroprotective neurogenerative impact flavonoid polyphenol fisetin neurological diseases leading cause disability mortality difficulty therapy diseases discussed complementary role flavonoids treatment neurodegenerative disorders presented mention “ potential flavonoids antioxidants antiviral antiinflammatory anticarcinogenic antibacterial neurotrophic neuroprotective immunestimulants ” p 2 functions fisetin particular prevention neurodegeneration mentioned reduced neuroinflammation improved immune response optimization signaling pathways disrupted aging neurodegenerative disorders research showing fisetin effective improving cognition presented followed mechanisms affected fisetin discussed main text review ‘ modulation cdk5p35 ’ associated neuroinflammation synaptic damage notably neuronal death ‘ regulation eicosanoids ’ proinflammatory lipid componds ‘ saving atpase ’ important homeostasis impaired oxidative stress ‘ fisetintfeb—mtorc1nrf2 linkage ’ role autophagy notably ‘ modulation kelchlike echassociated protein 1 keap 1 nuclear factor erythroid 2related factor 2 nrf2 antioxidant response elements pathway ’ control xenobiotic damage oxidative stress maintenance enegery metabolism redox balance cells ‘ regulation advanced glycation end products ages ’ inhibit protein functions impair antioxidant enzymes aggregate proteins notably well ‘ modulation creb ’ involved learning memory ‘ nad degradation ’ see ‘ restauration synaptic proteins ’ ‘ elevation acetyl coa ’ involved glycolysis fatty acid synthesis oxidation abnormalities acetylcoa lead dementia precursor neurotransmitter acetylcholine ‘ modulation nfkb ’ proinflammatory regulates cytokine expression involved neurodegeneration research fisetin relation neurodegeneration summarized table 1 figure 7 indicates fisetin decreases inhibits among others lipid peroxides il6 tnfalpha nfkb nitric oxide superoxides serum homocysteine increases activates among others bdnf acetylcholine butyrylcholine serotonine noradrenaline nrf2 trkb mekerk nutrients inducing neurotrophic effects several molecules considered crms neurotrophic effects molecules briefly introduced continuation annotated bibliography heberden c 2016 modulating adult neurogenesis dietary interventions nutrition research reviews 29 163–171 modulation adult neurogenesis polyphenols n3 polyunsaturated fatty acids examined heberden et al 2016 potential human brain regenerate might less rodents limited specific areas neural stem cells presented subgranular zone dentate gyrus subventricular zone lateral ventricle median eminence hypothalamus regulators effectors neurogenesis neurotrophins growth factors examined mention concentrated nature neural stem cells niches role leptin promoter neural stem cell proliferation well peptide hormones highlighted detrimental effect aging neurogenesis examined following dietary influences process unfavorable effects overnutrition addressed notably terms proliferation survival new neurons potential dietary intervention polyphenols see also n3 polyunsaturated fatty acids addressed beneficial terms neural stem cell proliferation differentiation neurogenesis arborization new neurons targets signaling pathways involved detailed ampk bdnfcreb nfkb sirt1 gut microbiota presented potential effector nutrition induced adult neurogenesis instance action metabolism inflammation carneiro oliveira b p alves r c 2021 neuroprotective properties coffee update trends food science technology 113 167179 httpsdoiorg101016jtifs202104052 carneiro et al 2021 provide updated systematic literature review neuroprotective effects coffee stimulant properties cns presented factor contributing large worldwide consumption coffee health benefits coffee also mentioned aims review synthesize literature relating coffee consumption reduction risk neurodegenerative disorders mechanisms involved 1000 components coffee important presented studied caffeine antagonist inhibitory neurotransmitter adenosine notably explains stimulant properties coffee another important compound trigonelline related neuroprotection neurotransmitter serotonin also compound coffee coffee also contains polysaccharides impact gut microbiome enhances cognitive function antioxidants cafestol kahweol nicotinic acid b3 component roasted coffee components enumerated health benefits mentioned eg antioxidant antiinflammatory anticarcinogenic next role coffee prevention several neurodegenerative diseases examined instance reduction excitotoxicity oxidation inflammation caffeine prevention memory impairments trigonelline phenolic components components coffee neuroprotective properties also mentioned research protective role coffee risk different neurodegenerative diseases detailed positive global health impact coffee notably relation neurodegenerative disorders discussed chen x ghribi geiger j 2010 caffeine protects disruptions bloodbrain barrier animal models alzheimer ’ parkinson ’ diseases journal alzheimer ’ disease 20s1 s127–s141 httpsdoiorg103233jad20101376 chen et al 2010 focus protective role caffeine regards integrity bbb one neuroprotective effects caffeine function bbb isolate brain toxins notably structure bbb first described disruption bbb mentioned one causes onset ad notably result high cholesterol levels potentially pd bbb disruption occurring loss dopaminergic neurons characteristic pd three mechanisms caffeine believed protect bbb examined notably “ blocking cell surface adenosine receptors inhibition camp phosphodiesterase pde activity affecting release calcium intracellular stores ” p s131 next integrity bbb chronic caffeine consumption might explain part neuroprotective effect caffeine examples relating instance better memory cognition reduced loss dopaminergic neurons indicators effect provided protective actions caffeine bbb mentioned primary comparison neuroprotective actions caffeine cui x gooch h petty mcgrath j j eyles 2017 vitamin brain genomic nongenomic actions molecular cellular endocrinology 453 131143 httpsdoiorg101016jmce201705035 cui et al 2017 examine role vitamin brain development neuroprotection immunity vitamin presented developmental neurosteroid positively involved brain development neuroprotection signaling functions vitamin vitamin receptor vdr detailed brain morphology physiology importantly linked vitamin goals review presented examination actions vitamin “ brain cell differentiation neurotransmitter release calcium signaling via genomic nongenomic functions ” p 132 vdr distributed brain rodent models discussed first “ pattern vdr distribution indicates vitamin may involved proliferation andor differentiation neuronal stem cells ” p 132 human brain “ vdr protein also identified human brain distribution pattern vdr found strikingly similar reported rodents p 133 genomic actions vitamin addressed particular involvement apoptosis cell proliferation neural growth role vitamin regulation development dopaminergic neurons cells differentiation adult neural stem cells myelination also examined effect vitamin neuronal survival programmed glioma cell death neurotransmitter release addressed followed neuroprotective effects vitamin aged brain relation neurotrophic factors bdnf notably next mention made vitamin compensate neuroinflammation aging brain well immune response also “ vitamin could potentially increase local estrogen synthesis glial cells important maintain neuronal function ” p 137 nongenomic functions vitamin underexplored area examined includes role vitamin regulation calcium kinase activated pathway signaling recently discovered developing cortex modulatory effects vitamin neuroprotective properties therapeutic potential vitamin negative consequences deficiencies vitamin finally discussed",
    "relevance_score": 0.81,
    "date_score": 0.0,
    "final_score": 0.405,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Unknown Author",
    "date": "2014-12-10T01:14:50",
    "filename": "1407.7622.pdf",
    "processed_text": "starvation cancer via induced ketogenesis severe hypoglycemia adam kapelner\u00031and matthew vorsangery2 1department mathematics queens college city university new york 2department cardiology new york university abstract neoplasms highly dependent glucose substrate energy production generally able catabolize fuel sources ketones fatty acids thus removing access glucose potential starve cancer cells induce apoptosis unfortunately body tissues also dependent glucose energy normal conditions however human starvation setting dietinduced ketogenesis body ketoadapts glucose requirements tissues drop almost nil exceptions include central nervous system cns various tissues small obligatory requirement glucose hypothesized treatment takes ketoadaptation prerequisite propose induction severe hypoglycemia depressing gluconeogenesis administering glucose brain although severe hypoglycemia normally produces adverse e ects seizure coma relatively safe following ketoadaptation hypothesize therapeutic hypoglycemia treatment potential rapidly induce tumor cell necrosis 1 introduction 1924 otto heinrich warburgs nobelprize winning research demonstrated neoplastic cells rely anaerobic glycolysis metabolic needs almost century later results implications ndings still hotly debated accepted tumors derive vast majority energy glucose major weakness attractive target therapeutic intervention however basic physiology dictates normal cells would also starved severe hypoglycemia targeting cancer exploiting metabolic weakness proven fruitful date1in fact cancer treatment \u0003electronic address kapelnerqccunyedu yelectronic address matthewvorsangernyumcorg 1there renewed interest success positron emission tomography diagnostic tool detects glucose uptake making use 18 uorine 2deoxyglucose 1arxiv14077622v2 qbioot 8 dec 2014moved away broadly cytotoxic modalities towards highly targeted therapies aggarwal 2010 treatments choice include monoclonal antibodies tyrosine kinase inhibitors induction speci c immune responses well others paper reexamine possibility therapeutic hypoglycemia antineo plastic treatment simultaneously delivering glucose body tissues require main hypothesis alterations metabolism occur starvation state namely neurologic adaptation hypoglycemia provide means safely inducing hypo glycemia course proposal mutually exclusive standard treatments radiation chemotherapy dietary supplementation outline paper follows section 2 provides background cancer cell metabolism reviews known cytotoxic e ects hypoglycemia cancerous cells justify assumptions needed hypothesized treatment litera ture next two subsections prerequisites understanding implementation hypothesized treatment section 31 discusses bodys theoretical minimum glucose requirements starvation well concept tissue ketoadaptation section 32 discusses ketogenic dieting viable alternative starvation retaining bodywide minimal glucose needs outline severe hypoglycemia therapy detail section 33 section 4 concludes discusses extensions well potential concerns 2 background cancer result multiple changes delicate balance cell function root cause neoplastic transformation still serious debate many theories cancer primarily genetic disease vogelstein et al 2013 cancer disease aberrant metabolism due dysfunctional respiration malfunctioning mitochondria seyfried shelton 2010 cancer due overproduction reactive oxygen species oleksyszyn et al 2014 well others regardless cause majority neoplastic cells feature aberrant glucose meta bolism rst discovered warburg et al 1924 known warburg e ect normal cells metabolize glucose two steps first glucose broken create pyru vate small amount adenosine triphosphate atp cytosol glycolysis second pyruvate shuttled mitochondria fully oxidized water carbon dioxide krebs cycle even enough oxygen cancer cells seem advance beyond cytosolic glycolysis employ vastly e\u000ecient factor 17 1 oxidative phos phorylation instead divert pyruvate produce lactic acid oxymoroni cally known aerobic glycolysis cancer cells ferment even conditions normoxia potential cause aberrant metabolism cancer cells fraction mitochondria available normal cells mitochondria structurally defective see review pedersen 1977 see elliott barnett 2011 electron microscopy study mitochondria breast carcinoma others say cause damaged glycolysis regulation koppenol et al 2011 regardless roads origin progression cancer pass mitochondria hallmark cancer malfunction oxidative phosphorylation varying degrees seyfried et al 2014 implies cancer cells access nonglycolytic fuels demand full 2oxidative combustion krebs cycle namely fatty acids ketone bodies beta hydroyxbutyrate ohb acetoacetate holm et al 1995 sawai et al 2004 two sub strates key players hypothesized treatment chang et al 2013 demonstrated glioma cells investigation lack enzymes break ketones evi dence may explain introduction healthy mitochondria cancer cell cytoplasm halts carcinogenesis see seyfried 2012 chapter 11 review studies relevant point hypothesis glucose predominant energy substrate cancers gullino et al 1967 glycolytic rates 8200 times higher normal tissues phelps 2004 chapter 5 producing 10 atp normal cells koppenol et al 2011 cancer large fuel requirement due high proliferation rate large need antioxidants addition high glucose consumption necessary inter mediaries required biosynthetic pathways ribose nucleotides glycerol pyruvate citrate lipids amino acids nicotinamide adenine dinucleotide phosphate nadph via pentose phosphate pathway deberardinis et al 2008 glycolysis exclusive source energy cancer hotly debated may true cancers throughout lifespan tumors may varied bioenergetic pro les may glycolytic andor oxidative jelluma et al 2006 morenos\u0013 anchez et al 2007 martinezoutschoorn et al 2011 jose et al 2011 carracedo et al 2013 purposes article address majority neoplasms consensus holds exclusively glycolytic await future research elucidate cancer lines hypothesized treatment applicable thus cancer particularly vulnerable glucose glycolytic substrate depriva tion starving cancer glucose novel idea proposals treat cancer via serum hypoglycemia date back editorial new york times 1887 abundant recent literature woolf scheck 2014 simone et al 2013 fine et al 2012 2008 seyfried et al 2008 mavropoulos et al 2006 kim et al 1978 another idea would inhibit glycolysis eg ganapathykanniappan et al 2010 strategy propose due universal cytotoxicity even though idea cancer starvation commonplace well designed studies evaluating premise exist simone et al 2013 argues absence clinical trials due unclear diet implementation protocols financial concerns also likely explanation time resources needed produce highquality clinical trial unlikely therapeutic hypoglycemia would produce adequate returnoninvestment pharmaceutical company time writing trials proposed eg tanshalaby seyfried 2013 list found table 2 simone et al 2013 many uncontrolled studies optimistic example zuccoli et al 2010 details account woman spontaneous remission ie sudden disappearance cancer glioblastoma multiforme two months diet formulated lower serum glucose niakan 2010 concluded 1000 similar spontaneous remission likely due hypoglycemia hypoxia arguably direct consequence hypoglycemia preclinical animal studies demonstrate promising results cutting cancers nutrient supply mukherjee et al 2002 2004 zhou et al 2007 otto et al 2008 mavropoulos et al 2009 shelton et al 2010 sta ord et al 2010 de lorenzo et al 2011 sivananthan 2013 jiang wang 2013 however studies inconclusive eg masko 3et al 2010 many creative invitro studies glucose starvation demetrakopoulos et al 1978 tumor cells found highly sensitive glucose deprivation spitz et al 2000 found glucose withdrawal induces cytotoxicity transformed broblasts colorectal cells argue result oxidative stress buzzai et al 2005 demonstrated activation commonly expressed oncogene akt prevents cancer cells metabolizing nonglycolytic substrates jelluma et al 2006 performed rst study glucose drawal gliobastoma multiforme cells found 90 cell death 24 hours death due atp depletion could rescued free radical scavenger thereby lending credence oxidative stress theory aykinburns et al 2009 demonstrated glucose deprivation induce cytotoxicity human breast cancer cells colon cancer cells invivo argue results due cancer unable synthesize reducing agents nadph pyruvate needed en masse detoxi cation high concentrations free radicals due mitochondrial abnormalities li et al 2010 observed growth inhibition apoptosis lung broblasts glucose restriction priebe et al 2011 demonstrated cell death ovarian cancer also graham et al 2012 demonstrated glucose withdrawal slows proliferation induces hyperthermia possibly induces cancer cell death four gliobastoma cell lines proposal natural extension previous cancer starvation proposals propose ketogenic diet allows safe induction severe hypoglycemia via gluconeogenesis attenuation serum levels propose lower ever proposed past order starve cancer cells rapidly turn detailing therapy 3 hypothesis next two sections provide background material human starvation ketogenic dieting necessary understanding hypothesized treatment detail section 33 31 starvation minimizing bodys glucose needs bodys glucose requirements minimized periods starvation consti tutes drastic transformation bodys energy metabolism broadly speaking starvation stages outlined table 1 normally end rst day hepatic glycogen stores depleted liver lesser extent kidneys begin produce glucose pyruvate glycerol amino acids vast majority tissues body skeletal muscle heart organs facultative choice substrate energy production period glucose scarcity cut glucose metabolism increase metabolism free fatty acids ffas starvation even early stage forces body tissues switch glycolysis lipid oxidation energy needs ketone bodies ohb acetoacetate acetone always present blood days starvation begin produced large quantities liver tissues body metabolize ketones exception acetone 4stage physiological time starvation description period 1 gastrointestinal absorption 1 day 2 glycogenolysis 2 days 3 gluconeogenesis \u00152 days 4 ketosis \u00153 days 5 prolonged decreased gluconeogenesis increased \u001514 days cerebral ketone consumption table 1 stages starvation time last ingestion reprinted slight modi cations cahill 1983 page 2 special interest stage 5 prolonged starvation two weeks longer cells long since cut uptake glucose also cut uptake ketones change coupled increased bloodbrainbarrier permeability ketones morris 2005 call ketoadaptation stage 5 cells rely purely ffas metabolic requirements robinson williamson 1980 however tissues still retain need glucose even ketoadaptation largest consumer brain cns whose health vital success hypothesis2 much glucose brain need typical brain glucose requirement approx imately 144 gday cahill 1970 figure 1 preferential utilization obligatory utilization point crucial hypothesis ketoadaptation brain glucose requirement drops approximately 44 gday cahill 1970 figure 53 supplies energy di erence approximately 100 gday glucose previously supplied ketone bodies ohb acetoacetate 61 proportion owen et al 1967 table 5 note brain metabolize ffas owen et al 1967 table 44in stage 5 starvation ketone blood levels surge 2597 mmoll contrast negligible level 001 mmoll nonstarving subjects brain readily use ketone bodies available even nonfasting periods condition ketone usage negligible sokolo 1973 morris 2005 suspects brains ketone metabolism evolutionarily developed ensure survival times glucose scarce 2note erythrocytes leukocytes bone marrow also solely rely glucose employ glycolysis thus lactate pyruvate waste products reconstituted glucose via cori cycle liver using energy supplied breakdown lipids therefore tissues zero netglucose consumption 3it known average brain less 44 gday glucose assume body get away providing less would gram glucose conserved one gram protein conserved protein sparing essential starvation since protein mans precious machinery vital cellular structure function depletion reserves limit longterm survival even massive lipid depots question also asked follows ketones unable provide 100 brains energy requirements answer unknown posit two theories first may incomplete ohb acetoacetate transport cells cns morris 2005 second ohb acetoacetate converted energy via oxidative phosphorylation mitochondria organelles scant long thin myelinated axons waxman et al 1995 page 17 posit brains energy production must default glycolysis axoplasm 4this mystery ffas able cross bloodbrainbarrier brain equipped betaoxidation enzymes combustion morris 2005 5cahill 1970 suspects body tissues slash ketone consumption favor ffas ensure adequate substrate brain cahill veech 2003 argue metabolic adaptation ketones exist homo sapiens could developed large advanced brain fuel metabolism stage 5 starvation illustrated figure 1 special interest inventory sources gluconeogenesis provide 44 gday cns requirement stored triacylglycerols 15g amino acids taken muscle tissue lesser extent tissues 20g pyruvate lactate 14g end product anaerobic glycolysis thus third glucose starvation burned cns recycled back glucose via cori cycle figure 1 fuel sources sinks daily metabolism stage 5 starvation assuming 1500 calorie resting metabolism inspired cahill 1970 figure 5 starvation useful tool minimize glucose needs body tissues fasting relatively safe stewart fleming 1973 unpleasant leads muscle wasting weight loss serious concerns cancer patients minimize bodys glucose needs avoiding undesired e ects turn solution next section 32 ketoadaptation via 41 ketogenic diet means emulate metabolic conditions starvation still ingesting food engineering problem faced 1920s expert childhood epileptologist dr 6russel wilder observed shortterm starvation therapeutic children intractable epilepsy obviously impractical longterm solution innovated ketogenic diet kd mimics characteristic starvation metabolism outlined section 31 still used today reduce seizures historical account recent clinical trial see neal et al 2008 wilders kd high fat low protein low carbohydrate diet mcdonald 1998 mimic starvation strict macronutrient proportions required called 41 kd carbohydrate must limited 20 gday amount muscle tissue provides prolonged starvation protein must limited amount set normal nonstarvation protein turnover estimated 25 gday 70kg person national research council us food nutrition board 1989 additional protein potential gluconeogenic thereby avoided calories must supplied fats5commercial formulas diet readily available physiological markers prolonged 41 kd exactly markers prolonged starvation depending macronutrient proportions serum glucose slightly higher ketone levels slightly lower phinney et al 1983 assume 41 kd equivalent ketoadapted metabolism observed prolonged starvation described section 31 glucose uptake minimization increased cerebral ketone uptake exclusive use ffas energy production every tissue body thus kd achieve starvation metabolism adaptation without unpleasant side e ects hunger muscle loss simone et al 2013 also reviews bene ts kd muscle sparing pos sibly even muscle synthesis bene cial cancer patients risk cachexia kd generally welltolerated minimal side e ects constipation salt loss mild acidosis increased incidence kidney stones employed chronically demonstrated safe even patients advanced cancer schmidt et al 2011 kosso et al 2007 reports longest duration continuous kd 21 years vir tually side e ects also evidence ketones right directly toxic cancer magee et al 1979 skinner et al 2009 fine et al 2009 improve immune systems ability target cancer husain et al 2013 added bene kd work tandem hypoglycemia strategy hypothesized treatment begins cancer patient administered 41 kd 14 days allow ketoadaptation proposed acute treatment begun turn implementation details 33 proposed treatment section 2 discussed previous literature experimented starvation kd cancer therapy via glucose starvation believe studies reduce serum glucose levels su\u000ecient starve cancer kd plasma glucose concentration falls 5we detail calculation 90 calories supplied triglycerides esters three fatty acid chains one glycerol 110th fat calories derived directly gluconeogenic glycerol thus 81 dietary calories supplied fatty acids 9 10 19 substrates yielding ratio 81 19\u00194 1 7only mildly remaining normal range normalweight individuals thus simple tumor glucose starvation therefore unlikely humans fine et al 2008 serum glucose prolonged starvation drops 65mgdl cahill 1970 table 2 prolonged 41 kd also result similar serum level unclear reduction blood glucose level similarly welltolerated keto adaptation adult cerebral blood ow approximately 750mlmin 013 dls implies 81mgs glucose potentially delivered brain section 31 noted brain obligatory requirement 44 gday 051 mgs6which 6 glucose available serum concentration 65 mgdl although experiments evaluating glucose extraction ratio human subjects limited animal studies suggest brain able extract 40 serum glucose hypoglycemic state mccall et al 1986 thus theorize body conservative serum glucose concentrations level 051 mgs actively transported neurons mere moments result cns damage 65 mgdl comfortably threshold evidence conjecture ketoadapted subjects survive serum glucose much lower 65mgdl hypoglycemia reported therapeutic fasting starvation 100 years chakrabarty 1948 investigated 407 starvation cases bengal famine nd 20 chronic blood sugar 40 mgdl symptoms hypoglycemia stewart fleming 1973 supervised world recordsetting 382day therapeutic fast found blood glucose became stable 30 mgdl dropping intermittently 20 mgdl without symptoms relevant evidence hypothesis observation intentional acute hypoglycemia induction drenick et al 1972 ketoadapted obese patients via 4560 days starvation perfused insulin within hour observed serum glucose low 9 mgdl without acute hypoglycemic symptoms serum glucose low would normally induce coma even observed blood sugar high 4049 mgdl according benami et al 1999 figure 3 plan simple ketoadaptation 41 kd propose acutely tenuate serum glucose concentration severely hypoglycemic levels observed drenick et al 1972 patientbypatient basis since insulin required cancer cells fuels metabolism iqbal et al 2013 also impede ketogenesis choose induce hypoglycemia via insulin perfusion drenick et al 1972 instead propose use gluconeogenesis inhibitor one possible inhibitor diabetic drug metformin inhibits gluconeogensis directly metformin may anticancer e ects jalving et al 2010 figure 3 certainly supporting epidemiological evidence metformins therapeutic e ect cancer ben sahra et al 2010 reasons proposed use hy pothesized treatment similar see oleksyszyn 2011 oleksyszyn et al 2014 however metformin many drawbacks first potent inducer hypo glycemia doses normally administered metformin also slow acting rapidly titratable additionally drug activates adenosine monophosphate activated pro 6this calculation within 20 brain arteriovenous glucose di erence observed starving subjects owen et al 1967 table 5 8tein kinase may e ects metabolism ketoadaptation see jalving et al 2010 figure 2 lastly supratherapeutic doses associated fatal lactic acidosis due shortcomings propose using drug pure liverkidney gluco neogenesis inhibitor luckily drugs investigated diabetes community high endogenous glucose production considered one characteristics disease therefore therapeutic target many control points within gluconeogenesis unidirectional synthesis fructose6phosphate fructose16bisphospate prudent point interrupt cause removed glycogenolysis mitochondrial function thus would fewest side e ects synthesis controlled via ratecontrolling enzyme fructose16 bisphosphatase two inhibitors clinically evaluated named cs917 mb07803 van poelje et al 2011 good safety pro les exibly attenuate gluconeogenesis desired level returning discussion target level hypoglycemia comment know e ective dose ed curves serum glucose levels tumor necrosis lethal dose ld curves human body death ketoadaptation possible 9 mgdl glucose concentration may high toxic cancer proves case hypoglycemia would need safely induced treatment e\u000ecacy turn since brain tissue obligatory glucose requirement opt direct perfusion glucose brain intraarterially via carotid arteries rate necessary provide minimum brain glycolytic needs perfusion glucose directly brain performed successfully rats borg et al 1997 baboons conway et al 1969 brain receives required glucose propose increase dose gluconeogenic inhibitor drug attenuate serum glucose negligible level safe enough erythocytes blood marrow leukocytes survive brain would perceive normoglycemia everywhere outside brain serum would extremely hypoglycemic necessary also perfuse ohb tandem risk level ketosis su\u000eciently high cns metabolic needs protocol would require extensive proofofconcept work animal models attempt undertake study human subjects reader may wonder strategy would e ective brain cancer since brain still receiving glucose seyfried et al 2003 reports data supporting treatment may e ective since glucose uptake brain cancers drops lower serum glucose cancer metabolize ketones may even toxic fast could procedure induce tumor death echo oleksyszyn et al 2014 idea deep hypoglycemia needs trigger spontaneous remission estimates drawn data invitro studies thus general izable human prognoses spitz et al 2000 figure 2 reports 55 near 100 necrosis rates three cancer lines within 48hr total glucose deprivation complete withdrawal possible human body reasons explained treatment could deliver minimum serum levels estimated 5 mgdl 94 discussion propose therapy starving cancer inducing ketoadaptation followed duction therapeutic hypoglycemia via gluconeogenesis inhibitor drugs propose rescue cerebral glucose infusion direct catheterization brainss blood supply would followed increase gluconeogenic inhibitor drug lower serum glucose even noncerebral tissues main concern person unique metabolic entity seyfried et al 2014 calculations presented throughout manuscript meant illustrative average person individual personalized dosing administration schedules require iterative netuning proper monitoring associated costs concern hypoglycemia risky might necessarily require monitoring setting intensive care unit patients diabetic ketoacidosis frequently treated insulin infusion outside intensive care unit although costs diet medications needed induce hypoglycemia proposal might far lower cost novel chemotherapeutic agents cost close monitoring may substantially erode bene several concerns speculative treatment cancer heteroge neous predictors currently available individual tumors response hypoglycemia research suggesting cancer cells make use ketones ffas cancer lines proliferate rapidly intense anabolism mandatory jose et al 2011 hypothesized treatment would work cancer lines known whether proposed hypoglycemic levels sustained long periods time without symptoms starvation research suggests hypoglycemia safe long term accounts documented serum levels many times proposed serum level predominantly documented obese subjects without cancer important consideration whether ketoadaptation additionally protects neu rohormal cardiovascular electrophysiologic consequences hypoglycemia frier et al 2011 additionally glucose sole nutritive substrate cancer cells instance glutamine also serve major metabolite yuneva 2008 well fermentation amino acids assume hypothesis glucose necessary metabolite metabolites neither availability capability transported volumes necessary serve replacements lastly times body need glucose ammation infection limits setting hypothesized treatment also fair chance proposed treatment e ective provided tandem therapies instance abdelwahab et al 2012 demonstrated brain cancer mice curtailed recur simultaneous administration 41 kd radiation therapy allen et al 2013 demonstrated 41 kd enhances radiochemotherapy mice models lung cancer see klement champ 2014 discussion kd act synergistically radiation therapy also lee et al 2012 demonstrated fasting enhances chemotherapy po et al 2013 demonstrated hyperbaric oxygen therapy enhanced kd alternative adjuvant therapies may also fruitful example majumdar et al 2009 demonstrated combination curcumin resveratrol could e ective therapy 10in colorectal cancer singh lai 2004 demonstrated cancer apoptosis wormwood extract tin et al 2007 demonstrated astralagus saponins inhibit colorectal cancer cell proliferation many supplements administered simultaneously hypoglycemia treatment acknowledgements would like thank justin bleich stephen kapelner helpful discussions com ments manuscript would like thank marie le pichon illustrating figure 1 adam kapelner acknowledges support national science foundations graduate search fellowship well support simons foundation autism research initiative references abdelwahab g fenton k e preul c rho j lynch sta ord p scheck c 2012 ketogenic diet e ective adjuvant radiation therapy treatment malignant glioma plos one 75e36197 aggarwal 2010 targeted cancer therapies nature reviews drug discovery 96427428 allen b g bhatia k buatti j brandt k e lindholm k e button szweda l smith b j spitz r fath 2013 ketogenic diets enhance oxidative stress radiochemotherapy responses lung cancer xenografts clinical cancer research o\u000ecial journal american association cancer research 1914390513 aykinburns n ahmad zhu oberley l w spitz r 2009 increased levels superoxide h2o2 mediate di erential susceptibility cancer cells versus normal cells glucose deprivation biochemical journal 41812937 benami h nagachandran p mendelson edoute 1999 druginduced hypoglycemic coma 102 diabetic patients archives internal medicine 15932814 ben sahra le marchandbrustel tanti jf bost f 2010 metformin cer therapy new perspective old antidiabetic drug molecular cancer therapeutics 9510921099 borg sherwin r borg w p tamborlane w v shulman g 1997 local ven tromedial hypothalamus glucose perfusion blocks counterregulation systemic hypoglycemia awake rats journal clinical investigation 9923615 buzzai bauer e jones r g deberardinis r j hatzivassiliou g elstrom r l thompson c b 2005 glucose dependence akttransformed cells reversed pharmacologic activation fatty acid betaoxidation oncogene 2426416573 cahill g veech r l 2003 ketoacids good medicine transactions american clinical climatological association 114149163 cahill g f 1970 starvation man new england journal medicine 282668675 11cahill g f 1983 starvation transaction american clinical climatological associa tion 94121 carracedo cantley l c pandol p p 2013 cancer metabolism fatty acid oxidation limelight nature reviews cancer 134227232 chakrabarty l 1948 bloodsugar levels slow starvation lancet 2516503596597 chang h olson l k schwartz k 2013 ketolytic glycolytic enzymatic expression pro les malignant gliomas implication ketogenic diet therapy nutrition metabolism 10147 conway j goodner c j werrbach j h gale c c 1969 studies substrate regulation fasting journal clinical investigation 4813491362 de lorenzo baljinnyam e vatner e abarz\u0013 ua p vatner f rabson b 2011 caloric restriction reduces growth mammary tumors metastases carcinogenesis 32913817 deberardinis r j sayed n ditsworth thompson c b 2008 brick brick metabolism tumor cell growth current opinion genetics development 1815461 demetrakopoulos g e linn b amos h 1978 rapid loss atp tumor cells deprived glucose contrast normal cells biochemical biophysical research communications 823787794 drenick e j alvarez l c tamasi g c brickman 1972 resistance symptomatic insulin reactions fasting journal clinical investigation 5110275762 elliott r barnett b 2011 ultrastructural observation mitochondria human breast carcinoma cells microscopy microanalysis 17suppl 2194195 fine e segalisaacson c feinman r sparano j 2008 carbohydrate restriction patients advanced cancer protocol assess safety feasibility accompanying hypothesis community oncology 512226 fine e j segalisaacson c j feinman r herszkopf romano c tomuta n bontempo f negassa sparano j 2012 targeting insulin inhibition metabolic therapy advanced cancer pilot safety feasibility dietary trial 10 patients nutrition 2810102835 fine r j miller quadros e v sequeira j feinman r 2009 acetoacetate reduces growth atp concentration cancer cell lines overexpress uncoupling protein 2cancer cell international 914111 frier b schernthaner g heller r 2011 hypoglycemia cardiovascular risks diabetes care 34 suppl 2s132s137 ganapathykanniappan vali kunjithapatham r buijs syed l h rao p p ota kwak b k lo roy r geschwind j f 2010 3bromopyruvate new targeted antiglycolytic agent promise cancer therapy current pharmaceutical biotechnology 1155107 12graham n tahmasian kohli b komisopoulou e zhu vivanco teitell wu h ribas lo r mellingho k mischel p graeber g 2012 glucose deprivation activates metabolic signaling ampli cation loop leading cell death molecular systems biology 8589116 gullino p grantham f courtney losonczy 1967 relationship oxygen glucose consumption transplanted tumors vivo cancer research 2710411052 holm e hagm uller e staedt u schlickeiser g gunther h j leweling h tokus kollmar h b 1995 substrate balances across colonic carcinomas humans cancer research 5513731378 husain z seth p sukhatme v p 2013 tumorderived lactate myeloidderived suppressor cells linking metabolism cancer immunology oncoimmunology 211e26383 iqbal siddiqui f gupta v chattopadhyay gopinath p kumar b manvati chaman n bamezai r n k 2013 insulin enhances metabolic capacities cancer cells dual regulation glycolytic enzyme pyruvate kinase m2 molecular cancer 12172 jalving gietema j lefrandt j de jong reyners k l gans r b de vries e g e 2010 metformin taking away candy cancer european journal cancer 461323692380 jelluma n yang x stokoe evan g dansen b haaskogan 2006 glucose withdrawal induces oxidative stress followed apoptosis glioblastoma cells normal human astrocytes molecular cancer research 45319330 jiang wang f 2013 caloric restriction reduces edema prolongs survival mouse glioma model journal neurooncology 11412532 jose c bellance n rossignol r 2011 choosing glycolysis oxidative phos phorylation tumors dilemma biochimica et biophysica acta 18076552561 kim h kim j h hahn e w 1978 selective potentiation hyperthermic killing hypoxic cells 5thiodglucose cancer research 3829352938 klement r j champ c e 2014 calories carbohydrates cancer therapy radi ation exploiting rs dietary manipulation cancer metastasis reviews pages 217229 koppenol w h bounds p l dang c v 2011 otto warburgs contributions current concepts cancer metabolism nature reviews cancer 115325337 kosso e h turner z bergey g k 2007 homeguided use ketogenic diet patient 20 years pediatric neurology 366424425 lee c ra aghello l brandhorst safdie f bianchi g martinmontalvo pistoia v wei hwang merlino emionite l de cabo longo v 2012 fasting cycles retard growth tumors sensitize range cancer cell types chemotherapy science translational medicine 4124124ra27 13li liu l tollefsbol 2010 glucose restriction extend normal cell lifespan impair precancerous cell growth epigenetic control htert p16 expression faseb journal 24514421453 magee b potezny n rofe conyers r 1979 inhibition malignant cell growth ketone bodies australian journal experimental biology medical science 57552939 majumdar p n banerjee nautiyal j patel b b patel v du j yu elliott levi e sarkar f h 2009 curcumin synergizes resveratrol inhibit colon cancer nutrition cancer 61454453 martinezoutschoorn u e prisco ertel tsirigos lin z pavlides wang c flomenberg n knudsen e howell pestell r g sotgia f lisanti p 2011 ketones lactate increase cancer cell stemness driving recurrence metastasis poor clinical outcome breast cancer achieving personalized medicine via metabologenomics cell cycle 108127186 masko e thomas j antonelli j lloyd j c phillips e poulton h dewhirst w pizzo v freedland j 2010 lowcarbohydrate diets prostate cancer low low enough cancer prevention research 3911241131 mavropoulos j c buschemeyer w c tewari k rokhfeld pollak zhao febbo p g cohen p hwang devi g demarkwahnefried w westman e c peterson b l pizzo v freedland j 2009 e ects varying dietary carbohydrate fat content survival murine lncap prostate cancer xenograft model cancer prevention research 2655765 mavropoulos j c isaacs w b pizzo v freedland j 2006 role lowcarbohydrate ketogenic diet management prostate cancer urology 6811518 mccall l fixman l b fleming n tornheim k chick w ruderman n b 1986 chronic hypoglycemia increases brain glucose transport american journal physiology 251e442e447 mcdonald l 1998 ketogenic diet complete guide dieter practitioner morris publishing austin tx morenos\u0013 anchez r rodr\u0013 \u0010guezenr\u0013 \u0010quez mar\u0013 \u0010nhern\u0013 andez saavedra e 2007 en ergy metabolism tumor cells febs journal 27461393418 morris 2005 cerebral ketone body metabolism journal inherited metabolic disease 28210921 mukherjee p abate l e seyfried n 2004 antiangiogenic proapoptotic e ects dietary restriction experimental mouse human brain tumors clinical cancer research 1056225629 mukherjee p elabbadi kasperzyk j l ranes k seyfried n 2002 dietary restriction reduces angiogenesis growth orthotopic mouse brain tumour model british journal cancer 8616151621 14national research council us food nutrition board 1989 recommended dietary allowances national academy press neal e g cha e h schwartz r h lawson edwards n fitzsimmons g whitney cross j h 2008 ketogenic diet treatment childhood epilepsy randomised controlled trial lancet neurology 765006 new york times 1887 sugar cancer dec 24 niakan b 2010 spontaneous remission cancer steady aggressive malignant growth faced hypoxia hypoglycemia medical hypotheses 7565056 oleksyszyn j 2011 complete control glucose level utilizing composition ketogenic diet gluconeogenesis inhibitor antidiabetic drug metformin potential anti cancer therapy medical hypotheses 7721713 oleksyszyn j wietrzyk j psurski 2014 cancer could cured spontaneous regression cancer cancer energy metabolism hyperglycemiahypoglycemia metformin warburg crabtree e ects new perspective cancer treatment journal cancer science therapy 06035661 otto c kaemmerer u illert b muehling b pfetzer n wittig r voelker h u thiede coy j f 2008 growth human gastric cancer cells nude mice delayed ketogenic diet supplemented omega3 fatty acids mediumchain triglycerides bmc cancer 8122 owen e morgan p kemp h g sullivan j herrera g cahill g f 1967 brain metabolism fasting journal clinical investigation 4610158995 pedersen p l 1977 tumor mitochondria bioenergetics cancer cells progress experimental tumor research 22190274 phelps e 2004 pet molecular imaging biological applications springer phinney bistrian b r wolfe r r blackburn g l 1983 human metabolic response chronic ketosis without caloric restriction physical biochemical adaptation metabolism 328757768 po ari c seyfried n dagostino p 2013 ketogenic diet hyperbaric oxygen therapy prolong survival mice systemic metastatic cancer plos one 86e65522 priebe tan l wahl h kueck g kwok r opipari liu j r 2011 glucose deprivation activates ampk induces cell death modulation akt ovarian cancer cells gynecologic oncology 122238995 robinson williamson h 1980 physiological roles ketone bodies substrates signals mammalian tissues physiological reviews 60114387 sawai yashiro nishiguchi ohira hirakawa k 2004 growthinhibitory e ects ketone body monoacetoacetin human gastric cancer cells succinylcoa 3oxoacid coatransferase scot de ciency anticancer research 24422137 15schmidt pfetzer n schwab strauss k ammerer u 2011 e ects keto genic diet quality life 16 patients advanced cancer pilot trial nutrition metabolism 8154 seyfried 2012 cancer metabolic disease origin management prevention cancer john wiley sons seyfried n flores r e po dagostino p 2014 cancer metabolic disease implications novel therapeutics carcinogenesis 35351527 seyfried n kiebish mukherjee p marsh j 2008 targeting energy metabolism brain cancer calorically restricted ketogenic diets epilepsia 49 suppl 81146 seyfried n sanderson elabbadi mcgowan r mukherjee p 2003 role glucose ketone bodies metabolic control experimental brain cancer british journal cancer 897137582 seyfried n shelton l 2010 cancer metabolic disease nutrition metabolism 77122 shelton l huysentruyt l c mukherjee p seyfried n 2010 calorie restriction antiinvasive therapy malignant brain cancer vm mouse asn neuro 23e00038 simone b champ c e rosenberg l berger c monti dicker p simone n l 2013 selectively starving cancer cells dietary manipulation methods clinical implications future oncology 97959976 singh n p lai h c 2004 artemisinin induces apoptosis human cancer cells anticancer research 24422772280 sivananthan p 2013 e ects ketogenic diet tumor progression breast cancer phd thesis icahn school medicine mount sinai skinner r trujillo x beierle e 2009 ketone bodies inhibit viability human neuroblastoma cells journal pediatric surgery 4412126 discussion 216 sokolo l 1973 metabolism ketone bodies brain annual review medicine 24271 280 spitz r sim j e ridnour l galoforo lee j 2000 glucose deprivationinduced oxidative stress human tumor cells fundamental defect metabolism annals new york academy sciences 899349362 sta ord p abdelwahab g kim preul c rho j scheck c 2010 ketogenic diet reverses gene expression patterns reduces reactive oxygen species levels used adjuvant therapy glioma nutrition metabolism 774 stewart w k fleming l w 1973 features successful therapeutic fast 382 days duration postgraduate medical journal 495692039 tanshalaby j seyfried 2013 ketogenic diet advanced cancer pilot feasibility safety trial veterans airs cancer patient population journal clinical trials 30447 16tin cho ch chan k james e ko j k 2007 astragalus saponins induce growth inhibition apoptosis human colon cancer cells tumor xenograft car cinogenesis 28613471355 van poelje p potter c erion 2011 diabetes perspectives drug therapy handbook experimental pharmacology 203279301 vogelstein b papadopoulos n velculescu v e zhou diaz l kinzler k w 2013 cancer genome landscapes science 3396127154658 warburg posener k negelein e 1924 ueber den sto wechsel der tumoren biochemis che zeitschrift 1521319344 waxman g kocsis j stys p k 1995 axon structure function patho physiology oxford university press woolf e c scheck c 2014 ketogenic diet treatment malignant glioma journal lipid research pages 119 yuneva 2008 finding achilles heel cancer role glucose glutamine metabolism survival transformed cells cell cycle 71420832089 zhou w mukherjee p kiebish markis w mantis j g seyfried n 2007 calorically restricted ketogenic diet e ective alternative therapy malignant brain cancer nutrition metabolism 45 zuccoli g marcello n pisanello servadei f vaccaro mukherjee p seyfried n 2010 metabolic management glioblastoma multiforme using standard therapy together restricted ketogenic diet case report nutrition metabolism 73317 17",
    "relevance_score": 0.8099,
    "date_score": 0,
    "final_score": 0.6074,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Unknown Author",
    "date": "2014-12-10T01:14:50",
    "filename": "1407.7622.pdf",
    "processed_text": "starvation cancer via induced ketogenesis severe hypoglycemia adam kapelner\u00031and matthew vorsangery2 1department mathematics queens college city university new york 2department cardiology new york university abstract neoplasms highly dependent glucose substrate energy production generally able catabolize fuel sources ketones fatty acids thus removing access glucose potential starve cancer cells induce apoptosis unfortunately body tissues also dependent glucose energy normal conditions however human starvation setting dietinduced ketogenesis body ketoadapts glucose requirements tissues drop almost nil exceptions include central nervous system cns various tissues small obligatory requirement glucose hypothesized treatment takes ketoadaptation prerequisite propose induction severe hypoglycemia depressing gluconeogenesis administering glucose brain although severe hypoglycemia normally produces adverse e ects seizure coma relatively safe following ketoadaptation hypothesize therapeutic hypoglycemia treatment potential rapidly induce tumor cell necrosis 1 introduction 1924 otto heinrich warburgs nobelprize winning research demonstrated neoplastic cells rely anaerobic glycolysis metabolic needs almost century later results implications ndings still hotly debated accepted tumors derive vast majority energy glucose major weakness attractive target therapeutic intervention however basic physiology dictates normal cells would also starved severe hypoglycemia targeting cancer exploiting metabolic weakness proven fruitful date1in fact cancer treatment \u0003electronic address kapelnerqccunyedu yelectronic address matthewvorsangernyumcorg 1there renewed interest success positron emission tomography diagnostic tool detects glucose uptake making use 18 uorine 2deoxyglucose 1arxiv14077622v2 qbioot 8 dec 2014moved away broadly cytotoxic modalities towards highly targeted therapies aggarwal 2010 treatments choice include monoclonal antibodies tyrosine kinase inhibitors induction speci c immune responses well others paper reexamine possibility therapeutic hypoglycemia antineo plastic treatment simultaneously delivering glucose body tissues require main hypothesis alterations metabolism occur starvation state namely neurologic adaptation hypoglycemia provide means safely inducing hypo glycemia course proposal mutually exclusive standard treatments radiation chemotherapy dietary supplementation outline paper follows section 2 provides background cancer cell metabolism reviews known cytotoxic e ects hypoglycemia cancerous cells justify assumptions needed hypothesized treatment litera ture next two subsections prerequisites understanding implementation hypothesized treatment section 31 discusses bodys theoretical minimum glucose requirements starvation well concept tissue ketoadaptation section 32 discusses ketogenic dieting viable alternative starvation retaining bodywide minimal glucose needs outline severe hypoglycemia therapy detail section 33 section 4 concludes discusses extensions well potential concerns 2 background cancer result multiple changes delicate balance cell function root cause neoplastic transformation still serious debate many theories cancer primarily genetic disease vogelstein et al 2013 cancer disease aberrant metabolism due dysfunctional respiration malfunctioning mitochondria seyfried shelton 2010 cancer due overproduction reactive oxygen species oleksyszyn et al 2014 well others regardless cause majority neoplastic cells feature aberrant glucose meta bolism rst discovered warburg et al 1924 known warburg e ect normal cells metabolize glucose two steps first glucose broken create pyru vate small amount adenosine triphosphate atp cytosol glycolysis second pyruvate shuttled mitochondria fully oxidized water carbon dioxide krebs cycle even enough oxygen cancer cells seem advance beyond cytosolic glycolysis employ vastly e\u000ecient factor 17 1 oxidative phos phorylation instead divert pyruvate produce lactic acid oxymoroni cally known aerobic glycolysis cancer cells ferment even conditions normoxia potential cause aberrant metabolism cancer cells fraction mitochondria available normal cells mitochondria structurally defective see review pedersen 1977 see elliott barnett 2011 electron microscopy study mitochondria breast carcinoma others say cause damaged glycolysis regulation koppenol et al 2011 regardless roads origin progression cancer pass mitochondria hallmark cancer malfunction oxidative phosphorylation varying degrees seyfried et al 2014 implies cancer cells access nonglycolytic fuels demand full 2oxidative combustion krebs cycle namely fatty acids ketone bodies beta hydroyxbutyrate ohb acetoacetate holm et al 1995 sawai et al 2004 two sub strates key players hypothesized treatment chang et al 2013 demonstrated glioma cells investigation lack enzymes break ketones evi dence may explain introduction healthy mitochondria cancer cell cytoplasm halts carcinogenesis see seyfried 2012 chapter 11 review studies relevant point hypothesis glucose predominant energy substrate cancers gullino et al 1967 glycolytic rates 8200 times higher normal tissues phelps 2004 chapter 5 producing 10 atp normal cells koppenol et al 2011 cancer large fuel requirement due high proliferation rate large need antioxidants addition high glucose consumption necessary inter mediaries required biosynthetic pathways ribose nucleotides glycerol pyruvate citrate lipids amino acids nicotinamide adenine dinucleotide phosphate nadph via pentose phosphate pathway deberardinis et al 2008 glycolysis exclusive source energy cancer hotly debated may true cancers throughout lifespan tumors may varied bioenergetic pro les may glycolytic andor oxidative jelluma et al 2006 morenos\u0013 anchez et al 2007 martinezoutschoorn et al 2011 jose et al 2011 carracedo et al 2013 purposes article address majority neoplasms consensus holds exclusively glycolytic await future research elucidate cancer lines hypothesized treatment applicable thus cancer particularly vulnerable glucose glycolytic substrate depriva tion starving cancer glucose novel idea proposals treat cancer via serum hypoglycemia date back editorial new york times 1887 abundant recent literature woolf scheck 2014 simone et al 2013 fine et al 2012 2008 seyfried et al 2008 mavropoulos et al 2006 kim et al 1978 another idea would inhibit glycolysis eg ganapathykanniappan et al 2010 strategy propose due universal cytotoxicity even though idea cancer starvation commonplace well designed studies evaluating premise exist simone et al 2013 argues absence clinical trials due unclear diet implementation protocols financial concerns also likely explanation time resources needed produce highquality clinical trial unlikely therapeutic hypoglycemia would produce adequate returnoninvestment pharmaceutical company time writing trials proposed eg tanshalaby seyfried 2013 list found table 2 simone et al 2013 many uncontrolled studies optimistic example zuccoli et al 2010 details account woman spontaneous remission ie sudden disappearance cancer glioblastoma multiforme two months diet formulated lower serum glucose niakan 2010 concluded 1000 similar spontaneous remission likely due hypoglycemia hypoxia arguably direct consequence hypoglycemia preclinical animal studies demonstrate promising results cutting cancers nutrient supply mukherjee et al 2002 2004 zhou et al 2007 otto et al 2008 mavropoulos et al 2009 shelton et al 2010 sta ord et al 2010 de lorenzo et al 2011 sivananthan 2013 jiang wang 2013 however studies inconclusive eg masko 3et al 2010 many creative invitro studies glucose starvation demetrakopoulos et al 1978 tumor cells found highly sensitive glucose deprivation spitz et al 2000 found glucose withdrawal induces cytotoxicity transformed broblasts colorectal cells argue result oxidative stress buzzai et al 2005 demonstrated activation commonly expressed oncogene akt prevents cancer cells metabolizing nonglycolytic substrates jelluma et al 2006 performed rst study glucose drawal gliobastoma multiforme cells found 90 cell death 24 hours death due atp depletion could rescued free radical scavenger thereby lending credence oxidative stress theory aykinburns et al 2009 demonstrated glucose deprivation induce cytotoxicity human breast cancer cells colon cancer cells invivo argue results due cancer unable synthesize reducing agents nadph pyruvate needed en masse detoxi cation high concentrations free radicals due mitochondrial abnormalities li et al 2010 observed growth inhibition apoptosis lung broblasts glucose restriction priebe et al 2011 demonstrated cell death ovarian cancer also graham et al 2012 demonstrated glucose withdrawal slows proliferation induces hyperthermia possibly induces cancer cell death four gliobastoma cell lines proposal natural extension previous cancer starvation proposals propose ketogenic diet allows safe induction severe hypoglycemia via gluconeogenesis attenuation serum levels propose lower ever proposed past order starve cancer cells rapidly turn detailing therapy 3 hypothesis next two sections provide background material human starvation ketogenic dieting necessary understanding hypothesized treatment detail section 33 31 starvation minimizing bodys glucose needs bodys glucose requirements minimized periods starvation consti tutes drastic transformation bodys energy metabolism broadly speaking starvation stages outlined table 1 normally end rst day hepatic glycogen stores depleted liver lesser extent kidneys begin produce glucose pyruvate glycerol amino acids vast majority tissues body skeletal muscle heart organs facultative choice substrate energy production period glucose scarcity cut glucose metabolism increase metabolism free fatty acids ffas starvation even early stage forces body tissues switch glycolysis lipid oxidation energy needs ketone bodies ohb acetoacetate acetone always present blood days starvation begin produced large quantities liver tissues body metabolize ketones exception acetone 4stage physiological time starvation description period 1 gastrointestinal absorption 1 day 2 glycogenolysis 2 days 3 gluconeogenesis \u00152 days 4 ketosis \u00153 days 5 prolonged decreased gluconeogenesis increased \u001514 days cerebral ketone consumption table 1 stages starvation time last ingestion reprinted slight modi cations cahill 1983 page 2 special interest stage 5 prolonged starvation two weeks longer cells long since cut uptake glucose also cut uptake ketones change coupled increased bloodbrainbarrier permeability ketones morris 2005 call ketoadaptation stage 5 cells rely purely ffas metabolic requirements robinson williamson 1980 however tissues still retain need glucose even ketoadaptation largest consumer brain cns whose health vital success hypothesis2 much glucose brain need typical brain glucose requirement approx imately 144 gday cahill 1970 figure 1 preferential utilization obligatory utilization point crucial hypothesis ketoadaptation brain glucose requirement drops approximately 44 gday cahill 1970 figure 53 supplies energy di erence approximately 100 gday glucose previously supplied ketone bodies ohb acetoacetate 61 proportion owen et al 1967 table 5 note brain metabolize ffas owen et al 1967 table 44in stage 5 starvation ketone blood levels surge 2597 mmoll contrast negligible level 001 mmoll nonstarving subjects brain readily use ketone bodies available even nonfasting periods condition ketone usage negligible sokolo 1973 morris 2005 suspects brains ketone metabolism evolutionarily developed ensure survival times glucose scarce 2note erythrocytes leukocytes bone marrow also solely rely glucose employ glycolysis thus lactate pyruvate waste products reconstituted glucose via cori cycle liver using energy supplied breakdown lipids therefore tissues zero netglucose consumption 3it known average brain less 44 gday glucose assume body get away providing less would gram glucose conserved one gram protein conserved protein sparing essential starvation since protein mans precious machinery vital cellular structure function depletion reserves limit longterm survival even massive lipid depots question also asked follows ketones unable provide 100 brains energy requirements answer unknown posit two theories first may incomplete ohb acetoacetate transport cells cns morris 2005 second ohb acetoacetate converted energy via oxidative phosphorylation mitochondria organelles scant long thin myelinated axons waxman et al 1995 page 17 posit brains energy production must default glycolysis axoplasm 4this mystery ffas able cross bloodbrainbarrier brain equipped betaoxidation enzymes combustion morris 2005 5cahill 1970 suspects body tissues slash ketone consumption favor ffas ensure adequate substrate brain cahill veech 2003 argue metabolic adaptation ketones exist homo sapiens could developed large advanced brain fuel metabolism stage 5 starvation illustrated figure 1 special interest inventory sources gluconeogenesis provide 44 gday cns requirement stored triacylglycerols 15g amino acids taken muscle tissue lesser extent tissues 20g pyruvate lactate 14g end product anaerobic glycolysis thus third glucose starvation burned cns recycled back glucose via cori cycle figure 1 fuel sources sinks daily metabolism stage 5 starvation assuming 1500 calorie resting metabolism inspired cahill 1970 figure 5 starvation useful tool minimize glucose needs body tissues fasting relatively safe stewart fleming 1973 unpleasant leads muscle wasting weight loss serious concerns cancer patients minimize bodys glucose needs avoiding undesired e ects turn solution next section 32 ketoadaptation via 41 ketogenic diet means emulate metabolic conditions starvation still ingesting food engineering problem faced 1920s expert childhood epileptologist dr 6russel wilder observed shortterm starvation therapeutic children intractable epilepsy obviously impractical longterm solution innovated ketogenic diet kd mimics characteristic starvation metabolism outlined section 31 still used today reduce seizures historical account recent clinical trial see neal et al 2008 wilders kd high fat low protein low carbohydrate diet mcdonald 1998 mimic starvation strict macronutrient proportions required called 41 kd carbohydrate must limited 20 gday amount muscle tissue provides prolonged starvation protein must limited amount set normal nonstarvation protein turnover estimated 25 gday 70kg person national research council us food nutrition board 1989 additional protein potential gluconeogenic thereby avoided calories must supplied fats5commercial formulas diet readily available physiological markers prolonged 41 kd exactly markers prolonged starvation depending macronutrient proportions serum glucose slightly higher ketone levels slightly lower phinney et al 1983 assume 41 kd equivalent ketoadapted metabolism observed prolonged starvation described section 31 glucose uptake minimization increased cerebral ketone uptake exclusive use ffas energy production every tissue body thus kd achieve starvation metabolism adaptation without unpleasant side e ects hunger muscle loss simone et al 2013 also reviews bene ts kd muscle sparing pos sibly even muscle synthesis bene cial cancer patients risk cachexia kd generally welltolerated minimal side e ects constipation salt loss mild acidosis increased incidence kidney stones employed chronically demonstrated safe even patients advanced cancer schmidt et al 2011 kosso et al 2007 reports longest duration continuous kd 21 years vir tually side e ects also evidence ketones right directly toxic cancer magee et al 1979 skinner et al 2009 fine et al 2009 improve immune systems ability target cancer husain et al 2013 added bene kd work tandem hypoglycemia strategy hypothesized treatment begins cancer patient administered 41 kd 14 days allow ketoadaptation proposed acute treatment begun turn implementation details 33 proposed treatment section 2 discussed previous literature experimented starvation kd cancer therapy via glucose starvation believe studies reduce serum glucose levels su\u000ecient starve cancer kd plasma glucose concentration falls 5we detail calculation 90 calories supplied triglycerides esters three fatty acid chains one glycerol 110th fat calories derived directly gluconeogenic glycerol thus 81 dietary calories supplied fatty acids 9 10 19 substrates yielding ratio 81 19\u00194 1 7only mildly remaining normal range normalweight individuals thus simple tumor glucose starvation therefore unlikely humans fine et al 2008 serum glucose prolonged starvation drops 65mgdl cahill 1970 table 2 prolonged 41 kd also result similar serum level unclear reduction blood glucose level similarly welltolerated keto adaptation adult cerebral blood ow approximately 750mlmin 013 dls implies 81mgs glucose potentially delivered brain section 31 noted brain obligatory requirement 44 gday 051 mgs6which 6 glucose available serum concentration 65 mgdl although experiments evaluating glucose extraction ratio human subjects limited animal studies suggest brain able extract 40 serum glucose hypoglycemic state mccall et al 1986 thus theorize body conservative serum glucose concentrations level 051 mgs actively transported neurons mere moments result cns damage 65 mgdl comfortably threshold evidence conjecture ketoadapted subjects survive serum glucose much lower 65mgdl hypoglycemia reported therapeutic fasting starvation 100 years chakrabarty 1948 investigated 407 starvation cases bengal famine nd 20 chronic blood sugar 40 mgdl symptoms hypoglycemia stewart fleming 1973 supervised world recordsetting 382day therapeutic fast found blood glucose became stable 30 mgdl dropping intermittently 20 mgdl without symptoms relevant evidence hypothesis observation intentional acute hypoglycemia induction drenick et al 1972 ketoadapted obese patients via 4560 days starvation perfused insulin within hour observed serum glucose low 9 mgdl without acute hypoglycemic symptoms serum glucose low would normally induce coma even observed blood sugar high 4049 mgdl according benami et al 1999 figure 3 plan simple ketoadaptation 41 kd propose acutely tenuate serum glucose concentration severely hypoglycemic levels observed drenick et al 1972 patientbypatient basis since insulin required cancer cells fuels metabolism iqbal et al 2013 also impede ketogenesis choose induce hypoglycemia via insulin perfusion drenick et al 1972 instead propose use gluconeogenesis inhibitor one possible inhibitor diabetic drug metformin inhibits gluconeogensis directly metformin may anticancer e ects jalving et al 2010 figure 3 certainly supporting epidemiological evidence metformins therapeutic e ect cancer ben sahra et al 2010 reasons proposed use hy pothesized treatment similar see oleksyszyn 2011 oleksyszyn et al 2014 however metformin many drawbacks first potent inducer hypo glycemia doses normally administered metformin also slow acting rapidly titratable additionally drug activates adenosine monophosphate activated pro 6this calculation within 20 brain arteriovenous glucose di erence observed starving subjects owen et al 1967 table 5 8tein kinase may e ects metabolism ketoadaptation see jalving et al 2010 figure 2 lastly supratherapeutic doses associated fatal lactic acidosis due shortcomings propose using drug pure liverkidney gluco neogenesis inhibitor luckily drugs investigated diabetes community high endogenous glucose production considered one characteristics disease therefore therapeutic target many control points within gluconeogenesis unidirectional synthesis fructose6phosphate fructose16bisphospate prudent point interrupt cause removed glycogenolysis mitochondrial function thus would fewest side e ects synthesis controlled via ratecontrolling enzyme fructose16 bisphosphatase two inhibitors clinically evaluated named cs917 mb07803 van poelje et al 2011 good safety pro les exibly attenuate gluconeogenesis desired level returning discussion target level hypoglycemia comment know e ective dose ed curves serum glucose levels tumor necrosis lethal dose ld curves human body death ketoadaptation possible 9 mgdl glucose concentration may high toxic cancer proves case hypoglycemia would need safely induced treatment e\u000ecacy turn since brain tissue obligatory glucose requirement opt direct perfusion glucose brain intraarterially via carotid arteries rate necessary provide minimum brain glycolytic needs perfusion glucose directly brain performed successfully rats borg et al 1997 baboons conway et al 1969 brain receives required glucose propose increase dose gluconeogenic inhibitor drug attenuate serum glucose negligible level safe enough erythocytes blood marrow leukocytes survive brain would perceive normoglycemia everywhere outside brain serum would extremely hypoglycemic necessary also perfuse ohb tandem risk level ketosis su\u000eciently high cns metabolic needs protocol would require extensive proofofconcept work animal models attempt undertake study human subjects reader may wonder strategy would e ective brain cancer since brain still receiving glucose seyfried et al 2003 reports data supporting treatment may e ective since glucose uptake brain cancers drops lower serum glucose cancer metabolize ketones may even toxic fast could procedure induce tumor death echo oleksyszyn et al 2014 idea deep hypoglycemia needs trigger spontaneous remission estimates drawn data invitro studies thus general izable human prognoses spitz et al 2000 figure 2 reports 55 near 100 necrosis rates three cancer lines within 48hr total glucose deprivation complete withdrawal possible human body reasons explained treatment could deliver minimum serum levels estimated 5 mgdl 94 discussion propose therapy starving cancer inducing ketoadaptation followed duction therapeutic hypoglycemia via gluconeogenesis inhibitor drugs propose rescue cerebral glucose infusion direct catheterization brainss blood supply would followed increase gluconeogenic inhibitor drug lower serum glucose even noncerebral tissues main concern person unique metabolic entity seyfried et al 2014 calculations presented throughout manuscript meant illustrative average person individual personalized dosing administration schedules require iterative netuning proper monitoring associated costs concern hypoglycemia risky might necessarily require monitoring setting intensive care unit patients diabetic ketoacidosis frequently treated insulin infusion outside intensive care unit although costs diet medications needed induce hypoglycemia proposal might far lower cost novel chemotherapeutic agents cost close monitoring may substantially erode bene several concerns speculative treatment cancer heteroge neous predictors currently available individual tumors response hypoglycemia research suggesting cancer cells make use ketones ffas cancer lines proliferate rapidly intense anabolism mandatory jose et al 2011 hypothesized treatment would work cancer lines known whether proposed hypoglycemic levels sustained long periods time without symptoms starvation research suggests hypoglycemia safe long term accounts documented serum levels many times proposed serum level predominantly documented obese subjects without cancer important consideration whether ketoadaptation additionally protects neu rohormal cardiovascular electrophysiologic consequences hypoglycemia frier et al 2011 additionally glucose sole nutritive substrate cancer cells instance glutamine also serve major metabolite yuneva 2008 well fermentation amino acids assume hypothesis glucose necessary metabolite metabolites neither availability capability transported volumes necessary serve replacements lastly times body need glucose ammation infection limits setting hypothesized treatment also fair chance proposed treatment e ective provided tandem therapies instance abdelwahab et al 2012 demonstrated brain cancer mice curtailed recur simultaneous administration 41 kd radiation therapy allen et al 2013 demonstrated 41 kd enhances radiochemotherapy mice models lung cancer see klement champ 2014 discussion kd act synergistically radiation therapy also lee et al 2012 demonstrated fasting enhances chemotherapy po et al 2013 demonstrated hyperbaric oxygen therapy enhanced kd alternative adjuvant therapies may also fruitful example majumdar et al 2009 demonstrated combination curcumin resveratrol could e ective therapy 10in colorectal cancer singh lai 2004 demonstrated cancer apoptosis wormwood extract tin et al 2007 demonstrated astralagus saponins inhibit colorectal cancer cell proliferation many supplements administered simultaneously hypoglycemia treatment acknowledgements would like thank justin bleich stephen kapelner helpful discussions com ments manuscript would like thank marie le pichon illustrating figure 1 adam kapelner acknowledges support national science foundations graduate search fellowship well support simons foundation autism research initiative references abdelwahab g fenton k e preul c rho j lynch sta ord p scheck c 2012 ketogenic diet e ective adjuvant radiation therapy treatment malignant glioma plos one 75e36197 aggarwal 2010 targeted cancer therapies nature reviews drug discovery 96427428 allen b g bhatia k buatti j brandt k e lindholm k e button szweda l smith b j spitz r fath 2013 ketogenic diets enhance oxidative stress radiochemotherapy responses lung cancer xenografts clinical cancer research o\u000ecial journal american association cancer research 1914390513 aykinburns n ahmad zhu oberley l w spitz r 2009 increased levels superoxide h2o2 mediate di erential susceptibility cancer cells versus normal cells glucose deprivation biochemical journal 41812937 benami h nagachandran p mendelson edoute 1999 druginduced hypoglycemic coma 102 diabetic patients archives internal medicine 15932814 ben sahra le marchandbrustel tanti jf bost f 2010 metformin cer therapy new perspective old antidiabetic drug molecular cancer therapeutics 9510921099 borg sherwin r borg w p tamborlane w v shulman g 1997 local ven tromedial hypothalamus glucose perfusion blocks counterregulation systemic hypoglycemia awake rats journal clinical investigation 9923615 buzzai bauer e jones r g deberardinis r j hatzivassiliou g elstrom r l thompson c b 2005 glucose dependence akttransformed cells reversed pharmacologic activation fatty acid betaoxidation oncogene 2426416573 cahill g veech r l 2003 ketoacids good medicine transactions american clinical climatological association 114149163 cahill g f 1970 starvation man new england journal medicine 282668675 11cahill g f 1983 starvation transaction american clinical climatological associa tion 94121 carracedo cantley l c pandol p p 2013 cancer metabolism fatty acid oxidation limelight nature reviews cancer 134227232 chakrabarty l 1948 bloodsugar levels slow starvation lancet 2516503596597 chang h olson l k schwartz k 2013 ketolytic glycolytic enzymatic expression pro les malignant gliomas implication ketogenic diet therapy nutrition metabolism 10147 conway j goodner c j werrbach j h gale c c 1969 studies substrate regulation fasting journal clinical investigation 4813491362 de lorenzo baljinnyam e vatner e abarz\u0013 ua p vatner f rabson b 2011 caloric restriction reduces growth mammary tumors metastases carcinogenesis 32913817 deberardinis r j sayed n ditsworth thompson c b 2008 brick brick metabolism tumor cell growth current opinion genetics development 1815461 demetrakopoulos g e linn b amos h 1978 rapid loss atp tumor cells deprived glucose contrast normal cells biochemical biophysical research communications 823787794 drenick e j alvarez l c tamasi g c brickman 1972 resistance symptomatic insulin reactions fasting journal clinical investigation 5110275762 elliott r barnett b 2011 ultrastructural observation mitochondria human breast carcinoma cells microscopy microanalysis 17suppl 2194195 fine e segalisaacson c feinman r sparano j 2008 carbohydrate restriction patients advanced cancer protocol assess safety feasibility accompanying hypothesis community oncology 512226 fine e j segalisaacson c j feinman r herszkopf romano c tomuta n bontempo f negassa sparano j 2012 targeting insulin inhibition metabolic therapy advanced cancer pilot safety feasibility dietary trial 10 patients nutrition 2810102835 fine r j miller quadros e v sequeira j feinman r 2009 acetoacetate reduces growth atp concentration cancer cell lines overexpress uncoupling protein 2cancer cell international 914111 frier b schernthaner g heller r 2011 hypoglycemia cardiovascular risks diabetes care 34 suppl 2s132s137 ganapathykanniappan vali kunjithapatham r buijs syed l h rao p p ota kwak b k lo roy r geschwind j f 2010 3bromopyruvate new targeted antiglycolytic agent promise cancer therapy current pharmaceutical biotechnology 1155107 12graham n tahmasian kohli b komisopoulou e zhu vivanco teitell wu h ribas lo r mellingho k mischel p graeber g 2012 glucose deprivation activates metabolic signaling ampli cation loop leading cell death molecular systems biology 8589116 gullino p grantham f courtney losonczy 1967 relationship oxygen glucose consumption transplanted tumors vivo cancer research 2710411052 holm e hagm uller e staedt u schlickeiser g gunther h j leweling h tokus kollmar h b 1995 substrate balances across colonic carcinomas humans cancer research 5513731378 husain z seth p sukhatme v p 2013 tumorderived lactate myeloidderived suppressor cells linking metabolism cancer immunology oncoimmunology 211e26383 iqbal siddiqui f gupta v chattopadhyay gopinath p kumar b manvati chaman n bamezai r n k 2013 insulin enhances metabolic capacities cancer cells dual regulation glycolytic enzyme pyruvate kinase m2 molecular cancer 12172 jalving gietema j lefrandt j de jong reyners k l gans r b de vries e g e 2010 metformin taking away candy cancer european journal cancer 461323692380 jelluma n yang x stokoe evan g dansen b haaskogan 2006 glucose withdrawal induces oxidative stress followed apoptosis glioblastoma cells normal human astrocytes molecular cancer research 45319330 jiang wang f 2013 caloric restriction reduces edema prolongs survival mouse glioma model journal neurooncology 11412532 jose c bellance n rossignol r 2011 choosing glycolysis oxidative phos phorylation tumors dilemma biochimica et biophysica acta 18076552561 kim h kim j h hahn e w 1978 selective potentiation hyperthermic killing hypoxic cells 5thiodglucose cancer research 3829352938 klement r j champ c e 2014 calories carbohydrates cancer therapy radi ation exploiting rs dietary manipulation cancer metastasis reviews pages 217229 koppenol w h bounds p l dang c v 2011 otto warburgs contributions current concepts cancer metabolism nature reviews cancer 115325337 kosso e h turner z bergey g k 2007 homeguided use ketogenic diet patient 20 years pediatric neurology 366424425 lee c ra aghello l brandhorst safdie f bianchi g martinmontalvo pistoia v wei hwang merlino emionite l de cabo longo v 2012 fasting cycles retard growth tumors sensitize range cancer cell types chemotherapy science translational medicine 4124124ra27 13li liu l tollefsbol 2010 glucose restriction extend normal cell lifespan impair precancerous cell growth epigenetic control htert p16 expression faseb journal 24514421453 magee b potezny n rofe conyers r 1979 inhibition malignant cell growth ketone bodies australian journal experimental biology medical science 57552939 majumdar p n banerjee nautiyal j patel b b patel v du j yu elliott levi e sarkar f h 2009 curcumin synergizes resveratrol inhibit colon cancer nutrition cancer 61454453 martinezoutschoorn u e prisco ertel tsirigos lin z pavlides wang c flomenberg n knudsen e howell pestell r g sotgia f lisanti p 2011 ketones lactate increase cancer cell stemness driving recurrence metastasis poor clinical outcome breast cancer achieving personalized medicine via metabologenomics cell cycle 108127186 masko e thomas j antonelli j lloyd j c phillips e poulton h dewhirst w pizzo v freedland j 2010 lowcarbohydrate diets prostate cancer low low enough cancer prevention research 3911241131 mavropoulos j c buschemeyer w c tewari k rokhfeld pollak zhao febbo p g cohen p hwang devi g demarkwahnefried w westman e c peterson b l pizzo v freedland j 2009 e ects varying dietary carbohydrate fat content survival murine lncap prostate cancer xenograft model cancer prevention research 2655765 mavropoulos j c isaacs w b pizzo v freedland j 2006 role lowcarbohydrate ketogenic diet management prostate cancer urology 6811518 mccall l fixman l b fleming n tornheim k chick w ruderman n b 1986 chronic hypoglycemia increases brain glucose transport american journal physiology 251e442e447 mcdonald l 1998 ketogenic diet complete guide dieter practitioner morris publishing austin tx morenos\u0013 anchez r rodr\u0013 \u0010guezenr\u0013 \u0010quez mar\u0013 \u0010nhern\u0013 andez saavedra e 2007 en ergy metabolism tumor cells febs journal 27461393418 morris 2005 cerebral ketone body metabolism journal inherited metabolic disease 28210921 mukherjee p abate l e seyfried n 2004 antiangiogenic proapoptotic e ects dietary restriction experimental mouse human brain tumors clinical cancer research 1056225629 mukherjee p elabbadi kasperzyk j l ranes k seyfried n 2002 dietary restriction reduces angiogenesis growth orthotopic mouse brain tumour model british journal cancer 8616151621 14national research council us food nutrition board 1989 recommended dietary allowances national academy press neal e g cha e h schwartz r h lawson edwards n fitzsimmons g whitney cross j h 2008 ketogenic diet treatment childhood epilepsy randomised controlled trial lancet neurology 765006 new york times 1887 sugar cancer dec 24 niakan b 2010 spontaneous remission cancer steady aggressive malignant growth faced hypoxia hypoglycemia medical hypotheses 7565056 oleksyszyn j 2011 complete control glucose level utilizing composition ketogenic diet gluconeogenesis inhibitor antidiabetic drug metformin potential anti cancer therapy medical hypotheses 7721713 oleksyszyn j wietrzyk j psurski 2014 cancer could cured spontaneous regression cancer cancer energy metabolism hyperglycemiahypoglycemia metformin warburg crabtree e ects new perspective cancer treatment journal cancer science therapy 06035661 otto c kaemmerer u illert b muehling b pfetzer n wittig r voelker h u thiede coy j f 2008 growth human gastric cancer cells nude mice delayed ketogenic diet supplemented omega3 fatty acids mediumchain triglycerides bmc cancer 8122 owen e morgan p kemp h g sullivan j herrera g cahill g f 1967 brain metabolism fasting journal clinical investigation 4610158995 pedersen p l 1977 tumor mitochondria bioenergetics cancer cells progress experimental tumor research 22190274 phelps e 2004 pet molecular imaging biological applications springer phinney bistrian b r wolfe r r blackburn g l 1983 human metabolic response chronic ketosis without caloric restriction physical biochemical adaptation metabolism 328757768 po ari c seyfried n dagostino p 2013 ketogenic diet hyperbaric oxygen therapy prolong survival mice systemic metastatic cancer plos one 86e65522 priebe tan l wahl h kueck g kwok r opipari liu j r 2011 glucose deprivation activates ampk induces cell death modulation akt ovarian cancer cells gynecologic oncology 122238995 robinson williamson h 1980 physiological roles ketone bodies substrates signals mammalian tissues physiological reviews 60114387 sawai yashiro nishiguchi ohira hirakawa k 2004 growthinhibitory e ects ketone body monoacetoacetin human gastric cancer cells succinylcoa 3oxoacid coatransferase scot de ciency anticancer research 24422137 15schmidt pfetzer n schwab strauss k ammerer u 2011 e ects keto genic diet quality life 16 patients advanced cancer pilot trial nutrition metabolism 8154 seyfried 2012 cancer metabolic disease origin management prevention cancer john wiley sons seyfried n flores r e po dagostino p 2014 cancer metabolic disease implications novel therapeutics carcinogenesis 35351527 seyfried n kiebish mukherjee p marsh j 2008 targeting energy metabolism brain cancer calorically restricted ketogenic diets epilepsia 49 suppl 81146 seyfried n sanderson elabbadi mcgowan r mukherjee p 2003 role glucose ketone bodies metabolic control experimental brain cancer british journal cancer 897137582 seyfried n shelton l 2010 cancer metabolic disease nutrition metabolism 77122 shelton l huysentruyt l c mukherjee p seyfried n 2010 calorie restriction antiinvasive therapy malignant brain cancer vm mouse asn neuro 23e00038 simone b champ c e rosenberg l berger c monti dicker p simone n l 2013 selectively starving cancer cells dietary manipulation methods clinical implications future oncology 97959976 singh n p lai h c 2004 artemisinin induces apoptosis human cancer cells anticancer research 24422772280 sivananthan p 2013 e ects ketogenic diet tumor progression breast cancer phd thesis icahn school medicine mount sinai skinner r trujillo x beierle e 2009 ketone bodies inhibit viability human neuroblastoma cells journal pediatric surgery 4412126 discussion 216 sokolo l 1973 metabolism ketone bodies brain annual review medicine 24271 280 spitz r sim j e ridnour l galoforo lee j 2000 glucose deprivationinduced oxidative stress human tumor cells fundamental defect metabolism annals new york academy sciences 899349362 sta ord p abdelwahab g kim preul c rho j scheck c 2010 ketogenic diet reverses gene expression patterns reduces reactive oxygen species levels used adjuvant therapy glioma nutrition metabolism 774 stewart w k fleming l w 1973 features successful therapeutic fast 382 days duration postgraduate medical journal 495692039 tanshalaby j seyfried 2013 ketogenic diet advanced cancer pilot feasibility safety trial veterans airs cancer patient population journal clinical trials 30447 16tin cho ch chan k james e ko j k 2007 astragalus saponins induce growth inhibition apoptosis human colon cancer cells tumor xenograft car cinogenesis 28613471355 van poelje p potter c erion 2011 diabetes perspectives drug therapy handbook experimental pharmacology 203279301 vogelstein b papadopoulos n velculescu v e zhou diaz l kinzler k w 2013 cancer genome landscapes science 3396127154658 warburg posener k negelein e 1924 ueber den sto wechsel der tumoren biochemis che zeitschrift 1521319344 waxman g kocsis j stys p k 1995 axon structure function patho physiology oxford university press woolf e c scheck c 2014 ketogenic diet treatment malignant glioma journal lipid research pages 119 yuneva 2008 finding achilles heel cancer role glucose glutamine metabolism survival transformed cells cell cycle 71420832089 zhou w mukherjee p kiebish markis w mantis j g seyfried n 2007 calorically restricted ketogenic diet e ective alternative therapy malignant brain cancer nutrition metabolism 45 zuccoli g marcello n pisanello servadei f vaccaro mukherjee p seyfried n 2010 metabolic management glioblastoma multiforme using standard therapy together restricted ketogenic diet case report nutrition metabolism 73317 17",
    "relevance_score": 0.8099,
    "date_score": 0.0,
    "final_score": 0.4049,
    "date_numeric": 0
  },
  {
    "title": "Microsoft Word - moonshots-for-aging-revision1-041919-arxiv.docx",
    "author": "Unknown Author",
    "date": "2019-04-19T20:33:44",
    "filename": "1901.04053.pdf",
    "processed_text": "title moonshots aging authors sandeep kumar1 timothy r peterson1 affiliation 1 department internal medicine division bone mineral diseases department genetics institute public health washington university school medicine bjc institute health 425 euclid ave st louis mo 63110 usa correspondence timrpetersonwustledu trp abstract global population ages increased interest living longer improving one ’ quality life later years however studying aging – decline body function – expensive timeconsuming despite research success make model organisms live longer still ’ really feasible solutions delaying aging humans space travel scientists ’ know would take get moon extrapolate theory shorterrange tests perhaps aging need similar moonshot philosophy though “ shot ” might imply medicine perhaps need think beyond biological interventions like moon seem long way away provable therapies increase human healthspan healthy period one ’ life lifespan long one lives review therefore focuses radical proposals hope might stimulate discussion might consider significantly differently ongoing aging research introduction – incrementalism thinking linear vs logscale silicon valley wants 10x engineers people 10x work average engineer likewise biomedical researchers starting careers told senior colleagues chase big findings ignore small effects aim big increases human healthspan lifespan assuming earth handle consequences enough people want let ’ first consider current state aging delaying therapies many ways think treating aging existing treatments treat specific aging conditions form drugs improve one area body diseased aging populations drugs diabetes high blood glucose osteoporosis bone loss common examples currently fdaapproved remedies reduce aging per se ie increase healthspan lifespan experiments aimed identifying new interventions aging historically done species ranging primates mice worms yeast 1 yet pharmaceutical industry become weary treatments work model systems proven ineffective humans 2 unfortunately especially true treatments agingassociated chronic diseases 3 thus considering human clinical trials aging therapies take years play important scrutinize effect sizes seen preclinical models less encouraging sign many lifespan experiments done mammals modest effect sizes often statistically significant effects one genders often specific dietary andor housing conditions 4 even inhibiting one potent aging pathways 57 mechanistic target rapamycin mtor pathway 8 arguably modest effects lifespan – 1224 increase mice 1423 females926 males 9 10 notably rapamycin associated harmful effects including increased risk aggressive hematological malignancies dramatic microbiome alterations 11 also experiments done controlled environment limits pathogens exposure relevant rapamycin immunosuppressant used clinically organ transplantation 12 suggests realworld scenario people ’ immune systems would challenged regularly ’ clear rapamycin would significant beneficial effect healthspan lifespan ask rapamycin one potential bestcase scenarios might predicted modest effect possibly detrimental one people continue receive much focus aging community note problems aging field small inconsistent effects leading strategies ’ specific rapamycin popular reactive oxygen species ros theory aging 13 challenged found deleting genes capable detoxifying superoxide dispensable worm lifespan 14 related example worms different labs produced dramatically different lifespanmodulating effect sizes rosaltering drug 15 worms simpler mice took decade highly qualified labs resolve inconsistent results ros drug ’ bode well rosbased therapies real world people treating individual agingrelated diseases encountered roadblocks also call question whether optimal path human aging alzheimer ’ diabetes particularly wellfunded wellresearched agingrelated topics still huge gaps understanding lack good treatment options alzheimer ’ considerable focus amyloid beta tau targeting molecules ’ done much alzheimer ’ far leaving many searching answers 16 17 regarding diabetes people think insulin resistance caused intracellular overaccumulation lipids despite many smart people working decades ’ clear whether diacylglycerol 18 ceramide 19 lipids might main culprit point spend collectively long time something ’ working well manipulating single gene biological process seem natural consider conceptually different approaches herein discuss different therapeutic concepts aging might push us beyond current thinking beyond reductionist onehypothesis onepathway onedisease view perhaps problem aging might single molecular pathway collection pathways biologists typically understand pathways following omnigenic model complex disease 20 aging might involve genes therefore true would one thing extend life inhibiting one pathway drug really expected lot still part omnigenic model “ hub ” ” core ” genes relatively important genes intuitive target genes consider impactful one drug manipulating one gene may good enough looking synergistic combinations treating aids 21 cancer 22 23 seems like next logical step one proofofconcept aginglimiting cocktail yamanaka pluripotency factors 24 tested good results mouse model premature aging condition progeria 25 manipulating insulinlike growth factor igf sterolresponsive element binding protein srebp also produced strong synergistic healthspanextending effects 26 several combinations likewise validated model organisms 27 28 using synergistic combinations potential lower amount agent one use beneficial lowering potential side effects 29 30 still effect sizes combinations factors might much single factor even begin contemplate 10x effects like silicon valley aims need concentrate strategies generate synergistic figure 1 10x healthspanlifespan strategy 1 identify maximally synergistic lifeextending factors drugs gene manipulations four factors depicted needed promote synergistic effects aging phenotype ρ rho analogy yamuna pluripotency cocktail contains four factors synergistic factors could drugs andor gene manipulations ideally chosen large list candidates following systematic unbiased largescale experimentation combinations figure 1 challenge number possible combinations tested multiple number factors consideration consider hypothetical drugs targeting 20000 proteincoding human genes testing combination would four hundred million combinations ’ feasible today noting contexts effects combinations many factors approximated effects pairs reduces number combinations test 31 potentially might need choose could throw kitchen sink problem perturb many genes time precedence manygene approach using crispr 62 retroviral genes knocked pig liver make organs theoretically safer transplantation 32 yet regulatory hurdles need cleared currently fda requires testing individual components combination treatment however one envision future need get great fda allow applications cocktails without individual components gaining approval first 33 even thinking specific agingassociated conditions rather aging per se synergistic factors could provide valuable new path forward core genes tend important across aging conditions 34 suggests would benefit researchers interested specific conditions look aging per se aging conditions besides one ’ studying better understand physicians might also mean onedrug approach failing like alzheimer ’ might consider drug synergies drugs alleviate agingassociated conditions would form drug repositioning 35 already evidence could work alzheimer ’ example drugs several agingrelated conditions heart disease 36 37 diabetes 38 osteoporosis 39 shown alleviate neurodegeneration various models yamanaka started pursuit pluripotency cocktail short list genes make short list molecular factors aging would look like point ’ like make plug factors add back function aging tissues many existing strategies increase healthspan lifespan involve taking something away often inhibiting molecular pathways dietary limitation caloric restriction intermittent fasting mostwell known approaches category 40 41 dietary regimens involve reducing calorie intake without causing malnutrition though caloric restriction longstanding “ gold standard ” aging field associated 50 increases lifespan 1 two major issues 1 poor feasibility questionable whether many humans could cut large number calories eg 33 reduction needed longterm demonstrate generalizable efficacy approach 42 2 importantly though many studies including dating back almost century ago showed significant benefits cr 4345 many studies ’ panned 4648 cr work well contexts others like rapamycin one wonder whether rather devote resources cr might better approaches therefore instead restricting something arguably defensible idea would restore functionality makes sense considering aging explicitly means decreasing function would one simultaneously restore declining molecular functioning various tissues bone 49 immune system 50 heart 51 parabiosis involving sharing blood streams young old mice provides proofofconcept might add back combinations factors restore functionality throughout body 52 though renewable multiplexed source “ young ” signaling ’ require another human ’ involvement using extracellular vesicles 53 would seem feasible approach measuring lifespan right experimental model case many areas molecular biology models get lot attention others get less measuring organismal lifespan – time birth death – core assay aging field studying trees examples extreme longevity 54 trees longestlived species earth living 5000 years stem cells actively divide differentiate throughout existence 55 many hubcore genes humans 56 enriched pathways elevated young mammalian tissues relative older counterparts 57 58 therefore ’ principles could learn mainstreaming longlived naked mole rat various aquatic species last decades brought many new ideas aging field 59 60 though starting study longevity determinants trees 61 safe say underexplored measuring lifespan makes sense measuring thing want improve however identify factors might extend life without measuring lifespan worms alive means worm moves even slightly similarly humans key symbolic medical part considered alive means able respond external cues worms people considered alive says nothing quality life though worms yes one disrupt mitochondria function extend lifespan model organisms significantly would inhibiting key organelle longterm humans resemble anything like normal life spirit pioneers explorers astronauts ’ know headed instead measuring lifespan perhaps one could aim simpler goals example could figure maintain young state incremental timescale younger vs older states could defined example determining mrna levels various genes time point key would able detect slight differences levels factors interest ie biomarkers two time points figure 2 young phenotype preserved reasonable timescale would seek extrapolate longer time scales essence healthspan experiment rather lifespan experiment thus ’ measuring lifespan agingrelevant phenotypes look replicative life span number divisions cell undergo dies decreases chronological age organism 62 therefore measuring cell replication provides simple model evaluate small differences young vs slightly older state cell number experimentally tractable phenotype inexpensive measure though cell replication rates one aspect age many aging field know might considered solved issue telomerase confer immortal growth 63 however telomerase reactivated 90 cancers influences dna damage responses 64 ’ influence corehub genes thus identify robust agingrelevant phenotypes seem due comprehensive assessment molecular differences cellstissues age figure 2 10x healthspanlifespan strategy 2 minimize agingrelated changes small timescale rather waiting lifespan observe effects putative agingdelayinghealthspanincreasing factors one measure agingrelevant phenotype ρ small time scale eg hours identify changes make rate change ie derivative ∆ρ∆t go negative 0 requires highly quantitative rigorous experimentation beyond molecular biology often discoveries one field made using findings orthogonal fields contemporary internet stemming efforts military build communication network classic example 65 principles disciplines could employed help biologist tackle aging around time world war ii physicists flooded biology help solve problems structure dna perhaps could use help aging thinking engineer consider bodies car engine aging biologist ’ focus combustion linear pathway energy generation less attention flywheel 66 maximizes energy combustion via rotational momentum figure 3 flywheels also ensure smoother ride sparkplug sparks ’ feel jolt due discontinuous action piston engine analogy seems apt aging many aging field focused cellular sparkplugs mitochondria less effort could flywheel moreover molecular biology one way make flywheel perhaps generalize inputs body ’ engine include factors biomolecules car flywheel moment inertias optimized maximize fuel efficiency besides molecules might diminish moment inertia get older certainly physical chemistry underexplored role aging could make environmental changes detrimental planet could keep flywheels spinning body temperature atmosphere experience optimized healthspans lifespans effects varying atmospheric gases tested context endurance athletes 67 divers 68 69 knowledge figure 3 10x healthspanlifespan strategy 3 identify flywheels preserve body ’ energy engines work gas injected cylinders regular intervals ignited sparkplug spark gas volatilized expands driving piston turns crankshaft crankshaft attached flywheel wheels flywheel large moment inertia maintains rotation time interval sparkplug fires therefore flywheel maximizes energy derived gas smoothens ride currently unclear whether biomolecules nonmolecular factors function flywheel humans context aging know molecular oxygen important components atmosphere surprising studies measured effects abundant atmospheric gas nitrogen human physiology 70 several species geogemma barossii live extreme temperatures 250 degrees 71 correlations external internal temperatures longevity humans tested systematically potential electrical mechanical energy aging know lack gravity leads decline muscles bone resembles aging mechanical forces exercise help delay aging 72 73 though exercising muscles bones seems inadequate way fix aging tissues way deliver mechanical forces organs beyond muscle bones exercise liver careful type mechanical forces though tissues liver blood flow congestion induces fibrosis impairs function 74 also many manmade factors profoundly affect aging social isolation strongly negatively affects health 75 socioeconomic factors broad discussion forum ’ stretch say focusing might possibly produce larger global health benefits many medical therapies looking ahead summary laid first steps three potential strategies believe optimized might potential increase human healthspan andor lifespan significantly beyond ’ currently possible 1 identify factors strongly synergize ideally without regard number factors need combined 2 identify factors prevent ageassociated changes tractable time increments retain prophylactic effects time interval lengthened 3 identify factors play flywheel function bodies make energy efficient balance fluctuations physiology review thought exercise could could study anything think might help aging time constraints also drive progress light would combat aging knowledge molecular biology ’ exist references 1 fontana l partridge l longo vd extending healthy life spanfrom yeast humans science 201032859763216 2 scannell jw blanckley boldon h warrington b diagnosing decline pharmaceutical rd efficiency nat rev drug discov 2012113191200 3 barzilai n cuervo austad aging biological target prevention therapy jama 20183201313212 4 austad sn geroscience hypothesis possible change rate aging sierra f kohanski r eds2015 5 lopezotin c blasco partridge l serrano kroemer g hallmarks aging cell 201315361194217 6 kennedy bk berger sl brunet campisi j cuervo epel es et al geroscience linking aging chronic disease cell 2014159470913 7 sierra f kohanski r advances geroscience2016 8 kennedy bk lamming dw mechanistic target rapamycin grand conductor metabolism aging cell metab 20162369901003 9 harrison de strong r sharp zd nelson jf astle cm flurkey k et al rapamycin fed late life extends lifespan genetically heterogeneous mice nature 200946072533925 10 miller ra harrison de astle cm fernandez e flurkey k han et al rapamycinmediated lifespan increase mice dose sex dependent metabolically distinct dietary restriction aging cell 201413346877 11 bitto ito tk pineda vv letexier nj huang hz sutlief e et al transient rapamycin treatment increase lifespan healthspan middleaged mice elife 20165 12 waldner fantus solari thomson aw new perspectives mtor inhibitors rapamycin rapalogs torkinibs transplantation br j clin pharmacol 2016825115870 13 harman aging theory based free radical radiation chemistry j gerontol 1956113298300 14 van raamsdonk jm hekimi superoxide dismutase dispensable normal animal lifespan proc natl acad sci u 201210915578590 15 lithgow gj driscoll phillips p long journey reproducible results nature 201754876683878 16 mehta jackson r paul g shi j sabbagh trials alzheimers disease drugs keep failing discontinued drug perspective 20102015 expert opin investig drugs 20172667359 17 murphy mp amyloidbeta solubility treatment alzheimers disease n engl j med 201837843912 18 erion dm shulman gi diacylglycerolmediated insulin resistance nat med 20101644002 19 meikle pj summers sa sphingolipids phospholipids insulin resistance related metabolic disorders nat rev endocrinol 20171327991 20 boyle ea li yi pritchard jk expanded view complex traits polygenic omnigenic cell 20171697117786 21 larder ba kemp sd harrigan pr potential mechanism sustained antiretroviral efficacy azt3tc combination therapy science 199526952246969 22 oneil nj bailey ml hieter p synthetic lethality cancer nat rev genet 2017181061323 23 humphrey rw brockwaylunardi lm bonk dt dohoney km doroshow jh meech sj et al opportunities challenges development experimental drug combinations cancer j natl cancer inst 20111031612226 24 takahashi k yamanaka induction pluripotent stem cells mouse embryonic adult fibroblast cultures defined factors cell 2006126466376 25 ocampo reddy p martinezredondo p plateroluengo hatanaka f hishida et al vivo amelioration ageassociated hallmarks partial reprogramming cell 20161677171933 e12 26 admasu td chaithanya batchu k barardo ng lf lam vym xiao l et al drug synergy slows aging improves healthspan igf srebp lipid signaling dev cell 20184716779 e5 27 evason k huang c yamben covey df kornfeld k anticonvulsant medications extend worm lifespan science 2005307570725862 28 chen li pw goldstein ba cai w thomas el chen f et al germline signaling mediates synergistically prolonged longevity produced double mutations daf2 rsks1 c elegans cell rep 201356160010 29 foucquier j guedj analysis drug combinations current methodological landscape pharmacol res perspect 201533e00149 30 keith ct borisy aa stockwell br multicomponent therapeutics networked systems nat rev drug discov 200541718 31 wood kb pairwise interactions battle combinatorics multidrug therapies proc natl acad sci u 201611337102313 32 yang l guell niu george h lesha e grishin et al genomewide inactivation porcine endogenous retroviruses pervs science 2015350626411014 33 choi sh wang conti ds raney sg delvadia r leboeuf aa et al generic drug device combination products regulatory scientific considerations int j pharm 2018544244354 34 kammenga je background puzzle identical mutations gene lead different disease symptoms febs j 201728420336273 35 pushpakom iorio f eyers pa escott kj hopper wells et al drug repurposing progress challenges recommendations nat rev drug discov 2018 36 williams pt lower risk alzheimers disease mortality exercise statin fruit intake j alzheimers dis 201544411219 37 daneschvar hl aronson md smetana gw statins prevent alzheimers disease narrative review eur j intern med 20152696669 38 markowiczpiasecka sikora j szydlowska skupien mikiciukolasik e huttunen km metformin future therapy neurodegenerative diseases theme drug discovery development delivery alzheimers disease guest editor davide brambilla pharm res 20173412261427 39 tiihonen taipale h tanskanen tiihonen j hartikainen incidence duration cumulative bisphosphonate use among communitydwelling persons without alzheimers disease j alzheimers dis 201652112732 40 j tosti v redman lm fontana l calorie restriction humans update ageing res rev 2017393645 41 longo vd panda fasting circadian rhythms timerestricted feeding healthy lifespan cell metab 2016236104859 42 minor rk allard js younts cm ward tm de cabo r dietary interventions extend life span health span based calorie restriction j gerontol biol sci med sci 2010657695703 43 mccay cm crowell mf maynard la effect retarded growth upon length life span upon ultimate body size 1935 nutrition 19895315571 discussion 72 44 colman rj anderson rm johnson sc kastman ek kosmatka kj beasley tm et al caloric restriction delays disease onset mortality rhesus monkeys science 200932559372014 45 colman rj beasley tm kemnitz jw johnson sc weindruch r anderson rm caloric restriction reduces agerelated allcause mortality rhesus monkeys nat commun 201453557 46 vaughan kl kaiser peaden r anson rm de cabo r mattison ja caloric restriction study design limitations rodent nonhuman primate studies j gerontol biol sci med sci 20177314853 47 mattison ja roth gs beasley tm tilmont em handy herbert rl et al impact caloric restriction health survival rhesus monkeys nia study nature 2012489741531821 48 harper jm leathers cw austad sn caloric restriction extend life wild mice aging cell 2006564419 49 ribault habib abdelmajid k barbara mitrovic agerelated decrease responsiveness rat articular chondrocytes egf associated diminished number affinity ligand cell surface binding sites mech ageing dev 199810012540 50 de haan g van zant g dynamic changes mouse hematopoietic stem cell numbers aging blood 199993103294301 51 gerstenblith g spurgeon ha froehlich jp weisfeldt ml lakatta eg diminished inotropic responsiveness ouabain aged rat myocardium circ res 197944451723 52 villeda sa luo j mosher ki zou b britschgi bieri g et al ageing systemic milieu negatively regulates neurogenesis cognitive function nature 20114777362904 53 robbins pd extracellular vesicles aging stem cell investig 2017498 54 anson rm willcox b austad perls within betweenspecies study extreme longevitycomments commonalities goals j gerontol biol sci med sci 201267434750 55 flanary kletetschka g analysis telomere length telomerase activity tree species various lifespans age bristlecone pine pinus longaeva rejuvenation res 200691613 56 altenhoff glover nm train cm kaleb k warwick vesztrocy dylus et al oma orthology database 2018 retrieving evolutionary relationships among domains life richer web programmatic interfaces nucleic acids res 201846d1d477d85 57 peterson tr gene expression patterns young versus old tissues 2018 58 xu yh liao yc zhang z liu j sun pw gao zh et al jasmonic acid crucial signal transducer heat shock induced sesquiterpene formation aquilaria sinensis sci rep 2016621843 59 lagunasrangel fa chavezvalencia v learning nature curious case naked mole rat mech ageing dev 20171647681 60 austad sn methusalehs zoo nature provides us clues extending human health span j comp pathol 2010142 suppl 1s1021 61 plomion c aury jm amselem j leroy murat f duplessis et al oak genome reveals facets long lifespan nat plants 20184744052 62 lee js lee sm jeong sw sung yg lee jh kim kw effects age replicative lifespan growth rate human nucleus pulposus cells selecting age range cellbased biological therapies degenerative disc diseases biotech histochem 201691537785 63 blackburn eh epel es lin j human telomere biology contributory interactive factor aging disease risks protection science 2015350626511938 64 masutomi k possemato r wong jm currier jl tothova z manola jb et al telomerase reverse transcriptase regulates chromatin state dna damage responses proc natl acad sci u 20051022382227 65 httpsenwikipediaorgwikihistoryoftheinternet 66 httpsenwikipediaorgwikiflywheel 67 levine bd straygundersen j doseresponse altitude training much altitude enough adv exp med biol 200658823347 68 freiberger jj derrick bj natoli mj akushevich schinazi ea parker c et al assessment interaction hyperbaric n2 co2 o2 psychomotor performance divers j appl physiol 1985 2016121495364 69 bove aa diving medicine j respir crit care med 201418912147986 70 harmens h hayes f sharps k mills g calatayud v leaf traits photosynthetic responses betula pendula saplings range groundlevel ozone concentrations range nitrogen loads j plant physiol 20172114252 71 kashefi k lovley dr extending upper temperature limit life science 20033015635934 72 turner ch takano owan aging changes mechanical loading thresholds bone formation rats j bone miner res 1995101015449 73 garg k boppart md influence exercise aging extracellular matrix composition skeletal muscle stem cell niche j appl physiol 1985 2016121510538 74 simonetto da yang hy yin de assuncao tm kwon jh hilscher et al chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis mechanical forces hepatology 201561264859 75 valtorta n hanratty b loneliness isolation health older adults need new research agenda j r soc med 20121051251822",
    "relevance_score": 0.8097,
    "date_score": 0,
    "final_score": 0.6073,
    "date_numeric": 0
  },
  {
    "title": "Microsoft Word - moonshots-for-aging-revision1-041919-arxiv.docx",
    "author": "Unknown Author",
    "date": "2019-04-19T20:33:44",
    "filename": "1901.04053.pdf",
    "processed_text": "title moonshots aging authors sandeep kumar1 timothy r peterson1 affiliation 1 department internal medicine division bone mineral diseases department genetics institute public health washington university school medicine bjc institute health 425 euclid ave st louis mo 63110 usa correspondence timrpetersonwustledu trp abstract global population ages increased interest living longer improving one ’ quality life later years however studying aging – decline body function – expensive timeconsuming despite research success make model organisms live longer still ’ really feasible solutions delaying aging humans space travel scientists ’ know would take get moon extrapolate theory shorterrange tests perhaps aging need similar moonshot philosophy though “ shot ” might imply medicine perhaps need think beyond biological interventions like moon seem long way away provable therapies increase human healthspan healthy period one ’ life lifespan long one lives review therefore focuses radical proposals hope might stimulate discussion might consider significantly differently ongoing aging research introduction – incrementalism thinking linear vs logscale silicon valley wants 10x engineers people 10x work average engineer likewise biomedical researchers starting careers told senior colleagues chase big findings ignore small effects aim big increases human healthspan lifespan assuming earth handle consequences enough people want let ’ first consider current state aging delaying therapies many ways think treating aging existing treatments treat specific aging conditions form drugs improve one area body diseased aging populations drugs diabetes high blood glucose osteoporosis bone loss common examples currently fdaapproved remedies reduce aging per se ie increase healthspan lifespan experiments aimed identifying new interventions aging historically done species ranging primates mice worms yeast 1 yet pharmaceutical industry become weary treatments work model systems proven ineffective humans 2 unfortunately especially true treatments agingassociated chronic diseases 3 thus considering human clinical trials aging therapies take years play important scrutinize effect sizes seen preclinical models less encouraging sign many lifespan experiments done mammals modest effect sizes often statistically significant effects one genders often specific dietary andor housing conditions 4 even inhibiting one potent aging pathways 57 mechanistic target rapamycin mtor pathway 8 arguably modest effects lifespan – 1224 increase mice 1423 females926 males 9 10 notably rapamycin associated harmful effects including increased risk aggressive hematological malignancies dramatic microbiome alterations 11 also experiments done controlled environment limits pathogens exposure relevant rapamycin immunosuppressant used clinically organ transplantation 12 suggests realworld scenario people ’ immune systems would challenged regularly ’ clear rapamycin would significant beneficial effect healthspan lifespan ask rapamycin one potential bestcase scenarios might predicted modest effect possibly detrimental one people continue receive much focus aging community note problems aging field small inconsistent effects leading strategies ’ specific rapamycin popular reactive oxygen species ros theory aging 13 challenged found deleting genes capable detoxifying superoxide dispensable worm lifespan 14 related example worms different labs produced dramatically different lifespanmodulating effect sizes rosaltering drug 15 worms simpler mice took decade highly qualified labs resolve inconsistent results ros drug ’ bode well rosbased therapies real world people treating individual agingrelated diseases encountered roadblocks also call question whether optimal path human aging alzheimer ’ diabetes particularly wellfunded wellresearched agingrelated topics still huge gaps understanding lack good treatment options alzheimer ’ considerable focus amyloid beta tau targeting molecules ’ done much alzheimer ’ far leaving many searching answers 16 17 regarding diabetes people think insulin resistance caused intracellular overaccumulation lipids despite many smart people working decades ’ clear whether diacylglycerol 18 ceramide 19 lipids might main culprit point spend collectively long time something ’ working well manipulating single gene biological process seem natural consider conceptually different approaches herein discuss different therapeutic concepts aging might push us beyond current thinking beyond reductionist onehypothesis onepathway onedisease view perhaps problem aging might single molecular pathway collection pathways biologists typically understand pathways following omnigenic model complex disease 20 aging might involve genes therefore true would one thing extend life inhibiting one pathway drug really expected lot still part omnigenic model “ hub ” ” core ” genes relatively important genes intuitive target genes consider impactful one drug manipulating one gene may good enough looking synergistic combinations treating aids 21 cancer 22 23 seems like next logical step one proofofconcept aginglimiting cocktail yamanaka pluripotency factors 24 tested good results mouse model premature aging condition progeria 25 manipulating insulinlike growth factor igf sterolresponsive element binding protein srebp also produced strong synergistic healthspanextending effects 26 several combinations likewise validated model organisms 27 28 using synergistic combinations potential lower amount agent one use beneficial lowering potential side effects 29 30 still effect sizes combinations factors might much single factor even begin contemplate 10x effects like silicon valley aims need concentrate strategies generate synergistic figure 1 10x healthspanlifespan strategy 1 identify maximally synergistic lifeextending factors drugs gene manipulations four factors depicted needed promote synergistic effects aging phenotype ρ rho analogy yamuna pluripotency cocktail contains four factors synergistic factors could drugs andor gene manipulations ideally chosen large list candidates following systematic unbiased largescale experimentation combinations figure 1 challenge number possible combinations tested multiple number factors consideration consider hypothetical drugs targeting 20000 proteincoding human genes testing combination would four hundred million combinations ’ feasible today noting contexts effects combinations many factors approximated effects pairs reduces number combinations test 31 potentially might need choose could throw kitchen sink problem perturb many genes time precedence manygene approach using crispr 62 retroviral genes knocked pig liver make organs theoretically safer transplantation 32 yet regulatory hurdles need cleared currently fda requires testing individual components combination treatment however one envision future need get great fda allow applications cocktails without individual components gaining approval first 33 even thinking specific agingassociated conditions rather aging per se synergistic factors could provide valuable new path forward core genes tend important across aging conditions 34 suggests would benefit researchers interested specific conditions look aging per se aging conditions besides one ’ studying better understand physicians might also mean onedrug approach failing like alzheimer ’ might consider drug synergies drugs alleviate agingassociated conditions would form drug repositioning 35 already evidence could work alzheimer ’ example drugs several agingrelated conditions heart disease 36 37 diabetes 38 osteoporosis 39 shown alleviate neurodegeneration various models yamanaka started pursuit pluripotency cocktail short list genes make short list molecular factors aging would look like point ’ like make plug factors add back function aging tissues many existing strategies increase healthspan lifespan involve taking something away often inhibiting molecular pathways dietary limitation caloric restriction intermittent fasting mostwell known approaches category 40 41 dietary regimens involve reducing calorie intake without causing malnutrition though caloric restriction longstanding “ gold standard ” aging field associated 50 increases lifespan 1 two major issues 1 poor feasibility questionable whether many humans could cut large number calories eg 33 reduction needed longterm demonstrate generalizable efficacy approach 42 2 importantly though many studies including dating back almost century ago showed significant benefits cr 4345 many studies ’ panned 4648 cr work well contexts others like rapamycin one wonder whether rather devote resources cr might better approaches therefore instead restricting something arguably defensible idea would restore functionality makes sense considering aging explicitly means decreasing function would one simultaneously restore declining molecular functioning various tissues bone 49 immune system 50 heart 51 parabiosis involving sharing blood streams young old mice provides proofofconcept might add back combinations factors restore functionality throughout body 52 though renewable multiplexed source “ young ” signaling ’ require another human ’ involvement using extracellular vesicles 53 would seem feasible approach measuring lifespan right experimental model case many areas molecular biology models get lot attention others get less measuring organismal lifespan – time birth death – core assay aging field studying trees examples extreme longevity 54 trees longestlived species earth living 5000 years stem cells actively divide differentiate throughout existence 55 many hubcore genes humans 56 enriched pathways elevated young mammalian tissues relative older counterparts 57 58 therefore ’ principles could learn mainstreaming longlived naked mole rat various aquatic species last decades brought many new ideas aging field 59 60 though starting study longevity determinants trees 61 safe say underexplored measuring lifespan makes sense measuring thing want improve however identify factors might extend life without measuring lifespan worms alive means worm moves even slightly similarly humans key symbolic medical part considered alive means able respond external cues worms people considered alive says nothing quality life though worms yes one disrupt mitochondria function extend lifespan model organisms significantly would inhibiting key organelle longterm humans resemble anything like normal life spirit pioneers explorers astronauts ’ know headed instead measuring lifespan perhaps one could aim simpler goals example could figure maintain young state incremental timescale younger vs older states could defined example determining mrna levels various genes time point key would able detect slight differences levels factors interest ie biomarkers two time points figure 2 young phenotype preserved reasonable timescale would seek extrapolate longer time scales essence healthspan experiment rather lifespan experiment thus ’ measuring lifespan agingrelevant phenotypes look replicative life span number divisions cell undergo dies decreases chronological age organism 62 therefore measuring cell replication provides simple model evaluate small differences young vs slightly older state cell number experimentally tractable phenotype inexpensive measure though cell replication rates one aspect age many aging field know might considered solved issue telomerase confer immortal growth 63 however telomerase reactivated 90 cancers influences dna damage responses 64 ’ influence corehub genes thus identify robust agingrelevant phenotypes seem due comprehensive assessment molecular differences cellstissues age figure 2 10x healthspanlifespan strategy 2 minimize agingrelated changes small timescale rather waiting lifespan observe effects putative agingdelayinghealthspanincreasing factors one measure agingrelevant phenotype ρ small time scale eg hours identify changes make rate change ie derivative ∆ρ∆t go negative 0 requires highly quantitative rigorous experimentation beyond molecular biology often discoveries one field made using findings orthogonal fields contemporary internet stemming efforts military build communication network classic example 65 principles disciplines could employed help biologist tackle aging around time world war ii physicists flooded biology help solve problems structure dna perhaps could use help aging thinking engineer consider bodies car engine aging biologist ’ focus combustion linear pathway energy generation less attention flywheel 66 maximizes energy combustion via rotational momentum figure 3 flywheels also ensure smoother ride sparkplug sparks ’ feel jolt due discontinuous action piston engine analogy seems apt aging many aging field focused cellular sparkplugs mitochondria less effort could flywheel moreover molecular biology one way make flywheel perhaps generalize inputs body ’ engine include factors biomolecules car flywheel moment inertias optimized maximize fuel efficiency besides molecules might diminish moment inertia get older certainly physical chemistry underexplored role aging could make environmental changes detrimental planet could keep flywheels spinning body temperature atmosphere experience optimized healthspans lifespans effects varying atmospheric gases tested context endurance athletes 67 divers 68 69 knowledge figure 3 10x healthspanlifespan strategy 3 identify flywheels preserve body ’ energy engines work gas injected cylinders regular intervals ignited sparkplug spark gas volatilized expands driving piston turns crankshaft crankshaft attached flywheel wheels flywheel large moment inertia maintains rotation time interval sparkplug fires therefore flywheel maximizes energy derived gas smoothens ride currently unclear whether biomolecules nonmolecular factors function flywheel humans context aging know molecular oxygen important components atmosphere surprising studies measured effects abundant atmospheric gas nitrogen human physiology 70 several species geogemma barossii live extreme temperatures 250 degrees 71 correlations external internal temperatures longevity humans tested systematically potential electrical mechanical energy aging know lack gravity leads decline muscles bone resembles aging mechanical forces exercise help delay aging 72 73 though exercising muscles bones seems inadequate way fix aging tissues way deliver mechanical forces organs beyond muscle bones exercise liver careful type mechanical forces though tissues liver blood flow congestion induces fibrosis impairs function 74 also many manmade factors profoundly affect aging social isolation strongly negatively affects health 75 socioeconomic factors broad discussion forum ’ stretch say focusing might possibly produce larger global health benefits many medical therapies looking ahead summary laid first steps three potential strategies believe optimized might potential increase human healthspan andor lifespan significantly beyond ’ currently possible 1 identify factors strongly synergize ideally without regard number factors need combined 2 identify factors prevent ageassociated changes tractable time increments retain prophylactic effects time interval lengthened 3 identify factors play flywheel function bodies make energy efficient balance fluctuations physiology review thought exercise could could study anything think might help aging time constraints also drive progress light would combat aging knowledge molecular biology ’ exist references 1 fontana l partridge l longo vd extending healthy life spanfrom yeast humans science 201032859763216 2 scannell jw blanckley boldon h warrington b diagnosing decline pharmaceutical rd efficiency nat rev drug discov 2012113191200 3 barzilai n cuervo austad aging biological target prevention therapy jama 20183201313212 4 austad sn geroscience hypothesis possible change rate aging sierra f kohanski r eds2015 5 lopezotin c blasco partridge l serrano kroemer g hallmarks aging cell 201315361194217 6 kennedy bk berger sl brunet campisi j cuervo epel es et al geroscience linking aging chronic disease cell 2014159470913 7 sierra f kohanski r advances geroscience2016 8 kennedy bk lamming dw mechanistic target rapamycin grand conductor metabolism aging cell metab 20162369901003 9 harrison de strong r sharp zd nelson jf astle cm flurkey k et al rapamycin fed late life extends lifespan genetically heterogeneous mice nature 200946072533925 10 miller ra harrison de astle cm fernandez e flurkey k han et al rapamycinmediated lifespan increase mice dose sex dependent metabolically distinct dietary restriction aging cell 201413346877 11 bitto ito tk pineda vv letexier nj huang hz sutlief e et al transient rapamycin treatment increase lifespan healthspan middleaged mice elife 20165 12 waldner fantus solari thomson aw new perspectives mtor inhibitors rapamycin rapalogs torkinibs transplantation br j clin pharmacol 2016825115870 13 harman aging theory based free radical radiation chemistry j gerontol 1956113298300 14 van raamsdonk jm hekimi superoxide dismutase dispensable normal animal lifespan proc natl acad sci u 201210915578590 15 lithgow gj driscoll phillips p long journey reproducible results nature 201754876683878 16 mehta jackson r paul g shi j sabbagh trials alzheimers disease drugs keep failing discontinued drug perspective 20102015 expert opin investig drugs 20172667359 17 murphy mp amyloidbeta solubility treatment alzheimers disease n engl j med 201837843912 18 erion dm shulman gi diacylglycerolmediated insulin resistance nat med 20101644002 19 meikle pj summers sa sphingolipids phospholipids insulin resistance related metabolic disorders nat rev endocrinol 20171327991 20 boyle ea li yi pritchard jk expanded view complex traits polygenic omnigenic cell 20171697117786 21 larder ba kemp sd harrigan pr potential mechanism sustained antiretroviral efficacy azt3tc combination therapy science 199526952246969 22 oneil nj bailey ml hieter p synthetic lethality cancer nat rev genet 2017181061323 23 humphrey rw brockwaylunardi lm bonk dt dohoney km doroshow jh meech sj et al opportunities challenges development experimental drug combinations cancer j natl cancer inst 20111031612226 24 takahashi k yamanaka induction pluripotent stem cells mouse embryonic adult fibroblast cultures defined factors cell 2006126466376 25 ocampo reddy p martinezredondo p plateroluengo hatanaka f hishida et al vivo amelioration ageassociated hallmarks partial reprogramming cell 20161677171933 e12 26 admasu td chaithanya batchu k barardo ng lf lam vym xiao l et al drug synergy slows aging improves healthspan igf srebp lipid signaling dev cell 20184716779 e5 27 evason k huang c yamben covey df kornfeld k anticonvulsant medications extend worm lifespan science 2005307570725862 28 chen li pw goldstein ba cai w thomas el chen f et al germline signaling mediates synergistically prolonged longevity produced double mutations daf2 rsks1 c elegans cell rep 201356160010 29 foucquier j guedj analysis drug combinations current methodological landscape pharmacol res perspect 201533e00149 30 keith ct borisy aa stockwell br multicomponent therapeutics networked systems nat rev drug discov 200541718 31 wood kb pairwise interactions battle combinatorics multidrug therapies proc natl acad sci u 201611337102313 32 yang l guell niu george h lesha e grishin et al genomewide inactivation porcine endogenous retroviruses pervs science 2015350626411014 33 choi sh wang conti ds raney sg delvadia r leboeuf aa et al generic drug device combination products regulatory scientific considerations int j pharm 2018544244354 34 kammenga je background puzzle identical mutations gene lead different disease symptoms febs j 201728420336273 35 pushpakom iorio f eyers pa escott kj hopper wells et al drug repurposing progress challenges recommendations nat rev drug discov 2018 36 williams pt lower risk alzheimers disease mortality exercise statin fruit intake j alzheimers dis 201544411219 37 daneschvar hl aronson md smetana gw statins prevent alzheimers disease narrative review eur j intern med 20152696669 38 markowiczpiasecka sikora j szydlowska skupien mikiciukolasik e huttunen km metformin future therapy neurodegenerative diseases theme drug discovery development delivery alzheimers disease guest editor davide brambilla pharm res 20173412261427 39 tiihonen taipale h tanskanen tiihonen j hartikainen incidence duration cumulative bisphosphonate use among communitydwelling persons without alzheimers disease j alzheimers dis 201652112732 40 j tosti v redman lm fontana l calorie restriction humans update ageing res rev 2017393645 41 longo vd panda fasting circadian rhythms timerestricted feeding healthy lifespan cell metab 2016236104859 42 minor rk allard js younts cm ward tm de cabo r dietary interventions extend life span health span based calorie restriction j gerontol biol sci med sci 2010657695703 43 mccay cm crowell mf maynard la effect retarded growth upon length life span upon ultimate body size 1935 nutrition 19895315571 discussion 72 44 colman rj anderson rm johnson sc kastman ek kosmatka kj beasley tm et al caloric restriction delays disease onset mortality rhesus monkeys science 200932559372014 45 colman rj beasley tm kemnitz jw johnson sc weindruch r anderson rm caloric restriction reduces agerelated allcause mortality rhesus monkeys nat commun 201453557 46 vaughan kl kaiser peaden r anson rm de cabo r mattison ja caloric restriction study design limitations rodent nonhuman primate studies j gerontol biol sci med sci 20177314853 47 mattison ja roth gs beasley tm tilmont em handy herbert rl et al impact caloric restriction health survival rhesus monkeys nia study nature 2012489741531821 48 harper jm leathers cw austad sn caloric restriction extend life wild mice aging cell 2006564419 49 ribault habib abdelmajid k barbara mitrovic agerelated decrease responsiveness rat articular chondrocytes egf associated diminished number affinity ligand cell surface binding sites mech ageing dev 199810012540 50 de haan g van zant g dynamic changes mouse hematopoietic stem cell numbers aging blood 199993103294301 51 gerstenblith g spurgeon ha froehlich jp weisfeldt ml lakatta eg diminished inotropic responsiveness ouabain aged rat myocardium circ res 197944451723 52 villeda sa luo j mosher ki zou b britschgi bieri g et al ageing systemic milieu negatively regulates neurogenesis cognitive function nature 20114777362904 53 robbins pd extracellular vesicles aging stem cell investig 2017498 54 anson rm willcox b austad perls within betweenspecies study extreme longevitycomments commonalities goals j gerontol biol sci med sci 201267434750 55 flanary kletetschka g analysis telomere length telomerase activity tree species various lifespans age bristlecone pine pinus longaeva rejuvenation res 200691613 56 altenhoff glover nm train cm kaleb k warwick vesztrocy dylus et al oma orthology database 2018 retrieving evolutionary relationships among domains life richer web programmatic interfaces nucleic acids res 201846d1d477d85 57 peterson tr gene expression patterns young versus old tissues 2018 58 xu yh liao yc zhang z liu j sun pw gao zh et al jasmonic acid crucial signal transducer heat shock induced sesquiterpene formation aquilaria sinensis sci rep 2016621843 59 lagunasrangel fa chavezvalencia v learning nature curious case naked mole rat mech ageing dev 20171647681 60 austad sn methusalehs zoo nature provides us clues extending human health span j comp pathol 2010142 suppl 1s1021 61 plomion c aury jm amselem j leroy murat f duplessis et al oak genome reveals facets long lifespan nat plants 20184744052 62 lee js lee sm jeong sw sung yg lee jh kim kw effects age replicative lifespan growth rate human nucleus pulposus cells selecting age range cellbased biological therapies degenerative disc diseases biotech histochem 201691537785 63 blackburn eh epel es lin j human telomere biology contributory interactive factor aging disease risks protection science 2015350626511938 64 masutomi k possemato r wong jm currier jl tothova z manola jb et al telomerase reverse transcriptase regulates chromatin state dna damage responses proc natl acad sci u 20051022382227 65 httpsenwikipediaorgwikihistoryoftheinternet 66 httpsenwikipediaorgwikiflywheel 67 levine bd straygundersen j doseresponse altitude training much altitude enough adv exp med biol 200658823347 68 freiberger jj derrick bj natoli mj akushevich schinazi ea parker c et al assessment interaction hyperbaric n2 co2 o2 psychomotor performance divers j appl physiol 1985 2016121495364 69 bove aa diving medicine j respir crit care med 201418912147986 70 harmens h hayes f sharps k mills g calatayud v leaf traits photosynthetic responses betula pendula saplings range groundlevel ozone concentrations range nitrogen loads j plant physiol 20172114252 71 kashefi k lovley dr extending upper temperature limit life science 20033015635934 72 turner ch takano owan aging changes mechanical loading thresholds bone formation rats j bone miner res 1995101015449 73 garg k boppart md influence exercise aging extracellular matrix composition skeletal muscle stem cell niche j appl physiol 1985 2016121510538 74 simonetto da yang hy yin de assuncao tm kwon jh hilscher et al chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis mechanical forces hepatology 201561264859 75 valtorta n hanratty b loneliness isolation health older adults need new research agenda j r soc med 20121051251822",
    "relevance_score": 0.8097,
    "date_score": 0.0,
    "final_score": 0.4048,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Thomas",
    "date": "2016-12-30T14:10:16",
    "filename": "1503.07040.pdf",
    "processed_text": "email thomasjicun gmailcom 1 traditional aging theories ones useful jicun wang michelitsch1 thomas michelitsch2 1department medicine addenbrookes hospital university cambridge uk work address 2007 2 institut jean le rond ’ alembert paris 6 cnrs u mr 7190 paris france abstract many theories proposed answer ing two questions aging “ age ” “ h ow age ” ones finally tenable made analysis theories select useful one evolutionary theories made interpret ing evolutionary advantage aging “ saving resources group benefit ” thought purpose aging however saving resources economic strategy make individual reproduction age undergo rapid death rather undergo slow aging biological theories made identify ing causes biological process es aging h owever including cell senescence telomere theory gene controlling theory developmental theory unfortunately ignore influence damage aging freeradical theory suggests free radicals causing intrinsic damage main cause aging however even intracellular free radical cause injuries may associated aging changes damage fault accumulation theory predicts intrinsic faults damage accumulate lead aging reality unrepaired fault possi bly remain living organism since destroy structural integrity tissue cause rapid failure organism therefore hese theories untenable interpreting aging nevertheless among developmental theory damage fault accumulation theory useful others emphasize importance damage body development aging p hysical theories also useful point ing common characteristics aging process loss complexity increase entropy failure information transmission advanced aging theory theory include useful ideas traditional theories keywords aging aging theories deductive analysis impossi bility evolvability theory mutation accumulation heory antagonistic pleiotropy theory disposable soma theory freeradical theory cell senescence telomere theory developmental theory amage fault accumulation theory g enecontrolling theory loss complexity ncrease entropy failure information transmission ulticellular chaos misrepair accumulation theory email thomasjicun gmailcom 2 “ age ” “ h ow age ” two different questions first need explain aging un avoidable f second need explain underlying biological process aging many theories created answer ing two questions evolutionary theories including evolvability theory weismann 1889 mutation accumulation heory medawar 1952 antagonistic pleiotropy theory williams 1957 disposable soma theory kirkwood 1977 proposed interpret evolutionary advantage aging biological theories made identify causes biological processes aging example f reeradical theory emphasizes central role free radicals aging harman 1956 cell senescence telomere theory suggests telomere controlled senescence cells main cause aging blackbur n 2000 development al theory supposes aging result development medvedev 1990 damage fault accumulation theory genecontrolling theory actually leading theories nowadays damage fault accumulation theory predicts intrinsic faults left unrepaired due limitation repair maintenance sources aging kirkwood 200 5 2006 genecontrolling theory demonstrates certain genes control process aging completely ind ependently physical theories summarized physical properties aging loss complexity lipsitz 1992 consequence increase entropy bortz 1986 failure information transmission mulá 2004 question among theories ones finally tenab le explaining aging present paper analyze answer question discussi devoted following subjects method disproving theory ii limitations traditional aging theories 21 evolutionary theories 22 freeradical theory 23 cell senescence telomere theory 24 gene controlling theory 25 developmental heory 26 damage fault accumulation theory 27 physical theories iii useful theories unanswered questions method disproving theory accept abandon th eory important find negative evidence rather collect positive evidence theory falsified even “ one ” negative fact popper 1994 search real criminal number suspects feasible simple way exclude first impossible suspects judging theory strategy also useful w e analyze impossibility theory collecting negative evidence email thomasjicun gmailcom 3 basis propose method disproving theory name “ deductive analysis impossibility ” taken genecontrolling theory example procedure analysis follows premise 1 prediction “ aging controlled gene ” correct distribution aging changes indepe ndent locations damage figure 1a premise 2 fact distribution wrinkles face closely related locations damage figure 1a figure 1b conclusion therefore prediction “ aging controlled gene ” impossible genecontrolling theory untenable figure 1a negative fact exists theory acceptable despite number positive evidence unfortun ately biologists forgotten princip le judging works mak e effort collect positive data conclusion disproved single negative case following discussion analyze aging theories method b figure 1 deductive analysis im possibility aging theory “ deductive analysis impossibility ” useful method disprove aging theory analyze impossibility theory collecting negative evidence taken gene controlling theory example process deductive analysis follows premise 1 prediction “ aging controlled gene ” correct distribution aging changes independent locations damage premise 2 fact distribution wrinkles face closely related locations damage b conclusion therefore prediction “ aging controlled gene ” impossible gene controlling theory untenable ii limitations traditional aging theories traditional ging theories interpret aging different aspects however far none give full story aging mechanism part w e look p rediction “ aging controlled gene ” correct distribution aging changes independent locations damage premise 1 fact distribution wrinkles face closely related locations damage premise 2 therefore prediction “ aging controlled gene ” impossible gene controlling theory unte nable conclusion wrinkles face email thomasjicun gmailcom 4 theories tell complete acce ptable n untenable theory given however useful ideas inherited important study ing aging 21 evolutionary theories one earliest theories aging evolvability theory firstly proposed weismann recently modified mitteldorf weismann 1889 mitteldorf 2006 theory suggests purpose limited lifespan save living resources younger generations “ group benefit ” direction theories provided possible mechanisms organism “ sacrifice ” “ group benefit ” theories include mutation accumulation theory antagonistic pleiotropy theory disposable soma theory true group benefit evolutionary advantage h owever saving resources production effective strate gy remove old individuals “ planned rapid death ” rather long process aging r eality maximum lifespans indiv iduals species ’ animals much longer time development example woman live 30 years age 70 90 reproduction age age 15 45 mutation accumulation theory main point mutation accumulation theo ry weak fitness selection old organism allows wide range gene mutations n somatic cells deleterious effects organism medawar 1952 martin 1996 dna mutations take place reproduction age affect next generation therefore mutations wiped evolution accumulate somatic body however n reality type aging changes age spots often develop paral lelly independently different parts organ aging changes develop way possibly result dna mutations impossible form dna change takes place paral lelly independently different somatic cells different parts organ another question theory cells altered phenotype dna changes removed immune system develop tumors antagonistic pleiotropy theory 1957 williams gave another supposition aging sympto ms antagonistic pleiotropy theory williams 1957 supposed genes antagonistic pleiotropic effect might exist bene fiting effects early life detriment al effects later age williams also pointed agei ng sid e effect necessary functions alteration ageing process impossible theory sounds reasonable presuming kind pleiotropic genes h owever genes possibly exist detriment al effects som atic cell result quick death rather gradual aging organ reality organs maintain sufficient function ality 60 years even aging disposable soma theor disposable soma theory presumes organism must budget limited energy available energy well distributed metabolism email thomasjicun gmailcom 5 reprod uction repair maintenance organism prefers save energy reproduction rather maintain mature body insufficient repair therefore cause deleterious change body ag e kirkwood 1977 however insufficiency repair fatal organism wound skin left unrepaired due insufficiency repair consequence would death body bleeding infection rather aging skin 22 free radical theory theory points free radical main origin aging causing cellular injuries harman 1956 molecules f ree radicals biological organism include superoxide reactive oxygen species small molecules produced cells substrates products biochemical reactions although studies shown effect anti freeradical extending lifespan animal drosophila roundworms van raamsdonk 2009 role free radicals aging controversial ahluwalia 2004 juránek 2005 oxidative free radicals cause potentially cell injuries free state however part ce metabolism molecules n accurate control distributions activities like molecules cells normally free radicals immediately removed deactivated functioning intracellular antioxidants maintain ing intracellular stability even cause times injuries injured cells molecules fully repaired removed necessarily affecting tissue structure tissue function even injuries made free radicals fully repaired injuries associated aging changes 23 cell senescence telomere theory reduction cell number always thought cause aging idea enhanc ed discovery telomeres telomeres end ing part chromosomes important protecting chromosomes regulating activities chromosomes dna duplication 3 ’ ending part template dna telomere used priming sequence synthesizi ng new dna therefore new dna shorter template dna telomere new dna shorter template dna length telomere therefore shortened time dna duplication cell division telomere short dna synthesis cell division anymore proceed basis cell senescen cetelomere theory proposed theory suggests telomere determined cell senescence origin aging hayflick 1965 blackburn 2000 di scovery telomerase enzyme prolong telomere powerful support theory telomerase found produced mainly germ cells tumor cells kim 1994 however studies shown consistent relationship telomere length animal lifespan kipling 1990 hemann 2000 addition theory incompatible known facts potential cell division also controlled fact ors stem cell essentially longer telomere neighbor nonstem cells b reduction cell number unique change aged tissue contrast aging changes email thomasjicun gmailcom 6 including hyperplasia appear increase number cells c organs still reproduce new cells repair 70 years old 24 gene controlling theory life science nowadays era “ gene ” “ genome ” aging thought solvable discovering controlling genes summarize belie f genecontrolling theory searching “ aging related genes ” “ lifespan related genes ” becomes therefore main work many scientists de magalhaes 2009 fabrizio 2010 bell 2012 mccormick 2012 belief gene controlling aging fundamental gene programming theory aging process thought preprogrammed genetically development longo 2005 earliest idea programmed aging might come phenomenon planned death biological suicide species ’ animals individuals semelparous salmon female octopus go die quickly following reproduction hormone signaling identified mechanism programmed death octopus wodinsky 1977 however programmed death sudden short quiet different aging process reality individuals species living different environments protected protected may quite different lifespans even environment individuals die different ages idea programmed aging given scientists austad 2004 many aging related genes lifespan related genes identified mccormick 2012 university wash ington 2012 however exact roles aging known view belief aging genes misleading idea severe defects even genes associated lifespan essentially aging related b even genes aging related essentially elements control aging process completely independently c aging controlled certain genes distribution aging changes independent locations damage however fact distribution age spots skin closely related locations damage aging con trolled completely gene g ene fails individual dna mutation individual could immortal however immortal case observed far world therefore gene programming mechanism aging may possibly exist 25 developmental heory alternati development pathway alter significant ly lifespan rganism klass 1976 basis johnson assumed aging development coupled johnson et al 1984 medvedev proposed developmental theory theory suggest aging result development aging process regulated b mechanism development medvedev 1990 zwaan 2003 idea supported discovery correlation potential longevity mature time animal charnov 1993 dauer pathway altered pathway development c e legans dauer individuals prolonged lifespans dauer pathway found induced environment change mediated insulin like signaling pathway wolkow 2000 email thomasjicun gmailcom 7 hormones hormone related genes thought important regulating aging process apart regulating development de magalhaes 2005 idea coupling process aging process development revealing however theory three defects ignored influen ce damage aging b clarify difference development process aging process c effect alteration development lifespan essentia lly via retarding aging 26 damage fault accumulation theory somatic injuries unnegligible development aging changes aspect kirkwood predicted “ aging result accumulation ‘ faults ’ cellular molecular level limitation maintenance repair underlying driving forc e damage genetic control longevity comes regulation essential maintenance repair processes slow build –up faults ” kirkwood 2005 summarize prediction “ damage fault accumulation theory ” theo ry emphasizes importance damage repairmaintenance system aging h owever since terms specified conclusion theory confusing term “ fault ” prediction understood kind “ intrinsic damage ” however clear whether “ intrinsic damage ” referred change moleculecell repair change repair example scar formation burnt skin wound skin burning primary damage repair scar change skin repair two changes skin repair repair obviously different thus distinguishe term “ faults ” prediction possibly referred primary damage repair since “ accumulate limitation repair maintenance ” critical question theory kind “ faults ” left unrepaired view faults kind primary damage remain unrepaired living organism primary damage fact defect living structure molecule cell tissue defect closed time structure lose structural integrity functionality whole organism fail rapi dly another word unrepaired faults lead rapid death rather aging organism hence concept accumulation “ faults ” misl eading main idea theory untenable 27 physical theories aging take place n living organisms also n nonliving structures searching common well different characteristics aging two different systems important uncovering secret aging p hysical theories give object ive description aging living non living systems loss complexity increase entropy failure information transmission physical theories therefore useful revealing physical theory give full stor aging mechanism describe biological process aging loss complexit living system kind complex adaptive system composed numbers interacting sub systems term complexity approach phy sics describe interactions whole system sub systems complexity ratio email thomasjicun gmailcom 8 degree difficulty predicting properties whole system given properties subsystems weaver 1948 complexity system exhibits several aspects example emergence feedback effect interdependence self organization self adaptation morowitz 1995 loss complexity appears failure communication subsystems living system loss c omplexity appears degeneration cellstissues chaos communications cellstissues lipsitz 1992 loss ofcomplexity chaos theory lipsitz pointed loss complexity loss functionality occurs agin g aging thus price cooperation complexity kiss 2009 increase entropy entropy useful measure marking tendency natural processes always direction increase entropy closed system term entropy also understood “ uncertainty ” “ lack information ” fields mackay 2003 statistic interpretation entropy firstly introduced boltzmann phenomenological measure “ disorder ” landsberg 1988 increase disorder corresponding decrease complexity functionality system living systems need release entropy continuously protect running thermodynamic equilibrium death niedermueller 1990 haken 1990 wunderlin 1992 respiration perspiration excretion measures release entropy however living get rid entropy part remain increase age aging therefore consequence increase entropy entropy inc reases energies ordering diminish bortz 1986 failure information transmission theory multi cellular chaos emphasized multi cellular structure organism based cell differentiation preconditio n aging mulá 2004 information transmission pathways different cells surviving lines cells organism time signal transmission become chaos gradually nature aging colony bacterial aging colony neither cell organization information transmission cells failure information transmission corresponding loss complexity organization idea outstanding recognizing importance cell differentiation cell organization aging iii useful theories unanswered questions analysis shows theories incomplete n advanced theory needed better theory consistent facts old theories uncovered facts include damag e driving force aging damage fault accumulation theory b modification development alter lifespan developmental theory c aging process loss comp lexity failure information transmission physical theories therefore among theories damage fault accumulation theory developmental theory physical theories useful others far basic questions aging yet satisfactorily answered aging unavoidable b age c limited longevity therefore better email thomasjicun gmailcom 9 theory also able answer critical questions end proposed novel theory aging misrepair accumulation theory wang 2009 reference 1 ahluwalia j tinker clapp lh duchen mr abramov ay pope nobles segal aw 2004 large conductance ca2 activated k channel essential innate immunity nature 427 853–858 2004 doi101038nature 02356 2 amrit frg boehnisch cml may rc 2010 phenotypic covariance longevity immunity stress resistance caenorhabditis nematodes plos one 5 4 e9978 3 anderson rm shanmuganayagam weindruch r 2009 caloric restriction aging studies mice monkeys toxicologic pathology 37 1 47 –51 4 austad n 2004 aging programed aging cell 35 249 251 5 bak p 1996 nature works science self organized critical ity copernicus press new york us cloth isbn 0 38794791 4 6 bansal miyake k vogel ss groh chen cc williamson r mcneil pl campbell kp 2003 defective membrane repair dysferlin deficient muscular dystrophy nature 423 168 7 bell jt tsai p c yang p pidsley r nisbet j et al 2012 epigenome wide scans identify differentially methylated regions age age related phenotypes healthy ageing population plos genet 84 e1002629 doi101371journalpgen1002629 8 bishay k ory k olivier mf lebeau j levalois c chevillard 2001 dna damage related rna expression assess individual sensitivity ionizing radiation carcinogenesis 228 1179 9 blackburn eh 2000 telomere states cell fates nature 408 5356 10 bodnar ag ouellette frolkis holt se chiu cp morin gb harley cb shay jw lichtsteiner wright 1998 extension life span introduction telomerase normal human cells science 279 349352 11 bortz wm 2 nd 1986 aging entropy exp gerontol 21 45 321 8 12 bulckaen h prévost g boulanger e et al 2008 lowdose aspirin prevents age related endothelial dysfunction mouse model physiological aging j physiol heart circ physiol 294 1562 13 charnov el 1993 li fe history invariants explorations symmetry evolutionary ecology oxford university press oxford 14 collins fs et al 2004 international human genome sequencing consortium finishing euchromatic sequence human genome nature 431 931945 doi101038nature03001 15 cook h stephens p k davies j harding kg thomas dw 2000 defective extracellular matrix reorganization chronic wound fibroblasts associated alterations timp 1 timp 2 mmp 2 activity journal investigative dermatology 115 225 16 de magalhães jp church gm 2005 genomes optimize reproduction aging consequence developmental program physiology 20252259 17 de magalhaes jp curado j church gm 2009 meta analysis age related gene expression profiles identifies common signatures aging bioinformatics 25 875 881 18 fabrizio p hoon shamalnasab galbani wei giaever g nislow c longo vd 2010 genome wide screen saccharomyces cerevisiae identifies vacuolar protein sorting autophagy biosynthetic trna methylation genes involved life span regulation plos genetics 67e1001024 19 haken h wunderlin 1990 synergetik eine einführung nichtgleichgewichts und selbstorganisation physik che mie u nd biologie kratky kw und wallner f grundprinzipien der selbstorganisation hrsg darmstadt wbg 1990 isbn 3 53410971 6 20 harman 1956 aging theory based free radical radiation chemistry journal gerontology 11 3 298–300 21 hemann mt greider cw 2000 wild derived inbred mouse strains short telomeres nucleic acids research 28 22 4474 –4478 email thomasjicun gmailcom 10 22 herndon la schmeissner pj dudaronek jm brown pa listner km sakano paupard mc hall dh driscoll 2002 tochastic genetic factors influence tissue specific decline ageing c elegans nature 419 808 –814 23 hayflick l 1965 limited vitro lifetime human diploid cell strains exp cell res 37 614 636 24 johnson te mitchell dh kline kemalr foy j 1984 arresting development arrests aging nematode caenorhabditis elegans mech ageing dev 28 123 40 25 johnson 2001 emergence connected lives ants brains cities software new york scribner isbn 068486875 x 26 juránek bezek š 2005 controversy free radical hypothesis reactive oxygen species – cause consequence tissue injury gen physiol biophys 24 263 —278 27 kim nw piatyszek prowse kr harley cb west md ho pl coviello gm wright weinrich sl shay jw 1994 specific association human telomerase activity immortal cells cancer science 266 2011 2015 28 kipling cooke hj 1990 hypervariable ultra long telomeres mice nature 347 6291 400 29 kirkwood tb 1 977 evolution ageing nature 270 5635301 –304 30 kirkwood tb austad sn 2000 age nature genet 408 6809 233 8 31 kirkwood tb 2006 ageing fast mistake nature 444 7122 1015 7 32 kirkwood tb 2005 understanding odd science aging cell 1204 437 47 33 kiss hjm mihalik nanasi ory b spiro z soti c csermely p 2009 ageing price cooperation complexity self organization complex systems causes ageing constituent networks bioessays 316 651 64 arxiv08120325v2 q biomn 012009 34 klass hirsh 1976 non ageing developmental variant caenorhabditis elegans nature 2605551523 5 35 landsberg pt 1984 entropy “ order ” increase together physics letters 102a 171–173 36 lipsitz la goldberger al 1992 loss complexity aging potential applications fractals chaos theory senescence jama 26713 1806 9 37 lipsitz la 2006 aging process complexity loss complex systems science biomedicine topics biomedical engineering international book series part iii section 7 641 654 doi 101007978 038733532 228 38 li ty yorke ja 1975 period three implies chaos american mathematical monthly 82 10 985 39 longo vd mitteldorf j skulachev vp 2005 programmed altruistic ageing nat rev genet 6 11866 872 40 mackay djc 2003 information theory inference learning algorithms cambri dge cambridge university press 2003 isbn 0 52164298 1 41 martin gm ustad sn johnson te 1996 genetic analysis aging role oxidative damage environmental stresses nature genet 13 125 34 42 may rm 1976 simple mathematical models complicated dynamics nature 261 5560 459–467doi1010382 61459a0 pmid 934280 43 mccormick chen k ramaswamy p kenyon c 2012 new genes extend caenorhabditis elegans lifespan response reproductive signals aging cell 112192 202 44 medawar pb 1952 unsolved problem biology lewis london 45 medvedev za 1990 attempt rational classification theories ageing biol rev camb philos soc 65 3 375 398 46 mitteldorf j 2006 chaotic population dynamics evolution ageing proposing demographic theory senescenc e evol ecol res 8 561 –74 47 morowitz hj singer jl eds1995 mind brain complex adaptive systems addison wesley isbn 0201409860 48 mulá mav 2004 age httpwwwmeucatcomvihtml 49 niedermueller h hofecker g 1990 anwendungsmöglichkeiten des prinzips der autopoiese auf physiologische und gerontologische fragestellungen k ratky kw und wallner f grundprinzipien der selbstorganisation hrsg darmstadt wbg 1990 isbn 3 53410971 6 email thomasjicun gmailcom 11 50 popper kr 1994 zwei bedeutungen von falsifizierbarkeit two meanings falsifiability seiffert h radnitzky g handlexiko n der wissenschaftstheorie münchen deutscher taschenbuch verlag pp 82–85 isbn 342304586 8 51 university washington aging genes interventions database 2012 httpwwwprimateportalorglinkuniversity washington aging genes andinterventions database 52 van raamsdonk jm hekimi 2009 deletion mitochondrial superoxide dismutase sod 2 extends lifespan caenorhabditis elegans plos genetics 5 2 e1000361 53 wang j michelitsch wunderlin mahadeva r 2009 aging consequence misrepair – novel theory aging arxiv 09040575 arxivorg 54 weaver w 1948 science complexity american scientist 36 4 536 –44 55 weismann 1889 essays upon heredity kindred biological problems clarendon press oxford 56 williams gc 1957 pleiotropy natural selection evolution senescence evolution 11398 – 411 57 wodinsky j 1977 hormonal inhibition feeding death octopus control optic gland secretion science 148 4320 948 –51 58 wolkow ca kimura kd lee ms ruvkun g 2000 regulation c elegans life span insulinlike signaling nervous system science 290 147 –150 59 wunderlin friedrich r 1992 evolution dynamical structures complex systems springer verlag berlin isbn 3642847838 60 zwaan b 20 03 linking development aging sci aging knowledge environ 47 32",
    "relevance_score": 0.8094,
    "date_score": 0,
    "final_score": 0.6071,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Unknown Author",
    "date": "2020-02-21T16:05:22",
    "filename": "2101.07350.pdf",
    "processed_text": "review open access update genetic epigenetic etiology gestational diabetes mellitus review tajudeen yahaya1 titilola salisu2 yusuf b abdulrahman3and abdulrazak k umar3 abstract background many studies conducted genetic epigenetic etiology gestational diabetes mellitus gdm last two decades disease ’ increasing prevalence role global diabetes mellitus dm explosion update genetic epigenetic etiology gdm becomes imperative better understand stem rising incidence disease review therefore articulated gdm candidate genes pathophysiology awareness stakeholders main body genetic epigenetic etiology gdm search discovered 83 gdm candidate genes tcf7l2 mtnr1b cdkal1 irs1 kcnq1 prevalent certain polymorphisms genes modulate betacell dysfunction adiposity obesity insulin resistance several mechanisms environmental triggers diets pollutants microbes may also cause epigenetic changes genes resulting loss insulinboosting glucose metabolism functions early detection adequate management may resolve condition delivery otherwise progress maternal type 2 diabetes mellitus t2dm fetal configuration future obesity dm shows gdm strong risk factor t2dm rare cases type 1 diabetes mellitus t1dm maturityonset diabetes young mody shows gdm significantly contributes rising incidence burden dm worldwide prevention may reverse trend conclusion mutations epigenetic changes certain genes strong risk factors gdm affected individuals etiologies medical practitioners formulate drugs treatment procedures target genes pathophysiology keywords adiposity betacell dysfunction epigenetics insulin resistance obesity background pregnant women develop insulin resistance certain stages owing increased placenta hormones women overcome condition upregulating insulin production beta cell expansion 1 gestational diabetes mellitus gdm begins pregnant female make extra insulin needed normalize blood glucose second third trimester pregnancy 1 sometimes glucose intolerance may present pregnancy diagnosed 23 uncontrolled gdm cause high blood pressure type2 diabetes mellitus t2dm increased risks vas cular diseases pregnant women 45 intrauterine ex posure high blood glucose may program offspring develop diabetes obesity later life 6 may also cause macrosomia birth defects preterm birth de velopmental delay 7–9 gdm common metabolic condition pregnancy 10 global incidence rate 1 28 11 2017 gdm affected 204 million women worldwide projection increase 308 million 2045 mostly developing countries 12 though times glucose intolerance normalizes soon delivery women gdm high risk developing t2dm later life 13 compared women normal glucose tolerance women © authors 2020 open access article distributed terms creative commons attribution 40 international license httpcreativecommonsorglicensesby40 permits unrestricted use distribution reproduction medium provided give appropriate credit original authors source provide link creative commons license indicate changes made correspondence yahayatajudeengmailcom yahayatajudeenfubkedung 1federal university birnin kebbi pmb 1157 birnin kebbi nigeria full list author information available end articleegyptian journal medical human genetic syahaya et al egyptian journal medical human genetics 2020 2113 httpsdoiorg101186s43042020000548gdm least seven times predisposed t2dm 14 moreover almost half pregnant females gdm develop diabetes decade 14 spring women gdm also 8 times prone diabetes prediabetes 15 show gdm contributes immensely alarming incidence dia betes worldwide 16 diabetes affected 451 mil lion people 2017 5 million died usd 850 billion spent healthcare expenditure 17 considering impact gdm reduction prevalence effective management affected go long way stemming incidence burden diabetes however achieve reduced prevalence gdm proper understanding etiology neces sary fortunately improved biological techniques last two decades led understanding genetic epigenetic etiology disease thus update becomes necessary review therefore articu lated current findings genetic epigenetic eti ology gdm methods databases searched indepth search pubmed scopus springerlink google scholar researchgate databases per formed relevant research articles gdm search terms search terms used retrieve articles gesta tional diabetes mellitus hyperglycemia insulin resist ance obesity glucose metabolism betacell dysfunction gestational diabetes genes search terms used include glucose insensitivity epigenetics diabetes mel litus gestational diabetes testing costeffectiveness prevalence gestational diabetes article inclusion criteria inclusion criteria include following research published english language research focused gdm studies focused genetic epigenetic eti ology gdm articles centered gdm testing cost effectiveness studies published 2000 till date article exclusion criteria exclusion criteria include following studies available english language studies abstract available research described gdm clear gen etic epigenetic mechanisms studies published year 2000results genetic etiology gdm search found mutations genes variants may interact one another environ mental triggers cause gdm fig 1 genetic eti ology gdm overlaps t2dm gdm candidate genes also predispose humans t2dm explains common pathophysiology gdm t2dm express betacell dysfunction abnormal glucose metabolism 18 contrary reports gdm also shares common pathophysi ology type 1 diabetes mellitus t1dm maturityonset diabetes young mody less 10 gdm patients show associations 18 though many genes reportedly showed association obesity insulin resistance betacell dysfunction present study discovered 83 genes clear gdm pathophysiology presented table 1 frequent gdm candidate genes list gdm candidate genes inexhaustible genes continually discovered however certain genes often linked disease table 2 shows frequent gdm candidate genes variants various ethnic groups table 2 used pie chart fig 2 express percentage occurrence gene based ethni city tcf7l2 gene frequent present 17 ethnics followed mtnr1b 15 cdkal1 10 kcnq1 10 irs1 10 genes widespread often found certain ethnics regions genes include zranb3 found africa 96abcc8 found among finnish 119chemerin found among iranians 120 ins found among greeks 121 genes used develop genetic testing guideline predict like lihood gdm determine genetic epigenetic etiology important genetic testing procedure yet gdm partly con dition multifactorial several genes interact environmental triggers cause disease thus mutation single gene may explain full suscepti bility gdm testing candidate genes expensive cumbersome low prevalence gdm past also contributes lack interest developing genetic testing guideline disease epigenetic etiology gdm epigenetics refers study heritable changes biological processes caused modification chemical tags dna methyl ethyl groups 122 modifications mediated mechanisms including dna methylation histone modification andyahaya et al egyptian journal medical human genetics 2020 2113 page 2 13microrna expression 122 epigenetic mechanisms play important roles several cellular activities cer tain environmental triggers reprogram epige nome resulting disease pathologies 123 particular epigenetic mechanisms regulate several genes maintain betacell morphology proliferation functions thus implies epigenetic modification may disrupt insulin secretion sensitivity causing meta bolic diseases including gdm 124125 epigenetic changes expressed somatic gamete cells thus transmitted generation gener ation 126 studies reported many ins tances epigenetic modi fications involving insulin synthesis glucose metabolism gdm instance histone underacetylation methylation promoter region pdx1 gene duce insulinboosting function gene 127 also study examined methylation il10 gene among pregnant women hypomethylation maternal blood cells elevated plasma il10 levels noticed women gdm 128 another study compared themirna profiles diabetic pregnant rats nondiabetic repression mir338 overexpression mir451 associated reduced βcell mass diabetic 129 vitro upregulation mir451 repres sion mir338 study increased βcell mass leading improved glucose metabolism 129 study investigated mirna expressions maternal fetal blood cells pregnant women 29 mirnas upregulated individuals gdm 130 mir nasmirna340 confirmed downregulate ex pression paip1 gene 130 vitro normalization themirna340 expression diabetic mothers creased insulin production 130environmental triggers genetic epigenetic etiology gdm genetic epigenetic etiology gdm diated certain environmental triggers change gene functions genetic triggers mutate genes epigenetic triggers affect chemical tags dna without affecting nucleotide sequence fig 3 among environmental triggers pollution microbial ex posures whose gdm modulatory roles estab lished several studies study monitored effects air pollution among pregnant southern califor nians prepregnancy exposures nitrogen dioxide 2 particulate matter pm25 pm10 dioxin lated gdm 131 nitrogen dioxide particulate matter cause oxidative stress overexpression proin flammatory cytokines endothelial dysfunction result n gi ni n c r e e di n u l nr e n c e 132 dioxin compounds interact peroxisome proliferator activated receptor γpparg disrupting insulin signaling pathways resulting insulin resistance abnormal glucose metabolism 133 exposure pathogenic micro bial organisms may disrupt gut microbiota com promise immune system leading metabolic disorders gdm vu et al 134d e n r e di nr b bits toxin produced staphylococcus aureus may interact fat cells immune system resulting inflammation insulin resistance glucose intolerance 134 study microbiota pregnant women individuals gdm showed gut microbiota im balance containing majorly phylum actinobacteria genus collinsella rothia desulfovibrio 135 balanced gut microbiota necessary optimum tabolism immune system aside microbial infection environmental factors may disrupt fig 1 genetic etiology gestational diabetes mellitusyahaya et al egyptian journal medical human genetics 2020 2113 page 3 13table 1 gdm predisposing genes showing locations phathophysiology number gene full name locus pathophysiology 1 tcf7l2 transcription factor 7like 2 10q2 increases apoptosis impairing insulin secretion 19 2 kcnq1 potassium voltagegated channel sub family q member 111p155 154it disrupts influx calcium channel resulting decreased insulin secretion 20 3 centd2 arap1centaurindelta2 arfgap rhogap domain ankyrin repeat ph domain 111q134 causes disruption glucoseinduced insulin secretion 21 4 mtnr1b melatonin receptor 1b 11q143 decreases insulin secretion elevating fasting glucose levels 22 5 igf1 insulinlike growth factor 1 12q232 induces high body mass hbm leading metabolic disturbances especially insulin resistance hyperinsulinemia 23 6 igf2 insulinlike growth factor 2 11p155 overexpression igf2 leads βcell dedifferentiation endoplas mic reticulum stress causing islet dysfunction 24 7 igfbp1 insulin like growth factor binding protein 17p123 decreased blood levels igfbp1 cause overexpression igfi result ing inflammation 25 8 igfbp2 insulin like growth factor binding protein 32q35 reduced expression igfbp2 inhibits adipogenesis leading obesity insulin resistance 26 9 igf2bp2 insulin like growth factor 2 mrna binding protein 23q272 impairs βcell function modulates obesity altering insulin sensitivity 27 10 igfbp3 insulin like growth factor binding protein 37p123 overexpression igfbp3 predisposes hbm body disrupting glu cose metabolism 28 11 igfbp4 insulin like growth factor binding protein 417q212 reduced levels cause hbm insulin resistance 28 12 igfbp5 insulin like growth factor binding protein 52q35 disrupts igf1 signaling pathway leading insulin insensitivity 29 13 pparg peroxisome proliferatoractivated recep tor gamma3p252 stimulates abnormal fat deposition tissues causing obesity insulin resistance 27 14 kcnj11 potassium voltagegated channel sub family j member 1111p151 reduces sensitivity pancreatic betacell katp channel subunit kir62 resulting decreased insulin release 28 15 insr insulin receptor 19p132 predisposes obesity leading insulin resistance 29 16 adrb2 adrenoceptor beta 2 5q32 increases secretion vascular endothelial growth factora vegf βcells resulting hypervascularized islets disrupting sulin secretion glucose metabolism 30 17 adrb3 adrenoceptor beta 3 8p1123 increases body weight predisposing obesity insulin resistance 31 18 gnb3 g protein subunit beta 3 12p1331 causes highfat deposition obesity 32 19 abcc8 atp binding cassette subfamily c member 811p151 loss function gene disrupts katp channel function increasing body weight causing hyperinsulinism 33 20 capn10 malpain 10 2q373 increases body mass initiating insulin resistance 34 21 mbl2 mannosebinding lectin 10q211 causes frequent infections chronic inflammatory diseases leading highfat deposition insulin resistance 35 22 glut4 slc2a4glucose transporter type 4solute carrier family 2 member 417p131 impairs insulin signaling pathway 36 23 rbp4 retinol binding protein4 10q2333 increases gluconeogenesis impairs insulin signaling muscles 37 24 pck1 phosphoenolpyruvate carboxykinase 1 20q1331 induces high levels fasting insulin causing abnormal glucose metabolism 38 25 pik3r1 pi3k phosphoinositide3kinase regulatory subunit 15q131 disrupts insulin signaling pathway skeletal muscle inhibit liver gluconeogenesis 38 26 stra6 signaling receptor transporter retinol stra615q241 promotes fat deposition predisposing obesity insulin resistance 39 27 vdr vitamin receptor 12q13 predisposes obesity causing metabolic disorder especially insulin resistance 4041 28 cdkal1 cyclindependent kinase 5 regulatory subunitassociated protein 1like 16p223 inhibits conversion proinsulin insulin protein translation leading insulin resistance 42 29 gck glucokinase 7p13 increases body fat mass resulting insulin resistance 43yahaya et al egyptian journal medical human genetics 2020 2113 page 4 13table 1 gdm predisposing genes showing locations phathophysiology continued number gene full name locus pathophysiology 30 cdkn2a2b cyclindependent kinase inhibitor 2a 9p213 affects proinsulin conversion insulin reduces insulin sensitivity 44 31 srr serine racemase 17p133 disrupts secretion insulin andor glucagon 45 32 hhexide hematopoietically expressed homeobox 10q2333 causes pancreatic liver developmental error 46 33 slc30a8 solute carrier family 30 member 8 8q2411 modulates loss zinc beta cells destabilizing insulin molecule s47 34 lep leptin 7q313 promotes inflammation causing energy imbalance obesity 48 35 lepr leptin receptor 1p31 induces highfat mass insulin resistance 49 36 hnf1btcf2 hepatocyte nuclear factor 1b 17q12 causes βcell dysfunction 5051 37 tnfαtnf tumor necrosis factor α 6p2133 causes inflammatory oxidative stress 52 38 hnf4atcf1 hepatocyte nuclear factor 4 alpha 20q12 induces βcell dysfunction 5051 39 wfs1 wolfram syndrome 1 4p161 initiates endoplasmic reticulum stress mitochondrial disorder leading βcell dysfunction 53 40 irs1 insulin receptor substrate 1 2q363 induces inflammatory response causing low insulin sensitivity 54 41 htr2b 5ht 1a5hydroxytryptamine receptor 1a 5q123 reduces betacell proliferation increases body weight 55 42 tph1 tryptophan hydroxylase 1 11p151 causes low levels serotonin increasing weight gain causing insulin intolerance 56 43 5ht1a htr3a5hydroxytryptamine receptor 1a 5q123 causes low serotonin levels resulting insulin resistance 57 44 hnf1a hepatocyte nuclear factor1 alpha 12q2431 causes adiposity leading prepregnancy obesity insulin resist ance 57 45 gckr glucokinase regulator 2p233 overexpression gckr causes hyperactivity gck reducing glucose increasing fat accumulation 58 loss function reduces gck expression impairing glucose clearance 59 46 mif macrophage migration inhibitory factor 22q1123 overexpression mif gene placental tissue causes insulin resistance 60 47 adra2a alpha2adrenergic receptors 10q252 increases body fat mass leading loss glucose regulation 61 48 slc6a4 solute carrier family 6 member 4 17q112 impairs serotonin metabolism increasing body weight causing insulin resistance 62 49 fto fat mass obesityassociated gene alphaketoglutarate dependent dioxygenase16q122 causes adiposity leading prepregnancy obesity insulin resist ance 63 50 tle1 transducinlike enhancer split1 9q2132 elevates fasting glucose level reduces insulin secretion 64 51 adcy5 adenylate cyclase 5 3q211 alters adcy5 expression pancreatic beta cells impairing glucose signaling 65 52 il1β interleukin1 beta 2q141 impairs pancreatic βcells decreasing insulin secretion 66 53 il6 interleukin6 7p153 overexpression destroys pancreatic βcells resulting apoptosis low insulin synthesis 67 54 il10 interleukin10 1q321 overexpression compromises immune response disrupting insulin metabolism 68 55 pax8 paired box 8 2q141 reduces islet viability beta cell survival 69 56 adipoq diponectin geneadiponectin c1q collagen domain containing3q273 causes low adiponectin leading obesity insulin resistance 70 57 rarres2 chemerin generetinoic acid receptor responder 2 7q361 initiates inflammation energy imbalance leading obesity insulin resistance 71 58 serpina12 vaspin geneserpin family member 12 14q3213 causes inflammation loss energy balance obesity 72 59 retn resistin 19p132 causes loss energy balance obesity insulin resistance 73yahaya et al egyptian journal medical human genetics 2020 2113 page 5 13gut microbiota include certain diseases oral microbiome diets antibiotic use among others 136 lifestyles short sleep poor nutritional choices advanced age physical inactivity environmen tal triggers may predispose humans gdm short hour sleep night increase body fat accumulation duce glucose metabolism predispose t2dm gdm study determines frequency gdmamong sleepdeprived 668 singaporeans 131 representing 19 diagnosed gdm 273 sleep less 6 hours night 168 sleep 78 hours 137 poor nutrition en ergydense western diets may cause overweight obesity disrupting insulin signal ing pathways insulin sensit ivity saturated fats dis rupt insulin signaling induce inflammation endothelial dysfunction resulting gdm study evaluatedtable 1 gdm predisposing genes showing locations phathophysiology continued number gene full name locus pathophysiology 60 apln apelin xq261 causes loss energy balance obesity insulin resistance 74 61 nucb2 nesfatin 1 genenucleobindin 2 11p151 causes loss energy balance obesity insulin resistance 75 62 itln1 intelectin1omentin1 1q233 loss function induces insulin resistance 76 63 namptpbef1 visfatin genenicotinamide phosphoribosyltransferase 7q223 causes obesity insulin resistance 76 64 hmg20a ibrafhigh mobility group protein 20a 15q243 depletion represses expression insulinproducing genes neu rod mafa gck enhances betacell dedifferentiating gene pax4 rest 77 65 rreb1 ras responsive element binding protein 16p243 causes fat deposition beta cell dysfunction 78 66 glis3 glis family zinc finger 3 9p242 causes fat deposition beta cell dysfunction 78 67 gpsm1 g protein signaling modulator 1 9q343 causes fat deposition beta cell dysfunction 78 68 mtdna mitochondrial dna cells induces oxidative stress mitochondrial disorder causing insulin resistance 79 69 prlr prolactin receptor 5p132 modulates loss prlr signaling βcells reducing βcell proliferation expansion pregnancy 80 70 mafb maf bzip transcription factor b 20q12 causes inadequate βcell expansion 80 71 sert serotonin transporter 17q111 12stimulates abnormal fat accumulation white brown adipose tissues causing glucose intolerance insulin resistance 81 72 pai1 plasminogen activator inhibitor 1 7q22 predisposes adiposity increasing body weight affecting pancreatic betacell function 82 73 tspan8 tetraspanin8 12q211 impairs gestational glucose tolerance 83 74 g6pc2 glucose6phosphatase catalytic subunit 22q311 elevates fasting glucose level reduces insulin secretion 64 75 ptprd protein tyrosine phosphatase receptor type d9p241 p23disrupts insulin signaling pathway leading altered insulin sensitivity glucose homeostasis 84 76 crp creactive protein 1q232 overexpression causes obesity resulting systemic inflammation insulin resistance 85 77 gk glycerol kinase xp212 deficiency causes abnormal insulin metabolism 86 78 pax4 paired box gene 4 7q321 impairs fetal islet cell differentiation altering insulin sensitivity later life 87 79 hdac4 histone deacetylase 4 2q373 causes βcell loss leading decreased insulin secretion also represses betacell transcriptional factors 88 80 fetua ahsg fetuina 3q273 increases body mass insulin secretion cpeptide levels lower insulin sensitivity 89 81 fetub fetuinb 3q273 increases hepatic steatosis impairing insulin secretion glucose metabolism 90 82 fgf21 fibroblast growth factor 21 10q2613 cause abnormal glucose metabolism independent insulin resistance 91 83 snora8 emerging candidate gene 92yahaya et al egyptian journal medical human genetics 2020 2113 page 6 13table 2 prevalent gestational diabetes mellitus genes across countries ethnicity race world gene countriesethnicityrace variants level significance references tcf7l2 mexicans rs7901695 p 216 × 10−693 rs7901696 p 005 93 rs7901697 p 005 93 rs7901698 p 005 93 asians rs7903146 p 0001 94 scandinavians rs7903146 p 005 95 africans rs7903146 p 7288 × 10−1396 hispaniclatinos rs7903146 p 005 97 caucasiansdanish rs7903146 p 000017 98 caucasian rs4506565 p 0001 99 kcnq1 mexicans rs2237892 p 198 × 10−593 rs163184 p 005 93 rs2237897 p 005 93 koreans rs2074196 p 0039 100 rs2237892 p 005 100 east asians rs2074196 p 0039 100 rs2237892 p 005 100 pakistan rs2237895 p 005 101 mtnr1b mexicans rs1387153 p 005358 93 asians rs10830963 p 0001 94 caucasians rs10830963 p 0001 94 koreans rs10830962 p 249 × 10−13102 danish rs10830963 p 005 103 rs1387153 p 005 103 saudi arabians rs1387153 p 005 104 rs10830963 p 005 104 pparg asians rs1801282 p 0011 94 caucasians rs1801282 p 005 99 rs3856806 p 005 99 caucasiansdanish rs1801282 p 005 98 cdkal1 koreans rs7754840 p 249 × 10−13102 caucasians rs7756992 p 005 99 caucasiandanish rs7756992 p 000017 98 iranians rs7754840 p 0001 105 irs1 scandinavians irs1 arg972 p 005 106 americans arg972 p 005 107 saudi arabians rs1801278 p 001 108 austrohungarians rs7578326 p 005 109 hmga2 africans rs138066904 p 2516 × 10−996 africa americans rs343092 p 005 96 europeans rs2258238 p 005 96 igf2bp2 koreans rs4402960 p 0001 110 caucasiansdanish rs4402960 p 0001 111 chinese rs4402960 p 0001 112yahaya et al egyptian journal medical human genetics 2020 2113 page 7 13the effect dietary patterns among pregnant chinese women diets containing high protein low starch associated reduced risk gdm 138 energydense diets deficient betaine methyl donor methylating important biological processes well substrate methionine metabolism 139 diets low betaine may induce abnormal methylation genes involved insulin synthesis glucose metabolism ad vanced age may also predispose pregnant women gdm mitochondrial functions decline age leading reduced metabolic activities increased body mass index 140 aging changes epigenetic pattern affecting h ee x p r e fs eg e n e si n volved glucose metabol ism particularly cox7a1 gene respiratory chain 141 study 1688 women northwest london developed gdm advanced maternal age linked gdm 142 studies demonstrate role physical inactivity pathogenesis gdm scarce however e ca n dm e n l sb ym n g et al 143s h w physical activity pregnancy decrease oc currence gdm suggesting lack exercise risk factor mechanisms inactivitymediates diseases include itochondrial dysfunction changes composition uscles insulin resist ance among others 144 physical inactivity influences epigenome negatively affecting several generations 145 gdm testing efficacy costeffectiveness early detection gdm important prevent short longterm effects especially maternal progression t2dm fetal programming dm later life cer tain features bm1 30 kgm2as well previ ous gdm baby birth weight 45 kg macrosomia suggest need gdm test 146 preg nant women family history dm ethnic groups high prevalence dm asian black africancaribbean middle eastern also consider test 146147 stated earlier genetic testing procedure yet gdm however two tests namely glucose challenge test gct oral glucose tol erance test ogtt frequently conducted 2428 weeks pregnancy diagnose gdm two tests done succession known 2step screening ogtt alone done called 1step screening 2step screening gct otherwise known glucose screening test done first entails testing blood glucose one hour drinking sweet sub stance without fasting blood glucose 140 mgdl 78 mmoll higher ogtt necessary 148 ogtt measures blood glucose 8hour fasting glucose substance 75 g taken blood glucose remeasured 1 2 3 hours high blood glucose levels two blood test times suggest gdm 148 though patho physiology gdm similar t2dm gct 200 mgdl could indicate t2dm 148 relatively recently serum levels creactive protein crp well glycated hemoglobin hba1c ran dom blood sugar rbs used screening tools gdm first trimester crp concentrations 6 mgl higher undiluted serum samples con sidered positive gdm 149 according inter national association diabetes pregnancy study group iadpsg cutoff level hba1c 65 rbs 111 mmol 200mgdl 150table 2 prevalent gestational diabetes mellitus genes across countries ethnicity race world continued gene countriesethnicityrace variants level significance references gckr malaysians rs780094 p 005 113 american caucasians rs780094 p 005 114 brazilians rs780094 p 005 115 fgf21 iranians expression mrna p 0001 116 chinese expression mrna p 0001 117 australians expression mrna p 0001 118 fig 2 percentage prevalence implicated gdm genes data extractedyahaya et al egyptian journal medical human genetics 2020 2113 page 8 13the costeffectiveness gdm testing controversial depends region race screening tools methods systematic review fitria 151 ported gdm testing controlling effective highincome countries could due low prevalence disease region encompassing health care system however gdm test ing could worthwhile countries high preva lence gdm nations poor healthcare system example marseille et al 152 reported costeffectiveness gdm testing using devised model israel india known high gdm inci dence rates 2step gtt often recommended however systematic review metaanalysis saconne et al 153 showed significant costeffective difference two methods 2step screen ing also timeconsuming inconvenient may put patients 150154 glycated hemoglobin rbs simple gdm screening tools gain ing acceptance worldwide however awareness understanding tools necessary conclusion several articles reviewed showed mutation epi genetic modifications certain genes predispose humans gdm gdm candidate genes identified also implicated pathogenesis t2dm diseases share common pathophysi ology two metabolic disorders expressed oxidative stressinduced betacell dysfunction insulin resistance adiposity obesity one major difference tween gdm t2dm resolves times delivery however may progress t2dm checked shows gdm strong risk factor t2dm thus detection management may reduce prevalence dm worldwide gdm candidate genes identified variants tcf7l2 mtnr1b cdkal1 irs1 kcnq1 widespread others confined certain ethnic groups genetic testing procedure developed around genes predict likelihood gdm deter mine genetic epigenetic etiology go long way stemming incidence dm worldwide abbreviations crp creactive protein dm diabetes mellitus gct glucose challenge test gdm gestational diabetes mellitus hba1c glycated hemoglobin iadpsg international association diabetes pregnancy study group mody maturity onset diabetes young 2 nitrogen dioxide ogtt oral glucose tolerance test pm25 particulate matter size 25 pm10 particulate matter size 10 rbs random blood sugar t1dm type 1 diabetes mellitus t2dm type 2 diabetes mellitus acknowledgements none authors ’ contributions ty conceptualized literature search drafted manuscript correspondence ts designed article literature search ya article selection proofreading au article selection proofreading authors read approved manuscript funding none availability data materials applicable ethics approval consent participate applicable consent publication applicable competing interests authors declare competing interests author details 1federal university birnin kebbi pmb 1157 birnin kebbi nigeria2department zoology environmental biology olabisi onabanjo university agoiwoye agoiwoye ogun state nigeria3department biochemistry molecular biology federal university birnin kebbi birnin kebbi nigeria fig 3 epigenetic etiology gestational diabetes mellitusyahaya et al egyptian journal medical human genetics 2020 2113 page 9 13received 14 november 2019 accepted 11 february 2020 references 1 national institute diabetes digestive kidney diseases niddk symptoms causes gestational diabetes httpswwwniddknihgov healthinformationdiabetesoverviewwhatisdiabetesgestational symptomscauses 2 fernándezmorera jl rodríguezrodero menéndeztorre e et al 2010 possible role epigenetics gestational diabetes cause consequence obstet gynecol int 2010605163 httpsdoiorg10 11552010605163 3 american diabetes association ada standards medical care diabetes 2018 ” diabetes care 201841suppl 1s13 –s27 doi httpsdoi org102337dc18s002 4 rayanagoudar g hashi aa zamora j et al 2016 quantification type 2 diabetes risk women gestational diabetes systematic review metaanalysis 95750 women diabetologia 591403 –1411 httpsdoiorg 101007s0012501639272 5 burlina dalfrà mg lapolla clinical biochemical approach predicting postpregnancy metabolic decompensation diabetes res clin pract 2018145178 –183 doi101016jdiabres201802035 doi httpsdoi org101016jdiabres20180203 5 6 yessoufou moutairou k maternal diabetes pregnancy early long term outcomes offspring concept “ metabolic memory experimental diabetes research 2011 2011 article id 218598 httpsdoi org1011552011218598 7 metzger 2009 hapo study cooperative research group hyperglycemia adverse pregnancy outcome hapo study associations neonatal anthropometrics diabetes 58453 –459 https doiorg102337db081112 8 freinkel n 1980 banting lecture 1980 pregnancy progeny diabetes 291023 –1035 9 farahvar walfisch sheiner e 2019 gestational diabetes risk factors longterm consequences mother offspring literature review expert rev endocrinol metab 14163 –74httpsdoiorg10108017446651 20181476135 10 franzago fraticelli f stuppia l vitacolonna e 2019 nutrigenetics epigenetics gestational diabetes consequences mother child eigenetics 143215 –235httpsdoiorg1010801559229420191582277 11 hod kapur sacks et al 2015 international federation gynecology obstetrics figo initiative gestational diabetes mellitus pragmatic guide diagnosis management care j gynecol obstet 131suppl 3s173 –s211 12 diabetes g international diabetes federation –home available online wwwidforgouractivitiescarepreventiongdm 13 zhao j1 weiler ha longterm effects gestational diabetes offspring health pronounced skeletal growth body composition glucose tolerance br j nutr 20101041116419 doi 101017 s0007114510002631 14 damm p1 houshmandoeregaard kelstrup l et al gestational diabetes mellitus longterm consequences mother offspring view denmark diabetologia 201659 713961399 doi httpsdoiorg10 1007s0012501639855 15 clausen td mathiesen er hansen et al 2008 high prevalence type 2 diabetes prediabetes adult offspring women gestational diabetes mellitus type 1 diabetes role intrauterine hyperglycemia diabetes care 31340 –346 httpsdoiorg102337dc071596 16 assche fav holemans k aerts l 2011 longterm consequences offspring diabetes pregnancy british medical bulletin 601173 – 182httpsdoiorg101093bmb601173 17 international diabetes federation diabetes atlas 8th ed 2017 available online httpfmdiabetesorgwpcontentuploads201803idf2017pdf 18 kaaja r rönnemaa 2008 gestational diabetes pathogenesis consequences mother offspring rev diabet stud 54194 –202 httpsdoiorg101900rds20085194 19 shu l sauter ns schulthess ft matveyenko av oberholzer transcription factor 7like 2 regulates betacell survival function human pancreatic islets diabetes 2008 57 645653 20 macdonald pe ha xf wang j smukler sr sun gaisano hy 2001 members kv1 kv2 voltagedependent k channel familiesregulate insulin secretion mol endocrinol 1581423 –1435 httpsdoiorg 101210mend1580685 21 huertachagoya vázquezcárdenas p morenomacías h tapiamaruri l rodríguezguillén r lópezvite e 2015 genetic determinants gestational diabetes mellitus related metabolic traits mexican women plos one 105e0126408 httpsdoiorg101371journalpone 0126408 22 prokopenko langenberg c florez jc et al 2009 variants mtnr1b influence fasting glucose levels nature genetics 41177 –8119060907 23 shang wen z 2018 increased placental igf1mtor activity macrosomia born women gestational diabetes diabetes research clinical practice 146211 –219httpsdoiorg101016jdiabres201810 017 24 casellas mallol c salavert jimenez v garcia agudo j 2015 insulin like growth factor 2 overexpression induces βcell dysfunction increases betacell susceptibility damage journal biological chemistry 29016772 –16785 httpsdoiorg101074jbcm115642041 25 ramirez vi miller e meireles cl gelfond j krummel da powell tl 2014 adiponectin igfbp1 development gestational diabetes obese mothers bmj open diabetes research care 2e000010 https doiorg101136 bmjdrc2013000010 26 demambro clemmons dr horton lg bouxsein ml wood tl beamer wg 2008 genderspecific changes bone turnover skeletal architecture igfbp2null mice endocrinology 1492051 –2061 httpsdoi org101210en20071068 27 chon sj kim sy cho nr min dl hwang yj mamura 2013 association variants ppar γ² igf2bp2 kcnq1 susceptibility gestational diabetes mellitus korean population yonsei medical journal 542352 –357 httpsdoiorg103349ymj2013542352 28 schwanstecher c meyer u schwanstecher 2002 kir62 polymorphism predisposes type 2 diabetes inducing overactivity pancreatic beta cell atpsensitive k channels diabetes 51875 –879 httpsdoiorg10 2337diabetes513875 29 ober c xiang ks thisted ra indovina ka wason cj dooley 1989 increased risk gestational diabetes mellitus associated insulin receptor insulinlike growth factor ii restriction fragment length polymorphisms genet epidemiol 6559 –569 30 ceasrine lin ee lumelsky dn iyer r kuruvilla r 2018 adrb2 controls glucose homeostasis developmental regulation pancreatic islet vasculature elife 7e39689 httpsdoiorg107554elife39689 31 guan l cui x zhou h 2018 metaanalysis association trp64arg polymorphism beta3 adrenergic receptor susceptibility gestational diabetes mellitus j obstet gynaecol 382172 – 176 httpsdoiorg1010800144361520171331339 32 feng jiang cd chang et al 2019 interactions among insulin resistance inflammation factors obesityrelated gene polymorphisms environmental risk factors diet development gestational diabetes mellitus j matern fetal neonatal med 322339 –347 httpsdoi org1010801476705820181446207 33 kapoor rr flanagan se james ct mckiernan j thomas harmer sc 2011 hyperinsulinaemic hypoglycaemia diabetes mellitus due dominant abcc8kcnj11 mutations diabetologia 54102575 –2583 https doiorg101007s0012501122074 34 castromartínez ag sánchezcorona j vázquezvargas ap garcíazapién ag lópezquintero villalpandovelazco hj association analysis calpain 10 gene variantshaplotypes gestational diabetes mellitus among mexican women cell mol biol noisylegrand 2018 286438186 doi httpsdoiorg1014715cmb201864313 35 megia gallart l 2004 fernándezreal jm vendrell j simón gutierrez c mannosebinding lectin gene polymorphisms associated gestational diabetes mellitus journal clinical endocrinology metabolism 89105081 –5087 httpsdoiorg101210jc20040211 36 catalano pm 2014 trying understand gestational diabetes diabet med 31273 –281 httpsdoiorg101111dme12381 37 yang q graham te mody n et al 2005 serum retinol binding protein 4 contributes insulin resistance obesity type 2 diabetes nature 436 356 –362 38 shimin hu shujuan xun li et al relationships slc2a4 rbp4 pck1 pi3k gene polymorphisms gestational diabetes mellitus chinese population biomed research international 2018 2019article id 7398063 httpsdoiorg10115520197398063 yahaya et al egyptian journal medical human genetics 2020 2113 page 10 1339 shimin h junxia yiping guilian hui z xun l 2019 association polymorphisms stra6 gene gestational diabetes mellitus chinese han population medicine 9811e14885 httpsdoiorg101097 md0000000000014885 40 zhu b huang k yan et al vdr variants rather early pregnancy vitamin concentrations associated risk gestational diabetes ’ anshan birth cohort mabc study j diabetes res 2019 2019 article id 8313901 httpsdoiorg10115520198313901 41 apayd ın beyse eyerci n pinarli fa ulubay kizilgul vdr gene foki polymorphism associated gestational diabetes mellitus turkish women bmc medical genetics 2019 20 article number 82 doi httpsdoiorg101186s1288101908200 42 wang k chen q feng et al single nucleotide polymorphisms cdkal1 gene associated risk gestational diabetes mellitus chinese population j diabetes res 2019 2019 article id 3618103 httpsdoiorg 10115520193618103 43 okruszko kinalski ku źmicki miro ńczuk k wawrusiewiczkurylonek n kretowski kia 2007 glucokinase gene mutations gestational diabetes polish population prediction diabetes mellitus development delivery przegl lek 646401 –405 44 mei j liao liu tan wang h liang 2015 association variants cdkn2a2b cdkal1 genes gestational insulin sensitivity disposition pregnant han chinese women j diabetes investig 63295 – 301 httpsdoiorg101111jdi12315 45 wang nie li w et al 2011 association six single nucleotide polymorphisms gestational diabetes mellitus chinese population plos one 611e26953 httpsdoiorg101371journalpone0026953 46 cho ym kim th lim choi sh shin hd lee hk 2009 type 2 diabetes associated genetic variants discovered recent genomewide association studies related gestational diabetes mellitus korean population diabetol 52253 –261 httpsdoiorg101007s0012500811964 47 seman na mohamud wn östenson cg et al increased dna methylation slc30a8 gene promoter associated type 2 diabetes malay population clin epigenetics 2015 7 30 httpsdoiorg101186 s1314801500495 48 marcello calixto ar de almeida jf et al polymorphism lep lepr may modify leptin levels represent risk factors thyroid cancer int j endocrinol 2015 173218 httpsdoiorg1011552015 173218 49 lin r ju h yuan z zeng l sun su z 2017 association maternal fetal lepr common variants maternal glycemic traits pregnancy sci rep 713112 httpsdoiorg101038s4159801703518x 50 watanabe rm xiang ah allayee h et al variation p2promoter region hepatocyte nuclear factor4a hnf4a associated ßcell function mexican american families proband gestational diabetes diabetes 2005 54 supplement 1 a28 51 ridderstråle groop l 2009 genetic dissection type 2 diabetes molecular cellular endocrinology 2971210 –17 52 ategbo jm grissa yessoufou hichami dramane kl moutairou k 2006 modulation adipokines cytokines gestational diabetes macrosomia j clin endocrinol metab 914137 –4143 53 toppings nb mcmillan jm au p suchowersky donovan le wolfram syndrome case report review clinical manifestations genetics pathophysiology potential therapies case reports endocrinol 2018 2018 article id 9412676 doi httpsdoiorg10115520189412676 54 vana dr adapa prasad vss choudhury ahuja g diabetes mellitus types key genetic determinants risk assessment genet mol res 2019 18 2 gmr16039952 55 kwak sh park bl kim h german ms go mj jung hs association variations tph1 htr2b gestational weight gain measures obesity obesity 2012 20 1 httpsdoiorg101038oby 2011253 56 oh cm park kim h 2016 serotonin new therapeutic target diabetes mellitus obesity diabetes metab j 40289 –98httpsdoi org104093dmj201640289 57 beysel eyerci n ulubay caliskan kizilgul haf ızoğlu maternal genetic contribution prepregnancy obesity gestational weight gain gestational diabetes mellitus diabetol metabol synd 2019 11 article number 37 httpsdoiorg101186s130980190434x 58 pollin ti jablonski ka mcateer jb et al 2011 triglyceride response intensive lifestyle intervention enhanced carriers gckrpro446leu polymorphism j clin endocrinol metab 96e1142 –e1147 https doiorg101210jc20102324 59 grimsby j coffey jw dvorozniak mt magram j li g matschinsky fm characterization glucokinase regulatory proteindeficient mice j biol chem 2000 275 7826 –7831 doi httpsdoiorg101074jbc275117826 60 zheng l li c qi wh et al 2017 expression macrophage migration inhibitory factor gene placenta tissue correlation gestational diabetes mellitus zhonghua yi xue za zhi 973388 –3391 61 kawai vk levinson rt adefurin kurnik collier sp conway 2017 variation α2aadrenergic receptor gene risk gestational diabetes pharmacog 18151381 –1386 httpsdoiorg102217pgs2017 0079 62 leitner fragner l danner holeschofsky n leitner k tischler 2017 combined metabolomic analysis plasma urine reveals ahba tryptophan serotonin metabolism potential risk factors gestational diabetes mellitus gdm front mol biosci 484 httpsdoiorg 103389fmolb201700084 63 beysel eyerci n ulubay caliskan kizilgul haf ızoğlu maternal genetic contribution prepregnancy obesity gestational weight gain gestational diabetes mellitus diabetol metab synd 2019 11 article number 37 httpsdoiorg101186s130980190434x 64 melladogil jm fuentemartín e lorenzo pi cobovuilleumier n lópez noriega l martínmontalvo type 2 diabetesassociated hmg20a gene mandatory islet beta cell functional maturity cell death disease 2018 9 article number 279 65 hodson dj mitchell rk marselli l pullen tj gimeno brias semplici f 2014 adcy5 couples glucose insulin secretion human islets diabetes 6393009 –3021 httpsdoiorg102337db131607 66 mojtaba e mahdi k mehdi kjr amir 2011 serum interleukin1 beta plays important role insulin secretion type ii diabetic inter j bio 1393 –99 67 meier jj ritzel ra maedler k gurlo butler pc 2006 increased vulnerability newly forming beta cells cytokineinduced cell death diabetolog 4983 –89httpsdoiorg101007s0012500500693 68 kang j liu ch lee cn li hy yang cw huang sc 2019 novel interleukin10 gene polymorphism linked gestational diabetes taiwanese population front genet 1089 httpsdoiorg103389fgene 201900089 69 martinmontalvo lópeznoriega l jiménezmoreno c herranz lorenzo pi cobovuilleumier n 2019 transient pax8 expression islets pregnancy correlates βcell survival revealing novel candidate gene gestational diabetes mellitus diabetes 681109 –118httpsdoi org102337db180285 70 takhshid haem z aboualizadeh f 2015 association circulating adiponectin 45 tg polymorphism adiponectin gene gestational diabetes mellitus iranian population j diabetes metab disord 1430 httpsdoiorg101186s402000150156z 71 hasanvand z sadeghi rezvanfar mr goodarzi mt rahmannezhad g mashayekh fj 2018 association chemerin rs17173608 rs4721 gene polymorphisms gestational diabetes mellitus iranian pregnant women gene 64987 –92 httpsdoiorg101016jgene201801061 72 ademoglu e berberoglu z dellal fd ariel mk kose candan z higher levels circulating chemerin obese women gestational diabetes mellitus acta endocrinologica buc 2015 xi 1 3237 doi httpsdoiorg 104183aeb201532 73 steppan cm bailey st bhat et al 2001 hormone resistin links obesity diabetes nature 409307 –312 74 aslan celik celik n et al 2012 cord blood nesfatin1 apelin36 levels gestational diabetes mellitus endocrine 41424 –429 75 franz polterauer springer kuessel l haslinger p worda c 2018 maternal neonatal omentin1 levels gestational diabetes arch gynecol obst 2974885 –889 httpsdoiorg101007s0040401846525 76 ferreira af rezende jc vaikousi e et al 2011 maternal serum visfatin 1113 weeks gestation gestational diabetes mellitus clin chem 57 609 –613 77 melladogil jm fuentemartín e lorenzo pi cobovuilleumier n lópez noriega l martínmontalvo type 2 diabetesassociated hmg20a gene mandatory islet beta cell functional maturity cell death disease 2018 9article number 279 78 ding chavarro j olsen lin ley sh bao w genetic variants gestational diabetes mellitus study 112 snps among 8722 women inyahaya et al egyptian journal medical human genetics 2020 2113 page 11 13two independent populations diabetolog 2018 61 8 1758 –1768 https doiorg101007s0012501846378 79 khan ia shaik na pasupuleti n chav jahan p hasan q 2015 screening mitochondrial mutations insertion –deletion polymorphism gestational diabetes mellitus asian indian population saudi j bio sci 223243 –248httpsdoiorg101016jsjbs201411001 80 banerjee rr cyphert ha walker em chakravarthy h peiris h gu x 2016 gestational diabetes mellitus inactivation prolactin receptor mafb islet βcells diabetes 6582331 –2341 httpsdoiorg102337 db151527 81 zha w ho htb hu hebert mf wang mj serotonin transporter deficiency drives estrogendependent obesity glucose intolerance sci rep 2017 7 article number 1137 doi httpsdoiorg101038s41598017 012915 82 leipold h knoefler gruber c klein k haslinger p worda c 2006 plasminogen activator inhibitor 1 gene polymorphism gestational diabetes mellitus obstet gynecol 1073651 –656 httpsdoiorg101097 01aog000019995327961f9 83 stuebe wise nguyen herring north ke siegariz 2014 maternal genotype gestational diabetes j perinatol 31169 –76 httpsdoiorg101055s00331334451 84 chagnon mj elchebly uetani n dombrowski l cheng mooney ra 2006 altered glucose homeostasis mice lacking receptor protein tyrosine phosphatase sigma j physiol pharmacol 84755 –763 https doiorg101139y06020 85 alamolhoda sh yazdkhasti namdari zakariayi sj mirabi p 2019 association creactive protein gestational diabetes prospective study j obstet gynaecol 91 –5httpsdoiorg101080 0144361520191631767 86 zhang yh van hove jl mccabe er dipple km 2015 gestational diabetes associated novel mutation 378379instt glycerol kinase gene mol genet metab rep 442 –45httpsdoiorg101016jymgmr2015 06004 87 xu shi liu j liu zhu xie c 2017 rs10229583 polymorphism near paired box gene 4 associated gestational diabetes mellitus chinese women j inter med res 461116 –121 httpsdoiorg101177 0300060517714934 88 gong yu liang l vuralli froehler kuehnen p 2019 hdac4 mutations cause diabetes induce βcell foxo1 nuclear exclusion mol genet gen med 75e602 httpsdoiorg101002mgg3602 89 farhan handisurya todoric j tura pacini g wagner 2012 fetuin characteristics pregnancy result case control pilot study inter j endocrinol 896736 httpsdoiorg1011552012896736 90 kralisch hoffmann lössner u 2017 kratzsch j3 blüher stumvoll regulation novel adipokines hepatokines fetuin fetuin b gestational diabetes mellitus metab 6888 –94httpsdoiorg101016j metabol201611017 91 bonakdaran khorasani zm jafarzadeh f 2017 increased serum level fgf21 gestational diabetes mellitus acta endocrinol 133278 –281 httpsdoiorg104183aeb2017278 92 xie k chen zhang wen j cui x l association rs10830962 polymorphism gestational diabetes mellitus risk chinese population sci rep 2019 9article number 5357 doi httpsdoiorg10 1038s41598019416053 93 huertachagoya vázquezcárdenas p morenomacías h et al 2015 genetic determinants gestational diabetes mellitus related metabolic traits mexican women plos one 105e0126408 httpsdoi org101371journalpone0126408 94 wu l cui l tam w et al 2016 genetic variants associated gestational diabetes mellitus metaanalysis subgroup analysis sci rep 630539 httpsdoiorg101038srep30539 95 shaat n lernmark karlsson e et al 2007 variant transcription factor 7like 2 tcf7l2 gene associated increased risk gestational diabetes mellitus diabetologia 50972 –979 96 adeyemo aa zaghloul na chen g et al 2019 zranb3 african specific type 2 diabetes locus associated betacell mass insulin response nat commun 103195 httpsdoiorg101038s41467019109677 97 lin pc lin wt yeh yh wung sf 2016 transcription factor 7like 2 tcf7l2 rs7903146 polymorphism risk factor gestational diabetes mellitus metaanalysis plos one 114e0153044 httpsdoiorg101371 journalpone015304498 lauenborg j grarup n damm p et al 2009 common type 2 diabetes risk gene variants associate gestational diabetes j clin endocrinol metab 941145 –150httpsdoiorg101210jc20081336 99 kawai vk levinson rt adefurin et al 2017 genetic risk score includes common type 2 diabetes risk variants associated gestational diabetes clin endocrinol 872149 –155 httpsdoiorg10 1111cen13356 100 kwak sh kim th cho ym choi sh jang hc park ks 2010 polymorphisms kcnq1 associated gestational diabetes korean population horm res paediatr 74333 –338 101 fatima ss chaudhry b khan ta farooq kcnq1 rs2237895 polymorphism associated gestational diabetes pakistani women pak j med sci 2016 novdec32613801385 doi httpsdoiorg1012669pjms32611052 102 kwak sh jang hc park ks 2012 finding genetic risk factors gestational diabetes genomics inform 104239 –243 httpsdoiorg10 5808gi2012104239 103 ding 2018 chavarro j1 olsen lin ley sh1 bao w et al genetic variants gestational diabetes mellitus study 112 snps among 8722 women two independent populations diabetologia 6181758 –1768 httpsdoiorg101007s0012501846378 104 alharbi kk alsulaiman bin shedaid mk et al mtnr1b genetic polymorphisms risk factors gestational diabetes mellitus case control study single tertiary care center ann saudi med 2019 395 309318 doi httpsdoiorg105144025649472019309 105 mansoori daraei naghizadeh mm salehi r 2015 significance common variant cdkal1 gene susceptibility type 2 diabetes mellitus iranian population adv biomed res 445 httpsdoiorg104103 22779175151256 106 shaat n ekelund lernmark et al 2005 association e23k polymorphism kcnj11 gene gestational diabetes mellitus diabetolog 482544 –2551 107 fallucca f dalfra mg sciullo e et al 2006 polymorphisms insulin receptor substrate 1 beta3adrenergic receptor genes gestational diabetes normal pregnancy metab 551451 –1456 108 alharbi kk khan ia abotalib z alhakeem mm insulin receptor substrate1 irs1 gly927arg correlation gestational diabetes mellitus saudi women biomed res intern 2014 article id 146495 httpsdoiorg101155 2014146495 109 rosta k alaissa z hadarits et al 2017 association study 77 snps confirms robust role rs10830963g mtnr1b variant identifies two novel associations gestational diabetes mellitus development plos one 12e0169781 110 cho ym kim th lim et al 2009 type 2 diabetesassociated genetic variants discovered recent genomewide association studies related gestational diabetes mellitus korean population diabetolog 522253 –261 111 wang nie li w et al 2011 association six single nucleotide polymorphisms gestational diabetes mellitus chinese population plos one 611e26953 112 lauenborg j grarup n damm p et al 2009 common type 2 diabetes risk gene variants associate gestational diabetes j clin endocrinol metab 941145 –150 113 stuebe wise nguyen herring north k siegariz 2013 maternal genotype gestational diabetes j perinatol 31069 –076 114 jamalpour zain sm mosavat mohamed z omar sz casecontrol study metaanalysis confirm glucokinase regulatory gene rs780094 risk factor gestational diabetes mellitus gene 2018 650 34 –40 115 anghebemoliveira mi webber alberton et al 2017 gckr gene polymorphism rs780094 risk factor gestational diabetes brazilian population j clin lab anal 31e22035 116 bonakdaran khorasani zm jafarzadeh f 2017 increased serum level fgf21 gestational diabetes mellitus acta endocrinol buchar 133278 – 281 httpsdoiorg104183aeb2017278 117 chen c cheung bm tso aw et al 2011 high plasma level fibroblast growth factor 21 independent predictor type 2 diabetes 54year populationbased prospective study chinese subjects diabetes care 3492113 –2115 httpsdoiorg102337dc110294 118 nitert barrett hl kubala mh et al 2014 increased placental expression fibroblast growth fa ctor 21 gestational diabetes mellitus j clin endocrinol metab 994e591 –e598 httpsdoiorg10 1210jc20132581yahaya et al egyptian journal medical human genetics 2020 2113 page 12 13119 rissanen j markkanen karkkainen p et al 2000 sulfonylurea receptor 1 gene variants associated gestational diabetes type 2 diabetes altered secretion insulin diabetes care 2370 –73 120 hasanvand z sadeghi rezvanfar mr goodarzi mt rahmannezhad g mashayekhi fj 2018 association chemerin rs17173608 rs4721 gene polymorphisms gestational diabetes mellitus iranian pregnant women gene 64987 –92httpsdoiorg101016jgene201801061 121 litou h anastasiou e thalassinou l et al 2007 increased prevalence vntr iii insulin gene women gestational diabetes mellitus gdm diabetes res clin pract 76223 –228 122 handy de castro r loscalzo j 2011 epigenetic modifications basic mechanisms role cardiovascular disease circulation 123192145 – 2156 httpsdoiorg101161circulationaha110956839 123 feil r fraga mf 2011 epigenetics environment emerging patterns implications nat rev genet 1397 –109 httpsdoiorg101038nrg3142 124 ordovas jm smith ce 2010 epigenetics cardiovascular disease nat rev cardiol 7510 –519 httpsdoiorg101038nrcardio2010104 125 stankov k benc draskovic 2013 genetic epigenetic factors etiology diabetes mellitus type 1 pediatr 1321112 –1122 126 xie z chang c zhou z 2014 molecular mechanisms autoimmune type 1 diabetes critical review clin rev allergy immunol 47174 –192 127 kimmins sassonecorsi p 2005 chromatin remodelling epigenetic features germ cells nature 4347033583 –589 128 kang j lee cn li hy hsu kh wang sh lin sy 2018 association interleukin10 methylation levels gestational diabetes taiwanese population front genet 9222 httpsdoiorg103389fgene201800222 129 jacovetti c abderrahmani parnaud g jonas jc peyot ml cornu 2012 micrornas contribute compensatory βcell expansion pregnancy obesity j clin invest 122103541 –3551 httpsdoiorg10 1172jci64151 130 stirm l huypens p sass batra r fritsche l brucker maternal whole blood cell mirna340 elevated gestational diabetes inversely regulated glucose insulin sci rep 2018 813661378 doi https doiorg101038s41598018192009 131 jo h eckel sp chen jc cockburn martinez mp chow 2019 associations gestational diabetes mellitus residential air pollution exposure large southern california pregnancy cohort environ inter 130 104933 –104939 httpsdoiorg101016jenvint2019104933 132 lodovici bigagli e oxidative stress air pollution exposure j toxicol 2011 2011 article 487074 133 saldana tm basso hoppin ja baird dd knott c blair 2007 pesticide exposure selfreported gestational diabetes mellitus agricultural health study diabetes care 303529 –534 httpsdoiorg102337dc06 1832 134 vu bg stach cs kulhankova k salgadopabón w klingelhutz aj schlievert pm chronic superantigen exposure induces systemic inflammation elevated bloodstream endotoxin abnormal glucose tolerance rabbits possible role diabetes mbio 2015 6 2 e0255414 doi https doiorg101128mbio0255414 135 crusell mkw hansen th nielsen allin kh rühlemann mc damm p 2018 gestational diabetes associated change gut microbiota composition third trimester pregnancy postpartum microbiome 6 89httpsdoiorg101186s401680180472x 136 mokkala k röytiö h munukka e pietilä ekblad u rönnemaa 2016 gut microbiota richness composition dietary intake overweight pregnant women related serum zonulin concentration marker intestinal permeability j nutr 14691694 –1700 httpsdoiorg103945jn 116235358 137 dukenus medical school association insufficient sleep gestational diabetes mellitus discovered sciencedaily wwwsciencedaily comreleases201701170109092634htm accessed october 26 2019 138 mak jkl pham nm lee ah tang l pan xf binns cw dietary patterns pregnancy risk gestational diabetes prospective cohort study western china nutr j 2018 17article number 107 doi httpsdoi org101186s1293701804133 139 cai liu h hu jiang zhao r gestational betaine liver metabolism epigenetics patel v preedy v eds handbook nutrition diet epigenetics springer cham 2017 doi httpsdoiorg1010079783 319311432821 140 sivitz w mitochondrial dysfunction obesity diabetes us endocrinol 2010 6 1 2027 doi httpsdoiorg1017925use201006120 141 r¨onn poulsen p hansson et al age influences dna methylation gene expression cox7a1 human skeletal muscle diabetolog 2008 51 11591168 doi httpsdoiorg101007s0012500810188 142 makgoba savvidou steer p 2012 analysis interrelationship maternal age body mass index racial origin development gestational diabetes mellitus bjog 119276 –282 https doiorg101111j14710528201103156x 143 ming w ding w zhang cjp zhong l long li z effect exercise pregnancy gestational diabetes mellitus normalweight women systematic review metaanalysis bmc pregnancy childbirth 2018 18 article number 440 doi httpsdoiorg101186 s1288401820687 144 eriksson kf lindg¨arde f poor physical fitness impaired early insulin response late hyperinsulinaemia predictors niddm middleaged swedish men diabetolog 1996 39573579 145 grazioli e dimauro mercatelli n et al 2017 physical activity prevention human diseases role epigenetic modifications bic genomics 18suppl 8802 httpsdoiorg101186s1286401741935 146 world health organization diagnostic criteria classification hyperglycaemia first detected pregnancy geneva 2013 httpwww whointdiabetespublicationshyperglycaemiainpregnancyen 147 united kingdom national health service overview gestational diabetes updated 2019 available httpswwwnhsukconditi onsgestationaldiabetes 148 united states national institute health tests diagnosis gestational diabetes updated 2017 available httpswwwniddknihgovhealth informationdiabetesoverviewwhatisdiabetesgestationaltestsdiagnosis 149 farghaly ta helmy na abbas ahmed agm creactive protein screening test gestational diabetes mellitus firsttrimester pregnancy prospective cohort study int j reprod contracept obstet gynecol 201874798803 doi httpsdoiorg101820323201770 ijrcog20184922 150 schaible b calhoun bc bush ramser b seybold dj broce hemoglobin a1c screening strategy gestational diabetes med dent res 2018 1 1 14 doi httpsdoiorg1015761mdr1000103 151 fitria n van asselt adi postma mj 2019 costeffectiveness controlling gestational diabetes mellitus systematic review eur j health eco 203 407 –417 httpsdoiorg101007s101980181006y 152 marseille e lohse n jiwani hod seshiah v yajnik cs cost effectiveness gestational diabetes screening including prevention type 2 diabetes application new model india israel j maternalfetal neonat med 2013 26 8 httpsdoiorg103109147670582013765845 153 saccone g caissutti c khalifeh mda scifres c simhan hn 2017 one step versus two step approach gestational diabetes screening systematic review metaanalysis randomized trials journal maternalfetal neonat med 3281 –211 httpsdoiorg1010801476705820171408068 154 amreen suneel shetty vasudeva kumar p use glycosylated hba1c random blood sugar screening tool gestational diabetes mellitus first trimester int j reprod contracept obstet gynecol 20187 5248 doi httpsdoiorg101820323201770ijrcog20180166 publisher ’ sn e springer nature remains neutral regard jurisdictional claims published maps institutional affiliationsyahaya et al egyptian journal medical human genetics 2020 2113 page 13 13",
    "relevance_score": 0.8094,
    "date_score": 0,
    "final_score": 0.6071,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Iman",
    "date": "2025-03-10T14:20:37",
    "filename": "2503.07798.pdf",
    "processed_text": "1 risk protective factors parkinson ’ disease iman beheshti department human anatomy cell science rady faculty health sciences university manitoba winnipeg mb canada corresponding author dr iman beheshti address 745 bannatyne ave winnipeg manitoba r3e 0j9 canada email imanbeheshtiumanitobaca httpsscholargooglecacitationsuserx0aqyvkaaaajhlenoiao 2 abstract understanding risk protective factors associated parkinson ’ disease pd crucial improving outcomes patients individuals risk healthcare providers healthcare systems studying factors enhances knowledge disease also aids developing effective prevention management treatment strategies paper reviews key risk protective factors associated pd particular focus biological mechanisms underlying factors risk factors include genetic mutations racial predispositions environmental exposures contribute increased likelihood developing pd accelerating disease progression conversely protective factors regular physical exercise adherence mediterranean diet higher urate levels demonstrated potential reduce inflammation support mitochondrial function thereby mitigating disease risk however identifying validating factors presents signific ant challenges include absence reliable biomarkers intricate interactions genetic environmental components clinical heterogeneity observed pd patients barriers complicate establishment clear causal r elationships hinder development targeted prevention strategies overcome challenges propose several solutions recommendations future research prioritize development standardized biomarkers early diagnosis inv estigate gene environment interactions greater depth refine animal models better mimic human pd pathology additionally offer actionable recommendations pd prevention management tailored healthy individuals patients diagnosed wi th pd healthcare systems strategies aim improve clinical outcomes enhance quality life optimize healthcare delivery pd keywords parkinsons disease risk factors symptom genetics biological mechanisms 1 introduction parkinsons disease pd progressive neurodegenerative disorder characterized motor disabilities making second leading cause disabilities adults strokes disease marked classical motor manifestations bradykinesia rigidity gait 3 disorders fluctuate disease progresses 1 core pd involves degeneration dopaminergic neurons substantia nigra pars compacta leading decrease dopamine levels striatum formation intracellular aggregates known lewy bodies 1 disease ’ etiology involves genetic environmental factors crucial understanding developing effective treatments prevention strategies 15 genetic research identified risk factors mutations genes like lrrk2 gba1 common pd patients suggesting genetic predisposition disease mutations vary across populations offering potential tailored treatments 3 environmental factors including pesticides heavy metals air pollution may contribute oxidative stress mitochondrial dysfunction neuroinflammation key mechanisms pd progression 6 lifestyle factors also play protective role regular exercise especially high intensity aerobic activity shown preserve dopamine producing neurons slow symptom progression 7 diets rich antioxidants polyphenols polyunsaturated fatty acids may reduce pd risk cognitive social engagement linked protection cognitive decline pd patients emphasizing importance mental stimulation 8 recent studies also focused gut brain axis microbiome dysbiosis offering new therapeutic possibilities 9 10 review explore various categories risk protective factors associated pd focusing primarily biological mechanisms behind interactions rather epidemiological correlations address current challenges identifying verifying factors propose potential solutions development standardized biomarkers studying gene environment interactions improving animal models importantly also emphasize need increased awa reness education patients risk individuals healthcare providers —an aspect often overlooked research includes providing insight underlying molecular mechanisms risk protective factors pd integrating gen etic environmental lifestyle factors research aims enhance understanding pds risk protective mechanisms finally highlight preventive strategies lifestyle changes early interventions reduce global burden f pd improve patient outcomes 4 2 molecular mechanisms pd molecular mechanisms underlying pd constitute complex interconnected network key factors including α synuclein aggregation mitochondrial dysfunction oxidative stress neuroinflammation ferroptosis gut dysbiosis contribute progressive neurodegeneration seen pd fig 1 understanding mechanisms essential identifying risk factors preventive strategies potential interventions slow halt pd progression table 1 presents list key biological mechanisms pd along associated risk factors section provides overview primary molecular processes involved pd highlighting interactions role pathogenesis disease figure 1 interrelationship key biological mechanisms pd 21 αsynuclein aggregation 5 αsynuclein aggregation considered one earliest central events pd pathogenesis pathological conditions α synuclein presynaptic neuronal protein misfolds aggregates insoluble fibrils forming lewy bodies —a hallmark pd 11 aggregates disrupt neuronal function believed propagate cell cell contributing spread pathology recent studies shown α synuclein aggregates transmitted neighboring cells seeding aggregatio n healthy neurons cell tocell transmission critical factor spread pathology pd 12 furthermore binding calcium ions ca2 c terminus α synuclein shown regulate binding synaptic membranes may influence aggregation dynamics 13 αsynuclein aggregation initiates cascade events lead • mitochondrial dysfunction direct interaction mitochondria impairing function reducing atp production • oxidative stress disrupting cellular metabolism mitochondrial function • neuroinflammation activating microglia brains immune cells • gut dysbiosis misfolded αsynuclein potentially propagate gut brain axis 22 mitochondrial dysfunction mitochondrial dysfunction plays pivotal role pd pathogenesis impairment mitochondrial function particularly complex electron transport chain leads reduced atp production increased generation reactive oxygen species ros 14 dysfunction exacerbated interaction α synuclein aggregates mitochondria recent research highlighted generalized reduction mitochondrial quality control proteins dopaminergic neurons pd patients includes decrease proteins pink1 parkin mitochondrial chaperones crucial main taining mitochondrial proteostasis function 14 mitochondrial dysfunction contributes • oxidative stress increased ros production • energy deficits neurons particularly affecting dopaminergic neurons substantia nigra 6 • ferroptosis enhancing iron accumulation lipid peroxidation 23 oxidative stress oxidative stress occurs theres imbalance production ros bodys ability detoxify reactive intermediates repair resulting damage pd elevated ros levels cause damage lipids proteins dna exacerbati ng neuronal injury interplay oxidative stress pd mechanisms creates vicious cycle • mitochondrial dysfunction cause consequence oxidative stress • oxidative damage activates microglia inducing neuroinflammation • lipid peroxidation caused oxidative stress contributes ferroptosis dopaminergic neurons 24 neuroinflammation neuroinflammation pd involves activation microglia immune cells response neuronal damage α synuclein aggregates chronic inflammation damages neurons promotes disease progression recent studies shown tha microglial activation response neuronal damage also contributor progression pd 15 activated microglia release exosomes containing α synuclein may propagate neuroinflammation neurodegeneration affecting distant dopaminergic neurons neuroinflammation exacerbates pd pathology • promoting αsynuclein aggregation • increasing oxidative stress release pro inflammatory cytokines ros • contributing ferroptosis increasing iron burden neurons 25 ferroptosis ferroptosis iron dependent form regulated cell death driven lipid peroxidation pd iron accumulation substantia nigra enhances oxidative stress lipid peroxidation leading ferroptotic death dopaminergic neurons recent rese arch linked α synuclein aggregation ferroptosis 16 misfolded α synuclein disrupt cellular iron homeostasis promote lipid peroxidation thereby facilitating ferroptosis ferroptosis contributes pd progression 7 • exacerbating oxidative stress excessive ros production lipid peroxidation • triggering neuroinflammation release damage associated molecular patterns damps • impairing mitochondrial function due iron accumulation oxidative stress 26 gut dysbiosis emerging evidence suggests gut dysbiosis imbalance gut microbiota composition may precede central nervous system involvement pd gut brain axis allows potential propagation misfolded α synuclein enteric nervous ystem brain via vagus nerve studies shown individuals pd exhibit significant alterations gut microbiota composition compared healthy controls notable depletion short chain fatty acid scfa producing bacteria enrichment pro inflammatory bacteria 17 gut dysbiosis contributes pd pathology • facilitating propagation αsynuclein aggregates gut brain • activating systemic immune responses promoting neuroinflammation • altering production neurotransmitters metabolites influence brain function table 1 main biological mechanisms associated factors pd mechanism factors αsynuclein aggregation genetics snca gene mutation early onset pd lewy body formation environmental heavy metals mercury manganese lead infections viral infections trigger immune responses gut dysbiosis disrupts gut brain axis promotes misfolding nonmotor symptoms anosmia rem sleep behavior disorder oxidative stress aging natural increase oxidative damage genetics park7 dj 1 mutation oxidative stress defense failure environmental pesticides herbicides heavy metals air pollution metabolic factors low ldl c loss antioxidant protection mixed effects hyperuricemia antioxidant linked decline ferroptosis aging iron accumulation substantia nigra heavy metals iron manganese lead redox imbalance dietary factors dairy consumption potential increased iron load industrial chemicals solvents trichloroethylene mitochondrial dysfunction genetics pink1 prkn parkin mutations defective mitophagy environmental herbicides pesticides heavy metals solvents metabolic factors insulin dysregulation diabetes medications neuroinflammation aging increased pro inflammatory cytokines sex differences men higher risk estrogen neuroprotective genetics park7 dj 1 gene linked inflammation infections viral infections chronic inflammatory diseases 8 environmental heavy metals air pollution psychological chronic stress depression anxiety hpa axis gut dysbiosis gutbrain axis links gastrointestinal neurodegenerative issues chronic constipation early symptom linked pd progression antibiotic use macrolides lincosamides gut microbiome disruption probioticsdiet possible protective role pd 3 risk factors pd risk factors conditions increase likelihood developing disease genetic environmental lifestyle related may modifiable eg smoking diet non modifiable eg age family history pd risk factors incl ude age common 60 genetics family history environmental toxins eg pesticides head injuries figure 2 disease progression slower diagnosed younger age severe motor symptoms cognitive decline poor response treatments suggest faster progression non motor symptoms like depression sleep issues also affect disease course figure 2 classification various risk factors parkinsons disease 31 demographic genetic factors 9 demographic genetic factors key risk factors pd significantly impact diseases onset progression response treatment understanding factors essential enhancing diagnosis improving treatment outcomes predicting disease trajectories thereby enabling cust omization interventions meet individual patient needs table 2 age age significant risk factor pd median onset age 60 years 1 5 several mechanisms explain association aging linked neuronal loss approximately 30 elderly non pd individuals experiencing degeneration substantia nigra sn 18 neuronal loss heightens sensitivity sn neurons mitochondrial dysfunction protein degradation impairments 5 pd symptoms manifest 50 60 sn neurons lost aging also contributes increased oxidative stress damages dna proteins lipids accelerating dopaminergic neuron death iron accumulation age generates free radicals via fento n reaction exacerbating oxidative stress neurodegeneration 19 furthermore aging reduces efficiency autophagy ubiquitin proteasome system processes critical protein quality control thereby facilitating accumulation misfolded proteins like α synuclein hallmark pd 20 mitochondrial dysfunction due aging diminishes energy production increases oxidative damage pd predominantly affects older individuals 5 cases occur 50 years often due genetic mutations 21 5 sex pd approximately twice prevalent men compared women 21 protective effects female sex hormones estrogen may explain disparity estrogen ’ neuroprotective roles include upregulating neurotrophic factors enhancing dopamine synthesis reducing inflammation preventing α synuclein aggregati lewy body formation 22 reduced lifetime estrogen exposure seen early menopause oophorectomy correlates higher pd risk 22 23 sexspecific genetic mechanisms also influence pd risk variants like lrrk2 g2019s mutation exhibit higher prevalence women sex dependent phenotypic differences 22 urate levels endogenous antioxidant associated reduced pd risk slower 10 progression particularly men 23 differences immune response neuroinflammation may contribute higher pd incidence men 22 racial ethnic groups prevalence pd varies across racial ethnic groups caucasians hispanics higher risks compared black asian populations 21 24 black individuals show approximately half pd prevalence white individuals 25 disparity attributed genetic biological socioeconomic factors genetic predispositions vary among ethnicities certain mutations population specific instance lrrk2 g2019s variant prevalent europe north africa united states rare japan lrrk2 pr1628p pg2385r varian ts common 26 ancestry related gene expression differences also influence pd risk ancestry associated differentially expressed genes degs account 27 pd heritability often relate immune responses vascular functions 27 environmental socioeconomic factors intersect genetic predispositions influencing pd progression stress healthcare access comorbidities play critical roles exacerbating disparities 28 racial differences immune response neuroinflammation — evident ancestry associated gene expression patterns —may explain variability pd risk progression 27 family history pd family history pd significant risk factor 15 25 individuals pd reporting familial connections 10 20 first degree relative condition 29 30 individuals family history three times likely develop pd often presenting earlier onset symptoms 2 30 interestingly familial background melanoma also linked increased risk pd 31 familial pd accounts approximately 15 cases remaining 85 categorized sporadic 32 genetic contributions approximately 5 pd cases result mutations specific genes 200 pd related genes identified date 33 key genetic contributors include 11 snca mutations snca gene cause alpha synuclein aggregation lewy bodies hallmark pd snca mutations often linked early onset pd mean onset 46 years cognitive decline 3 34 lrrk2 mutations lrrk2 gene common cause familial pd also increase sporadic pd risk lrrk2 mutations g2019s disrupt autophagy synaptic function leading dopamine toxicity 3539 gba1 mutations gba1 gene encodes glucocerebrosidase impair lysosomal function associated familial sporadic pd account 7 10 pd cases 3941 park7 dj 1 mutations park7 disrupt oxidative stress defense neuroinflammatory responses contributing early onset pd 50 years potentially idiopathic pd 42 44 pink1 mutations pink1 impair mitochondrial function autophagy leading hereditary early onset pd 4549 prkn parkin mutations prkn affect lysosomal activity leading toxic protein aggregation dopaminergic neuron loss prkn mutations linked 10 20 early onset pd cases 5054 uchl1 abnormalities uchl1 disrupt ubiquitin proteasome system contributing protein aggregation motor symptom severity pd 5558 double mutations combined genetic risks cases individuals may carry multiple genetic mutations lrrk2 g2019s combined gba1 mutations lead earlier onset faster progression pd symptoms combinations also influence non motor symptoms like dementia psychosis rem sleep behavior disorder rbd 5962 table 2 overview demographic genetic factors pd category subcategory key observations mechanisms references 12 age median onset 60 years 5 cases 50 neuronal loss substantia nigra increased oxidative stress mitochondrial dysfunction iron accumulation 5 18 19 sex twice prevalent men compared women protective effects estrogen sex specific genetic mechanisms eg lrrk2 variants differences immune response 22 23 racial ethnic higher prevalence caucasians hispanics lower black asian populations genetic predispositions ancestry linked gene expression environmental socioeconomic interactions 25 27 gene snca associated early onset pd cognitive decline alpha synuclein aggregation lewy body formation 3 34 lrrk2 common cause familial pd also linked sporadic pd disrupted autophagy synaptic dysfunction dopamine toxicity 3539 gba1 found 7 10 pd cases linked familial sporadic forms impaired lysosomal function glucosylceramide buildup 3941 park7 dj1 associated early onset idiopathic pd oxidative stress defense disruption neuroinflammation 4244 pink1 linked hereditary early onset pd mitochondrial dysfunction impaired autophagy 4549 prkn parkin present 10 20 early onset pd cases lysosomal dysfunction toxic protein aggregation 5054 uchl1 associated protein aggregation motor symptom severity disruption ubiquitin proteasome system alpha synuclein buildup 5558 gba glucosylceramidase beta lrrk2 leucine rich repeat kinase 2 park7 parkin rbr e3 ubiquitin protein ligase pink1 pten induced kinase 1 prkn parkin snca alpha synuclein uchl1 ubiquitin c terminal hydrolase l1 32 education intelligence surprisingly high level education 9 years well higher cognitive capacity early adulthood measured intelligence iq associated higher risk developing pd particularly among men 6365while reasons link remain unclear several theories proposed firstly lifestyle differences may play role research indicates individuals higher iqs education often lower cholesterol levels 66 associated higher risk pd 67 68 relationship iq education cholesterol levels might also influenced socioeconomic status lifestyle habits 66 additionally individuals higher iqs education levels less likely smoke 69 70 previously noted smoking considered protective pd occupational differences may also contribute people higher education levels often engage jobs requiring less physical activity potentially increasing pd risk 71 conversely adults lower education levels likely smoke possibly due stress targeted tobacco advertising 65 however higher 13 education associated greater cognitive reserve may influence cognitive performance pd potentially delay progression 72 table 3 presents summary relationship education iq risk developing pd table 3 summary relationship education iq pd category key observations mechanisms references education iq higher education ≥9 years iq associated increased pd risk particularly men lower cholesterol levels reduced smoking rates less physical activity higher cognitive reserve 7072 lifestyle factors individuals higher educationiq exhibit healthier lifestyles eg non smoking lower cholesterol reduced smoking may negate protective effects lower cholesterol linked increased pd risk 65 66 occupational role higher education correlates less physically demanding jobs potentially increasing pd risk sedentary occupations may contribute neurodegeneration 71 cognitive reserve greater cognitive reserve may modulate pd symptoms delay progression enhanced cognitive performance may obscure early pd symptoms 72 33 environmental occupational factors pd risk progression influenced various environmental occupational socioeconomic geographic factors factors interact complex mechanisms include oxidative stress neuroinflammation genetic predisposition disrupted cellula r processes table 4 exposure herbicides pesticides exposure herbicides pesticides paraquat strongly associated increased risk pd 73 74 agricultural workers individuals living rural areas face heightened exposure direct contact environmental contamination chemicals induce oxidative stress mitochondrial dysfunction critical processes dopaminergic neuron degeneration linked genetic alterations elevate susceptibility pd 75 heavy metal exposure heavy metals including mercury manganese lead disrupt redox homeostasis leading excessive reactive oxygen species ros production impaired antioxidant defense systems 76 oxidative stress contributes mitochondrial dysfunction aggregation alpha synuclein forming lewy bodies —a hallmark pd 77 metals also trigger neuroinflammation activation inflammasomes proinflammatory cytokines exacerbating neuronal 14 loss 78 79 additionally heavy metals cross blood brain barrier accumulate brain affect gut brain communication via microbiome disruptions amplifying pd risk 79 80 industrial chemicals occupational exposure industrial solvents trichloroethylene associated pd development 76 81 solvents impair autophagy lysosomal function mitochondrial integrity leading neuronal dysfunction 81 genetic factors combined solvent exposure may synergistically increase pd susceptibility urban rural living urban living characterized higher air pollution levels poses significant risk pd 82 pollutants contribute neurotoxicity systemic inflammation genetic interactions predispose individuals pd 6 83 84 particulate matter polluted air shown directly damage neurons exacerbate oxidative stress highlighting importance mitigating pollution exposure urban areas contrast people residing rural areas well working farms addition chemical exposures eg pesticides herbicides prone head injuries 85 infections 86 soil borne pathogens 86 unwellwater consumption — factors may causally connected pd 87 occupational workplace factors certain occupations particularly agriculture 88 mining industries involving heavy metals 89 solvents trichloroethylene 81 elevate pd risk 88 agricultural workers face exposure pesticides herbicides miners encounter high levels metals like manganese lead professions requiring high cognitive engagement healthcare 90 teaching 91 may also linked pd potentially due combination environmental exposures genetic predispositions affect key cellular processes 92 individuals engage contact sports boxing american football soccer heightened risk experiencing head trauma particularly repeated head trauma increases susceptibility developing neurodegenerative disorder like alzheimers disease pd 93 socioeconomic status 15 lower socioeconomic status ses often defined income education levels correlates higher pd prevalence limited access healthcare among lower ses groups delay diagnosis treatment accelerating disease progression 94 95 conversely higher ses associated lifestyle factors physical activity dietary antioxidant intake reduce pd risk environmental exposures pollutants occupational hazards often prevalent lower ses populations contributing pd onset severity table 4 overview environmental occupational socioeconomic geographic risk factors pd factor key observations mechanisms references herbicidespesticides exposure linked pd risk particularly among agricultural workers rural residents oxidative stress mitochondrial dysfunction genetic alterations 75 heavy metals exposure mercury manganese lead increases pd risk disruption redox homeostasis alpha synuclein aggregation neuroinflammation microbiome disruption 77 78 industrial chemicals solvents like trichloroethylene associated pd impair autophagy lysosomal function mitochondrial integrity 92 urban living air pollution contributes pd risk neurotoxicity systemic inflammation oxidative stress 83 84 rural living increased risk unwellwater consumption soil pathogens head injuries environmental exposures infections lifestyle factors 59 60 61 occupational roles agriculture mining industries involving solvents heavy metals linked pd risk environmental toxins genetic susceptibility neurotoxic exposures 71 79 90 91 socioeconomic status lower ses correlates higher pd prevalence limited healthcare access higher exposure environmental risk factors protective lifestyle factors higher ses groups 94 95 34 lifestyle factors lifestyle factors significantly influence development pd 96 factors physical activity diet smoking alcohol consumption shown affect risk developing pd table 5 thorough understanding lifestyle factors essential prevention early detection management pd body mass index bmi relationship bmi pd remains contentious studies report significant link obesity prolonged sedentary behavior pd risk 97 conversely research 16 suggests abdominal obesity increased waist circumference may elevate pd risk 98 99 effects may mediated elevated inflammatory cytokines oxidative stress obesity related metabolic disturbances like insulin resistance dyslipidemia contribute mitochondrial dysfunction neuronal damage pd 100 additionally obesity induced changes gut microbiome may exacerbate inflammation oxidative stress influencing pd progression unintentional weight loss however common feature pd affecting approximately 60 patients average loss 3 6 kg disease progression 9 weight loss correlates poor prognosis diminished quality life 9 101 alcohol consumption relationship alcohol consumption pd risk remains inconsistent across studies research identified significant link alcohol pd 102 studies suggest protective effect moderate alcohol consumption motor function decline 103 104 acute alcohol intake may temporarily alleviate motor symptoms tremors bradykinesia increasing dopamine release specific brain regions however heavy prolonged alcohol use lead persistent reductions dopamine levels exac erbating pd symptoms time 105 neuroimaging studies reveal alcohol intake negatively associated brain structure connectivity changes potentially accelerating pd progression 106 additionally alcohol interfere efficacy medications like levodopa precursor dopamine impairing absorption effectiveness intensify tremors motor symptoms furthermore alcohol consumption disrupts sleep patterns compounding existing sleep disturbances commonly experienced individuals pd dietary habits nutrition consumption dairy products associated increased risk developing pd 107 particularly men 108 109 potential contributing factors include milk proteins casein lactalbumin may lower serum urate levels since urate protective effects pd reduction could increase vulnerability 108 additionally contaminants like pesticides dairy products may play role 110 associations establish causality suggest potential risk link diets high pro inflammatory foods red meat refined sugars trans fats may promote systemic inflammation increasing pd risk similarly carbo nated beverages cold cuts also linked higher risk pd 17 111 nutrient deficiencies including omega 3 fatty acids vitamin b vitamins coenzyme q10 impair neuronal health mitochondrial function potentially accelerating neurodegeneration worsening pd symptoms 112 moreover high protein diets may interfere absorption levodopa primary medication managing pd symptoms sedentary lifestyle physical inactivity sedentary lifestyle associated development progression pd sedentary behavior worsens non motor symptoms cognitive impairment depression poor sleep quality significantly reducing quality life individuals pd 96 113 physical inactivity also correlated increased depression cognitive decline pd patients suggesting reducing sedentary time could help alleviate symptoms furthermore dysregulated genes identified pd patients overlap tho se affected sedentary behavior particularly cellular pathways linked pd progression network based research underscores impact lifestyle factors significant genetic molecular pathways highlighting potential therapeutic targets slowing pd progression table 5 summary lifestyle risk factors pd category key observations mechanisms references body mass index conflicting evidence association unintentional weight loss common pd abdominal obesity may elevate risk weight loss correlates poor prognosis 8084 dairy consumption linked higher risk pd particularly men decreases serum urate levels potential contaminants like pesticides 7073 alcohol consumption mixed evidence moderate consumption may reduce pd risk heavy use may exacerbate progression dopamine release acute use prolonged use depletes dopamine interferes pd medication impacts brain structureconnectivity 7579 sedentary lifestyle associated worse non motor symptoms eg cognitive decline depression dysregulated genes linked cellular pathways overlaps molecular pathways influencing pd progression 96 113 35 metabolic systemic factors metabolic systemic factors worsen neurodegeneration promoting inflammation oxidative stress mitochondrial dysfunction accelerating pd progression table 6 understanding factors crucial developing strategies manage slow disease diabetes 18 type 2 diabetes mellitus t2dm significantly impacts pd development progression 114 116 t2dm exacerbates motor symptoms eg instability mobility issues non motor symptoms cognitive impairments eg slower thinking attention deficits accelerates disease progression 117120 neurovascular burden associated t2dm white matter hyperintensities contributes effects 121 122 t2dm thus considered independent factor negatively influencing pd outcomes 122 123 hypertension hypertension may increase pd risk due hypertensive vasculopathy regions basal ganglia brain stem thalamus 124 125 also contributes cardiovascular diseases cerebral small vessel diseases leading white matter hyperintensities may exacerbate pd progression 126128 early diagnosis management hypertension could mitigate pd risk progression cholesterol triglycerides pd patients often exhibit lower levels cholesterol triglycerides compared healthy controls 129 130 studies reported consistently reduced total cholesterol ldl c hdl c triglycerides pd patients 20 years diagnosis 131 reduction associated increased oxidative stress alpha synuclein aggregation dopaminergic neurons 132 high plasma ldl c levels total cholesterol linked slower pd progression improved motor function 133 134 low hdl c levels associated higher pd risk 135 however findings lipid levels remain inconsistent likely due confounding factors obesity diabetes lifestyle genetics 134 136 137 138 table 6 overview metabolic physiological factors contributing harm pd category key observations mechanisms references diabetes t2dm linked severe motornon motor symptoms accelerated pd progression neurovascular burden white matter hyperintensities cognitive decline 8595 hypertension may elevate pd risk worsen progression hypertensive vasculopathy cerebral small vessel disease white matter hyperintensities 96101 cholesteroltriglycerides lower levels associated higher pd risk high ldl c total cholesterol linked slower progression oxidative stress alpha synuclein aggregation protective effects ldl c 102112 ldl c low density lipoprotein cholesterol hdl c high density lipoprotein cholesterol t2 dm type 2 diabetes mellitus 19 36 inflammation immunity gut brain axis inflammatory factors immune dysfunction gut brain axis dysbiosis contribute neurodegeneration progression pd 86 chronic inflammation microglial activation release harmful cytokines oxidative molecules dysbiosis disrupts gut function triggering brain inflammation neuronal damage factors may influence pd onset early symptoms often prec ede central nervous system changes summary impact pd table 7 understanding mechanisms key developing therapies slow disease progression viral infections viral infections play significant role development progression pd contributing chronic neuroinflammation neuroinflammation triggered viruses activate immune response particularly activation microglia release pro inflammatory cytokines chemokines molecules cro ss blood brain barrier cause neuronal cell death 139 140 furthermore certain viruses influenza epstein barr viruses found promote aggregation alpha synuclein protein critical pathology pd 141 addition activation toll like receptors tlrs particularly tlr4 viral proteins leads heightened immune responses neuroinflammation ultimately causing neuronal damage 142 viral rna also trigger microglial activation receptors like mac 1 resulting production reactive oxygen species contribute neuronal injury 143 epidemiological studies identified specific viruses including cytomegalovirus cmv epstein barr virus ebv hepatitis c virus factors may induce chronic inflammation immune dysregulation potentially increasing risk pd de velopment 139 neuroinflammation chronic inflammatory diseases inflammation normal immune response designed protect body becomes chronic lead tissue damage contribute development diseases like pd chronic inflammation pd driven cytokines reactive oxygen species chemokines 20 produced various immune cells including endothelial cells microglia astrocytes peripheral immune cells inflammation manifest two forms acute rapid onset short duration localized symptoms chronic per sists time leads tissue damage increased risk disease pd markers inflammation crp tnf α il 6 linked disease may serve potential biomarkers therapeutic targets 144 145 gut brain axis wherein inflammation gastrointestinal tract influenced gut microbiota exacerbate neuroinflammation promoting pd progression also key factor 146 additionally genetic factors like lrrk2 mutations environmental exposures toxins infections play role driving neuroinflammation pd 147 gut dysbiosis gut dysbiosis imbalance gut microbiota increasingly recognized critical factor pd pathogenesis gut brain axis bidirectional communication system gut central nervous system essential maintaining neurological health dysbiosis disrupt axis leading neuroinflammation misfolding alpha synuclein prot ein closely associated pd pathology 147 148 altered gut microbiota produce pathogenic metabolites create pro inflammatory environment exacerbating neuroinflammation promoting pd progression 148 149 several biological pathways connect gut dysbiosis progression pd dysbiosis may lead overproduction pro inflammatory cytokines tumor necrosis factor tnf interleukins cross blood brain barrier induce neuroinflammation 150 additionally gut microbiota influences immune responses tolllike receptors dysregulation receptors contribute alpha synuclein pathology 150 moreover gut brain axis relies neuroendocrine signals direct neural pathways disrupted dysbiosis exacerbating pd progression 151 152 chronic constipation chronic constipation prevalent non motor symptom often precedes motor manifestations pd condition linked gut dysbiosis increased intestinal permeability may result systemic inflammation enteric nervous system activation changes trigger alpha synuclein misfolding gut potentially propagating 21 brain via vagus nerve thereby contributing pd development 149 early occurrence gastrointestinal symptoms including constipation supports hypothesis pd pathology might originate gut years motor symptoms appear 151 table 7 summary inflammatory microbiome gut brain axis factors pd category key observations mechanisms references viral infections linked pd chronic neuroinflammation immune dysregulation activation microglia tlrs alpha synuclein aggregation immune responses viral proteins 139 142 neuroinflammation contributes pd onset progression elevated cytokines eg tnf α il6 microglial activation oxidative stress 144 153 chronic inflammatory diseases associated heightened pd risk progression persistent cytokine production gut brain axis inflammation genetic predispositions 153 154 155 156 gutbrain axis bidirectional link gastrointestinal inflammation neurodegeneration pd shared genetic factors inflammatory markers gut 146 147 gut dysbiosis linked neuroinflammation alpha synuclein misfolding promotes pd progression proinflammatory cytokines tolllike receptor dysregulation disrupted gut brain communication 147 148 150 chronic constipation common preclinical symptom pd linked gut dysbiosis intestinal permeability alpha synuclein misfolding gut propagating via vagus nerve brain 149 151 157 37 neurological psychological factors neurological psychological factors increase risk progression pd affecting neural circuits neuroinflammation promoting oxidative stress damage neurons impaired dopamine regulation common neurological psychological disorders may also contribute early onset worsening pd sympto ms table 8 provides summary mechanisms underlying neurological psychological factors pd traumatic brain injury traumatic brain injury tbi significant risk factor pd biological mechanisms including inflammation metabolic dysregulation protein accumulation tbi promotes upregulation proteins amyloid precursor protein app alpha synuclein hyper phosphorylated tau tar dna binding protei n 43 linked pd pathology 158 acute neuroinflammation catecholamine dysfunction triggered tbi contribute pd progression 159 inflammatory response involves microglia astrocyte activation 22 become detrimental prolonged accelerating neurodegeneration 158 notably us veterans tbi 56 increased risk pd risk escalating injury severity 158 sleep disorders rem sleep behavior disorder rbd serves important early indicator pd studies demonstrated individuals rbd increased risk developing pd synucleinopathies dementia lewy bodies 160 relationship rbd pd believed stem accumulation misfolded alpha synuclein proteins brain regions responsible regulating rem sleep leading formation lewy bodies characteristic feature pd rbd mar ked absence muscle atonia rem sleep causing dream enactment often precedes onset motor symptoms pd several years 161 beyond rbd sleep fragmentation difficulties sleep maintenance frequently observed pd patients contributing worsening cognitive decline non motor symptoms 160 risk factor early sign pd progression rbd reflects underlying neurodegenerative changes associated disease loss smell anosmia anosmia loss smell early non motor symptom pd often precedes motor symptoms years even decades linked accumulation alpha synuclein olfactory bulb related regions among first areas affe cted pd 162 pathology begins olfactory bulb related regions anterior olfactory nucleus among first areas affected pd reduced integrity substantia nigra characteristic feature pd also observed individuals unexplained smell loss supporting connection anosmia pd suggests anosmia signals pd risk may also serve early marker disease 163 disruption olfactory function alpha synuclein pathology may contribute progression neurodegeneration brain regions chronic stress psychological emotional health significantly influence risk progression pd progression pd also closely linked various biological mechanisms influenced psychological stress mood disorders stress accelerate damage dopamine producing neurons worsen motor symptoms like bradykinesia motor blocking nd tremors reduce effectiveness dopaminergic medications 164 mesocortical mesolimbic dopaminergic 23 pathways crucial mood regulation disrupted pd contributing high prevalence depression anxiety patients 165 166 chronic stress identified significant risk factor pd exacerbates loss dopamine producing neurons animal models suggest prolonged stress accelerates dopaminergic cell death underscoring potential benefits stre ssreduction interventions 167 168 depression anxiety mental health conditions depression anxiety serve early indicators prodromal phase pd though presence necessarily predict development disease research shows individuals 50 mental health disorders including schizophrenia bipolar disorder insomnia depression anxiety heightened risk pd particularly environmental contributory factors present 169 170 depression anxiety prevalent non motor symptoms pd may also precede onset motor symptoms increasingly recognized integral disease ’ pathophysiology biological mechanisms linking stress depression anxiety pd include activation hypothalamus pituitary adrenal hpa axis sympathetic nervous system sns elevated levels glucocorticoids catecholamines leading neuronal injury increased proinflammatory cytokines contributing neurode generation stress induced vulnerability dopamine neurons via glucocorticoid receptor activity chronic stress mood disorders exacerbate motor non motor symptoms also synergize factors increase neuronal vulnerability potentially accelerating progression pd therefore addressing stress mood disorder pd patients crucial slowing diseases progression improving quality life 171 table 8 overview neurological psychological risk factors pd category key observations mechanisms references traumatic brain injury increases pd risk 56 severity dependent inflammation protein accumulation app alpha synuclein etc microglial activation 158 159 sleep disorders rem sleep behavior disorder often precedes motor symptoms years degeneration brainstem nuclei alpha synuclein accumulation forming lewy bodies 160 161 loss smell anosmia early non motor symptom precedes motor signs alpha synuclein accumulation olfactory pathways 162 163 24 chronic stress increases neuronal vulnerability exacerbates motor non motor symptoms disrupts dopaminergic pathways increases proinflammatory cytokines accelerates cell death 164 167 depression anxiety common non motor symptoms may precede motor symptom onset activates hpa axis sns increases glucocorticoids catecholamines induces neuroinflammation 165 171 38 hormonal health conditions hormonal factors influence onset progression severity pd imbalances hormones thyroid cortisol affect neuronal health exacerbate symptoms understanding factors essential developing gender specific therapies improving disease management summary hormonal risk factors pd presented table 9 estrogen neuroprotective role estrogen plays significant role risk progression pd influencing key processes involved dopaminergic function dopamine synthesis metabolism transport believed neuroprotective effects potentially shielding dopaminergic neurons degeneration animal models support howing estrogen may reduce inflammation interacting brains renin angiotensin system counteract oxidative stress damage neurons mechanisms estrogen helps protect brains dopaminergic system potentially slowing pd progression 172 postmenopausal women pd risk postmenopausal women particularly undergoing hormone replacement therapy hrt face increased risk pd heightened risk linked reduced lifetime exposure endogenous estrogens whether due early menopause shorter fertile lifespan absence estrogen supplementation hrt menopause exacerbates risk 173 174 hormone replacement therapy link hormone replacement therapy hrt pd risk multifaceted estrogen alone may offer protective effects long term use combined estrogen progesterone therapy appears increase risk developing pd 172 175 estrogen replacement therapy 25 ert help alleviate symptoms slow progression pd women especially early stages l dopa therapy begins 176 lower incidence pd women compared men may partly attributed protective influence endogenous estrogen estrogen thought protect neurodegeneration reducing oxidative stress regulating dopamine metabolism imp roving mitochondrial function may help preserve dopaminergic neurons substantia nigra region progressively affected pd 177 hyperuricemia uric acid antioxidant properties helps reduce oxidative stress key factor neurodegeneration pd relationship uric acid levels pd risk complex elevated uric acid levels associated reduced risk pd due neuroprotective effects however hyperuricemia also linked cognitive impairment conditions like go ut may exacerbate neurodegeneration 178 additionally co existing conditions cerebrovascular injury amplify effects hyperuricemia increasing risk cognitive decline accelerating pd progression 179 table 9 overview hormonal health condition risk factors pd category key observations mechanisms references estrogen levels may protect dopaminergic neurons reduced levels post menopause linked higher pd risk modulates dopamine pathways reduces inflammation oxidative stress 172174 postmenopausal women higher pd risk linked early menopause shorter fertile life lack hrt reduced lifetime estrogen exposure affects neuroprotection 173 174 hrt mixed effects longterm combined estrogen progesterone therapy may increase risk duration regimen specific impact estrogen ’ neuroprotective role 172 175 hyperuricemia paradoxical effects antioxidant properties may protect linked cognitive decline gout reduces oxidative stress compounds neurodegeneration coexisting conditions 178 179 39 medications certain antibiotics calcium channel blockers treating high blood pressure heart conditions certain anti diabetic medications rosiglitazone pioglitazone statins treating high cholesterol levels possible associations ncreased risk pd 4 180 181 summary medications associated increased risk parkinsons disease presented table 10 26 β2adrenoceptor antagonists eg propranolol propranolol β2 adrenoceptor antagonist associated increased risk pd β2 adrenoceptors play critical role regulating metabolic functions dopaminergic activity essential neuroprotection chronic use propranolol may contribute degeneration dopaminergic neurons substantia nig ra hallmark pd β2 adrenoceptor blockade exacerbate motor symptoms accelerate pd progression reducing dopaminergic signaling additionally modulation adrenergic activity may disrupt already compromised balance neurotransmitters impairing dopaminergic systems 182 diabetes medications metformin widely used diabetes medication linked increased risk pd due influence various physiological processes contribute insulin dysregulation leading neuroinflammation mitochondrial dysfunction may also alter synaptic plasticity implicating neurodegeneration pathways common diabetes pd contrast diabetes treatments glucagon like peptide 1 agonists glp1a may offer protective effects pd progression modulating insulin signaling 183 184 antibiotics macrolides lincosamides classes antibiotics associated increased risk pd likely due disruptive effects gut microbiota alterations microbial composition may exacerbate neuroinflammation promote aggregation α synuclein protein implicated pd pathogenesis contrast emerging therapies p rasinezumab monoclonal antibody targeting aggregated α synuclein show potential slowing motor progression rapidly advancing pd cases 185 186 psychological medications psychotropic medications including antidepressants anxiolytics linked increased risk pd older populations drugs impact dopaminergic systems antipsychotics particular blocking dopamine receptors may increase vulnerability pd 187 cancer medications 27 although direct evidence limited certain chemotherapeutic agents cancer medications may elevate risk pd mechanisms inducing oxidative stress generates reactive oxygen species ros exacerbates neuronal damage causing mitochondrial dysfunction impairs cellular energy production —a known contributor pd pathology 188 epigenetic modifications certain medications modify epigenetic marks thereby influencing gene expression associated pd prolonged use drugs may induce changes dna methylation modification commonly observed pd patients 189 epigenetic alterations including dna methylation histone modifications hydroxy methylation integral molecular mechanisms underlying pd facilitating interaction genetic environmental factors contribute disease onset progression 44 table 10 summary medications associated increased risk pd factor key observations mechanisms references β2adrenoceptor antagonists linked increased pd risk particularly chronic use eg propranolol disrupts dopaminergic activity metabolic functions accelerates lewy body formation 182 diabetes medications mixed effects metformin may increase risk glp1a treatments may protective insulin dysregulation mitochondrial dysfunction neuroinflammation 183 184 antibiotics macrolides lincosamides associated higher pd risk disrupt gut microbiota exacerbate neuroinflammation α synuclein aggregation 185 186 psychotropic medications increased pd risk observed older populations using antidepressants anxiolytics blocks dopamine receptors affecting dopaminergic systems 187 cancer medications potential increase pd risk certain chemotherapy agents induces oxidative stress mitochondrial dysfunction affects immune system 188 epigenetic modifications long term medication use may influence pd altered dna methylation changes epigenetic marks affecting gene expression 44 189 310 comorbid conditions neurodegenerative chronic diseases may increase risk worsen progression 28 4 prevent factors pd preventive factors pd focus strategies aimed reducing risk delaying onset progressive neurodegenerative disorder fig 3 research indicates lifestyle choices nutrition occupational factors may play role lowering risk developing pd identifying understanding factors guide development strategies delay pd onset als potentially reduce overall prevalence incorporating preventive measures individuals may lower risk developing p slow progression figure 3 important preventive factors pd 41 lifestyle factors lifestyle factors play crucial role preventing onset pd slowing progression research indicates specific lifestyle habits protective effects brain health potentially reducing risk developing pd delaying onset mitigating progression symptoms summary lifestyle factors may help prevent pd provided table 11 physical activity 29 engaging highest level physical activity exercise advantage decreasing incidence pd 21 190 possible onset pd could delayed significant amount physical activity may slow diseases pathological processes 191 particularly individuals physically active middle years 192 prodromal phase pd individuals may experience nonmotor symptoms sleep disorders constipation along subtle motor signs like rigidity balance impairment tremor leading likely decrease physical activity period 191 patients early stages pd consistently engaged physical activity exercise long period time may notice slower decline gait stability activities daily living processing speed 193 additionally participating physical activity exercise improve non motor symptoms like depression apathy postural instability also reducing motor symptoms reducing inflammation individuals pd 194 consequently maintaining high level physical activity exercise could stimulate interest potential therapeutic targets pd ultimately contributing improved quality life individuals condition vigorous physical activity reduced sitting time noted neuroprotective effects including improved gait stability daily living activities processing speed 68 exercise shown alleviate non motor symptoms depression apathy postural instability reducing motor symptoms anti inflammatory mechanisms 69 engaging regular physical activity may also delay pd onset contribute better quality life high quality sleep high quality sleep plays crucial role reducing risk pd several interconnected biological mechanisms one key factor promotion efficient protein clearance particularly glymphatic system becomes active sleep clearing toxic proteins like α synuclein contribute p sleep also regulates neuroinflammation reducing activation immune cells microglia astrocytes exacerbate neural injury 195 additionally good sleep helps mitigate oxidative stress reducing production reactive oxygen species supporting bodys antioxidant systems critical protecting brain cells damage furthermore maintaining regul ar circadian rhythms highquality sleep vital dopamine regulation essential pd prevention 196 disruptions circadian rhythms reduce dopamine levels increasing pd risk sleep also 30 improves sleep architecture reducing fragmentation enhancing restorative sleep supports overall brain health 196 combined mechanisms highlight neuroprotective role sleep suggesting interventions improve sleep quality may help delay reduce onset pd 197 social support social support plays crucial role reducing risk pd impacts psychological physical health studies show strong social networks linked better mental health reducing depression anxiety stress —key risk factors pd 198 connections may lower likelihood developing disease social support also helps slow pd progression several mechanisms encourages physical activity shown improve motor cognitive functions pd patients enhancing cerebral mechanisms cardiovascular fitness 199 200 additionally psychological benefits social support increased positivity reduced distress improve disease management treatment adherence 198 furthermore access information social networks provides patients strategies like dietary changes may help slow progression modifications influence gut microbiome 201 cognitive engagement cognitive engagement participating mentally stimulating activities may help reduce risk developing pd associated cognitive decline one mechanism cognitive engagement may protect pd enhancing neuroplasticity brains ability reorganize form new neural connections process stimulated engaging complex tasks may build cognitive reserve potentially delaying onset cognitive symptoms pd 202 additionally cognitive engagement may support neurotransmitter systems crucial pd dopamine serotonin noradrenaline acetylcholine implicated cognitive processes affected pd engaging mental activities may help mai ntain systems potentially slowing cognitive decline 203 moreover cognitive engagement may influence mitochondrial function reducing oxidative stress improving energy metabolism neurons could slow cognitive deterioration 204 may also interact genetic factors variations apoe gba genes linked cognitive decline pd potentially 31 mitigating effects 205 cognitive engagement also help slow pd progression building cognitive reserve allowing individuals compensate neural damage delay cognitive symptoms 206 furthermore cognitive activities often associated increased physical activity shown enhance brain function structure leading improved cognitive outcomes pd patients 207 cognitive engagement may also help reduce anxiety indirectly supporting cognitive health slowing disease progression 207 smoking undeniable smoking tobacco cigarettes detrimental health several studies shown cigarette smoking may reduce risk developing pd 208 smokers found half likely non smokers develop pd 209 significant inverse dose response correlation discovered relation pd risk greater duration frequency smoking among individuals lower chances developing pd 6 consequently smoking linked later age onset pd 2 potential protective effect smoking pd may due presence nicotine tobacco smoke may trigger release dopamine neurotransmitter associated pd 208 moreover nicotine ability block formation toxins directly impacting enzyme functions mao b 210 cigarette smoking also observed diminish aggregation alpha synuclein cell cultures suggesting potential slowdown development pd 211 although cigarette smoking may protective effects pd found directly linked increased issues drooling swallowing freezing patients pd 7 pd smokers likely experience non motor symptoms unexplained pains feelings sadness memory problems 7 moreover may strong connection smoking mortality pd clear individuals pd smoke higher risk developing smoking related cancers like lung cancer cardiovascular disease respirat ory issues 212 table 11 overview lifestyle factors potentially preventing pd factor key observations mechanisms references physical activity reduces pd incidence 21 delays onset improves symptoms enhances neuroprotection reduces inflammation improves gait quality life 190 192 193 high quality sleep reduces pd risk promoting protein clearance dopamine regulation clears toxic proteins reduces neuroinflammation supports brain health 195197 213 32 social support reduces pd risk supports mental health encourages physical activity reduces stress improves motorcognitive functions supports disease management 198200 cognitive engagement mental activities reduce pd risk cognitive decline enhancing neuroplasticity boosts brain function maintains neurotransmitters supports mitochondrial health 202205 smoking smokers less likely develop pd worsens nonmotor symptoms health risks nicotine may trigger dopamine release reduce alpha synuclein aggregation increases health risks 69 208 209 211 212 214 42 dietary nutritional factors dietary nutritional factors crucial context pd influence risk developing disease management symptoms proper nutrition supports brain health neuroprotection reduces inflammation promotes gut health maintains overall wellbeing —all vital n managing neurodegenerative condition like pd additionally interactions medications dietary factors important consideration treatment summary dietary nutritional factors may preventive influence pd provided table 12 coffee drinking coffee may help prevent onset pd 30 214216 additionally consuming coffee linked decreased likelihood developing pd well slowing advancement 217 recent study reported strong correlation duration coffee consumption age onset pd well relatively low association number cups coffee age onset pd 214 potential explanation protective effect coffee pd attributed caffeine supported fact black tea contains lower amount caffeine demonstrated moderate association onset age pd 214 paradox regarding effects caffeine motor non motor symptoms among pd patients one hand research drug naive early stage pd patients shown severity non motor symptoms related mood cognition verse relationship coffee consumption 218 additionally research indicated individuals consume coffee exhibit lower tremor scores compared 33 correlation observed severity tremors amount coffee consumed 219 also coffee found protective effect motor function decline mortality cognitive decline pd patients 105 hand studies shown meaningful connection dosage duration coffee consumption presence motor non motor symptoms early stage pd patients 7 multiple reasons coffee may offer protection development pd one reasons component coffee acts adenosine a2a receptor antagonist leading decreasing α synuclein aggregation synt synphilin 1 ne uroglioma cells 220 additionally coffee consumption exhibits anti inflammatory properties also mitigates risk chronic diseases like diabetes obesity cardiovascular disease indirectly influence development progression pd 221 tea multiple studies meta analyses consistently shown inverse relationship tea consumption risk developing pd increased tea consumption associated reduced risk developing pd 222 potential decrease pd risk 26 223 studies focus preventive effects tea consumption emerging evidence suggests tea may also potential slow pd progression study highlighted role tea drinking modifying progression idiopathic sleep behavior disorder irbd α synucleinopathies including pd 224 study found tea drinking associated decreased risk phenoconversion irbd pd suggesting protective role tea early stages neurodegenerative disease progression 224 tea rich polyphenols especially catechins like egcg possess significant neuroprotective properties compounds reduce oxidative stress major factor pd pathogenesis scavenging free radicals enhancing antioxidant defenses 223 polyphenols also modulate signaling pathways metal chelation crucial reducing neuronal damage studies black tea consistently shown significant inverse association black tea consumption pd risk singapore chine se health study found black tea consumption associated reduced risk pd independent caffeine intake tobacco smoking 225 protective effect thought due presence thearubigins theaflavins formed oxidation 34 catechins black teawhile green tea rich polyphenols particularly catechins like epigallocatechin gallate egcg association reduced pd risk human populations remains inconclusive 225 studies shown significant association green tea consumption reduced pd risk 225 however green tea polyphenols gtps demonstrated protective effects dopaminergic neuron degeneration preclinical models suggesting potential neuroprotective properties 225 study japan found intake japanese chinese teas significantly inversely associated risk pd supporting notion various types tea beneficial 226 theanine amino acid found tea inhibit glutamate receptors regulate extracellular glutamine concentrations providing neuroprotective effects reducing excitotoxicity 223 diet habits diet habits factor negative positive impacts pd dietary regimen characterized elevated consumption fruits fish vegetables whole grains nuts legumes poultry coupled reduced intake saturated fats moderate alcohol consumption potentially serves protective factor pd 227 relationship nutrition pd complex involving various dietary patterns specific nutrients may influence risk progression disease mediterranean diet rich fruits vegetables nuts fish associated reduced risk pd slower disease progression diet thought exert effects anti inflammatory antioxidant mechanisms help mitigate oxidative stress neuroinflammation key factors pd pathogenesis 228 229 vitamins longitudinal studies indicated persistent deficiency vitamin associated higher likelihood developing pd 230 increased risk may due chronic lack vitamin result depletion dopaminergic neurons substantia nigra region ultimately contribute onset pd 230 moreover previous studies shown seasonal sunlight related impacts dopamine transporter dat expression individuals without health issues early stages pd 231 suggested dietary vitamin e may play role protecting pd indicating incorporating vitamin e rich foods ones diet could immediate option reducing 35 risk pd 232 pd patients found lower levels vitamin b12 healthy controls could potentially linked onset early gait instability neuropathy 233 additionally observed pd patients experience dementia elevated levels vitamin b12 cognitively healthy pd ones suggesting higher vitamin b12 level might reduce risk developing dementia future 234 similarly adequate intake vitamins b6 folate may support neurological health reduce pd risk lowering homocysteine levels linked neurodegeneration 235 minerals like magnesium zinc also important involved numerous enzymatic processes support neuronal function may help slow pd progression 235 calcium calciums role pd less clear essential various cellular processes including neurotransmitter release neuronal excitability dysregulation calcium homeostasis contribute neuronal death hallmark pd therefore mainta ining adequate calcium levels diet may support neuronal health potentially slow disease progression 235 gutbrain axis emerging research highlights gut brain axis significant factor pd gut microbiota influence neuroinflammation neurodegeneration suggesting dietary interventions promote healthy gut microbiome may impact pd risk progression diets rich fiber probiotics may enhance gut health consequently brain health offering potential therapeutic avenue pd 236 uric acid urate levels recent studies highlight potential uric acid ua reducing pd risk 1 mgdl increase serum urate associated 6 reduction pd risk 237 potent endogenous antioxidant ua accounts 60 –70 antioxidant activity human plasma 238 properties especially relevant pd oxidative stress key factor neuronal damage 239 ua mitigates oxidative stress scavenging free radicals reactive oxygen species ros neuronal cells also inhibits lipid peroxidation protecting cellular components damage mitochondrial dysfunction central pd ua ’ ability protect mitochondrial 36 integrity may help preserve neuronal function 239 additionally ua may reduce inflammatory damage neurons modulating inflammatory pathways activated pd 239 also aids maintaining calcium homeostasis critical factor neuronal function disruptions calcium signaling implicated pd pathogenesis one proposed mechanism ua ’ neuroprotective effect activation nrf2 transcription factor regulates antioxidant proteins offering protection oxidative damage pd research comparing ua levels pd patients healthy control shows significantly lower serum cerebrospinal fluid csf ua levels pd patients sugg esting factors beyond purine metabolism age sex weight may influence ua levels 240 higher serum urate associated reduced pd risk supporting ua ’ potential neuroprotective effects 237 despite findings studies report significant correlation high ua levels reduced pd risk role ua pd progression remains debated 240 additionally causality low ua levels pd still discussion 240 table 12 summary dietary nutritional factors may help prevent pd factor key observations mechanisms references coffee coffee may reduce pd risk 30 slow progression inconsistent effects motornon motor symptoms pd patients caffeine acts adenosine a2a receptor antagonist reducing α synuclein aggregation inflammation 214 215 218 221 tea tea consumption linked 26 reduction pd risk black tea may protective green tea polyphenols catechins theaflavins reduce oxidative stress modulate signaling chelate metals 222 223 225 226 nutrition diet mediterranean diet fruits vegetables fish linked reduced pd risk slower progression antiinflammatory antioxidant effects help mitigate oxidative stress neuroinflammation 228 229 vitamins vitamin deficiency increases pd risk vitamin e b12 b6 folate may help protect pd reduce disease progression vitamins support neuronal function reduce oxidative stress lower homocysteine linked neurodegeneration 179 228 235 calcium role calcium pd unclear crucial neuronal processes dysregulation may contribute neuronal death maintaining calcium homeostasis supports neurotransmitter release neuronal health 235 gutbrain axis healthy gut microbiome may influence pd risk progression diets rich fiber probiotics may promote brain health improves gut health reducing neuroinflammation supporting brain health gut brain connection 236 uric acid ua higher uric acid levels may reduce pd risk 6 every 1 mgdl increase ua acts antioxidant protecting oxidative stress ua scavenges free radicals protects mitochondrial integrity modulates inflammation supporting neuronal function 178 238 240 37 43 medications medical factors medications medical factors vital preventing slowing pd progression example antiinflammatory drugs reduce neuroinflammation associated pd development potentially slowing disease progression besides neuroprotective medications help preserve neurons neutralizing free radicals supporting mitochondrial function table 13 provides overview medications medical factors along respective mechanisms prevention slowing pd progression nonsteroidal anti inflammatory drugs nsaids nsaids explored potential neuroprotective effects pd due ability inhibit cyclooxygenase cox enzymes particularly cox 2 upregulated pd 241 inhibiting cox 2 nsaids reduce production pro inflammatory prostaglandins potentially mitigating neuroinflammation slowing neurodegeneration 241 nsaids aspirin ibuprofen may also decrease elevated cytokines like tnf α il 1β contribute neuroinflammation neuronal death pd 242 aspirin ibuprofen shown effectively reduce risk pd postpone age onset parkinsons disease much 5 years 214 243 could anti inflammatory effects aspirin ibuprofen play role decreasing pd risk 244 furthermore aspirin proven boost production tyrosine hydroxylase th enzyme controls rate dopamine da synthesis leads elevation level da found dopaminergic neurons 245 additionally aspirin ibuprofen potential decrease likelihood lrrk2 mutation indicating anti inflammatory medications could serve beneficial treatments modifying progression lrrk2 pd 246 epidemiological studies suggest regular nsaid use associated reduced risk developing pd although results inconsistent across studies experimental models also demonstrate protective effects nsaids neurotoxin induced dopam inergic neuron degeneration however long term nsaid use linked gastrointestinal cardiovascular risks warranting careful consideration pd treatment 38 calcium channel blockers ccbs ccbs studied potential reduce risk progression pd modulating calcium ion flows crucial neurotransmitter release neuronal health dopaminergic neurons particularly substantia nigra cc bs help regulate calcium influx critical given vulnerability neurons calcium induced stress due pacemaking activity 247 ltype calcium channels cav13 subunits contribute mitochondrial oxidant stress key factor pd pathogenesis recent research also suggests cav23 channels may play role regulating neuronal viability substanti nigra potentially offering neuroprotective benefits 248 systematic review meta analysis found ccb use associated significantly reduced risk pd relative risk 078 95 ci 062 –099 249 studies large prospective cohort study found significant association 250 additionally clinical trial isradipine ccb show significant effects slowing early stage pd progression 249 statins statins primarily known cholesterol lowering effects investigated neuroprotective potential pd due anti inflammatory anti oxidative neuroprotective properties suppressing proinflammatory molecules icroglial activation statins help reduce neuroinflammation pd effects mediated inhibition mevalonate pathway crucial synthesizing inflammatory mediators statins also inhibit oxidative stress major fac tor pd pathogenesis potentially protecting dopaminergic neurons degeneration furthermore statins act ligands pparα regulator mitochondrial function often compromised pd 251 evidence suggests statins particularly simvastatin due ability cross blood brain barrier may slow pd progression attenuating α synuclein aggregation 251 systematic review meta analysis suggested atorvastatin may reduce pd risk attributed potent anti inflammatory anti oxidative effects 252 however randomized controlled trials needed confirm findings α1adrenergic antagonists 39 α1adrenergic antagonists terazosin doxazosin alfuzosin primarily used treat benign prostatic hyperplasia shown potential neuroprotective effects pd enhancing glycolysis energy metabolism impaired pd 253 drugs activate pgk1 first atp generating enzyme glycolysis increasing atp production potentially counteracting energy deficits observed pd moreover α1 adrenoceptor antagonists may modulate locus coeruleus key noradrener gic center affected pd potentially influencing dopamine release providing neuroprotection cohort study involving danish us health registries found users terazosin doxazosin alfuzosin significantly lower risk developi ng pd compared users tamsulosin enhance glycolysis hazard ratios developing pd 088 danish cohort 063 us cohort indicating reduced risk associated drugs 253 table 13 overview medications medical factors may potentially prevent risk pd factor key observations mechanisms references nonsteroidal anti inflammatory drugs nsaids aspirin ibuprofen may reduce pd risk postpone age onset much 5 years regular use linked reduced risk pd inhibit cox 2 enzymes reduce pro inflammatory prostaglandins decrease elevated cytokines like tnf α il 1β potentially mitigate neuroinflammation aspirin boosts dopamine production 241 242 245 246 calcium channel blockers ccbs ccbs like isradipine may reduce pd risk mixed results slowing progression modulate calcium ion flows regulate neurotransmitter release reduce mitochondrial oxidant stress protect dopaminergic neurons 247250 statins statins particularly simvastatin may slow pd progression attenuating α synuclein aggregation reducing neuroinflammation inhibit pro inflammatory molecules reduce oxidative stress regulate mitochondrial function via pparα 251 252 α1adrenergic antagonists terazosin doxazosin alfuzosin show reduced pd risk due enhanced glycolysis energy metabolism activate pgk1 enzyme glycolysis increase atp production modulate locus coeruleus influence dopamine release provide neuroprotection 253 44 occupational factors certain occupational categories particularly involving high levels physical activity shown significantly reduce risk developing pd occupations engineering production work including machine operators fabricators metalworking construction extractive work eg mining oil well drilling associated lower pd risk 40 254 research highlighted jobs requiring significant physical exertion linked decreased risk pd consistent well established protective effects regular physical exercise table 14 occupations demand consistent physical activity may confer similar neuroprotective benefits structured exercise regimens multiple studies also demonstrated strong association artistic occupations reduced risk pd instance one study indicated men engaged artistic professions later life significantly lower risk developing pd 255 protective effect thought related dopaminergic activity required creativity may better preserved individuals working artistic fields 255 case control study conducted japan found professional technical occupations inversely related risk pd particularly among men suggests careers requiring high levels cognitive engagement technical skills may hav e protective effect disease 256 interestingly certain farming activities linked lower risk pd study french farm managers revealed activities gardening landscaping reforestation small animal farming horse related tasks eg training dressag e riding associated reduced pd risk 257 finding particularly notable given farming typically associated increased pd risk due pesticide exposure occupations involve physical activity cognitive engagement may enhance neuroplasticity promote overall brain health activities thought reduce risk neurodegenerative diseases like pd maintaining robust neural networks fostering neuronal resilience physical activity key component many protective occupations also linked improved mitochondrial function reduced oxidative stress —both crucial maintaining neuronal health potentially slowing neurodegenerative processes additionally occupations involve regular physical activity cognitive stimulation may increase production neurotrophic factors brain derived neurotrophic factors bdnf support neuronal survival function production bdnf may provide protection pd occupational ctivities may also contribute reduction neuroinflammation key factor pd pathogenesis effect could mediated direct anti inflammatory effects physical activity indirect mechanisms involving occupational exposu res modulate inflammatory pathways furthermore occupations promoting physical activity may enhance autophagy cellular process crucial removing 41 damaged proteins organelles efficient autophagy particularly important preventing accumulation αsynuclein hallmark pd pathology table 1 4 overview mechanisms occupations potentially reducing risk pd factor key observations mechanisms references physical activity occupations jobs involving physical exertion eg engineering production construction metalworking reduce pd risk physical activity promotes neuroprotective benefits similar structured exercise improving mitochondrial function reducing oxidative stress enhancing neuroplasticity 254 artistic occupations engagement artistic professions eg visual arts music writing correlates lower pd risk artistic occupations may preserve dopaminergic activity creativity requires dopaminergic function offering neuroprotective effects sustained brain function 255 professionaltechnical occupations occupations requiring cognitive engagement technical skills eg engineering technical professions show inverse relationship pd risk high cognitive engagement may promote neuroplasticity maintaining neural networks brain health protects neurodegenerative diseases 256 farming activities certain farming activities eg gardening landscaping horse related tasks linked reduced pd risk physical activity farming along cognitive engagement may support neuronal resilience reduce neuroinflammation promote neurotrophic factor production like bdnf supports neuronal survival 257 45 therapeutic implications state gut microbiota significantly influences pd progression maintaining chronic inflammation facilitating spread misfolded proteins gut brain emerging therapeutic strategies targeting gut dysbiosis aim restore microbiota balance potentially slow pd pro gression strategies include probiotics dietary interventions shown promise preclinical studies 147 149 5 challenges solutions identifying risk protective factors pd identifying risk protective factors pd complex task due multifactorial nature disease intricate interplay genetic environmental behavioral factors pd influenced combination genetic predisposition environmental exposures lifestyle 42 behaviors 257 genome wide association studies gwas identified 200 genes associated pd 19 however genetic landscape complicated rare variants difficult replicate across studies due low frequency 258 additionally interactions genetic factors environmental exposures pesticides industrial chemicals remain poorly understood making challenging identify common molecular pathways therapeutic targets 259 pd heterogeneous disorder multiple subtypes potentially governed distinct molecular mechanisms 259 heterogeneity complicates identification universal risk protective factors findings relevant one subtype may apply others variability disease progression shaped genetic diversity environmental influences underscor es need personalized research approaches consideration population specific genetic architectures 26 several methodological challenges hinder progress identifying risk protective factors pd cross sectional studies commonly used pd research fail capture temporal relationships exposures disease onset longitudinal tudies informative resource intensive less frequently conducted 260 confounding factors lifestyle differences regional variations environmental exposures genetic predispositions obscure true associations common 261 many studies also face issues like recall bias case control designs difficulties establishing causality observational research furthermore inconsistencies across studies —stemming variations study design sample size methodolog ies—impede development clear preventive guidelines example studies identified smoking coffee consumption protective factors others observed significant associations 261 recent advancements research methodologies offer promising avenues understanding pd etiology techniques polygenic risk scores epigenetic analyses mendelian randomization mr provide new opportunities explore genetic environmen tal interactions 259 however approaches require validation standardization ensure broad applicability lack comprehensive data integrating genetic environmental lifestyle factors limits holistic understanding pd risk 261 address challenges standardizing research methodologies essential implementing uniform protocols data collection clinical assessments environmental 43 exposure reporting reduce inconsistencies across studies 262 multi omics approaches integrate genomics proteomics metabolomics artificial intelligence uncover patterns traditional methods might miss aiding identification biomarkers elucidating pd ’ molecular underpinnings advanced trial designs including adaptive trials studies targeting pre symptomatic stages improve understanding risk factors protective measures significant neuronal damage occurs incorporating digital tools telehealth research provide continuous monitoring overcome limitations associated traditional clinical endpoints 260 large scale collaborative initiatives critical overcoming data fragmentation leveraging diverse expertise establishing centers excellence focusing complex disease genetics eg university helsinki fostering inter national collaborations accelerate data sharing discovery 262 emerging technologies including next generation sequencing ngs medical digital twins blockchain based data management systems offer promising pathways enhance data integration ensure privacy enable personalized research strategies addressing challenges embracing innovative solutions field progress towards comprehensive understanding pd ’ etiology ultimately enabling effective prevention therapeutic interventions table 1 5 provides summary challenges proposed solutions identifying risk protective factors pd table 15 challenges proposed solutions identifying risk protective factors pd challenge details proposed solutions references complex interplay genetic environmental factors genetic predispositions interact environmental exposures complicating risk factor identification 200 genes implicated rare variants posing replication challenges integrate multi omics data genomics proteomics etc using ai uncover patterns identify specific biomarkers advanced techniques 26 257 259 heterogeneity pd pd encompasses multiple subtypes distinct molecular mechanisms variability progression complicates universal findings employ personalized approaches population specific studies account subtype specific variability genetic environmental influences 26 259 methodological challenges cross sectional designs fail capture temporal relationships confounding factors like lifestyle recall bias obscure results conduct longitudinal studies establish causality standardize protocols clinical assessments exposure reporting integrate digital tools telehealth continuous monitoring 260 261 44 inconsistencies across studies variations study designs sample sizes methodologies lead contradictory findings examples include mixed results smoking coffee protective factors standardize methodologies across studies use collaborative international frameworks uniformity research approaches data collection 261 evolving research methodologies advanced techniques like mendelian randomization polygenic risk scores require validation standardization validate emerging methods large scale studies develop global standards ensure applicability across populations 259 lack comprehensive data current studies focus isolated factors limiting holistic understanding create large scale collaborative initiatives centers excellence data integration leverage blockchain digital twins secure holistic personalized research 261 262 technological advancements new tools like next generation sequencing ngs digital twins offer potential need broader adoption adopt ngs genetic analysis medical digital twins personalized simulation 262 use blockchain secure data management sharing 6 raising awareness pd raising awareness pd crucial understanding mechanisms risk factors factors influencing onset progression healthcare providers staying informed pd helps better managing risk factors like genetics age environmental influences high lighting preventive measures regular physical activity balanced nutrition early detection essential reduce risks improve patient outcomes raising awareness among professionals patients lead effective management strategies ultimately enhancing quality life minimizing impact disease table 16 outlines recommendations prevention management parkinsons disease addressing healthy individuals individuals diagnosed pd healthcare systems demographic genetic factors • age aging major risk factor pd especially among 60 regular screenings eg cognitive assessments dopamine transporter scans neurodegenerative markers crucial early detection healthy individuals 60 consider preventive measures pd patients regul ar check ups monitor disease progression health systems prioritize neurodegenerative screenings older adults early intervention 45 • sex men higher risk pd public health campaigns target men focusing motor non motor symptoms healthy men engage regular screenings diagnosed pd need tailored care gender specific symptoms • race ethnicity certain racial ethnic groups higher pd risk targeted health programs screenings improve early diagnosis access treatments high risk populations participate community based screenings health systems implemen targeted interventions groups • family history genetics family history pd increases risk genetic counseling predictive testing eg lrrk2 mutations help monitor personalize preventive care genetic predisposed individuals might benefit targeted therapies like lrrk2 inhibitors health systems provide genetic counseling predictive testing risk families cognitive educational factors engaging intellectually stimulating activities eg reading learning new skills reduce risk pd progression support cognitive health pd patients incorporate cognitive therapies daily routines healthcare providers encourage lifelong cognitive engagement brain health focused educational programs environmental occupational risks • toxins exposure pesticides heavy metals industrial chemicals increases pd risk workers wear protective gear seek safer alternatives regular health check ups screenings vital exposed toxins health systems mandat e safety regulations offer regular screenings risk workers • air pollution living high pollution areas increases risk urban residents use air purifiers masks public health initiatives emphasize connection air pollution pd risk advocate cleaner air policies • socioeconomic disparities limited healthcare access increases pd risk underserved populations expanding preventive screenings improving access care communities essential health systems provide affordable screenings treatments underserved pop ulations 46 lifestyle health habits • nutrition diet diet rich antioxidants healthy fats anti inflammatory nutrients eg mediterranean diet supports brain health pd patients focus neuroprotective foods eg omega 3s vitamin e health systems encourage nutritional counse ling individuals risk pd patients • physical activity regular exercise especially aerobic activities balance enhancing exercises reduce pd risk pd patients follow personalized exercise plans manage symptoms health systems promote physical activity integrate physical therapy pd care • alcohol consumption excessive alcohol intake may contribute neurotoxicity healthy individuals limit alcohol intake protect brain health pd patients monitor alcohol consumption avoid interactions medications health systems promote health drinking habits provide resources alcohol reduction • body weight metabolic health maintaining healthy weight diet exercise reduces risk neurodegeneration pd patients monitor bmi metabolic health prevent disease progression health systems prioritize metabolic health screening risk indi viduals pd patients metabolic systemic health conditions • diabetes hypertension managing blood sugar blood pressure reduce pd risk pd patients closely monitor conditions may exacerbate neurological decline healthcare providers emphasize managing diabetes hypertension pd care • cholesterol triglycerides maintaining balanced lipid levels diet medications reduce inflammation protect brain health pd patients monitor lipid levels regularly health systems incorporate lipid screenings pd management preventive care • metabolic syndrome addressing metabolic syndrome weight management healthy lifestyle reduces neurodegenerative risks pd patients focus improving diet weight management reduce systemic inflammation health systems offer metabolic screenin gs risk populations inflammatory immune related factors 47 • neuroinflammation chronic diseases anti inflammatory treatments eg nsaids curcumin may help mitigate pd related inflammation managing chronic inflammatory diseases eg arthritis support neurological health vaccinations also reduce infection risk pd patients con sider anti inflammatory treatments manage chronic conditions health systems integrate care chronic inflammatory diseases promote vaccination programs neurological psychological factors • traumatic brain injury tbi high risk occupations enforce safety measures eg helmet use concussion monitoring provide annual neurocognitive assessments • sleep disorders screening sleep disturbances eg rem sleep behavior disorder important linked increased pd risk treatment options like melatonin cpap therapy improve sleep quality • loss smell anosmia anosmia early symptom pd routine smell tests neurological assessments help detect high risk individuals • stress depression anxiety chronic stress mental health issues accelerate neurodegeneration psychological support eg cbt essential early intervention depression anxiety improve quality life may slow pd progression gutbrain axis microbiome health maintaining gut health balanced diet prebiotics probiotics essential pd patients work healthcare providers monitor gut health explore probiotic therapies health systems facilitate collaboration neur ologists gastroenterologists explore gut brain connections pd care hormonal factors health conditions • estrogen neuroprotection postmenopausal women may benefit hormone replacement therapy hrt neuroprotection regular hormonal evaluations guide treatment • uric acid levels managing uric acid levels diet hydration may help lower neurodegenerative risks pd patients monitor uric acid levels reduce 48 neurodegeneration health systems offer regular evaluations hrt monitor uric acid levels pd patients medications emerging treatments • neuroprotective drug strategies emerging treatments like glp 1 receptor agonists may reduce pd risk healthy individuals risk discuss treatments healthcare providers pd patients explore drugs monitor long term medication effects health systems sh ould support research neuroprotective drugs monitor longterm medication effects pd care table 1 6 pd prevention management recommendations factor recommendation healthy people recommendation pd patients health system consideration age regular screenings neurodegenerative markers cognitive assessments regular check ups monitor disease progression adjust treatment prioritize neurodegenerative screenings older adults sex engage regular screening focus motor non motor symptoms tailored care gender specific risks targeted health campaigns focusing men early diagnosis race ethnicity participate community based health programs screenings targeted interventions early diagnosis treatment access implement targeted screenings highrisk racial ethnic groups family history genetics consider genetic counseling predictive testing eg lrrk2 explore targeted therapies genetically predisposed individuals offer genetic counseling predictive testing families pd history cognitive educational factors engage mentally stimulating activities eg reading memory exercises incorporate cognitive therapies brain training exercises encourage educational programs cognitive activities brain health exposure toxins use protective gear high risk occupations reduce toxin exposure regular consultations monitor toxin exposure neurological health advocate safer pesticide use enforce safety regulations industries air pollution use air purifiers masks high pollution areas focus reducing exposure air pollutants promote clean air policies raise awareness air pollution risks socioeconomic disparities seek affordable preventive screenings expand access healthcare underserved communities offer subsidized screenings care underserved areas nutrition diet adopt diet rich antioxidants healthy fats anti inflammatory foods follow specialized diet omega 3s antioxidants vitamin e encourage nutritional counseling risk pd patients physical activity engage aerobic balance enhancing exercises regular physical therapy exercise regimens manage motor symptoms promote physical activity integrate therapy pd management plans alcohol consumption limit excessive alcohol intake consult healthcare providers monitor alcohol use interactions educate risks excessive alcohol intake offer reduction resources 49 body weight metabolic health maintain healthy weight diet exercise monitor bmi metabolic health manage obesity related risks regular metabolic health bmi screenings part preventive care diabetes hypertension maintain blood sugar levels blood pressure manage blood pressure glucose levels support neurological function emphasize managing diabetes hypertension pd prevention care cholesterol triglycerides manage lipid levels diet medications ensure cholesterol triglyceride levels check support brain health regular lipid screenings part pd management metabolic syndrome address weight management healthier lifestyle choices manage weight diet reduce inflammation support brain health provide metabolic screenings counseling risk neuroinflammation chronic diseases anti inflammatory treatments consider incorporating anti inflammatory foods eg curcumin flavonoids diet reduce inflammation anti inflammatory treatments pd patients could benefit anti inflammatory medications eg nsaids dietary supplements help manage pdrelated inflammation promote research anti inflammatory treatments provide guidance inflammation management pd patients chronic inflammatory diseases autoimmune conditions manage chronic inflammatory diseases like arthritis early prevent complications may contribute neurodegeneration manage autoimmune conditions appropriate treatments reduce inflammation minimize impact neurological health provide integrated care neurologists specialists autoimmune diseases ensure better management pd related inflammation preventive vaccinations get regular vaccinations eg flu shots prevent infections may increase risk neurodegeneration preventive vaccinations antiviral therapies may reduce risk infections exacerbate pd symptoms ensure access vaccines antiviral treatments pd patients reduce likelihood infection induced complications traumatic brain injury tbi follow safety measures highrisk occupations eg wearing helmets contact sports construction monitor history traumatic brain injury may accelerate neurodegeneration pd patients implement policies mandatory concussion screening neurocognitive assessments individuals high risk occupations sleep disorders prioritize good sleep hygiene seek medical advice sleep disturbances screen sleep disorders like rem sleep behavior disorder use treatments like melatonin cpap therapy improve sleep quality incorporate sleep disorder screenings routine neurological assessments healthy individuals risk pd patients loss smell anosmia stay aware early signs anosmia seek medical consultation symptoms develop use routine smell tests neurological assessments detect high risk individuals diagnose early pd offer routine smell tests part early pd detection especially individuals risk developing pd stress depression anxiety manage chronic stress lifestyle changes including exercise mindfulness practices engage psychological support like cognitive behavioral therapy cbt consider medications eg ssris manage depression anxiety integrate mental health support services pd care emphasize early interventions stress depression healthy individuals pd patients gutbrain axis microbiome health maintain healthy gut consuming diet rich prebiotics probiotics fiber support brain health work neurologists gastroenterologists identify gut dysbiosis early incorporate gut health promote interdisciplinary collaboration neurologists gastroenterologists monitor 50 therapies probiotics dietary changes manage gut brain connection pd patients estrogen neuroprotection postmenopausal women consult healthcare providers potential benefits hormone replacement therapy hrt postmenopausal women pd may benefit hrt neuroprotection discuss option healthcare providers offer regular hormonal evaluations consider hrt postmenopausal women risk diagnosed pd support brain health uric acid levels maintain healthy uric acid levels dietary modifications eg reducing purine rich foods clinicians monitor uric acid levels pd patients consider medication levels elevated reduce neurodegenerative risks regularly monitor uric acid levels risk individuals pd patients part preventive care neuroprotective drug strategies consider discussing emerging treatments glp 1 receptor agonists healthcare provider high risk pd pd patients emerging drugs like glp 1 receptor agonists β2 adrenoceptor antagonists could considered part treatment plan encourage research new neuroprotective drug therapies integrate emerging treatments clinical practice pd prevention management long term drug use aware potential neurological effects long term drug use discuss concerns healthcare providers monitor neurological effects long term medications consider safer alternatives necessary provide regular assessments longterm effects medications offer alternative therapies available 7 conclusion paper provided comprehensive overview key risk prevalent factors highlight considerable heterogeneity complexity underlying neuropathogenesis pd likely multiple factors varying degrees risk intera ct within genetically predisposed individuals critical stages neurodegeneration ultimately leading clinical manifestation pd risk prevalent factor discussed molecular mechanisms involved may help identif interactive effects multiple risk factors simultaneously additionally explored evolving understanding risk prevalence factors pd acknowledging complex neurological disorder new risk factors — particularly related genetics —are likely uncovered future furthermore highlighted several protective factors may mitigate development pd slow progression physical activity factors warrant increased attention individ uals 51 health systems alike raise awareness improve public health initiatives within communities competing interests competing interests declared author references 1 j lees j hardy revesz parkinsons disease lancet vol 373 9680 pp 2055 2066 2009 2 huang et al risk factors associated age onset parkinson ’ disease uk biobank npj parkinsons disease vol 10 1 p 3 2024 3 n pankratz foroud genetics parkinson disease genetics medicine vol 9 12 pp 801 811 2007 4 ascherio schwarzschild epidemiology parkinsons disease risk factors prevention lancet neurology vol 15 12 pp 1257 1272 2016 5 reeve e simcox turnbull ageing parkinsons disease advancing age biggest risk factor ageing research reviews vol 14 pp 19 30 2014 6 tsalenchuk gentleman j marzi linking environmental risk factors epigenetic mechanisms parkinson ’ disease npj parkinsons disease vol 9 1 p 123 2023 7 c gabbert et al lifestyle factors clinical severity parkinson ’ disease scientific reports vol 13 1 p 9537 2023 8 l wu et al effects dietary supplements foods dietary patterns parkinson ’ disease meta analysis systematic review randomized crossover studies european journal clinical nutrition pp 1 11 2024 9 lc shih r j lin l chen c fu unravelling mechanisms underweight parkinson ’ disease investigating role gut microbiome npj parkinsons disease vol 10 1 p 28 2024 10 kwon et al diet gut microbiome patients parkinson ’ disease npj parkinsons disease vol 10 1 p 89 2024 11 peña díaz j garcía pardo ventura development small molecules targeting α synuclein aggregation promising strategy treat parkinsons disease eng pharmaceutics vol 15 3 mar 3 2023 doi 103390pharmaceutics15030839 12 p calabresi mechelli g natale l volpicelli daley g di lazzaro v ghiglieri alpha synuclein parkinsons disease synucleinopathies overt neurodegeneration back early synaptic dysfunction eng cell death dis vol 14 3 p 176 mar 1 2023 doi 101038s41419 02305672 9 52 13 p calabresi g di lazzaro g marino f campanelli v ghiglieri advances understanding function alpha synuclein implications parkinsons disease eng brain vol 146 9 pp 3587 3597 sep 1 2023 doi 101093brainawad150 14 j lee et al targeted degradation ⍺synuclein aggregates parkinsons disease using autotac technology eng mol neurodegener vol 18 1 p 41 jun 24 2023 doi 101186s13024 02300630 7 15 henrich w h oertel j surmeier f f geibl mitochondrial dysfunction parkinsons disease key disease hallmark therapeutic potential eng mol neurodegener vol 18 1 p 83 nov 11 2023 doi 101186s13024 02300676 7 16 j l eriksen z wszolek l petrucelli molecular pathogenesis parkinson disease archives neurology vol 62 3 pp 353 357 2005 17 k xu et al neuroinflammation parkinsons disease focus relationship mirnas microglia eng front cell neurosci vol 18 p 1429977 2024 doi 103389fncel20241429977 18 buchman et al nigral pathology parkinsonian signs elders without parkinson disease annals neurology vol 71 2 pp 258 266 2012 19 friedman j galazka‐friedman e r bauminger iron trigger neurodegeneration parkinsons disease handbook clinical neurology vol 83 pp 493505 2007 20 c rubinsztein g mariño g kroemer autophagy aging cell vol 146 5 pp 682 695 2011 21 k van den eeden et al incidence parkinson ’ disease variation age gender raceethnicity american journal epidemiology vol 157 11 pp 1015 1022 2003 22 k nordengen et al pleiotropy sex specific traits reveals genetic aspects sex differences parkinsons disease eng brain vol 147 3 pp 858 870 mar 1 2024 doi 101093brainawad297 23 cerri l mus f blandini parkinsons disease women men whats difference eng j parkinsons dis vol 9 3 pp 501 515 2019 doi 103233jpd 191683 24 wright willis b evanoff lian r criswell b racette geographic ethnic variation parkinson disease population based study us medicare beneficiaries neuroepidemiology vol 34 3 pp 143 151 2010 25 harris n narayanan tranel black vs white race affect practitioners appraisal parkinsons disease eng npj parkinsons dis vol 9 1 p 106 jul 7 2023 doi 101038s41531 02300549 2 26 funayama k nishioka li n hattori molecular genetics parkinsons disease contributions global trends eng j hum genet vol 68 3 pp 125 130 mar 2023 doi 101038s10038 02201058 5 27 k j benjamin et al analysis gene expression postmortem brain neurotypical black americans reveals contributions genetic ancestry eng nat neurosci vol 27 6 pp 1064 1074 jun 2024 doi 101038s41593 02401636 0 28 c lim et al quantification raceethnicity representation alzheimers disease neuroimaging research usa systematic review eng commun med lond vol 3 1 p 101 jul 25 2023 doi 101038s43856 02300333 6 53 29 h payami g cohen c f murchison r sampson g standaert z wallen population fraction parkinson disease attributable preventable risk factors npj parkinsons disease p 202305 1923290231 2023 30 n sellbach r boyle p silburn g mellick parkinsons disease family history parkinsonism related disorders vol 12 7 pp 399 409 2006 31 gokuladhas fadason farrow cooper j ’ sullivan discovering genetic mechanisms underlying co occurrence parkinson ’ disease non motor traits npj parkinsons disease vol 10 1 p 27 2024 32 j tran h anastacio c bardy genetic predispositions parkinson ’ disease revealed patient derived brain cells npj parkinsons disease vol 6 1 p 8 2020 33 buniello et al nhgri ebi gwas catalog published genome wide association studies targeted arrays summary statistics 2019 nucleic acids research vol 47 d1 pp d1005 d1012 2019 34 h diaw et al characterization pathogenic α synuclein variant v15a parkinson´ disease npj parkinsons disease vol 9 1 p 148 2023 35 zimprich et al mutations lrrk2 cause autosomal dominant parkinsonism pleomorphic pathology neuron vol 44 4 pp 601 607 2004 36 russo l bubacco e greggio lrrk2 neuroinflammation partners crime parkinson ’ disease journal neuroinflammation vol 11 pp 1 9 2014 37 nguyen krainc lrrk2 phosphorylation auxilin mediates synaptic defects dopaminergic neurons patients parkinson ’ disease proceedings national academy sciences vol 115 21 pp 5576 5581 2018 38 c lovegrove genetic clinical phenotype lrrk2 associated familial pd nature clinical practice neurology vol 2 3 pp 125 125 2006 39 ysselstein et al lrrk2 kinase activity regulates lysosomal glucocerebrosidase neurons derived parkinson ’ disease patients nature communications vol 10 1 p 5570 2019 40 l streubel gallasch et al parkinson ’ disease –associated lrrk2 interferes astrocyte mediated alpha synuclein clearance molecular neurobiology vol 58 pp 3119 3140 2021 41 g ’ regan r desouza r balestrino h schapira glucocerebrosidase mutations parkinson disease journal parkinsons disease vol 7 3 pp 411 422 2017 42 v bonifati et al mutations dj 1 gene associated autosomal recessive early onset parkinsonism science vol 299 5604 pp 256 259 2003 43 f lind holm mogensen scafidi poli michelucci park7dj 1 microglia implications parkinson ’ disease relevance therapeutic target journal neuroinflammation vol 20 1 pp 1 19 2023 44 j kochmanski n c kuhn bernstein parkinson ’ disease associated sex specific changes dna methylation park7 dj 1 slc17a6 vglut2 ptprn2 ia2β nr4a2 nurr1 cortical neurons npj parkinsons disease vol 8 1 p 120 2022 45 vizziello l borellini g franco g ardolino disruption mitochondrial homeostasis role pink1 parkinson ’ disease cells vol 10 11 p 3022 2021 54 46 n jones pink1 targets dysfunctional mitochondria autophagy parkinson disease nature reviews neurology vol 6 4 pp 181 181 2010 47 e valente et al hereditary early onset parkinsons disease caused mutations pink1 science vol 304 5674 pp 1158 1160 2004 48 j brown et al pink1 deficiency impairs adult neurogenesis dopaminergic neurons scientific reports vol 11 1 p 6617 2021 49 r tufi et al enhancing nucleotide metabolism protects mitochondrial dysfunction neurodegeneration pink1 model parkinson ’ disease nature cell biology vol 16 2 pp 157 166 2014 50 kano et al reduced astrocytic reactivity human brains midbrain organoids prkn mutations npj parkinsons disease vol 6 1 p 33 2020 51 oczkowska w kozubski lianeri j dorszewska mutations prkn snca genes important progress parkinson ’ disease current genomics vol 14 8 pp 502 517 2013 52 p castelo rueda et al molecular phenotypes mitochondrial dysfunction clinically non manifesting heterozygous prkn variant carriers npj parkinsons disease vol 9 1 p 65 2023 53 kasten et al genotype‐phenotype relations parkinsons disease genes parkin pink1 dj1 mdsgene systematic review movement disorders vol 33 5 pp 730741 2018 54 c zhou et al progressive brain atrophy parkinsons disease patients convert mild cognitive impairment cns neuroscience therapeutics vol 26 1 pp 117 125 2020 55 p youssef et al evaluation plasma levels nfl gfap uchl1 tau parkinsons disease biomarkers using multiplexed single molecule counting scientific reports vol 13 1 p 5217 2023 56 ragland c hutter c zabetian k edwards association ubiquitin carboxyl terminal esterase l1 gene uchl1 s18y variant parkinsons disease huge review meta analysis american journal epidemiology vol 170 11 pp 1344 1357 2009 57 mondello r constantinescu h zetterberg u andreasson b holmberg jeromin csf α synuclein uch l1 levels parkinsons disease atypical parkinsonian disorders parkinsonism related disorders vol 20 4 pp 382 387 2014 58 l ng et al plasma ubiquitin c terminal hydrolase l1 levels reflect disease stage motor severity parkinson ’ disease aging albany ny vol 12 2 p 1488 2020 59 g yahalom et al carriers gba lrrk2 mutations compared carriers either parkinsons disease risk estimates genotype phenotype correlations parkinsonism related disorders vol 62 pp 179 184 2019 60 c p da silva et al clinical profiles associated lrrk2 gba mutations brazilians parkinsons disease journal neurological sciences vol 381 pp 160164 2017 61 r cilia et al survival dementia gba‐associated parkinsons disease mutation matters annals neurology vol 80 5 pp 662 673 2016 55 62 g liu et al prediction cognition parkinsons disease clinical –genetic score longitudinal analysis nine cohorts lancet neurology vol 16 8 pp 620 629 2017 63 r frigerio et al education occupations preceding parkinson disease population based case control study neurology vol 65 10 pp 1575 1583 2005 64 c fardell k torén l schiöler h nissbrandt åberg high iq early adulthood associated parkinson ’ disease journal parkinsons disease vol 10 4 pp 1649 1656 2020 65 j shi et al intelligence education level risk parkinson ’ disease european populations mendelian randomization study frontiers genetics vol 13 p 963163 2022 66 lara h amigo association education blood lipid levels income increases decade cohort study bmc public health vol 18 pp 1 8 2018 67 lv b xu x zhang c chen gao n li association serum cholesterol parkinsons disease cohort statin‐free individuals brain behavior vol 12 1 p e2454 2022 68 p garcía‐sanz j mfg aerts r moratalla role cholesterol α‐synuclein lewy body pathology gba1 parkinsons disease movement disorders vol 36 5 pp 1070 1085 2021 69 k pärna l pürjer ringmets tekkel educational differences cigarette smoking among adult population estonia 1990 –2010 trend fit model tobacco epidemic bmc public health vol 14 1 pp 1 8 2014 70 k modig k silventoinen p tynelius j kaprio f rasmussen genetics association intelligence nicotine dependence study male swedish twins addiction vol 106 5 pp 995 1002 2011 71 r frigerio et al education occupations preceding parkinson disease population based case control study eng neurology vol 65 10 pp 1575 83 nov 22 2005 doi 10121201wnl000018452021744a2 72 cohen e vakil tanne z nitsan r schwartz hassin baer educational level modulator cognitive performance neuropsychyatric features parkinson disease eng cogn behav neurol vol 20 1 pp 68 72 mar 2007 doi 101097wnn0b013e3180335f8e 73 pl gamache h salem n roux dubois j le bouthillier z gan n dupré exposure pesticides welding hastens age atonset parkinson ’ disease canadian journal neurological sciences vol 46 6 pp 711 716 2019 74 caballero amiri j denney p monsivais p hystad amram estimated residential exposure agricultural chemicals premature mortality parkinson ’ disease washington state international journal environmental research public health vol 15 12 p 2885 2018 75 nalls et al identification novel risk loci causal insights heritable risk parkinsons disease meta analysis genome wide association studies eng lancet neurol vol 18 12 pp 1091 1102 dec 2019 doi 101016s1474 44221930320 5 76 x zeng n l debono harris v h arrandale p demers neurodegenerative diseases among miners ontario canada using linked cohort occupational environmental medicine 2020 56 77 v n uversky j li l fink metal triggered structural transformations aggregation fibrillation human alpha synuclein possible molecular nk parkinsons disease heavy metal exposure eng j biol chem vol 276 47 pp 44284 96 nov 23 2001 doi 101074jbcm105343200 78 pyatha h kim lee k kim association heavy metal exposure parkinsons disease review mechanisms related oxidative stress eng antioxidants basel vol 11 12 dec 15 2022 doi 103390antiox11122467 79 l shvachiy v geraldes f outeiro uncovering molecular link lead toxicity parkinsons disease eng antioxid redox signal vol 39 4 6 pp 321 335 aug 2023 doi 101089ars20220076 80 l j forero rodríguez j josephs spaulding flor pinzón c kaleta parkinsons disease metal microbiome gutbrain axis systems toxicology approach eng antioxidants basel vol 11 1 dec 28 2021 doi 103390antiox11010071 81 goldman et al solvent exposures parkinson disease risk twins annals neurology vol 71 6 pp 776 784 2012 82 jo et al association no2 air pollution exposures risk parkinson disease jama neurology vol 78 7 pp 800 808 2021 83 jami h murata l barnhill li j bronstein diesel exhaust exposure alters expression networks implicated neurodegeneration zebrafish brains eng cell biol toxicol vol 39 3 pp 641 655 jun 2023 doi 101007s10565 02109618 9 84 h murata l barnhill j bronstein air pollution risk parkinsons disease review eng mov disord vol 37 5 pp 894 904 may 2022 doi 101002mds28922 85 r stern riley h daneshvar c j nowinski r c cantu c mckee long term consequences repetitive brain trauma chronic traumatic encephalopathy pmr vol 3 10 pp s460 s467 2011 86 p whitton inflammation causative factor aetiology parkinsons disease british journal pharmacology vol 150 8 pp 963 976 2007 87 c b breckenridge c berry e chang r l sielken jr j mandel association parkinson ’ disease cigarette smoking rural living well water consumption farming pesticide use systematic review meta analysis plos one vol 11 4 p e0151841 2016 88 j timpka et al reduced workforce participation 5 years prior first parkinson ’ disease sick leave npj parkinsons disease vol 4 1 p 36 2018 89 lan j chen z chai hu neurotoxicity iron copper cobalt parkinson ’ disease ros mediated mechanisms biometals vol 29 pp 665 678 2016 90 j park et al occupations parkinson ’ disease multi center case control study south korea neurotoxicology vol 26 1 pp 99 105 2005 91 j k tsui b calne wang schulzer marion occupational risk factors parkinson ’ disease canadian journal public health vol 90 pp 334 337 1999 57 92 chang et al meta analysis genome wide association studies identifies 17 new parkinsons disease risk loci eng nat genet vol 49 10 pp 1511 1516 oct 2017 doi 101038ng3955 93 h j bruce et al american football play parkinson disease among men jama network open vol 6 8 pp e2328644 e2328644 2023 94 f yang l v johansson n l pedersen f fang gatz k wirdefeldt socioeconomic status relation parkinsons disease risk mortality population based prospective study eng medicine baltimore vol 95 30 p e4337 jul 2016 doi 101097md0000000000004337 95 l lix e hobson azimaee w leslie c burchill hobson socioeconomic variations prevalence incidence parkinsons disease population based analysis eng j epidemiol community health vol 64 4 pp 33540 apr 2010 doi 101136jech2008084954 96 ascherio schwarzschild lifestyle parkinsons disease progression eng mov disord vol 34 1 pp 7 8 jan 2019 doi 101002mds27566 97 e roos et al body mass index sitting time risk parkinson disease neurology vol 90 16 pp e1413 e1417 2018 98 g hu p jousilahti nissinen r antikainen kivipelto j tuomilehto body mass index risk parkinson disease neurology vol 67 11 pp 1955 1959 2006 99 ky park g e nam k han h k park h hwang waist circumference risk parkinson ’ disease npj parkinsons disease vol 8 1 p 89 2022 100 g hu p jousilahti nissinen r antikainen kivipelto j tuomilehto body mass index risk parkinson disease eng neurology vol 67 11 pp 1955 9 dec 12 2006 doi 10121201wnl000024705218422e5 101 k cumming macleod p k myint c e counsell early weight loss parkinsonism predicts poor outcomes evidence incident cohort study neurology vol 89 22 pp 2254 2261 2017 102 peters et al alcohol consumption risk parkinsons disease data large prospective european cohort movement disorders vol 35 7 pp 1258 1263 2020 103 c shao x wang p wang h tang j n wu parkinsons disease risk alcohol intake systematic review dose response meta analysis prospective studies frontiers nutrition vol 8 p 709846 2021 104 f j jiménez jiménez h alonso navarro e garcía martín j agúndez alcohol consumption risk parkinson ’ disease systematic review meta analysis journal neurology vol 266 8 pp 1821 1834 2019 105 r kelsey lifestyle factors progression pd nature reviews neurology vol 15 3 pp 126 126 2019 106 r daviet et al associations alcohol consumption gray white matter volumes uk biobank nature communications vol 13 1 p 1175 2022 107 c domenighetti et al dairy intake parkinsons disease mendelian randomization study movement disorders vol 37 4 pp 857 864 2022 108 k c hughes et al intake dairy foods risk parkinson disease neurology vol 89 1 pp 46 52 2017 109 h chen et al consumption dairy products risk parkinsons disease american journal epidemiology vol 165 9 pp 998 1006 2007 58 110 r abbott et al midlife milk consumption substantia nigra neuron density death neurology vol 86 6 pp 512 519 2016 111 torti et al effect family history occupation diet risk parkinson disease case control study plos one vol 15 12 p e0243612 2020 112 k w lange et al diet medical foods parkinson ’ disease food science human wellness vol 8 2 pp 83 95 2019 113 khan j ezeugwa v e ezeugwu systematic review associations sedentary behavior physical inactivity non motor symptoms parkinsons disease eng plos one vol 19 3 p e0293382 2024 doi 101371journalpone0293382 114 h chohan et al type 2 diabetes determinant parkinsons disease risk progression movement disorders vol 36 6 pp 1420 1429 2021 115 e de pablo fernandez r goldacre j pakpoor j noyce warner association diabetes subsequent parkinson disease record linkage cohort study neurology vol 91 2 pp e139 e142 2018 116 h yu et al association parkinson ’ disease diabetes mellitus epidemiology pathophysiology prevention treatment aging disease vol 13 6 p 1591 2022 117 g pagano et al diabetes mellitus parkinson disease neurology vol 90 19 pp e1654 e1662 2018 118 r ou et al effect diabetes control status progression parkinson ’ disease prospective study annals clinical translational neurology vol 8 4 pp 887897 2021 119 b mollenhauer et al baseline predictors progression 4 years parkinsons disease diagnosis de novo parkinson cohort denopa movement disorders vol 34 1 pp 67 77 2019 120 e cereda barichella e cassani r caccialanza g pezzoli clinical features parkinson disease onset diabetes came first case control study neurology vol 78 19 pp 1507 1511 2012 121 f camargo maluf feder alves de siqueira carvalho analysis relationship type ii diabetes mellitus parkinson ’ disease systematic review parkinson ’ disease vol 2019 2019 122 athauda et al impact type 2 diabetes parkinsons disease movement disorders vol 37 8 pp 1612 1623 2022 123 k han b kim h lee k kim nationwide cohort study diabetes severity risk parkinson disease npj parkinsons disease vol 9 1 p 11 2023 124 greenberg et al cerebral microbleeds guide detection interpretation eng lancet neurol vol 8 2 pp 165 74 feb 2009 doi 101016s1474 44220970013 4 125 viswanathan r salman steven warach j lenore cerebral microbleeds field guide detection interpretation lancet neurol vol 8 2 pp 165 174 2009 126 lemprière white matter hyperintensities —location matters nature reviews neurology vol 19 3 pp 129 129 2023 59 127 c dufouil et al longitudinal study blood pressure white matter hyperintensities eva mri cohort neurology vol 56 7 pp 921 926 2001 128 k yang et al white matter changes parkinson ’ disease npj parkinsons disease vol 9 1 p 150 2023 129 macías garcía et al serum lipid profile among sporadic familial forms parkinson ’ disease npj parkinsons disease vol 7 1 p 59 2021 130 l de lau p j koudstaal hofman breteler serum cholesterol levels risk parkinsons disease american journal epidemiology vol 164 10 pp 998 1002 2006 131 f fang et al lipids apolipoproteins risk parkinson disease prospective cohort study mendelian randomization analysis circulation research vol 125 6 pp 643 652 2019 132 r paul choudhury borah cholesterol –a putative endogenous contributor towards parkinsons disease neurochemistry international vol 90 pp 125 133 2015 133 x huang et al serum cholesterol progression parkinsons disease results datatop plos one vol 6 8 p e22854 2011 134 k hurh park jang e c park jang association serum lipid levels time risk parkinson ’ disease scientific reports vol 12 1 p 21020 2022 135 jh park et al association high density lipoprotein cholesterol variability risk developing parkinson disease neurology vol 96 10 pp e1391 e1401 2021 136 benn b g nordestgaard r frikke schmidt tybjærg hansen low ldl cholesterol pcsk9 hmgcr genetic variation risk alzheimer ’ disease parkinson ’ disease mendelian randomisation study bmj vol 357 2017 137 g e nam et al metabolic syndrome risk parkinson disease nationwide cohort study plos medicine vol 15 8 p e1002640 2018 138 g hu r antikainen p jousilahti kivipelto j tuomilehto total cholesterol risk parkinson disease neurology vol 70 21 pp 1972 1979 2008 139 r j smeyne j noyce byrne r savica c marras infection risk parkinsons disease eng j parkinsons dis vol 11 1 pp 31 43 2021 doi 103233jpd 202279 140 anghelescu et al parkinsons disease sars cov 2 infection particularities molecular cellular mechanisms regarding pathogenesis treatment eng biomedicines vol 10 5 apr 26 2022 doi 103390biomedicines10051000 141 ding et al parkinsons disease causative mutation vps35 disturbs tetherin trafficking cell surfaces facilitates virus spread eng cells vol 10 4 mar 28 2021 doi 103390cells10040746 142 c conte possible link sars cov 2 infection parkinsons disease role toll like receptor 4 eng int j mol sci vol 22 13 jul 1 2021 doi 103390ijms22137135 143 w xu et al double stranded rna induced dopaminergic neuronal loss substantia nigra presence mac1 receptor eng biochem biophys res commun vol 533 4 pp 1148 1154 dec 17 2020 doi 101016jbbrc202009101 60 144 herrero c estrada l maatouk vyas inflammation parkinsons disease role glucocorticoids eng front neuroanat vol 9 p 32 2015 doi 103389fnana201500032 145 c marogianni sokratous e dardiotis g hadjigeorgiou bogdanos g xiromerisiou neurodegeneration inflammation interesting interplay parkinsons disease eng int j mol sci vol 21 22 nov 10 2020 doi 103390ijms21228421 146 rolli derkinderen l leclair visonneau bourreille e coron neunlist p derkinderen parkinsons disease chronic low grade inflammatory bowel disease eng j neurol vol 267 8 pp 2207 2213 aug 2020 doi 101007s00415 019 09321 0 147 h lee e lobbestael vermeire j sabino cleynen inflammatory bowel disease parkinsons disease common pathophysiological links eng gut vol 70 2 pp 408 417 feb 2021 doi 101136gutjnl 2020 322429 148 g xiromerisiou c marogianni androutsopoulou p ntavaroukas mysiris papoutsopoulou parkinsons disease takes guts correlation intestinal microbiome cytokine network neurodegeneration eng biology basel vol 12 1 jan 7 2023 doi 103390biology12010093 149 g chan k ventura villeneuve p du bois r holahan exploring connection gut microbiome parkinsons disease symptom progression pathology implications supplementary treatment options eng j parkinsons dis vol 12 8 pp 2339 2352 2022 doi 103233jpd 223461 150 v caputi c giron microbiome gutbrain axis toll like receptors parkinsons disease eng int j mol sci vol 19 6 jun 6 2018 doi 103390ijms19061689 151 mulak b bonaz brain gutmicrobiota axis parkinsons disease eng world j gastroenterol vol 21 37 pp 10609 20 oct 7 2015 doi 103748wjgv21i3710609 152 varesi et al interplay gut microbiota parkinsons disease implications diagnosis treatment eng int j mol sci vol 23 20 oct 14 2022 doi 103390ijms232012289 153 j disabato n quan j p godbout neuroinflammation devil details journal neurochemistry vol 139 pp 136 153 2016 154 c sartori e vance l z slater crowe impact inflammation cognitive function older adults implications health care practice research journal neuroscience nursing vol 44 4 p 206 2012 155 g tansey r l wallings c houser k herrick c e keating v joers inflammation immune dysfunction parkinson disease nature reviews immunology vol 22 11 pp 657 673 2022 156 h e allen reish g standaert role α synuclein inducing innate adaptive immunity parkinson disease journal parkinsons disease vol 5 1 pp 1 19 2015 157 e klann et al gut brain axis relation parkinsons disease review eng front aging neurosci vol 13 p 782082 2021 doi 103389fnagi2021782082 61 158 v delic k beck k c h pang b citron biological links traumatic brain injury parkinsons disease eng acta neuropathol commun vol 8 1 p 45 apr 7 2020 doi 101186s40478 02000924 7 159 c wee arulsamy f corrigan l collins praino long term impact diffuse traumatic brain injury neuroinflammation catecholaminergic signaling potential relevance parkinsons disease risk eng molecules vol 29 7 mar 26 2024 doi 103390molecules29071470 160 p dodet et al sleep disorders parkinsons disease early multiple problem eng npj parkinsons dis vol 10 1 p 46 feb 29 2024 doi 101038s41531 02400642 0 161 g loddo et al treatment sleep disorders parkinsons disease research clinical practice eng front neurol vol 8 p 42 2017 doi 103389fneur201700042 162 tarakad j jankovic anosmia ageusia parkinsons disease eng int rev neurobiol vol 133 pp 541 556 2017 doi 101016bsirn201705028 163 r l doty olfaction parkinsons disease related disorders eng neurobiol dis vol 46 3 pp 527 52 jun 2012 doi 101016jnbd201110026 164 j k garlovsky p g overton j simpson psychological predictors anxiety depression parkinsons disease systematic review eng j clin psychol vol 72 10 pp 979 98 oct 2016 doi 101002jclp22308 165 hemmerle j p herman k b seroogy stress depression parkinsons disease eng exp neurol vol 233 1 pp 79 86 jan 2012 doi 101016jexpneurol201109035 166 sagna j j gallo g pontone systematic review factors associated depression anxiety disorders among older adults parkinsons disease eng parkinsonism relat disord vol 20 7 pp 708 15 jul 2014 doi 101016jparkreldis201403020 167 van der heide j meinders e speckens f peerbolte b r bloem r c helmich stress mindfulness parkinsons disease clinical effects potential underlying mechanisms eng mov disord vol 36 1 pp 64 70 jan 2021 doi 101002mds28345 168 k w austin w ameringer l j cloud integrated review psychological stress parkinsons disease biological mechanisms symptom health outcomes eng parkinsons dis vol 2016 p 9869712 2016 doi 10115520169869712 169 e k blundell l e grover j stott schrag experience anxiety people parkinson ’ disease npj parkinsons disease vol 9 1 p 75 2023 170 yoon c lee j h suh n yang k han w kim different risks early onset late onset parkinson disease individuals mental illness npj parkinsons disease vol 10 1 p 17 2024 171 g hou r tian j li f yuan chronic stress parkinsons disease eng cns neurosci ther vol 20 1 pp 1 2 jan 2014 doi 101111cns12209 172 j e yoo et al female reproductive factors risk parkinsons disease nationwide cohort study eng eur j epidemiol vol 35 9 pp 871 878 sep 2020 doi 101007s10654 02000672 x 62 173 r popat et al effect reproductive factors postmenopausal hormone use risk parkinson disease eng neurology vol 65 3 pp 383 90 aug 9 2005 doi 10121201wnl00001713448780294 174 p ragonese damelio g savettieri implications estrogens parkinsons disease epidemiological approach eng ann n acad sci vol 1089 pp 373 82 nov 2006 doi 101196annals1386004 175 j yuk h jeong association menopausal hormone therapy risk parkinsons disease eng j parkinsons dis vol 13 8 pp 1357 1367 2023 doi 103233jpd 230230 176 r saunders pullman j gordon elliott parides fahn h r saunders bressman effect estrogen replacement early parkinsons disease eng neurology vol 52 7 pp 1417 21 apr 22 1999 doi 101212wnl5271417 177 villa e vegeto poletti maggi estrogens neuroinflammation neurodegeneration eng endocr rev vol 37 4 pp 372 402 aug 2016 doi 101210er2016 1007 178 alrouji et al role uric acid neurodegenerative diseases focusing alzheimer parkinson disease new perspective eng neuropsychopharmacol rep vol 44 3 pp 639 649 sep 2024 doi 101002npr212445 179 v e bianchi l rizzi f somaa role nutrition parkinsons disease systematic review eng nutr neurosci vol 26 7 pp 605 628 jul 2023 doi 1010801028415x20222073107 180 h mertsalmi e pekkonen f scheperjans antibiotic exposure risk parkinsons disease finland nationwide case‐control study movement disorders vol 35 3 pp 431 442 2020 181 mittal et al β2 adrenoreceptor regulator α synuclein gene driving risk parkinson ’ disease science vol 357 6354 pp 891 898 2017 182 c l chen wang c chen c chuang association β2 adrenoreceptor medications risk parkinsons disease meta analysis eng medicina kaunas vol 57 10 sep 24 2021 doi 103390medicina57101006 183 j l cheong e de pablo fernandez foltynie j noyce association type 2 diabetes mellitus parkinsons disease eng j parkinsons dis vol 10 3 pp 775 789 2020 doi 103233jpd 191900 184 x qin et al association diabetes medications risk parkinsons disease systematic review meta analysis eng front neurol vol 12 p 678649 2021 doi 103389fneur2021678649 185 x dong chen c yong x yang chen yu p li hua signaling pathways parkinsons disease molecular mechanisms therapeutic interventions eng signal transduct target ther vol 8 1 p 73 feb 21 2023 doi 101038s41392 02301353 3 186 g pagano et al sustained effect prasinezumab parkinsons disease motor progression open label extension pasadena trial eng nat med vol 30 12 pp 3669 3675 dec 2024 doi 101038s41591 02403270 6 187 h beydoun et al psychotropic medication use parkinsons disease risk amongst older women eng ann clin transl neurol vol 9 8 pp 1163 1176 aug 2022 doi 101002acn351614 63 188 r k weersma zhernakova j fu interaction drugs gut microbiome eng gut vol 69 8 pp 1510 1519 aug 2020 doi 101136gutjnl 2019 320204 189 h song et al epigenetic modification parkinsons disease eng front cell dev biol vol 11 p 1123621 2023 doi 103389fcell20231123621 190 x fang et al association levels physical activity risk parkinson disease systematic review meta analysis jama network open vol 1 5 pp e182421 e182421 2018 191 b portugal et al association physical activity parkinson disease women longterm follow e3n cohort study neurology vol 101 4 pp e386 e398 2023 192 k c hughes x gao molsberry l valeri schwarzschild ascherio physical activity prodromal features parkinson disease neurology vol 93 23 pp e2157 e2169 2019 193 k tsukita h sakamaki tsukita r takahashi long term effect regular physical activity exercise habits patients early parkinson disease neurology vol 98 8 pp e859 e871 2022 194 speelman b p van de warrenburg van nimwegen g petzinger munneke b r bloem might physical activity benefit patients parkinson disease nature reviews neurology vol 7 9 pp 528 534 2011 195 morawska et al slow wave sleep affects synucleinopathy regulates proteostatic processes mouse models parkinsons disease eng sci transl med vol 13 623 p eabe7099 dec 8 2021 doi 101126scitranslmedabe7099 196 j hunt e j coulson r rajnarayanan h oster videnovic rawashdeh sleep circadian rhythms parkinsons disease preclinical models eng mol neurodegener vol 17 1 p 2 jan 9 2022 doi 101186s13024 02100504 w 197 c j mao et al association sleep characteristics likelihood prodromal parkinsons disease cross sectional analysis habit study eng nat sci sleep vol 16 pp 1355 1364 2024 doi 102147nsss476348 198 j simpson k haines g lekwuwa j wardle crawford social support psychological outcome people parkinsons disease evidence specific pattern associations eng br j clin psychol vol 45 pt 4 pp 585 90 nov 2006 doi 101348014466506x96490 199 j ravenek schneider social support physical activity perceptions control early parkinsons disease eng disabil rehabil vol 31 23 pp 1925 36 2009 doi 10108009638280902850261 200 j e ahlskog aerobic exercise evidence direct brain effect slow parkinson disease progression eng mayo clin proc vol 93 3 pp 360 372 mar 2018 doi 101016jmayocp201712015 201 jackson et al diet parkinsons disease critical role microbiome eng front neurol vol 10 p 1245 2019 doi 103389fneur201901245 202 aarsland et al parkinson disease associated cognitive impairment eng nat rev dis primers vol 7 1 p 47 jul 1 2021 doi 101038s41572 02100280 3 203 g halliday j b leverenz j schneider c h adler neurobiological basis cognitive impairment parkinsons disease eng mov disord vol 29 5 pp 634 50 apr 15 2014 doi 101002mds25857 64 204 g liu et al mitochondrial haplogroups cognitive progression parkinsons disease eng brain vol 146 1 pp 42 49 jan 5 2023 doi 101093brainawac327 205 g liu et al genome wide survival study identifies novel synaptic locus polygenic score cognitive progression parkinsons disease eng nat genet vol 53 6 pp 787 793 jun 2021 doi 101038s41588 02100847 6 206 e r wallace c segerstrom c g van horne f schmitt l koehl meta analysis cognition parkinsons disease mild cognitive impairment dementia progression eng neuropsychol rev vol 32 1 pp 149 160 mar 2022 doi 101007s11065 02109502 7 207 j jones et al physical activity mediator anxiety cognitive functioning parkinsons disease mental health physical activity vol 20 p 100382 2021 208 b mappin kasirer et al tobacco smoking risk parkinson disease 65 year follow 30000 male british doctors neurology vol 94 20 pp e2132 e2138 2020 209 b ritz l rhodes half century research smoking pd go neurology vol 74 11 pp 870 871 2010 210 wh piao campagnolo c dayao r j lukas j wu f shi nicotine inflammatory neurological disorders acta pharmacologica sinica vol 30 6 pp 715722 2009 211 dp hong l fink v n uversky smoking parkinsons disease nicotine affect α synuclein fibrillation biochimica et biophysica acta bba proteins proteomics vol 1794 2 pp 282 290 2009 212 yoon et al association smoking cause mortality parkinson ’ disease npj parkinsons disease vol 9 1 p 59 2023 213 lysen k l darweesh k ikram luik ikram sleep risk parkinsonism parkinsons disease population based study eng brain vol 142 7 pp 2013 2022 jul 1 2019 doi 101093brainawz113 214 c gabbert et al coffee smoking aspirin associated age onset idiopathic parkinson ’ disease journal neurology vol 269 8 pp 4195 4203 2022 215 k sääksjärvi p knekt h rissanen laaksonen reunanen männistö prospective study coffee consumption risk parkinsons disease european journal clinical nutrition vol 62 7 pp 908 915 2008 216 k wirdefeldt h adami p cole trichopoulos j mandel epidemiology etiology parkinson ’ disease review evidence european journal epidemiology vol 26 pp 1 58 2011 217 c hong l chan c h bai effect caffeine risk progression parkinson ’ disease meta analysis nutrients vol 12 6 p 1860 2020 218 bh cho choi j kim b c kim association coffee consumption non motor symptoms drug naïve early stage parkinsons disease parkinsonism related disorders vol 50 pp 42 47 2018 219 bh cho choi b c kim gender dependent effect coffee consumption tremor severity de novo parkinson ’ disease bmc neurology vol 19 pp 1 9 2019 65 220 jf chen schwarzschild caffeine selective adenosine a2a receptor antagonists protect dopaminergic neurodegeneration parkinsons disease parkinsonism related disorders vol 80 pp s45 s53 2020 221 g grosso j godos f galvano e l giovannucci coffee caffeine health outcomes umbrella review annual review nutrition vol 37 pp 131 156 2017 222 f j li h f ji l shen meta analysis tea drinking risk parkinsons disease eng scientificworldjournal vol 2012 p 923464 2012 doi 1011002012923464 223 q chen et al neuroprotective effects mechanisms tea bioactive components neurodegenerative diseases eng molecules vol 23 3 feb 25 2018 doi 103390molecules23030512 224 yuan et al factors associated phenoconversion idiopathic rapid eye movement sleep behavior disorder prospective study eng npj parkinsons dis vol 11 1 p 10 jan 6 2025 doi 101038s41531 02400856 2 225 l c tan et al differential effects black versus green tea risk parkinsons disease singapore chinese health study eng j epidemiol vol 167 5 pp 553 60 mar 1 2008 doi 101093ajekwm338 226 k tanaka et al intake japanese chinese teas reduces risk parkinsons disease eng parkinsonism relat disord vol 17 6 pp 446 50 jul 2011 doi 101016jparkreldis201102016 227 x gao et al prospective study dietary pattern risk parkinson disease american journal clinical nutrition vol 86 5 pp 1486 1494 2007 228 k n tosefsky j zhu n wang j lam cammalleri appel cresswell role diet parkinsons disease eng j parkinsons dis vol 14 s1 pp s21 s34 2024 doi 103233jpd 230264 229 l k mischley r c lau r bennett role diet nutritional supplements parkinsons disease progression eng oxid med cell longev vol 2017 p 6405278 2017 doi 10115520176405278 230 p knekt kilkkinen h rissanen j marniemi k sääksjärvi heliövaara serum vitamin risk parkinson disease archives neurology vol 67 7 pp 808 811 2010 231 j booij p tellier j seibyl c vriend dopamine transporter availability early parkinsons disease dependent sunlight exposure movement disorders vol 38 11 pp 2131 2135 2023 232 schirinzi et al dietary vitamin e protective factor parkinsons disease clinical experimental evidence frontiers neurology vol 10 p 148 2019 233 c dietiker kim zhang c w christine n n p investigators characterization vitamin b12 supplementation correlation clinical outcomes large longitudinal study early parkinson ’ disease journal movement disorders vol 12 2 p 91 2019 234 j mccarter et al higher vitamin b12 level parkinsons disease diagnosis associated lower risk future dementia parkinsonism related disorders vol 73 pp 19 22 2020 235 alizadeh kheirouri keramati dietary vitamins minerals might protective parkinsons disease eng brain sci vol 13 7 jul 24 2023 doi 103390brainsci13071119 66 236 c boulos n yaghi r el hayeck g n heraoui n fakhoury sayegh nutritional risk factors microbiota parkinsons disease current evidence eng nutrients vol 11 8 aug 14 2019 doi 103390nu11081896 237 h chang b wang shi r zhu dose response meta analysis urate gout risk parkinsons disease eng npj parkinsons dis vol 8 1 p 160 nov 22 2022 doi 101038s41531 02200433 5 238 e c leira planas k chauhan chamorro uric acid translational journey cerebroprotection spanned preclinical human data eng neurology vol 101 23 pp 1068 1074 dec 4 2023 doi 101212wnl0000000000207825 239 g f crotty ascherio schwarzschild targeting urate reduce oxidative stress parkinson disease eng exp neurol vol 298 pt b pp 210 224 dec 2017 doi 101016jexpneurol201706017 240 shima et al uric acid alterations purine recycling disorders parkinsons disease cross sectional study eng npj parkinsons dis vol 10 1 p 170 sep 9 2024 doi 101038s41531 02400785 0 241 e esposito v di matteo benigno pierucci g crescimanno g di giovanni non steroidal anti inflammatory drugs parkinsons disease eng exp neurol vol 205 2 pp 295 312 jun 2007 doi 101016jexpneurol200702008 242 q wang liu j zhou neuroinflammation parkinsons disease potential therapeutic target eng transl neurodegener vol 4 p 19 2015 doi 101186s40035 0150042 0 243 x gao h chen schwarzschild ascherio use ibuprofen risk parkinson disease neurology vol 76 10 pp 863 869 2011 244 h chen et al nonsteroidal anti inflammatory drugs risk parkinson disease archives neurology vol 60 8 pp 1059 1064 2003 245 b rangasamy dasarathi p pahan jana k pahan low dose aspirin upregulates tyrosine hydroxylase increases dopamine production dopaminergic neurons implications parkinson ’ disease journal neuroimmune pharmacology vol 14 pp 173 187 2019 246 fyfe aspirin ibuprofen could lower risk lrrk2 parkinson disease nature reviews neurology vol 16 9 pp 460 460 2020 247 kang et al cav13 selective l type calcium channel antagonists potential new therapeutics parkinsons disease eng nat commun vol 3 p 1146 2012 doi 101038ncomms2149 248 j benkert et al cav23 channels contribute dopaminergic neuron loss model parkinsons disease eng nat commun vol 10 1 p 5094 nov 8 2019 doi 101038s41467 01912834 x 249 j lin et al calcium channel blockers parkinsons disease systematic review meta analysis eng ther adv neurol disord vol 17 p 17562864241252713 2024 doi 10117717562864241252713 250 k c simon x gao h chen schwarzschild ascherio calcium channel blocker use risk parkinsons disease eng mov disord vol 25 12 pp 1818 22 sep 15 2010 doi 101002mds23191 67 251 c b carroll r k h wyse simvastatin potential disease modifying therapy patients parkinsons disease rationale clinical trial current progress eng j parkinsons dis vol 7 4 pp 545 568 2017 doi 103233jpd 171203 252 j yan et al effect statins parkinsons disease systematic review meta analysis eng medicine baltimore vol 98 12 p e14852 mar 2019 doi 101097md0000000000014852 253 j e simmering j welsh l liu n narayanan pottegård association glycolysis enhancing α 1 blockers risk developing parkinson disease eng jama neurol vol 78 4 pp 407 413 apr 1 2021 doi 101001jamaneurol20205157 254 j firestone et al occupational factors risk parkinsons disease population based case control study eng j ind med vol 53 3 pp 217 23 mar 2010 doi 101002ajim20788 255 c haaxma g f borm van der linden c kappelle b r bloem artistic occupations associated reduced risk parkinsons disease eng j neurol vol 262 9 pp 2171 6 sep 2015 doi 101007s00415 0157828 256 k tanaka et al occupational risk factors parkinsons disease case control study japan eng bmc neurol vol 11 p 83 jul 7 2011 doi 1011861471 2377 11 83 257 p petit f berger v bonneterre n vuillerme investigating parkinsons disease risk across farming activities using data mining large scale administrative health data eng npj parkinsons dis vol 11 1 p 13 jan 8 2025 doi 101038s41531 02400864 2 258 v pitz et al analysis rare parkinsons disease variants millions people eng npj parkinsons dis vol 10 1 p 11 jan 8 2024 doi 101038s41531 023 00608 8 259 j jankovic e k tan parkinsons disease etiopathogenesis treatment eng j neurol neurosurg psychiatry vol 91 8 pp 795 808 aug 2020 doi 101136jnnp 2019 322338 260 ben shlomo darweesh j llibre guerra c marras san luciano c tanner epidemiology parkinsons disease eng lancet vol 403 10423 pp 283 292 jan 20 2024 doi 101016s0140 67362301419 8 261 belvisi et al risk factors parkinson disease simultaneous assessment interactions etiologic subtypes eng neurology vol 95 18 pp e2500 e2508 nov 3 2020 doi 101212wnl0000000000010813 262 b k beaulieu jones et al disease progression strikingly differs research real world parkinsons populations eng npj parkinsons dis vol 10 1 p 58 mar 13 2024 doi 101038s41531 02400667 5",
    "relevance_score": 0.8094,
    "date_score": 0,
    "final_score": 0.6071,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "marios kyriazis",
    "date": "2014-07-20T02:10:00",
    "filename": "1407.6030.pdf",
    "processed_text": "information sharing adaptive epigenetics human l ongevity author marios kyriazis elpis foundation indefinite lifespans email drma riosliveit abstract emerging empirical theoretical thinking human aging places considerable value upon role environment major factor promote prolonged healthy longevity contemporary ‘ information rich ’ environment taken mean merely actual physical surroundings person also considered abstract sense denote cultural societal technological influence modern environment far static stable fact continually chang ing exponential manner necessitating constant adaptive respons es behalf developmental evolutionary mechanisms paper attempt describe continual balanced meaningful exposure stimulating environment including exposure ‘ information thatrequires action ’ trivial information direct indirect repercussions n epigenetic mechanisms may act prolong healthy longevity information gained environment acts hormetic stimulus regulates biological responses f eedback loops eventually leading improved repair age related amage consequence biological information processing mechanism may influence resource allocation redress imbalance somatic cell versus germ line cell repairs eventually evolutionary consequences resulting drastic reduction agerelated disease degeneration key words hormesis longevity information adaptation techno cultural environment environmental enrichment introduction adaptive phenotypic plasticity important factor human evolution considerable evidence suggesting environment influences plasticity phenotype 1 exist precise hitherto well studied mechanisms respond stimulating changes environment attempt adapt stimulus 2 adaptation stimulus relevant study age related pathology evolution ag ing general increasing ly research shows environment crucial determining prolonged healthy longevity 3 human terms ‘ environment ’ abstract notion amalgam physical virtual surroundings interactions modern society techno cultura l elements words highly ‘ information rich ’ milieu worth noting point define information ‘ meaningful set data patterns influence formation transformation data patterns order reduce uncertainty help achieve goal ’ 4 figure 1 figure1 information complexity functionality fitness survival organisation figure 1 information plus organisation increases complexity increases functionality improves fitness thus survival increase internal fitness requires formation new links strengthening interconnectedne ss nodes ie increased complexity thus increased fitness increased survival however environment constantly changing recently changing ever accelerating manner 5 need quickly adapt se changes order able survive may depend artificial selection technology example exposure meaningful information r ather slower darwinian natural selection processes 6 epigenetic factors mediate g enome environment play n important role respect allowing rapid changes protein expression may applied almost immediately needed increasing body research highlights role epigenetic changes age related degeneration 7 epigenetic changes chromatin remodelling dna methylation modify phenotype play modulating role senescence agediseas e one reasons based fact epigenet ic processes regulat e mechanisms necessary development 8 process aging explained everal authors continual excessive operation basic developmental eventually lead timerelated malfunction 9 10 therefore corrective regulation defective process could lead control least aging mechanisms addition known could ‘ molecular breaks ’ restrict plasticity adult cells particular neu rons 11 use epigenetic interventions may lead stabilisation nd delayed expression break factors thus allow easier quick plasticity cell fact several factors found extracellular space makes likely epigenetic control would effective compared genetic intracellular mechanisms hormesis stress several e nvironmental factors closely linked epigenetic regulation gene expression epigenetic regulation may lead adaptive changes increase likelihood successful survival within particular niche epigenetic changes predictable occur early late developmental stages result improvement functional ability organism 12 shown environmental stress induces epigenetic changes result adaptive respon se tress question 13 question arises “ stress ” context stress taken mean exposure stimulus disrupts homeostasis necessitates reaction order organism adapt stimulus stress colloquially ‘ positive stress ’ hormetic origin ie doseresponse phenomenon lowdose stim ulation highdose inhibition 1417 hormesis considered process continual novelty affects basic biological parameters 18 vaiserman 19 conside rs mild stress induced ho rmetic response involves mechanisms similar mechanisms underlie developmental epigenetic adaptations resulting lifespan prolonging properties examples positive hormetic stress include calorie restriction physical exercise certain chemical compounds including free radicals mild toxins addition could types hormetic stimulation cultural societal psychological factors whi ch interact multiple levels argued hormetic stress type encountered everyday highly technological intensely information sharing environment may cause direct epigenetic changes facilitate adaptation env ironment scrut inising epigenetic changes closely one may find similarities mechanisms repair agerelated damage may due rapid regulation genes responsible adaptive response wh ich effect healthy life extension 20 highlighted however excessive stress wellknown determinant disease although epigenetic adaptations changing environment occur early stages development also possible experience epigenetic plasticity later life stages 21 promising fact supports view hormetic stressors upregulate healthy longevity mechanisms even applied later life although search ideal type mild positive hormetic stress still continues makes sense consider stimuli directly rel evant current technological information rich environment stresses must lead adaptation instance exposure relentless information sharing environment meaningful online hyper connectedness acts kind hormetic stimulus would lead adaptive response may upregulate several health parameters 22 discussed must emphasized issue concerns meaningful stimulation containing information requires action trivial meaningless info rmation resource allocation information rich environment affect biological parameters lead reduced rate senescence suggested although efficient repair mechanisms present somatic cells traded germ line cells optimal successful survival species heininger 23 quotes evolution natural selection described driven perpetual conflict individuals competin g limited resources somatic death germ cell triggered event emphasis mine established evolutionary fixed default state following asymmetric reproduction world finite resources aging hand stress res istance dependent phenotype somatic resilience counteracts germ cell inflicted death pathway thus aging survival response contrast current beliefs antagonistically linked death imposed group selection enforced upon soma selfish genes “ enemy within ” ie germ line cells comment mine environmental conditions shape trade solutions compromise conflicting germ –soma interests mechanistically neuroendocrine system particularly components control energy balance reproduction stress responses orc hestrate events therefore concept aging viewed least partly conflict germ line cells soma tic cells whereby immortalisation factors preferentially diverted towards germ line cells order assure survival species instead used somatic cells 24 results continual effective repair germ cells exhibit robust anti senescence traits expense somatic cells eventu ally become overwhelmed damage maintenance gap matter resources required resources llocated say resources constantly required allocated order assure long term survival despite sho rtterm evolutionary cost 25 main existing evolutionary reason need assure survival species currently achieved much energy efficiently immortalisation germ line cells suggested may possible balance germ soma conflict using continual exposure insightful information mechanism depends epigenetic modification accordance basic evolutionary requirements 26 typical example environmental effects ie hyper connection continual exposure digital technology example direct impact upon age regulating mechanisms via epigenetic instead genetic changes possible examine role epigenetic mechanisms relation hifting resources germ line somatic repair instance known exist n onautonomous contribution somatic cells germ line cells leading germ line immortal isation 27 contributions aid germ line survival immortalisation strategies may also present somatic cells significantly regulate 28 aim examine rejuvenation process driven operate somatic cells 29 important highlight certain mechanisms germ line rejuvenation could dependent upon epigenetic modifications factors regulate transcription 30 thus also plausible epigenetic co ordination may certain rejuvenating effects upon somatic cells although clearly research needed area also worth remembering epigenetic regulation may lead positive results example increasing methylation may regulate deleterious signa lling pathway may also regulate tumo ur suppressor genes increasing risk cancer 31 32 also needs research conflict survival somatic germ line cells conceivabl reversed survival somatic cells becomes priority th e survival germ line cells mechanism likely involve hormetic epigenetic influences environment upon soma effectiveness process may time dependent ie may depend early life organism subjected ‘ stressor ’ evidence exists hormetic epigenetic stressors applied early life pronounc ed lasting effect 33 flatt et al 34 shown ch anges environment direct effect upon regulation somatic maintenance hey suggest genotype express either two alternative phenotypes depending particular environment example supports principle suggestion suitable manipu lation environment via exposure relevant digital information example effects human epigenome modulate aging calvanese et al 35 suggest role epigenetic modifications aging defined need specific epigenetic changes exist changes must functionally associated aged phenotype impact information upon cell mentioned information meaningful set data influence formation transformation data order reduce uncertainty thus entropy achieve goal practical sense assume shannon ’ information entropy 36 similar thermodynamical entropy discussion based upon general model 37 authorities agree hat e nvironmental enrichment ee ie stimulating cha nging ‘ information rich ’ environment hormesis effect n several parameters regulation b rain derived neurotrophic factor particular case also shown enriched information rich environment early life results highly regulated histone acetylation bdnf gene adulthood happens quite fast stimulating exposure 3 8 regards bdnf also known concentration raised exercise 39 direct relevance quote paper 26 suggestion sustained exposure actionable information forcibly induces change basic hitherto stable evolutionary processes entirely speculative one proposed tha increased aerobic activity thus case physical instead cognitive effort direct evolutionary impact human brain 40 increased sustained aerobic activity hunter gatherers resulted regulation peripheral b dnf increased concentration degree eventually crossed blood brain barrier directly influenced function survival neurons plasma concentrations factors normally found periphery ie brain insulin like growth factor 1 igf 1 vascular endothelial growth factor vegf increase physical activity elevated sustained physical effort crossed blood brain barrier rea ched brain resulting improved neurogenesis thus hypothesized sustained activities case cognitive stimulation may phys ical effects cause transition one evolutionary stage another known several e pigenetic mechanisms including methylation dna chromatin remodelling mediate gene regulation neurons thus important effect regulating development nervous system epigenetic modelling effects shape neural structure function depend upon external environmental clues epigenetic gene regulation important regulating synaptic plasticity neural behaviour high order cognitive functions memory learning problem solving abilities 41 order gain better insights information may affect epigenetic regulation useful explore detail process information manipulation cell case relevant example consider visual information new information captured retinal cells photonic recycling cell surface 42 ligand receptor associations alter conformation extracellular portion intramembranous proteins change transmitted cytoplasm trans membranous helical segments non linear vibrations proteins 42 addition photon photon interactions induce molecular vibrations responsible bio amplification weak signals described bvlq mass th e molecule c velocity electromagnetic field b magnetic flux density v velocity carrier particle exists l dimension q unit charge signal transmitted appropriate neuronal areas case occipital cortex effects neuronal response terms mainly epigenetic modulation dna acetylation steps leading acquisition assimilation information require energy energy needs diverted away processes order made available information manipulation process adaptation mechanisms depend pa rtly genetic function inly epigenetic factors able act faster ge netically originated reaction provide flexibility optimising performance known epigenetically dependent adaptation visual stimulation rapid 43 thus environment epigenetic regulation affects brain function follows environmental stimulation certain magnitude quality direct effects cognition cognition higher mental functions essen tial current technological high info rmation dependant environment able adapt challenges likely survive within milieu recent research shed light mechanisms effects environment upon epigenetic regulation instance known genetic elements micrornas mirnas effective epigenetic regulators genomic response environmental stimuli environmental agents o3 exposure disrupt mirna expression profiles interfere inflammation regulation 44 micrornas contribute genome plasticity evolution essential controlling expression genes may interfere aging process howev er study needed respect many effects mirna regulation still unknown 45 known number function mirnas significantly regulated humans compared animals chimpanzee macaque mouse rat dog 46 may indicate humans may developed unique evolutionary genetic elements facilitate better repair damage exactly need adapt quickly n information rich technological environment 47 evolutionary situation relevant non human animals finally worth mentioning chronically unpre dictable environment e c onstantly changing society techno culture induce ph enotypic changes parents reflected unexposed offspring suggesting least epigenetic changes itable adds robustness notion suggesting epigeneti c changes important evolution permanent subjected evolutionary selection also repeated stress early life protect sustained stress later life 48 social factors play role epigenetic regulation effects persist throughout life also tr ansmitted offspring via epigenetic inheritance 49 addition specific epigenetic profile associated longevity 50 transmitted offspring gentilini et al 51 shown centenarians certain specific dna methylation characteristics found nucleodite biosynthesis control signal transmission also found offspring suggesting characteristics itable conclusion epigenetic regulation mediates adaptation environment environment specific type n information sharing fast changing techno cultural setting fast adaptation may impact upon life extending biolog ical pro cesses epigenetic regulation together genetic cell specific factors influence longevity studied within nonreductionist integrative framework ag ing 52 reductionist view aging manipulated simple biomedical repairs unlikely lead appreciable practical results used order diminish impact age related degeneration instead wider approach likely succeed would study role complexity regulation adaptation harness function fundamental processes role emergence ‘ direction ’ human evolution 53 world view encapsulated philosophical reflections transcend time place “ tempora mutantur nos et mutamur illis ” times change change environment society culture change must order adapt change increase fitness chanc e survival 54 one way effect positiv e change increase exposure meaningful technological information requires action 55 exploit nature relati vely fast epigenetic mechanisms bound evolutionary constraints must result suitable beneficial adaptations thus extended survival author declare conflicts interest paper references 1 price td qvarnström irwin de 2003 role phenotypic plasticity driving genetic evolution proceedings royal society b biological sciences 270 1523 1433 –40 2 kelly sa panhuis tm stoehr 2012 phenotypic plasticity molecular mechanisms adaptive significance compr physiol 21417 1439 3 takano nakamura k watanabe 2002 urban residential environments senior citizens longevity megacity areas importance walkable green spaces j epidemiol community health 5612913 8 4 frieden br gatenby ra 2011 information dynamics living systems prokaryotes eukaryotes cancer plos one 67 e22085 5 smart j 2005 measuring innovation accelerating world technological forecasting social change 728988 995 6 heylighen f 1994 fitne ss default evolutionary basis cognitive complexity reduction cybernetics systems 1994 r trappl ed world science singapore p1595 1602 7 gravina vijg j 2010 epigenetic factors aging longevity pflugers arch 4592 24758 8 combes whitelaw e 2010 epigenetic reprogramming enforcer enabler developmental fate dev growth differ 526483 91 9 carnes ba 2011 lifespan regulation exist biogerontology 124367 74 10 walker rf 2011 developmental theory aging revisited focus causal mechanistic links development aging rejuvenation res 14429 436 11 takesian ae hensch tk 2013 balancing plasticitystability across brain development prog brain res 2073 34 12 vaiserman 2011 hormesis epigenetics link ageing res rev 104413 21 13 jablonka e lamb mj 1998 epigenetic inheritance evolution j evol biol 112159 –183 14 calabrese ej mattson mp 2011 hormesis provides gener alized quantitative estimate biological plasticity j cell commun signal 5125 38 15 rattan si 2014 molecular gerontology homeodynamics hormesis curr pharm des 20183036 9 16 calabrese v cornelius c dinkova kostova calabrese e j mattson mp 2010 cellular stress responses hormesis paradigm vitagenes novel targets therapeutic intervention neurodegenerative disorders antioxid redox signal13111763 811 17 mattson mp 2008 awareness hormesis enhan ce future research basic applied neuroscience crit rev toxicol 387633 9 18 agutter ps 2008 elucidating mechanisms hormesis cellular level universal cell response j pharmacol toxicol 31100 110 19 vaiserman 2 010 hormesis adaptive epigenetic reorganization implications human health longevity dose response 81 16 –21 20 vaiserman 2008 epigenetic engineering possible role anti aging intervention rejuvenation res 11139 42 21 fraga mf ballestar e paz mf et al 2005 epigenetic differences arise lifetime monozygotic twins proc natl acad sci u 1023010604 9 22 heylighen f 2014 cybernetic principles aging rejuvenation buffering challengin g strategy life extension curr aging sci may 20 epub ahead print 23 heininger k 2002 aging deprivation syndrome driven germ – soma conflict aging res rev 13 481 536 24 cossetti c lugini l astrologo l saggio fais spadafo ra c 2014 soma togermline transmission rna mice xenografted human tumour cells possible transport exosomes plos one 97e101629 25 baudisch vaupel jw 2012 getting root aging science 338 6107 618 619 26 kyriazis 2014 reversal informational entropy acquisition germ like immortality somatic cells curr aging sci may 20 epub ahead print 27 kirkwood b 1987 immortality germ line versus disposability soma basic life sc iences 42209 –218 28 smellick c ahmed 2005 achieving immortality celegans germline ageing research reviews 467 82 29 avise jc 1993 evolutionary biology aging sexual reproduction dna repair evolution 47 1293 1301 30 santos f dean w 2004 epigenetic reprogramming early development mammals reproduction 127 643 651 31 kemp cj moore jm moser r et al 2014 ctcf haploinsufficiency destabilizes dna methylation predisposes cancer cell rep74102 09 32 choi jd lee js2013 interplay epigenetics genetics cancer genomics inform 4164 73 33 burger jm hwangbo ds corby harris v et al 2007 functional costs benefits dietary restriction drosophila aging cell 61 6371 34 flatt amdam gv kirkwood tb et al 2013 life history evolution polyphonic regulation somatic maintenance survival q rev biol 883185 218 35 calvanese v lara e kahn et al 2009 role epigenetics aging agerelated diseases ageing res rev 84268 76 36 shannon ce 1948 mathematical theory communication bell system tech j 27 3 379 –423 37 heylighen f joslyn c 2001 cybernetics second order cybernetics ra meyers ed encyclope dia f physical science technology vol 4 3rd ed academic press new york p 155 170 38 branchi karpova nn dandrea et al 2011 epigenetic modifications induced early enrichment associated changes timing induction bdn f expression neurosci lett 4953168 72 39 ferris lt williams js shen cl 2007 effect acute exercise serum brain derived neurotrophic factor levels cognitiv e function med sci sports exerc 394728 34 40 raichlen da polk jd 2013 l inking brains brawn exercise evolution human neurobiology proc biol sci 280175020122250 41 feng j fouse fan g 2007 epigenetic regulation neural gene expression neuronal function pediatr res 615 pt 258r 63r 42 saxena jacobson j yamanashi w et al 2003 hypothetical mathematical construct explaining mechanism biological amplification experimental model utilizing picotesla pt electromagnetic fields med hypotheses 606821 39 43 adorjan p1 sc hwabe l wenning g et al 2002 rapid adaptation internal states coding strategy visual cortex neuroreport 4133337 42 44 fry rc rager je bauer rn et al 2014 air toxics epigenetic effects ozone altered micrornas sputum f human subjects j physiol lung cell mol physiol epub ahead print 45 le td liu l zhang j et al 2014 mirna regulation mirna tf co regulation computational approaches challenges brief bioinform pii bbu023 epub ahead pri nt 46 dweep h georgiou gd gretz n et al 2013 cnvs micrornas interactions demonstrate unique characteristics human genome interspecies silico analysis plos one 812e81204 47 heylighen f evolutionary psychology michalos ed 2011 encyclopedia quality life research springer berlin 48 natt 2011 heritable epigenetic changes environmental challenges linkoping studies science technology dissertation 1383 linkoping university sweeden 49 thayer zm k uzawa cw 2011 biological memories past environments epigenetic pathways health disparities epigenetics 67798 803 50 gentilini castaldi mari et al 2012 age dependent skewing x chromosome inactivation appears delayed centenari ans offspring role allelic imbalance healthy aging longevity aging cell 11277 83 51 gentilini mari castaldi et al 2013 role epigenetics human aging longevity genome wide dna methylation profile centenari ans centenarians offspring age dordr 351961 73 52 nikoletopoulou v kyriakakis e tavernarakis n 2014 cellular molecular longevity pathways old new trends endocrinol metab 254212 23 53 kyriazis 2014 novel approaches old problem insights theory practice eliminating aging current aging science 7 1 1 54 transhumanist reader classical contemporary essays science technology philosophy human future eds vita n 2013 john wiley sons chichester uk 55 iansiti 1995 technology integration managing technological evolution complex environment research policy 24 521 542",
    "relevance_score": 0.8094,
    "date_score": 0,
    "final_score": 0.607,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Thomas",
    "date": "2016-12-30T14:10:16",
    "filename": "1503.07040.pdf",
    "processed_text": "email thomasjicun gmailcom 1 traditional aging theories ones useful jicun wang michelitsch1 thomas michelitsch2 1department medicine addenbrookes hospital university cambridge uk work address 2007 2 institut jean le rond ’ alembert paris 6 cnrs u mr 7190 paris france abstract many theories proposed answer ing two questions aging “ age ” “ h ow age ” ones finally tenable made analysis theories select useful one evolutionary theories made interpret ing evolutionary advantage aging “ saving resources group benefit ” thought purpose aging however saving resources economic strategy make individual reproduction age undergo rapid death rather undergo slow aging biological theories made identify ing causes biological process es aging h owever including cell senescence telomere theory gene controlling theory developmental theory unfortunately ignore influence damage aging freeradical theory suggests free radicals causing intrinsic damage main cause aging however even intracellular free radical cause injuries may associated aging changes damage fault accumulation theory predicts intrinsic faults damage accumulate lead aging reality unrepaired fault possi bly remain living organism since destroy structural integrity tissue cause rapid failure organism therefore hese theories untenable interpreting aging nevertheless among developmental theory damage fault accumulation theory useful others emphasize importance damage body development aging p hysical theories also useful point ing common characteristics aging process loss complexity increase entropy failure information transmission advanced aging theory theory include useful ideas traditional theories keywords aging aging theories deductive analysis impossi bility evolvability theory mutation accumulation heory antagonistic pleiotropy theory disposable soma theory freeradical theory cell senescence telomere theory developmental theory amage fault accumulation theory g enecontrolling theory loss complexity ncrease entropy failure information transmission ulticellular chaos misrepair accumulation theory email thomasjicun gmailcom 2 “ age ” “ h ow age ” two different questions first need explain aging un avoidable f second need explain underlying biological process aging many theories created answer ing two questions evolutionary theories including evolvability theory weismann 1889 mutation accumulation heory medawar 1952 antagonistic pleiotropy theory williams 1957 disposable soma theory kirkwood 1977 proposed interpret evolutionary advantage aging biological theories made identify causes biological processes aging example f reeradical theory emphasizes central role free radicals aging harman 1956 cell senescence telomere theory suggests telomere controlled senescence cells main cause aging blackbur n 2000 development al theory supposes aging result development medvedev 1990 damage fault accumulation theory genecontrolling theory actually leading theories nowadays damage fault accumulation theory predicts intrinsic faults left unrepaired due limitation repair maintenance sources aging kirkwood 200 5 2006 genecontrolling theory demonstrates certain genes control process aging completely ind ependently physical theories summarized physical properties aging loss complexity lipsitz 1992 consequence increase entropy bortz 1986 failure information transmission mulá 2004 question among theories ones finally tenab le explaining aging present paper analyze answer question discussi devoted following subjects method disproving theory ii limitations traditional aging theories 21 evolutionary theories 22 freeradical theory 23 cell senescence telomere theory 24 gene controlling theory 25 developmental heory 26 damage fault accumulation theory 27 physical theories iii useful theories unanswered questions method disproving theory accept abandon th eory important find negative evidence rather collect positive evidence theory falsified even “ one ” negative fact popper 1994 search real criminal number suspects feasible simple way exclude first impossible suspects judging theory strategy also useful w e analyze impossibility theory collecting negative evidence email thomasjicun gmailcom 3 basis propose method disproving theory name “ deductive analysis impossibility ” taken genecontrolling theory example procedure analysis follows premise 1 prediction “ aging controlled gene ” correct distribution aging changes indepe ndent locations damage figure 1a premise 2 fact distribution wrinkles face closely related locations damage figure 1a figure 1b conclusion therefore prediction “ aging controlled gene ” impossible genecontrolling theory untenable figure 1a negative fact exists theory acceptable despite number positive evidence unfortun ately biologists forgotten princip le judging works mak e effort collect positive data conclusion disproved single negative case following discussion analyze aging theories method b figure 1 deductive analysis im possibility aging theory “ deductive analysis impossibility ” useful method disprove aging theory analyze impossibility theory collecting negative evidence taken gene controlling theory example process deductive analysis follows premise 1 prediction “ aging controlled gene ” correct distribution aging changes independent locations damage premise 2 fact distribution wrinkles face closely related locations damage b conclusion therefore prediction “ aging controlled gene ” impossible gene controlling theory untenable ii limitations traditional aging theories traditional ging theories interpret aging different aspects however far none give full story aging mechanism part w e look p rediction “ aging controlled gene ” correct distribution aging changes independent locations damage premise 1 fact distribution wrinkles face closely related locations damage premise 2 therefore prediction “ aging controlled gene ” impossible gene controlling theory unte nable conclusion wrinkles face email thomasjicun gmailcom 4 theories tell complete acce ptable n untenable theory given however useful ideas inherited important study ing aging 21 evolutionary theories one earliest theories aging evolvability theory firstly proposed weismann recently modified mitteldorf weismann 1889 mitteldorf 2006 theory suggests purpose limited lifespan save living resources younger generations “ group benefit ” direction theories provided possible mechanisms organism “ sacrifice ” “ group benefit ” theories include mutation accumulation theory antagonistic pleiotropy theory disposable soma theory true group benefit evolutionary advantage h owever saving resources production effective strate gy remove old individuals “ planned rapid death ” rather long process aging r eality maximum lifespans indiv iduals species ’ animals much longer time development example woman live 30 years age 70 90 reproduction age age 15 45 mutation accumulation theory main point mutation accumulation theo ry weak fitness selection old organism allows wide range gene mutations n somatic cells deleterious effects organism medawar 1952 martin 1996 dna mutations take place reproduction age affect next generation therefore mutations wiped evolution accumulate somatic body however n reality type aging changes age spots often develop paral lelly independently different parts organ aging changes develop way possibly result dna mutations impossible form dna change takes place paral lelly independently different somatic cells different parts organ another question theory cells altered phenotype dna changes removed immune system develop tumors antagonistic pleiotropy theory 1957 williams gave another supposition aging sympto ms antagonistic pleiotropy theory williams 1957 supposed genes antagonistic pleiotropic effect might exist bene fiting effects early life detriment al effects later age williams also pointed agei ng sid e effect necessary functions alteration ageing process impossible theory sounds reasonable presuming kind pleiotropic genes h owever genes possibly exist detriment al effects som atic cell result quick death rather gradual aging organ reality organs maintain sufficient function ality 60 years even aging disposable soma theor disposable soma theory presumes organism must budget limited energy available energy well distributed metabolism email thomasjicun gmailcom 5 reprod uction repair maintenance organism prefers save energy reproduction rather maintain mature body insufficient repair therefore cause deleterious change body ag e kirkwood 1977 however insufficiency repair fatal organism wound skin left unrepaired due insufficiency repair consequence would death body bleeding infection rather aging skin 22 free radical theory theory points free radical main origin aging causing cellular injuries harman 1956 molecules f ree radicals biological organism include superoxide reactive oxygen species small molecules produced cells substrates products biochemical reactions although studies shown effect anti freeradical extending lifespan animal drosophila roundworms van raamsdonk 2009 role free radicals aging controversial ahluwalia 2004 juránek 2005 oxidative free radicals cause potentially cell injuries free state however part ce metabolism molecules n accurate control distributions activities like molecules cells normally free radicals immediately removed deactivated functioning intracellular antioxidants maintain ing intracellular stability even cause times injuries injured cells molecules fully repaired removed necessarily affecting tissue structure tissue function even injuries made free radicals fully repaired injuries associated aging changes 23 cell senescence telomere theory reduction cell number always thought cause aging idea enhanc ed discovery telomeres telomeres end ing part chromosomes important protecting chromosomes regulating activities chromosomes dna duplication 3 ’ ending part template dna telomere used priming sequence synthesizi ng new dna therefore new dna shorter template dna telomere new dna shorter template dna length telomere therefore shortened time dna duplication cell division telomere short dna synthesis cell division anymore proceed basis cell senescen cetelomere theory proposed theory suggests telomere determined cell senescence origin aging hayflick 1965 blackburn 2000 di scovery telomerase enzyme prolong telomere powerful support theory telomerase found produced mainly germ cells tumor cells kim 1994 however studies shown consistent relationship telomere length animal lifespan kipling 1990 hemann 2000 addition theory incompatible known facts potential cell division also controlled fact ors stem cell essentially longer telomere neighbor nonstem cells b reduction cell number unique change aged tissue contrast aging changes email thomasjicun gmailcom 6 including hyperplasia appear increase number cells c organs still reproduce new cells repair 70 years old 24 gene controlling theory life science nowadays era “ gene ” “ genome ” aging thought solvable discovering controlling genes summarize belie f genecontrolling theory searching “ aging related genes ” “ lifespan related genes ” becomes therefore main work many scientists de magalhaes 2009 fabrizio 2010 bell 2012 mccormick 2012 belief gene controlling aging fundamental gene programming theory aging process thought preprogrammed genetically development longo 2005 earliest idea programmed aging might come phenomenon planned death biological suicide species ’ animals individuals semelparous salmon female octopus go die quickly following reproduction hormone signaling identified mechanism programmed death octopus wodinsky 1977 however programmed death sudden short quiet different aging process reality individuals species living different environments protected protected may quite different lifespans even environment individuals die different ages idea programmed aging given scientists austad 2004 many aging related genes lifespan related genes identified mccormick 2012 university wash ington 2012 however exact roles aging known view belief aging genes misleading idea severe defects even genes associated lifespan essentially aging related b even genes aging related essentially elements control aging process completely independently c aging controlled certain genes distribution aging changes independent locations damage however fact distribution age spots skin closely related locations damage aging con trolled completely gene g ene fails individual dna mutation individual could immortal however immortal case observed far world therefore gene programming mechanism aging may possibly exist 25 developmental heory alternati development pathway alter significant ly lifespan rganism klass 1976 basis johnson assumed aging development coupled johnson et al 1984 medvedev proposed developmental theory theory suggest aging result development aging process regulated b mechanism development medvedev 1990 zwaan 2003 idea supported discovery correlation potential longevity mature time animal charnov 1993 dauer pathway altered pathway development c e legans dauer individuals prolonged lifespans dauer pathway found induced environment change mediated insulin like signaling pathway wolkow 2000 email thomasjicun gmailcom 7 hormones hormone related genes thought important regulating aging process apart regulating development de magalhaes 2005 idea coupling process aging process development revealing however theory three defects ignored influen ce damage aging b clarify difference development process aging process c effect alteration development lifespan essentia lly via retarding aging 26 damage fault accumulation theory somatic injuries unnegligible development aging changes aspect kirkwood predicted “ aging result accumulation ‘ faults ’ cellular molecular level limitation maintenance repair underlying driving forc e damage genetic control longevity comes regulation essential maintenance repair processes slow build –up faults ” kirkwood 2005 summarize prediction “ damage fault accumulation theory ” theo ry emphasizes importance damage repairmaintenance system aging h owever since terms specified conclusion theory confusing term “ fault ” prediction understood kind “ intrinsic damage ” however clear whether “ intrinsic damage ” referred change moleculecell repair change repair example scar formation burnt skin wound skin burning primary damage repair scar change skin repair two changes skin repair repair obviously different thus distinguishe term “ faults ” prediction possibly referred primary damage repair since “ accumulate limitation repair maintenance ” critical question theory kind “ faults ” left unrepaired view faults kind primary damage remain unrepaired living organism primary damage fact defect living structure molecule cell tissue defect closed time structure lose structural integrity functionality whole organism fail rapi dly another word unrepaired faults lead rapid death rather aging organism hence concept accumulation “ faults ” misl eading main idea theory untenable 27 physical theories aging take place n living organisms also n nonliving structures searching common well different characteristics aging two different systems important uncovering secret aging p hysical theories give object ive description aging living non living systems loss complexity increase entropy failure information transmission physical theories therefore useful revealing physical theory give full stor aging mechanism describe biological process aging loss complexit living system kind complex adaptive system composed numbers interacting sub systems term complexity approach phy sics describe interactions whole system sub systems complexity ratio email thomasjicun gmailcom 8 degree difficulty predicting properties whole system given properties subsystems weaver 1948 complexity system exhibits several aspects example emergence feedback effect interdependence self organization self adaptation morowitz 1995 loss complexity appears failure communication subsystems living system loss c omplexity appears degeneration cellstissues chaos communications cellstissues lipsitz 1992 loss ofcomplexity chaos theory lipsitz pointed loss complexity loss functionality occurs agin g aging thus price cooperation complexity kiss 2009 increase entropy entropy useful measure marking tendency natural processes always direction increase entropy closed system term entropy also understood “ uncertainty ” “ lack information ” fields mackay 2003 statistic interpretation entropy firstly introduced boltzmann phenomenological measure “ disorder ” landsberg 1988 increase disorder corresponding decrease complexity functionality system living systems need release entropy continuously protect running thermodynamic equilibrium death niedermueller 1990 haken 1990 wunderlin 1992 respiration perspiration excretion measures release entropy however living get rid entropy part remain increase age aging therefore consequence increase entropy entropy inc reases energies ordering diminish bortz 1986 failure information transmission theory multi cellular chaos emphasized multi cellular structure organism based cell differentiation preconditio n aging mulá 2004 information transmission pathways different cells surviving lines cells organism time signal transmission become chaos gradually nature aging colony bacterial aging colony neither cell organization information transmission cells failure information transmission corresponding loss complexity organization idea outstanding recognizing importance cell differentiation cell organization aging iii useful theories unanswered questions analysis shows theories incomplete n advanced theory needed better theory consistent facts old theories uncovered facts include damag e driving force aging damage fault accumulation theory b modification development alter lifespan developmental theory c aging process loss comp lexity failure information transmission physical theories therefore among theories damage fault accumulation theory developmental theory physical theories useful others far basic questions aging yet satisfactorily answered aging unavoidable b age c limited longevity therefore better email thomasjicun gmailcom 9 theory also able answer critical questions end proposed novel theory aging misrepair accumulation theory wang 2009 reference 1 ahluwalia j tinker clapp lh duchen mr abramov ay pope nobles segal aw 2004 large conductance ca2 activated k channel essential innate immunity nature 427 853–858 2004 doi101038nature 02356 2 amrit frg boehnisch cml may rc 2010 phenotypic covariance longevity immunity stress resistance caenorhabditis nematodes plos one 5 4 e9978 3 anderson rm shanmuganayagam weindruch r 2009 caloric restriction aging studies mice monkeys toxicologic pathology 37 1 47 –51 4 austad n 2004 aging programed aging cell 35 249 251 5 bak p 1996 nature works science self organized critical ity copernicus press new york us cloth isbn 0 38794791 4 6 bansal miyake k vogel ss groh chen cc williamson r mcneil pl campbell kp 2003 defective membrane repair dysferlin deficient muscular dystrophy nature 423 168 7 bell jt tsai p c yang p pidsley r nisbet j et al 2012 epigenome wide scans identify differentially methylated regions age age related phenotypes healthy ageing population plos genet 84 e1002629 doi101371journalpgen1002629 8 bishay k ory k olivier mf lebeau j levalois c chevillard 2001 dna damage related rna expression assess individual sensitivity ionizing radiation carcinogenesis 228 1179 9 blackburn eh 2000 telomere states cell fates nature 408 5356 10 bodnar ag ouellette frolkis holt se chiu cp morin gb harley cb shay jw lichtsteiner wright 1998 extension life span introduction telomerase normal human cells science 279 349352 11 bortz wm 2 nd 1986 aging entropy exp gerontol 21 45 321 8 12 bulckaen h prévost g boulanger e et al 2008 lowdose aspirin prevents age related endothelial dysfunction mouse model physiological aging j physiol heart circ physiol 294 1562 13 charnov el 1993 li fe history invariants explorations symmetry evolutionary ecology oxford university press oxford 14 collins fs et al 2004 international human genome sequencing consortium finishing euchromatic sequence human genome nature 431 931945 doi101038nature03001 15 cook h stephens p k davies j harding kg thomas dw 2000 defective extracellular matrix reorganization chronic wound fibroblasts associated alterations timp 1 timp 2 mmp 2 activity journal investigative dermatology 115 225 16 de magalhães jp church gm 2005 genomes optimize reproduction aging consequence developmental program physiology 20252259 17 de magalhaes jp curado j church gm 2009 meta analysis age related gene expression profiles identifies common signatures aging bioinformatics 25 875 881 18 fabrizio p hoon shamalnasab galbani wei giaever g nislow c longo vd 2010 genome wide screen saccharomyces cerevisiae identifies vacuolar protein sorting autophagy biosynthetic trna methylation genes involved life span regulation plos genetics 67e1001024 19 haken h wunderlin 1990 synergetik eine einführung nichtgleichgewichts und selbstorganisation physik che mie u nd biologie kratky kw und wallner f grundprinzipien der selbstorganisation hrsg darmstadt wbg 1990 isbn 3 53410971 6 20 harman 1956 aging theory based free radical radiation chemistry journal gerontology 11 3 298–300 21 hemann mt greider cw 2000 wild derived inbred mouse strains short telomeres nucleic acids research 28 22 4474 –4478 email thomasjicun gmailcom 10 22 herndon la schmeissner pj dudaronek jm brown pa listner km sakano paupard mc hall dh driscoll 2002 tochastic genetic factors influence tissue specific decline ageing c elegans nature 419 808 –814 23 hayflick l 1965 limited vitro lifetime human diploid cell strains exp cell res 37 614 636 24 johnson te mitchell dh kline kemalr foy j 1984 arresting development arrests aging nematode caenorhabditis elegans mech ageing dev 28 123 40 25 johnson 2001 emergence connected lives ants brains cities software new york scribner isbn 068486875 x 26 juránek bezek š 2005 controversy free radical hypothesis reactive oxygen species – cause consequence tissue injury gen physiol biophys 24 263 —278 27 kim nw piatyszek prowse kr harley cb west md ho pl coviello gm wright weinrich sl shay jw 1994 specific association human telomerase activity immortal cells cancer science 266 2011 2015 28 kipling cooke hj 1990 hypervariable ultra long telomeres mice nature 347 6291 400 29 kirkwood tb 1 977 evolution ageing nature 270 5635301 –304 30 kirkwood tb austad sn 2000 age nature genet 408 6809 233 8 31 kirkwood tb 2006 ageing fast mistake nature 444 7122 1015 7 32 kirkwood tb 2005 understanding odd science aging cell 1204 437 47 33 kiss hjm mihalik nanasi ory b spiro z soti c csermely p 2009 ageing price cooperation complexity self organization complex systems causes ageing constituent networks bioessays 316 651 64 arxiv08120325v2 q biomn 012009 34 klass hirsh 1976 non ageing developmental variant caenorhabditis elegans nature 2605551523 5 35 landsberg pt 1984 entropy “ order ” increase together physics letters 102a 171–173 36 lipsitz la goldberger al 1992 loss complexity aging potential applications fractals chaos theory senescence jama 26713 1806 9 37 lipsitz la 2006 aging process complexity loss complex systems science biomedicine topics biomedical engineering international book series part iii section 7 641 654 doi 101007978 038733532 228 38 li ty yorke ja 1975 period three implies chaos american mathematical monthly 82 10 985 39 longo vd mitteldorf j skulachev vp 2005 programmed altruistic ageing nat rev genet 6 11866 872 40 mackay djc 2003 information theory inference learning algorithms cambri dge cambridge university press 2003 isbn 0 52164298 1 41 martin gm ustad sn johnson te 1996 genetic analysis aging role oxidative damage environmental stresses nature genet 13 125 34 42 may rm 1976 simple mathematical models complicated dynamics nature 261 5560 459–467doi1010382 61459a0 pmid 934280 43 mccormick chen k ramaswamy p kenyon c 2012 new genes extend caenorhabditis elegans lifespan response reproductive signals aging cell 112192 202 44 medawar pb 1952 unsolved problem biology lewis london 45 medvedev za 1990 attempt rational classification theories ageing biol rev camb philos soc 65 3 375 398 46 mitteldorf j 2006 chaotic population dynamics evolution ageing proposing demographic theory senescenc e evol ecol res 8 561 –74 47 morowitz hj singer jl eds1995 mind brain complex adaptive systems addison wesley isbn 0201409860 48 mulá mav 2004 age httpwwwmeucatcomvihtml 49 niedermueller h hofecker g 1990 anwendungsmöglichkeiten des prinzips der autopoiese auf physiologische und gerontologische fragestellungen k ratky kw und wallner f grundprinzipien der selbstorganisation hrsg darmstadt wbg 1990 isbn 3 53410971 6 email thomasjicun gmailcom 11 50 popper kr 1994 zwei bedeutungen von falsifizierbarkeit two meanings falsifiability seiffert h radnitzky g handlexiko n der wissenschaftstheorie münchen deutscher taschenbuch verlag pp 82–85 isbn 342304586 8 51 university washington aging genes interventions database 2012 httpwwwprimateportalorglinkuniversity washington aging genes andinterventions database 52 van raamsdonk jm hekimi 2009 deletion mitochondrial superoxide dismutase sod 2 extends lifespan caenorhabditis elegans plos genetics 5 2 e1000361 53 wang j michelitsch wunderlin mahadeva r 2009 aging consequence misrepair – novel theory aging arxiv 09040575 arxivorg 54 weaver w 1948 science complexity american scientist 36 4 536 –44 55 weismann 1889 essays upon heredity kindred biological problems clarendon press oxford 56 williams gc 1957 pleiotropy natural selection evolution senescence evolution 11398 – 411 57 wodinsky j 1977 hormonal inhibition feeding death octopus control optic gland secretion science 148 4320 948 –51 58 wolkow ca kimura kd lee ms ruvkun g 2000 regulation c elegans life span insulinlike signaling nervous system science 290 147 –150 59 wunderlin friedrich r 1992 evolution dynamical structures complex systems springer verlag berlin isbn 3642847838 60 zwaan b 20 03 linking development aging sci aging knowledge environ 47 32",
    "relevance_score": 0.8094,
    "date_score": 0.0,
    "final_score": 0.4047,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Unknown Author",
    "date": "2020-02-21T16:05:22",
    "filename": "2101.07350.pdf",
    "processed_text": "review open access update genetic epigenetic etiology gestational diabetes mellitus review tajudeen yahaya1 titilola salisu2 yusuf b abdulrahman3and abdulrazak k umar3 abstract background many studies conducted genetic epigenetic etiology gestational diabetes mellitus gdm last two decades disease ’ increasing prevalence role global diabetes mellitus dm explosion update genetic epigenetic etiology gdm becomes imperative better understand stem rising incidence disease review therefore articulated gdm candidate genes pathophysiology awareness stakeholders main body genetic epigenetic etiology gdm search discovered 83 gdm candidate genes tcf7l2 mtnr1b cdkal1 irs1 kcnq1 prevalent certain polymorphisms genes modulate betacell dysfunction adiposity obesity insulin resistance several mechanisms environmental triggers diets pollutants microbes may also cause epigenetic changes genes resulting loss insulinboosting glucose metabolism functions early detection adequate management may resolve condition delivery otherwise progress maternal type 2 diabetes mellitus t2dm fetal configuration future obesity dm shows gdm strong risk factor t2dm rare cases type 1 diabetes mellitus t1dm maturityonset diabetes young mody shows gdm significantly contributes rising incidence burden dm worldwide prevention may reverse trend conclusion mutations epigenetic changes certain genes strong risk factors gdm affected individuals etiologies medical practitioners formulate drugs treatment procedures target genes pathophysiology keywords adiposity betacell dysfunction epigenetics insulin resistance obesity background pregnant women develop insulin resistance certain stages owing increased placenta hormones women overcome condition upregulating insulin production beta cell expansion 1 gestational diabetes mellitus gdm begins pregnant female make extra insulin needed normalize blood glucose second third trimester pregnancy 1 sometimes glucose intolerance may present pregnancy diagnosed 23 uncontrolled gdm cause high blood pressure type2 diabetes mellitus t2dm increased risks vas cular diseases pregnant women 45 intrauterine ex posure high blood glucose may program offspring develop diabetes obesity later life 6 may also cause macrosomia birth defects preterm birth de velopmental delay 7–9 gdm common metabolic condition pregnancy 10 global incidence rate 1 28 11 2017 gdm affected 204 million women worldwide projection increase 308 million 2045 mostly developing countries 12 though times glucose intolerance normalizes soon delivery women gdm high risk developing t2dm later life 13 compared women normal glucose tolerance women © authors 2020 open access article distributed terms creative commons attribution 40 international license httpcreativecommonsorglicensesby40 permits unrestricted use distribution reproduction medium provided give appropriate credit original authors source provide link creative commons license indicate changes made correspondence yahayatajudeengmailcom yahayatajudeenfubkedung 1federal university birnin kebbi pmb 1157 birnin kebbi nigeria full list author information available end articleegyptian journal medical human genetic syahaya et al egyptian journal medical human genetics 2020 2113 httpsdoiorg101186s43042020000548gdm least seven times predisposed t2dm 14 moreover almost half pregnant females gdm develop diabetes decade 14 spring women gdm also 8 times prone diabetes prediabetes 15 show gdm contributes immensely alarming incidence dia betes worldwide 16 diabetes affected 451 mil lion people 2017 5 million died usd 850 billion spent healthcare expenditure 17 considering impact gdm reduction prevalence effective management affected go long way stemming incidence burden diabetes however achieve reduced prevalence gdm proper understanding etiology neces sary fortunately improved biological techniques last two decades led understanding genetic epigenetic etiology disease thus update becomes necessary review therefore articu lated current findings genetic epigenetic eti ology gdm methods databases searched indepth search pubmed scopus springerlink google scholar researchgate databases per formed relevant research articles gdm search terms search terms used retrieve articles gesta tional diabetes mellitus hyperglycemia insulin resist ance obesity glucose metabolism betacell dysfunction gestational diabetes genes search terms used include glucose insensitivity epigenetics diabetes mel litus gestational diabetes testing costeffectiveness prevalence gestational diabetes article inclusion criteria inclusion criteria include following research published english language research focused gdm studies focused genetic epigenetic eti ology gdm articles centered gdm testing cost effectiveness studies published 2000 till date article exclusion criteria exclusion criteria include following studies available english language studies abstract available research described gdm clear gen etic epigenetic mechanisms studies published year 2000results genetic etiology gdm search found mutations genes variants may interact one another environ mental triggers cause gdm fig 1 genetic eti ology gdm overlaps t2dm gdm candidate genes also predispose humans t2dm explains common pathophysiology gdm t2dm express betacell dysfunction abnormal glucose metabolism 18 contrary reports gdm also shares common pathophysi ology type 1 diabetes mellitus t1dm maturityonset diabetes young mody less 10 gdm patients show associations 18 though many genes reportedly showed association obesity insulin resistance betacell dysfunction present study discovered 83 genes clear gdm pathophysiology presented table 1 frequent gdm candidate genes list gdm candidate genes inexhaustible genes continually discovered however certain genes often linked disease table 2 shows frequent gdm candidate genes variants various ethnic groups table 2 used pie chart fig 2 express percentage occurrence gene based ethni city tcf7l2 gene frequent present 17 ethnics followed mtnr1b 15 cdkal1 10 kcnq1 10 irs1 10 genes widespread often found certain ethnics regions genes include zranb3 found africa 96abcc8 found among finnish 119chemerin found among iranians 120 ins found among greeks 121 genes used develop genetic testing guideline predict like lihood gdm determine genetic epigenetic etiology important genetic testing procedure yet gdm partly con dition multifactorial several genes interact environmental triggers cause disease thus mutation single gene may explain full suscepti bility gdm testing candidate genes expensive cumbersome low prevalence gdm past also contributes lack interest developing genetic testing guideline disease epigenetic etiology gdm epigenetics refers study heritable changes biological processes caused modification chemical tags dna methyl ethyl groups 122 modifications mediated mechanisms including dna methylation histone modification andyahaya et al egyptian journal medical human genetics 2020 2113 page 2 13microrna expression 122 epigenetic mechanisms play important roles several cellular activities cer tain environmental triggers reprogram epige nome resulting disease pathologies 123 particular epigenetic mechanisms regulate several genes maintain betacell morphology proliferation functions thus implies epigenetic modification may disrupt insulin secretion sensitivity causing meta bolic diseases including gdm 124125 epigenetic changes expressed somatic gamete cells thus transmitted generation gener ation 126 studies reported many ins tances epigenetic modi fications involving insulin synthesis glucose metabolism gdm instance histone underacetylation methylation promoter region pdx1 gene duce insulinboosting function gene 127 also study examined methylation il10 gene among pregnant women hypomethylation maternal blood cells elevated plasma il10 levels noticed women gdm 128 another study compared themirna profiles diabetic pregnant rats nondiabetic repression mir338 overexpression mir451 associated reduced βcell mass diabetic 129 vitro upregulation mir451 repres sion mir338 study increased βcell mass leading improved glucose metabolism 129 study investigated mirna expressions maternal fetal blood cells pregnant women 29 mirnas upregulated individuals gdm 130 mir nasmirna340 confirmed downregulate ex pression paip1 gene 130 vitro normalization themirna340 expression diabetic mothers creased insulin production 130environmental triggers genetic epigenetic etiology gdm genetic epigenetic etiology gdm diated certain environmental triggers change gene functions genetic triggers mutate genes epigenetic triggers affect chemical tags dna without affecting nucleotide sequence fig 3 among environmental triggers pollution microbial ex posures whose gdm modulatory roles estab lished several studies study monitored effects air pollution among pregnant southern califor nians prepregnancy exposures nitrogen dioxide 2 particulate matter pm25 pm10 dioxin lated gdm 131 nitrogen dioxide particulate matter cause oxidative stress overexpression proin flammatory cytokines endothelial dysfunction result n gi ni n c r e e di n u l nr e n c e 132 dioxin compounds interact peroxisome proliferator activated receptor γpparg disrupting insulin signaling pathways resulting insulin resistance abnormal glucose metabolism 133 exposure pathogenic micro bial organisms may disrupt gut microbiota com promise immune system leading metabolic disorders gdm vu et al 134d e n r e di nr b bits toxin produced staphylococcus aureus may interact fat cells immune system resulting inflammation insulin resistance glucose intolerance 134 study microbiota pregnant women individuals gdm showed gut microbiota im balance containing majorly phylum actinobacteria genus collinsella rothia desulfovibrio 135 balanced gut microbiota necessary optimum tabolism immune system aside microbial infection environmental factors may disrupt fig 1 genetic etiology gestational diabetes mellitusyahaya et al egyptian journal medical human genetics 2020 2113 page 3 13table 1 gdm predisposing genes showing locations phathophysiology number gene full name locus pathophysiology 1 tcf7l2 transcription factor 7like 2 10q2 increases apoptosis impairing insulin secretion 19 2 kcnq1 potassium voltagegated channel sub family q member 111p155 154it disrupts influx calcium channel resulting decreased insulin secretion 20 3 centd2 arap1centaurindelta2 arfgap rhogap domain ankyrin repeat ph domain 111q134 causes disruption glucoseinduced insulin secretion 21 4 mtnr1b melatonin receptor 1b 11q143 decreases insulin secretion elevating fasting glucose levels 22 5 igf1 insulinlike growth factor 1 12q232 induces high body mass hbm leading metabolic disturbances especially insulin resistance hyperinsulinemia 23 6 igf2 insulinlike growth factor 2 11p155 overexpression igf2 leads βcell dedifferentiation endoplas mic reticulum stress causing islet dysfunction 24 7 igfbp1 insulin like growth factor binding protein 17p123 decreased blood levels igfbp1 cause overexpression igfi result ing inflammation 25 8 igfbp2 insulin like growth factor binding protein 32q35 reduced expression igfbp2 inhibits adipogenesis leading obesity insulin resistance 26 9 igf2bp2 insulin like growth factor 2 mrna binding protein 23q272 impairs βcell function modulates obesity altering insulin sensitivity 27 10 igfbp3 insulin like growth factor binding protein 37p123 overexpression igfbp3 predisposes hbm body disrupting glu cose metabolism 28 11 igfbp4 insulin like growth factor binding protein 417q212 reduced levels cause hbm insulin resistance 28 12 igfbp5 insulin like growth factor binding protein 52q35 disrupts igf1 signaling pathway leading insulin insensitivity 29 13 pparg peroxisome proliferatoractivated recep tor gamma3p252 stimulates abnormal fat deposition tissues causing obesity insulin resistance 27 14 kcnj11 potassium voltagegated channel sub family j member 1111p151 reduces sensitivity pancreatic betacell katp channel subunit kir62 resulting decreased insulin release 28 15 insr insulin receptor 19p132 predisposes obesity leading insulin resistance 29 16 adrb2 adrenoceptor beta 2 5q32 increases secretion vascular endothelial growth factora vegf βcells resulting hypervascularized islets disrupting sulin secretion glucose metabolism 30 17 adrb3 adrenoceptor beta 3 8p1123 increases body weight predisposing obesity insulin resistance 31 18 gnb3 g protein subunit beta 3 12p1331 causes highfat deposition obesity 32 19 abcc8 atp binding cassette subfamily c member 811p151 loss function gene disrupts katp channel function increasing body weight causing hyperinsulinism 33 20 capn10 malpain 10 2q373 increases body mass initiating insulin resistance 34 21 mbl2 mannosebinding lectin 10q211 causes frequent infections chronic inflammatory diseases leading highfat deposition insulin resistance 35 22 glut4 slc2a4glucose transporter type 4solute carrier family 2 member 417p131 impairs insulin signaling pathway 36 23 rbp4 retinol binding protein4 10q2333 increases gluconeogenesis impairs insulin signaling muscles 37 24 pck1 phosphoenolpyruvate carboxykinase 1 20q1331 induces high levels fasting insulin causing abnormal glucose metabolism 38 25 pik3r1 pi3k phosphoinositide3kinase regulatory subunit 15q131 disrupts insulin signaling pathway skeletal muscle inhibit liver gluconeogenesis 38 26 stra6 signaling receptor transporter retinol stra615q241 promotes fat deposition predisposing obesity insulin resistance 39 27 vdr vitamin receptor 12q13 predisposes obesity causing metabolic disorder especially insulin resistance 4041 28 cdkal1 cyclindependent kinase 5 regulatory subunitassociated protein 1like 16p223 inhibits conversion proinsulin insulin protein translation leading insulin resistance 42 29 gck glucokinase 7p13 increases body fat mass resulting insulin resistance 43yahaya et al egyptian journal medical human genetics 2020 2113 page 4 13table 1 gdm predisposing genes showing locations phathophysiology continued number gene full name locus pathophysiology 30 cdkn2a2b cyclindependent kinase inhibitor 2a 9p213 affects proinsulin conversion insulin reduces insulin sensitivity 44 31 srr serine racemase 17p133 disrupts secretion insulin andor glucagon 45 32 hhexide hematopoietically expressed homeobox 10q2333 causes pancreatic liver developmental error 46 33 slc30a8 solute carrier family 30 member 8 8q2411 modulates loss zinc beta cells destabilizing insulin molecule s47 34 lep leptin 7q313 promotes inflammation causing energy imbalance obesity 48 35 lepr leptin receptor 1p31 induces highfat mass insulin resistance 49 36 hnf1btcf2 hepatocyte nuclear factor 1b 17q12 causes βcell dysfunction 5051 37 tnfαtnf tumor necrosis factor α 6p2133 causes inflammatory oxidative stress 52 38 hnf4atcf1 hepatocyte nuclear factor 4 alpha 20q12 induces βcell dysfunction 5051 39 wfs1 wolfram syndrome 1 4p161 initiates endoplasmic reticulum stress mitochondrial disorder leading βcell dysfunction 53 40 irs1 insulin receptor substrate 1 2q363 induces inflammatory response causing low insulin sensitivity 54 41 htr2b 5ht 1a5hydroxytryptamine receptor 1a 5q123 reduces betacell proliferation increases body weight 55 42 tph1 tryptophan hydroxylase 1 11p151 causes low levels serotonin increasing weight gain causing insulin intolerance 56 43 5ht1a htr3a5hydroxytryptamine receptor 1a 5q123 causes low serotonin levels resulting insulin resistance 57 44 hnf1a hepatocyte nuclear factor1 alpha 12q2431 causes adiposity leading prepregnancy obesity insulin resist ance 57 45 gckr glucokinase regulator 2p233 overexpression gckr causes hyperactivity gck reducing glucose increasing fat accumulation 58 loss function reduces gck expression impairing glucose clearance 59 46 mif macrophage migration inhibitory factor 22q1123 overexpression mif gene placental tissue causes insulin resistance 60 47 adra2a alpha2adrenergic receptors 10q252 increases body fat mass leading loss glucose regulation 61 48 slc6a4 solute carrier family 6 member 4 17q112 impairs serotonin metabolism increasing body weight causing insulin resistance 62 49 fto fat mass obesityassociated gene alphaketoglutarate dependent dioxygenase16q122 causes adiposity leading prepregnancy obesity insulin resist ance 63 50 tle1 transducinlike enhancer split1 9q2132 elevates fasting glucose level reduces insulin secretion 64 51 adcy5 adenylate cyclase 5 3q211 alters adcy5 expression pancreatic beta cells impairing glucose signaling 65 52 il1β interleukin1 beta 2q141 impairs pancreatic βcells decreasing insulin secretion 66 53 il6 interleukin6 7p153 overexpression destroys pancreatic βcells resulting apoptosis low insulin synthesis 67 54 il10 interleukin10 1q321 overexpression compromises immune response disrupting insulin metabolism 68 55 pax8 paired box 8 2q141 reduces islet viability beta cell survival 69 56 adipoq diponectin geneadiponectin c1q collagen domain containing3q273 causes low adiponectin leading obesity insulin resistance 70 57 rarres2 chemerin generetinoic acid receptor responder 2 7q361 initiates inflammation energy imbalance leading obesity insulin resistance 71 58 serpina12 vaspin geneserpin family member 12 14q3213 causes inflammation loss energy balance obesity 72 59 retn resistin 19p132 causes loss energy balance obesity insulin resistance 73yahaya et al egyptian journal medical human genetics 2020 2113 page 5 13gut microbiota include certain diseases oral microbiome diets antibiotic use among others 136 lifestyles short sleep poor nutritional choices advanced age physical inactivity environmen tal triggers may predispose humans gdm short hour sleep night increase body fat accumulation duce glucose metabolism predispose t2dm gdm study determines frequency gdmamong sleepdeprived 668 singaporeans 131 representing 19 diagnosed gdm 273 sleep less 6 hours night 168 sleep 78 hours 137 poor nutrition en ergydense western diets may cause overweight obesity disrupting insulin signal ing pathways insulin sensit ivity saturated fats dis rupt insulin signaling induce inflammation endothelial dysfunction resulting gdm study evaluatedtable 1 gdm predisposing genes showing locations phathophysiology continued number gene full name locus pathophysiology 60 apln apelin xq261 causes loss energy balance obesity insulin resistance 74 61 nucb2 nesfatin 1 genenucleobindin 2 11p151 causes loss energy balance obesity insulin resistance 75 62 itln1 intelectin1omentin1 1q233 loss function induces insulin resistance 76 63 namptpbef1 visfatin genenicotinamide phosphoribosyltransferase 7q223 causes obesity insulin resistance 76 64 hmg20a ibrafhigh mobility group protein 20a 15q243 depletion represses expression insulinproducing genes neu rod mafa gck enhances betacell dedifferentiating gene pax4 rest 77 65 rreb1 ras responsive element binding protein 16p243 causes fat deposition beta cell dysfunction 78 66 glis3 glis family zinc finger 3 9p242 causes fat deposition beta cell dysfunction 78 67 gpsm1 g protein signaling modulator 1 9q343 causes fat deposition beta cell dysfunction 78 68 mtdna mitochondrial dna cells induces oxidative stress mitochondrial disorder causing insulin resistance 79 69 prlr prolactin receptor 5p132 modulates loss prlr signaling βcells reducing βcell proliferation expansion pregnancy 80 70 mafb maf bzip transcription factor b 20q12 causes inadequate βcell expansion 80 71 sert serotonin transporter 17q111 12stimulates abnormal fat accumulation white brown adipose tissues causing glucose intolerance insulin resistance 81 72 pai1 plasminogen activator inhibitor 1 7q22 predisposes adiposity increasing body weight affecting pancreatic betacell function 82 73 tspan8 tetraspanin8 12q211 impairs gestational glucose tolerance 83 74 g6pc2 glucose6phosphatase catalytic subunit 22q311 elevates fasting glucose level reduces insulin secretion 64 75 ptprd protein tyrosine phosphatase receptor type d9p241 p23disrupts insulin signaling pathway leading altered insulin sensitivity glucose homeostasis 84 76 crp creactive protein 1q232 overexpression causes obesity resulting systemic inflammation insulin resistance 85 77 gk glycerol kinase xp212 deficiency causes abnormal insulin metabolism 86 78 pax4 paired box gene 4 7q321 impairs fetal islet cell differentiation altering insulin sensitivity later life 87 79 hdac4 histone deacetylase 4 2q373 causes βcell loss leading decreased insulin secretion also represses betacell transcriptional factors 88 80 fetua ahsg fetuina 3q273 increases body mass insulin secretion cpeptide levels lower insulin sensitivity 89 81 fetub fetuinb 3q273 increases hepatic steatosis impairing insulin secretion glucose metabolism 90 82 fgf21 fibroblast growth factor 21 10q2613 cause abnormal glucose metabolism independent insulin resistance 91 83 snora8 emerging candidate gene 92yahaya et al egyptian journal medical human genetics 2020 2113 page 6 13table 2 prevalent gestational diabetes mellitus genes across countries ethnicity race world gene countriesethnicityrace variants level significance references tcf7l2 mexicans rs7901695 p 216 × 10−693 rs7901696 p 005 93 rs7901697 p 005 93 rs7901698 p 005 93 asians rs7903146 p 0001 94 scandinavians rs7903146 p 005 95 africans rs7903146 p 7288 × 10−1396 hispaniclatinos rs7903146 p 005 97 caucasiansdanish rs7903146 p 000017 98 caucasian rs4506565 p 0001 99 kcnq1 mexicans rs2237892 p 198 × 10−593 rs163184 p 005 93 rs2237897 p 005 93 koreans rs2074196 p 0039 100 rs2237892 p 005 100 east asians rs2074196 p 0039 100 rs2237892 p 005 100 pakistan rs2237895 p 005 101 mtnr1b mexicans rs1387153 p 005358 93 asians rs10830963 p 0001 94 caucasians rs10830963 p 0001 94 koreans rs10830962 p 249 × 10−13102 danish rs10830963 p 005 103 rs1387153 p 005 103 saudi arabians rs1387153 p 005 104 rs10830963 p 005 104 pparg asians rs1801282 p 0011 94 caucasians rs1801282 p 005 99 rs3856806 p 005 99 caucasiansdanish rs1801282 p 005 98 cdkal1 koreans rs7754840 p 249 × 10−13102 caucasians rs7756992 p 005 99 caucasiandanish rs7756992 p 000017 98 iranians rs7754840 p 0001 105 irs1 scandinavians irs1 arg972 p 005 106 americans arg972 p 005 107 saudi arabians rs1801278 p 001 108 austrohungarians rs7578326 p 005 109 hmga2 africans rs138066904 p 2516 × 10−996 africa americans rs343092 p 005 96 europeans rs2258238 p 005 96 igf2bp2 koreans rs4402960 p 0001 110 caucasiansdanish rs4402960 p 0001 111 chinese rs4402960 p 0001 112yahaya et al egyptian journal medical human genetics 2020 2113 page 7 13the effect dietary patterns among pregnant chinese women diets containing high protein low starch associated reduced risk gdm 138 energydense diets deficient betaine methyl donor methylating important biological processes well substrate methionine metabolism 139 diets low betaine may induce abnormal methylation genes involved insulin synthesis glucose metabolism ad vanced age may also predispose pregnant women gdm mitochondrial functions decline age leading reduced metabolic activities increased body mass index 140 aging changes epigenetic pattern affecting h ee x p r e fs eg e n e si n volved glucose metabol ism particularly cox7a1 gene respiratory chain 141 study 1688 women northwest london developed gdm advanced maternal age linked gdm 142 studies demonstrate role physical inactivity pathogenesis gdm scarce however e ca n dm e n l sb ym n g et al 143s h w physical activity pregnancy decrease oc currence gdm suggesting lack exercise risk factor mechanisms inactivitymediates diseases include itochondrial dysfunction changes composition uscles insulin resist ance among others 144 physical inactivity influences epigenome negatively affecting several generations 145 gdm testing efficacy costeffectiveness early detection gdm important prevent short longterm effects especially maternal progression t2dm fetal programming dm later life cer tain features bm1 30 kgm2as well previ ous gdm baby birth weight 45 kg macrosomia suggest need gdm test 146 preg nant women family history dm ethnic groups high prevalence dm asian black africancaribbean middle eastern also consider test 146147 stated earlier genetic testing procedure yet gdm however two tests namely glucose challenge test gct oral glucose tol erance test ogtt frequently conducted 2428 weeks pregnancy diagnose gdm two tests done succession known 2step screening ogtt alone done called 1step screening 2step screening gct otherwise known glucose screening test done first entails testing blood glucose one hour drinking sweet sub stance without fasting blood glucose 140 mgdl 78 mmoll higher ogtt necessary 148 ogtt measures blood glucose 8hour fasting glucose substance 75 g taken blood glucose remeasured 1 2 3 hours high blood glucose levels two blood test times suggest gdm 148 though patho physiology gdm similar t2dm gct 200 mgdl could indicate t2dm 148 relatively recently serum levels creactive protein crp well glycated hemoglobin hba1c ran dom blood sugar rbs used screening tools gdm first trimester crp concentrations 6 mgl higher undiluted serum samples con sidered positive gdm 149 according inter national association diabetes pregnancy study group iadpsg cutoff level hba1c 65 rbs 111 mmol 200mgdl 150table 2 prevalent gestational diabetes mellitus genes across countries ethnicity race world continued gene countriesethnicityrace variants level significance references gckr malaysians rs780094 p 005 113 american caucasians rs780094 p 005 114 brazilians rs780094 p 005 115 fgf21 iranians expression mrna p 0001 116 chinese expression mrna p 0001 117 australians expression mrna p 0001 118 fig 2 percentage prevalence implicated gdm genes data extractedyahaya et al egyptian journal medical human genetics 2020 2113 page 8 13the costeffectiveness gdm testing controversial depends region race screening tools methods systematic review fitria 151 ported gdm testing controlling effective highincome countries could due low prevalence disease region encompassing health care system however gdm test ing could worthwhile countries high preva lence gdm nations poor healthcare system example marseille et al 152 reported costeffectiveness gdm testing using devised model israel india known high gdm inci dence rates 2step gtt often recommended however systematic review metaanalysis saconne et al 153 showed significant costeffective difference two methods 2step screen ing also timeconsuming inconvenient may put patients 150154 glycated hemoglobin rbs simple gdm screening tools gain ing acceptance worldwide however awareness understanding tools necessary conclusion several articles reviewed showed mutation epi genetic modifications certain genes predispose humans gdm gdm candidate genes identified also implicated pathogenesis t2dm diseases share common pathophysi ology two metabolic disorders expressed oxidative stressinduced betacell dysfunction insulin resistance adiposity obesity one major difference tween gdm t2dm resolves times delivery however may progress t2dm checked shows gdm strong risk factor t2dm thus detection management may reduce prevalence dm worldwide gdm candidate genes identified variants tcf7l2 mtnr1b cdkal1 irs1 kcnq1 widespread others confined certain ethnic groups genetic testing procedure developed around genes predict likelihood gdm deter mine genetic epigenetic etiology go long way stemming incidence dm worldwide abbreviations crp creactive protein dm diabetes mellitus gct glucose challenge test gdm gestational diabetes mellitus hba1c glycated hemoglobin iadpsg international association diabetes pregnancy study group mody maturity onset diabetes young 2 nitrogen dioxide ogtt oral glucose tolerance test pm25 particulate matter size 25 pm10 particulate matter size 10 rbs random blood sugar t1dm type 1 diabetes mellitus t2dm type 2 diabetes mellitus acknowledgements none authors ’ contributions ty conceptualized literature search drafted manuscript correspondence ts designed article literature search ya article selection proofreading au article selection proofreading authors read approved manuscript funding none availability data materials applicable ethics approval consent participate applicable consent publication applicable competing interests authors declare competing interests author details 1federal university birnin kebbi pmb 1157 birnin kebbi nigeria2department zoology environmental biology olabisi onabanjo university agoiwoye agoiwoye ogun state nigeria3department biochemistry molecular biology federal university birnin kebbi birnin kebbi nigeria fig 3 epigenetic etiology gestational diabetes mellitusyahaya et al egyptian journal medical human genetics 2020 2113 page 9 13received 14 november 2019 accepted 11 february 2020 references 1 national institute diabetes digestive kidney diseases niddk symptoms causes gestational diabetes httpswwwniddknihgov healthinformationdiabetesoverviewwhatisdiabetesgestational symptomscauses 2 fernándezmorera jl rodríguezrodero menéndeztorre e et al 2010 possible role epigenetics gestational diabetes cause consequence obstet gynecol int 2010605163 httpsdoiorg10 11552010605163 3 american diabetes association ada standards medical care diabetes 2018 ” diabetes care 201841suppl 1s13 –s27 doi httpsdoi org102337dc18s002 4 rayanagoudar g hashi aa zamora j et al 2016 quantification type 2 diabetes risk women gestational diabetes systematic review metaanalysis 95750 women diabetologia 591403 –1411 httpsdoiorg 101007s0012501639272 5 burlina dalfrà mg lapolla clinical biochemical approach predicting postpregnancy metabolic decompensation diabetes res clin pract 2018145178 –183 doi101016jdiabres201802035 doi httpsdoi org101016jdiabres20180203 5 6 yessoufou moutairou k maternal diabetes pregnancy early long term outcomes offspring concept “ metabolic memory experimental diabetes research 2011 2011 article id 218598 httpsdoi org1011552011218598 7 metzger 2009 hapo study cooperative research group hyperglycemia adverse pregnancy outcome hapo study associations neonatal anthropometrics diabetes 58453 –459 https doiorg102337db081112 8 freinkel n 1980 banting lecture 1980 pregnancy progeny diabetes 291023 –1035 9 farahvar walfisch sheiner e 2019 gestational diabetes risk factors longterm consequences mother offspring literature review expert rev endocrinol metab 14163 –74httpsdoiorg10108017446651 20181476135 10 franzago fraticelli f stuppia l vitacolonna e 2019 nutrigenetics epigenetics gestational diabetes consequences mother child eigenetics 143215 –235httpsdoiorg1010801559229420191582277 11 hod kapur sacks et al 2015 international federation gynecology obstetrics figo initiative gestational diabetes mellitus pragmatic guide diagnosis management care j gynecol obstet 131suppl 3s173 –s211 12 diabetes g international diabetes federation –home available online wwwidforgouractivitiescarepreventiongdm 13 zhao j1 weiler ha longterm effects gestational diabetes offspring health pronounced skeletal growth body composition glucose tolerance br j nutr 20101041116419 doi 101017 s0007114510002631 14 damm p1 houshmandoeregaard kelstrup l et al gestational diabetes mellitus longterm consequences mother offspring view denmark diabetologia 201659 713961399 doi httpsdoiorg10 1007s0012501639855 15 clausen td mathiesen er hansen et al 2008 high prevalence type 2 diabetes prediabetes adult offspring women gestational diabetes mellitus type 1 diabetes role intrauterine hyperglycemia diabetes care 31340 –346 httpsdoiorg102337dc071596 16 assche fav holemans k aerts l 2011 longterm consequences offspring diabetes pregnancy british medical bulletin 601173 – 182httpsdoiorg101093bmb601173 17 international diabetes federation diabetes atlas 8th ed 2017 available online httpfmdiabetesorgwpcontentuploads201803idf2017pdf 18 kaaja r rönnemaa 2008 gestational diabetes pathogenesis consequences mother offspring rev diabet stud 54194 –202 httpsdoiorg101900rds20085194 19 shu l sauter ns schulthess ft matveyenko av oberholzer transcription factor 7like 2 regulates betacell survival function human pancreatic islets diabetes 2008 57 645653 20 macdonald pe ha xf wang j smukler sr sun gaisano hy 2001 members kv1 kv2 voltagedependent k channel familiesregulate insulin secretion mol endocrinol 1581423 –1435 httpsdoiorg 101210mend1580685 21 huertachagoya vázquezcárdenas p morenomacías h tapiamaruri l rodríguezguillén r lópezvite e 2015 genetic determinants gestational diabetes mellitus related metabolic traits mexican women plos one 105e0126408 httpsdoiorg101371journalpone 0126408 22 prokopenko langenberg c florez jc et al 2009 variants mtnr1b influence fasting glucose levels nature genetics 41177 –8119060907 23 shang wen z 2018 increased placental igf1mtor activity macrosomia born women gestational diabetes diabetes research clinical practice 146211 –219httpsdoiorg101016jdiabres201810 017 24 casellas mallol c salavert jimenez v garcia agudo j 2015 insulin like growth factor 2 overexpression induces βcell dysfunction increases betacell susceptibility damage journal biological chemistry 29016772 –16785 httpsdoiorg101074jbcm115642041 25 ramirez vi miller e meireles cl gelfond j krummel da powell tl 2014 adiponectin igfbp1 development gestational diabetes obese mothers bmj open diabetes research care 2e000010 https doiorg101136 bmjdrc2013000010 26 demambro clemmons dr horton lg bouxsein ml wood tl beamer wg 2008 genderspecific changes bone turnover skeletal architecture igfbp2null mice endocrinology 1492051 –2061 httpsdoi org101210en20071068 27 chon sj kim sy cho nr min dl hwang yj mamura 2013 association variants ppar γ² igf2bp2 kcnq1 susceptibility gestational diabetes mellitus korean population yonsei medical journal 542352 –357 httpsdoiorg103349ymj2013542352 28 schwanstecher c meyer u schwanstecher 2002 kir62 polymorphism predisposes type 2 diabetes inducing overactivity pancreatic beta cell atpsensitive k channels diabetes 51875 –879 httpsdoiorg10 2337diabetes513875 29 ober c xiang ks thisted ra indovina ka wason cj dooley 1989 increased risk gestational diabetes mellitus associated insulin receptor insulinlike growth factor ii restriction fragment length polymorphisms genet epidemiol 6559 –569 30 ceasrine lin ee lumelsky dn iyer r kuruvilla r 2018 adrb2 controls glucose homeostasis developmental regulation pancreatic islet vasculature elife 7e39689 httpsdoiorg107554elife39689 31 guan l cui x zhou h 2018 metaanalysis association trp64arg polymorphism beta3 adrenergic receptor susceptibility gestational diabetes mellitus j obstet gynaecol 382172 – 176 httpsdoiorg1010800144361520171331339 32 feng jiang cd chang et al 2019 interactions among insulin resistance inflammation factors obesityrelated gene polymorphisms environmental risk factors diet development gestational diabetes mellitus j matern fetal neonatal med 322339 –347 httpsdoi org1010801476705820181446207 33 kapoor rr flanagan se james ct mckiernan j thomas harmer sc 2011 hyperinsulinaemic hypoglycaemia diabetes mellitus due dominant abcc8kcnj11 mutations diabetologia 54102575 –2583 https doiorg101007s0012501122074 34 castromartínez ag sánchezcorona j vázquezvargas ap garcíazapién ag lópezquintero villalpandovelazco hj association analysis calpain 10 gene variantshaplotypes gestational diabetes mellitus among mexican women cell mol biol noisylegrand 2018 286438186 doi httpsdoiorg1014715cmb201864313 35 megia gallart l 2004 fernándezreal jm vendrell j simón gutierrez c mannosebinding lectin gene polymorphisms associated gestational diabetes mellitus journal clinical endocrinology metabolism 89105081 –5087 httpsdoiorg101210jc20040211 36 catalano pm 2014 trying understand gestational diabetes diabet med 31273 –281 httpsdoiorg101111dme12381 37 yang q graham te mody n et al 2005 serum retinol binding protein 4 contributes insulin resistance obesity type 2 diabetes nature 436 356 –362 38 shimin hu shujuan xun li et al relationships slc2a4 rbp4 pck1 pi3k gene polymorphisms gestational diabetes mellitus chinese population biomed research international 2018 2019article id 7398063 httpsdoiorg10115520197398063 yahaya et al egyptian journal medical human genetics 2020 2113 page 10 1339 shimin h junxia yiping guilian hui z xun l 2019 association polymorphisms stra6 gene gestational diabetes mellitus chinese han population medicine 9811e14885 httpsdoiorg101097 md0000000000014885 40 zhu b huang k yan et al vdr variants rather early pregnancy vitamin concentrations associated risk gestational diabetes ’ anshan birth cohort mabc study j diabetes res 2019 2019 article id 8313901 httpsdoiorg10115520198313901 41 apayd ın beyse eyerci n pinarli fa ulubay kizilgul vdr gene foki polymorphism associated gestational diabetes mellitus turkish women bmc medical genetics 2019 20 article number 82 doi httpsdoiorg101186s1288101908200 42 wang k chen q feng et al single nucleotide polymorphisms cdkal1 gene associated risk gestational diabetes mellitus chinese population j diabetes res 2019 2019 article id 3618103 httpsdoiorg 10115520193618103 43 okruszko kinalski ku źmicki miro ńczuk k wawrusiewiczkurylonek n kretowski kia 2007 glucokinase gene mutations gestational diabetes polish population prediction diabetes mellitus development delivery przegl lek 646401 –405 44 mei j liao liu tan wang h liang 2015 association variants cdkn2a2b cdkal1 genes gestational insulin sensitivity disposition pregnant han chinese women j diabetes investig 63295 – 301 httpsdoiorg101111jdi12315 45 wang nie li w et al 2011 association six single nucleotide polymorphisms gestational diabetes mellitus chinese population plos one 611e26953 httpsdoiorg101371journalpone0026953 46 cho ym kim th lim choi sh shin hd lee hk 2009 type 2 diabetes associated genetic variants discovered recent genomewide association studies related gestational diabetes mellitus korean population diabetol 52253 –261 httpsdoiorg101007s0012500811964 47 seman na mohamud wn östenson cg et al increased dna methylation slc30a8 gene promoter associated type 2 diabetes malay population clin epigenetics 2015 7 30 httpsdoiorg101186 s1314801500495 48 marcello calixto ar de almeida jf et al polymorphism lep lepr may modify leptin levels represent risk factors thyroid cancer int j endocrinol 2015 173218 httpsdoiorg1011552015 173218 49 lin r ju h yuan z zeng l sun su z 2017 association maternal fetal lepr common variants maternal glycemic traits pregnancy sci rep 713112 httpsdoiorg101038s4159801703518x 50 watanabe rm xiang ah allayee h et al variation p2promoter region hepatocyte nuclear factor4a hnf4a associated ßcell function mexican american families proband gestational diabetes diabetes 2005 54 supplement 1 a28 51 ridderstråle groop l 2009 genetic dissection type 2 diabetes molecular cellular endocrinology 2971210 –17 52 ategbo jm grissa yessoufou hichami dramane kl moutairou k 2006 modulation adipokines cytokines gestational diabetes macrosomia j clin endocrinol metab 914137 –4143 53 toppings nb mcmillan jm au p suchowersky donovan le wolfram syndrome case report review clinical manifestations genetics pathophysiology potential therapies case reports endocrinol 2018 2018 article id 9412676 doi httpsdoiorg10115520189412676 54 vana dr adapa prasad vss choudhury ahuja g diabetes mellitus types key genetic determinants risk assessment genet mol res 2019 18 2 gmr16039952 55 kwak sh park bl kim h german ms go mj jung hs association variations tph1 htr2b gestational weight gain measures obesity obesity 2012 20 1 httpsdoiorg101038oby 2011253 56 oh cm park kim h 2016 serotonin new therapeutic target diabetes mellitus obesity diabetes metab j 40289 –98httpsdoi org104093dmj201640289 57 beysel eyerci n ulubay caliskan kizilgul haf ızoğlu maternal genetic contribution prepregnancy obesity gestational weight gain gestational diabetes mellitus diabetol metabol synd 2019 11 article number 37 httpsdoiorg101186s130980190434x 58 pollin ti jablonski ka mcateer jb et al 2011 triglyceride response intensive lifestyle intervention enhanced carriers gckrpro446leu polymorphism j clin endocrinol metab 96e1142 –e1147 https doiorg101210jc20102324 59 grimsby j coffey jw dvorozniak mt magram j li g matschinsky fm characterization glucokinase regulatory proteindeficient mice j biol chem 2000 275 7826 –7831 doi httpsdoiorg101074jbc275117826 60 zheng l li c qi wh et al 2017 expression macrophage migration inhibitory factor gene placenta tissue correlation gestational diabetes mellitus zhonghua yi xue za zhi 973388 –3391 61 kawai vk levinson rt adefurin kurnik collier sp conway 2017 variation α2aadrenergic receptor gene risk gestational diabetes pharmacog 18151381 –1386 httpsdoiorg102217pgs2017 0079 62 leitner fragner l danner holeschofsky n leitner k tischler 2017 combined metabolomic analysis plasma urine reveals ahba tryptophan serotonin metabolism potential risk factors gestational diabetes mellitus gdm front mol biosci 484 httpsdoiorg 103389fmolb201700084 63 beysel eyerci n ulubay caliskan kizilgul haf ızoğlu maternal genetic contribution prepregnancy obesity gestational weight gain gestational diabetes mellitus diabetol metab synd 2019 11 article number 37 httpsdoiorg101186s130980190434x 64 melladogil jm fuentemartín e lorenzo pi cobovuilleumier n lópez noriega l martínmontalvo type 2 diabetesassociated hmg20a gene mandatory islet beta cell functional maturity cell death disease 2018 9 article number 279 65 hodson dj mitchell rk marselli l pullen tj gimeno brias semplici f 2014 adcy5 couples glucose insulin secretion human islets diabetes 6393009 –3021 httpsdoiorg102337db131607 66 mojtaba e mahdi k mehdi kjr amir 2011 serum interleukin1 beta plays important role insulin secretion type ii diabetic inter j bio 1393 –99 67 meier jj ritzel ra maedler k gurlo butler pc 2006 increased vulnerability newly forming beta cells cytokineinduced cell death diabetolog 4983 –89httpsdoiorg101007s0012500500693 68 kang j liu ch lee cn li hy yang cw huang sc 2019 novel interleukin10 gene polymorphism linked gestational diabetes taiwanese population front genet 1089 httpsdoiorg103389fgene 201900089 69 martinmontalvo lópeznoriega l jiménezmoreno c herranz lorenzo pi cobovuilleumier n 2019 transient pax8 expression islets pregnancy correlates βcell survival revealing novel candidate gene gestational diabetes mellitus diabetes 681109 –118httpsdoi org102337db180285 70 takhshid haem z aboualizadeh f 2015 association circulating adiponectin 45 tg polymorphism adiponectin gene gestational diabetes mellitus iranian population j diabetes metab disord 1430 httpsdoiorg101186s402000150156z 71 hasanvand z sadeghi rezvanfar mr goodarzi mt rahmannezhad g mashayekh fj 2018 association chemerin rs17173608 rs4721 gene polymorphisms gestational diabetes mellitus iranian pregnant women gene 64987 –92 httpsdoiorg101016jgene201801061 72 ademoglu e berberoglu z dellal fd ariel mk kose candan z higher levels circulating chemerin obese women gestational diabetes mellitus acta endocrinologica buc 2015 xi 1 3237 doi httpsdoiorg 104183aeb201532 73 steppan cm bailey st bhat et al 2001 hormone resistin links obesity diabetes nature 409307 –312 74 aslan celik celik n et al 2012 cord blood nesfatin1 apelin36 levels gestational diabetes mellitus endocrine 41424 –429 75 franz polterauer springer kuessel l haslinger p worda c 2018 maternal neonatal omentin1 levels gestational diabetes arch gynecol obst 2974885 –889 httpsdoiorg101007s0040401846525 76 ferreira af rezende jc vaikousi e et al 2011 maternal serum visfatin 1113 weeks gestation gestational diabetes mellitus clin chem 57 609 –613 77 melladogil jm fuentemartín e lorenzo pi cobovuilleumier n lópez noriega l martínmontalvo type 2 diabetesassociated hmg20a gene mandatory islet beta cell functional maturity cell death disease 2018 9article number 279 78 ding chavarro j olsen lin ley sh bao w genetic variants gestational diabetes mellitus study 112 snps among 8722 women inyahaya et al egyptian journal medical human genetics 2020 2113 page 11 13two independent populations diabetolog 2018 61 8 1758 –1768 https doiorg101007s0012501846378 79 khan ia shaik na pasupuleti n chav jahan p hasan q 2015 screening mitochondrial mutations insertion –deletion polymorphism gestational diabetes mellitus asian indian population saudi j bio sci 223243 –248httpsdoiorg101016jsjbs201411001 80 banerjee rr cyphert ha walker em chakravarthy h peiris h gu x 2016 gestational diabetes mellitus inactivation prolactin receptor mafb islet βcells diabetes 6582331 –2341 httpsdoiorg102337 db151527 81 zha w ho htb hu hebert mf wang mj serotonin transporter deficiency drives estrogendependent obesity glucose intolerance sci rep 2017 7 article number 1137 doi httpsdoiorg101038s41598017 012915 82 leipold h knoefler gruber c klein k haslinger p worda c 2006 plasminogen activator inhibitor 1 gene polymorphism gestational diabetes mellitus obstet gynecol 1073651 –656 httpsdoiorg101097 01aog000019995327961f9 83 stuebe wise nguyen herring north ke siegariz 2014 maternal genotype gestational diabetes j perinatol 31169 –76 httpsdoiorg101055s00331334451 84 chagnon mj elchebly uetani n dombrowski l cheng mooney ra 2006 altered glucose homeostasis mice lacking receptor protein tyrosine phosphatase sigma j physiol pharmacol 84755 –763 https doiorg101139y06020 85 alamolhoda sh yazdkhasti namdari zakariayi sj mirabi p 2019 association creactive protein gestational diabetes prospective study j obstet gynaecol 91 –5httpsdoiorg101080 0144361520191631767 86 zhang yh van hove jl mccabe er dipple km 2015 gestational diabetes associated novel mutation 378379instt glycerol kinase gene mol genet metab rep 442 –45httpsdoiorg101016jymgmr2015 06004 87 xu shi liu j liu zhu xie c 2017 rs10229583 polymorphism near paired box gene 4 associated gestational diabetes mellitus chinese women j inter med res 461116 –121 httpsdoiorg101177 0300060517714934 88 gong yu liang l vuralli froehler kuehnen p 2019 hdac4 mutations cause diabetes induce βcell foxo1 nuclear exclusion mol genet gen med 75e602 httpsdoiorg101002mgg3602 89 farhan handisurya todoric j tura pacini g wagner 2012 fetuin characteristics pregnancy result case control pilot study inter j endocrinol 896736 httpsdoiorg1011552012896736 90 kralisch hoffmann lössner u 2017 kratzsch j3 blüher stumvoll regulation novel adipokines hepatokines fetuin fetuin b gestational diabetes mellitus metab 6888 –94httpsdoiorg101016j metabol201611017 91 bonakdaran khorasani zm jafarzadeh f 2017 increased serum level fgf21 gestational diabetes mellitus acta endocrinol 133278 –281 httpsdoiorg104183aeb2017278 92 xie k chen zhang wen j cui x l association rs10830962 polymorphism gestational diabetes mellitus risk chinese population sci rep 2019 9article number 5357 doi httpsdoiorg10 1038s41598019416053 93 huertachagoya vázquezcárdenas p morenomacías h et al 2015 genetic determinants gestational diabetes mellitus related metabolic traits mexican women plos one 105e0126408 httpsdoi org101371journalpone0126408 94 wu l cui l tam w et al 2016 genetic variants associated gestational diabetes mellitus metaanalysis subgroup analysis sci rep 630539 httpsdoiorg101038srep30539 95 shaat n lernmark karlsson e et al 2007 variant transcription factor 7like 2 tcf7l2 gene associated increased risk gestational diabetes mellitus diabetologia 50972 –979 96 adeyemo aa zaghloul na chen g et al 2019 zranb3 african specific type 2 diabetes locus associated betacell mass insulin response nat commun 103195 httpsdoiorg101038s41467019109677 97 lin pc lin wt yeh yh wung sf 2016 transcription factor 7like 2 tcf7l2 rs7903146 polymorphism risk factor gestational diabetes mellitus metaanalysis plos one 114e0153044 httpsdoiorg101371 journalpone015304498 lauenborg j grarup n damm p et al 2009 common type 2 diabetes risk gene variants associate gestational diabetes j clin endocrinol metab 941145 –150httpsdoiorg101210jc20081336 99 kawai vk levinson rt adefurin et al 2017 genetic risk score includes common type 2 diabetes risk variants associated gestational diabetes clin endocrinol 872149 –155 httpsdoiorg10 1111cen13356 100 kwak sh kim th cho ym choi sh jang hc park ks 2010 polymorphisms kcnq1 associated gestational diabetes korean population horm res paediatr 74333 –338 101 fatima ss chaudhry b khan ta farooq kcnq1 rs2237895 polymorphism associated gestational diabetes pakistani women pak j med sci 2016 novdec32613801385 doi httpsdoiorg1012669pjms32611052 102 kwak sh jang hc park ks 2012 finding genetic risk factors gestational diabetes genomics inform 104239 –243 httpsdoiorg10 5808gi2012104239 103 ding 2018 chavarro j1 olsen lin ley sh1 bao w et al genetic variants gestational diabetes mellitus study 112 snps among 8722 women two independent populations diabetologia 6181758 –1768 httpsdoiorg101007s0012501846378 104 alharbi kk alsulaiman bin shedaid mk et al mtnr1b genetic polymorphisms risk factors gestational diabetes mellitus case control study single tertiary care center ann saudi med 2019 395 309318 doi httpsdoiorg105144025649472019309 105 mansoori daraei naghizadeh mm salehi r 2015 significance common variant cdkal1 gene susceptibility type 2 diabetes mellitus iranian population adv biomed res 445 httpsdoiorg104103 22779175151256 106 shaat n ekelund lernmark et al 2005 association e23k polymorphism kcnj11 gene gestational diabetes mellitus diabetolog 482544 –2551 107 fallucca f dalfra mg sciullo e et al 2006 polymorphisms insulin receptor substrate 1 beta3adrenergic receptor genes gestational diabetes normal pregnancy metab 551451 –1456 108 alharbi kk khan ia abotalib z alhakeem mm insulin receptor substrate1 irs1 gly927arg correlation gestational diabetes mellitus saudi women biomed res intern 2014 article id 146495 httpsdoiorg101155 2014146495 109 rosta k alaissa z hadarits et al 2017 association study 77 snps confirms robust role rs10830963g mtnr1b variant identifies two novel associations gestational diabetes mellitus development plos one 12e0169781 110 cho ym kim th lim et al 2009 type 2 diabetesassociated genetic variants discovered recent genomewide association studies related gestational diabetes mellitus korean population diabetolog 522253 –261 111 wang nie li w et al 2011 association six single nucleotide polymorphisms gestational diabetes mellitus chinese population plos one 611e26953 112 lauenborg j grarup n damm p et al 2009 common type 2 diabetes risk gene variants associate gestational diabetes j clin endocrinol metab 941145 –150 113 stuebe wise nguyen herring north k siegariz 2013 maternal genotype gestational diabetes j perinatol 31069 –076 114 jamalpour zain sm mosavat mohamed z omar sz casecontrol study metaanalysis confirm glucokinase regulatory gene rs780094 risk factor gestational diabetes mellitus gene 2018 650 34 –40 115 anghebemoliveira mi webber alberton et al 2017 gckr gene polymorphism rs780094 risk factor gestational diabetes brazilian population j clin lab anal 31e22035 116 bonakdaran khorasani zm jafarzadeh f 2017 increased serum level fgf21 gestational diabetes mellitus acta endocrinol buchar 133278 – 281 httpsdoiorg104183aeb2017278 117 chen c cheung bm tso aw et al 2011 high plasma level fibroblast growth factor 21 independent predictor type 2 diabetes 54year populationbased prospective study chinese subjects diabetes care 3492113 –2115 httpsdoiorg102337dc110294 118 nitert barrett hl kubala mh et al 2014 increased placental expression fibroblast growth fa ctor 21 gestational diabetes mellitus j clin endocrinol metab 994e591 –e598 httpsdoiorg10 1210jc20132581yahaya et al egyptian journal medical human genetics 2020 2113 page 12 13119 rissanen j markkanen karkkainen p et al 2000 sulfonylurea receptor 1 gene variants associated gestational diabetes type 2 diabetes altered secretion insulin diabetes care 2370 –73 120 hasanvand z sadeghi rezvanfar mr goodarzi mt rahmannezhad g mashayekhi fj 2018 association chemerin rs17173608 rs4721 gene polymorphisms gestational diabetes mellitus iranian pregnant women gene 64987 –92httpsdoiorg101016jgene201801061 121 litou h anastasiou e thalassinou l et al 2007 increased prevalence vntr iii insulin gene women gestational diabetes mellitus gdm diabetes res clin pract 76223 –228 122 handy de castro r loscalzo j 2011 epigenetic modifications basic mechanisms role cardiovascular disease circulation 123192145 – 2156 httpsdoiorg101161circulationaha110956839 123 feil r fraga mf 2011 epigenetics environment emerging patterns implications nat rev genet 1397 –109 httpsdoiorg101038nrg3142 124 ordovas jm smith ce 2010 epigenetics cardiovascular disease nat rev cardiol 7510 –519 httpsdoiorg101038nrcardio2010104 125 stankov k benc draskovic 2013 genetic epigenetic factors etiology diabetes mellitus type 1 pediatr 1321112 –1122 126 xie z chang c zhou z 2014 molecular mechanisms autoimmune type 1 diabetes critical review clin rev allergy immunol 47174 –192 127 kimmins sassonecorsi p 2005 chromatin remodelling epigenetic features germ cells nature 4347033583 –589 128 kang j lee cn li hy hsu kh wang sh lin sy 2018 association interleukin10 methylation levels gestational diabetes taiwanese population front genet 9222 httpsdoiorg103389fgene201800222 129 jacovetti c abderrahmani parnaud g jonas jc peyot ml cornu 2012 micrornas contribute compensatory βcell expansion pregnancy obesity j clin invest 122103541 –3551 httpsdoiorg10 1172jci64151 130 stirm l huypens p sass batra r fritsche l brucker maternal whole blood cell mirna340 elevated gestational diabetes inversely regulated glucose insulin sci rep 2018 813661378 doi https doiorg101038s41598018192009 131 jo h eckel sp chen jc cockburn martinez mp chow 2019 associations gestational diabetes mellitus residential air pollution exposure large southern california pregnancy cohort environ inter 130 104933 –104939 httpsdoiorg101016jenvint2019104933 132 lodovici bigagli e oxidative stress air pollution exposure j toxicol 2011 2011 article 487074 133 saldana tm basso hoppin ja baird dd knott c blair 2007 pesticide exposure selfreported gestational diabetes mellitus agricultural health study diabetes care 303529 –534 httpsdoiorg102337dc06 1832 134 vu bg stach cs kulhankova k salgadopabón w klingelhutz aj schlievert pm chronic superantigen exposure induces systemic inflammation elevated bloodstream endotoxin abnormal glucose tolerance rabbits possible role diabetes mbio 2015 6 2 e0255414 doi https doiorg101128mbio0255414 135 crusell mkw hansen th nielsen allin kh rühlemann mc damm p 2018 gestational diabetes associated change gut microbiota composition third trimester pregnancy postpartum microbiome 6 89httpsdoiorg101186s401680180472x 136 mokkala k röytiö h munukka e pietilä ekblad u rönnemaa 2016 gut microbiota richness composition dietary intake overweight pregnant women related serum zonulin concentration marker intestinal permeability j nutr 14691694 –1700 httpsdoiorg103945jn 116235358 137 dukenus medical school association insufficient sleep gestational diabetes mellitus discovered sciencedaily wwwsciencedaily comreleases201701170109092634htm accessed october 26 2019 138 mak jkl pham nm lee ah tang l pan xf binns cw dietary patterns pregnancy risk gestational diabetes prospective cohort study western china nutr j 2018 17article number 107 doi httpsdoi org101186s1293701804133 139 cai liu h hu jiang zhao r gestational betaine liver metabolism epigenetics patel v preedy v eds handbook nutrition diet epigenetics springer cham 2017 doi httpsdoiorg1010079783 319311432821 140 sivitz w mitochondrial dysfunction obesity diabetes us endocrinol 2010 6 1 2027 doi httpsdoiorg1017925use201006120 141 r¨onn poulsen p hansson et al age influences dna methylation gene expression cox7a1 human skeletal muscle diabetolog 2008 51 11591168 doi httpsdoiorg101007s0012500810188 142 makgoba savvidou steer p 2012 analysis interrelationship maternal age body mass index racial origin development gestational diabetes mellitus bjog 119276 –282 https doiorg101111j14710528201103156x 143 ming w ding w zhang cjp zhong l long li z effect exercise pregnancy gestational diabetes mellitus normalweight women systematic review metaanalysis bmc pregnancy childbirth 2018 18 article number 440 doi httpsdoiorg101186 s1288401820687 144 eriksson kf lindg¨arde f poor physical fitness impaired early insulin response late hyperinsulinaemia predictors niddm middleaged swedish men diabetolog 1996 39573579 145 grazioli e dimauro mercatelli n et al 2017 physical activity prevention human diseases role epigenetic modifications bic genomics 18suppl 8802 httpsdoiorg101186s1286401741935 146 world health organization diagnostic criteria classification hyperglycaemia first detected pregnancy geneva 2013 httpwww whointdiabetespublicationshyperglycaemiainpregnancyen 147 united kingdom national health service overview gestational diabetes updated 2019 available httpswwwnhsukconditi onsgestationaldiabetes 148 united states national institute health tests diagnosis gestational diabetes updated 2017 available httpswwwniddknihgovhealth informationdiabetesoverviewwhatisdiabetesgestationaltestsdiagnosis 149 farghaly ta helmy na abbas ahmed agm creactive protein screening test gestational diabetes mellitus firsttrimester pregnancy prospective cohort study int j reprod contracept obstet gynecol 201874798803 doi httpsdoiorg101820323201770 ijrcog20184922 150 schaible b calhoun bc bush ramser b seybold dj broce hemoglobin a1c screening strategy gestational diabetes med dent res 2018 1 1 14 doi httpsdoiorg1015761mdr1000103 151 fitria n van asselt adi postma mj 2019 costeffectiveness controlling gestational diabetes mellitus systematic review eur j health eco 203 407 –417 httpsdoiorg101007s101980181006y 152 marseille e lohse n jiwani hod seshiah v yajnik cs cost effectiveness gestational diabetes screening including prevention type 2 diabetes application new model india israel j maternalfetal neonat med 2013 26 8 httpsdoiorg103109147670582013765845 153 saccone g caissutti c khalifeh mda scifres c simhan hn 2017 one step versus two step approach gestational diabetes screening systematic review metaanalysis randomized trials journal maternalfetal neonat med 3281 –211 httpsdoiorg1010801476705820171408068 154 amreen suneel shetty vasudeva kumar p use glycosylated hba1c random blood sugar screening tool gestational diabetes mellitus first trimester int j reprod contracept obstet gynecol 20187 5248 doi httpsdoiorg101820323201770ijrcog20180166 publisher ’ sn e springer nature remains neutral regard jurisdictional claims published maps institutional affiliationsyahaya et al egyptian journal medical human genetics 2020 2113 page 13 13",
    "relevance_score": 0.8094,
    "date_score": 0.0,
    "final_score": 0.4047,
    "date_numeric": 0
  },
  {
    "title": "Unknown Title",
    "author": "Iman",
    "date": "2025-03-10T14:20:37",
    "filename": "2503.07798.pdf",
    "processed_text": "1 risk protective factors parkinson ’ disease iman beheshti department human anatomy cell science rady faculty health sciences university manitoba winnipeg mb canada corresponding author dr iman beheshti address 745 bannatyne ave winnipeg manitoba r3e 0j9 canada email imanbeheshtiumanitobaca httpsscholargooglecacitationsuserx0aqyvkaaaajhlenoiao 2 abstract understanding risk protective factors associated parkinson ’ disease pd crucial improving outcomes patients individuals risk healthcare providers healthcare systems studying factors enhances knowledge disease also aids developing effective prevention management treatment strategies paper reviews key risk protective factors associated pd particular focus biological mechanisms underlying factors risk factors include genetic mutations racial predispositions environmental exposures contribute increased likelihood developing pd accelerating disease progression conversely protective factors regular physical exercise adherence mediterranean diet higher urate levels demonstrated potential reduce inflammation support mitochondrial function thereby mitigating disease risk however identifying validating factors presents signific ant challenges include absence reliable biomarkers intricate interactions genetic environmental components clinical heterogeneity observed pd patients barriers complicate establishment clear causal r elationships hinder development targeted prevention strategies overcome challenges propose several solutions recommendations future research prioritize development standardized biomarkers early diagnosis inv estigate gene environment interactions greater depth refine animal models better mimic human pd pathology additionally offer actionable recommendations pd prevention management tailored healthy individuals patients diagnosed wi th pd healthcare systems strategies aim improve clinical outcomes enhance quality life optimize healthcare delivery pd keywords parkinsons disease risk factors symptom genetics biological mechanisms 1 introduction parkinsons disease pd progressive neurodegenerative disorder characterized motor disabilities making second leading cause disabilities adults strokes disease marked classical motor manifestations bradykinesia rigidity gait 3 disorders fluctuate disease progresses 1 core pd involves degeneration dopaminergic neurons substantia nigra pars compacta leading decrease dopamine levels striatum formation intracellular aggregates known lewy bodies 1 disease ’ etiology involves genetic environmental factors crucial understanding developing effective treatments prevention strategies 15 genetic research identified risk factors mutations genes like lrrk2 gba1 common pd patients suggesting genetic predisposition disease mutations vary across populations offering potential tailored treatments 3 environmental factors including pesticides heavy metals air pollution may contribute oxidative stress mitochondrial dysfunction neuroinflammation key mechanisms pd progression 6 lifestyle factors also play protective role regular exercise especially high intensity aerobic activity shown preserve dopamine producing neurons slow symptom progression 7 diets rich antioxidants polyphenols polyunsaturated fatty acids may reduce pd risk cognitive social engagement linked protection cognitive decline pd patients emphasizing importance mental stimulation 8 recent studies also focused gut brain axis microbiome dysbiosis offering new therapeutic possibilities 9 10 review explore various categories risk protective factors associated pd focusing primarily biological mechanisms behind interactions rather epidemiological correlations address current challenges identifying verifying factors propose potential solutions development standardized biomarkers studying gene environment interactions improving animal models importantly also emphasize need increased awa reness education patients risk individuals healthcare providers —an aspect often overlooked research includes providing insight underlying molecular mechanisms risk protective factors pd integrating gen etic environmental lifestyle factors research aims enhance understanding pds risk protective mechanisms finally highlight preventive strategies lifestyle changes early interventions reduce global burden f pd improve patient outcomes 4 2 molecular mechanisms pd molecular mechanisms underlying pd constitute complex interconnected network key factors including α synuclein aggregation mitochondrial dysfunction oxidative stress neuroinflammation ferroptosis gut dysbiosis contribute progressive neurodegeneration seen pd fig 1 understanding mechanisms essential identifying risk factors preventive strategies potential interventions slow halt pd progression table 1 presents list key biological mechanisms pd along associated risk factors section provides overview primary molecular processes involved pd highlighting interactions role pathogenesis disease figure 1 interrelationship key biological mechanisms pd 21 αsynuclein aggregation 5 αsynuclein aggregation considered one earliest central events pd pathogenesis pathological conditions α synuclein presynaptic neuronal protein misfolds aggregates insoluble fibrils forming lewy bodies —a hallmark pd 11 aggregates disrupt neuronal function believed propagate cell cell contributing spread pathology recent studies shown α synuclein aggregates transmitted neighboring cells seeding aggregatio n healthy neurons cell tocell transmission critical factor spread pathology pd 12 furthermore binding calcium ions ca2 c terminus α synuclein shown regulate binding synaptic membranes may influence aggregation dynamics 13 αsynuclein aggregation initiates cascade events lead • mitochondrial dysfunction direct interaction mitochondria impairing function reducing atp production • oxidative stress disrupting cellular metabolism mitochondrial function • neuroinflammation activating microglia brains immune cells • gut dysbiosis misfolded αsynuclein potentially propagate gut brain axis 22 mitochondrial dysfunction mitochondrial dysfunction plays pivotal role pd pathogenesis impairment mitochondrial function particularly complex electron transport chain leads reduced atp production increased generation reactive oxygen species ros 14 dysfunction exacerbated interaction α synuclein aggregates mitochondria recent research highlighted generalized reduction mitochondrial quality control proteins dopaminergic neurons pd patients includes decrease proteins pink1 parkin mitochondrial chaperones crucial main taining mitochondrial proteostasis function 14 mitochondrial dysfunction contributes • oxidative stress increased ros production • energy deficits neurons particularly affecting dopaminergic neurons substantia nigra 6 • ferroptosis enhancing iron accumulation lipid peroxidation 23 oxidative stress oxidative stress occurs theres imbalance production ros bodys ability detoxify reactive intermediates repair resulting damage pd elevated ros levels cause damage lipids proteins dna exacerbati ng neuronal injury interplay oxidative stress pd mechanisms creates vicious cycle • mitochondrial dysfunction cause consequence oxidative stress • oxidative damage activates microglia inducing neuroinflammation • lipid peroxidation caused oxidative stress contributes ferroptosis dopaminergic neurons 24 neuroinflammation neuroinflammation pd involves activation microglia immune cells response neuronal damage α synuclein aggregates chronic inflammation damages neurons promotes disease progression recent studies shown tha microglial activation response neuronal damage also contributor progression pd 15 activated microglia release exosomes containing α synuclein may propagate neuroinflammation neurodegeneration affecting distant dopaminergic neurons neuroinflammation exacerbates pd pathology • promoting αsynuclein aggregation • increasing oxidative stress release pro inflammatory cytokines ros • contributing ferroptosis increasing iron burden neurons 25 ferroptosis ferroptosis iron dependent form regulated cell death driven lipid peroxidation pd iron accumulation substantia nigra enhances oxidative stress lipid peroxidation leading ferroptotic death dopaminergic neurons recent rese arch linked α synuclein aggregation ferroptosis 16 misfolded α synuclein disrupt cellular iron homeostasis promote lipid peroxidation thereby facilitating ferroptosis ferroptosis contributes pd progression 7 • exacerbating oxidative stress excessive ros production lipid peroxidation • triggering neuroinflammation release damage associated molecular patterns damps • impairing mitochondrial function due iron accumulation oxidative stress 26 gut dysbiosis emerging evidence suggests gut dysbiosis imbalance gut microbiota composition may precede central nervous system involvement pd gut brain axis allows potential propagation misfolded α synuclein enteric nervous ystem brain via vagus nerve studies shown individuals pd exhibit significant alterations gut microbiota composition compared healthy controls notable depletion short chain fatty acid scfa producing bacteria enrichment pro inflammatory bacteria 17 gut dysbiosis contributes pd pathology • facilitating propagation αsynuclein aggregates gut brain • activating systemic immune responses promoting neuroinflammation • altering production neurotransmitters metabolites influence brain function table 1 main biological mechanisms associated factors pd mechanism factors αsynuclein aggregation genetics snca gene mutation early onset pd lewy body formation environmental heavy metals mercury manganese lead infections viral infections trigger immune responses gut dysbiosis disrupts gut brain axis promotes misfolding nonmotor symptoms anosmia rem sleep behavior disorder oxidative stress aging natural increase oxidative damage genetics park7 dj 1 mutation oxidative stress defense failure environmental pesticides herbicides heavy metals air pollution metabolic factors low ldl c loss antioxidant protection mixed effects hyperuricemia antioxidant linked decline ferroptosis aging iron accumulation substantia nigra heavy metals iron manganese lead redox imbalance dietary factors dairy consumption potential increased iron load industrial chemicals solvents trichloroethylene mitochondrial dysfunction genetics pink1 prkn parkin mutations defective mitophagy environmental herbicides pesticides heavy metals solvents metabolic factors insulin dysregulation diabetes medications neuroinflammation aging increased pro inflammatory cytokines sex differences men higher risk estrogen neuroprotective genetics park7 dj 1 gene linked inflammation infections viral infections chronic inflammatory diseases 8 environmental heavy metals air pollution psychological chronic stress depression anxiety hpa axis gut dysbiosis gutbrain axis links gastrointestinal neurodegenerative issues chronic constipation early symptom linked pd progression antibiotic use macrolides lincosamides gut microbiome disruption probioticsdiet possible protective role pd 3 risk factors pd risk factors conditions increase likelihood developing disease genetic environmental lifestyle related may modifiable eg smoking diet non modifiable eg age family history pd risk factors incl ude age common 60 genetics family history environmental toxins eg pesticides head injuries figure 2 disease progression slower diagnosed younger age severe motor symptoms cognitive decline poor response treatments suggest faster progression non motor symptoms like depression sleep issues also affect disease course figure 2 classification various risk factors parkinsons disease 31 demographic genetic factors 9 demographic genetic factors key risk factors pd significantly impact diseases onset progression response treatment understanding factors essential enhancing diagnosis improving treatment outcomes predicting disease trajectories thereby enabling cust omization interventions meet individual patient needs table 2 age age significant risk factor pd median onset age 60 years 1 5 several mechanisms explain association aging linked neuronal loss approximately 30 elderly non pd individuals experiencing degeneration substantia nigra sn 18 neuronal loss heightens sensitivity sn neurons mitochondrial dysfunction protein degradation impairments 5 pd symptoms manifest 50 60 sn neurons lost aging also contributes increased oxidative stress damages dna proteins lipids accelerating dopaminergic neuron death iron accumulation age generates free radicals via fento n reaction exacerbating oxidative stress neurodegeneration 19 furthermore aging reduces efficiency autophagy ubiquitin proteasome system processes critical protein quality control thereby facilitating accumulation misfolded proteins like α synuclein hallmark pd 20 mitochondrial dysfunction due aging diminishes energy production increases oxidative damage pd predominantly affects older individuals 5 cases occur 50 years often due genetic mutations 21 5 sex pd approximately twice prevalent men compared women 21 protective effects female sex hormones estrogen may explain disparity estrogen ’ neuroprotective roles include upregulating neurotrophic factors enhancing dopamine synthesis reducing inflammation preventing α synuclein aggregati lewy body formation 22 reduced lifetime estrogen exposure seen early menopause oophorectomy correlates higher pd risk 22 23 sexspecific genetic mechanisms also influence pd risk variants like lrrk2 g2019s mutation exhibit higher prevalence women sex dependent phenotypic differences 22 urate levels endogenous antioxidant associated reduced pd risk slower 10 progression particularly men 23 differences immune response neuroinflammation may contribute higher pd incidence men 22 racial ethnic groups prevalence pd varies across racial ethnic groups caucasians hispanics higher risks compared black asian populations 21 24 black individuals show approximately half pd prevalence white individuals 25 disparity attributed genetic biological socioeconomic factors genetic predispositions vary among ethnicities certain mutations population specific instance lrrk2 g2019s variant prevalent europe north africa united states rare japan lrrk2 pr1628p pg2385r varian ts common 26 ancestry related gene expression differences also influence pd risk ancestry associated differentially expressed genes degs account 27 pd heritability often relate immune responses vascular functions 27 environmental socioeconomic factors intersect genetic predispositions influencing pd progression stress healthcare access comorbidities play critical roles exacerbating disparities 28 racial differences immune response neuroinflammation — evident ancestry associated gene expression patterns —may explain variability pd risk progression 27 family history pd family history pd significant risk factor 15 25 individuals pd reporting familial connections 10 20 first degree relative condition 29 30 individuals family history three times likely develop pd often presenting earlier onset symptoms 2 30 interestingly familial background melanoma also linked increased risk pd 31 familial pd accounts approximately 15 cases remaining 85 categorized sporadic 32 genetic contributions approximately 5 pd cases result mutations specific genes 200 pd related genes identified date 33 key genetic contributors include 11 snca mutations snca gene cause alpha synuclein aggregation lewy bodies hallmark pd snca mutations often linked early onset pd mean onset 46 years cognitive decline 3 34 lrrk2 mutations lrrk2 gene common cause familial pd also increase sporadic pd risk lrrk2 mutations g2019s disrupt autophagy synaptic function leading dopamine toxicity 3539 gba1 mutations gba1 gene encodes glucocerebrosidase impair lysosomal function associated familial sporadic pd account 7 10 pd cases 3941 park7 dj 1 mutations park7 disrupt oxidative stress defense neuroinflammatory responses contributing early onset pd 50 years potentially idiopathic pd 42 44 pink1 mutations pink1 impair mitochondrial function autophagy leading hereditary early onset pd 4549 prkn parkin mutations prkn affect lysosomal activity leading toxic protein aggregation dopaminergic neuron loss prkn mutations linked 10 20 early onset pd cases 5054 uchl1 abnormalities uchl1 disrupt ubiquitin proteasome system contributing protein aggregation motor symptom severity pd 5558 double mutations combined genetic risks cases individuals may carry multiple genetic mutations lrrk2 g2019s combined gba1 mutations lead earlier onset faster progression pd symptoms combinations also influence non motor symptoms like dementia psychosis rem sleep behavior disorder rbd 5962 table 2 overview demographic genetic factors pd category subcategory key observations mechanisms references 12 age median onset 60 years 5 cases 50 neuronal loss substantia nigra increased oxidative stress mitochondrial dysfunction iron accumulation 5 18 19 sex twice prevalent men compared women protective effects estrogen sex specific genetic mechanisms eg lrrk2 variants differences immune response 22 23 racial ethnic higher prevalence caucasians hispanics lower black asian populations genetic predispositions ancestry linked gene expression environmental socioeconomic interactions 25 27 gene snca associated early onset pd cognitive decline alpha synuclein aggregation lewy body formation 3 34 lrrk2 common cause familial pd also linked sporadic pd disrupted autophagy synaptic dysfunction dopamine toxicity 3539 gba1 found 7 10 pd cases linked familial sporadic forms impaired lysosomal function glucosylceramide buildup 3941 park7 dj1 associated early onset idiopathic pd oxidative stress defense disruption neuroinflammation 4244 pink1 linked hereditary early onset pd mitochondrial dysfunction impaired autophagy 4549 prkn parkin present 10 20 early onset pd cases lysosomal dysfunction toxic protein aggregation 5054 uchl1 associated protein aggregation motor symptom severity disruption ubiquitin proteasome system alpha synuclein buildup 5558 gba glucosylceramidase beta lrrk2 leucine rich repeat kinase 2 park7 parkin rbr e3 ubiquitin protein ligase pink1 pten induced kinase 1 prkn parkin snca alpha synuclein uchl1 ubiquitin c terminal hydrolase l1 32 education intelligence surprisingly high level education 9 years well higher cognitive capacity early adulthood measured intelligence iq associated higher risk developing pd particularly among men 6365while reasons link remain unclear several theories proposed firstly lifestyle differences may play role research indicates individuals higher iqs education often lower cholesterol levels 66 associated higher risk pd 67 68 relationship iq education cholesterol levels might also influenced socioeconomic status lifestyle habits 66 additionally individuals higher iqs education levels less likely smoke 69 70 previously noted smoking considered protective pd occupational differences may also contribute people higher education levels often engage jobs requiring less physical activity potentially increasing pd risk 71 conversely adults lower education levels likely smoke possibly due stress targeted tobacco advertising 65 however higher 13 education associated greater cognitive reserve may influence cognitive performance pd potentially delay progression 72 table 3 presents summary relationship education iq risk developing pd table 3 summary relationship education iq pd category key observations mechanisms references education iq higher education ≥9 years iq associated increased pd risk particularly men lower cholesterol levels reduced smoking rates less physical activity higher cognitive reserve 7072 lifestyle factors individuals higher educationiq exhibit healthier lifestyles eg non smoking lower cholesterol reduced smoking may negate protective effects lower cholesterol linked increased pd risk 65 66 occupational role higher education correlates less physically demanding jobs potentially increasing pd risk sedentary occupations may contribute neurodegeneration 71 cognitive reserve greater cognitive reserve may modulate pd symptoms delay progression enhanced cognitive performance may obscure early pd symptoms 72 33 environmental occupational factors pd risk progression influenced various environmental occupational socioeconomic geographic factors factors interact complex mechanisms include oxidative stress neuroinflammation genetic predisposition disrupted cellula r processes table 4 exposure herbicides pesticides exposure herbicides pesticides paraquat strongly associated increased risk pd 73 74 agricultural workers individuals living rural areas face heightened exposure direct contact environmental contamination chemicals induce oxidative stress mitochondrial dysfunction critical processes dopaminergic neuron degeneration linked genetic alterations elevate susceptibility pd 75 heavy metal exposure heavy metals including mercury manganese lead disrupt redox homeostasis leading excessive reactive oxygen species ros production impaired antioxidant defense systems 76 oxidative stress contributes mitochondrial dysfunction aggregation alpha synuclein forming lewy bodies —a hallmark pd 77 metals also trigger neuroinflammation activation inflammasomes proinflammatory cytokines exacerbating neuronal 14 loss 78 79 additionally heavy metals cross blood brain barrier accumulate brain affect gut brain communication via microbiome disruptions amplifying pd risk 79 80 industrial chemicals occupational exposure industrial solvents trichloroethylene associated pd development 76 81 solvents impair autophagy lysosomal function mitochondrial integrity leading neuronal dysfunction 81 genetic factors combined solvent exposure may synergistically increase pd susceptibility urban rural living urban living characterized higher air pollution levels poses significant risk pd 82 pollutants contribute neurotoxicity systemic inflammation genetic interactions predispose individuals pd 6 83 84 particulate matter polluted air shown directly damage neurons exacerbate oxidative stress highlighting importance mitigating pollution exposure urban areas contrast people residing rural areas well working farms addition chemical exposures eg pesticides herbicides prone head injuries 85 infections 86 soil borne pathogens 86 unwellwater consumption — factors may causally connected pd 87 occupational workplace factors certain occupations particularly agriculture 88 mining industries involving heavy metals 89 solvents trichloroethylene 81 elevate pd risk 88 agricultural workers face exposure pesticides herbicides miners encounter high levels metals like manganese lead professions requiring high cognitive engagement healthcare 90 teaching 91 may also linked pd potentially due combination environmental exposures genetic predispositions affect key cellular processes 92 individuals engage contact sports boxing american football soccer heightened risk experiencing head trauma particularly repeated head trauma increases susceptibility developing neurodegenerative disorder like alzheimers disease pd 93 socioeconomic status 15 lower socioeconomic status ses often defined income education levels correlates higher pd prevalence limited access healthcare among lower ses groups delay diagnosis treatment accelerating disease progression 94 95 conversely higher ses associated lifestyle factors physical activity dietary antioxidant intake reduce pd risk environmental exposures pollutants occupational hazards often prevalent lower ses populations contributing pd onset severity table 4 overview environmental occupational socioeconomic geographic risk factors pd factor key observations mechanisms references herbicidespesticides exposure linked pd risk particularly among agricultural workers rural residents oxidative stress mitochondrial dysfunction genetic alterations 75 heavy metals exposure mercury manganese lead increases pd risk disruption redox homeostasis alpha synuclein aggregation neuroinflammation microbiome disruption 77 78 industrial chemicals solvents like trichloroethylene associated pd impair autophagy lysosomal function mitochondrial integrity 92 urban living air pollution contributes pd risk neurotoxicity systemic inflammation oxidative stress 83 84 rural living increased risk unwellwater consumption soil pathogens head injuries environmental exposures infections lifestyle factors 59 60 61 occupational roles agriculture mining industries involving solvents heavy metals linked pd risk environmental toxins genetic susceptibility neurotoxic exposures 71 79 90 91 socioeconomic status lower ses correlates higher pd prevalence limited healthcare access higher exposure environmental risk factors protective lifestyle factors higher ses groups 94 95 34 lifestyle factors lifestyle factors significantly influence development pd 96 factors physical activity diet smoking alcohol consumption shown affect risk developing pd table 5 thorough understanding lifestyle factors essential prevention early detection management pd body mass index bmi relationship bmi pd remains contentious studies report significant link obesity prolonged sedentary behavior pd risk 97 conversely research 16 suggests abdominal obesity increased waist circumference may elevate pd risk 98 99 effects may mediated elevated inflammatory cytokines oxidative stress obesity related metabolic disturbances like insulin resistance dyslipidemia contribute mitochondrial dysfunction neuronal damage pd 100 additionally obesity induced changes gut microbiome may exacerbate inflammation oxidative stress influencing pd progression unintentional weight loss however common feature pd affecting approximately 60 patients average loss 3 6 kg disease progression 9 weight loss correlates poor prognosis diminished quality life 9 101 alcohol consumption relationship alcohol consumption pd risk remains inconsistent across studies research identified significant link alcohol pd 102 studies suggest protective effect moderate alcohol consumption motor function decline 103 104 acute alcohol intake may temporarily alleviate motor symptoms tremors bradykinesia increasing dopamine release specific brain regions however heavy prolonged alcohol use lead persistent reductions dopamine levels exac erbating pd symptoms time 105 neuroimaging studies reveal alcohol intake negatively associated brain structure connectivity changes potentially accelerating pd progression 106 additionally alcohol interfere efficacy medications like levodopa precursor dopamine impairing absorption effectiveness intensify tremors motor symptoms furthermore alcohol consumption disrupts sleep patterns compounding existing sleep disturbances commonly experienced individuals pd dietary habits nutrition consumption dairy products associated increased risk developing pd 107 particularly men 108 109 potential contributing factors include milk proteins casein lactalbumin may lower serum urate levels since urate protective effects pd reduction could increase vulnerability 108 additionally contaminants like pesticides dairy products may play role 110 associations establish causality suggest potential risk link diets high pro inflammatory foods red meat refined sugars trans fats may promote systemic inflammation increasing pd risk similarly carbo nated beverages cold cuts also linked higher risk pd 17 111 nutrient deficiencies including omega 3 fatty acids vitamin b vitamins coenzyme q10 impair neuronal health mitochondrial function potentially accelerating neurodegeneration worsening pd symptoms 112 moreover high protein diets may interfere absorption levodopa primary medication managing pd symptoms sedentary lifestyle physical inactivity sedentary lifestyle associated development progression pd sedentary behavior worsens non motor symptoms cognitive impairment depression poor sleep quality significantly reducing quality life individuals pd 96 113 physical inactivity also correlated increased depression cognitive decline pd patients suggesting reducing sedentary time could help alleviate symptoms furthermore dysregulated genes identified pd patients overlap tho se affected sedentary behavior particularly cellular pathways linked pd progression network based research underscores impact lifestyle factors significant genetic molecular pathways highlighting potential therapeutic targets slowing pd progression table 5 summary lifestyle risk factors pd category key observations mechanisms references body mass index conflicting evidence association unintentional weight loss common pd abdominal obesity may elevate risk weight loss correlates poor prognosis 8084 dairy consumption linked higher risk pd particularly men decreases serum urate levels potential contaminants like pesticides 7073 alcohol consumption mixed evidence moderate consumption may reduce pd risk heavy use may exacerbate progression dopamine release acute use prolonged use depletes dopamine interferes pd medication impacts brain structureconnectivity 7579 sedentary lifestyle associated worse non motor symptoms eg cognitive decline depression dysregulated genes linked cellular pathways overlaps molecular pathways influencing pd progression 96 113 35 metabolic systemic factors metabolic systemic factors worsen neurodegeneration promoting inflammation oxidative stress mitochondrial dysfunction accelerating pd progression table 6 understanding factors crucial developing strategies manage slow disease diabetes 18 type 2 diabetes mellitus t2dm significantly impacts pd development progression 114 116 t2dm exacerbates motor symptoms eg instability mobility issues non motor symptoms cognitive impairments eg slower thinking attention deficits accelerates disease progression 117120 neurovascular burden associated t2dm white matter hyperintensities contributes effects 121 122 t2dm thus considered independent factor negatively influencing pd outcomes 122 123 hypertension hypertension may increase pd risk due hypertensive vasculopathy regions basal ganglia brain stem thalamus 124 125 also contributes cardiovascular diseases cerebral small vessel diseases leading white matter hyperintensities may exacerbate pd progression 126128 early diagnosis management hypertension could mitigate pd risk progression cholesterol triglycerides pd patients often exhibit lower levels cholesterol triglycerides compared healthy controls 129 130 studies reported consistently reduced total cholesterol ldl c hdl c triglycerides pd patients 20 years diagnosis 131 reduction associated increased oxidative stress alpha synuclein aggregation dopaminergic neurons 132 high plasma ldl c levels total cholesterol linked slower pd progression improved motor function 133 134 low hdl c levels associated higher pd risk 135 however findings lipid levels remain inconsistent likely due confounding factors obesity diabetes lifestyle genetics 134 136 137 138 table 6 overview metabolic physiological factors contributing harm pd category key observations mechanisms references diabetes t2dm linked severe motornon motor symptoms accelerated pd progression neurovascular burden white matter hyperintensities cognitive decline 8595 hypertension may elevate pd risk worsen progression hypertensive vasculopathy cerebral small vessel disease white matter hyperintensities 96101 cholesteroltriglycerides lower levels associated higher pd risk high ldl c total cholesterol linked slower progression oxidative stress alpha synuclein aggregation protective effects ldl c 102112 ldl c low density lipoprotein cholesterol hdl c high density lipoprotein cholesterol t2 dm type 2 diabetes mellitus 19 36 inflammation immunity gut brain axis inflammatory factors immune dysfunction gut brain axis dysbiosis contribute neurodegeneration progression pd 86 chronic inflammation microglial activation release harmful cytokines oxidative molecules dysbiosis disrupts gut function triggering brain inflammation neuronal damage factors may influence pd onset early symptoms often prec ede central nervous system changes summary impact pd table 7 understanding mechanisms key developing therapies slow disease progression viral infections viral infections play significant role development progression pd contributing chronic neuroinflammation neuroinflammation triggered viruses activate immune response particularly activation microglia release pro inflammatory cytokines chemokines molecules cro ss blood brain barrier cause neuronal cell death 139 140 furthermore certain viruses influenza epstein barr viruses found promote aggregation alpha synuclein protein critical pathology pd 141 addition activation toll like receptors tlrs particularly tlr4 viral proteins leads heightened immune responses neuroinflammation ultimately causing neuronal damage 142 viral rna also trigger microglial activation receptors like mac 1 resulting production reactive oxygen species contribute neuronal injury 143 epidemiological studies identified specific viruses including cytomegalovirus cmv epstein barr virus ebv hepatitis c virus factors may induce chronic inflammation immune dysregulation potentially increasing risk pd de velopment 139 neuroinflammation chronic inflammatory diseases inflammation normal immune response designed protect body becomes chronic lead tissue damage contribute development diseases like pd chronic inflammation pd driven cytokines reactive oxygen species chemokines 20 produced various immune cells including endothelial cells microglia astrocytes peripheral immune cells inflammation manifest two forms acute rapid onset short duration localized symptoms chronic per sists time leads tissue damage increased risk disease pd markers inflammation crp tnf α il 6 linked disease may serve potential biomarkers therapeutic targets 144 145 gut brain axis wherein inflammation gastrointestinal tract influenced gut microbiota exacerbate neuroinflammation promoting pd progression also key factor 146 additionally genetic factors like lrrk2 mutations environmental exposures toxins infections play role driving neuroinflammation pd 147 gut dysbiosis gut dysbiosis imbalance gut microbiota increasingly recognized critical factor pd pathogenesis gut brain axis bidirectional communication system gut central nervous system essential maintaining neurological health dysbiosis disrupt axis leading neuroinflammation misfolding alpha synuclein prot ein closely associated pd pathology 147 148 altered gut microbiota produce pathogenic metabolites create pro inflammatory environment exacerbating neuroinflammation promoting pd progression 148 149 several biological pathways connect gut dysbiosis progression pd dysbiosis may lead overproduction pro inflammatory cytokines tumor necrosis factor tnf interleukins cross blood brain barrier induce neuroinflammation 150 additionally gut microbiota influences immune responses tolllike receptors dysregulation receptors contribute alpha synuclein pathology 150 moreover gut brain axis relies neuroendocrine signals direct neural pathways disrupted dysbiosis exacerbating pd progression 151 152 chronic constipation chronic constipation prevalent non motor symptom often precedes motor manifestations pd condition linked gut dysbiosis increased intestinal permeability may result systemic inflammation enteric nervous system activation changes trigger alpha synuclein misfolding gut potentially propagating 21 brain via vagus nerve thereby contributing pd development 149 early occurrence gastrointestinal symptoms including constipation supports hypothesis pd pathology might originate gut years motor symptoms appear 151 table 7 summary inflammatory microbiome gut brain axis factors pd category key observations mechanisms references viral infections linked pd chronic neuroinflammation immune dysregulation activation microglia tlrs alpha synuclein aggregation immune responses viral proteins 139 142 neuroinflammation contributes pd onset progression elevated cytokines eg tnf α il6 microglial activation oxidative stress 144 153 chronic inflammatory diseases associated heightened pd risk progression persistent cytokine production gut brain axis inflammation genetic predispositions 153 154 155 156 gutbrain axis bidirectional link gastrointestinal inflammation neurodegeneration pd shared genetic factors inflammatory markers gut 146 147 gut dysbiosis linked neuroinflammation alpha synuclein misfolding promotes pd progression proinflammatory cytokines tolllike receptor dysregulation disrupted gut brain communication 147 148 150 chronic constipation common preclinical symptom pd linked gut dysbiosis intestinal permeability alpha synuclein misfolding gut propagating via vagus nerve brain 149 151 157 37 neurological psychological factors neurological psychological factors increase risk progression pd affecting neural circuits neuroinflammation promoting oxidative stress damage neurons impaired dopamine regulation common neurological psychological disorders may also contribute early onset worsening pd sympto ms table 8 provides summary mechanisms underlying neurological psychological factors pd traumatic brain injury traumatic brain injury tbi significant risk factor pd biological mechanisms including inflammation metabolic dysregulation protein accumulation tbi promotes upregulation proteins amyloid precursor protein app alpha synuclein hyper phosphorylated tau tar dna binding protei n 43 linked pd pathology 158 acute neuroinflammation catecholamine dysfunction triggered tbi contribute pd progression 159 inflammatory response involves microglia astrocyte activation 22 become detrimental prolonged accelerating neurodegeneration 158 notably us veterans tbi 56 increased risk pd risk escalating injury severity 158 sleep disorders rem sleep behavior disorder rbd serves important early indicator pd studies demonstrated individuals rbd increased risk developing pd synucleinopathies dementia lewy bodies 160 relationship rbd pd believed stem accumulation misfolded alpha synuclein proteins brain regions responsible regulating rem sleep leading formation lewy bodies characteristic feature pd rbd mar ked absence muscle atonia rem sleep causing dream enactment often precedes onset motor symptoms pd several years 161 beyond rbd sleep fragmentation difficulties sleep maintenance frequently observed pd patients contributing worsening cognitive decline non motor symptoms 160 risk factor early sign pd progression rbd reflects underlying neurodegenerative changes associated disease loss smell anosmia anosmia loss smell early non motor symptom pd often precedes motor symptoms years even decades linked accumulation alpha synuclein olfactory bulb related regions among first areas affe cted pd 162 pathology begins olfactory bulb related regions anterior olfactory nucleus among first areas affected pd reduced integrity substantia nigra characteristic feature pd also observed individuals unexplained smell loss supporting connection anosmia pd suggests anosmia signals pd risk may also serve early marker disease 163 disruption olfactory function alpha synuclein pathology may contribute progression neurodegeneration brain regions chronic stress psychological emotional health significantly influence risk progression pd progression pd also closely linked various biological mechanisms influenced psychological stress mood disorders stress accelerate damage dopamine producing neurons worsen motor symptoms like bradykinesia motor blocking nd tremors reduce effectiveness dopaminergic medications 164 mesocortical mesolimbic dopaminergic 23 pathways crucial mood regulation disrupted pd contributing high prevalence depression anxiety patients 165 166 chronic stress identified significant risk factor pd exacerbates loss dopamine producing neurons animal models suggest prolonged stress accelerates dopaminergic cell death underscoring potential benefits stre ssreduction interventions 167 168 depression anxiety mental health conditions depression anxiety serve early indicators prodromal phase pd though presence necessarily predict development disease research shows individuals 50 mental health disorders including schizophrenia bipolar disorder insomnia depression anxiety heightened risk pd particularly environmental contributory factors present 169 170 depression anxiety prevalent non motor symptoms pd may also precede onset motor symptoms increasingly recognized integral disease ’ pathophysiology biological mechanisms linking stress depression anxiety pd include activation hypothalamus pituitary adrenal hpa axis sympathetic nervous system sns elevated levels glucocorticoids catecholamines leading neuronal injury increased proinflammatory cytokines contributing neurode generation stress induced vulnerability dopamine neurons via glucocorticoid receptor activity chronic stress mood disorders exacerbate motor non motor symptoms also synergize factors increase neuronal vulnerability potentially accelerating progression pd therefore addressing stress mood disorder pd patients crucial slowing diseases progression improving quality life 171 table 8 overview neurological psychological risk factors pd category key observations mechanisms references traumatic brain injury increases pd risk 56 severity dependent inflammation protein accumulation app alpha synuclein etc microglial activation 158 159 sleep disorders rem sleep behavior disorder often precedes motor symptoms years degeneration brainstem nuclei alpha synuclein accumulation forming lewy bodies 160 161 loss smell anosmia early non motor symptom precedes motor signs alpha synuclein accumulation olfactory pathways 162 163 24 chronic stress increases neuronal vulnerability exacerbates motor non motor symptoms disrupts dopaminergic pathways increases proinflammatory cytokines accelerates cell death 164 167 depression anxiety common non motor symptoms may precede motor symptom onset activates hpa axis sns increases glucocorticoids catecholamines induces neuroinflammation 165 171 38 hormonal health conditions hormonal factors influence onset progression severity pd imbalances hormones thyroid cortisol affect neuronal health exacerbate symptoms understanding factors essential developing gender specific therapies improving disease management summary hormonal risk factors pd presented table 9 estrogen neuroprotective role estrogen plays significant role risk progression pd influencing key processes involved dopaminergic function dopamine synthesis metabolism transport believed neuroprotective effects potentially shielding dopaminergic neurons degeneration animal models support howing estrogen may reduce inflammation interacting brains renin angiotensin system counteract oxidative stress damage neurons mechanisms estrogen helps protect brains dopaminergic system potentially slowing pd progression 172 postmenopausal women pd risk postmenopausal women particularly undergoing hormone replacement therapy hrt face increased risk pd heightened risk linked reduced lifetime exposure endogenous estrogens whether due early menopause shorter fertile lifespan absence estrogen supplementation hrt menopause exacerbates risk 173 174 hormone replacement therapy link hormone replacement therapy hrt pd risk multifaceted estrogen alone may offer protective effects long term use combined estrogen progesterone therapy appears increase risk developing pd 172 175 estrogen replacement therapy 25 ert help alleviate symptoms slow progression pd women especially early stages l dopa therapy begins 176 lower incidence pd women compared men may partly attributed protective influence endogenous estrogen estrogen thought protect neurodegeneration reducing oxidative stress regulating dopamine metabolism imp roving mitochondrial function may help preserve dopaminergic neurons substantia nigra region progressively affected pd 177 hyperuricemia uric acid antioxidant properties helps reduce oxidative stress key factor neurodegeneration pd relationship uric acid levels pd risk complex elevated uric acid levels associated reduced risk pd due neuroprotective effects however hyperuricemia also linked cognitive impairment conditions like go ut may exacerbate neurodegeneration 178 additionally co existing conditions cerebrovascular injury amplify effects hyperuricemia increasing risk cognitive decline accelerating pd progression 179 table 9 overview hormonal health condition risk factors pd category key observations mechanisms references estrogen levels may protect dopaminergic neurons reduced levels post menopause linked higher pd risk modulates dopamine pathways reduces inflammation oxidative stress 172174 postmenopausal women higher pd risk linked early menopause shorter fertile life lack hrt reduced lifetime estrogen exposure affects neuroprotection 173 174 hrt mixed effects longterm combined estrogen progesterone therapy may increase risk duration regimen specific impact estrogen ’ neuroprotective role 172 175 hyperuricemia paradoxical effects antioxidant properties may protect linked cognitive decline gout reduces oxidative stress compounds neurodegeneration coexisting conditions 178 179 39 medications certain antibiotics calcium channel blockers treating high blood pressure heart conditions certain anti diabetic medications rosiglitazone pioglitazone statins treating high cholesterol levels possible associations ncreased risk pd 4 180 181 summary medications associated increased risk parkinsons disease presented table 10 26 β2adrenoceptor antagonists eg propranolol propranolol β2 adrenoceptor antagonist associated increased risk pd β2 adrenoceptors play critical role regulating metabolic functions dopaminergic activity essential neuroprotection chronic use propranolol may contribute degeneration dopaminergic neurons substantia nig ra hallmark pd β2 adrenoceptor blockade exacerbate motor symptoms accelerate pd progression reducing dopaminergic signaling additionally modulation adrenergic activity may disrupt already compromised balance neurotransmitters impairing dopaminergic systems 182 diabetes medications metformin widely used diabetes medication linked increased risk pd due influence various physiological processes contribute insulin dysregulation leading neuroinflammation mitochondrial dysfunction may also alter synaptic plasticity implicating neurodegeneration pathways common diabetes pd contrast diabetes treatments glucagon like peptide 1 agonists glp1a may offer protective effects pd progression modulating insulin signaling 183 184 antibiotics macrolides lincosamides classes antibiotics associated increased risk pd likely due disruptive effects gut microbiota alterations microbial composition may exacerbate neuroinflammation promote aggregation α synuclein protein implicated pd pathogenesis contrast emerging therapies p rasinezumab monoclonal antibody targeting aggregated α synuclein show potential slowing motor progression rapidly advancing pd cases 185 186 psychological medications psychotropic medications including antidepressants anxiolytics linked increased risk pd older populations drugs impact dopaminergic systems antipsychotics particular blocking dopamine receptors may increase vulnerability pd 187 cancer medications 27 although direct evidence limited certain chemotherapeutic agents cancer medications may elevate risk pd mechanisms inducing oxidative stress generates reactive oxygen species ros exacerbates neuronal damage causing mitochondrial dysfunction impairs cellular energy production —a known contributor pd pathology 188 epigenetic modifications certain medications modify epigenetic marks thereby influencing gene expression associated pd prolonged use drugs may induce changes dna methylation modification commonly observed pd patients 189 epigenetic alterations including dna methylation histone modifications hydroxy methylation integral molecular mechanisms underlying pd facilitating interaction genetic environmental factors contribute disease onset progression 44 table 10 summary medications associated increased risk pd factor key observations mechanisms references β2adrenoceptor antagonists linked increased pd risk particularly chronic use eg propranolol disrupts dopaminergic activity metabolic functions accelerates lewy body formation 182 diabetes medications mixed effects metformin may increase risk glp1a treatments may protective insulin dysregulation mitochondrial dysfunction neuroinflammation 183 184 antibiotics macrolides lincosamides associated higher pd risk disrupt gut microbiota exacerbate neuroinflammation α synuclein aggregation 185 186 psychotropic medications increased pd risk observed older populations using antidepressants anxiolytics blocks dopamine receptors affecting dopaminergic systems 187 cancer medications potential increase pd risk certain chemotherapy agents induces oxidative stress mitochondrial dysfunction affects immune system 188 epigenetic modifications long term medication use may influence pd altered dna methylation changes epigenetic marks affecting gene expression 44 189 310 comorbid conditions neurodegenerative chronic diseases may increase risk worsen progression 28 4 prevent factors pd preventive factors pd focus strategies aimed reducing risk delaying onset progressive neurodegenerative disorder fig 3 research indicates lifestyle choices nutrition occupational factors may play role lowering risk developing pd identifying understanding factors guide development strategies delay pd onset als potentially reduce overall prevalence incorporating preventive measures individuals may lower risk developing p slow progression figure 3 important preventive factors pd 41 lifestyle factors lifestyle factors play crucial role preventing onset pd slowing progression research indicates specific lifestyle habits protective effects brain health potentially reducing risk developing pd delaying onset mitigating progression symptoms summary lifestyle factors may help prevent pd provided table 11 physical activity 29 engaging highest level physical activity exercise advantage decreasing incidence pd 21 190 possible onset pd could delayed significant amount physical activity may slow diseases pathological processes 191 particularly individuals physically active middle years 192 prodromal phase pd individuals may experience nonmotor symptoms sleep disorders constipation along subtle motor signs like rigidity balance impairment tremor leading likely decrease physical activity period 191 patients early stages pd consistently engaged physical activity exercise long period time may notice slower decline gait stability activities daily living processing speed 193 additionally participating physical activity exercise improve non motor symptoms like depression apathy postural instability also reducing motor symptoms reducing inflammation individuals pd 194 consequently maintaining high level physical activity exercise could stimulate interest potential therapeutic targets pd ultimately contributing improved quality life individuals condition vigorous physical activity reduced sitting time noted neuroprotective effects including improved gait stability daily living activities processing speed 68 exercise shown alleviate non motor symptoms depression apathy postural instability reducing motor symptoms anti inflammatory mechanisms 69 engaging regular physical activity may also delay pd onset contribute better quality life high quality sleep high quality sleep plays crucial role reducing risk pd several interconnected biological mechanisms one key factor promotion efficient protein clearance particularly glymphatic system becomes active sleep clearing toxic proteins like α synuclein contribute p sleep also regulates neuroinflammation reducing activation immune cells microglia astrocytes exacerbate neural injury 195 additionally good sleep helps mitigate oxidative stress reducing production reactive oxygen species supporting bodys antioxidant systems critical protecting brain cells damage furthermore maintaining regul ar circadian rhythms highquality sleep vital dopamine regulation essential pd prevention 196 disruptions circadian rhythms reduce dopamine levels increasing pd risk sleep also 30 improves sleep architecture reducing fragmentation enhancing restorative sleep supports overall brain health 196 combined mechanisms highlight neuroprotective role sleep suggesting interventions improve sleep quality may help delay reduce onset pd 197 social support social support plays crucial role reducing risk pd impacts psychological physical health studies show strong social networks linked better mental health reducing depression anxiety stress —key risk factors pd 198 connections may lower likelihood developing disease social support also helps slow pd progression several mechanisms encourages physical activity shown improve motor cognitive functions pd patients enhancing cerebral mechanisms cardiovascular fitness 199 200 additionally psychological benefits social support increased positivity reduced distress improve disease management treatment adherence 198 furthermore access information social networks provides patients strategies like dietary changes may help slow progression modifications influence gut microbiome 201 cognitive engagement cognitive engagement participating mentally stimulating activities may help reduce risk developing pd associated cognitive decline one mechanism cognitive engagement may protect pd enhancing neuroplasticity brains ability reorganize form new neural connections process stimulated engaging complex tasks may build cognitive reserve potentially delaying onset cognitive symptoms pd 202 additionally cognitive engagement may support neurotransmitter systems crucial pd dopamine serotonin noradrenaline acetylcholine implicated cognitive processes affected pd engaging mental activities may help mai ntain systems potentially slowing cognitive decline 203 moreover cognitive engagement may influence mitochondrial function reducing oxidative stress improving energy metabolism neurons could slow cognitive deterioration 204 may also interact genetic factors variations apoe gba genes linked cognitive decline pd potentially 31 mitigating effects 205 cognitive engagement also help slow pd progression building cognitive reserve allowing individuals compensate neural damage delay cognitive symptoms 206 furthermore cognitive activities often associated increased physical activity shown enhance brain function structure leading improved cognitive outcomes pd patients 207 cognitive engagement may also help reduce anxiety indirectly supporting cognitive health slowing disease progression 207 smoking undeniable smoking tobacco cigarettes detrimental health several studies shown cigarette smoking may reduce risk developing pd 208 smokers found half likely non smokers develop pd 209 significant inverse dose response correlation discovered relation pd risk greater duration frequency smoking among individuals lower chances developing pd 6 consequently smoking linked later age onset pd 2 potential protective effect smoking pd may due presence nicotine tobacco smoke may trigger release dopamine neurotransmitter associated pd 208 moreover nicotine ability block formation toxins directly impacting enzyme functions mao b 210 cigarette smoking also observed diminish aggregation alpha synuclein cell cultures suggesting potential slowdown development pd 211 although cigarette smoking may protective effects pd found directly linked increased issues drooling swallowing freezing patients pd 7 pd smokers likely experience non motor symptoms unexplained pains feelings sadness memory problems 7 moreover may strong connection smoking mortality pd clear individuals pd smoke higher risk developing smoking related cancers like lung cancer cardiovascular disease respirat ory issues 212 table 11 overview lifestyle factors potentially preventing pd factor key observations mechanisms references physical activity reduces pd incidence 21 delays onset improves symptoms enhances neuroprotection reduces inflammation improves gait quality life 190 192 193 high quality sleep reduces pd risk promoting protein clearance dopamine regulation clears toxic proteins reduces neuroinflammation supports brain health 195197 213 32 social support reduces pd risk supports mental health encourages physical activity reduces stress improves motorcognitive functions supports disease management 198200 cognitive engagement mental activities reduce pd risk cognitive decline enhancing neuroplasticity boosts brain function maintains neurotransmitters supports mitochondrial health 202205 smoking smokers less likely develop pd worsens nonmotor symptoms health risks nicotine may trigger dopamine release reduce alpha synuclein aggregation increases health risks 69 208 209 211 212 214 42 dietary nutritional factors dietary nutritional factors crucial context pd influence risk developing disease management symptoms proper nutrition supports brain health neuroprotection reduces inflammation promotes gut health maintains overall wellbeing —all vital n managing neurodegenerative condition like pd additionally interactions medications dietary factors important consideration treatment summary dietary nutritional factors may preventive influence pd provided table 12 coffee drinking coffee may help prevent onset pd 30 214216 additionally consuming coffee linked decreased likelihood developing pd well slowing advancement 217 recent study reported strong correlation duration coffee consumption age onset pd well relatively low association number cups coffee age onset pd 214 potential explanation protective effect coffee pd attributed caffeine supported fact black tea contains lower amount caffeine demonstrated moderate association onset age pd 214 paradox regarding effects caffeine motor non motor symptoms among pd patients one hand research drug naive early stage pd patients shown severity non motor symptoms related mood cognition verse relationship coffee consumption 218 additionally research indicated individuals consume coffee exhibit lower tremor scores compared 33 correlation observed severity tremors amount coffee consumed 219 also coffee found protective effect motor function decline mortality cognitive decline pd patients 105 hand studies shown meaningful connection dosage duration coffee consumption presence motor non motor symptoms early stage pd patients 7 multiple reasons coffee may offer protection development pd one reasons component coffee acts adenosine a2a receptor antagonist leading decreasing α synuclein aggregation synt synphilin 1 ne uroglioma cells 220 additionally coffee consumption exhibits anti inflammatory properties also mitigates risk chronic diseases like diabetes obesity cardiovascular disease indirectly influence development progression pd 221 tea multiple studies meta analyses consistently shown inverse relationship tea consumption risk developing pd increased tea consumption associated reduced risk developing pd 222 potential decrease pd risk 26 223 studies focus preventive effects tea consumption emerging evidence suggests tea may also potential slow pd progression study highlighted role tea drinking modifying progression idiopathic sleep behavior disorder irbd α synucleinopathies including pd 224 study found tea drinking associated decreased risk phenoconversion irbd pd suggesting protective role tea early stages neurodegenerative disease progression 224 tea rich polyphenols especially catechins like egcg possess significant neuroprotective properties compounds reduce oxidative stress major factor pd pathogenesis scavenging free radicals enhancing antioxidant defenses 223 polyphenols also modulate signaling pathways metal chelation crucial reducing neuronal damage studies black tea consistently shown significant inverse association black tea consumption pd risk singapore chine se health study found black tea consumption associated reduced risk pd independent caffeine intake tobacco smoking 225 protective effect thought due presence thearubigins theaflavins formed oxidation 34 catechins black teawhile green tea rich polyphenols particularly catechins like epigallocatechin gallate egcg association reduced pd risk human populations remains inconclusive 225 studies shown significant association green tea consumption reduced pd risk 225 however green tea polyphenols gtps demonstrated protective effects dopaminergic neuron degeneration preclinical models suggesting potential neuroprotective properties 225 study japan found intake japanese chinese teas significantly inversely associated risk pd supporting notion various types tea beneficial 226 theanine amino acid found tea inhibit glutamate receptors regulate extracellular glutamine concentrations providing neuroprotective effects reducing excitotoxicity 223 diet habits diet habits factor negative positive impacts pd dietary regimen characterized elevated consumption fruits fish vegetables whole grains nuts legumes poultry coupled reduced intake saturated fats moderate alcohol consumption potentially serves protective factor pd 227 relationship nutrition pd complex involving various dietary patterns specific nutrients may influence risk progression disease mediterranean diet rich fruits vegetables nuts fish associated reduced risk pd slower disease progression diet thought exert effects anti inflammatory antioxidant mechanisms help mitigate oxidative stress neuroinflammation key factors pd pathogenesis 228 229 vitamins longitudinal studies indicated persistent deficiency vitamin associated higher likelihood developing pd 230 increased risk may due chronic lack vitamin result depletion dopaminergic neurons substantia nigra region ultimately contribute onset pd 230 moreover previous studies shown seasonal sunlight related impacts dopamine transporter dat expression individuals without health issues early stages pd 231 suggested dietary vitamin e may play role protecting pd indicating incorporating vitamin e rich foods ones diet could immediate option reducing 35 risk pd 232 pd patients found lower levels vitamin b12 healthy controls could potentially linked onset early gait instability neuropathy 233 additionally observed pd patients experience dementia elevated levels vitamin b12 cognitively healthy pd ones suggesting higher vitamin b12 level might reduce risk developing dementia future 234 similarly adequate intake vitamins b6 folate may support neurological health reduce pd risk lowering homocysteine levels linked neurodegeneration 235 minerals like magnesium zinc also important involved numerous enzymatic processes support neuronal function may help slow pd progression 235 calcium calciums role pd less clear essential various cellular processes including neurotransmitter release neuronal excitability dysregulation calcium homeostasis contribute neuronal death hallmark pd therefore mainta ining adequate calcium levels diet may support neuronal health potentially slow disease progression 235 gutbrain axis emerging research highlights gut brain axis significant factor pd gut microbiota influence neuroinflammation neurodegeneration suggesting dietary interventions promote healthy gut microbiome may impact pd risk progression diets rich fiber probiotics may enhance gut health consequently brain health offering potential therapeutic avenue pd 236 uric acid urate levels recent studies highlight potential uric acid ua reducing pd risk 1 mgdl increase serum urate associated 6 reduction pd risk 237 potent endogenous antioxidant ua accounts 60 –70 antioxidant activity human plasma 238 properties especially relevant pd oxidative stress key factor neuronal damage 239 ua mitigates oxidative stress scavenging free radicals reactive oxygen species ros neuronal cells also inhibits lipid peroxidation protecting cellular components damage mitochondrial dysfunction central pd ua ’ ability protect mitochondrial 36 integrity may help preserve neuronal function 239 additionally ua may reduce inflammatory damage neurons modulating inflammatory pathways activated pd 239 also aids maintaining calcium homeostasis critical factor neuronal function disruptions calcium signaling implicated pd pathogenesis one proposed mechanism ua ’ neuroprotective effect activation nrf2 transcription factor regulates antioxidant proteins offering protection oxidative damage pd research comparing ua levels pd patients healthy control shows significantly lower serum cerebrospinal fluid csf ua levels pd patients sugg esting factors beyond purine metabolism age sex weight may influence ua levels 240 higher serum urate associated reduced pd risk supporting ua ’ potential neuroprotective effects 237 despite findings studies report significant correlation high ua levels reduced pd risk role ua pd progression remains debated 240 additionally causality low ua levels pd still discussion 240 table 12 summary dietary nutritional factors may help prevent pd factor key observations mechanisms references coffee coffee may reduce pd risk 30 slow progression inconsistent effects motornon motor symptoms pd patients caffeine acts adenosine a2a receptor antagonist reducing α synuclein aggregation inflammation 214 215 218 221 tea tea consumption linked 26 reduction pd risk black tea may protective green tea polyphenols catechins theaflavins reduce oxidative stress modulate signaling chelate metals 222 223 225 226 nutrition diet mediterranean diet fruits vegetables fish linked reduced pd risk slower progression antiinflammatory antioxidant effects help mitigate oxidative stress neuroinflammation 228 229 vitamins vitamin deficiency increases pd risk vitamin e b12 b6 folate may help protect pd reduce disease progression vitamins support neuronal function reduce oxidative stress lower homocysteine linked neurodegeneration 179 228 235 calcium role calcium pd unclear crucial neuronal processes dysregulation may contribute neuronal death maintaining calcium homeostasis supports neurotransmitter release neuronal health 235 gutbrain axis healthy gut microbiome may influence pd risk progression diets rich fiber probiotics may promote brain health improves gut health reducing neuroinflammation supporting brain health gut brain connection 236 uric acid ua higher uric acid levels may reduce pd risk 6 every 1 mgdl increase ua acts antioxidant protecting oxidative stress ua scavenges free radicals protects mitochondrial integrity modulates inflammation supporting neuronal function 178 238 240 37 43 medications medical factors medications medical factors vital preventing slowing pd progression example antiinflammatory drugs reduce neuroinflammation associated pd development potentially slowing disease progression besides neuroprotective medications help preserve neurons neutralizing free radicals supporting mitochondrial function table 13 provides overview medications medical factors along respective mechanisms prevention slowing pd progression nonsteroidal anti inflammatory drugs nsaids nsaids explored potential neuroprotective effects pd due ability inhibit cyclooxygenase cox enzymes particularly cox 2 upregulated pd 241 inhibiting cox 2 nsaids reduce production pro inflammatory prostaglandins potentially mitigating neuroinflammation slowing neurodegeneration 241 nsaids aspirin ibuprofen may also decrease elevated cytokines like tnf α il 1β contribute neuroinflammation neuronal death pd 242 aspirin ibuprofen shown effectively reduce risk pd postpone age onset parkinsons disease much 5 years 214 243 could anti inflammatory effects aspirin ibuprofen play role decreasing pd risk 244 furthermore aspirin proven boost production tyrosine hydroxylase th enzyme controls rate dopamine da synthesis leads elevation level da found dopaminergic neurons 245 additionally aspirin ibuprofen potential decrease likelihood lrrk2 mutation indicating anti inflammatory medications could serve beneficial treatments modifying progression lrrk2 pd 246 epidemiological studies suggest regular nsaid use associated reduced risk developing pd although results inconsistent across studies experimental models also demonstrate protective effects nsaids neurotoxin induced dopam inergic neuron degeneration however long term nsaid use linked gastrointestinal cardiovascular risks warranting careful consideration pd treatment 38 calcium channel blockers ccbs ccbs studied potential reduce risk progression pd modulating calcium ion flows crucial neurotransmitter release neuronal health dopaminergic neurons particularly substantia nigra cc bs help regulate calcium influx critical given vulnerability neurons calcium induced stress due pacemaking activity 247 ltype calcium channels cav13 subunits contribute mitochondrial oxidant stress key factor pd pathogenesis recent research also suggests cav23 channels may play role regulating neuronal viability substanti nigra potentially offering neuroprotective benefits 248 systematic review meta analysis found ccb use associated significantly reduced risk pd relative risk 078 95 ci 062 –099 249 studies large prospective cohort study found significant association 250 additionally clinical trial isradipine ccb show significant effects slowing early stage pd progression 249 statins statins primarily known cholesterol lowering effects investigated neuroprotective potential pd due anti inflammatory anti oxidative neuroprotective properties suppressing proinflammatory molecules icroglial activation statins help reduce neuroinflammation pd effects mediated inhibition mevalonate pathway crucial synthesizing inflammatory mediators statins also inhibit oxidative stress major fac tor pd pathogenesis potentially protecting dopaminergic neurons degeneration furthermore statins act ligands pparα regulator mitochondrial function often compromised pd 251 evidence suggests statins particularly simvastatin due ability cross blood brain barrier may slow pd progression attenuating α synuclein aggregation 251 systematic review meta analysis suggested atorvastatin may reduce pd risk attributed potent anti inflammatory anti oxidative effects 252 however randomized controlled trials needed confirm findings α1adrenergic antagonists 39 α1adrenergic antagonists terazosin doxazosin alfuzosin primarily used treat benign prostatic hyperplasia shown potential neuroprotective effects pd enhancing glycolysis energy metabolism impaired pd 253 drugs activate pgk1 first atp generating enzyme glycolysis increasing atp production potentially counteracting energy deficits observed pd moreover α1 adrenoceptor antagonists may modulate locus coeruleus key noradrener gic center affected pd potentially influencing dopamine release providing neuroprotection cohort study involving danish us health registries found users terazosin doxazosin alfuzosin significantly lower risk developi ng pd compared users tamsulosin enhance glycolysis hazard ratios developing pd 088 danish cohort 063 us cohort indicating reduced risk associated drugs 253 table 13 overview medications medical factors may potentially prevent risk pd factor key observations mechanisms references nonsteroidal anti inflammatory drugs nsaids aspirin ibuprofen may reduce pd risk postpone age onset much 5 years regular use linked reduced risk pd inhibit cox 2 enzymes reduce pro inflammatory prostaglandins decrease elevated cytokines like tnf α il 1β potentially mitigate neuroinflammation aspirin boosts dopamine production 241 242 245 246 calcium channel blockers ccbs ccbs like isradipine may reduce pd risk mixed results slowing progression modulate calcium ion flows regulate neurotransmitter release reduce mitochondrial oxidant stress protect dopaminergic neurons 247250 statins statins particularly simvastatin may slow pd progression attenuating α synuclein aggregation reducing neuroinflammation inhibit pro inflammatory molecules reduce oxidative stress regulate mitochondrial function via pparα 251 252 α1adrenergic antagonists terazosin doxazosin alfuzosin show reduced pd risk due enhanced glycolysis energy metabolism activate pgk1 enzyme glycolysis increase atp production modulate locus coeruleus influence dopamine release provide neuroprotection 253 44 occupational factors certain occupational categories particularly involving high levels physical activity shown significantly reduce risk developing pd occupations engineering production work including machine operators fabricators metalworking construction extractive work eg mining oil well drilling associated lower pd risk 40 254 research highlighted jobs requiring significant physical exertion linked decreased risk pd consistent well established protective effects regular physical exercise table 14 occupations demand consistent physical activity may confer similar neuroprotective benefits structured exercise regimens multiple studies also demonstrated strong association artistic occupations reduced risk pd instance one study indicated men engaged artistic professions later life significantly lower risk developing pd 255 protective effect thought related dopaminergic activity required creativity may better preserved individuals working artistic fields 255 case control study conducted japan found professional technical occupations inversely related risk pd particularly among men suggests careers requiring high levels cognitive engagement technical skills may hav e protective effect disease 256 interestingly certain farming activities linked lower risk pd study french farm managers revealed activities gardening landscaping reforestation small animal farming horse related tasks eg training dressag e riding associated reduced pd risk 257 finding particularly notable given farming typically associated increased pd risk due pesticide exposure occupations involve physical activity cognitive engagement may enhance neuroplasticity promote overall brain health activities thought reduce risk neurodegenerative diseases like pd maintaining robust neural networks fostering neuronal resilience physical activity key component many protective occupations also linked improved mitochondrial function reduced oxidative stress —both crucial maintaining neuronal health potentially slowing neurodegenerative processes additionally occupations involve regular physical activity cognitive stimulation may increase production neurotrophic factors brain derived neurotrophic factors bdnf support neuronal survival function production bdnf may provide protection pd occupational ctivities may also contribute reduction neuroinflammation key factor pd pathogenesis effect could mediated direct anti inflammatory effects physical activity indirect mechanisms involving occupational exposu res modulate inflammatory pathways furthermore occupations promoting physical activity may enhance autophagy cellular process crucial removing 41 damaged proteins organelles efficient autophagy particularly important preventing accumulation αsynuclein hallmark pd pathology table 1 4 overview mechanisms occupations potentially reducing risk pd factor key observations mechanisms references physical activity occupations jobs involving physical exertion eg engineering production construction metalworking reduce pd risk physical activity promotes neuroprotective benefits similar structured exercise improving mitochondrial function reducing oxidative stress enhancing neuroplasticity 254 artistic occupations engagement artistic professions eg visual arts music writing correlates lower pd risk artistic occupations may preserve dopaminergic activity creativity requires dopaminergic function offering neuroprotective effects sustained brain function 255 professionaltechnical occupations occupations requiring cognitive engagement technical skills eg engineering technical professions show inverse relationship pd risk high cognitive engagement may promote neuroplasticity maintaining neural networks brain health protects neurodegenerative diseases 256 farming activities certain farming activities eg gardening landscaping horse related tasks linked reduced pd risk physical activity farming along cognitive engagement may support neuronal resilience reduce neuroinflammation promote neurotrophic factor production like bdnf supports neuronal survival 257 45 therapeutic implications state gut microbiota significantly influences pd progression maintaining chronic inflammation facilitating spread misfolded proteins gut brain emerging therapeutic strategies targeting gut dysbiosis aim restore microbiota balance potentially slow pd pro gression strategies include probiotics dietary interventions shown promise preclinical studies 147 149 5 challenges solutions identifying risk protective factors pd identifying risk protective factors pd complex task due multifactorial nature disease intricate interplay genetic environmental behavioral factors pd influenced combination genetic predisposition environmental exposures lifestyle 42 behaviors 257 genome wide association studies gwas identified 200 genes associated pd 19 however genetic landscape complicated rare variants difficult replicate across studies due low frequency 258 additionally interactions genetic factors environmental exposures pesticides industrial chemicals remain poorly understood making challenging identify common molecular pathways therapeutic targets 259 pd heterogeneous disorder multiple subtypes potentially governed distinct molecular mechanisms 259 heterogeneity complicates identification universal risk protective factors findings relevant one subtype may apply others variability disease progression shaped genetic diversity environmental influences underscor es need personalized research approaches consideration population specific genetic architectures 26 several methodological challenges hinder progress identifying risk protective factors pd cross sectional studies commonly used pd research fail capture temporal relationships exposures disease onset longitudinal tudies informative resource intensive less frequently conducted 260 confounding factors lifestyle differences regional variations environmental exposures genetic predispositions obscure true associations common 261 many studies also face issues like recall bias case control designs difficulties establishing causality observational research furthermore inconsistencies across studies —stemming variations study design sample size methodolog ies—impede development clear preventive guidelines example studies identified smoking coffee consumption protective factors others observed significant associations 261 recent advancements research methodologies offer promising avenues understanding pd etiology techniques polygenic risk scores epigenetic analyses mendelian randomization mr provide new opportunities explore genetic environmen tal interactions 259 however approaches require validation standardization ensure broad applicability lack comprehensive data integrating genetic environmental lifestyle factors limits holistic understanding pd risk 261 address challenges standardizing research methodologies essential implementing uniform protocols data collection clinical assessments environmental 43 exposure reporting reduce inconsistencies across studies 262 multi omics approaches integrate genomics proteomics metabolomics artificial intelligence uncover patterns traditional methods might miss aiding identification biomarkers elucidating pd ’ molecular underpinnings advanced trial designs including adaptive trials studies targeting pre symptomatic stages improve understanding risk factors protective measures significant neuronal damage occurs incorporating digital tools telehealth research provide continuous monitoring overcome limitations associated traditional clinical endpoints 260 large scale collaborative initiatives critical overcoming data fragmentation leveraging diverse expertise establishing centers excellence focusing complex disease genetics eg university helsinki fostering inter national collaborations accelerate data sharing discovery 262 emerging technologies including next generation sequencing ngs medical digital twins blockchain based data management systems offer promising pathways enhance data integration ensure privacy enable personalized research strategies addressing challenges embracing innovative solutions field progress towards comprehensive understanding pd ’ etiology ultimately enabling effective prevention therapeutic interventions table 1 5 provides summary challenges proposed solutions identifying risk protective factors pd table 15 challenges proposed solutions identifying risk protective factors pd challenge details proposed solutions references complex interplay genetic environmental factors genetic predispositions interact environmental exposures complicating risk factor identification 200 genes implicated rare variants posing replication challenges integrate multi omics data genomics proteomics etc using ai uncover patterns identify specific biomarkers advanced techniques 26 257 259 heterogeneity pd pd encompasses multiple subtypes distinct molecular mechanisms variability progression complicates universal findings employ personalized approaches population specific studies account subtype specific variability genetic environmental influences 26 259 methodological challenges cross sectional designs fail capture temporal relationships confounding factors like lifestyle recall bias obscure results conduct longitudinal studies establish causality standardize protocols clinical assessments exposure reporting integrate digital tools telehealth continuous monitoring 260 261 44 inconsistencies across studies variations study designs sample sizes methodologies lead contradictory findings examples include mixed results smoking coffee protective factors standardize methodologies across studies use collaborative international frameworks uniformity research approaches data collection 261 evolving research methodologies advanced techniques like mendelian randomization polygenic risk scores require validation standardization validate emerging methods large scale studies develop global standards ensure applicability across populations 259 lack comprehensive data current studies focus isolated factors limiting holistic understanding create large scale collaborative initiatives centers excellence data integration leverage blockchain digital twins secure holistic personalized research 261 262 technological advancements new tools like next generation sequencing ngs digital twins offer potential need broader adoption adopt ngs genetic analysis medical digital twins personalized simulation 262 use blockchain secure data management sharing 6 raising awareness pd raising awareness pd crucial understanding mechanisms risk factors factors influencing onset progression healthcare providers staying informed pd helps better managing risk factors like genetics age environmental influences high lighting preventive measures regular physical activity balanced nutrition early detection essential reduce risks improve patient outcomes raising awareness among professionals patients lead effective management strategies ultimately enhancing quality life minimizing impact disease table 16 outlines recommendations prevention management parkinsons disease addressing healthy individuals individuals diagnosed pd healthcare systems demographic genetic factors • age aging major risk factor pd especially among 60 regular screenings eg cognitive assessments dopamine transporter scans neurodegenerative markers crucial early detection healthy individuals 60 consider preventive measures pd patients regul ar check ups monitor disease progression health systems prioritize neurodegenerative screenings older adults early intervention 45 • sex men higher risk pd public health campaigns target men focusing motor non motor symptoms healthy men engage regular screenings diagnosed pd need tailored care gender specific symptoms • race ethnicity certain racial ethnic groups higher pd risk targeted health programs screenings improve early diagnosis access treatments high risk populations participate community based screenings health systems implemen targeted interventions groups • family history genetics family history pd increases risk genetic counseling predictive testing eg lrrk2 mutations help monitor personalize preventive care genetic predisposed individuals might benefit targeted therapies like lrrk2 inhibitors health systems provide genetic counseling predictive testing risk families cognitive educational factors engaging intellectually stimulating activities eg reading learning new skills reduce risk pd progression support cognitive health pd patients incorporate cognitive therapies daily routines healthcare providers encourage lifelong cognitive engagement brain health focused educational programs environmental occupational risks • toxins exposure pesticides heavy metals industrial chemicals increases pd risk workers wear protective gear seek safer alternatives regular health check ups screenings vital exposed toxins health systems mandat e safety regulations offer regular screenings risk workers • air pollution living high pollution areas increases risk urban residents use air purifiers masks public health initiatives emphasize connection air pollution pd risk advocate cleaner air policies • socioeconomic disparities limited healthcare access increases pd risk underserved populations expanding preventive screenings improving access care communities essential health systems provide affordable screenings treatments underserved pop ulations 46 lifestyle health habits • nutrition diet diet rich antioxidants healthy fats anti inflammatory nutrients eg mediterranean diet supports brain health pd patients focus neuroprotective foods eg omega 3s vitamin e health systems encourage nutritional counse ling individuals risk pd patients • physical activity regular exercise especially aerobic activities balance enhancing exercises reduce pd risk pd patients follow personalized exercise plans manage symptoms health systems promote physical activity integrate physical therapy pd care • alcohol consumption excessive alcohol intake may contribute neurotoxicity healthy individuals limit alcohol intake protect brain health pd patients monitor alcohol consumption avoid interactions medications health systems promote health drinking habits provide resources alcohol reduction • body weight metabolic health maintaining healthy weight diet exercise reduces risk neurodegeneration pd patients monitor bmi metabolic health prevent disease progression health systems prioritize metabolic health screening risk indi viduals pd patients metabolic systemic health conditions • diabetes hypertension managing blood sugar blood pressure reduce pd risk pd patients closely monitor conditions may exacerbate neurological decline healthcare providers emphasize managing diabetes hypertension pd care • cholesterol triglycerides maintaining balanced lipid levels diet medications reduce inflammation protect brain health pd patients monitor lipid levels regularly health systems incorporate lipid screenings pd management preventive care • metabolic syndrome addressing metabolic syndrome weight management healthy lifestyle reduces neurodegenerative risks pd patients focus improving diet weight management reduce systemic inflammation health systems offer metabolic screenin gs risk populations inflammatory immune related factors 47 • neuroinflammation chronic diseases anti inflammatory treatments eg nsaids curcumin may help mitigate pd related inflammation managing chronic inflammatory diseases eg arthritis support neurological health vaccinations also reduce infection risk pd patients con sider anti inflammatory treatments manage chronic conditions health systems integrate care chronic inflammatory diseases promote vaccination programs neurological psychological factors • traumatic brain injury tbi high risk occupations enforce safety measures eg helmet use concussion monitoring provide annual neurocognitive assessments • sleep disorders screening sleep disturbances eg rem sleep behavior disorder important linked increased pd risk treatment options like melatonin cpap therapy improve sleep quality • loss smell anosmia anosmia early symptom pd routine smell tests neurological assessments help detect high risk individuals • stress depression anxiety chronic stress mental health issues accelerate neurodegeneration psychological support eg cbt essential early intervention depression anxiety improve quality life may slow pd progression gutbrain axis microbiome health maintaining gut health balanced diet prebiotics probiotics essential pd patients work healthcare providers monitor gut health explore probiotic therapies health systems facilitate collaboration neur ologists gastroenterologists explore gut brain connections pd care hormonal factors health conditions • estrogen neuroprotection postmenopausal women may benefit hormone replacement therapy hrt neuroprotection regular hormonal evaluations guide treatment • uric acid levels managing uric acid levels diet hydration may help lower neurodegenerative risks pd patients monitor uric acid levels reduce 48 neurodegeneration health systems offer regular evaluations hrt monitor uric acid levels pd patients medications emerging treatments • neuroprotective drug strategies emerging treatments like glp 1 receptor agonists may reduce pd risk healthy individuals risk discuss treatments healthcare providers pd patients explore drugs monitor long term medication effects health systems sh ould support research neuroprotective drugs monitor longterm medication effects pd care table 1 6 pd prevention management recommendations factor recommendation healthy people recommendation pd patients health system consideration age regular screenings neurodegenerative markers cognitive assessments regular check ups monitor disease progression adjust treatment prioritize neurodegenerative screenings older adults sex engage regular screening focus motor non motor symptoms tailored care gender specific risks targeted health campaigns focusing men early diagnosis race ethnicity participate community based health programs screenings targeted interventions early diagnosis treatment access implement targeted screenings highrisk racial ethnic groups family history genetics consider genetic counseling predictive testing eg lrrk2 explore targeted therapies genetically predisposed individuals offer genetic counseling predictive testing families pd history cognitive educational factors engage mentally stimulating activities eg reading memory exercises incorporate cognitive therapies brain training exercises encourage educational programs cognitive activities brain health exposure toxins use protective gear high risk occupations reduce toxin exposure regular consultations monitor toxin exposure neurological health advocate safer pesticide use enforce safety regulations industries air pollution use air purifiers masks high pollution areas focus reducing exposure air pollutants promote clean air policies raise awareness air pollution risks socioeconomic disparities seek affordable preventive screenings expand access healthcare underserved communities offer subsidized screenings care underserved areas nutrition diet adopt diet rich antioxidants healthy fats anti inflammatory foods follow specialized diet omega 3s antioxidants vitamin e encourage nutritional counseling risk pd patients physical activity engage aerobic balance enhancing exercises regular physical therapy exercise regimens manage motor symptoms promote physical activity integrate therapy pd management plans alcohol consumption limit excessive alcohol intake consult healthcare providers monitor alcohol use interactions educate risks excessive alcohol intake offer reduction resources 49 body weight metabolic health maintain healthy weight diet exercise monitor bmi metabolic health manage obesity related risks regular metabolic health bmi screenings part preventive care diabetes hypertension maintain blood sugar levels blood pressure manage blood pressure glucose levels support neurological function emphasize managing diabetes hypertension pd prevention care cholesterol triglycerides manage lipid levels diet medications ensure cholesterol triglyceride levels check support brain health regular lipid screenings part pd management metabolic syndrome address weight management healthier lifestyle choices manage weight diet reduce inflammation support brain health provide metabolic screenings counseling risk neuroinflammation chronic diseases anti inflammatory treatments consider incorporating anti inflammatory foods eg curcumin flavonoids diet reduce inflammation anti inflammatory treatments pd patients could benefit anti inflammatory medications eg nsaids dietary supplements help manage pdrelated inflammation promote research anti inflammatory treatments provide guidance inflammation management pd patients chronic inflammatory diseases autoimmune conditions manage chronic inflammatory diseases like arthritis early prevent complications may contribute neurodegeneration manage autoimmune conditions appropriate treatments reduce inflammation minimize impact neurological health provide integrated care neurologists specialists autoimmune diseases ensure better management pd related inflammation preventive vaccinations get regular vaccinations eg flu shots prevent infections may increase risk neurodegeneration preventive vaccinations antiviral therapies may reduce risk infections exacerbate pd symptoms ensure access vaccines antiviral treatments pd patients reduce likelihood infection induced complications traumatic brain injury tbi follow safety measures highrisk occupations eg wearing helmets contact sports construction monitor history traumatic brain injury may accelerate neurodegeneration pd patients implement policies mandatory concussion screening neurocognitive assessments individuals high risk occupations sleep disorders prioritize good sleep hygiene seek medical advice sleep disturbances screen sleep disorders like rem sleep behavior disorder use treatments like melatonin cpap therapy improve sleep quality incorporate sleep disorder screenings routine neurological assessments healthy individuals risk pd patients loss smell anosmia stay aware early signs anosmia seek medical consultation symptoms develop use routine smell tests neurological assessments detect high risk individuals diagnose early pd offer routine smell tests part early pd detection especially individuals risk developing pd stress depression anxiety manage chronic stress lifestyle changes including exercise mindfulness practices engage psychological support like cognitive behavioral therapy cbt consider medications eg ssris manage depression anxiety integrate mental health support services pd care emphasize early interventions stress depression healthy individuals pd patients gutbrain axis microbiome health maintain healthy gut consuming diet rich prebiotics probiotics fiber support brain health work neurologists gastroenterologists identify gut dysbiosis early incorporate gut health promote interdisciplinary collaboration neurologists gastroenterologists monitor 50 therapies probiotics dietary changes manage gut brain connection pd patients estrogen neuroprotection postmenopausal women consult healthcare providers potential benefits hormone replacement therapy hrt postmenopausal women pd may benefit hrt neuroprotection discuss option healthcare providers offer regular hormonal evaluations consider hrt postmenopausal women risk diagnosed pd support brain health uric acid levels maintain healthy uric acid levels dietary modifications eg reducing purine rich foods clinicians monitor uric acid levels pd patients consider medication levels elevated reduce neurodegenerative risks regularly monitor uric acid levels risk individuals pd patients part preventive care neuroprotective drug strategies consider discussing emerging treatments glp 1 receptor agonists healthcare provider high risk pd pd patients emerging drugs like glp 1 receptor agonists β2 adrenoceptor antagonists could considered part treatment plan encourage research new neuroprotective drug therapies integrate emerging treatments clinical practice pd prevention management long term drug use aware potential neurological effects long term drug use discuss concerns healthcare providers monitor neurological effects long term medications consider safer alternatives necessary provide regular assessments longterm effects medications offer alternative therapies available 7 conclusion paper provided comprehensive overview key risk prevalent factors highlight considerable heterogeneity complexity underlying neuropathogenesis pd likely multiple factors varying degrees risk intera ct within genetically predisposed individuals critical stages neurodegeneration ultimately leading clinical manifestation pd risk prevalent factor discussed molecular mechanisms involved may help identif interactive effects multiple risk factors simultaneously additionally explored evolving understanding risk prevalence factors pd acknowledging complex neurological disorder new risk factors — particularly related genetics —are likely uncovered future furthermore highlighted several protective factors may mitigate development pd slow progression physical activity factors warrant increased attention individ uals 51 health systems alike raise awareness improve public health initiatives within communities competing interests competing interests declared author references 1 j lees j hardy revesz parkinsons disease lancet vol 373 9680 pp 2055 2066 2009 2 huang et al risk factors associated age onset parkinson ’ disease uk biobank npj parkinsons disease vol 10 1 p 3 2024 3 n pankratz foroud genetics parkinson disease genetics medicine vol 9 12 pp 801 811 2007 4 ascherio schwarzschild epidemiology parkinsons disease risk factors prevention lancet neurology vol 15 12 pp 1257 1272 2016 5 reeve e simcox turnbull ageing parkinsons disease advancing age biggest risk factor ageing research reviews vol 14 pp 19 30 2014 6 tsalenchuk gentleman j marzi linking environmental risk factors epigenetic mechanisms parkinson ’ disease npj parkinsons disease vol 9 1 p 123 2023 7 c gabbert et al lifestyle factors clinical severity parkinson ’ disease scientific reports vol 13 1 p 9537 2023 8 l wu et al effects dietary supplements foods dietary patterns parkinson ’ disease meta analysis systematic review randomized crossover studies european journal clinical nutrition pp 1 11 2024 9 lc shih r j lin l chen c fu unravelling mechanisms underweight parkinson ’ disease investigating role gut microbiome npj parkinsons disease vol 10 1 p 28 2024 10 kwon et al diet gut microbiome patients parkinson ’ disease npj parkinsons disease vol 10 1 p 89 2024 11 peña díaz j garcía pardo ventura development small molecules targeting α synuclein aggregation promising strategy treat parkinsons disease eng pharmaceutics vol 15 3 mar 3 2023 doi 103390pharmaceutics15030839 12 p calabresi mechelli g natale l volpicelli daley g di lazzaro v ghiglieri alpha synuclein parkinsons disease synucleinopathies overt neurodegeneration back early synaptic dysfunction eng cell death dis vol 14 3 p 176 mar 1 2023 doi 101038s41419 02305672 9 52 13 p calabresi g di lazzaro g marino f campanelli v ghiglieri advances understanding function alpha synuclein implications parkinsons disease eng brain vol 146 9 pp 3587 3597 sep 1 2023 doi 101093brainawad150 14 j lee et al targeted degradation ⍺synuclein aggregates parkinsons disease using autotac technology eng mol neurodegener vol 18 1 p 41 jun 24 2023 doi 101186s13024 02300630 7 15 henrich w h oertel j surmeier f f geibl mitochondrial dysfunction parkinsons disease key disease hallmark therapeutic potential eng mol neurodegener vol 18 1 p 83 nov 11 2023 doi 101186s13024 02300676 7 16 j l eriksen z wszolek l petrucelli molecular pathogenesis parkinson disease archives neurology vol 62 3 pp 353 357 2005 17 k xu et al neuroinflammation parkinsons disease focus relationship mirnas microglia eng front cell neurosci vol 18 p 1429977 2024 doi 103389fncel20241429977 18 buchman et al nigral pathology parkinsonian signs elders without parkinson disease annals neurology vol 71 2 pp 258 266 2012 19 friedman j galazka‐friedman e r bauminger iron trigger neurodegeneration parkinsons disease handbook clinical neurology vol 83 pp 493505 2007 20 c rubinsztein g mariño g kroemer autophagy aging cell vol 146 5 pp 682 695 2011 21 k van den eeden et al incidence parkinson ’ disease variation age gender raceethnicity american journal epidemiology vol 157 11 pp 1015 1022 2003 22 k nordengen et al pleiotropy sex specific traits reveals genetic aspects sex differences parkinsons disease eng brain vol 147 3 pp 858 870 mar 1 2024 doi 101093brainawad297 23 cerri l mus f blandini parkinsons disease women men whats difference eng j parkinsons dis vol 9 3 pp 501 515 2019 doi 103233jpd 191683 24 wright willis b evanoff lian r criswell b racette geographic ethnic variation parkinson disease population based study us medicare beneficiaries neuroepidemiology vol 34 3 pp 143 151 2010 25 harris n narayanan tranel black vs white race affect practitioners appraisal parkinsons disease eng npj parkinsons dis vol 9 1 p 106 jul 7 2023 doi 101038s41531 02300549 2 26 funayama k nishioka li n hattori molecular genetics parkinsons disease contributions global trends eng j hum genet vol 68 3 pp 125 130 mar 2023 doi 101038s10038 02201058 5 27 k j benjamin et al analysis gene expression postmortem brain neurotypical black americans reveals contributions genetic ancestry eng nat neurosci vol 27 6 pp 1064 1074 jun 2024 doi 101038s41593 02401636 0 28 c lim et al quantification raceethnicity representation alzheimers disease neuroimaging research usa systematic review eng commun med lond vol 3 1 p 101 jul 25 2023 doi 101038s43856 02300333 6 53 29 h payami g cohen c f murchison r sampson g standaert z wallen population fraction parkinson disease attributable preventable risk factors npj parkinsons disease p 202305 1923290231 2023 30 n sellbach r boyle p silburn g mellick parkinsons disease family history parkinsonism related disorders vol 12 7 pp 399 409 2006 31 gokuladhas fadason farrow cooper j ’ sullivan discovering genetic mechanisms underlying co occurrence parkinson ’ disease non motor traits npj parkinsons disease vol 10 1 p 27 2024 32 j tran h anastacio c bardy genetic predispositions parkinson ’ disease revealed patient derived brain cells npj parkinsons disease vol 6 1 p 8 2020 33 buniello et al nhgri ebi gwas catalog published genome wide association studies targeted arrays summary statistics 2019 nucleic acids research vol 47 d1 pp d1005 d1012 2019 34 h diaw et al characterization pathogenic α synuclein variant v15a parkinson´ disease npj parkinsons disease vol 9 1 p 148 2023 35 zimprich et al mutations lrrk2 cause autosomal dominant parkinsonism pleomorphic pathology neuron vol 44 4 pp 601 607 2004 36 russo l bubacco e greggio lrrk2 neuroinflammation partners crime parkinson ’ disease journal neuroinflammation vol 11 pp 1 9 2014 37 nguyen krainc lrrk2 phosphorylation auxilin mediates synaptic defects dopaminergic neurons patients parkinson ’ disease proceedings national academy sciences vol 115 21 pp 5576 5581 2018 38 c lovegrove genetic clinical phenotype lrrk2 associated familial pd nature clinical practice neurology vol 2 3 pp 125 125 2006 39 ysselstein et al lrrk2 kinase activity regulates lysosomal glucocerebrosidase neurons derived parkinson ’ disease patients nature communications vol 10 1 p 5570 2019 40 l streubel gallasch et al parkinson ’ disease –associated lrrk2 interferes astrocyte mediated alpha synuclein clearance molecular neurobiology vol 58 pp 3119 3140 2021 41 g ’ regan r desouza r balestrino h schapira glucocerebrosidase mutations parkinson disease journal parkinsons disease vol 7 3 pp 411 422 2017 42 v bonifati et al mutations dj 1 gene associated autosomal recessive early onset parkinsonism science vol 299 5604 pp 256 259 2003 43 f lind holm mogensen scafidi poli michelucci park7dj 1 microglia implications parkinson ’ disease relevance therapeutic target journal neuroinflammation vol 20 1 pp 1 19 2023 44 j kochmanski n c kuhn bernstein parkinson ’ disease associated sex specific changes dna methylation park7 dj 1 slc17a6 vglut2 ptprn2 ia2β nr4a2 nurr1 cortical neurons npj parkinsons disease vol 8 1 p 120 2022 45 vizziello l borellini g franco g ardolino disruption mitochondrial homeostasis role pink1 parkinson ’ disease cells vol 10 11 p 3022 2021 54 46 n jones pink1 targets dysfunctional mitochondria autophagy parkinson disease nature reviews neurology vol 6 4 pp 181 181 2010 47 e valente et al hereditary early onset parkinsons disease caused mutations pink1 science vol 304 5674 pp 1158 1160 2004 48 j brown et al pink1 deficiency impairs adult neurogenesis dopaminergic neurons scientific reports vol 11 1 p 6617 2021 49 r tufi et al enhancing nucleotide metabolism protects mitochondrial dysfunction neurodegeneration pink1 model parkinson ’ disease nature cell biology vol 16 2 pp 157 166 2014 50 kano et al reduced astrocytic reactivity human brains midbrain organoids prkn mutations npj parkinsons disease vol 6 1 p 33 2020 51 oczkowska w kozubski lianeri j dorszewska mutations prkn snca genes important progress parkinson ’ disease current genomics vol 14 8 pp 502 517 2013 52 p castelo rueda et al molecular phenotypes mitochondrial dysfunction clinically non manifesting heterozygous prkn variant carriers npj parkinsons disease vol 9 1 p 65 2023 53 kasten et al genotype‐phenotype relations parkinsons disease genes parkin pink1 dj1 mdsgene systematic review movement disorders vol 33 5 pp 730741 2018 54 c zhou et al progressive brain atrophy parkinsons disease patients convert mild cognitive impairment cns neuroscience therapeutics vol 26 1 pp 117 125 2020 55 p youssef et al evaluation plasma levels nfl gfap uchl1 tau parkinsons disease biomarkers using multiplexed single molecule counting scientific reports vol 13 1 p 5217 2023 56 ragland c hutter c zabetian k edwards association ubiquitin carboxyl terminal esterase l1 gene uchl1 s18y variant parkinsons disease huge review meta analysis american journal epidemiology vol 170 11 pp 1344 1357 2009 57 mondello r constantinescu h zetterberg u andreasson b holmberg jeromin csf α synuclein uch l1 levels parkinsons disease atypical parkinsonian disorders parkinsonism related disorders vol 20 4 pp 382 387 2014 58 l ng et al plasma ubiquitin c terminal hydrolase l1 levels reflect disease stage motor severity parkinson ’ disease aging albany ny vol 12 2 p 1488 2020 59 g yahalom et al carriers gba lrrk2 mutations compared carriers either parkinsons disease risk estimates genotype phenotype correlations parkinsonism related disorders vol 62 pp 179 184 2019 60 c p da silva et al clinical profiles associated lrrk2 gba mutations brazilians parkinsons disease journal neurological sciences vol 381 pp 160164 2017 61 r cilia et al survival dementia gba‐associated parkinsons disease mutation matters annals neurology vol 80 5 pp 662 673 2016 55 62 g liu et al prediction cognition parkinsons disease clinical –genetic score longitudinal analysis nine cohorts lancet neurology vol 16 8 pp 620 629 2017 63 r frigerio et al education occupations preceding parkinson disease population based case control study neurology vol 65 10 pp 1575 1583 2005 64 c fardell k torén l schiöler h nissbrandt åberg high iq early adulthood associated parkinson ’ disease journal parkinsons disease vol 10 4 pp 1649 1656 2020 65 j shi et al intelligence education level risk parkinson ’ disease european populations mendelian randomization study frontiers genetics vol 13 p 963163 2022 66 lara h amigo association education blood lipid levels income increases decade cohort study bmc public health vol 18 pp 1 8 2018 67 lv b xu x zhang c chen gao n li association serum cholesterol parkinsons disease cohort statin‐free individuals brain behavior vol 12 1 p e2454 2022 68 p garcía‐sanz j mfg aerts r moratalla role cholesterol α‐synuclein lewy body pathology gba1 parkinsons disease movement disorders vol 36 5 pp 1070 1085 2021 69 k pärna l pürjer ringmets tekkel educational differences cigarette smoking among adult population estonia 1990 –2010 trend fit model tobacco epidemic bmc public health vol 14 1 pp 1 8 2014 70 k modig k silventoinen p tynelius j kaprio f rasmussen genetics association intelligence nicotine dependence study male swedish twins addiction vol 106 5 pp 995 1002 2011 71 r frigerio et al education occupations preceding parkinson disease population based case control study eng neurology vol 65 10 pp 1575 83 nov 22 2005 doi 10121201wnl000018452021744a2 72 cohen e vakil tanne z nitsan r schwartz hassin baer educational level modulator cognitive performance neuropsychyatric features parkinson disease eng cogn behav neurol vol 20 1 pp 68 72 mar 2007 doi 101097wnn0b013e3180335f8e 73 pl gamache h salem n roux dubois j le bouthillier z gan n dupré exposure pesticides welding hastens age atonset parkinson ’ disease canadian journal neurological sciences vol 46 6 pp 711 716 2019 74 caballero amiri j denney p monsivais p hystad amram estimated residential exposure agricultural chemicals premature mortality parkinson ’ disease washington state international journal environmental research public health vol 15 12 p 2885 2018 75 nalls et al identification novel risk loci causal insights heritable risk parkinsons disease meta analysis genome wide association studies eng lancet neurol vol 18 12 pp 1091 1102 dec 2019 doi 101016s1474 44221930320 5 76 x zeng n l debono harris v h arrandale p demers neurodegenerative diseases among miners ontario canada using linked cohort occupational environmental medicine 2020 56 77 v n uversky j li l fink metal triggered structural transformations aggregation fibrillation human alpha synuclein possible molecular nk parkinsons disease heavy metal exposure eng j biol chem vol 276 47 pp 44284 96 nov 23 2001 doi 101074jbcm105343200 78 pyatha h kim lee k kim association heavy metal exposure parkinsons disease review mechanisms related oxidative stress eng antioxidants basel vol 11 12 dec 15 2022 doi 103390antiox11122467 79 l shvachiy v geraldes f outeiro uncovering molecular link lead toxicity parkinsons disease eng antioxid redox signal vol 39 4 6 pp 321 335 aug 2023 doi 101089ars20220076 80 l j forero rodríguez j josephs spaulding flor pinzón c kaleta parkinsons disease metal microbiome gutbrain axis systems toxicology approach eng antioxidants basel vol 11 1 dec 28 2021 doi 103390antiox11010071 81 goldman et al solvent exposures parkinson disease risk twins annals neurology vol 71 6 pp 776 784 2012 82 jo et al association no2 air pollution exposures risk parkinson disease jama neurology vol 78 7 pp 800 808 2021 83 jami h murata l barnhill li j bronstein diesel exhaust exposure alters expression networks implicated neurodegeneration zebrafish brains eng cell biol toxicol vol 39 3 pp 641 655 jun 2023 doi 101007s10565 02109618 9 84 h murata l barnhill j bronstein air pollution risk parkinsons disease review eng mov disord vol 37 5 pp 894 904 may 2022 doi 101002mds28922 85 r stern riley h daneshvar c j nowinski r c cantu c mckee long term consequences repetitive brain trauma chronic traumatic encephalopathy pmr vol 3 10 pp s460 s467 2011 86 p whitton inflammation causative factor aetiology parkinsons disease british journal pharmacology vol 150 8 pp 963 976 2007 87 c b breckenridge c berry e chang r l sielken jr j mandel association parkinson ’ disease cigarette smoking rural living well water consumption farming pesticide use systematic review meta analysis plos one vol 11 4 p e0151841 2016 88 j timpka et al reduced workforce participation 5 years prior first parkinson ’ disease sick leave npj parkinsons disease vol 4 1 p 36 2018 89 lan j chen z chai hu neurotoxicity iron copper cobalt parkinson ’ disease ros mediated mechanisms biometals vol 29 pp 665 678 2016 90 j park et al occupations parkinson ’ disease multi center case control study south korea neurotoxicology vol 26 1 pp 99 105 2005 91 j k tsui b calne wang schulzer marion occupational risk factors parkinson ’ disease canadian journal public health vol 90 pp 334 337 1999 57 92 chang et al meta analysis genome wide association studies identifies 17 new parkinsons disease risk loci eng nat genet vol 49 10 pp 1511 1516 oct 2017 doi 101038ng3955 93 h j bruce et al american football play parkinson disease among men jama network open vol 6 8 pp e2328644 e2328644 2023 94 f yang l v johansson n l pedersen f fang gatz k wirdefeldt socioeconomic status relation parkinsons disease risk mortality population based prospective study eng medicine baltimore vol 95 30 p e4337 jul 2016 doi 101097md0000000000004337 95 l lix e hobson azimaee w leslie c burchill hobson socioeconomic variations prevalence incidence parkinsons disease population based analysis eng j epidemiol community health vol 64 4 pp 33540 apr 2010 doi 101136jech2008084954 96 ascherio schwarzschild lifestyle parkinsons disease progression eng mov disord vol 34 1 pp 7 8 jan 2019 doi 101002mds27566 97 e roos et al body mass index sitting time risk parkinson disease neurology vol 90 16 pp e1413 e1417 2018 98 g hu p jousilahti nissinen r antikainen kivipelto j tuomilehto body mass index risk parkinson disease neurology vol 67 11 pp 1955 1959 2006 99 ky park g e nam k han h k park h hwang waist circumference risk parkinson ’ disease npj parkinsons disease vol 8 1 p 89 2022 100 g hu p jousilahti nissinen r antikainen kivipelto j tuomilehto body mass index risk parkinson disease eng neurology vol 67 11 pp 1955 9 dec 12 2006 doi 10121201wnl000024705218422e5 101 k cumming macleod p k myint c e counsell early weight loss parkinsonism predicts poor outcomes evidence incident cohort study neurology vol 89 22 pp 2254 2261 2017 102 peters et al alcohol consumption risk parkinsons disease data large prospective european cohort movement disorders vol 35 7 pp 1258 1263 2020 103 c shao x wang p wang h tang j n wu parkinsons disease risk alcohol intake systematic review dose response meta analysis prospective studies frontiers nutrition vol 8 p 709846 2021 104 f j jiménez jiménez h alonso navarro e garcía martín j agúndez alcohol consumption risk parkinson ’ disease systematic review meta analysis journal neurology vol 266 8 pp 1821 1834 2019 105 r kelsey lifestyle factors progression pd nature reviews neurology vol 15 3 pp 126 126 2019 106 r daviet et al associations alcohol consumption gray white matter volumes uk biobank nature communications vol 13 1 p 1175 2022 107 c domenighetti et al dairy intake parkinsons disease mendelian randomization study movement disorders vol 37 4 pp 857 864 2022 108 k c hughes et al intake dairy foods risk parkinson disease neurology vol 89 1 pp 46 52 2017 109 h chen et al consumption dairy products risk parkinsons disease american journal epidemiology vol 165 9 pp 998 1006 2007 58 110 r abbott et al midlife milk consumption substantia nigra neuron density death neurology vol 86 6 pp 512 519 2016 111 torti et al effect family history occupation diet risk parkinson disease case control study plos one vol 15 12 p e0243612 2020 112 k w lange et al diet medical foods parkinson ’ disease food science human wellness vol 8 2 pp 83 95 2019 113 khan j ezeugwa v e ezeugwu systematic review associations sedentary behavior physical inactivity non motor symptoms parkinsons disease eng plos one vol 19 3 p e0293382 2024 doi 101371journalpone0293382 114 h chohan et al type 2 diabetes determinant parkinsons disease risk progression movement disorders vol 36 6 pp 1420 1429 2021 115 e de pablo fernandez r goldacre j pakpoor j noyce warner association diabetes subsequent parkinson disease record linkage cohort study neurology vol 91 2 pp e139 e142 2018 116 h yu et al association parkinson ’ disease diabetes mellitus epidemiology pathophysiology prevention treatment aging disease vol 13 6 p 1591 2022 117 g pagano et al diabetes mellitus parkinson disease neurology vol 90 19 pp e1654 e1662 2018 118 r ou et al effect diabetes control status progression parkinson ’ disease prospective study annals clinical translational neurology vol 8 4 pp 887897 2021 119 b mollenhauer et al baseline predictors progression 4 years parkinsons disease diagnosis de novo parkinson cohort denopa movement disorders vol 34 1 pp 67 77 2019 120 e cereda barichella e cassani r caccialanza g pezzoli clinical features parkinson disease onset diabetes came first case control study neurology vol 78 19 pp 1507 1511 2012 121 f camargo maluf feder alves de siqueira carvalho analysis relationship type ii diabetes mellitus parkinson ’ disease systematic review parkinson ’ disease vol 2019 2019 122 athauda et al impact type 2 diabetes parkinsons disease movement disorders vol 37 8 pp 1612 1623 2022 123 k han b kim h lee k kim nationwide cohort study diabetes severity risk parkinson disease npj parkinsons disease vol 9 1 p 11 2023 124 greenberg et al cerebral microbleeds guide detection interpretation eng lancet neurol vol 8 2 pp 165 74 feb 2009 doi 101016s1474 44220970013 4 125 viswanathan r salman steven warach j lenore cerebral microbleeds field guide detection interpretation lancet neurol vol 8 2 pp 165 174 2009 126 lemprière white matter hyperintensities —location matters nature reviews neurology vol 19 3 pp 129 129 2023 59 127 c dufouil et al longitudinal study blood pressure white matter hyperintensities eva mri cohort neurology vol 56 7 pp 921 926 2001 128 k yang et al white matter changes parkinson ’ disease npj parkinsons disease vol 9 1 p 150 2023 129 macías garcía et al serum lipid profile among sporadic familial forms parkinson ’ disease npj parkinsons disease vol 7 1 p 59 2021 130 l de lau p j koudstaal hofman breteler serum cholesterol levels risk parkinsons disease american journal epidemiology vol 164 10 pp 998 1002 2006 131 f fang et al lipids apolipoproteins risk parkinson disease prospective cohort study mendelian randomization analysis circulation research vol 125 6 pp 643 652 2019 132 r paul choudhury borah cholesterol –a putative endogenous contributor towards parkinsons disease neurochemistry international vol 90 pp 125 133 2015 133 x huang et al serum cholesterol progression parkinsons disease results datatop plos one vol 6 8 p e22854 2011 134 k hurh park jang e c park jang association serum lipid levels time risk parkinson ’ disease scientific reports vol 12 1 p 21020 2022 135 jh park et al association high density lipoprotein cholesterol variability risk developing parkinson disease neurology vol 96 10 pp e1391 e1401 2021 136 benn b g nordestgaard r frikke schmidt tybjærg hansen low ldl cholesterol pcsk9 hmgcr genetic variation risk alzheimer ’ disease parkinson ’ disease mendelian randomisation study bmj vol 357 2017 137 g e nam et al metabolic syndrome risk parkinson disease nationwide cohort study plos medicine vol 15 8 p e1002640 2018 138 g hu r antikainen p jousilahti kivipelto j tuomilehto total cholesterol risk parkinson disease neurology vol 70 21 pp 1972 1979 2008 139 r j smeyne j noyce byrne r savica c marras infection risk parkinsons disease eng j parkinsons dis vol 11 1 pp 31 43 2021 doi 103233jpd 202279 140 anghelescu et al parkinsons disease sars cov 2 infection particularities molecular cellular mechanisms regarding pathogenesis treatment eng biomedicines vol 10 5 apr 26 2022 doi 103390biomedicines10051000 141 ding et al parkinsons disease causative mutation vps35 disturbs tetherin trafficking cell surfaces facilitates virus spread eng cells vol 10 4 mar 28 2021 doi 103390cells10040746 142 c conte possible link sars cov 2 infection parkinsons disease role toll like receptor 4 eng int j mol sci vol 22 13 jul 1 2021 doi 103390ijms22137135 143 w xu et al double stranded rna induced dopaminergic neuronal loss substantia nigra presence mac1 receptor eng biochem biophys res commun vol 533 4 pp 1148 1154 dec 17 2020 doi 101016jbbrc202009101 60 144 herrero c estrada l maatouk vyas inflammation parkinsons disease role glucocorticoids eng front neuroanat vol 9 p 32 2015 doi 103389fnana201500032 145 c marogianni sokratous e dardiotis g hadjigeorgiou bogdanos g xiromerisiou neurodegeneration inflammation interesting interplay parkinsons disease eng int j mol sci vol 21 22 nov 10 2020 doi 103390ijms21228421 146 rolli derkinderen l leclair visonneau bourreille e coron neunlist p derkinderen parkinsons disease chronic low grade inflammatory bowel disease eng j neurol vol 267 8 pp 2207 2213 aug 2020 doi 101007s00415 019 09321 0 147 h lee e lobbestael vermeire j sabino cleynen inflammatory bowel disease parkinsons disease common pathophysiological links eng gut vol 70 2 pp 408 417 feb 2021 doi 101136gutjnl 2020 322429 148 g xiromerisiou c marogianni androutsopoulou p ntavaroukas mysiris papoutsopoulou parkinsons disease takes guts correlation intestinal microbiome cytokine network neurodegeneration eng biology basel vol 12 1 jan 7 2023 doi 103390biology12010093 149 g chan k ventura villeneuve p du bois r holahan exploring connection gut microbiome parkinsons disease symptom progression pathology implications supplementary treatment options eng j parkinsons dis vol 12 8 pp 2339 2352 2022 doi 103233jpd 223461 150 v caputi c giron microbiome gutbrain axis toll like receptors parkinsons disease eng int j mol sci vol 19 6 jun 6 2018 doi 103390ijms19061689 151 mulak b bonaz brain gutmicrobiota axis parkinsons disease eng world j gastroenterol vol 21 37 pp 10609 20 oct 7 2015 doi 103748wjgv21i3710609 152 varesi et al interplay gut microbiota parkinsons disease implications diagnosis treatment eng int j mol sci vol 23 20 oct 14 2022 doi 103390ijms232012289 153 j disabato n quan j p godbout neuroinflammation devil details journal neurochemistry vol 139 pp 136 153 2016 154 c sartori e vance l z slater crowe impact inflammation cognitive function older adults implications health care practice research journal neuroscience nursing vol 44 4 p 206 2012 155 g tansey r l wallings c houser k herrick c e keating v joers inflammation immune dysfunction parkinson disease nature reviews immunology vol 22 11 pp 657 673 2022 156 h e allen reish g standaert role α synuclein inducing innate adaptive immunity parkinson disease journal parkinsons disease vol 5 1 pp 1 19 2015 157 e klann et al gut brain axis relation parkinsons disease review eng front aging neurosci vol 13 p 782082 2021 doi 103389fnagi2021782082 61 158 v delic k beck k c h pang b citron biological links traumatic brain injury parkinsons disease eng acta neuropathol commun vol 8 1 p 45 apr 7 2020 doi 101186s40478 02000924 7 159 c wee arulsamy f corrigan l collins praino long term impact diffuse traumatic brain injury neuroinflammation catecholaminergic signaling potential relevance parkinsons disease risk eng molecules vol 29 7 mar 26 2024 doi 103390molecules29071470 160 p dodet et al sleep disorders parkinsons disease early multiple problem eng npj parkinsons dis vol 10 1 p 46 feb 29 2024 doi 101038s41531 02400642 0 161 g loddo et al treatment sleep disorders parkinsons disease research clinical practice eng front neurol vol 8 p 42 2017 doi 103389fneur201700042 162 tarakad j jankovic anosmia ageusia parkinsons disease eng int rev neurobiol vol 133 pp 541 556 2017 doi 101016bsirn201705028 163 r l doty olfaction parkinsons disease related disorders eng neurobiol dis vol 46 3 pp 527 52 jun 2012 doi 101016jnbd201110026 164 j k garlovsky p g overton j simpson psychological predictors anxiety depression parkinsons disease systematic review eng j clin psychol vol 72 10 pp 979 98 oct 2016 doi 101002jclp22308 165 hemmerle j p herman k b seroogy stress depression parkinsons disease eng exp neurol vol 233 1 pp 79 86 jan 2012 doi 101016jexpneurol201109035 166 sagna j j gallo g pontone systematic review factors associated depression anxiety disorders among older adults parkinsons disease eng parkinsonism relat disord vol 20 7 pp 708 15 jul 2014 doi 101016jparkreldis201403020 167 van der heide j meinders e speckens f peerbolte b r bloem r c helmich stress mindfulness parkinsons disease clinical effects potential underlying mechanisms eng mov disord vol 36 1 pp 64 70 jan 2021 doi 101002mds28345 168 k w austin w ameringer l j cloud integrated review psychological stress parkinsons disease biological mechanisms symptom health outcomes eng parkinsons dis vol 2016 p 9869712 2016 doi 10115520169869712 169 e k blundell l e grover j stott schrag experience anxiety people parkinson ’ disease npj parkinsons disease vol 9 1 p 75 2023 170 yoon c lee j h suh n yang k han w kim different risks early onset late onset parkinson disease individuals mental illness npj parkinsons disease vol 10 1 p 17 2024 171 g hou r tian j li f yuan chronic stress parkinsons disease eng cns neurosci ther vol 20 1 pp 1 2 jan 2014 doi 101111cns12209 172 j e yoo et al female reproductive factors risk parkinsons disease nationwide cohort study eng eur j epidemiol vol 35 9 pp 871 878 sep 2020 doi 101007s10654 02000672 x 62 173 r popat et al effect reproductive factors postmenopausal hormone use risk parkinson disease eng neurology vol 65 3 pp 383 90 aug 9 2005 doi 10121201wnl00001713448780294 174 p ragonese damelio g savettieri implications estrogens parkinsons disease epidemiological approach eng ann n acad sci vol 1089 pp 373 82 nov 2006 doi 101196annals1386004 175 j yuk h jeong association menopausal hormone therapy risk parkinsons disease eng j parkinsons dis vol 13 8 pp 1357 1367 2023 doi 103233jpd 230230 176 r saunders pullman j gordon elliott parides fahn h r saunders bressman effect estrogen replacement early parkinsons disease eng neurology vol 52 7 pp 1417 21 apr 22 1999 doi 101212wnl5271417 177 villa e vegeto poletti maggi estrogens neuroinflammation neurodegeneration eng endocr rev vol 37 4 pp 372 402 aug 2016 doi 101210er2016 1007 178 alrouji et al role uric acid neurodegenerative diseases focusing alzheimer parkinson disease new perspective eng neuropsychopharmacol rep vol 44 3 pp 639 649 sep 2024 doi 101002npr212445 179 v e bianchi l rizzi f somaa role nutrition parkinsons disease systematic review eng nutr neurosci vol 26 7 pp 605 628 jul 2023 doi 1010801028415x20222073107 180 h mertsalmi e pekkonen f scheperjans antibiotic exposure risk parkinsons disease finland nationwide case‐control study movement disorders vol 35 3 pp 431 442 2020 181 mittal et al β2 adrenoreceptor regulator α synuclein gene driving risk parkinson ’ disease science vol 357 6354 pp 891 898 2017 182 c l chen wang c chen c chuang association β2 adrenoreceptor medications risk parkinsons disease meta analysis eng medicina kaunas vol 57 10 sep 24 2021 doi 103390medicina57101006 183 j l cheong e de pablo fernandez foltynie j noyce association type 2 diabetes mellitus parkinsons disease eng j parkinsons dis vol 10 3 pp 775 789 2020 doi 103233jpd 191900 184 x qin et al association diabetes medications risk parkinsons disease systematic review meta analysis eng front neurol vol 12 p 678649 2021 doi 103389fneur2021678649 185 x dong chen c yong x yang chen yu p li hua signaling pathways parkinsons disease molecular mechanisms therapeutic interventions eng signal transduct target ther vol 8 1 p 73 feb 21 2023 doi 101038s41392 02301353 3 186 g pagano et al sustained effect prasinezumab parkinsons disease motor progression open label extension pasadena trial eng nat med vol 30 12 pp 3669 3675 dec 2024 doi 101038s41591 02403270 6 187 h beydoun et al psychotropic medication use parkinsons disease risk amongst older women eng ann clin transl neurol vol 9 8 pp 1163 1176 aug 2022 doi 101002acn351614 63 188 r k weersma zhernakova j fu interaction drugs gut microbiome eng gut vol 69 8 pp 1510 1519 aug 2020 doi 101136gutjnl 2019 320204 189 h song et al epigenetic modification parkinsons disease eng front cell dev biol vol 11 p 1123621 2023 doi 103389fcell20231123621 190 x fang et al association levels physical activity risk parkinson disease systematic review meta analysis jama network open vol 1 5 pp e182421 e182421 2018 191 b portugal et al association physical activity parkinson disease women longterm follow e3n cohort study neurology vol 101 4 pp e386 e398 2023 192 k c hughes x gao molsberry l valeri schwarzschild ascherio physical activity prodromal features parkinson disease neurology vol 93 23 pp e2157 e2169 2019 193 k tsukita h sakamaki tsukita r takahashi long term effect regular physical activity exercise habits patients early parkinson disease neurology vol 98 8 pp e859 e871 2022 194 speelman b p van de warrenburg van nimwegen g petzinger munneke b r bloem might physical activity benefit patients parkinson disease nature reviews neurology vol 7 9 pp 528 534 2011 195 morawska et al slow wave sleep affects synucleinopathy regulates proteostatic processes mouse models parkinsons disease eng sci transl med vol 13 623 p eabe7099 dec 8 2021 doi 101126scitranslmedabe7099 196 j hunt e j coulson r rajnarayanan h oster videnovic rawashdeh sleep circadian rhythms parkinsons disease preclinical models eng mol neurodegener vol 17 1 p 2 jan 9 2022 doi 101186s13024 02100504 w 197 c j mao et al association sleep characteristics likelihood prodromal parkinsons disease cross sectional analysis habit study eng nat sci sleep vol 16 pp 1355 1364 2024 doi 102147nsss476348 198 j simpson k haines g lekwuwa j wardle crawford social support psychological outcome people parkinsons disease evidence specific pattern associations eng br j clin psychol vol 45 pt 4 pp 585 90 nov 2006 doi 101348014466506x96490 199 j ravenek schneider social support physical activity perceptions control early parkinsons disease eng disabil rehabil vol 31 23 pp 1925 36 2009 doi 10108009638280902850261 200 j e ahlskog aerobic exercise evidence direct brain effect slow parkinson disease progression eng mayo clin proc vol 93 3 pp 360 372 mar 2018 doi 101016jmayocp201712015 201 jackson et al diet parkinsons disease critical role microbiome eng front neurol vol 10 p 1245 2019 doi 103389fneur201901245 202 aarsland et al parkinson disease associated cognitive impairment eng nat rev dis primers vol 7 1 p 47 jul 1 2021 doi 101038s41572 02100280 3 203 g halliday j b leverenz j schneider c h adler neurobiological basis cognitive impairment parkinsons disease eng mov disord vol 29 5 pp 634 50 apr 15 2014 doi 101002mds25857 64 204 g liu et al mitochondrial haplogroups cognitive progression parkinsons disease eng brain vol 146 1 pp 42 49 jan 5 2023 doi 101093brainawac327 205 g liu et al genome wide survival study identifies novel synaptic locus polygenic score cognitive progression parkinsons disease eng nat genet vol 53 6 pp 787 793 jun 2021 doi 101038s41588 02100847 6 206 e r wallace c segerstrom c g van horne f schmitt l koehl meta analysis cognition parkinsons disease mild cognitive impairment dementia progression eng neuropsychol rev vol 32 1 pp 149 160 mar 2022 doi 101007s11065 02109502 7 207 j jones et al physical activity mediator anxiety cognitive functioning parkinsons disease mental health physical activity vol 20 p 100382 2021 208 b mappin kasirer et al tobacco smoking risk parkinson disease 65 year follow 30000 male british doctors neurology vol 94 20 pp e2132 e2138 2020 209 b ritz l rhodes half century research smoking pd go neurology vol 74 11 pp 870 871 2010 210 wh piao campagnolo c dayao r j lukas j wu f shi nicotine inflammatory neurological disorders acta pharmacologica sinica vol 30 6 pp 715722 2009 211 dp hong l fink v n uversky smoking parkinsons disease nicotine affect α synuclein fibrillation biochimica et biophysica acta bba proteins proteomics vol 1794 2 pp 282 290 2009 212 yoon et al association smoking cause mortality parkinson ’ disease npj parkinsons disease vol 9 1 p 59 2023 213 lysen k l darweesh k ikram luik ikram sleep risk parkinsonism parkinsons disease population based study eng brain vol 142 7 pp 2013 2022 jul 1 2019 doi 101093brainawz113 214 c gabbert et al coffee smoking aspirin associated age onset idiopathic parkinson ’ disease journal neurology vol 269 8 pp 4195 4203 2022 215 k sääksjärvi p knekt h rissanen laaksonen reunanen männistö prospective study coffee consumption risk parkinsons disease european journal clinical nutrition vol 62 7 pp 908 915 2008 216 k wirdefeldt h adami p cole trichopoulos j mandel epidemiology etiology parkinson ’ disease review evidence european journal epidemiology vol 26 pp 1 58 2011 217 c hong l chan c h bai effect caffeine risk progression parkinson ’ disease meta analysis nutrients vol 12 6 p 1860 2020 218 bh cho choi j kim b c kim association coffee consumption non motor symptoms drug naïve early stage parkinsons disease parkinsonism related disorders vol 50 pp 42 47 2018 219 bh cho choi b c kim gender dependent effect coffee consumption tremor severity de novo parkinson ’ disease bmc neurology vol 19 pp 1 9 2019 65 220 jf chen schwarzschild caffeine selective adenosine a2a receptor antagonists protect dopaminergic neurodegeneration parkinsons disease parkinsonism related disorders vol 80 pp s45 s53 2020 221 g grosso j godos f galvano e l giovannucci coffee caffeine health outcomes umbrella review annual review nutrition vol 37 pp 131 156 2017 222 f j li h f ji l shen meta analysis tea drinking risk parkinsons disease eng scientificworldjournal vol 2012 p 923464 2012 doi 1011002012923464 223 q chen et al neuroprotective effects mechanisms tea bioactive components neurodegenerative diseases eng molecules vol 23 3 feb 25 2018 doi 103390molecules23030512 224 yuan et al factors associated phenoconversion idiopathic rapid eye movement sleep behavior disorder prospective study eng npj parkinsons dis vol 11 1 p 10 jan 6 2025 doi 101038s41531 02400856 2 225 l c tan et al differential effects black versus green tea risk parkinsons disease singapore chinese health study eng j epidemiol vol 167 5 pp 553 60 mar 1 2008 doi 101093ajekwm338 226 k tanaka et al intake japanese chinese teas reduces risk parkinsons disease eng parkinsonism relat disord vol 17 6 pp 446 50 jul 2011 doi 101016jparkreldis201102016 227 x gao et al prospective study dietary pattern risk parkinson disease american journal clinical nutrition vol 86 5 pp 1486 1494 2007 228 k n tosefsky j zhu n wang j lam cammalleri appel cresswell role diet parkinsons disease eng j parkinsons dis vol 14 s1 pp s21 s34 2024 doi 103233jpd 230264 229 l k mischley r c lau r bennett role diet nutritional supplements parkinsons disease progression eng oxid med cell longev vol 2017 p 6405278 2017 doi 10115520176405278 230 p knekt kilkkinen h rissanen j marniemi k sääksjärvi heliövaara serum vitamin risk parkinson disease archives neurology vol 67 7 pp 808 811 2010 231 j booij p tellier j seibyl c vriend dopamine transporter availability early parkinsons disease dependent sunlight exposure movement disorders vol 38 11 pp 2131 2135 2023 232 schirinzi et al dietary vitamin e protective factor parkinsons disease clinical experimental evidence frontiers neurology vol 10 p 148 2019 233 c dietiker kim zhang c w christine n n p investigators characterization vitamin b12 supplementation correlation clinical outcomes large longitudinal study early parkinson ’ disease journal movement disorders vol 12 2 p 91 2019 234 j mccarter et al higher vitamin b12 level parkinsons disease diagnosis associated lower risk future dementia parkinsonism related disorders vol 73 pp 19 22 2020 235 alizadeh kheirouri keramati dietary vitamins minerals might protective parkinsons disease eng brain sci vol 13 7 jul 24 2023 doi 103390brainsci13071119 66 236 c boulos n yaghi r el hayeck g n heraoui n fakhoury sayegh nutritional risk factors microbiota parkinsons disease current evidence eng nutrients vol 11 8 aug 14 2019 doi 103390nu11081896 237 h chang b wang shi r zhu dose response meta analysis urate gout risk parkinsons disease eng npj parkinsons dis vol 8 1 p 160 nov 22 2022 doi 101038s41531 02200433 5 238 e c leira planas k chauhan chamorro uric acid translational journey cerebroprotection spanned preclinical human data eng neurology vol 101 23 pp 1068 1074 dec 4 2023 doi 101212wnl0000000000207825 239 g f crotty ascherio schwarzschild targeting urate reduce oxidative stress parkinson disease eng exp neurol vol 298 pt b pp 210 224 dec 2017 doi 101016jexpneurol201706017 240 shima et al uric acid alterations purine recycling disorders parkinsons disease cross sectional study eng npj parkinsons dis vol 10 1 p 170 sep 9 2024 doi 101038s41531 02400785 0 241 e esposito v di matteo benigno pierucci g crescimanno g di giovanni non steroidal anti inflammatory drugs parkinsons disease eng exp neurol vol 205 2 pp 295 312 jun 2007 doi 101016jexpneurol200702008 242 q wang liu j zhou neuroinflammation parkinsons disease potential therapeutic target eng transl neurodegener vol 4 p 19 2015 doi 101186s40035 0150042 0 243 x gao h chen schwarzschild ascherio use ibuprofen risk parkinson disease neurology vol 76 10 pp 863 869 2011 244 h chen et al nonsteroidal anti inflammatory drugs risk parkinson disease archives neurology vol 60 8 pp 1059 1064 2003 245 b rangasamy dasarathi p pahan jana k pahan low dose aspirin upregulates tyrosine hydroxylase increases dopamine production dopaminergic neurons implications parkinson ’ disease journal neuroimmune pharmacology vol 14 pp 173 187 2019 246 fyfe aspirin ibuprofen could lower risk lrrk2 parkinson disease nature reviews neurology vol 16 9 pp 460 460 2020 247 kang et al cav13 selective l type calcium channel antagonists potential new therapeutics parkinsons disease eng nat commun vol 3 p 1146 2012 doi 101038ncomms2149 248 j benkert et al cav23 channels contribute dopaminergic neuron loss model parkinsons disease eng nat commun vol 10 1 p 5094 nov 8 2019 doi 101038s41467 01912834 x 249 j lin et al calcium channel blockers parkinsons disease systematic review meta analysis eng ther adv neurol disord vol 17 p 17562864241252713 2024 doi 10117717562864241252713 250 k c simon x gao h chen schwarzschild ascherio calcium channel blocker use risk parkinsons disease eng mov disord vol 25 12 pp 1818 22 sep 15 2010 doi 101002mds23191 67 251 c b carroll r k h wyse simvastatin potential disease modifying therapy patients parkinsons disease rationale clinical trial current progress eng j parkinsons dis vol 7 4 pp 545 568 2017 doi 103233jpd 171203 252 j yan et al effect statins parkinsons disease systematic review meta analysis eng medicine baltimore vol 98 12 p e14852 mar 2019 doi 101097md0000000000014852 253 j e simmering j welsh l liu n narayanan pottegård association glycolysis enhancing α 1 blockers risk developing parkinson disease eng jama neurol vol 78 4 pp 407 413 apr 1 2021 doi 101001jamaneurol20205157 254 j firestone et al occupational factors risk parkinsons disease population based case control study eng j ind med vol 53 3 pp 217 23 mar 2010 doi 101002ajim20788 255 c haaxma g f borm van der linden c kappelle b r bloem artistic occupations associated reduced risk parkinsons disease eng j neurol vol 262 9 pp 2171 6 sep 2015 doi 101007s00415 0157828 256 k tanaka et al occupational risk factors parkinsons disease case control study japan eng bmc neurol vol 11 p 83 jul 7 2011 doi 1011861471 2377 11 83 257 p petit f berger v bonneterre n vuillerme investigating parkinsons disease risk across farming activities using data mining large scale administrative health data eng npj parkinsons dis vol 11 1 p 13 jan 8 2025 doi 101038s41531 02400864 2 258 v pitz et al analysis rare parkinsons disease variants millions people eng npj parkinsons dis vol 10 1 p 11 jan 8 2024 doi 101038s41531 023 00608 8 259 j jankovic e k tan parkinsons disease etiopathogenesis treatment eng j neurol neurosurg psychiatry vol 91 8 pp 795 808 aug 2020 doi 101136jnnp 2019 322338 260 ben shlomo darweesh j llibre guerra c marras san luciano c tanner epidemiology parkinsons disease eng lancet vol 403 10423 pp 283 292 jan 20 2024 doi 101016s0140 67362301419 8 261 belvisi et al risk factors parkinson disease simultaneous assessment interactions etiologic subtypes eng neurology vol 95 18 pp e2500 e2508 nov 3 2020 doi 101212wnl0000000000010813 262 b k beaulieu jones et al disease progression strikingly differs research real world parkinsons populations eng npj parkinsons dis vol 10 1 p 58 mar 13 2024 doi 101038s41531 02400667 5",
    "relevance_score": 0.8094,
    "date_score": 0.0,
    "final_score": 0.4047,
    "date_numeric": 0
  }
]